Citrus Sinensis ID: 026939

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230
Protein Sequence
MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccHHHEEEEHHccccccccccccccccHHHHHHHHcccccccccccHHHHccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEEcccccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
cccccccHHHHHHHHHHHHHHHHHHHHHcHccEEcccccHHHEEEcccccEEEccccHHHHcccccccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccEEEEcHHHcccccHHHHHHHHHHHHHEEcccHcccccHHHEEEEEcccccccccccccEEEEEccccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVlldhemnpkisdfemarifggnqseastnrivgtygymapeyamEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCvqadsadrptmSSVVVMLAsdnvtlpqptepafsvgrnvarpsqfssgaevcsvnevtlsnvspr
Flexible Loop (DISEMBL)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFggnqseastnrIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRNVARPSqfssgaevcsvnevtlsnvspr
Low Complexity Region (SEG)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR
Disordered region (IsUnstruct)
*****LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA******SVVVMLA**********************************************
Disordered Region (DISOPRED)
*RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAF***********************VTLSNVSPR
Disordered Region (DISEMBL)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR
Disordered Region (DISPRO)
***VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRN*************CSVNEVTLSNVSP*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	230	2.2.26 [Sep-21-2011]
Q39086	843	Receptor-like serine/thre	yes	no	0.995	0.271	0.587	5e-76
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.982	0.337	0.558	1e-75
Q9S972	847	Receptor-like serine/thre	no	no	0.995	0.270	0.591	3e-75
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.995	0.339	0.547	3e-73
O65468	676	Cysteine-rich receptor-li	no	no	0.865	0.294	0.623	4e-73
Q8RX80	659	Cysteine-rich receptor-li	no	no	0.978	0.341	0.572	7e-73
O81906	849	G-type lectin S-receptor-	no	no	0.943	0.255	0.615	8e-73
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.960	0.259	0.596	2e-72
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.852	0.312	0.602	1e-71
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.982	0.342	0.545	1e-71

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  283 bits (725), Expect = 5e-76,   Method: Compositional matrix adjust.
 Identities = 138/235 (58%), Positives = 172/235 (73%), Gaps = 6/235 (2%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           RS  L+W++R  IINGIARGLLYLH+DSR RIIHRDLKASNVLLD  M PKISDF MARI
Sbjct: 609 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 668

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           FG  ++EA+T R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEIISGK+N GFY S  
Sbjct: 669 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 728

Query: 122 GQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGLLCVQADSADRPTMS 177
             +LL + W+ W EG  LE+++P+    L       E+L+ I IGLLCVQ  + DRP MS
Sbjct: 729 DLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMS 788

Query: 178 SVVVMLASDNVTLPQPTEPAFSVGRNV--ARPSQFSSGAEVCSVNEVTLSNVSPR 230
           SV+VML S+   +PQP  P F +GR+   A  S  +   + C+VN++TLS +  R
Sbjct: 789 SVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  282 bits (722), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 128/229 (55%), Positives = 175/229 (76%), Gaps = 3/229 (1%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLDW RR  II G+ARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DF MARIFG 
Sbjct: 441 QLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGL 500

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +Q+E +T+RIVGTYGYM+PEYAM G +S+KSDV+SFGVL+LEIISGKKNS FY ++    
Sbjct: 501 DQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHD 560

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 184
           L+SY W LW  G  LEL++P + ++C   E+++ +HIGLLCVQ D A+RPT+S++V+ML 
Sbjct: 561 LVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLT 620

Query: 185 SDNVTLPQPTEPAFSVGRNVAR---PSQFSSGAEVCSVNEVTLSNVSPR 230
           S+ VTLP P +P       + +    +  +S + + SV++ +++++ PR
Sbjct: 621 SNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  281 bits (719), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 139/235 (59%), Positives = 171/235 (72%), Gaps = 6/235 (2%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           RS  L+W++R  IINGIARGLLYLH+DSR RIIHRDLKASNVLLD  M PKISDF MARI
Sbjct: 613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           FG  ++EA+T R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEIISGK+N GFY S  
Sbjct: 673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732

Query: 122 GQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGLLCVQADSADRPTMS 177
             +LL + W+ W EG+ LE+++P+    L       E+L+ I IGLLCVQ  + DRP MS
Sbjct: 733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792

Query: 178 SVVVMLASDNVTLPQPTEPAFSVGR--NVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           SV+VML S+   +PQP  P F VGR       S  +   + C+VN+VTLS +  R
Sbjct: 793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  274 bits (701), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 128/234 (54%), Positives = 180/234 (76%), Gaps = 5/234 (2%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           + +QLDW +R +II GIARG+LYLH+DSRL IIHRDLKASN+LLD ++NPKI+DF MARI
Sbjct: 441 KQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARI 500

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           FG +Q++ +T+RIVGTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISG+KNS F  S+ 
Sbjct: 501 FGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDG 560

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q LL++ W+LW   +AL+L++P++ ++C  +E+++ IHIGLLCVQ D A RP +S+V +
Sbjct: 561 AQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVFM 620

Query: 182 MLASDNVTLPQPTEPAFSVG-RNVARP----SQFSSGAEVCSVNEVTLSNVSPR 230
           ML S+ VTLP P +P F +  R V  P       ++ +   S+++ +++++ PR
Sbjct: 621 MLTSNTVTLPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDESITDLYPR 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  274 bits (701), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 124/199 (62%), Positives = 162/199 (81%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           +  QLDW +R +II GIARG+LYLH+DSRL IIHRDLKASN+LLD ++NPKI+DF MARI
Sbjct: 443 KQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARI 502

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           FG +Q++ +T+RIVGTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISG+KNS F  S+ 
Sbjct: 503 FGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDG 562

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q LL++TW+LW    AL+L++P++  +C  +E+++ IHIGLLCVQ D A RPT+S+V +
Sbjct: 563 AQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFM 622

Query: 182 MLASDNVTLPQPTEPAFSV 200
           ML S+ VTLP P +P F +
Sbjct: 623 MLTSNTVTLPVPRQPGFFI 641

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RX80|CRK18_ARATH Cysteine-rich receptor-like protein kinase 18 OS=Arabidopsis thaliana GN=CRK18 PE=2 SV=2

 Score =  273 bits (698), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 131/229 (57%), Positives = 173/229 (75%), Gaps = 4/229 (1%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLDW  R +II GI RG+LYLH+DSRL+IIHRDLKASN+LLD +MNPKI+DF MARIFG 
Sbjct: 432 QLDWTMRRNIIGGITRGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGMARIFGV 491

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY-LSELGQ 123
           +Q+ A+T R+VGT+GYM+PEY   G FS+KSDV+SFGVL+LEIISGKKNS FY +  L  
Sbjct: 492 DQTVANTGRVVGTFGYMSPEYVTHGQFSMKSDVYSFGVLILEIISGKKNSSFYQMDGLVN 551

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           +L++Y WKLW      EL++P + Q   + E++++IHIGLLCVQ + ADRPTMS++  ML
Sbjct: 552 NLVTYVWKLWENKSLHELLDPFINQDFTSEEVIRYIHIGLLCVQENPADRPTMSTIHQML 611

Query: 184 ASDNVTLPQPTEPAFSVGRN--VARPSQFSSGAEVCSVNEVTLSNVSPR 230
            + ++TLP P  P F   RN   + P Q +S +  CSV+E T+++V+PR
Sbjct: 612 TNSSITLPVPLPPGFFF-RNGPGSNPGQSNSKSFACSVDEATITDVNPR 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  273 bits (698), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 136/221 (61%), Positives = 166/221 (75%), Gaps = 4/221 (1%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           +DWK R SII GIARGLLYLH DSRLRIIHRDLK SNVLLD EMNPKISDF MARIFGGN
Sbjct: 623 IDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGN 682

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
           Q+EA+T R+VGTYGYM+PEYAMEGLFSVKSDV+SFGVLLLEI+SGK+N+    SE G SL
Sbjct: 683 QNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SL 741

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
           + Y W L+  G + EL++P ++ +C   E L+ IH+ +LCVQ  +A+RP M+SV++ML S
Sbjct: 742 IGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLES 801

Query: 186 DNVTLPQPTEPAFSVGRNVARPSQF---SSGAEVCSVNEVT 223
           D  TL  P +P F+  R  +    F   SS   + S NE+T
Sbjct: 802 DTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEIT 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  271 bits (694), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 133/223 (59%), Positives = 171/223 (76%), Gaps = 2/223 (0%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +LDWK R +II GIARGLLYLH+DSRLRIIHRDLK SN+LLD EMNPKISDF +ARIFGG
Sbjct: 625 RLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGG 684

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +++ A+TNR+VGTYGYM+PEYA+EGLFS KSDVFSFGV+++E ISGK+N+GF+  E   S
Sbjct: 685 SETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLS 744

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML- 183
           LL + W LW     +EL++  L++SC     LK +++GLLCVQ D  DRPTMS+VV ML 
Sbjct: 745 LLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLG 804

Query: 184 ASDNVTLPQPTEPAFSVGR-NVARPSQFSSGAEVCSVNEVTLS 225
           +S+  TLP P +PAF + R   +  +  S+  E CS NE+T++
Sbjct: 805 SSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTIT 847

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  269 bits (688), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 118/196 (60%), Positives = 159/196 (81%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLDW RR  +I GIARG+LYLH+DSRL IIHRDLKASN+LLD +MNPK++DF +ARIFG 
Sbjct: 430 QLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGM 489

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +Q++ +T+RIVGT+GYMAPEYA+ G FSVKSDV+SFGVL+LEIISGKKN+ FY ++    
Sbjct: 490 DQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHD 549

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 184
           L+++ W+LW  G AL+L++P++  +C  +E+++ IHI LLCVQ D A+RP +S++ +ML 
Sbjct: 550 LVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLT 609

Query: 185 SDNVTLPQPTEPAFSV 200
           S+ VTLP P +P F V
Sbjct: 610 SNTVTLPVPLQPGFPV 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  269 bits (687), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 126/231 (54%), Positives = 171/231 (74%), Gaps = 5/231 (2%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QL W +R  II GIARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DF MARIFG 
Sbjct: 429 QLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGM 488

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +Q++ +T+RIVGTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG+KN+ F  ++  Q 
Sbjct: 489 DQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQD 548

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 184
           L+++ W+LW  G AL+L++P +  SC  +E+++  HIGLLCVQ D   RP MS++ VML 
Sbjct: 549 LVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLT 608

Query: 185 SDNVTLPQPTEPAFSV----GRNVARPSQFSSGAEVC-SVNEVTLSNVSPR 230
           S+ + LP P +P F V    G N     Q ++   V  S+++ ++S++ PR
Sbjct: 609 SNTMALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	230
224076400	666	predicted protein [Populus trichocarpa]	0.982	0.339	0.784	8e-98
224113927	381	predicted protein [Populus trichocarpa]	0.982	0.593	0.766	5e-97
255555021	686	ATP binding protein, putative [Ricinus c	0.982	0.329	0.735	6e-94
356554939	662	PREDICTED: cysteine-rich receptor-like p	0.995	0.345	0.698	1e-93
356546303	662	PREDICTED: cysteine-rich receptor-like p	0.982	0.341	0.694	5e-93
356554943	670	PREDICTED: cysteine-rich receptor-like p	0.982	0.337	0.694	1e-91
356510387	647	PREDICTED: cysteine-rich receptor-like p	0.982	0.349	0.716	2e-90
358346817	626	Cysteine-rich receptor-like protein kina	0.978	0.359	0.693	2e-89
358346648	573	Cysteine-rich receptor-like protein kina	0.978	0.392	0.693	3e-89
357515489	670	S-locus lectin protein kinase family pro	0.982	0.337	0.700	5e-88

>gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa]

 Score =  362 bits (928), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 178/227 (78%), Positives = 199/227 (87%), Gaps = 1/227 (0%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           VQLDW+RR+SIINGIARGLLYLHEDSRLRIIHRDLKASN+LLD+EMNPKISDF MARIFG
Sbjct: 441 VQLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFG 500

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
           GN SEA+TNRIVGTYGYMAPEYAMEGL SVKSDVFSFGVL+LEIISGK+N GF+LSE G+
Sbjct: 501 GNHSEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLSEEGK 560

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           SLL++TWKLW EG+ LELM+ +L++S VA E+LK IHIGLLCVQ D  DRPTMSSVVVML
Sbjct: 561 SLLNFTWKLWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQEDPVDRPTMSSVVVML 620

Query: 184 ASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           A DN  +P PT+PAFSVGR VA  +  SS   V SVN+VTLSNV PR
Sbjct: 621 AGDNFKIPIPTKPAFSVGRIVAEETT-SSNQRVSSVNKVTLSNVLPR 666

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113927|ref|XP_002316616.1| predicted protein [Populus trichocarpa] gi|222859681|gb|EEE97228.1| predicted protein [Populus trichocarpa]

 Score =  359 bits (922), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 174/227 (76%), Positives = 200/227 (88%), Gaps = 1/227 (0%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           V LDW+RR+SIINGIARGLLYLHEDSRLRIIHRDLK SN+LLD+EMNPKISDF MARIFG
Sbjct: 156 VLLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKTSNILLDYEMNPKISDFGMARIFG 215

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
           GNQSEA+TNRIVGTYGYMAPEYAM GLFSVKSDVFSFGVLLLEIISG+KN GF+LSE G+
Sbjct: 216 GNQSEANTNRIVGTYGYMAPEYAMVGLFSVKSDVFSFGVLLLEIISGEKNVGFHLSEEGE 275

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           SLL++ WKLW +G+ LELM+P+L++S VA E+L+ IHIGLLCVQ D ADRPTMSSV+ ML
Sbjct: 276 SLLTFAWKLWSDGQGLELMDPMLEKSGVATEVLRCIHIGLLCVQEDPADRPTMSSVLHML 335

Query: 184 ASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           ASD +TLP P +PAFS+GR VA   Q SS  +VCS NE+T+S +SPR
Sbjct: 336 ASDTITLPIPKQPAFSIGRFVAMEGQ-SSNQKVCSSNELTISVLSPR 381

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis]

 Score =  349 bits (895), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 167/227 (73%), Positives = 200/227 (88%), Gaps = 1/227 (0%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           V+LDW+RR+SII+GIARGLLYLHEDSRLRIIHRDLKASN+LLD++MNPKISDF MARIFG
Sbjct: 461 VRLDWQRRLSIISGIARGLLYLHEDSRLRIIHRDLKASNILLDYDMNPKISDFGMARIFG 520

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
           GN S+ STNRIVGTYGYM+PEYAMEGLFS+KSD+FSFGVLLLEIISG++N+ FY+ E G+
Sbjct: 521 GNDSK-STNRIVGTYGYMSPEYAMEGLFSMKSDIFSFGVLLLEIISGRRNNRFYVEEEGE 579

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           SLL++ WKLW + + LEL++P +  S VA E+LK +HIGLLCVQ D A+RPTMSSVVVML
Sbjct: 580 SLLTFAWKLWNKDQGLELLDPAVVNSSVAIEVLKCVHIGLLCVQDDPAERPTMSSVVVML 639

Query: 184 ASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           ASD +TLPQP +PAFS+G+ VAR +  SS  +V SVN+VTLSNVSPR
Sbjct: 640 ASDTITLPQPRKPAFSIGQFVARSATSSSNPKVSSVNQVTLSNVSPR 686

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356554939|ref|XP_003545798.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  348 bits (892), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 160/229 (69%), Positives = 192/229 (83%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           +  QLDWK R+SIINGIARG+LYLHEDSRLR+IHRDLKASNVLLDH+MNPKISDF +AR 
Sbjct: 434 KKKQLDWKLRLSIINGIARGILYLHEDSRLRVIHRDLKASNVLLDHDMNPKISDFGLARA 493

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           F   Q +A+TNR++GTYGYMAPEYAMEGLFSVKSDVFSFGVL+LEII GKKNSGFYLSE 
Sbjct: 494 FSKGQKQANTNRVMGTYGYMAPEYAMEGLFSVKSDVFSFGVLVLEIICGKKNSGFYLSEC 553

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
           GQ LL Y WK+WC G+ LEL++PVL++SC+ +E++K IHIGLLCVQ D+ADRP MS+VVV
Sbjct: 554 GQGLLLYAWKIWCAGKFLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPNMSTVVV 613

Query: 182 MLASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           MLASD + LP+P  PAFSVGR     +  S  +   S+N++T+SN+ PR
Sbjct: 614 MLASDTMVLPKPNRPAFSVGRMALGDASTSKSSNKHSINDITISNILPR 662

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  346 bits (887), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 157/226 (69%), Positives = 195/226 (86%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLDW  R+SIINGIA+GLLYLHEDSRL++IHRDLKASN+LLD EMNPKISDF +AR F  
Sbjct: 437 QLDWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEK 496

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
            Q++A+TNR++GTYGYM+PEYAMEGLFSVKSDVFS+GVL+LEII GKKNSGFYLSE GQS
Sbjct: 497 GQNQANTNRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQS 556

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 184
           L  Y WK+WC G++LELM+PVL++SC+ +E++K IHIGLLCVQ D+ADRPTMS+VVVMLA
Sbjct: 557 LTLYAWKIWCAGKSLELMDPVLEKSCIESEVMKCIHIGLLCVQEDAADRPTMSTVVVMLA 616

Query: 185 SDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           SD ++LP+P +PAFSVGR     +  S  ++  S+N+VT++N+ PR
Sbjct: 617 SDKMSLPEPNQPAFSVGRMTLEGASTSKSSKNLSINDVTVTNILPR 662

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356554943|ref|XP_003545800.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  342 bits (876), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 157/226 (69%), Positives = 192/226 (84%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLDW  R+SIINGIA+GLLYLHEDSRL++IHRDLKASN+LLD EMNPKISDF +AR F  
Sbjct: 445 QLDWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEK 504

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
            Q++A+T R++GTYGYM+PEYAMEGLFSVKSDVFS+GVL+LEII GKKNSGFYLSE GQS
Sbjct: 505 GQNQANTKRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQS 564

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 184
           L  Y WKLWC G+ LEL++PVL++SC+ +E++K IHIGLLCVQ D+ADRPTMS+VVVMLA
Sbjct: 565 LTLYAWKLWCAGKCLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPTMSTVVVMLA 624

Query: 185 SDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           SD + LP+P +PAFSVGR     +  S  ++  S+N+VT+SN+ PR
Sbjct: 625 SDKMPLPKPNQPAFSVGRMTLEDASTSKSSKNLSINDVTVSNILPR 670

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  337 bits (865), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 162/226 (71%), Positives = 190/226 (84%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L+WK R++IINGIA+GLLYLHEDSRLR+IHRDLKASN+LLDHEMNPKISDF +AR FGG
Sbjct: 422 HLEWKNRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNILLDHEMNPKISDFGLARTFGG 481

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +Q +A+T R+VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK++S FYLS+ GQS
Sbjct: 482 DQKQANTIRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKRSSKFYLSDQGQS 541

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 184
           LL Y W LWCE + LELM+P++++SCV +E+LK +HIGLLCVQ D+ADRP MSSVV MLA
Sbjct: 542 LLIYAWNLWCERKGLELMDPIIEKSCVRSEVLKCMHIGLLCVQEDAADRPKMSSVVHMLA 601

Query: 185 SDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           SD V+L  PT PAFSVGR V      S+ +   SVNE T+S V PR
Sbjct: 602 SDTVSLSVPTRPAFSVGRAVTERECSSNTSMHYSVNEATVSEVIPR 647

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358346817|ref|XP_003637461.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503396|gb|AES84599.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  334 bits (857), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 156/225 (69%), Positives = 185/225 (82%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LDWK R++IINGIA+GLLYLHEDSRLR+IHRDLKASNVLLD EMNPKISDF +AR F  +
Sbjct: 402 LDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQEMNPKISDFGLARAFEKD 461

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
           Q + +T R+VGTYGYMAPEYAMEGL+SVKSDVFSFGVLLLEII G++N GFYL+E GQSL
Sbjct: 462 QCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEIICGRRNGGFYLAEHGQSL 521

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
           L Y+W LWCE ++LEL++P+LK +    E++K IHIGLLCVQ D+ DRPTMS+VVVMLAS
Sbjct: 522 LVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHIGLLCVQEDAVDRPTMSNVVVMLAS 581

Query: 186 DNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           D +TLP P  PAFSVGR V      S  +   SVNEVT++N+ PR
Sbjct: 582 DTMTLPNPNHPAFSVGRKVVEGESTSKASNDPSVNEVTVTNILPR 626

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358346648|ref|XP_003637378.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503313|gb|AES84516.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  333 bits (854), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 156/225 (69%), Positives = 185/225 (82%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LDWK R++IINGIA+GLLYLHEDSRLR+IHRDLKASNVLLD EMNPKISDF +AR F  +
Sbjct: 349 LDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQEMNPKISDFGLARAFEKD 408

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
           Q + +T R+VGTYGYMAPEYAMEGL+SVKSDVFSFGVLLLEII G++N GFYL+E GQSL
Sbjct: 409 QCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEIICGRRNGGFYLAEHGQSL 468

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
           L Y+W LWCE ++LEL++P+LK +    E++K IHIGLLCVQ D+ DRPTMS+VVVMLAS
Sbjct: 469 LVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHIGLLCVQEDAVDRPTMSNVVVMLAS 528

Query: 186 DNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           D +TLP P  PAFSVGR V      S  +   SVNEVT++N+ PR
Sbjct: 529 DTMTLPNPNHPAFSVGRKVVEGESTSKASNDPSVNEVTVTNILPR 573

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357515489|ref|XP_003628033.1| S-locus lectin protein kinase family protein [Medicago truncatula] gi|355522055|gb|AET02509.1| S-locus lectin protein kinase family protein [Medicago truncatula]

 Score =  329 bits (844), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 159/227 (70%), Positives = 193/227 (85%), Gaps = 1/227 (0%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +L+WK  +SIINGIA+GLLYLHEDSRLR+IHRDLKASNVLLDHEMNPKISDF +AR F  
Sbjct: 429 ELNWKLSLSIINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDHEMNPKISDFGLARAFDI 488

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
            Q++A+T RI+GTYGYMAPEYAMEG+FSVK+DVFSFGVL+LEIISGKKN+GFYLSE GQS
Sbjct: 489 GQNQANTRRIMGTYGYMAPEYAMEGVFSVKTDVFSFGVLVLEIISGKKNTGFYLSEHGQS 548

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCV-AAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           LL YTWK WCEG  LE+M+ VL +SC+   E+++ I+IGLLCVQ D+ADRPTMS+VVVML
Sbjct: 549 LLLYTWKKWCEGTCLEIMDSVLGKSCIDDNEVVRCINIGLLCVQEDAADRPTMSTVVVML 608

Query: 184 ASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
           ASD +TLP+P +PAFS+GR  +  S  S   +  S+N+VT+SN+ PR
Sbjct: 609 ASDTMTLPKPKQPAFSIGRMTSTDSSSSKSFKDPSINDVTVSNILPR 655

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	230
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.995	0.270	0.595	3.8e-69
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.995	0.271	0.587	6.3e-69
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.978	0.276	0.591	9.2e-68
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.982	0.337	0.563	1.9e-67
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.973	0.263	0.605	1.1e-66
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.978	0.271	0.551	2.5e-65
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.995	0.338	0.551	3.2e-65
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.995	0.269	0.557	4.1e-65
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.986	0.351	0.552	9.7e-64
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.982	0.337	0.543	1.6e-63

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 701 (251.8 bits), Expect = 3.8e-69, P = 3.8e-69
 Identities = 140/235 (59%), Positives = 172/235 (73%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             RS  L+W++R  IINGIARGLLYLH+DSR RIIHRDLKASNVLLD  M PKISDF MARI
Sbjct:   613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672

Query:    62 FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
             FG  ++EA+T R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEIISGK+N GFY S  
Sbjct:   673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732

Query:   122 GQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGLLCVQADSADRPTMS 177
               +LL + W+ W EG+ LE+++P+    L       E+L+ I IGLLCVQ  + DRP MS
Sbjct:   733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792

Query:   178 SVVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGA--EVCSVNEVTLSNVSPR 230
             SV+VML S+   +PQP  P F VGR+       SS    + C+VN+VTLS +  R
Sbjct:   793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 699 (251.1 bits), Expect = 6.3e-69, P = 6.3e-69
 Identities = 138/235 (58%), Positives = 171/235 (72%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             RS  L+W++R  IINGIARGLLYLH+DSR RIIHRDLKASNVLLD  M PKISDF MARI
Sbjct:   609 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 668

Query:    62 FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
             FG  ++EA+T R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEIISGK+N GFY S  
Sbjct:   669 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 728

Query:   122 GQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGLLCVQADSADRPTMS 177
               +LL + W+ W EG  LE+++P+    L       E+L+ I IGLLCVQ  + DRP MS
Sbjct:   729 DLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMS 788

Query:   178 SVVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGA--EVCSVNEVTLSNVSPR 230
             SV+VML S+   +PQP  P F +GR+       SS    + C+VN++TLS +  R
Sbjct:   789 SVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
 Identities = 136/230 (59%), Positives = 177/230 (76%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             RS +LDWK+R++IING+ARG+LYLH+DSRLRIIHRDLKA NVLLD++MNPKISDF +A+ 
Sbjct:   590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649

Query:    62 FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
             FGG+QSE+STNR+VGTYGYM PEYA++G FSVKSDVFSFGVL+LEII+GK N GF  ++ 
Sbjct:   650 FGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADH 709

Query:   122 GQSLLSYTWKLWCEGEALELMEPV-LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
               +LL + WK+W E   +E+ E   L+++ V  E+L+ IH+ LLCVQ    DRPTM+SVV
Sbjct:   710 DLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVV 769

Query:   181 VMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
             +M  SD+ +LP PT+P F   RNV  P   SS   + S NEV+++ +  R
Sbjct:   770 LMFGSDS-SLPHPTQPGFFTNRNV--PD-ISSSLSLRSQNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 129/229 (56%), Positives = 176/229 (76%)

Query:     5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
             QLDW RR  II G+ARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DF MARIFG 
Sbjct:   441 QLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGL 500

Query:    65 NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
             +Q+E +T+RIVGTYGYM+PEYAM G +S+KSDV+SFGVL+LEIISGKKNS FY ++    
Sbjct:   501 DQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHD 560

Query:   125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 184
             L+SY W LW  G  LEL++P + ++C   E+++ +HIGLLCVQ D A+RPT+S++V+ML 
Sbjct:   561 LVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLT 620

Query:   185 SDNVTLPQPTEPAFSVGRNVAR-P--SQFSSGAEVCSVNEVTLSNVSPR 230
             S+ VTLP P +P       + + P  +  +S + + SV++ +++++ PR
Sbjct:   621 SNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 678 (243.7 bits), Expect = 1.1e-66, P = 1.1e-66
 Identities = 138/228 (60%), Positives = 169/228 (74%)

Query:     6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
             +DWK R SII GIARGLLYLH DSRLRIIHRDLK SNVLLD EMNPKISDF MARIFGGN
Sbjct:   623 IDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGN 682

Query:    66 QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
             Q+EA+T R+VGTYGYM+PEYAMEGLFSVKSDV+SFGVLLLEI+SGK+N+    SE G SL
Sbjct:   683 QNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SL 741

Query:   126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
             + Y W L+  G + EL++P ++ +C   E L+ IH+ +LCVQ  +A+RP M+SV++ML S
Sbjct:   742 IGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLES 801

Query:   186 DNVTLPQPTEPAFSVGRNVARPSQF---SSGAEVCSVNEVTLSNVSPR 230
             D  TL  P +P F+  R  +    F   SS   + S NE+T + V  R
Sbjct:   802 DTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
 Identities = 124/225 (55%), Positives = 164/225 (72%)

Query:     6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
             LDWK R +II+GI RGL+YLH DSRL+IIHRDLKASN+LLD  +NPKISDF +ARIF GN
Sbjct:   606 LDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGN 665

Query:    66 QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
             + E ST R+VGTYGYMAPEYAM GLFS KSDVFS GV+LLEI+SG++NS FY      +L
Sbjct:   666 EDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNL 725

Query:   126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
              +Y WKLW  GE + L++PV+ + C   E+ + +H+GLLCVQ  + DRP++++V+ ML+S
Sbjct:   726 SAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSS 785

Query:   186 DNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
             +N  LP+P +PAF   R  +            S+N V+L+ ++ R
Sbjct:   786 ENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 664 (238.8 bits), Expect = 3.2e-65, P = 3.2e-65
 Identities = 129/234 (55%), Positives = 176/234 (75%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             +  QLDW +R +II GIARG+LYLH+DSRL IIHRDLKASN+LLD ++NPKI+DF MARI
Sbjct:   443 KQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARI 502

Query:    62 FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
             FG +Q++ +T+RIVGTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISG+KNS F  S+ 
Sbjct:   503 FGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDG 562

Query:   122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
              Q LL++TW+LW    AL+L++P++  +C  +E+++ IHIGLLCVQ D A RPT+S+V +
Sbjct:   563 AQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFM 622

Query:   182 MLASDNVTLPQPTEPAFSVGRN-VARPSQFSSGAEV----CSVNEVTLSNVSPR 230
             ML S+ VTLP P +P F +  + V  P+             S+++  ++++ PR
Sbjct:   623 MLTSNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 663 (238.4 bits), Expect = 4.1e-65, P = 4.1e-65
 Identities = 131/235 (55%), Positives = 174/235 (74%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             R+ +L+W+ R  IINGIARGLLYLH+DSR RIIHRDLKASN+LLD  M PKISDF MARI
Sbjct:   616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI 675

Query:    62 FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
             FG +++EA+T ++VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEIIS K+N GFY S+ 
Sbjct:   676 FGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDR 735

Query:   122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAA---ELLKFIHIGLLCVQADSADRPTMSS 178
               +LL   W+ W EG+ LE+++P++  S       E+L+ I IGLLCVQ  + DRPTMS 
Sbjct:   736 DLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSL 795

Query:   179 VVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGA---EVCSVNEVTLSNVSPR 230
             V++ML S++ T+PQP  P + + R++      SS     E  +VN++T+S +  R
Sbjct:   796 VILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 650 (233.9 bits), Expect = 9.7e-64, P = 9.7e-64
 Identities = 126/228 (55%), Positives = 163/228 (71%)

Query:     4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
             ++LDW RR  II GIARG+LYLH+DSRL IIHRDLKA N+LLD +MNPKI+DF MARIFG
Sbjct:   418 MKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFG 477

Query:    64 GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY-LSELG 122
              +Q+EA T R+VGTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG KNS  Y + E  
Sbjct:   478 MDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESV 537

Query:   123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
              +L++YTW+LW  G   EL++P    +   +E+ + IHI LLCVQ D+ DRPTMSS+V M
Sbjct:   538 GNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQM 597

Query:   183 LASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEVCSVNEVTLSNVSPR 230
             L +  + L +P  P F       +       +  CSV+E +++ V+PR
Sbjct:   598 LTTSLIALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 648 (233.2 bits), Expect = 1.6e-63, P = 1.6e-63
 Identities = 126/232 (54%), Positives = 173/232 (74%)

Query:     5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
             +LDW RR +II GIARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DF MARIFG 
Sbjct:   438 ELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGV 497

Query:    65 NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY-LSELGQ 123
             +QS+A+T RI GT+GYM+PEYAM G FS+KSDV+SFGVL+LEIISGKKNS FY + + G 
Sbjct:   498 DQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGS 557

Query:   124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
             +L+++ W+LW  G  LEL++P + +S  ++E  + IHI LLCVQ D ADRP + ++++ML
Sbjct:   558 NLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMML 617

Query:   184 ASDNVTLPQPTEPAFSV-GRNVARP----SQFSSGAEVCSVNEVTLSNVSPR 230
              S   TL  P  P F + GR++ +     ++ +S +   S+N+ +++   PR
Sbjct:   618 TSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.IV.1878.1 hypothetical protein (648 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	230
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-30
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-28
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-25
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-24
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-16
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-14
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-09
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	1e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  110 bits (276), Expect = 8e-30
 Identities = 43/108 (39%), Positives = 61/108 (56%), Gaps = 7/108 (6%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMAR 60
              +L     + I+  I  GL YLH      IIHRDLK  N+LLD      K++DF +++
Sbjct: 85  NEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSK 141

Query: 61  IFGGNQSEASTNRIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEI 107
           +   ++S   T  IVGT  YMAPE    +G +S KSD++S GV+L E+
Sbjct: 142 LLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  111 bits (279), Expect = 9e-30
 Identities = 59/181 (32%), Positives = 76/181 (41%), Gaps = 16/181 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            R   L       I   I RGL YLH      IIHRDLK  N+LLD     KI+DF +A+
Sbjct: 90  SRGGPLSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAK 146

Query: 61  IFGGNQSEASTNRIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
               + S  +T   VGT  YMAPE       +  K DV+S GV+L E+++GK    F   
Sbjct: 147 KLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK--PPFSGE 202

Query: 120 ELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
            +   L      L        L     K S  + E    I    L    D + RPT   +
Sbjct: 203 NILDQLQLIRRILGP-----PLEFDEPKWSSGSEEAKDLIK-KCLNK--DPSKRPTAEEI 254

Query: 180 V 180
           +
Sbjct: 255 L 255

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 3e-29
 Identities = 60/182 (32%), Positives = 86/182 (47%), Gaps = 24/182 (13%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGG 64
           L  K  +S    IA+G+ YL      + +HRDL A N L+  ++  KISDF ++R ++  
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK-NSGFYLSELG 122
           +     T   +    +MAPE   +G+F+ KSDV+SFGVLL EI + G     G    E+ 
Sbjct: 159 DYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL 217

Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
           + L         +G  L   E          EL + +   L C Q D  DRPT S +V  
Sbjct: 218 EYLR--------KGYRLPKPE------YCPDELYELM---LSCWQLDPEDRPTFSELVER 260

Query: 183 LA 184
           L 
Sbjct: 261 LE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  106 bits (268), Expect = 4e-28
 Identities = 60/183 (32%), Positives = 82/183 (44%), Gaps = 27/183 (14%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +L     +S    IARG+ YL        IHRDL A N L+   +  KISDF ++R    
Sbjct: 98  KLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR---- 150

Query: 65  NQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSE 120
           +  +    R  G      +MAPE   EG F+ KSDV+SFGVLL EI + G++    Y   
Sbjct: 151 DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGM 207

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
             + +L Y       G  L         +C      +   + L C   D  DRPT S +V
Sbjct: 208 SNEEVLEYLKN----GYRLPQPP-----NCPP----ELYDLMLQCWAEDPEDRPTFSELV 254

Query: 181 VML 183
            +L
Sbjct: 255 EIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  106 bits (266), Expect = 7e-28
 Identities = 64/186 (34%), Positives = 86/186 (46%), Gaps = 27/186 (14%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           R  +L     +S    IARG+ YL        IHRDL A N L+   +  KISDF ++R 
Sbjct: 96  RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR- 151

Query: 62  FGGNQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFY 117
              +  +    ++ G      +MAPE   EG F+ KSDV+SFGVLL EI + G++    Y
Sbjct: 152 ---DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEE---PY 205

Query: 118 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMS 177
                  +L Y  K    G  L         +C   EL K +   L C   D  DRPT S
Sbjct: 206 PGMSNAEVLEYLKK----GYRLPKPP-----NCP-PELYKLM---LQCWAEDPEDRPTFS 252

Query: 178 SVVVML 183
            +V +L
Sbjct: 253 ELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  105 bits (264), Expect = 1e-27
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 19/158 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      I+HRDLK  N+LLD + + K++DF +AR     +        VGT
Sbjct: 106 ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             YMAPE  +   +    D++S GV+L E+++GK    F     G   L   +K   + +
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK--PPFP----GDDQLLELFKKIGKPK 213

Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
                 P    S  A +L++     LL    D   R T
Sbjct: 214 -PPFPPPEWDISPEAKDLIR----KLLVK--DPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 4e-25
 Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 24/162 (14%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I +GL YLH  ++  IIHRD+K SN+L++ +   KI+DF ++++      + +T   VGT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGT 163

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ----SLLSYTWKLW 133
             YM+PE      +S  +D++S G+ LLE   GK    F     GQ     L+       
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGK----FPFLPPGQPSFFELMQAI---- 215

Query: 134 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
           C+G    L          + E   FI     C+Q D   RP+
Sbjct: 216 CDGPPPSLPA-----EEFSPEFRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 97.2 bits (243), Expect = 2e-24
 Identities = 61/183 (33%), Positives = 85/183 (46%), Gaps = 28/183 (15%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGG 64
           L  K  + +   IA+G+ YL        +HRDL A N L+   +  KISDF ++R I+  
Sbjct: 99  LTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +         +    +MAPE   +G F+ KSDV+SFGVLL EI +           LG+ 
Sbjct: 156 DYYRKRGGGKL-PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT-----------LGEQ 203

Query: 125 LLSYTWKLWCEGEALELME--PVLKQ--SCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
              Y        E LEL+E    L +  +C   EL + +   L C   D  DRPT S +V
Sbjct: 204 --PYPGMSNE--EVLELLEDGYRLPRPENC-PDELYELM---LQCWAYDPEDRPTFSELV 255

Query: 181 VML 183
             L
Sbjct: 256 EDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 94.2 bits (235), Expect = 3e-23
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 17/158 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL YLH      I+HRD+K +N+L+D +   K++DF  A+  G  ++   T  + GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE      +   +D++S G  ++E+ +GK       SELG + ++  +K+   GE
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP----WSELG-NPMAALYKIGSSGE 221

Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
             E+  P      ++ E   F+     C++ D   RPT
Sbjct: 222 PPEI--P----EHLSEEAKDFL---RKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 5e-21
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 34/171 (19%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I   + +GL YLHE    +IIHRD+K SN+L++     K+ DF ++       S A T  
Sbjct: 105 IAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF- 159

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLW 133
            VGT  YMAPE      +SVKSD++S G+ L+E+ +G+                + +   
Sbjct: 160 -VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR----------------FPYPPE 202

Query: 134 CEGEA--LELME-------PVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
            +      EL++       P L     + +   F++   LC+  D  +RP+
Sbjct: 203 NDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN---LCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 87.6 bits (218), Expect = 6e-21
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 6/98 (6%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +   + +GL YLH      IIHRD+KA+N+LL  +   K+ DF ++          + N 
Sbjct: 103 VCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNT 156

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +VGT  +MAPE      +  K+D++S G+  +E+  GK
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 2e-20
 Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH    L II+RDLK  N+LLD + + K++DF +A+        + TN   GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGT 156

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE  +   +    D +S GVLL E+++GK
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 82.5 bits (205), Expect = 4e-19
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   L YLH     +I+HRD+K  N+ L      K+ DF ++++       A T  +VGT
Sbjct: 112 LCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             Y++PE      ++ KSD++S G +L E+ + K 
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 2e-18
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 34/176 (19%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           IA G+ YL      + +HRDL A N ++  ++  KI DF M R I+  +        ++ 
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-------GKKNSGFYLSELGQSLLSYT 129
              +MAPE   +G+F+ KSDV+SFGV+L E+ +       G  N         + +L + 
Sbjct: 185 VR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---------EEVLKFV 234

Query: 130 WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
                +G  L+L E          +LL+ +    +C Q +   RPT   +V  L  
Sbjct: 235 ----IDGGHLDLPE------NCPDKLLELM---RMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.9 bits (200), Expect = 2e-18
 Identities = 38/92 (41%), Positives = 56/92 (60%), Gaps = 5/92 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ YL E      IHRDL A N+L+  ++  K++DF +AR+   +   +S  +I   
Sbjct: 113 VAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--P 167

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           Y + APE A  G FS KSDV+SFG+LL E+ +
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.0 bits (198), Expect = 4e-18
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 5/98 (5%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I+    +GL YLH     + IHRD+KA N+LL+ E   K++DF ++       ++ +T  
Sbjct: 104 ILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           ++GT  +MAPE   E  ++ K+D++S G+  +E+  GK
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.9 bits (197), Expect = 7e-18
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL +LH   + RI++RDLK  NVLLD   N +ISD  +A    G +         GT
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGT 157

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GYMAPE     ++    D F+ G  L E+I+G+
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 10/95 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ YL        IHRDL A N+L+   +  KI+DF +AR+   ++  A      G 
Sbjct: 112 IAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GA 164

Query: 78  ---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                + APE A  G F++KSDV+SFG+LL EI++
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.0 bits (195), Expect = 1e-17
 Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I   + +GL YLH     +IIHRD+K SN+LL  +   K+ DF ++       S A T  
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT-- 162

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             GT  YMAPE      +S+ SDV+S G+ LLE+   +
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.5 bits (194), Expect = 1e-17
 Identities = 37/95 (38%), Positives = 48/95 (50%), Gaps = 6/95 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRD+K  N+LLD + +  I+DF +A     +     T    GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
            GYMAPE      +SV  D +S GV   E + GK+
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.8 bits (195), Expect = 2e-17
 Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 21/112 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI--- 74
           I   L YLH      IIHRDLK  N+LLD +M+ KI+DF  A++   N S  S       
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 75  ---------------VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                          VGT  Y++PE   E      SD+++ G ++ ++++GK
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.8 bits (192), Expect = 3e-17
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 13/181 (7%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q++ KR +   + I +G+ YL      R IHRDL A N+L++ E   KISDF +A++   
Sbjct: 105 QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161

Query: 65  NQSEASTNRIVGTYG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSEL 121
           +  +    +  G     + APE      FS  SDV+SFGV L E+ + G  +     S  
Sbjct: 162 D-KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ----SPP 216

Query: 122 GQSLLSYTWKLWCEG--EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
            + L               LEL++   +     +   +   +  LC +A+  DRP+ + +
Sbjct: 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276

Query: 180 V 180
           +
Sbjct: 277 I 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 22  LLYLHE-----DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVG 76
           LL L+E     D    ++HRDLK +N+ LD   N K+ DF +A+I G + S A T   VG
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVG 172

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  YM+PE      +  KSD++S G L+ E+ +  
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 78.2 bits (191), Expect = 7e-17
 Identities = 51/189 (26%), Positives = 76/189 (40%), Gaps = 17/189 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-PKISDFEMA 59
            R   L     + I+  I   L YLH      IIHRD+K  N+LLD +    K+ DF +A
Sbjct: 93  GRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLA 149

Query: 60  RIFGGNQSEAS----TNRIVGTYGYMAPEYAMEGLF---SVKSDVFSFGVLLLEIISGKK 112
           ++     S +S     +  VGT GYMAPE  +       S  SD++S G+ L E+++G  
Sbjct: 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Query: 113 -NSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 171
              G   S      L    +L         +   L  S           +    +  D  
Sbjct: 210 PFEGEKNSSATSQTLKIILEL-----PTPSLASPLSPSNPELISKAASDLLKKLLAKDPK 264

Query: 172 DRPTMSSVV 180
           +R + SS +
Sbjct: 265 NRLSSSSDL 273

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 9e-17
 Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 10/95 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ YL   +    IHRDL A NVL+      K++DF +AR+   +  EA      G 
Sbjct: 112 VASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GA 164

Query: 78  ---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                + APE A+   FS+KSDV+SFG+LL EI++
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.4 bits (188), Expect = 1e-16
 Identities = 40/104 (38%), Positives = 63/104 (60%), Gaps = 9/104 (8%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS 67
           W+  I I+ G+A    +LH     +I+HRD+K+ N+ LD   N KI D  +A++   N +
Sbjct: 104 WRFFIQILLGLA----HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156

Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            A+T  IVGT  Y++PE   +  ++ KSDV++ GV+L E  +GK
Sbjct: 157 FANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 2e-16
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 6/98 (6%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I   +  GL YL+     RI+HRD+K SN+L++     K+ DF ++    G    +  + 
Sbjct: 108 IAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADT 161

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            VGT  YM+PE    G ++VKSDV+S G+ ++E+  GK
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 76.3 bits (188), Expect = 2e-16
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I  GL +LHE     II+RDLK  NVLLD E + KI+DF M +  I GG     +T+   
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           GT  Y+APE      +    D ++ GVLL E+++G+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + +GL YLHE     +IHRD+KA+N+L   +   K++DF +A              +VGT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGT 162

Query: 78  YGYMAPE-YAMEGLFSVKSDVFSFGVLLLEIISGK 111
             +MAPE   M G  S  SD++S G  ++E+++G 
Sbjct: 163 PYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 4e-16
 Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 5/95 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  GL YLH +    I+HRD+K SN+L++++   K++DF +AR +    S   TNR++ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164

Query: 78  YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
             Y  PE  +    +  + D++S G +L E+  GK
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 74.6 bits (184), Expect = 6e-16
 Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + +GL YLH      +IHRD+K+ N+LL  + + K++DF  A      +S+ ++  +VGT
Sbjct: 125 VLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             +MAPE      +  K D++S G++ +E+  G
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 74.1 bits (182), Expect = 7e-16
 Identities = 36/92 (39%), Positives = 55/92 (59%), Gaps = 4/92 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ ++    R   IHRDL+A+N+L+   +  KI+DF +AR+   N+  A        
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-P 166

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE    G F++KSDV+SFG+LL EI++
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 37/98 (37%), Positives = 59/98 (60%), Gaps = 6/98 (6%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           II  +   L Y+H+     +IHRD+KA+N+L+ +  N K+ DF +A +   N S+ ST  
Sbjct: 106 IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-- 160

Query: 74  IVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISG 110
            VGT  +MAPE   EG  +  K+D++S G+ + E+ +G
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 5/98 (5%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I+  +  GL YLHE+     IHRD+KA+N+LL  E + K++DF ++       S+ +T  
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-- 157

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 2e-15
 Identities = 39/94 (41%), Positives = 52/94 (55%), Gaps = 12/94 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL E      +HRDL A NVL+  ++  K+SDF +A+       EAS  +  G 
Sbjct: 111 VCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGK 160

Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               + APE   E  FS KSDV+SFG+LL EI S
Sbjct: 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.4 bits (178), Expect = 4e-15
 Identities = 57/167 (34%), Positives = 82/167 (49%), Gaps = 26/167 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLL--DHEMNPKISDFEMARIFGGNQSEASTNRIV 75
           +ARG+ +L   S+ + IHRDL A NVL+  DH M  KI+DF +AR          T    
Sbjct: 141 VARGMEFL--ASK-KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNGR 195

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYTWKLW 133
               +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL        +KL 
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--------FKLL 247

Query: 134 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
            EG  +E  +P   Q+C      +  H+   C     + RPT   +V
Sbjct: 248 KEGYRME--KP---QNCT----QELYHLMRDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.5 bits (178), Expect = 5e-15
 Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           IA GL +LH      II+RDLK  NV+LD E + KI+DF M +  IFGG     +T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.2 bits (177), Expect = 7e-15
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 29/168 (17%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I++GIA    YLH   R  I+HRD+K SN+L++   N KI+DF ++RI    Q+    N 
Sbjct: 177 ILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNS 227

Query: 74  IVGTYGYMAPEYAMEGLFSVK-----SDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY 128
            VGT  YM+PE     L          D++S GV +LE   G+    F +   G      
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR--FPFGVGRQGD----- 280

Query: 129 TW-KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
            W  L C   A+ + +P    +  + E   FI     C+Q + A R +
Sbjct: 281 -WASLMC---AICMSQPPEAPATASREFRHFIS---CCLQREPAKRWS 321

Length = 353

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.3 bits (175), Expect = 8e-15
 Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 15/102 (14%)

Query: 17  GIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN--QSEASTNRI 74
            I + L YLH   +L +IHRD+K SNVL++     K+ DF ++    G    S A T   
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDA 164

Query: 75  VGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            G   YMAPE        +G + VKSDV+S G+ ++E+ +G+
Sbjct: 165 -GCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 1e-14
 Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 14/97 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL Y H  S  RI+HRDLK  N+L++ +   K++DF +AR F G      T+ +V T  
Sbjct: 109 RGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLW 163

Query: 80  YMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           Y APE     L   K      D++S G +  E+I+GK
Sbjct: 164 YRAPEI----LLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 51/178 (28%), Positives = 69/178 (38%), Gaps = 35/178 (19%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ YL        +HRDL A NVLL +    KISDF M+R  G   S+       G 
Sbjct: 104 VAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGR 159

Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-------GKKNSGFYLSELGQSLLSY 128
           +   + APE    G FS KSDV+S+GV L E  S         K +              
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------------- 205

Query: 129 TWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 186
                   E + ++E   +         +   I L C +    DRPT S +      D
Sbjct: 206 --------EVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 70.0 bits (171), Expect = 2e-14
 Identities = 35/92 (38%), Positives = 58/92 (63%), Gaps = 4/92 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ Y+    R+  IHRDL+++N+L+   +  KI+DF +AR+   N+  A        
Sbjct: 111 VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-P 166

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE A+ G F++KSDV+SFG+LL E+++
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 70.7 bits (173), Expect = 2e-14
 Identities = 40/95 (42%), Positives = 56/95 (58%), Gaps = 9/95 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I   L++LH+     II+RDLK  NVLLDHE + K++DF M +  IF G     +T+   
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFC 157

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           GT  Y+APE   E L+    D ++ GVLL E++ G
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.0 bits (171), Expect = 3e-14
 Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 6/109 (5%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
              L+ +R I     I  G+L+LH    + I++RD+K  NVLLD + N ++SD  +A   
Sbjct: 89  ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145

Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              ++     +  GT GYMAPE   E  +S   D F+ G  + E+++G+
Sbjct: 146 KDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 69.4 bits (170), Expect = 4e-14
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 18/166 (10%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
                +  GL YLH      I+HRDLKA N+L+D +   KISDF +++            
Sbjct: 112 FFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168

Query: 73  RIVGTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            + G+  +MAPE  ++    +S K D++S G ++LE+ +G++          +  ++  +
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DEEAIAAMF 222

Query: 131 KLWCEGEALELMEPVLKQ-SCVAAELLKFIHIGLLCVQADSADRPT 175
           KL  +  A  +   V    S VA + L        C   +  +RPT
Sbjct: 223 KLGNKRSAPPIPPDVSMNLSPVALDFLN------ACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 4e-14
 Identities = 46/136 (33%), Positives = 70/136 (51%), Gaps = 12/136 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I  GL +LH+     II+RDLK  NVLLD + + KI+DF M +  + G    E   +   
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYT--WKL 132
           GT  Y+APE      ++   D +SFGVLL E++ G+    G    EL  S+L+    +  
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR 217

Query: 133 WCEGEALELMEPVLKQ 148
           W   EA + +  + ++
Sbjct: 218 WISKEAKDCLSKLFER 233

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 68.9 bits (168), Expect = 5e-14
 Identities = 37/92 (40%), Positives = 58/92 (63%), Gaps = 4/92 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ Y+    R+  IHRDL+A+N+L+   +  KI+DF +AR+   N+  A        
Sbjct: 111 IADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-P 166

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE A+ G F++KSDV+SFG+LL E+++
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 68.5 bits (167), Expect = 6e-14
 Identities = 38/92 (41%), Positives = 55/92 (59%), Gaps = 4/92 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ Y+    R   IHRDL+A+NVL+   +  KI+DF +AR+   N+  A        
Sbjct: 112 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-P 167

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE    G F++KSDV+SFG+LL EI++
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.5 bits (168), Expect = 8e-14
 Identities = 57/169 (33%), Positives = 81/169 (47%), Gaps = 37/169 (21%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
             + L YL E+  L+IIHRD+K SN+LLD   N K+ DF    I G      +  R  G 
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGC 170

Query: 78  YGYMAPE----YAMEGLFSVKSDVFSFGVLLLEIISGKK-----NSGFYLSELGQSLLSY 128
             YMAPE     A +G + V+SDV+S G+ L E+ +GK      NS F   +L Q +   
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPKWNSVF--DQLTQVV--- 224

Query: 129 TWKLWCEGEALELMEPVLKQS---CVAAELLKFIHIGLLCVQADSADRP 174
                 +G+      P+L  S     +   + FI+   LC+  D + RP
Sbjct: 225 ------KGDP-----PILSNSEEREFSPSFVNFIN---LCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.2 bits (167), Expect = 9e-14
 Identities = 37/102 (36%), Positives = 63/102 (61%), Gaps = 8/102 (7%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEM-ARIF-GGNQSEAST 71
           ++  + +GL YLH + +   IHRD+KA N+LL  + + KI+DF + A +  GG+++    
Sbjct: 107 VLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163

Query: 72  NRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGK 111
              VGT  +MAPE  ME +  +  K+D++SFG+  +E+ +G 
Sbjct: 164 KTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 9e-14
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 8/98 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIV 75
           IA+G+ YL E    R++HRDL A NVL+    + KI+DF +A++   ++ E  A   ++ 
Sbjct: 118 IAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV- 173

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK 112
               +MA E  +  +++ KSDV+S+GV + E+++ G K
Sbjct: 174 -PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 68.3 bits (167), Expect = 1e-13
 Identities = 39/94 (41%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL +LH+    RII+RDLK  NVLLD++ N +ISD  +A      QS+  T    GT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            G+MAPE      +    D F+ GV L E+I+ +
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 46/117 (39%), Positives = 61/117 (52%), Gaps = 18/117 (15%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFE 57
           R   L  K  +     +A+G  YL E+     IHRD+ A N LL  +  P    KI+DF 
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFG 164

Query: 58  MAR-IFGGNQSEASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           MAR I+      AS  R  G       +M PE  ++G+F+ K+DV+SFGVLL EI S
Sbjct: 165 MARDIYR-----ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 37/99 (37%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFE------MARIFGGNQSEAST 71
           I   L YLH      IIHRDLK  N+L+D   + K++DF       + R    N  E   
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            RIVGT  Y+APE  +    S   D +S G +L E + G
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 8/101 (7%)

Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           +ISI   + RGL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 103 KISI--AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 154

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      ++V+SD++S G+ L+E+  G+
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.8 bits (165), Expect = 1e-13
 Identities = 35/92 (38%), Positives = 57/92 (61%), Gaps = 4/92 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A        
Sbjct: 111 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 166

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE A+ G F++KSDV+SFG+LL E+ +
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 67.6 bits (165), Expect = 2e-13
 Identities = 37/103 (35%), Positives = 64/103 (62%), Gaps = 7/103 (6%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           + +  I +GL YLH  +R  IIHRD+K +N+L+D++   KISDF +++    N     TN
Sbjct: 110 NFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Query: 73  R----IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                + G+  +MAPE   +  ++ K+D++S G L++E+++GK
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 20/163 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   L ++H     RI+HRD+K +NV +      K+ D  + R F    + A +  +VGT
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKL-WCEG 136
             YM+PE   E  ++ KSD++S G LL E+ + +  S FY  ++  +L S   K+  C+ 
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKM--NLYSLCKKIEKCD- 224

Query: 137 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
                  P L     + EL   +     C+  D   RP +S V
Sbjct: 225 ------YPPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 5/105 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGG 64
           LD    + I   IA G+ YL   S    +HRDL A N L+   +  KISDF ++R I+  
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +     +  ++    +M PE  + G F+ +SD++SFGV+L EI S
Sbjct: 178 DYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.4 bits (164), Expect = 2e-13
 Identities = 36/99 (36%), Positives = 59/99 (59%), Gaps = 5/99 (5%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           +I+  I +GL YLH +   R IHRD+KA+NVLL  + + K++DF +A       ++   N
Sbjct: 105 TILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRN 159

Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 3e-13
 Identities = 52/187 (27%), Positives = 92/187 (49%), Gaps = 34/187 (18%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +    + + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R    
Sbjct: 102 KFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Query: 65  NQSEASTN--RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSEL 121
           +++  +T   +I     + APE      F+  SDV+SFG+++ E++S G++    Y    
Sbjct: 159 SEATYTTKGGKI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP---YWDMS 213

Query: 122 GQSLLSYTWKLWCEGEALE----LMEPVLKQSCVAAELLKFIH-IGLLCVQADSADRPTM 176
            Q ++           A+E    L  P+    C +A     ++ + L C Q D  +RPT 
Sbjct: 214 NQDVIK----------AVEDGYRLPPPM---DCPSA-----LYQLMLDCWQKDRNERPTF 255

Query: 177 SSVVVML 183
           S +V  L
Sbjct: 256 SQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 35/92 (38%), Positives = 57/92 (61%), Gaps = 4/92 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DF +AR+   N+  A        
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-P 166

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE    G F++KSDV+SFG+LL+EI++
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 6/88 (6%)

Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH      II+RDLK  N+LLD     K+ DF  A+     Q    T    GT  Y+AP
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAP 161

Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           E  +   +    D +S G+LL E+++G+
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.4 bits (162), Expect = 4e-13
 Identities = 38/92 (41%), Positives = 58/92 (63%), Gaps = 4/92 (4%)

Query: 22  LLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           LL LH      I+HRDLK  N+LLD H+M  KI DF +++I   ++S+A T  +VGT  Y
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCY 167

Query: 81  MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
           ++PE      ++ KSD+++ G +L E+ S K+
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.9 bits (161), Expect = 5e-13
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 23/167 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   + Y+H+     I+HRD+K  N+ L      K+ DF +++I G   S A T  +VGT
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYTWKLWCEG 136
             YM+PE      ++ KSD+++ G +L E+++ K+         L   ++   +      
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY------ 218

Query: 137 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                  PV+     ++EL+  +H     +Q D   RPT   V+   
Sbjct: 219 ------TPVVSV--YSSELISLVH---SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.9 bits (160), Expect = 8e-13
 Identities = 37/106 (34%), Positives = 60/106 (56%), Gaps = 5/106 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DF +A      
Sbjct: 98  LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--T 152

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            ++   N  VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 8e-13
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 10/103 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I+    RGL YLHE+   ++IHRD+K  N+LL      K+ DF ++     + +    N 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT 172

Query: 74  IVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            +GT  +MAPE        +  +  +SDV+S G+  +E+  GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 8e-13
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 10/98 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   + YL  +     IHRDL A N L+  +   K+SDF +AR    +Q  +S     GT
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GT 161

Query: 78  ---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
                +  PE      FS KSDV+SFGVL+ E+ S  K
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.5 bits (159), Expect = 9e-13
 Identities = 37/111 (33%), Positives = 65/111 (58%), Gaps = 5/111 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R+   D  +  +++  I +GL YLH + +   IHRD+KA+NVLL  + + K++DF +A 
Sbjct: 93  LRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG 149

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                Q + +T   VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 150 QLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.8 bits (160), Expect = 9e-13
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+RG+ YL E   ++++HRDL A NVL+      KISDF ++R      S    ++    
Sbjct: 136 ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 62/185 (33%), Positives = 90/185 (48%), Gaps = 30/185 (16%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QL +K  +S    +ARG+ YL  +SR R IHRDL A NVL+  +   KI+DF +AR  G 
Sbjct: 130 QLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GV 184

Query: 65  NQ----SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI--ISGKKNSGFYL 118
           +      + S  R+     +MAPE   + +++ +SDV+SFG+L+ EI  + G    G  +
Sbjct: 185 HDIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242

Query: 119 SELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSS 178
            EL        +KL  EG  ++      K S    EL   +     C  A    RPT   
Sbjct: 243 EEL--------FKLLREGHRMD------KPSNCTHELYMLMR---ECWHAVPTQRPTFKQ 285

Query: 179 VVVML 183
           +V  L
Sbjct: 286 LVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.2 bits (159), Expect = 1e-12
 Identities = 38/108 (35%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +LD ++ +   + I +G+ YL      R +HRDL   N+L++ E   KI DF + ++   
Sbjct: 104 RLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160

Query: 65  NQSEASTNRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++ E    R  G    + Y APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 161 DK-EYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.5 bits (159), Expect = 2e-12
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 8/101 (7%)

Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + RGL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 107 KVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 158

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 45/130 (34%), Positives = 68/130 (52%), Gaps = 12/130 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I  GL +LH      I++RDLK  N+LLD + + KI+DF M +  + G    +A T    
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYT--WKL 132
           GT  Y+APE  +   ++   D +SFGVLL E++ G+    G    EL QS+      +  
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR 217

Query: 133 WCEGEALELM 142
           W   EA +++
Sbjct: 218 WLTREAKDIL 227

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 40/93 (43%), Positives = 56/93 (60%), Gaps = 9/93 (9%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIVGTY 78
           GL +LH      II+RDLK  NV+LD + + KI+DF M +  +FG N+  AST    GT 
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--AST--FCGTP 160

Query: 79  GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            Y+APE      ++   D +SFGVLL E++ G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.4 bits (157), Expect = 3e-12
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRDL A NVLL H    KI DF +AR    + +          
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE     +++ +SDV+S+G+LL EI S
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.6 bits (157), Expect = 3e-12
 Identities = 60/179 (33%), Positives = 89/179 (49%), Gaps = 24/179 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL +K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI--ISGKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI  + G    G  + EL
Sbjct: 193 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 252 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 35/92 (38%), Positives = 47/92 (51%), Gaps = 3/92 (3%)

Query: 19  ARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTY 78
           A G+ YL  +S+   IHRDL A N L+      KISDF M+R   G     S        
Sbjct: 103 AAGMEYL--ESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159

Query: 79  GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            + APE    G ++ +SDV+S+G+LL E  S 
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 17/109 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTN--RI 74
           IA G++YL   +    +HRDL   N L+ +++  KI DF M+R ++       +T+  R+
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-------TTDYYRV 180

Query: 75  VGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
            G       +M PE  M   F+ +SDV+SFGV+L EI +  K   + LS
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 63.6 bits (155), Expect = 3e-12
 Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 25/163 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RGL  LHE    +I+HRDLK++N+LL      KI D  ++++   N         +GT
Sbjct: 112 LLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGT 164

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYTWKLWCEG 136
             YMAPE      +S KSD++S G LL E+ +         + +L   +    +      
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY------ 218

Query: 137 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
                  P+      + +L  FI      +Q     RP    +
Sbjct: 219 ------PPI--PPIYSQDLQNFIR---SMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 3e-12
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 133 QMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI--ISGKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI  + G    G  + EL 
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 248

Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 249 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAIPSHRPTFKQLV 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 37/100 (37%), Positives = 57/100 (57%), Gaps = 19/100 (19%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IF-------GGNQSEA 69
           IA G+ YLH   +  +IH+D+ A N ++D E+  KI+D  ++R +F       G N+   
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE--- 179

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             NR V    +MA E  +   +S  SDV+SFGVLL E+++
Sbjct: 180 --NRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 8/100 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST--NRIV 75
           +  GL YLH      I+HRD+K +N+ LDH    K+ DF  A     N +        + 
Sbjct: 108 LLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 76  GTYGYMAPEYAMEGLFSVK---SDVFSFGVLLLEIISGKK 112
           GT  YMAPE    G        +D++S G ++LE+ +GK+
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.1 bits (156), Expect = 4e-12
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 29/187 (15%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            + LD +  +S    +A+G+ +L   +    IHRDL A N+LL H    KI DF +AR  
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 264

Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG 122
             + +            +MAPE     +++ +SDV+S+G+LL EI S           LG
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS-----------LG 313

Query: 123 QS------LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTM 176
            S      + S  +K+  EG    ++ P     C  +E+   +     C  AD   RPT 
Sbjct: 314 SSPYPGMPVDSKFYKMIKEG--YRMLSP----ECAPSEMYDIMKS---CWDADPLKRPTF 364

Query: 177 SSVVVML 183
             +V ++
Sbjct: 365 KQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 5e-12
 Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +ARG+ +L   SR + IHRDL A N+LL      KI DF +AR    +            
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++ +SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.5 bits (154), Expect = 5e-12
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 3/115 (2%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QL   + ++I + IA G++YL   + L  +HRDL   N L+   +  KI DF M+R    
Sbjct: 118 QLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
                   R +    +M PE  +   F+ +SD++SFGV+L EI +  K   + LS
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 5e-12
 Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 24/179 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL +K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR +  
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 187 IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 246 --------FKLLKEGHRMD------KPANCTHELYMIMR---ECWHAVPSQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.4 bits (155), Expect = 6e-12
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
            G+ +LH++    I+HRDLK SN+LL++    KI DF +AR +G      +  ++V T  
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT--QLVVTLW 171

Query: 80  YMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  +    +S   D++S G +  E+++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.5 bits (154), Expect = 6e-12
 Identities = 41/113 (36%), Positives = 62/113 (54%), Gaps = 8/113 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR-IVG 76
           I+ GL +LH      II+RDLK  NV+LD E + KI+DF M +    +  +  T R   G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSY 128
           T  Y+APE      +    D +++GVLL E+++G+    G    EL QS++ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.5 bits (154), Expect = 7e-12
 Identities = 43/114 (37%), Positives = 63/114 (55%), Gaps = 10/114 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           IA GL +LH      II+RDLK  NV+LD E + KI+DF M +  ++ G     +T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSY 128
           GT  Y+APE      +    D ++FGVLL E+++G+    G    EL QS++ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.9 bits (153), Expect = 7e-12
 Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 4/101 (3%)

Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K+++++   IA G+ +L   S  R +HRDL A N L+  +   K+S   +++    ++  
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              N ++    ++APE   E  FS KSDV+SFGVL+ E+ +
Sbjct: 174 KLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 55/172 (31%), Positives = 75/172 (43%), Gaps = 24/172 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS--EASTNRIV 75
           IA G+ YL      R IHRDL A N+LL  +   KI DF + R    N+       +  V
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE--LGQSLLSYTWKLW 133
             + + APE      FS  SDV+ FGV L E+ +       Y  E   G S      K+ 
Sbjct: 163 -PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKID 214

Query: 134 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
            EGE LE   P   ++C         ++ L C   + ADRPT +++   L  
Sbjct: 215 KEGERLE--RP---EACP----QDIYNVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.6 bits (152), Expect = 1e-11
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD  +A  F   +  AS    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           +GYMAPE   +G+ +   +D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 1e-11
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)

Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 107 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 158

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 62.2 bits (151), Expect = 1e-11
 Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 10/98 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLL-----DHEMNPKISDFEMAR-IFGGNQSEAST 71
           +A+G +YL    ++  IHRDL A N L+     D +   KI DF +AR I+  +      
Sbjct: 115 VAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             ++    +MAPE  ++G F+ +SDV+SFGVL+ EI++
Sbjct: 172 EGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.9 bits (150), Expect = 1e-11
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ YL      +++HRDL A N+L+  +   K+SDF +AR+          +++   
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--P 160

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS KSDV+S+GVLL E+ S
Sbjct: 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.2 bits (151), Expect = 1e-11
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 39/176 (22%)

Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           RI++   + +GL YL     L+I+HRD+K SN+L++     K+ DF ++       S A 
Sbjct: 99  RIAV--AVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAK 151

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-------KNSGFYLSELGQ 123
           T   VGT  YMAPE      + + SDV+S G+  +E+  G+       KN G  +     
Sbjct: 152 T--YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM----- 204

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSC----VAAELLKFIHIGLLCVQADSADRPT 175
                          L+L++ ++ +      V     KF+H    C++    +RP 
Sbjct: 205 --------------PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.4 bits (151), Expect = 1e-11
 Identities = 38/106 (35%), Positives = 62/106 (58%), Gaps = 5/106 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G++YL E    R++HRDL A NVL+    + KI+DF +AR+  G++ E + +     
Sbjct: 118 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
             +MA E      F+ +SDV+S+GV + E+++  GK   G    E+
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 2e-11
 Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 8/113 (7%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            R   L      S +  + +GL + H      I+HRDLK  N+L++ E   K++DF +AR
Sbjct: 90  DRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR 146

Query: 61  IFGGNQSEASTNRIVGTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            FG       T+ +V T  Y APE     +G +S   D++S G +  E++S +
Sbjct: 147 SFGS-PVRPYTHYVV-TRWYRAPELLLGDKG-YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 22/159 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL YLH+      +HRD+K +N+L+D     K++DF MA+      S A +    G+
Sbjct: 111 ILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKS--FKGS 164

Query: 78  YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG 136
             +MAPE    +G + + +D++S G  +LE+ +GK       S+L    ++  +K+    
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP----WSQLEG--VAAVFKIGRSK 218

Query: 137 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
           E   + +       ++ E   FI   L C+Q D + RPT
Sbjct: 219 ELPPIPDH------LSDEAKDFI---LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 18/158 (11%)

Query: 26  HEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY 85
           H  SR R++HRD+K +NV +      K+ D  + R F    + A +  +VGT  YM+PE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 86  AMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKL-WCEGEALELMEP 144
             E  ++ KSD++S G LL E+ + +  S FY  ++  +L S   K+  C+        P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKM--NLYSLCKKIEQCD-------YP 226

Query: 145 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
            L     + EL + ++   +C+  D   RP ++ V  +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 8/94 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD  +A  F   +  AS    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           +GYMAPE   +G  +   +D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 39/98 (39%), Positives = 54/98 (55%), Gaps = 12/98 (12%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           +I +G  +GL YLH   R   IHRD+KA N+LL      K++DF  A +       +  N
Sbjct: 119 AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV------SPAN 169

Query: 73  RIVGTYGYMAPE--YAM-EGLFSVKSDVFSFGVLLLEI 107
             VGT  +MAPE   AM EG +  K DV+S G+  +E+
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVG 76
           I  GL YLH+    +I+HRD+K  NVL++ +    KISDF  ++   G      T    G
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTG 171

Query: 77  TYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGK 111
           T  YMAPE   +G   +   +D++S G  ++E+ +GK
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 3e-11
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  L +LH    L II+RDLK  N+LLD E + K++DF +++       E       GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 46/133 (34%), Positives = 69/133 (51%), Gaps = 15/133 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +ARG+ YL   S+ + IHRDL A N+L+      KI+DF ++R       E    + +G 
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 184

Query: 78  YG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL-LSYTWK- 131
               +MA E     +++  SDV+S+GVLL EI+S  G    G   +EL + L   Y  + 
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244

Query: 132 -LWCEGEALELME 143
            L C+ E  +LM 
Sbjct: 245 PLNCDDEVYDLMR 257

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 60.8 bits (147), Expect = 3e-11
 Identities = 40/110 (36%), Positives = 56/110 (50%), Gaps = 13/110 (11%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           RSV L     +     +   + YL  ++    +HRDL A NVL+  +   K+SDF + + 
Sbjct: 96  RSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK- 150

Query: 62  FGGNQSEASTNRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                 EAS+ +  G     + APE   E  FS KSDV+SFG+LL EI S
Sbjct: 151 ------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 3/98 (3%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           +S    +ARG+ +L   +    +HRDL A NVLL      KI DF +AR    + +  S 
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                   +MAPE   + L++  SDV+S+G+LL EI S
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.7 bits (147), Expect = 3e-11
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL   +   +IHRDL A N L+      K+SDF M R    +Q  +ST    GT
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GT 161

Query: 78  ---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
                + +PE      +S KSDV+SFGVL+ E+ S  K
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.4 bits (149), Expect = 5e-11
 Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 21/113 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRD+ A NVLL      KI DF +AR          +N +V  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272

Query: 78  YG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK-------NSGFY 117
                  +MAPE   + +++V+SDV+S+G+LL EI S GK        NS FY
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 5e-11
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 6/109 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            RS  L   + + I   I  GL YLH     RIIHRD+K  N+ ++      I D   A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                    +   + GT    APE      ++ K+D++S G++L E+++
Sbjct: 206 F---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 60.7 bits (147), Expect = 5e-11
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 17/175 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQ----SEASTN 72
           I  G+ YLH       IHRDL A NVLLD++   KI DF +A+ +  G++     E   +
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172

Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ--SLLSYTW 130
            +     + A E   E  FS  SDV+SFGV L E+++   +     S   +   ++    
Sbjct: 173 PVF----WYAVECLKENKFSYASDVWSFGVTLYELLT---HCDSKQSPPKKFEEMIGPKQ 225

Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
                   +EL+E  ++  C      +   +   C + ++  RPT  S++ +L  
Sbjct: 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.9 bits (148), Expect = 5e-11
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I RGL YLH      I+HRD+K  N+L++     KI DF +AR+   ++S+  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
           Y Y APE  M    ++   D++S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.4 bits (146), Expect = 5e-11
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA  L YLHE     I+HRDLK  NV L      K+ D  +AR+       AST  ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             YM+PE      ++ KSDV++ G  + E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.4 bits (146), Expect = 5e-11
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 22/165 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL E   +R++HRDL A NVL+    + KI+DF +AR+   +++E   +     
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYTWKLWCE 135
             +MA E  +   F+ +SDV+S+GV + E+++   K   G    E+              
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-------------- 220

Query: 136 GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
            + LE  E  L Q  +    +  I +   C   DS  RP    +V
Sbjct: 221 PDLLEKGER-LPQPPICTIDVYMIMVK--CWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.3 bits (146), Expect = 6e-11
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 31/179 (17%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165

Query: 72  NRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
            R     G      + APE      F+  SDV+S+G+++ E++S  +   + +S   Q +
Sbjct: 166 TR-----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDV 218

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL-CVQADSADRPTMSSVVVML 183
           +          E   L  P+    C AA     +H  +L C Q D  +RP    +V +L
Sbjct: 219 IKAI------EEGYRLPAPM---DCPAA-----LHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.6 bits (147), Expect = 7e-11
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I RGL Y+H      ++HRDLK SN+L++   + KI DF +ARI      +      V T
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168

Query: 78  YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  +    + V+ D++S G +  E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 60.3 bits (146), Expect = 7e-11
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 6/103 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEAS 70
           I+    + RGL YLHE+   +IIHRD+K +N+L+D      +I+DF  A       + A 
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162

Query: 71  --TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
               +++GT  +MAPE      +    DV+S G +++E+ + K
Sbjct: 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 7e-11
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 6/100 (6%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +G+ Y H  S  R++HRDLK  N+L+D E   K++DF +AR F G      T+
Sbjct: 103 SYLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTH 158

Query: 73  RIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 8e-11
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL  LH   R RI++RDLK  N+LLD   + +ISD  +A      ++       VGT
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGT 164

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GYMAPE      ++   D +  G L+ E+I GK
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.0 bits (145), Expect = 8e-11
 Identities = 47/133 (35%), Positives = 66/133 (49%), Gaps = 15/133 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ YL E    + IHRDL A NVL+   +  KI+DF ++R       E    + +G 
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGR 179

Query: 78  YG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL---LSYTW 130
               +MA E     +++ KSDV+SFGVLL EI+S  G    G   +EL + L        
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239

Query: 131 KLWCEGEALELME 143
              C+ E  ELM 
Sbjct: 240 PRNCDDEVYELMR 252

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.0 bits (145), Expect = 8e-11
 Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 6/111 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           M     +  R +     I  GL  LH++   RI++RDLK  N+LLD   + +ISD  +A 
Sbjct: 94  MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAV 150

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                Q+       VGT GYMAPE      ++   D ++ G LL E+I+G+
Sbjct: 151 HVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.2 bits (147), Expect = 9e-11
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 7/97 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS--TNRIV 75
           I RGL YLH  +   +IHRDLK SN+L++   + KI DF +AR    ++ E    T  +V
Sbjct: 112 ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 76  GTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            T  Y APE  +    ++   D++S G +  E+++ K
Sbjct: 169 -TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 9e-11
 Identities = 56/169 (33%), Positives = 78/169 (46%), Gaps = 23/169 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +ARG+ +L   SR + IHRDL A N+LL      KI DF +AR    +            
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSE-LGQSLLSYTWKLWC 134
             +MAPE   + +++ +SDV+SFGVLL EI S       G  ++E   Q L   T     
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT----- 294

Query: 135 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
              A E   P + +            I L C Q D  +RPT S++V +L
Sbjct: 295 RMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.0 bits (145), Expect = 9e-11
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 14/103 (13%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-T 71
           +I +G  +GL YLH  +   +IHRD+KA N+LL      K++DF       G+ S++S  
Sbjct: 125 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADF-------GSASKSSPA 174

Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
           N  VGT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 5/106 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
            L    ++ I   +A G+ YL E    + +HRDL   N L+   M  KI+DF ++R I+ 
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +  +AS N  +    +M PE      ++ +SDV+++GV+L EI S
Sbjct: 183 ADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 13/101 (12%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF---------GGNQSEAST 71
           G+ YLHE+    I+HRD+KA+N+L+D++   KI+DF +AR +         GG       
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 72  NRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
             +V T  Y  PE  + E  ++   D++  G +  E+ + +
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 32/92 (34%), Positives = 55/92 (59%), Gaps = 5/92 (5%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ NVLL  + + K++DF         QS+ ST  +VGT  
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E++ G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 10/162 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ YL   + L  +HRDL   N L+ +    KI+DF M+R            R V  
Sbjct: 138 IASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP 194

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MA E  + G F+  SDV++FGV L E+ +  K   + L    Q + +       +G 
Sbjct: 195 IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR 254

Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
            + L +  L  S V   +++       C   D  DRPT + +
Sbjct: 255 QIYLSQTPLCPSPVFKLMMR-------CWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQSEASTNRIVG 76
           I  G+ YLH +    I+HRD+K +N+L D   N K+ DF  + R+     S      + G
Sbjct: 113 ILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  +M+PE      +  K+DV+S G  ++E+++ K
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)

Query: 26  HEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY 85
           H  SR R++HRD+K +NV +      K+ D  + R F    + A +  +VGT  YM+PE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 86  AMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKL-WCEGEALELMEP 144
             E  ++ KSD++S G LL E+ +    S FY  ++  +L S   K+  C+        P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKM--NLFSLCQKIEQCD-------YP 226

Query: 145 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
            L     + +L + +    +C+  D   RP +  V
Sbjct: 227 PLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 22  LLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIVGTYG 79
           L++LH      +I+RDLK  N+LLD E + K++DF M +  I  G     +T    GT  
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPD 161

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y+APE   E  +    D ++ GVL+ E+++G+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 44/132 (33%), Positives = 67/132 (50%), Gaps = 17/132 (12%)

Query: 19  ARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTY 78
           ARG+ YL +    + IHRDL A N+L+      KI+DF ++R       E    + +G  
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173

Query: 79  G--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYTWKLW- 133
              +MA E     +++  SDV+S+GVLL EI+S  G    G   +EL +  L   ++L  
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEK 232

Query: 134 ---CEGEALELM 142
              C+ E  +LM
Sbjct: 233 PLNCDDEVYDLM 244

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 3/99 (3%)

Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K+ I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R        
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175

Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 107
               + +    +M+PE   +G+F+  SDV+SFGV+L EI
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.2 bits (143), Expect = 2e-10
 Identities = 34/87 (39%), Positives = 52/87 (59%), Gaps = 6/87 (6%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G+ Y+H+    RI+HRDLKA N+ L + +  KI DF ++R+  G+   A+T    GT  Y
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171

Query: 81  MAPEYAMEGLFSVKSDVFSFGVLLLEI 107
           M+PE      +  KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 32/91 (35%), Positives = 52/91 (57%)

Query: 22  LLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM 81
           LL +H      +IHRD+K++N+LL      K+ DF  ++++    S+       GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 82  APEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
           APE      +S K+D+FS GVLL E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 24/65 (36%), Positives = 39/65 (60%), Gaps = 4/65 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           +G+ Y+H      I+HRDLK +N+L+  +   KI+DF +AR+F   +    +++ V T  
Sbjct: 110 KGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRW 165

Query: 80  YMAPE 84
           Y APE
Sbjct: 166 YRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 58.8 bits (142), Expect = 2e-10
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 25/176 (14%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +  E + 
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTY 165

Query: 72  NRIVGTYG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS--ELGQSLLS 127
               G     + APE      F+  SDV+SFG+++ E++S  +   + +S  E+ +++  
Sbjct: 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-- 223

Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                    +   L  P+   S V   +L+       C Q D A RP    +V +L
Sbjct: 224 --------NDGFRLPAPMDCPSAVYQLMLQ-------CWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.3 bits (144), Expect = 2e-10
 Identities = 38/108 (35%), Positives = 59/108 (54%), Gaps = 15/108 (13%)

Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQS 67
           K  ++I+      L YL E     +IHRD+K SN+LLD   N K+ DF ++ R+     S
Sbjct: 118 KMTVAIVKA----LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DS 168

Query: 68  EASTNRIVGTYGYMAPEY----AMEGLFSVKSDVFSFGVLLLEIISGK 111
           +A T R  G   YMAPE          + +++DV+S G+ L+E+ +G+
Sbjct: 169 KAKT-RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 34/99 (34%), Positives = 59/99 (59%), Gaps = 5/99 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEAS 70
           + I+  IA G+ +L   S   ++H+DL   NVL+  ++N KISD  + R ++  +  +  
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N ++    +M+PE  M G FS+ SD++S+GV+L E+ S
Sbjct: 184 GNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.1 bits (144), Expect = 2e-10
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 20/99 (20%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   L YLH    L I++RDLK  N+LLD +   KI+DF  A+   G      T  + GT
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGT 161

Query: 78  YGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y+APE      Y      +V  D ++ G+L+ E+++G
Sbjct: 162 PEYLAPEIILSKGYGK----AV--DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   SR + IHRDL A N+LL      KI DF +AR    +            
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 12/98 (12%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           ++ +G  +GL YLH  +   +IHRD+KA N+LL      K+ DF  A I       A  N
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169

Query: 73  RIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEI 107
             VGT  +MAPE  +   EG +  K DV+S G+  +E+
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 12/102 (11%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           +I +G  +GL YLH  +   +IHRD+KA N+LL      K++DF  A I       +  N
Sbjct: 129 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPAN 179

Query: 73  RIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
             VGT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 32/92 (34%), Positives = 56/92 (60%), Gaps = 3/92 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL E    R++HRDL A NVL+    + KI+DF +A++ G ++ E         
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.8 bits (142), Expect = 2e-10
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 8/101 (7%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ ST  +VGT  
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE 120
           +MAPE      +  K D++S G++ +E++ G+     YL+E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 38/97 (39%), Positives = 56/97 (57%), Gaps = 14/97 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL YLHE+    IIHRDLK SN+LL  +   KI+DF +AR + G  ++  T ++V T  
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173

Query: 80  YMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           Y APE     L    +     D+++ G +L E+++ K
Sbjct: 174 YRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 6/98 (6%)

Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI 74
           I  I   L +LH+   L II+RD+K  N+LLD E +  ++DF +++ F   + E      
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSF 166

Query: 75  VGTYGYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISG 110
            GT  YMAPE      G      D +S GVL  E+++G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 3e-10
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 16/106 (15%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN--QSEAST 71
           I   + +GL +L E+    IIHRD+K +NVL++     K+ DF ++    GN   S A T
Sbjct: 107 ITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKT 160

Query: 72  NRIVGTYGYMAPEY------AMEGLFSVKSDVFSFGVLLLEIISGK 111
           N  +G   YMAPE            ++V+SDV+S G+ +LE+  G+
Sbjct: 161 N--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 11/105 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
            DW ++   I  +  G+  LH+     IIHRD+K  N+L+D   + K++DF ++R    N
Sbjct: 96  EDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +      + VGT  Y+APE  +       SD +S G ++ E + G
Sbjct: 151 K------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 3e-10
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 10/92 (10%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L +LH     ++IHRDLKA N+LL  + + K++DF ++        +  T   +GT  +
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYW 169

Query: 81  MAPEYAMEGLFS-----VKSDVFSFGVLLLEI 107
           MAPE      F       K+D++S G+ L+E+
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 58.7 bits (142), Expect = 3e-10
 Identities = 37/96 (38%), Positives = 57/96 (59%), Gaps = 9/96 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L +LHE     II+RDLK  NVLLD E + K++D+ M +   G +   +T+   GT
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGT 159

Query: 78  YGYMAPEY--AMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE     +  FSV  D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 32/101 (31%), Positives = 58/101 (57%), Gaps = 6/101 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL E   +  +HRDL A N+L++  +  K+SDF ++R    + S+ + 
Sbjct: 109 VGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165

Query: 72  NRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +G      + APE      F+  SDV+S+G+++ E++S
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.4 bits (142), Expect = 3e-10
 Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 17/107 (15%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I+  + + L Y+H  S   +IHRDLK SN+LL+ +   K++DF +AR       E   N 
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENP 167

Query: 74  I----VGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           +    V T  Y APE     L          D++S G +L E++ GK
Sbjct: 168 VLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.5 bits (141), Expect = 3e-10
 Identities = 38/116 (32%), Positives = 61/116 (52%), Gaps = 5/116 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           +L   + + I + IA G++YL   +    +HRDL   N L+   +  KI DF M+R ++ 
Sbjct: 119 ELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
            +      + ++    +M PE  M   F+ +SDV+SFGV+L EI +  K   F LS
Sbjct: 176 TDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 58.2 bits (141), Expect = 4e-10
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IVGT 77
           + L +LH      +IHRD+K+ ++LL  +   K+SDF     F    S+    R  +VGT
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGT 178

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             +MAPE      +  + D++S G++++E++ G+
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           IA G+ YL   S    +H+DL A N+L+  +++ KISD  ++R I+  +        ++ 
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +M PE  M G FS  SD++SFGV+L EI S
Sbjct: 190 IR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.0 bits (140), Expect = 4e-10
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEAS 70
           + +   IA G+ YL   S L  +HRDL   N L+   +  KI+DF M+R ++ G+     
Sbjct: 141 LHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ 197

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             R V    +MA E  + G F+  SDV++FGV L EI+ 
Sbjct: 198 -GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 3/101 (2%)

Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           +  I +   IA G+ YL+     + +HRDL A N ++ H+   KI DF M R        
Sbjct: 119 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175

Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 58.0 bits (141), Expect = 5e-10
 Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 14/104 (13%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +    RGL YLH      I+HRDLK +N+L+  +   K++DF +AR F G+ +   T+
Sbjct: 106 SYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTH 161

Query: 73  RIVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           ++V T  Y APE     LF  +      D++S G +  E++   
Sbjct: 162 QVV-TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 41/109 (37%), Positives = 63/109 (57%), Gaps = 11/109 (10%)

Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS- 67
           K    +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++  G +++ 
Sbjct: 95  KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151

Query: 68  -EASTNRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK 112
            +A T+   G +   + APE      FS KSDV+SFGVL+ E  S G+K
Sbjct: 152 YKAKTH---GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 5e-10
 Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 8/77 (10%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGN-QS 67
           S++  I  G+ YLH +    ++HRDLK +N+L+  E       KI D  +AR+F    + 
Sbjct: 112 SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 68  EASTNRIVGTYGYMAPE 84
            A  + +V T  Y APE
Sbjct: 169 LADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.8 bits (139), Expect = 5e-10
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L YLHE     II+RDLK  NVLLD E + K++D+ M +   G +   +T+   GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.8 bits (139), Expect = 5e-10
 Identities = 31/92 (33%), Positives = 55/92 (59%), Gaps = 5/92 (5%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ ST  +VGT  
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E++ G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.6 bits (139), Expect = 6e-10
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 113 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 168

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 107
             + APE      FS+KSDV++FGVLL EI
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.1 bits (138), Expect = 7e-10
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL      + +HRDL A N +LD     K++DF +AR     +  +  N     
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.4 bits (139), Expect = 7e-10
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           GL YLHE+   +I++RDLK  N+LLD E   KI+DF + +   G     ST    GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEF 167

Query: 81  MAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +APE   E  ++   D +  GVL+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.4 bits (139), Expect = 8e-10
 Identities = 27/67 (40%), Positives = 42/67 (62%), Gaps = 7/67 (10%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS---TNRIVGT 77
           GL Y+H   R +I+HRD+KA+N+L+  +   K++DF +AR F  +++      TNR+V T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186

Query: 78  YGYMAPE 84
             Y  PE
Sbjct: 187 LWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 36/111 (32%), Positives = 59/111 (53%), Gaps = 18/111 (16%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGN---QSEASTNR 73
           IA G+ YL   S    IHRDL A N +L+  M   ++DF +++ I+ G+   Q  AS   
Sbjct: 122 IASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-------GKKNSGFY 117
           +     ++A E   + +++  SDV++FGV + EI++       G +NS  Y
Sbjct: 179 V----KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST--NRIV 75
           + RGL Y+H  +   +IHRDLK SN+L++ +   +I DF MAR    + +E        V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 76  GTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEII 108
            T  Y APE   ++   ++   D++S G +  E++
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 7/104 (6%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +++ ++ G+ YL   +    +HRDL A NVLL ++   KISDF +++  G + S    
Sbjct: 98  VELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-YYK 153

Query: 72  NRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK 112
            R  G +   + APE      FS +SDV+S+G+ + E  S G+K
Sbjct: 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.0 bits (137), Expect = 1e-09
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ S   +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPY 181

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 56.4 bits (136), Expect = 1e-09
 Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 4/101 (3%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           +S+   +  G+ YL  +S    IHRDL A N L+      K+SDF M R    ++  +S+
Sbjct: 103 LSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159

Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
                   +  PE      +S KSDV+SFGVL+ E+ +  K
Sbjct: 160 GAKF-PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.4 bits (136), Expect = 1e-09
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 11/96 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGN---QSEASTNR 73
           IA G+ YL   S    IHRDL A N +L  +M   ++DF +++ I+ G+   Q   +   
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +     ++A E   + +++ KSDV++FGV + EI +
Sbjct: 179 V----KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 11/98 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL      + IHRDL A N L+D +   K+SDF ++R    ++  +S    VG+
Sbjct: 109 VCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGS 161

Query: 78  ---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GK 111
                +  PE  +   FS KSDV++FGVL+ E+ S GK
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 32/93 (34%), Positives = 56/93 (60%), Gaps = 6/93 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           +G+ + HE+   R++HRDLK  N+L++     K++DF +AR FG   +  S N +V T  
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS-NEVV-TLW 165

Query: 80  YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGK 111
           Y AP+  +    +S   D++S G ++ E+I+G+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 6/108 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            +D +   S +  I +G+L+ H     R++HRDLK  N+L+D++   K++DF +AR F G
Sbjct: 97  YMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-G 152

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGK 111
                 T+ +V T  Y APE  +    +S   D++S G +  E+ + K
Sbjct: 153 IPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 11/96 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ YL     L  +HRDL   N L+      KI+DF M+R    N   +   R+ G 
Sbjct: 139 IASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSDYYRVQGR 191

Query: 78  ----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                 +MA E  + G F+ KSDV++FGV L EI++
Sbjct: 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 34/100 (34%), Positives = 58/100 (58%), Gaps = 5/100 (5%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  +  GL Y H+ + L   HRD+K SN+LL+++   K++DF +AR++   +S   TN
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 73  RIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
           +++ T  Y  PE  + E  +    DV+S G +L E+ + K
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH     R++HRDLK  N+L+      K++DF +ARI+     + +   +V T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 7/96 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           I RG+ Y H     R++HRDLK  N+L+D   N  K++DF +AR F G      T+ +V 
Sbjct: 111 ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV- 165

Query: 77  TYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
           T  Y APE  +    +S   D++S G +  E+++ K
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 10/91 (10%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEM-ARIFGGNQSEASTNRIVGTY 78
           +GL YLHE      IHRD+K +N+LL  + + K++DF + A++     + A     +GT 
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSFIGTP 165

Query: 79  GYMAPEYA---MEGLFSVKSDVFSFGVLLLE 106
            +MAPE A    +G +  K D+++ G+  +E
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 7/97 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST--NRIV 75
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +ARI    + + +      V
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFLTEYV 170

Query: 76  GTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
            T  Y APE  +      K+ D++S G +L E++S +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 6/94 (6%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++  + RG+ +LH     RI+HRDLK  N+L+  +   KI+DF +ARI+    +  S   
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS--- 165

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 107
           +V T  Y APE  ++  ++   D++S G +  E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL E    R++HR+L A N+LL  +   +I+DF +A +   +  +   +     
Sbjct: 118 IAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MA E  + G ++ +SDV+S+GV + E++S
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 5/93 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA  L YLH    L II+RDLK  N+LLD + +  ++DF + +   G +   +T+   GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTG 174

Query: 74  IVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
            V T  Y APE  +  +   ++ D++S G ++ E+++GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 5/88 (5%)

Query: 25  LHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR-IVGTYGYMAP 83
           L +  R RI++RDLK  N+LLD   + +ISD  +A        E  T R  VGT GYMAP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV----QIPEGETVRGRVGTVGYMAP 170

Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           E      ++   D +  G L+ E+I G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176

Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 14/115 (12%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQSEAS 70
           +  +  IA G+ YL   S    IHRDL A N +L+  MN  ++DF ++ +I+ G+     
Sbjct: 115 VKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR-- 169

Query: 71  TNRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-------GKKNSGFY 117
             RI      ++A E   + +++ KSDV+SFGV + EI +       G +NS  Y
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.0 bits (132), Expect = 5e-09
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQSEASTNRIVGTYG 79
           GL  LH ++    ++RDLK  N+LLD   + +ISD  +A +I  G     S    VGT G
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVG 166

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           YMAPE      +++  D +  G L+ E+I G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 6e-09
 Identities = 34/112 (30%), Positives = 60/112 (53%), Gaps = 9/112 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DF +AR
Sbjct: 110 MKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
                Q+++     V T  Y APE  +  + ++   D++S G ++ E+++GK
Sbjct: 167 -----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 54.6 bits (131), Expect = 6e-09
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 10/92 (10%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L YLHE+   +IIHRDLKA N+L   + + K++DF ++      ++    +  +GT  +
Sbjct: 115 ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYW 169

Query: 81  MAPEYAM-----EGLFSVKSDVFSFGVLLLEI 107
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 54.6 bits (131), Expect = 6e-09
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH +    I+HRDLK  N+L+      K++DF +ARI+     + +   +V T  
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLW 172

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 54.2 bits (130), Expect = 7e-09
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G+ ++HE    R++HRD+K+ N+ L      K+ DF  AR+     + A T   VGT  Y
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYY 166

Query: 81  MAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           + PE      ++ KSD++S G +L E+ + K
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.7 bits (131), Expect = 8e-09
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L +LHE     II+RDLK  NVLLD + + K++D+ M +   G     +T+   GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 54.3 bits (130), Expect = 8e-09
 Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 10/91 (10%)

Query: 22  LLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM 81
           L YLH    ++IIHRDLKA NVLL  + + K++DF ++      ++    +  +GT  +M
Sbjct: 123 LQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWM 177

Query: 82  APEYAM-----EGLFSVKSDVFSFGVLLLEI 107
           APE  M     +  +  K+D++S G+ L+E+
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.9 bits (129), Expect = 8e-09
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 10/102 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I   I RGL +LH+    ++IHRD+K  NVLL      K+ DF ++     +++    N 
Sbjct: 116 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNT 170

Query: 74  IVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISG 110
            +GT  +MAPE        +  +  KSD++S G+  +E+  G
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 53.8 bits (129), Expect = 9e-09
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVG 76
           I+ GL ++H+    +I+HRD+K+ N+ L    M  K+ DF +AR    +   A T   VG
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVG 164

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  Y++PE      ++ K+D++S G +L E+ + K
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 9e-09
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  + RGL Y+H      IIHRDLK SNV ++ +   +I DF +AR     Q++     
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174

Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 9e-09
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 8/87 (9%)

Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH      II+RDLK  N+LLD++ + K++DF  A+     +    T  + GT  Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184

Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E           D ++ GVLL E I+G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.4 bits (131), Expect = 9e-09
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I+  L +LH   +  II+RDLK  N+LLD + + K++DF + +  I  G      T+   
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFC 161

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           GT  YMAPE  M        D +S G L+ ++++G
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 5/99 (5%)

Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           +R  +I   +   L YLH++ R  I+HRDL  +N++L  +    I+DF +A+     Q E
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPE 167

Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 107
           +    +VGT  Y  PE      +  K+DV++FG +L ++
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 7/98 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR---IFGGNQSEASTNRI 74
           I  G+ YLH +    ++HRD+K +NV+L      K+ DF  AR     G + + ++  + 
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167

Query: 75  V-GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           + GT  +MAPE   E  +  KSD++S G  + E+ +GK
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 31/110 (28%), Positives = 60/110 (54%), Gaps = 9/110 (8%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
            +L+ ++  ++   + + L YLH      +IHRD+K+ ++LL  +   K+SDF     F 
Sbjct: 112 TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFG----FC 164

Query: 64  GNQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              S+    R  +VGT  +MAPE      +  + D++S G++++E++ G+
Sbjct: 165 AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-STNRIVG 76
            A  L  L    +  +I+RDLK  N+LLD++ +  + DF + ++   N  +   TN   G
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCG 155

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           T  Y+APE  +   ++   D ++ GVLL E+++G
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 36/92 (39%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 19  ARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTNRIVGT 77
           A G+ YL   +    IHRDL A N L+      KISDF M+R    G  S +   +I   
Sbjct: 103 AAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--P 157

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE    G +S +SDV+S+G+LL E  S
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 38/103 (36%), Positives = 54/103 (52%), Gaps = 8/103 (7%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-- 70
           S I  I  GL Y+H  +   ++HRDLK  N+L++ +   KI DF +AR F  N  E +  
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 71  -TNRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
            T   V T  Y APE  +      K+ DV+S G +L E++  K
Sbjct: 166 MTE-YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 31/120 (25%), Positives = 50/120 (41%), Gaps = 27/120 (22%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF-----------EMARIFGGNQ 66
           IA  +L L    +L  IHRD+K  N+L+D + + K++DF               +   + 
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 67  SEASTNR----------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                N                  VGT  Y+APE      + ++ D +S GV+L E++ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 37/105 (35%), Positives = 51/105 (48%), Gaps = 3/105 (2%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +L  K  I ++   A G+ YL        IHRDL A N L+  +   KISDF M+R    
Sbjct: 90  RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEED 146

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               ++         + APE    G +S +SDV+SFG+LL E  S
Sbjct: 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 2e-08
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEAS 70
           I +   IA G+ YL   S L  +HRDL   N L+      KI+DF M+R ++ G+     
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             R V    +M+ E  + G F+  SDV++FGV L EI++
Sbjct: 190 -GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ +L   +    +HRDL A NVL+      KI DF +AR    + +  S       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE     L++  SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 36/115 (31%), Positives = 54/115 (46%), Gaps = 3/115 (2%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +L   + + I   IA G++YL   +    +HRDL   N L+   +  KI DF M+R    
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
                     +    +M PE  M   F+ +SDV+S GV+L EI +  K   + LS
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 42/184 (22%), Positives = 86/184 (46%), Gaps = 14/184 (7%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L W+RR  I  GIA+ L +LH      ++  +L    +++D +  P +            
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLP 829

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
               +  +   +  Y+APE       + KSD++ FG++L+E+++G K+       +  S+
Sbjct: 830 GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG-KSPADAEFGVHGSI 888

Query: 126 LSYTWKLWCEGEA-LEL-MEPVLKQ--SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
           +   W  +C  +  L++ ++P ++   S    E+++ +++ L C   D   RP  + V+ 
Sbjct: 889 VE--WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946

Query: 182 MLAS 185
            L S
Sbjct: 947 TLES 950

Length = 968

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 7/106 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  + YLH    L II+RDLK  N+LLD + +  ++DF + +   G + E +T+   GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
             Y+APE   +  +    D +  G +L E++ G     FY  ++ Q
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL--PPFYSRDVSQ 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G+ +LH      IIHRDLK SN+++  +   KI DF +AR  G +     T  +V  Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY-Y 183

Query: 81  MAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            APE  +   +    D++S G ++ E+I G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L +LH   +L II+RD+K  N+LLD   +  ++DF +++ F  ++ E + +   GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169

Query: 78  YGYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISG 110
             YMAP+     +G      D +S GVL+ E+++G
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.6 bits (126), Expect = 3e-08
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 6/94 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST--NRIV 75
           I +G+ YL   SR + +HRDL A NVL++ E   KI DF + +    ++   +   +   
Sbjct: 118 ICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + Y APE  ++  F + SDV+SFGV L E+++
Sbjct: 175 PVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 4e-08
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 8/103 (7%)

Query: 22  LLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM 81
           L +LH+     I++RDLK  N+LLD   +  + DF +++         +TN   GT  Y+
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 82  APEYAM-EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
           APE  + E  ++   D +S GVL+ E+  G   S FY  +  Q
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFYAEDTQQ 204

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 12/113 (10%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
           +++ DW   I     I RGL +LH     ++IHRD+K  NVLL      K+ DF ++   
Sbjct: 117 ALKEDWIAYIC--REILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171

Query: 63  GGNQSEASTNRIVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISG 110
             +++    N  +GT  +MAPE        +  +  +SD++S G+  +E+  G
Sbjct: 172 --DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 6/95 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR    ++        V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171

Query: 78  YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  +    ++   DV+S G +  E++  K
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 11/106 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LDW  +I +       L ++H+    +I+HRD+K+ N+ L  +   K+ DF +AR+    
Sbjct: 104 LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              A T   +GT  Y++PE      ++ KSD+++ G +L E+ + K
Sbjct: 155 VELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 51.6 bits (123), Expect = 6e-08
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 9/96 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IV 75
           + R L YLH      +IHRD+K+ ++LL  +   K+SDF     F    S+    R  +V
Sbjct: 127 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLV 179

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           GT  +MAPE      +  + D++S G++++E+I G+
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 7e-08
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 8/86 (9%)

Query: 25  LHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE 84
           LH    L  IHRDLK  N L+D   + K++DF +++   G  + A  N +VG+  YMAPE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYA--NSVVGSPDYMAPE 168

Query: 85  YAMEGLFSVKSDVFSFGVLLLEIISG 110
                 +    D +S G +L E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 8e-08
 Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 11/102 (10%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S I  + + + Y H      IIHRD+K  N+L+      K+ DF  AR      +   T+
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160

Query: 73  RIVGTYGYMAPE----YAMEGLFSVKSDVFSFGVLLLEIISG 110
             V T  Y APE        G   V  DV++ G ++ E++ G
Sbjct: 161 -YVATRWYRAPELLVGDTNYG-KPV--DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.2 bits (122), Expect = 8e-08
 Identities = 28/95 (29%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEM-ARIFGGNQSEASTNRIVG 76
           + + L  LH      +IHRD+K+ ++LL H+   K+SDF   A++   ++       +VG
Sbjct: 125 VLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVG 178

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  +MAPE      +  + D++S G++++E++ G+
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 8e-08
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L +LH   +L I++RD+K  N+LLD E +  ++DF +++ F   + E  T    GT
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGT 169

Query: 78  YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG 110
             YMAPE    +G      D +S G+L+ E+++G
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.5 bits (123), Expect = 9e-08
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.4 bits (123), Expect = 9e-08
 Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 11/109 (10%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
            GL Y+H      IIHRDLK  N+ ++ +   KI DF +AR      ++A     V T  
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 179

Query: 80  YMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           Y APE  +  +   ++ D++S G ++ E+++GK       YL +L Q L
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.2 bits (122), Expect = 9e-08
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH     +I++RDLK  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+ +V T  Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWY 166

Query: 81  MAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
            APE  +    +S   D++S G +  E+++ +
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 17/117 (14%)

Query: 9   KRRISIINGIA------RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
           KR I+I + +A      R + YLHE+   RIIHRD+KA N+ ++H  +  + DF  A   
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF- 231

Query: 63  GGNQSEASTNRIVGTYGYMA---PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGF 116
                + + N+  G  G +A   PE      +    D++S G++L E+ +   +S F
Sbjct: 232 ---PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC-HDSLF 284

Length = 391

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQSEASTNRIVG 76
           I  G+ YLH +    I+HRD+K +N+L D   N K+ DF  + R+     S      + G
Sbjct: 115 ILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  +M+PE      +  K+DV+S G  ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  S   +++RDLK  N++LD + + KI+DF + +   G +  A+     GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 1e-07
 Identities = 35/107 (32%), Positives = 58/107 (54%), Gaps = 8/107 (7%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QL   + + ++ G+A G+ YL E   +  +H+ L A  VL++ ++  KIS F   R    
Sbjct: 103 QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGF---RRLQE 156

Query: 65  NQSEA--STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++SEA  +T        + APE      FS  SDV+SFG+++ E++S
Sbjct: 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQSEASTNRIVG 76
           I +G+ YLH +    I+HRD+K +N+L D   N K+ DF  + RI     S      + G
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  +M+PE      +  K+DV+S    ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              S   T  +V  Y Y APE  +   +    D++S G ++ E+I G 
Sbjct: 178 --TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 46.5 bits (111), Expect = 1e-07
 Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 2/48 (4%)

Query: 185 SDNVTLPQPTEPAFSVGRNVARPSQFSSG--AEVCSVNEVTLSNVSPR 230
           S+   +PQP +P F VGR+       SS    E  +VN+VT+S +  R
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I+ G   GL +LH +   RIIHRD+K +N+LL  E   K+ DF ++      +   +T+ 
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188

Query: 74  IVGTYGYMAPEY-----AMEGLFSVKSDVFSFGVLLLEIISG 110
            VGT  +MAPE        +  +  + DV+S G+  +E+  G
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 14/111 (12%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR   
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-- 172

Query: 64  GNQSEASTNRIVGTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                A TN ++  Y     Y APE  +   +    D++S G ++ E++ G
Sbjct: 173 -----ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 28/88 (31%), Positives = 50/88 (56%)

Query: 22  LLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM 81
           +L L E    +++HRDLK++N+ L      K+ DF  ++ +  + S    +   GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 82  APEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           APE      +S K+D++S GV+L E+++
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      I++RDLK  N+LLD E + K++DF  A+     +    T  + GT
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE       +   D ++ G+L+ E++ G 
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 49.3 bits (117), Expect = 3e-07
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQSEASTNRIVG 76
           I  G+ YLH +    I+HRD+K +N+L D   N K+ DF  + R+     S      + G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  +M+PE      +  K+D++S G  ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      +++RDLK  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 48.8 bits (116), Expect = 6e-07
 Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 5/80 (6%)

Query: 31  LRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGL 90
           L I++RDLK  N+LLD +   K++DF  A++      +  T  + GT  Y+APE  +   
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVG 204

Query: 91  FSVKSDVFSFGVLLLEIISG 110
               +D ++ G+ + EI+ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.9 bits (116), Expect = 6e-07
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 5/93 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA  L YLH    L I++RDLK  N+LLD + +  ++DF + +     +   +T+   GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 7e-07
 Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 6/108 (5%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  G
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 171 --TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 7e-07
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 10/97 (10%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI-FGGNQSEASTNRIVGTY 78
           R L Y+H  +   + HRDLK  N+L + +   KI DF +AR+ F    +       V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 79  GYMAPEYAMEGLFSVKS----DVFSFGVLLLEIISGK 111
            Y APE    G F  K     D++S G +  E+++GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.5 bits (115), Expect = 8e-07
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA  L YLH    + I++RDLK  N+LLD + +  ++DF + +  G  QS+ +T    GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTT-FCGT 159

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 8e-07
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 8/109 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  +L +    +L  +HRD+K  NVLLD   + +++DF        + +  S N  VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS-NVAVGT 166

Query: 78  YGYMAPEY--AME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
             Y++PE   AME   G +  + D +S GV + E++ G+  + FY   L
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.5 bits (115), Expect = 9e-07
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 10/110 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI-VG 76
           IA  +L +H   +L  +HRD+K  NVLLD   + +++DF        NQ     + + VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF--GSCLKMNQDGTVQSSVAVG 165

Query: 77  TYGYMAPEY--AME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           T  Y++PE   AME   G +  + D +S GV + E++ G+  + FY   L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.0 bits (117), Expect = 9e-07
 Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 19/114 (16%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           +SI + I   + Y+H  S+  ++HRDLK  N+LL       I D+  A      + +   
Sbjct: 116 LSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 72  ----------------NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                            +IVGT  YMAPE  +    S  +D+++ GV+L ++++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 10/95 (10%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           GL +LH +   + IHRD+K +N+LL  E   K+ DF ++      +   +T+  VGT  +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190

Query: 81  MAPEY-----AMEGLFSVKSDVFSFGVLLLEIISG 110
           MAPE       ++  +  + DV+S G+  +E+  G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 18/112 (16%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN-------- 65
           I+  I  GL  LH+      +HRDL  +N+ ++ +   KI+DF +AR +G          
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 66  -----QSEASTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
                + E  T+++V T  Y APE  M    +    D++S G +  E+++GK
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I RGL Y H   R +++HRDLK  N+L++     K++DF +AR      ++  +N +V T
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-T 167

Query: 78  YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
             Y  P+  +    +S + D++  G +  E+ SG+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           ++  L YL      R +HRD+ A NVL+      K+ DF ++R +   +  +AS  ++  
Sbjct: 116 LSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-- 170

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK 112
              +MAPE      F+  SDV+ FGV + EI+  G K
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 35/129 (27%), Positives = 54/129 (41%), Gaps = 36/129 (27%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF------------EMARIFGGN 65
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDF            E  RI    
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 66  QSEAST------------------NRI------VGTYGYMAPEYAMEGLFSVKSDVFSFG 101
                                   NR       VGT  Y+APE  ++  ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 102 VLLLEIISG 110
           V++ E++ G
Sbjct: 227 VIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 9/120 (7%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           RS  L  ++ I+I   +   L YLH      IIHRD+K  N+ LD   N  + DF  A  
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI------ISGKKNSG 115
              +          GT    +PE      +  K+D++S G++L E+      + GK+   
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294

Length = 392

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL Y+H      I+HRDLK  N+L+ +    K++DF +AR      S+  ++ +V T  
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLW 168

Query: 80  YMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
           Y  P+  +    +S   D++  G + +E++ G+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 16/100 (16%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIF------GGNQSEASTN 72
           RGL Y+H  +   ++HRDLK +NV ++ E +  KI DF +ARI        G  SE    
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 73  RIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
               T  Y +P   +      K+ D+++ G +  E+++GK
Sbjct: 181 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.2 bits (109), Expect = 4e-06
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 6/93 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL Y H   R +++HRDLK  N+L++     K++DF +AR      ++  +N +V T  
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLW 169

Query: 80  YMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
           Y  P+  +    +S + D++  G +  E+ +G+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 29/160 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIV-- 75
           +A  +L +H   ++  +HRD+K  NVL+D   + K++DF       G+ +  + N++V  
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADF-------GSAARLTANKMVNS 160

Query: 76  ----GTYGYMAPEY--AMEG----LFSVKSDVFSFGVLLLEIISGKK-----NSGFYLSE 120
               GT  Y+APE    M G     + V+ D +S GV+  E+I G+       S    + 
Sbjct: 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220

Query: 121 L--GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 158
           +   Q  L +        + L+L++ +L   C   E L +
Sbjct: 221 IMNFQRFLKFPEDPKVSSDFLDLIQSLL---CGQKERLGY 257

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.8 bits (108), Expect = 5e-06
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           +GL YLH   ++   HRD+K +N+LL    + K++DF +A       + A     +GT  
Sbjct: 117 QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPY 171

Query: 80  YMAPEYAM---EGLFSVKSDVFSFGVLLLEI 107
           +MAPE A     G ++   D+++ G+  +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 45.9 bits (109), Expect = 6e-06
 Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 6/106 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LD  R    +  I RG+ + H  +   IIHRD+K  N+L+      K+ DF  AR     
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153

Query: 66  QSEASTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG 110
             E  T+  V T  Y APE  + +  +    D+++ G L+ E+++G
Sbjct: 154 G-EVYTD-YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.5 bits (108), Expect = 6e-06
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 6/99 (6%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H      ++HRDLK  N+L++     K++DF +AR FG      S  
Sbjct: 103 SFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159

Query: 73  RIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISG 110
             V T  Y  P+      L+S   D++S G +  E+ + 
Sbjct: 160 --VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 11/117 (9%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-----KISDF 56
           + VQL      S++  I  G+ YLH +    ++HRDLK +N+L+  E  P     KI+D 
Sbjct: 101 KPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADM 156

Query: 57  EMARIFGGN-QSEASTNRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
             AR+F    +  A  + +V T+ Y APE  +      K+ D+++ G +  E+++ +
Sbjct: 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 24/87 (27%), Positives = 45/87 (51%), Gaps = 8/87 (9%)

Query: 33  IIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEAS-----TNRIVGTYGYMAPE 84
           I+HRDLK  N+++       + K+ DF +  +  G +         T  ++GT  Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 85  YAMEGLFSVKSDVFSFGVLLLEIISGK 111
                  +  SD++++G++ LE ++G+
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 6/93 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL Y H   + +I+HRDLK  N+L++ +   K++DF +AR      ++  +N +V T  
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLW 168

Query: 80  YMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
           Y  P+  +    +S   D++  G +L E+ +G+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 10/92 (10%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEM-ARIFGGNQSEASTNRIVGTY 78
           +GL YLH   +   +HRD+K +N+LL    + K++DF + A+I     + A     +GT 
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTP 170

Query: 79  GYMAPEYAM---EGLFSVKSDVFSFGVLLLEI 107
            +MAPE A    +G ++   D+++ G+  +E+
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 7/93 (7%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVGTY 78
           +G+ + H   +  ++HRDLK  N+L+D +    KI+D  + R F     ++ T+ IV T 
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TL 175

Query: 79  GYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
            Y APE  +    +S   D++S G +  E+   
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 11/117 (9%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-----KISDF 56
           + +QL      S++  I  G+ YLH +    ++HRDLK +N+L+  E  P     KI+D 
Sbjct: 101 KPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADM 156

Query: 57  EMARIFGGN-QSEASTNRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
             AR+F    +  A  + +V T+ Y APE  +      K+ D+++ G +  E+++ +
Sbjct: 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL Y H   + R++HRDLK  N+L+      K++DF +AR      S+  +N +V T  
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLW 168

Query: 80  YMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           Y  P+  +    +S   D++  G +  E+ +G
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.5 bits (102), Expect = 4e-05
 Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 4/99 (4%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S I  + + + + H++    I+HRD+K  N+L+ H    K+ DF  AR      S A+  
Sbjct: 104 SYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYT 159

Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y +PE  +   +    D++S G +L E+  G+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RGL Y+H+     I+HRDLK  N+L+      K++DF +AR      S   +N +V T
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV-T 166

Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
             Y  P+  +    +S   D++  G + +E+I G
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 42.7 bits (100), Expect = 6e-05
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 7/107 (6%)

Query: 19  ARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTY 78
           A  +L L     + +IHRD+K  N+LLD   + K++DF               +  VGT 
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTP 207

Query: 79  GYMAPEY----AMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
            Y++PE       +G +  + D +S GV L E++ G  ++ FY   L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.4 bits (99), Expect = 8e-05
 Identities = 30/101 (29%), Positives = 55/101 (54%), Gaps = 10/101 (9%)

Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDF-EMARIFGGNQSEASTNRIVGTYGYMAPEY--A 86
           +L  +HRD+K  N+L+D   + +++DF    ++      ++S    VGT  Y++PE   A
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPEILQA 177

Query: 87  ME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           ME   G +  + D +S GV + E++ G+  + FY   L ++
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 216

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 9e-05
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 15  INGIARGLL----YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           +  +AR LL    Y+H +    IIHRD+K  NVL++   +  + DF  A    G+ S   
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 106
              I GT    APE      ++   D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 34  IHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY----AMEG 89
           IHRD+K  N+LLD   + K++DF         +     +  VGT  Y++PE       +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 90  LFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
            +  + D +S GV L E++ G  ++ FY   L
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 33/126 (26%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF------------EMARIFGGN 65
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDF            E  R    N
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 66  ------------QSEAST---NR------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                       + +A T   NR       VGT  Y+APE  M+  ++   D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 105 LEIISG 110
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 32/115 (27%), Positives = 56/115 (48%), Gaps = 10/115 (8%)

Query: 1   MRSVQLDWKRRI------SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKIS 54
           M     DWK R       +I+  +   + Y+H+    ++IHRD+K  N+ L+ +    + 
Sbjct: 253 MYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309

Query: 55  DFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           DF  A  F   + EA     VGT    +PE      +   +D++S G++LL+++S
Sbjct: 310 DFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 37/126 (29%), Positives = 57/126 (45%), Gaps = 33/126 (26%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF------------EMARIFG-- 63
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDF            E  R     
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 64  ----------GNQSEAST---NR------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                      ++ +A T   NR       VGT  Y+APE  M+  ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 105 LEIISG 110
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 34/119 (28%)

Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEM---------ARIFGGNQSEAS- 70
            L YLH    L I++RDLK  N+LL    +  +SDF++                +     
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 71  -----------------TNRIVGTYGYMAPEY-AMEG-LFSVKSDVFSFGVLLLEIISG 110
                            +N  VGT  Y+APE  + +G   +V  D ++ G+LL E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 7/92 (7%)

Query: 34  IHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAM----EG 89
           IHRD+K  N+LLD   + K++DF        N         VGT  Y++PE       +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDG 222

Query: 90  LFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
            +  + D +S GV L E++ G  ++ FY   L
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.4 bits (95), Expect = 3e-04
 Identities = 25/104 (24%), Positives = 46/104 (44%), Gaps = 10/104 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF--GGNQSEA-- 69
           I+  +   L Y+H       IHR +KAS++LL  +    +S    +      G +     
Sbjct: 106 ILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 70  -STNRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISG 110
                 V    +++PE   + L  ++ KSD++S G+   E+ +G
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 40.2 bits (95), Expect = 4e-04
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 7/100 (7%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           SII  I +GL ++H   +    HRDLK  N+L+      KI+DF +AR     +S     
Sbjct: 103 SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYT 156

Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D+++ G ++ E+ + +
Sbjct: 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.2 bits (94), Expect = 4e-04
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 16/102 (15%)

Query: 22  LLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI---------FGGN----QSE 68
           L YLH      I+HRDLK  N+L+    + K++DF +++I         + G+      E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               ++ GT  Y+APE  +   +    D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           + R L Y+H  S+  I HRDLK  N+L+D   +  K+ DF  A+     Q   S    + 
Sbjct: 179 LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YIC 232

Query: 77  TYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           +  Y APE  +    ++   D++S G ++ E+I G
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 19/47 (40%), Positives = 31/47 (65%), Gaps = 3/47 (6%)

Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           I+ +A  L YLH      IIHRDLK  N+L+ +E + K++DF ++++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 6/99 (6%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
            II    + + + H   +   IHRD+K  N+L+  +   K+ DF  ARI  G   +  T+
Sbjct: 104 KIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTD 159

Query: 73  RIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
             V T  Y APE  +    +    DV++ G +  E+++G
Sbjct: 160 -YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.9 bits (93), Expect = 6e-04
 Identities = 28/106 (26%), Positives = 56/106 (52%), Gaps = 10/106 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFE--MARIFGGNQSEAS 70
           +I+ G  RGL YLH++     IHR++KAS++L+  +    +S      + +  G +++  
Sbjct: 105 NILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161

Query: 71  ---TNRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGK 111
                       +++PE   + L  ++VKSD++S G+   E+ +G+
Sbjct: 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 6e-04
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 22/99 (22%)

Query: 32  RIIHRDLKASNVLLD-------------HEMN----PKISDFEMARIFGGNQSEASTNRI 74
           R++HRDLK  N+ L              + +N     KI DF +++  G    E+  +  
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSC 201

Query: 75  VGTYGYMAPEYAMEGLFSV--KSDVFSFGVLLLEIISGK 111
           VGT  Y +PE  +    S   KSD+++ G ++ E+ SGK
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 39.6 bits (93), Expect = 6e-04
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 8/93 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + + L ++H   R  I HRD+K  N+L+  +   K++DF   R  G       T  I  T
Sbjct: 109 LLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-ST 161

Query: 78  YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIIS 109
             Y APE  + +G +  K D+++ G +  EI+S
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 37.9 bits (88), Expect = 0.002
 Identities = 29/138 (21%), Positives = 53/138 (38%), Gaps = 45/138 (32%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-------------RIFGG 64
           +A  +L +    +L  IHRD+K  N+L+D   + K+SDF ++             ++  G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166

Query: 65  --NQSEASTNR------------------------------IVGTYGYMAPEYAMEGLFS 92
             N++                                     VGT  Y+APE  ++  + 
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226

Query: 93  VKSDVFSFGVLLLEIISG 110
            + D +S G ++ E + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 37.5 bits (87), Expect = 0.004
 Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 41/123 (33%)

Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEM---------ARIFGGNQ-------------S 67
           ++  IHRD+K  N+L+D + + K++DF +         ++ +                 S
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 68  EASTNR-------------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
           E    R                   +VGT  Y+APE  +   ++   D +S GV+L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 109 SGK 111
            G+
Sbjct: 239 VGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	230
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.98
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.96
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.96
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
PTZ00283	496	serine/threonine protein kinase; Provisional	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.95
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
PHA03207	392	serine/threonine kinase US3; Provisional	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
PTZ00267	478	NIMA-related protein kinase; Provisional	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.95
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.95
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.95
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.95
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
PTZ00284	467	protein kinase; Provisional	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.95
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.95
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.95
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.95
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.95
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.94
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.94
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.94
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
PHA03209	357	serine/threonine kinase US3; Provisional	99.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.94
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.94
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.94
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.94
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.94
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.94
KOG0589	426	consensus Serine/threonine protein kinase [General	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.94
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.94
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.94
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
KOG0605	550	consensus NDR and related serine/threonine kinases	99.94
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.94
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.94
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.93
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.93
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.93
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.93
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.93
PHA03210	501	serine/threonine kinase US3; Provisional	99.93
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.93
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.93
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.93
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.93
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.93
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.93
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.93
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.93
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.93
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.93
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.93
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.93
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.93
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.93
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.93
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.93
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.93
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.93
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.93
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.93
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.93
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.93
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.93
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.93
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.93
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.93
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.93
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.93
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.92
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.92
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.92
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.92
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.92
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.92
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.92
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.92
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.92
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.92
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.92
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.92
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.92
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.92
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.92
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.92
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.92
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.92
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.92
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.92
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.92
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.92
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.92
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.92
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.92
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.92
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.92
KOG0584	632	consensus Serine/threonine protein kinase [General	99.92
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.92
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.92
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.92
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.92
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.92
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.92
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.91
KOG0610	459	consensus Putative serine/threonine protein kinase	99.91
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.91
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.91
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.91
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.91
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.91
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.91
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.91
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.91
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.91
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.91
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.91
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.91
PLN00009	294	cyclin-dependent kinase A; Provisional	99.91
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.91
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.91
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.91
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.91
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.91
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.91
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.9
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.9
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.9
KOG3653	534	consensus Transforming growth factor beta/activin	99.9
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.9
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.89
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.89
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.89
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.88
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.88
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.87
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.87
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.87
KOG0586	596	consensus Serine/threonine protein kinase [General	99.86
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.86
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.86
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.85
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.85
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.85
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.84
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.83
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.83
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.83
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.82
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.81
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.81
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.81
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.8
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.79
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.78
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.72
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.72
KOG1152	772	consensus Signal transduction serine/threonine kin	99.71
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.7
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.67
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.66
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.65
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.65
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.64
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.61
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.6
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.55
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.48
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.46
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.41
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.32
PRK09188	365	serine/threonine protein kinase; Provisional	99.17
PRK12274	218	serine/threonine protein kinase; Provisional	99.16
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.14
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.14
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.11
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.08
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.88
smart00090	237	RIO RIO-like kinase.	98.77
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.61
PRK10345	210	hypothetical protein; Provisional	98.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.56
PRK14879	211	serine/threonine protein kinase; Provisional	98.48
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.41
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.36
KOG1243	690	consensus Protein kinase [General function predict	98.24
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.2
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.13
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.06
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.05
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.05
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.03
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.98
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.84
PRK09902	216	hypothetical protein; Provisional	97.83
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.76
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.66
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.64
KOG3087	229	consensus Serine/threonine protein kinase [General	97.48
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.23
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.04
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.88
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	96.82
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.69
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.67
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	96.56
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.88
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.75
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.27
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.04
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	93.86
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.81
PF01636	239	APH: Phosphotransferase enzyme family This family	93.78
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.64
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	93.26
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.05
PRK05231	319	homoserine kinase; Provisional	93.0
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	92.58
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.43
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	91.91
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	91.9
PRK10271	188	thiK thiamine kinase; Provisional	91.67
PLN02236	344	choline kinase	91.36
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.29
COG2334	331	Putative homoserine kinase type II (protein kinase	90.98
KOG2268	465	consensus Serine/threonine protein kinase [Signal	90.82
COG4499	434	Predicted membrane protein [Function unknown]	90.37
PRK09550	401	mtnK methylthioribose kinase; Reviewed	89.59
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	89.51
KOG1235	538	consensus Predicted unusual protein kinase [Genera	88.25
KOG1093	725	consensus Predicted protein kinase (contains TBC a	88.0
PHA03111	444	Ser/Thr kinase; Provisional	87.84
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	87.52
KOG0576	829	consensus Mitogen-activated protein kinase kinase	87.27
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	87.17
PRK11768	325	serine/threonine protein kinase; Provisional	87.02
PRK06148	1013	hypothetical protein; Provisional	86.69
PRK12396	409	5-methylribose kinase; Reviewed	86.64
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	86.35
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	84.84
PLN02756	418	S-methyl-5-thioribose kinase	83.92
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	83.86
PRK06149	972	hypothetical protein; Provisional	83.81
KOG2270	520	consensus Serine/threonine protein kinase involved	82.63

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=227.90  Aligned_cols=168  Identities=32%  Similarity=0.432  Sum_probs=135.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++..+++++.||+.|+.|||+++.  |||||||++|+|++.++ .+||+|||+++.......  ......|+..|+
T Consensus       136 ~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~--~~~~~~GT~~wM  211 (362)
T KOG0192|consen  136 KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT--SMTSVAGTYRWM  211 (362)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccccc--cccCCCCCcccc
Confidence            5789999999999999999999999872  89999999999999997 999999999987643221  111246789999


Q ss_pred             Chhhhh--cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           82 APEYAM--EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        82 aPe~~~--~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |||++.  ...|+.++||||||+++|||+||..||......      +.         .........++..+..+...+.
T Consensus       212 APEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~---------~~~v~~~~~Rp~~p~~~~~~l~  276 (362)
T KOG0192|consen  212 APEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QV---------ASAVVVGGLRPPIPKECPPHLS  276 (362)
T ss_pred             ChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HH---------HHHHHhcCCCCCCCccCCHHHH
Confidence            999999  568999999999999999999999998644321      11         2222233334445555777899


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      .+|.+||..||+.||++.+|+..|+.....
T Consensus       277 ~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  277 SLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             HHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            999999999999999999999999865443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=231.79  Aligned_cols=166  Identities=33%  Similarity=0.436  Sum_probs=143.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+...+.+.++.||++|++||++++   +|||||.++|||++.+..+|++|||+++.......... ....-+..|.|
T Consensus       297 ~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~~kfPIkWtA  372 (468)
T KOG0197|consen  297 GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EGGKFPIKWTA  372 (468)
T ss_pred             CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec-CCCCCCceecC
Confidence            467889999999999999999999999   99999999999999999999999999995543333222 22234679999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+....++.++|||||||++|||+| |+.||+.                +.+.++...++++.+...|..|+..++++
T Consensus       373 PEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~----------------msn~ev~~~le~GyRlp~P~~CP~~vY~l  436 (468)
T KOG0197|consen  373 PEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG----------------MSNEEVLELLERGYRLPRPEGCPDEVYEL  436 (468)
T ss_pred             HHHHhhCCcccccceeehhhhHHHHhccCCCCCCC----------------CCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence            999999999999999999999999999 6666542                34556778888888889999999999999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      |..||..+|++|||++.+...|++...
T Consensus       437 M~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  437 MKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            999999999999999999999987654

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5e-32  Score=225.88  Aligned_cols=182  Identities=43%  Similarity=0.693  Sum_probs=155.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecC-CCCCccccccccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG-NQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~~aP   83 (230)
                      +|+|.++++|+.++|.||+|||.....+|+|||||++|||+|.+..+||+|||++..... .......  ..|+..|++|
T Consensus       170 ~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~--~~gt~gY~~P  247 (361)
T KOG1187|consen  170 PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTT--VMGTFGYLAP  247 (361)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeee--cCCCCccCCh
Confidence            889999999999999999999998877899999999999999999999999999955432 1111110  0568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhc-chhhH-HHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK-QSCVA-AELLKFIHI  161 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l  161 (230)
                      |++..+..+.++||||||+++.|+++|..+.....+.......+|.+..+..+...+++|+.+. ..++. .+...+..+
T Consensus       248 Ey~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~  327 (361)
T KOG1187|consen  248 EYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAEL  327 (361)
T ss_pred             hhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHH
Confidence            9999999999999999999999999999987765555555578888888888899999999986 55554 688889999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      +.+|++.+|.+||+|.+|++.|+....
T Consensus       328 a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  328 ALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            999999999999999999999955443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-32  Score=217.33  Aligned_cols=157  Identities=31%  Similarity=0.434  Sum_probs=127.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +++++...-+++.+|+.||.|||. .+   |+||||||+|+|++..|.+||+|||.+....+.    ....+.|+..||+
T Consensus       173 g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMs  245 (364)
T KOG0581|consen  173 GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMS  245 (364)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccC
Confidence            578999999999999999999995 66   999999999999999999999999998776443    2334688999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhh---cchhhH-HHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVL---KQSCVA-AELLKF  158 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~l  158 (230)
                      ||.+++..|+.++||||||+.++|+.+|..||....+...              ....++....   .+..|. ..+.+|
T Consensus       246 PERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~--------------~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  246 PERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL--------------DIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             hhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC--------------CHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            9999999999999999999999999999999865411111              1111111111   122333 367779


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..++..||++||.+|||+.++++
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.8e-32  Score=228.02  Aligned_cols=156  Identities=26%  Similarity=0.367  Sum_probs=128.9

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++++|++.++..+++||+.||.|||+.+   |+|||||..|+|++.+..+||+|||++.........  .....|++.|.
T Consensus       111 rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYI  185 (592)
T KOG0575|consen  111 RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYI  185 (592)
T ss_pred             hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCccc
Confidence            4679999999999999999999999999   999999999999999999999999999887543222  22368899999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcc--hhhHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ--SCVAAELLKFI  159 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  159 (230)
                      |||++.....+..+||||+||++|.||.|.+||....                   +...+.+....  .+|...+....
T Consensus       186 APEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------------------vkety~~Ik~~~Y~~P~~ls~~A~  246 (592)
T KOG0575|consen  186 APEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------------------VKETYNKIKLNEYSMPSHLSAEAK  246 (592)
T ss_pred             ChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------------------HHHHHHHHHhcCcccccccCHHHH
Confidence            9999999999999999999999999999999986321                   11111111111  23445556688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +|+..+|+.||.+|||+++|+.
T Consensus       247 dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  247 DLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            8999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.7e-31  Score=206.34  Aligned_cols=165  Identities=25%  Similarity=0.330  Sum_probs=129.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCC-CCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDS-RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~-~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++.+++..+|+++.|++.||..+|.+- +..++||||||.||+++.+|.+||+|||+++++.....  .....+|++.||
T Consensus       118 kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYM  195 (375)
T KOG0591|consen  118 KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYM  195 (375)
T ss_pred             cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCccc
Confidence            568999999999999999999999942 23499999999999999999999999999998765433  333468999999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh-HHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV-AAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~  160 (230)
                      +||.+...+|+.++||||+||++|||..-++||...      ...+.- +.+.+++..         ..| ...+..+..
T Consensus       196 SPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~-~KI~qgd~~---------~~p~~~YS~~l~~  259 (375)
T KOG0591|consen  196 SPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLC-KKIEQGDYP---------PLPDEHYSTDLRE  259 (375)
T ss_pred             CHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHH-HHHHcCCCC---------CCcHHHhhhHHHH
Confidence            999999999999999999999999999999998633      222221 112222211         122 455667999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      |+..|+..||+.||+.-.+++.++.
T Consensus       260 li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  260 LINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHccCCcccCCCcchHHHHHHH
Confidence            9999999999999996555554443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=1.3e-30  Score=216.81  Aligned_cols=166  Identities=30%  Similarity=0.398  Sum_probs=125.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++................++..|+|
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence            357899999999999999999999999   99999999999999999999999999875432211111111233567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|+|++ |..||.......     .. ......+..         ...+...+..+.++
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~-~~~~~~~~~---------~~~~~~~~~~l~~l  309 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EF-CQRLKDGTR---------MRAPENATPEIYRI  309 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HH-HHHHhcCCC---------CCCCCCCCHHHHHH
Confidence            999988889999999999999999997 899986432110     00 011111111         11122344568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||++|||+.+|++.|++.
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=1.6e-29  Score=204.96  Aligned_cols=163  Identities=28%  Similarity=0.410  Sum_probs=126.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       119 ~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence            56889999999999999999999999   999999999999999999999999998754322221122223446789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||......                +....+........+...+..+.+++
T Consensus       196 E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~l~  259 (283)
T cd05048         196 EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----------------EVIEMIRSRQLLPCPEDCPARVYALM  259 (283)
T ss_pred             HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHHHcCCcCCCcccCCHHHHHHH
Confidence            99988889999999999999999998 88887532211                01111111111223344556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||++||++.+|+++|+.
T Consensus       260 ~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         260 IECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHccCChhhCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=212.19  Aligned_cols=160  Identities=24%  Similarity=0.365  Sum_probs=128.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.++..+++.++.||+|||.+|   |+|||||.+||+++.+|.+||+|||+|..+.......  ..-+|+++|+|
T Consensus       363 ~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR--~TmVGTPYWMA  437 (550)
T KOG0578|consen  363 KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR--STMVGTPYWMA  437 (550)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcc--ccccCCCCccc
Confidence            346889999999999999999999999   9999999999999999999999999998775544322  22588999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++....|.++.||||||++++||+.|++||-...+      +...+....++..        ....+...+..|.+++
T Consensus       438 PEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~P--------~lk~~~klS~~~kdFL  503 (550)
T KOG0578|consen  438 PEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGTP--------KLKNPEKLSPELKDFL  503 (550)
T ss_pred             hhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCCC--------CcCCccccCHHHHHHH
Confidence            9999999999999999999999999999999743211      1111111111111        1122445566789999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.|+++|+++.++++
T Consensus       504 ~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHhhcchhcCCCHHHHhc
Confidence            9999999999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=208.45  Aligned_cols=162  Identities=25%  Similarity=0.338  Sum_probs=122.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecC-CCCCccccccccccCccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGG-NQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~~a   82 (230)
                      .|++..+..+.+||++||+|||++|   ++|||||++|||++. ++.+||+|||++..... ...........|++.|+|
T Consensus       113 ~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~ma  189 (313)
T KOG0198|consen  113 KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMA  189 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccC
Confidence            6999999999999999999999999   999999999999999 79999999998876542 111122223577899999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.++ ....++|||||||++.||+||..||....     ......         ..+......+..+...+....++
T Consensus       190 PEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~---------~~ig~~~~~P~ip~~ls~~a~~F  255 (313)
T KOG0198|consen  190 PEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEAL---------LLIGREDSLPEIPDSLSDEAKDF  255 (313)
T ss_pred             chhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHH---------HHHhccCCCCCCCcccCHHHHHH
Confidence            9999863 23359999999999999999999985420     000000         11111111123444455668888


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHh
Q 026939          162 GLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +..|++.||++||||.++++..
T Consensus       256 l~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  256 LRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             HHHHhhcCcccCcCHHHHhhCh
Confidence            9999999999999999999844

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=2.5e-29  Score=209.32  Aligned_cols=165  Identities=31%  Similarity=0.376  Sum_probs=125.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.++.+++.||+.||+|||+.+   |+||||+|+||+++.++.++|+|||++................++..|+||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            47899999999999999999999999   999999999999999999999999998765322211111122345679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++++|++ |..||.......      ........+         .....+......+.+++
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~l~  309 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEG---------TRMRAPEYATPEIYSIM  309 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhcc---------CCCCCCccCCHHHHHHH
Confidence            99999999999999999999999998 988875322110      000111111         11111223445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.+|++||++.+|++.|+..
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=2.8e-29  Score=211.71  Aligned_cols=165  Identities=27%  Similarity=0.390  Sum_probs=124.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.++++++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++................++..|+||
T Consensus       207 ~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  283 (374)
T cd05106         207 WPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAP  283 (374)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCH
Confidence            46899999999999999999999999   999999999999999999999999998754322211111112234579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||........               .............+...+..+.+++
T Consensus       284 E~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li  348 (374)
T cd05106         284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---------------FYKMVKRGYQMSRPDFAPPEIYSIM  348 (374)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---------------HHHHHHcccCccCCCCCCHHHHHHH
Confidence            99988889999999999999999997 9999854221100               0001111111111122245688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|++.
T Consensus       349 ~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=202.94  Aligned_cols=158  Identities=23%  Similarity=0.219  Sum_probs=122.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.++..++..|+.||.|||++|   |+|||+||+|||++.+|.++|+|||++.......  .......|++.|+|
T Consensus       119 eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmA  193 (357)
T KOG0598|consen  119 EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMA  193 (357)
T ss_pred             cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccC
Confidence            457899999999999999999999999   9999999999999999999999999997543221  22233688999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+.+|+.++|.||||+++|+|++|.+||........                .+.+........+.-......+++
T Consensus       194 PEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----------------~~~I~~~k~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  194 PEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----------------YDKILKGKLPLPPGYLSEEARDLL  257 (357)
T ss_pred             hHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----------------HHHHhcCcCCCCCccCCHHHHHHH
Confidence            9999999999999999999999999999999864331111                011111001122333455678888


Q ss_pred             hhhcCCCCCCCC----CHHHHHH
Q 026939          163 LLCVQADSADRP----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP----s~~~i~~  181 (230)
                      ...|+.||++|.    ++.+|.+
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhc
Confidence            999999999995    5666543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=207.76  Aligned_cols=175  Identities=23%  Similarity=0.255  Sum_probs=131.4

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      |++.+++..+..|++||+.||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+..........   ++.+.+|.
T Consensus       103 R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTe---YVSTRWYR  176 (538)
T KOG0661|consen  103 RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTE---YVSTRWYR  176 (538)
T ss_pred             cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCCcch---hhhccccc
Confidence            4678999999999999999999999999   99999999999999888999999999987655443322   46788999


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh-----hHHHHhhh-hhhhhhc---hhh----c
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY-----TWKLWCEG-EALELME---PVL----K  147 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~---~~~----~  147 (230)
                      |||++... -|+...|+|++||+++|+.+-++-|....+.+....+-.     .+..|..+ .....+.   +..    -
T Consensus       177 APEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l  256 (538)
T KOG0661|consen  177 APEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPL  256 (538)
T ss_pred             chHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCCh
Confidence            99998754 689999999999999999999998876554433222210     11111111 0111110   000    0


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      ....+.....+.+||.+|+.+||++||||.+.++.
T Consensus       257 ~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  257 KDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11223477789999999999999999999999873

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.4e-29  Score=202.71  Aligned_cols=167  Identities=28%  Similarity=0.399  Sum_probs=124.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccc-cccccccCccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-AST-NRIVGTYGYMA   82 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~-~~~~~~~~~~a   82 (230)
                      .+++..+..|++++++||.|||++|   .+|||||+.|||++.+|.++|+|||.....-..... ... ....++++|+|
T Consensus       122 Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmA  198 (516)
T KOG0582|consen  122 GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMA  198 (516)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccC
Confidence            4788899999999999999999999   999999999999999999999999987654333222 111 34578999999


Q ss_pred             hhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||+++.  ..|+.|+||||||+...||.+|..||..+.+....       -...++......-..+..+........|.+
T Consensus       199 PEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-------l~tLqn~pp~~~t~~~~~d~~k~~~ksf~e  271 (516)
T KOG0582|consen  199 PEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-------LLTLQNDPPTLLTSGLDKDEDKKFSKSFRE  271 (516)
T ss_pred             hHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-------HHHhcCCCCCcccccCChHHhhhhcHHHHH
Confidence            999654  36999999999999999999999999765433210       011111111111111111222333447889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++..||++||.+|||++++++
T Consensus       272 ~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  272 MIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHHHHhhcCcccCCCHHHHhc
Confidence            999999999999999999986

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=4.2e-29  Score=202.64  Aligned_cols=163  Identities=25%  Similarity=0.358  Sum_probs=123.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................+++.|+||
T Consensus       119 ~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05091         119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP  195 (283)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCH
Confidence            45888999999999999999999999   999999999999999999999999988754322211111122345689999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||......      +. ......+.         ...++...+..+.+++
T Consensus       196 E~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~i~~~~---------~~~~~~~~~~~~~~li  259 (283)
T cd05091         196 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV-IEMIRNRQ---------VLPCPDDCPAWVYTLM  259 (283)
T ss_pred             HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHcCC---------cCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 77776532111      00 01111111         1122334455688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      ..||+.+|++||++.+|+.+|+.
T Consensus       260 ~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         260 LECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHhCCCcccCCCHHHHHHHhhC
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=3.8e-29  Score=203.36  Aligned_cols=162  Identities=19%  Similarity=0.266  Sum_probs=125.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      .+.+++.++++++.|++.||.+||+. +   ++||||+|+||+++.++.+||+|||++........     ...++..|+
T Consensus       116 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~  187 (283)
T PHA02988        116 EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF-----KNVNFMVYF  187 (283)
T ss_pred             CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccccc-----cccCccccc
Confidence            35789999999999999999999984 6   88999999999999999999999999875432211     124577899


Q ss_pred             Chhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           82 APEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        82 aPe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |||++.+  ..++.++|||||||++|+|++|..||......      +.. ...        .........+...+..+.
T Consensus       188 aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~-~~i--------~~~~~~~~~~~~~~~~l~  252 (283)
T PHA02988        188 SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIY-DLI--------INKNNSLKLPLDCPLEIK  252 (283)
T ss_pred             CHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHH-HHH--------HhcCCCCCCCCcCcHHHH
Confidence            9999976  67899999999999999999999998643211      000 000        011111122334456799


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      +++.+||+.||++|||+.+|++.|+..+
T Consensus       253 ~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        253 CIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            9999999999999999999999998654

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=6.4e-29  Score=209.65  Aligned_cols=164  Identities=28%  Similarity=0.415  Sum_probs=123.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+++++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  285 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP  285 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence            46899999999999999999999999   999999999999999999999999998765432221111112334579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||.......      .....         +........+...+..+.+++
T Consensus       286 E~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~---------~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         286 ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKM---------IKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             hHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHH---------HHhCccCCCCCCCCHHHHHHH
Confidence            99998899999999999999999998 788875322110      00011         111111111122244688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||++||++.+|++.|+.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             HHHccCChhHCcCHHHHHHHHHh
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=1.1e-29  Score=221.84  Aligned_cols=166  Identities=28%  Similarity=0.381  Sum_probs=139.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      +|+..+.+.|+.|||.|+.||-++.   +|||||..+|++|..+..+||+|||+++-.-...+......-.-+.+||+||
T Consensus       599 ~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  599 PLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            4999999999999999999999988   9999999999999999999999999997654444444443344578999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+..++|+.++||||+||++||+++ |..||...                .+.++.+.+...--..+|..++.+++.||.
T Consensus       676 sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl----------------Sn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~  739 (774)
T KOG1026|consen  676 SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL----------------SNQEVIECIRAGQLLSCPENCPTEVYSLML  739 (774)
T ss_pred             HhhcCcccchhhhhhhhhhhhhhhccccCccccc----------------chHHHHHHHHcCCcccCCCCCCHHHHHHHH
Confidence            9999999999999999999999998 88886432                233344444443335678888999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      .||+.+|++||++.+|-.+|+.....
T Consensus       740 ~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  740 ECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            99999999999999999999876554

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.96  E-value=4.1e-29  Score=203.35  Aligned_cols=172  Identities=21%  Similarity=0.248  Sum_probs=122.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ......++..|+||
T Consensus       105 ~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aP  178 (290)
T cd07862         105 PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAP  178 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccCh
Confidence            45899999999999999999999999   9999999999999999999999999987654321   11223567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH-----HHHhhh-hh-hhhhchhh---cchhhHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW-----KLWCEG-EA-LELMEPVL---KQSCVAA  153 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~-~~-~~~~~~~~---~~~~~~~  153 (230)
                      |.+.+..++.++|+|||||++|+|++|..||................     ..+... .. ........   .....+.
T Consensus       179 E~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T cd07862         179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD  258 (290)
T ss_pred             HHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccC
Confidence            99988889999999999999999999999986543221100000000     000000 00 00000000   0011122


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....+.+++.+||+.||++|||+.++++
T Consensus       259 ~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         259 IDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            3456789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=212.39  Aligned_cols=174  Identities=26%  Similarity=0.427  Sum_probs=132.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..|++.+.+.|+.||+.|+.|||.++   |+|+|||..|||+..+++|||+|||++..-..-..........+...|+|
T Consensus       482 etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmA  558 (678)
T KOG0193|consen  482 ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMA  558 (678)
T ss_pred             hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhc
Confidence            457889999999999999999999999   99999999999999999999999999876432211222233466779999


Q ss_pred             hhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||+++-   .+|++.+||||||+++|||++|..||.....+   +.+      |.-+..+-..+...   ....+.+.+.
T Consensus       559 PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d---qIi------fmVGrG~l~pd~s~---~~s~~pk~mk  626 (678)
T KOG0193|consen  559 PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD---QII------FMVGRGYLMPDLSK---IRSNCPKAMK  626 (678)
T ss_pred             HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh---heE------EEecccccCccchh---hhccCHHHHH
Confidence            999984   36999999999999999999999998732211   111      11111111111111   1234555688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      +|+..||..++++||.+.+|+..|++....++
T Consensus       627 ~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  627 RLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             HHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence            89999999999999999999999988766554

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.96  E-value=6.8e-29  Score=202.40  Aligned_cols=166  Identities=27%  Similarity=0.349  Sum_probs=126.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..+++++.||+.||+|||+++   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       119 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  195 (291)
T cd05094         119 ELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  195 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence            4889999999999999999999999   9999999999999999999999999986543222111112234467899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+||||+++|+|++ |..||.......       .......+...         ..+...+..+.+++.
T Consensus       196 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li~  259 (291)
T cd05094         196 SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECITQGRVL---------ERPRVCPKEVYDIML  259 (291)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhCCCCC---------CCCccCCHHHHHHHH
Confidence            9988889999999999999999999 898875432211       01111111111         111223456889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      +||+.||++||++.+|++.|+.....
T Consensus       260 ~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         260 GCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHcccChhhCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999887553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=1e-28  Score=202.51  Aligned_cols=170  Identities=25%  Similarity=0.350  Sum_probs=122.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+++++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       133 ~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         133 PAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            35788899999999999999999999   999999999999999999999999998765332221112222346689999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhc--CCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISG--KKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |.+.+..++.++|+||||+++|+|+++  ..||.......   ...........      .........+..++..+.++
T Consensus       210 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l  280 (304)
T cd05096         210 ECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRD------QGRQVYLFRPPPCPQGLYEL  280 (304)
T ss_pred             HHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhh------ccccccccCCCCCCHHHHHH
Confidence            999888899999999999999999874  45554322111   00000000000      00000011122344568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+||+.||++|||+.+|.+.|++
T Consensus       281 i~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         281 MLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHHccCCchhCcCHHHHHHHHhC
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-29  Score=206.49  Aligned_cols=163  Identities=26%  Similarity=0.327  Sum_probs=126.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC---------cc--cc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE---------AS--TN   72 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------~~--~~   72 (230)
                      ..|++.-...++.+|+.||+|||+.|   ||||||||+|||++.++.++|.|||.+..+......         ..  ..
T Consensus       169 Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~  245 (604)
T KOG0592|consen  169 GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRS  245 (604)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccc
Confidence            47888889999999999999999999   999999999999999999999999999876432111         11  13


Q ss_pred             ccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH
Q 026939           73 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA  152 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (230)
                      .++|+..|.+||++.....+..+|+|+|||++|+|+.|++||....+..     .+.       ++.+ ++-    .++.
T Consensus       246 SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-----iFq-------kI~~-l~y----~fp~  308 (604)
T KOG0592|consen  246 SFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-----IFQ-------KIQA-LDY----EFPE  308 (604)
T ss_pred             ceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-----HHH-------HHHH-hcc----cCCC
Confidence            3688999999999999999999999999999999999999986433211     010       1111 111    1233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ..++...+|+.+.|..||.+|+|+.+|.+  ++++.
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence            33355888899999999999999999987  44554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1e-29  Score=206.18  Aligned_cols=161  Identities=23%  Similarity=0.318  Sum_probs=121.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC---CCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ++.+.+.....+++|++.|+.|||++|   |+||||||+|||+..+   .-+|++|||++...+....   .....|++.
T Consensus       270 nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf---m~TlCGTps  343 (475)
T KOG0615|consen  270 NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF---MKTLCGTPS  343 (475)
T ss_pred             ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcccccee---hhhhcCCcc
Confidence            456777788899999999999999999   9999999999999876   5589999999988753222   223578999


Q ss_pred             ccChhhhhcCC---CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           80 YMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        80 ~~aPe~~~~~~---~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      |.|||++.+..   +..++|+||+||++|.+++|.+||........  +.    +....+...      +.+..-....+
T Consensus       344 YvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~----eQI~~G~y~------f~p~~w~~Ise  411 (475)
T KOG0615|consen  344 YVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LK----EQILKGRYA------FGPLQWDRISE  411 (475)
T ss_pred             ccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HH----HHHhcCccc------ccChhhhhhhH
Confidence            99999998765   34578999999999999999999964332220  00    111111100      01122234566


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +..+|+.+||..||++|||+.|+++
T Consensus       412 ea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  412 EALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHHHHHhhEeCcccCcCHHHHhc
Confidence            7889999999999999999999875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.96  E-value=1.2e-28  Score=197.33  Aligned_cols=165  Identities=28%  Similarity=0.377  Sum_probs=126.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc-ccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~   81 (230)
                      ...+++..++.++.|++.||++||+++   ++|+||+|.||+++.++.++|+|||++........... .....++..|+
T Consensus        89 ~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  165 (257)
T cd05116          89 NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY  165 (257)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCcccc
Confidence            356899999999999999999999999   99999999999999999999999999876543322111 11112246899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++|+|||||++|+|++ |..||.......      .          ...+........+...+..+.+
T Consensus       166 aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~----------~~~i~~~~~~~~~~~~~~~l~~  229 (257)
T cd05116         166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------V----------TQMIESGERMECPQRCPPEMYD  229 (257)
T ss_pred             CHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------H----------HHHHHCCCCCCCCCCCCHHHHH
Confidence            9999988888999999999999999998 899986432110      0          1111111112223344567899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ++.+||+.||++||++.+|.+.|++.
T Consensus       230 li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         230 LMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHHhccCchhCcCHHHHHHHHhcc
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-29  Score=207.11  Aligned_cols=157  Identities=23%  Similarity=0.272  Sum_probs=124.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ..++.+..+.+++.||++|++|||+.|   |+|||||++|++++.+ +.+||+|||++.....  .........|++.|+
T Consensus       114 ~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~  188 (370)
T KOG0583|consen  114 KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG--EDGLLKTFCGSPAYA  188 (370)
T ss_pred             cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC--CCCcccCCCCCcccC
Confidence            468899999999999999999999999   9999999999999999 9999999999987631  111222357899999


Q ss_pred             ChhhhhcCC-CC-ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH-HHHH
Q 026939           82 APEYAMEGL-FS-VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE-LLKF  158 (230)
Q Consensus        82 aPe~~~~~~-~~-~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l  158 (230)
                      |||++.+.. |. .++||||+||++|.|++|..||........       ...        +....  -.++... ...+
T Consensus       189 aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-------~~k--------i~~~~--~~~p~~~~S~~~  251 (370)
T KOG0583|consen  189 APEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-------YRK--------IRKGE--FKIPSYLLSPEA  251 (370)
T ss_pred             CHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-------HHH--------HhcCC--ccCCCCcCCHHH
Confidence            999999877 86 789999999999999999999975221100       000        00000  0122222 6678


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..++.+||..||.+|+++.+|++
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhh
Confidence            99999999999999999999984

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=1.1e-28  Score=198.88  Aligned_cols=164  Identities=24%  Similarity=0.327  Sum_probs=124.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+++   ++|+||+|+||+++.++.++|+|||++.................+..|++|
T Consensus       107 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         107 QYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCH
Confidence            35889999999999999999999999   999999999999999999999999998765432221111122345679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |...+..++.++|+||||+++|+|++ |..||......   .    .......+..         ...+......+.+++
T Consensus       184 e~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~~~---------~~~~~~~~~~~~~li  247 (272)
T cd05075         184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---E----IYDYLRQGNR---------LKQPPDCLDGLYSLM  247 (272)
T ss_pred             HHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHcCCC---------CCCCCCCCHHHHHHH
Confidence            99988889999999999999999999 77887532111   0    0111111111         011223344588999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|++.
T Consensus       248 ~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         248 SSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.96  E-value=1.3e-28  Score=200.53  Aligned_cols=165  Identities=25%  Similarity=0.326  Sum_probs=124.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       116 ~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  192 (288)
T cd05093         116 ELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  192 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHH
Confidence            5899999999999999999999999   9999999999999999999999999987543222111111223356799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++++|++ |..||.......      . ......+...         ..+...+..+.+++.
T Consensus       193 ~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~-~~~i~~~~~~---------~~~~~~~~~l~~li~  256 (288)
T cd05093         193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------V-IECITQGRVL---------QRPRTCPKEVYDLML  256 (288)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHHcCCcC---------CCCCCCCHHHHHHHH
Confidence            9988889999999999999999998 888875332110      0 0111111110         011123345899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      +||+.||.+|||+.+|+..|+....
T Consensus       257 ~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         257 GCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHccCChhhCCCHHHHHHHHHHHHH
Confidence            9999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.96  E-value=1.5e-28  Score=199.07  Aligned_cols=166  Identities=26%  Similarity=0.330  Sum_probs=125.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.................+..|++|
T Consensus       104 ~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         104 DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCH
Confidence            46899999999999999999999999   999999999999999999999999998765432221111112234679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |...+..++.++|+|||||++|+|++ |..||.......                ....+........+...+..+.+++
T Consensus       181 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li  244 (279)
T cd05109         181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----------------IPDLLEKGERLPQPPICTIDVYMIM  244 (279)
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHHCCCcCCCCccCCHHHHHHH
Confidence            99988889999999999999999998 888875322110                0001111111111223445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      ..||+.||++||++.++++.|+....
T Consensus       245 ~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         245 VKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            99999999999999999999876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=3.8e-29  Score=196.09  Aligned_cols=172  Identities=17%  Similarity=0.259  Sum_probs=126.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..++...+.++++|++.|+.|+|+++   ++||||||+||+++.+|.+||+|||+++.......  ....++.+.+|.||
T Consensus        96 ~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaP  170 (396)
T KOG0593|consen   96 NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAP  170 (396)
T ss_pred             CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccCh
Confidence            35788899999999999999999999   99999999999999999999999999987653222  22224568899999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhh---chhh----c
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELM---EPVL----K  147 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~~~----~  147 (230)
                      |.+.+ .+|...+||||+||++.||++|.+-|....+.+....+..        -+..+........+   .+.-    .
T Consensus       171 ELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe  250 (396)
T KOG0593|consen  171 ELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLE  250 (396)
T ss_pred             hhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchh
Confidence            99998 4799999999999999999999999876555443222211        11222222111111   1000    0


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..+ +....-+++++..||+.||++|++.++++.
T Consensus       251 ~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  251 RKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             hhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            011 222335889999999999999999998864

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=1.8e-28  Score=198.79  Aligned_cols=167  Identities=25%  Similarity=0.319  Sum_probs=125.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~  179 (279)
T cd05111         103 RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA  179 (279)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccC
Confidence            357899999999999999999999999   99999999999999999999999999976532221111122344568999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++|++++ |..||........       ......+.         ....+..+...+..+
T Consensus       180 pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~~l  243 (279)
T cd05111         180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGE---------RLAQPQICTIDVYMV  243 (279)
T ss_pred             HHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCC---------cCCCCCCCCHHHHHH
Confidence            999988889999999999999999998 8888753221100       00111111         111111233457888


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      +.+||..||++|||+.++++.|.....
T Consensus       244 i~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         244 MVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=1.8e-28  Score=198.50  Aligned_cols=162  Identities=27%  Similarity=0.301  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       117 ~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         117 GELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecCh
Confidence            45788999999999999999999999   999999999999999999999999998654322211111222345689999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||.......      .. ....         .......+...+..+.+++
T Consensus       194 E~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~-~~~~---------~~~~~~~~~~~~~~~~~li  257 (280)
T cd05049         194 ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VI-ECIT---------QGRLLQRPRTCPSEVYDIM  257 (280)
T ss_pred             hhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HH-HHHH---------cCCcCCCCCCCCHHHHHHH
Confidence            99998899999999999999999998 999874322111      00 0000         1111111223445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.||++||++.+|++.|+
T Consensus       258 ~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         258 LGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHcCCCcccCCCHHHHHHHhh
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.1e-28  Score=197.10  Aligned_cols=164  Identities=23%  Similarity=0.326  Sum_probs=125.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.................+..|++|
T Consensus       108 ~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         108 EKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCH
Confidence            46899999999999999999999999   999999999999999999999999998765433222222112335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||......      ..          .+.+........+......+.+++
T Consensus       185 e~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~~~li  248 (273)
T cd05035         185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EI----------YDYLRHGNRLKQPEDCLDELYDLM  248 (273)
T ss_pred             hhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HH----------HHHHHcCCCCCCCcCCCHHHHHHH
Confidence            99988889999999999999999999 78887432211      00          000011111122334456799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||.+|||+.+|++.|++.
T Consensus       249 ~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         249 YSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHhh
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=1.2e-28  Score=200.91  Aligned_cols=164  Identities=29%  Similarity=0.345  Sum_probs=124.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+++++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       127 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  203 (293)
T cd05053         127 ETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP  203 (293)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence            46889999999999999999999999   999999999999999999999999998765432221111112234579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||.......       .         .+..........+......+.+++
T Consensus       204 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~---------~~~~~~~~~~~~~~~~~~~~~~li  267 (293)
T cd05053         204 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------L---------FKLLKEGYRMEKPQNCTQELYHLM  267 (293)
T ss_pred             HHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------H---------HHHHHcCCcCCCCCCCCHHHHHHH
Confidence            99988889999999999999999997 888875322110       0         011111111122333455688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||..||++|||+.+|++.|++.
T Consensus       268 ~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         268 RDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHcccCcccCcCHHHHHHHHHHh
Confidence            999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=5.3e-28  Score=204.95  Aligned_cols=180  Identities=19%  Similarity=0.223  Sum_probs=123.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++........ .......+++.|+|
T Consensus       176 ~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~a  251 (391)
T PHA03212        176 KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNA  251 (391)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCC
Confidence            357899999999999999999999999   99999999999999999999999999864322111 11122457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccc--hhhhh--HHHH----------hhhhhhhhh------
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS--LLSYT--WKLW----------CEGEALELM------  142 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~--~~~~~--~~~~----------~~~~~~~~~------  142 (230)
                      ||++.+..++.++|||||||++|+|++|..||-......+..  .....  ....          .........      
T Consensus       252 PE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  331 (391)
T PHA03212        252 PELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKK  331 (391)
T ss_pred             hhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhc
Confidence            999988889999999999999999999998763222111100  00000  0000          000000000      


Q ss_pred             ---chhhcc--hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          143 ---EPVLKQ--SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       143 ---~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                         .+..+.  ......+..+.+++.+||+.||.+|||+.++++  .+.+.
T Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        332 SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             cCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence               000000  001234557889999999999999999999985  44443

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=1.5e-28  Score=202.79  Aligned_cols=165  Identities=24%  Similarity=0.366  Sum_probs=124.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.................+..|++|
T Consensus       104 ~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         104 DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecCh
Confidence            35788999999999999999999999   999999999999999999999999999865432221111112234579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      . ..         ..........+..+...+.+++
T Consensus       181 E~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~-~~---------~~~~~~~~~~~~~~~~~~~~li  244 (316)
T cd05108         181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------I-SS---------ILEKGERLPQPPICTIDVYMIM  244 (316)
T ss_pred             HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H-HH---------HHhCCCCCCCCCCCCHHHHHHH
Confidence            99998899999999999999999998 888875322111      0 00         1111111111223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.+|++||++.+|+..|....
T Consensus       245 ~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         245 VKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=6.2e-29  Score=199.54  Aligned_cols=162  Identities=31%  Similarity=0.441  Sum_probs=119.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.+   ++|++|+++||+++.++.+||+|||+.....................|+|
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~a  173 (259)
T PF07714_consen   97 KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLA  173 (259)
T ss_dssp             TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-
T ss_pred             ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            457899999999999999999999999   99999999999999999999999999876522222112222244668999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++||||||+++||+++ |..||......      ..          ...+........+...+..+.++
T Consensus       174 PE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~~~l  237 (259)
T PF07714_consen  174 PEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EI----------IEKLKQGQRLPIPDNCPKDIYSL  237 (259)
T ss_dssp             HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HH----------HHHHHTTEETTSBTTSBHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccc------cc----------cccccccccceeccchhHHHHHH
Confidence            999999889999999999999999999 67886432111      01          11111111122233345568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHh
Q 026939          162 GLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +..||..||++|||+.+|+++|
T Consensus       238 i~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  238 IQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHhcC
Confidence            9999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=9.8e-29  Score=200.54  Aligned_cols=180  Identities=26%  Similarity=0.322  Sum_probs=128.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-cccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-STNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~   81 (230)
                      ...+++.+++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......... ......+...|+
T Consensus       101 ~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  177 (283)
T cd05080         101 KHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY  177 (283)
T ss_pred             HcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceee
Confidence            346899999999999999999999999   9999999999999999999999999987654322111 111123345799


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      +||.+.+..++.++|+||||+++++|++|..|+........ ...................+.......+...+..+.++
T Consensus       178 ~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (283)
T cd05080         178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYIL  256 (283)
T ss_pred             CHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHH
Confidence            99999888899999999999999999999999754321100 00000000011111112222222222333445679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.+|++|||+.+|++.|+..
T Consensus       257 i~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         257 MKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             HHHHhccChhhCCCHHHHHHHHHHh
Confidence            9999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=4.4e-28  Score=194.72  Aligned_cols=162  Identities=25%  Similarity=0.352  Sum_probs=123.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......+..|++|
T Consensus        99 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aP  174 (263)
T cd05052          99 QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAP  174 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCH
Confidence            46889999999999999999999999   999999999999999999999999998765432211 11112224579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||.......      . ...         +........+...+..+.+++
T Consensus       175 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~-~~~---------~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------V-YEL---------LEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHH---------HHCCCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 888875322110      0 011         111111122333445699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||++||++.++++.|+.
T Consensus       239 ~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         239 RACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             HHHccCCcccCCCHHHHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.4e-28  Score=212.64  Aligned_cols=159  Identities=24%  Similarity=0.293  Sum_probs=124.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++................++..|+||
T Consensus       138 ~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        138 RTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP  214 (496)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCH
Confidence            46889999999999999999999999   999999999999999999999999998765432222222234678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|||||||++|+|++|..||......      ...... ..+         .....+...+..+.+++.
T Consensus       215 E~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~-~~~---------~~~~~~~~~~~~l~~li~  278 (496)
T PTZ00283        215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKT-LAG---------RYDPLPPSISPEMQEIVT  278 (496)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-hcC---------CCCCCCCCCCHHHHHHHH
Confidence            9999888999999999999999999999998532211      111000 000         011123334556899999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.||++||++.++++
T Consensus       279 ~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        279 ALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HHcccChhhCcCHHHHHh
Confidence            999999999999999875

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=4e-28  Score=196.81  Aligned_cols=163  Identities=26%  Similarity=0.327  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.|++|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       117 ~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         117 GQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence            35889999999999999999999999   999999999999999999999999998754322211111112335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||........      . .....+         .....+...+..+.+++
T Consensus       194 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~-~~~~~~---------~~~~~~~~~~~~~~~li  257 (280)
T cd05092         194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I-ECITQG---------RELERPRTCPPEVYAIM  257 (280)
T ss_pred             HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H-HHHHcC---------ccCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 8888743221110      0 000000         00111223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||.+||++.+|++.|+.
T Consensus       258 ~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         258 QGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHccCChhhCCCHHHHHHHHhC
Confidence            99999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=3.1e-28  Score=198.37  Aligned_cols=165  Identities=28%  Similarity=0.362  Sum_probs=125.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++|
T Consensus       122 ~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         122 RALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            46889999999999999999999999   999999999999999999999999998754322221111112335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++++|++ |..||....+..                .............+......+.+++
T Consensus       199 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~i  262 (290)
T cd05045         199 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER----------------LFNLLKTGYRMERPENCSEEMYNLM  262 (290)
T ss_pred             HHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 888875322110                0111111111222333445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      ..||+.+|++||++.+|++.|++..
T Consensus       263 ~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         263 LTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHccCCcccCCCHHHHHHHHHHHH
Confidence            9999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=4.7e-28  Score=197.91  Aligned_cols=167  Identities=17%  Similarity=0.149  Sum_probs=123.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-----ccccccccccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-----ASTNRIVGTYG   79 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~   79 (230)
                      ..++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++..+......     .......++..
T Consensus       122 ~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~  198 (294)
T PHA02882        122 CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY  198 (294)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCcc
Confidence            3577888999999999999999999   999999999999999999999999999765322110     11122357889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||...+..++.++|||||||++++|++|..||........  ........+    ...+.....   ........+.
T Consensus       199 y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~  269 (294)
T PHA02882        199 YAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--LIHAAKCDF----IKRLHEGKI---KIKNANKFIY  269 (294)
T ss_pred             ccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--HHHHhHHHH----HHHhhhhhh---ccCCCCHHHH
Confidence            9999999988999999999999999999999999864321110  000000000    000011100   1122346689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHh
Q 026939          160 HIGLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +++..||+.+|++||++.+|++.|
T Consensus       270 ~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        270 DFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHHhCCCCCCCCHHHHHHhh
Confidence            999999999999999999999876

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.95  E-value=4.4e-28  Score=196.20  Aligned_cols=161  Identities=30%  Similarity=0.374  Sum_probs=120.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC---CeEEcccccceeecCCCCCccccccccccCcc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM---NPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      .+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++   .++|+|||++.................+..|+
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  188 (277)
T cd05036         112 SLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM  188 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhC
Confidence            5899999999999999999999999   99999999999998654   58999999987653221111111122345799


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++|||||||++|+|++ |..||.......                ..+.+........+...+..+.+
T Consensus       189 aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~  252 (277)
T cd05036         189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------------VMEFVTGGGRLDPPKGCPGPVYR  252 (277)
T ss_pred             CHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHHcCCcCCCCCCCCHHHHH
Confidence            9999998889999999999999999997 888875322110                01111111111223334567899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      ++.+||+.+|++||++.+|++.|+
T Consensus       253 ~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         253 IMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHhh
Confidence            999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.5e-28  Score=209.57  Aligned_cols=157  Identities=27%  Similarity=0.297  Sum_probs=125.8

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++.+|++..+.++++||+.|+.|+|..+   |+|||+||+|++++..+.+|++|||.+........   ....+|+++|.
T Consensus       105 ~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---LeTSCGSPHYA  178 (786)
T KOG0588|consen  105 RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LETSCGSPHYA  178 (786)
T ss_pred             hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc---ccccCCCcccC
Confidence            5779999999999999999999999998   99999999999999999999999999876433222   22347899999


Q ss_pred             ChhhhhcCCCC-ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~-~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +||++.+.+|. .++||||+||++|.|++|..||+...   -+.++.-.    ..|. .         ..|...+.+..+
T Consensus       179 ~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV----~~G~-f---------~MPs~Is~eaQd  241 (786)
T KOG0588|consen  179 APEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKV----QRGV-F---------EMPSNISSEAQD  241 (786)
T ss_pred             CchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHH----HcCc-c---------cCCCcCCHHHHH
Confidence            99999999985 78999999999999999999997221   11111111    1111 1         123444556889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      |+.+|+..||+.|-|+++|++
T Consensus       242 LLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHHHHhccCccccccHHHHhh
Confidence            999999999999999999998

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=7.3e-28  Score=193.16  Aligned_cols=162  Identities=31%  Similarity=0.448  Sum_probs=124.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++......... ..........|++|
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  173 (261)
T cd05068          98 RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAP  173 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCc
Confidence            36899999999999999999999999   999999999999999999999999999876422111 11111223579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++++|++ |..||.......                ....+........+...+..+.+++
T Consensus       174 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----------------VLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            99988889999999999999999999 888875321110                0001111111122334456789999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.+|++||++.+|++.|++
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHhhcCcccCCCHHHHHHHHhc
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=3.7e-28  Score=193.81  Aligned_cols=162  Identities=30%  Similarity=0.358  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|.||+++.++.++|+|||++....................|+||
T Consensus        89 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  165 (252)
T cd05084          89 PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP  165 (252)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCc
Confidence            46899999999999999999999999   999999999999999999999999998654322111111111223469999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+...+..+.+++
T Consensus       166 E~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li  229 (252)
T cd05084         166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----------------TREAIEQGVRLPCPELCPDAVYRLM  229 (252)
T ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----------------HHHHHHcCCCCCCcccCCHHHHHHH
Confidence            99988889999999999999999998 777774321110                0111111111122334456789999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.+|++|||+.+|++.|+
T Consensus       230 ~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         230 ERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHcCCChhhCcCHHHHHHHHh
Confidence            9999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=3.5e-28  Score=197.76  Aligned_cols=159  Identities=23%  Similarity=0.283  Sum_probs=121.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++........   .....++..|+||
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aP  170 (285)
T cd05631          97 PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAP  170 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCH
Confidence            46899999999999999999999999   99999999999999999999999999876532211   1123568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|||||||++|+|++|..||.........   ......         +. .....++...+..+.+++.
T Consensus       171 E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~---------~~-~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRR---------VK-EDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             hhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHH---------hh-cccccCCccCCHHHHHHHH
Confidence            9999889999999999999999999999998643321110   000000         00 0011223334556889999


Q ss_pred             hhcCCCCCCCCC-----HHHHHH
Q 026939          164 LCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs-----~~~i~~  181 (230)
                      +||+.||.+||+     ++++++
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhc
Confidence            999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=5.6e-28  Score=198.15  Aligned_cols=164  Identities=29%  Similarity=0.324  Sum_probs=124.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||.|||++|   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       132 ~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP  208 (304)
T cd05101         132 EQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP  208 (304)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence            46888999999999999999999999   999999999999999999999999998765432221111112334679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||......      .....          +........+...+..+.+++
T Consensus       209 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~li  272 (304)
T cd05101         209 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ELFKL----------LKEGHRMDKPANCTNELYMMM  272 (304)
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHH----------HHcCCcCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 67776422111      11100          111111112234456688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.+|++|||+.+|++.|++.
T Consensus       273 ~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         273 RDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHHcccChhhCCCHHHHHHHHHHH
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=5.2e-28  Score=195.45  Aligned_cols=162  Identities=28%  Similarity=0.390  Sum_probs=123.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       115 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05032         115 PPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHH
Confidence            5788899999999999999999999   9999999999999999999999999986543322211111223456899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++|++++ |..||.......      .. .....+.         ....+...+..+.+++.
T Consensus       192 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~-~~~~~~~---------~~~~~~~~~~~~~~li~  255 (277)
T cd05032         192 SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VL-KFVIDGG---------HLDLPENCPDKLLELMR  255 (277)
T ss_pred             HHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HH-HHHhcCC---------CCCCCCCCCHHHHHHHH
Confidence            9988889999999999999999998 888875322111      00 0111111         11122333567899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||+.+|++|||+.+|++.|++
T Consensus       256 ~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         256 MCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHcCCChhhCCCHHHHHHHhcC
Confidence            9999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=2.6e-28  Score=202.71  Aligned_cols=176  Identities=22%  Similarity=0.250  Sum_probs=121.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+
T Consensus        97 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~  173 (338)
T cd07859          97 NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR  173 (338)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcC
Confidence            346899999999999999999999999   999999999999999999999999998754221111 1112235678999


Q ss_pred             Chhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhhhhhhhhhchh---hcc
Q 026939           82 APEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCEGEALELMEPV---LKQ  148 (230)
Q Consensus        82 aPe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~  148 (230)
                      |||++.+  ..++.++|||||||++|+|++|..||.............        ..............+...   ...
T Consensus       174 aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  253 (338)
T cd07859         174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPV  253 (338)
T ss_pred             CHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCC
Confidence            9999876  578899999999999999999999985432211000000        000000000001111000   000


Q ss_pred             hh---hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SC---VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+   .......+.+++.+||+.||++|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         254 PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             chHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00   0112345789999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=7.3e-28  Score=193.03  Aligned_cols=165  Identities=25%  Similarity=0.352  Sum_probs=125.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc-ccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~   81 (230)
                      ...+++..+++++.||+.||+|||+++   ++|+||+|+||+++.++.++|+|||++........... .....++..|+
T Consensus        89 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  165 (257)
T cd05115          89 KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY  165 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccC
Confidence            457899999999999999999999999   99999999999999999999999999875432211111 11112245799


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++|+||||+++|++++ |..||.......                ....+........+......+.+
T Consensus       166 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~  229 (257)
T cd05115         166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----------------VMSFIEQGKRLDCPAECPPEMYA  229 (257)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHHCCCCCCCCCCCCHHHHH
Confidence            9999988888999999999999999996 899975322110                11111111112233445567889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ++.+||+.+|++||++.+|.+.|+..
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            99999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=4.2e-28  Score=196.24  Aligned_cols=162  Identities=25%  Similarity=0.375  Sum_probs=121.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       115 ~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05062         115 PPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  191 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence            4678889999999999999999999   9999999999999999999999999986543222211111123356799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++|+|++ |..||.......       ..........         ...+...+..+.+++.
T Consensus       192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~  255 (277)
T cd05062         192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVMEGGL---------LDKPDNCPDMLFELMR  255 (277)
T ss_pred             HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCc---------CCCCCCCCHHHHHHHH
Confidence            9988889999999999999999999 677875322110       0011111110         1112233456899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||+.||++|||+.++++.|++
T Consensus       256 ~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         256 MCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCChhhCcCHHHHHHHhhC
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.95  E-value=4.2e-28  Score=197.11  Aligned_cols=174  Identities=19%  Similarity=0.226  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  170 (287)
T cd07848          95 NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSP  170 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCc
Confidence            46889999999999999999999999   999999999999999999999999998765322211 11223567889999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHh-hhhhhhhhchhh------cc
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWC-EGEALELMEPVL------KQ  148 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~~~~------~~  148 (230)
                      |.+.+..++.++|+|||||++|+|++|..||..............        ....+. .........+..      ..
T Consensus       171 E~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T cd07848         171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLER  250 (287)
T ss_pred             HHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHH
Confidence            999888899999999999999999999999864322111000000        000000 000000000000      00


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+....+..+.+++.+||+.||++|||++++++
T Consensus       251 ~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         251 RYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111223456999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.95  E-value=5e-28  Score=196.03  Aligned_cols=166  Identities=25%  Similarity=0.324  Sum_probs=125.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.............++..|+||
T Consensus       112 ~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         112 QALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence            56899999999999999999999999   999999999999999999999999998754322211111112345679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|++++ |..||....+.      ... .....+         .....+...+..+.+++
T Consensus       189 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~-~~~~~~---------~~~~~~~~~~~~~~~li  252 (280)
T cd05043         189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EMA-AYLKDG---------YRLAQPINCPDELFAVM  252 (280)
T ss_pred             HHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HHH-HHHHcC---------CCCCCCCcCCHHHHHHH
Confidence            99988889999999999999999999 89987542211      010 000000         01111122345689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .+||..||++|||+.++++.|++...
T Consensus       253 ~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         253 ACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            99999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=1e-27  Score=191.47  Aligned_cols=163  Identities=33%  Similarity=0.406  Sum_probs=126.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||++||+++   ++|+||+|+||+++.++.++|+|||.+................++..|+|
T Consensus        99 ~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  175 (262)
T cd00192          99 KSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA  175 (262)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccC
Confidence            367999999999999999999999999   99999999999999999999999999987654321112222345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+....++.++|+||||+++++|++ |..||.......      ..          ..+........+...+..+.++
T Consensus       176 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd00192         176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VL----------EYLRKGYRLPKPEYCPDELYEL  239 (262)
T ss_pred             HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HH----------HHHHcCCCCCCCccCChHHHHH
Confidence            999988889999999999999999999 588875432110      00          0011011112233445679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhh
Q 026939          162 GLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      +.+||+.+|.+|||+.++++.|+
T Consensus       240 i~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         240 MLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHccCCcccCcCHHHHHHhhC
Confidence            99999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=7.3e-28  Score=204.34  Aligned_cols=177  Identities=21%  Similarity=0.240  Sum_probs=125.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+.|   |+||||||+||+++.++.++|+|||++................++..|+|
T Consensus       179 ~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~a  255 (392)
T PHA03207        179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS  255 (392)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccC
Confidence            457899999999999999999999999   99999999999999999999999999876543332222223467889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh-------h---hh---hhhchhhcch
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG-------E---AL---ELMEPVLKQS  149 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~---~~---~~~~~~~~~~  149 (230)
                      ||++.+..++.++|||||||++|+|++|..||...........+..........       .   ..   .......+..
T Consensus       256 PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (392)
T PHA03207        256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPP  335 (392)
T ss_pred             HhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCC
Confidence            999998899999999999999999999999985433221111110000000000       0   00   0000000000


Q ss_pred             hh-------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          150 CV-------AAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       150 ~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      +.       ......+.+++.+||..||++|||+.+++..
T Consensus       336 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        336 YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00       1123457789999999999999999999863

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=8.4e-28  Score=193.31  Aligned_cols=164  Identities=27%  Similarity=0.386  Sum_probs=124.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.++++++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++|
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P  177 (266)
T cd05033         101 GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP  177 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccCh
Confidence            36899999999999999999999999   999999999999999999999999999876422221111112334679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+...+..+.+++
T Consensus       178 e~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li  241 (266)
T cd05033         178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----------------VIKAVEDGYRLPPPMDCPSALYQLM  241 (266)
T ss_pred             hhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 888874322110                0000011111111233455689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.+|++||++.+|++.|++.
T Consensus       242 ~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         242 LDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=2.3e-28  Score=202.29  Aligned_cols=157  Identities=20%  Similarity=0.219  Sum_probs=121.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||+|||+.|   |+||||+|+||+++.++.++|+|||++........  ......+++.|+|
T Consensus        89 ~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~a  163 (323)
T cd05571          89 ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA  163 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccC
Confidence            457899999999999999999999999   99999999999999999999999999864321111  1122457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......       ........          ...++......+.+++
T Consensus       164 PE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~----------~~~~p~~~~~~~~~li  226 (323)
T cd05571         164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILME----------EIRFPRTLSPEAKSLL  226 (323)
T ss_pred             hhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcC----------CCCCCCCCCHHHHHHH
Confidence            999998889999999999999999999999985322110       00001000          0112333455688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||+.||++||     ++.++++
T Consensus       227 ~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         227 AGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHccCCHHHcCCCCCCCHHHHHc
Confidence            999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=6.1e-28  Score=209.59  Aligned_cols=159  Identities=21%  Similarity=0.233  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.++..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++................+++.|+||
T Consensus       164 ~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aP  240 (478)
T PTZ00267        164 LPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP  240 (478)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCH
Confidence            46889999999999999999999999   999999999999999999999999999875433222222334578899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|||||||++|+|++|..||......      ....... .+.         ....+......+.+++.
T Consensus       241 E~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~-~~~---------~~~~~~~~s~~~~~li~  304 (478)
T PTZ00267        241 ELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVL-YGK---------YDPFPCPVSSGMKALLD  304 (478)
T ss_pred             hHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCC---------CCCCCccCCHHHHHHHH
Confidence            9998888999999999999999999999998532111      0000000 000         01122234456899999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.||++||++.+++.
T Consensus       305 ~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        305 PLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHhccChhhCcCHHHHHh
Confidence            999999999999998864

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=6.5e-28  Score=195.73  Aligned_cols=163  Identities=27%  Similarity=0.382  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++................++..|++|
T Consensus       119 ~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05090         119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP  195 (283)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecCh
Confidence            35788999999999999999999999   999999999999999999999999998765332221112222335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||......      ... .......         ....+......+.+++
T Consensus       196 E~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------~~~-~~~~~~~---------~~~~~~~~~~~~~~li  259 (283)
T cd05090         196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------EVI-EMVRKRQ---------LLPCSEDCPPRMYSLM  259 (283)
T ss_pred             HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HHHHcCC---------cCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 88887432211      000 0000100         0111223345688899


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||++||++.+|.+.|..
T Consensus       260 ~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         260 TECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcccCcccCcCHHHHHHHhhc
Confidence            99999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.95  E-value=6.2e-28  Score=196.16  Aligned_cols=172  Identities=22%  Similarity=0.240  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+||
T Consensus       103 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aP  176 (288)
T cd07863         103 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL---TPVVVTLWYRAP  176 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCcccC---CCccccccccCc
Confidence            35899999999999999999999999   999999999999999999999999998765322111   123457789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHhhh-hh-hhhhchhh---cchhhHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWCEG-EA-LELMEPVL---KQSCVAA  153 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~-~~-~~~~~~~~---~~~~~~~  153 (230)
                      |.+.+..++.++|+||+||++|+|++|.+||...............     ...+... .. ........   .......
T Consensus       177 E~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (288)
T cd07863         177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPE  256 (288)
T ss_pred             hHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcC
Confidence            9998888999999999999999999999998543221110000000     0000000 00 00000000   0011123


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....+.+++.+||+.||++|||+.+++.
T Consensus       257 ~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         257 IEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            3456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2e-28  Score=220.57  Aligned_cols=163  Identities=31%  Similarity=0.411  Sum_probs=131.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..|.+...+.++.|||+|+.||+++.   +|||||..+|+|++....+|++|||+++-..............-+..||||
T Consensus       797 ~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~P  873 (1025)
T KOG1095|consen  797 SNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPP  873 (1025)
T ss_pred             CCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCH
Confidence            46889999999999999999999998   999999999999999999999999999843322222222222335789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhh-hhchhhcchhhHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALE-LMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |.++...++.++|||||||++||++| |..||+.....                ++.. ..... +...|..++..++++
T Consensus       874 Esl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----------------~v~~~~~~gg-RL~~P~~CP~~ly~l  936 (1025)
T KOG1095|consen  874 ESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----------------EVLLDVLEGG-RLDPPSYCPEKLYQL  936 (1025)
T ss_pred             HHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------------HHHHHHHhCC-ccCCCCCCChHHHHH
Confidence            99999999999999999999999999 77887633211                1111 11112 445678888899999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      |..||+.+|++||++..|+++++..
T Consensus       937 M~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  937 MLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             HHHHccCChhhCccHHHHHhhhhhh
Confidence            9999999999999999999988664

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=9.9e-28  Score=191.95  Aligned_cols=165  Identities=31%  Similarity=0.386  Sum_probs=125.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc-ccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.|++.||++||..+   ++|+||+|+||+++.++.++|+|||++........... .....++..|++
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~a  166 (257)
T cd05060          90 REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA  166 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccC
Confidence            46899999999999999999999999   99999999999999999999999999876543322111 111122357999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++|+|++ |..||......   .   .. ......         .....+...+..+.++
T Consensus       167 PE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~---~~-~~~~~~---------~~~~~~~~~~~~l~~l  230 (257)
T cd05060         167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---E---VI-AMLESG---------ERLPRPEECPQEIYSI  230 (257)
T ss_pred             HHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---H---HH-HHHHcC---------CcCCCCCCCCHHHHHH
Confidence            999988889999999999999999998 89998533211   0   00 001111         1111223344578999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      +.+||+.+|.+||++.+|++.|++..
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=1.1e-27  Score=197.50  Aligned_cols=166  Identities=31%  Similarity=0.373  Sum_probs=124.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.++++++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++................++..|++|
T Consensus       129 ~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (314)
T cd05099         129 EQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP  205 (314)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence            46899999999999999999999999   999999999999999999999999998754322211111111223579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......       .......+.         ....+...+..+.+++
T Consensus       206 E~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~l~~li  269 (314)
T cd05099         206 EALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------LFKLLREGH---------RMDKPSNCTHELYMLM  269 (314)
T ss_pred             HHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------CCCCCCCCCHHHHHHH
Confidence            99988889999999999999999999 778874321110       001111111         1112233345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .+||+.+|++|||+.++++.|++...
T Consensus       270 ~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         270 RECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            99999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=9e-28  Score=193.36  Aligned_cols=163  Identities=25%  Similarity=0.302  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++++|||........... ......++..|+||
T Consensus       102 ~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  177 (266)
T cd05064         102 GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAP  177 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCH
Confidence            47899999999999999999999999   999999999999999999999999976543221111 11112234679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++|++++ |..||.......      .          .+.+........+...+..+.+++
T Consensus       178 E~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~----------~~~~~~~~~~~~~~~~~~~~~~li  241 (266)
T cd05064         178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------V----------IKAVEDGFRLPAPRNCPNLLHQLM  241 (266)
T ss_pred             HHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------H----------HHHHHCCCCCCCCCCCCHHHHHHH
Confidence            99998899999999999999999875 999985332110      0          000111111122334556689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ..||+.+|++||++.+|++.|+..
T Consensus       242 ~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         242 LDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHcCCCchhCCCHHHHHHHHHhh
Confidence            999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.95  E-value=1e-27  Score=192.05  Aligned_cols=161  Identities=31%  Similarity=0.457  Sum_probs=124.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+...........  ...++..|++|
T Consensus        99 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~P  173 (261)
T cd05148          99 QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS--DKKIPYKWTAP  173 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc--CCCCceEecCH
Confidence            46899999999999999999999999   99999999999999999999999999876532221111  12335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++++|++ |..||......   .             .............+...+..+.+++
T Consensus       174 E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~-------------~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---E-------------VYDQITAGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---H-------------HHHHHHhCCcCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 78887532210   0             0011111111222344456789999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||.+|||+.+|++.|+.
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         238 LECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHcCCCchhCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=1.4e-27  Score=196.90  Aligned_cols=111  Identities=29%  Similarity=0.476  Sum_probs=92.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe----CCCCCeEEcccccceeecCCCCC-cccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL----DHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~   78 (230)
                      ..++...+..++.||+.||+|||+.|   ++||||+|+||++    +.++.+||+|||++......... .......++.
T Consensus       103 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~  179 (317)
T cd07868         103 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF  179 (317)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccc
Confidence            36899999999999999999999999   9999999999999    45678999999999765432211 1122345678


Q ss_pred             CccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCC
Q 026939           79 GYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFY  117 (230)
Q Consensus        79 ~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~  117 (230)
                      .|+|||++.+. .++.++|+||+||++|+|++|..||...
T Consensus       180 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            89999998764 5889999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-28  Score=194.30  Aligned_cols=186  Identities=25%  Similarity=0.280  Sum_probs=133.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .|+..++..+++||+.||+|+|+.+   ++|||+||+|++++.+..+|++|||+++..........-...+-+.+|.|||
T Consensus       121 ~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPE  197 (359)
T KOG0660|consen  121 DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPE  197 (359)
T ss_pred             cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHH
Confidence            4999999999999999999999999   9999999999999999999999999999875321111112235578999999


Q ss_pred             hhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhchhh---cch---
Q 026939           85 YAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEPVL---KQS---  149 (230)
Q Consensus        85 ~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~---  149 (230)
                      ++... .|+.+.||||+||++.||++|++-|.+.........+..        ......+......+....   +.+   
T Consensus       198 lll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~  277 (359)
T KOG0660|consen  198 LLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSS  277 (359)
T ss_pred             HHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHH
Confidence            98764 699999999999999999999999865544332222211        011111111222221111   011   


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCCCCCCC
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNVTLPQP  193 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~~~~~~  193 (230)
                      ..+.......+|+.+||..||.+|+|+++.++  +|+.....-+.|
T Consensus       278 ~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  278 IFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            11244556889999999999999999999987  666665544444

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=4.2e-28  Score=208.56  Aligned_cols=170  Identities=21%  Similarity=0.202  Sum_probs=121.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++ .+||+|||++.........   ....++..|+
T Consensus       164 ~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~  237 (440)
T PTZ00036        164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYR  237 (440)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCc---ccCCCCcCcc
Confidence            457899999999999999999999999   99999999999998665 6999999999765322211   1235578899


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHh----------hhhh-----hhhhchh
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWC----------EGEA-----LELMEPV  145 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~-----~~~~~~~  145 (230)
                      |||++.+. .++.++|||||||++|+|++|.+||........  .... .....          ....     .......
T Consensus       238 aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  314 (440)
T PTZ00036        238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRI-IQVLGTPTEDQLKEMNPNYADIKFPDVKPKD  314 (440)
T ss_pred             CHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCCHHHHHHhchhhhcccCCccCchh
Confidence            99998764 689999999999999999999999864322111  0000 00000          0000     0000111


Q ss_pred             hcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +...++...+..+.+++.+||+.||.+|||+.++++
T Consensus       315 l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        315 LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            111223334567899999999999999999999885

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=1.6e-27  Score=194.46  Aligned_cols=169  Identities=25%  Similarity=0.365  Sum_probs=122.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       126 ~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (296)
T cd05051         126 SLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE  202 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence            6899999999999999999999999   9999999999999999999999999987543222211122223456799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh--cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      .+.+..++.++|||||||++|+|++  +..||.......   ........+...      ........+...+..+.+++
T Consensus       203 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li  273 (296)
T cd05051         203 SVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VIENAGHFFRDD------GRQIYLPRPPNCPKDIYELM  273 (296)
T ss_pred             HhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HHHHHHhccccc------cccccCCCccCCCHHHHHHH
Confidence            9988889999999999999999998  556654321110   000000000000      00000111223345799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||.+|||+.+|++.|+.
T Consensus       274 ~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         274 LECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHhccChhcCCCHHHHHHHhcC
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.95  E-value=5.4e-28  Score=203.11  Aligned_cols=172  Identities=27%  Similarity=0.380  Sum_probs=138.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++.++..+++|+++||.|||+.+   |+|||++|.||+++++|.+|++|||+++.+....  .....+.|++.|+|
T Consensus        94 d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmA  168 (808)
T KOG0597|consen   94 DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMA  168 (808)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCcccccC
Confidence            467999999999999999999999999   9999999999999999999999999999876533  34455789999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcc--hhhHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ--SCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~  160 (230)
                      ||++.+.+|+..+|+|||||++||++.|++||..                   ..+..+++..+..  ..|......|..
T Consensus       169 PElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------~si~~Lv~~I~~d~v~~p~~~S~~f~n  229 (808)
T KOG0597|consen  169 PELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------RSITQLVKSILKDPVKPPSTASSSFVN  229 (808)
T ss_pred             HHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------------------HHHHHHHHHHhcCCCCCcccccHHHHH
Confidence            9999999999999999999999999999999742                   1122222222211  124466777999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH--HhhcCCCCCCCCCCCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVV--MLASDNVTLPQPTEPAF  198 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~--~L~~~~~~~~~~~~p~~  198 (230)
                      ++...|.+||.+|.+..+++.  +.++.-+-.+.|..+.+
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~  269 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF  269 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence            999999999999999999986  55555444555544443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=207.07  Aligned_cols=166  Identities=27%  Similarity=0.370  Sum_probs=134.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ++++..+....|.++|+.|+.|||.+.   |||||||..||||+.+..+||+|||-+......   .+.-.+.|+..|||
T Consensus       206 ~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMA  279 (904)
T KOG4721|consen  206 GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMA  279 (904)
T ss_pred             cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhC
Confidence            457788889999999999999999999   999999999999999999999999988654322   33334678899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+.+.++++|||||||++|||+||.-||..-.    ...+-|.           .-...+....|..++..|.-|+
T Consensus       280 PEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd----ssAIIwG-----------VGsNsL~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  280 PEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD----SSAIIWG-----------VGSNSLHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             HHHhhcCCcccccceehhHHHHHHHHhcCCCccccc----hheeEEe-----------ccCCcccccCcccCchHHHHHH
Confidence            999999999999999999999999999999975211    1111111           1111223345677888899999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      ++||+..|.+||++++|+..|+-....
T Consensus       345 Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  345 KQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             HHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            999999999999999999999766554

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=5e-28  Score=197.12  Aligned_cols=173  Identities=20%  Similarity=0.239  Sum_probs=119.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++........  ......++..|+||
T Consensus        98 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aP  172 (288)
T cd07871          98 NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPP  172 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccCh
Confidence            35788999999999999999999999   99999999999999999999999999876432221  11223457889999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHh-hhhhhhhhchhhcc----h
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWC-EGEALELMEPVLKQ----S  149 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~~----~  149 (230)
                      |.+.+ ..++.++|+||+||++|+|++|..||.............        ..+.... .........+....    .
T Consensus       173 E~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (288)
T cd07871         173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLIN  252 (288)
T ss_pred             HHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHH
Confidence            99875 468899999999999999999999986433221110000        0000000 00000000000000    0


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ........+.+++.+||+.||.+|||++++++
T Consensus       253 ~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         253 HAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            01122345789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=200.61  Aligned_cols=154  Identities=25%  Similarity=0.346  Sum_probs=124.9

Q ss_pred             CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhh
Q 026939            7 DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYA   86 (230)
Q Consensus         7 ~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~   86 (230)
                      ++....-++++++.|+.|||..+   .+||||++.||++..+|.+||+|||++..........  ...+|++.|||||++
T Consensus       109 ~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI  183 (467)
T KOG0201|consen  109 DEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVI  183 (467)
T ss_pred             ccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccccccccchhhh
Confidence            66667778999999999999999   9999999999999999999999999998765443332  447899999999999


Q ss_pred             hcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhc
Q 026939           87 MEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV  166 (230)
Q Consensus        87 ~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  166 (230)
                      +...|+.++||||||++.+||.+|.+|+....+.....                ++.+...+.+.....+.|.+++..||
T Consensus       184 ~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  184 KQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             ccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCCCCccccccCHHHHHHHHHHh
Confidence            98899999999999999999999999986544422211                11112222233355566999999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 026939          167 QADSADRPTMSSVVV  181 (230)
Q Consensus       167 ~~dP~~RPs~~~i~~  181 (230)
                      ..||+.||+|.++++
T Consensus       248 ~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLK  262 (467)
T ss_pred             hcCcccCcCHHHHhh
Confidence            999999999999876

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.95  E-value=2.3e-27  Score=190.92  Aligned_cols=163  Identities=28%  Similarity=0.363  Sum_probs=122.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-----CeEEcccccceeecCCCCCcccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-----NPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++     .++|+|||++.................+.
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  177 (269)
T cd05044         101 PLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV  177 (269)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCc
Confidence            34788999999999999999999999   99999999999999877     89999999986543222211111223456


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      .|++||.+.+..++.++|+|||||++|+|++ |..||.......      ....          +........+...+..
T Consensus       178 ~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~~----------~~~~~~~~~~~~~~~~  241 (269)
T cd05044         178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQH----------VTAGGRLQKPENCPDK  241 (269)
T ss_pred             cccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHHH----------HhcCCccCCcccchHH
Confidence            8999999998889999999999999999998 888875322111      0000          0000011122334456


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+++.+||+.+|.+||++.+|++.|++
T Consensus       242 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         242 IYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            8899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.95  E-value=1.8e-27  Score=190.75  Aligned_cols=162  Identities=27%  Similarity=0.449  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  172 (260)
T cd05070          97 RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAP  172 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccCh
Confidence            35899999999999999999999999   999999999999999999999999999765432211 11112334579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||......      +....          +........+...+..+.+++
T Consensus       173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05070         173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQ----------VERGYRMPCPQDCPISLHELM  236 (260)
T ss_pred             HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHH----------HHcCCCCCCCCcCCHHHHHHH
Confidence            99988889999999999999999999 78887532110      00000          111111122333455699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||..+|++|||++++.+.|++
T Consensus       237 ~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         237 LQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.95  E-value=1.8e-27  Score=190.34  Aligned_cols=157  Identities=27%  Similarity=0.303  Sum_probs=121.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||++||+.+   ++|+||+|+||+++.++.++|+|||++........     .......|+|||
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE  169 (256)
T cd05082          98 VLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPE  169 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-----CCccceeecCHH
Confidence            4789999999999999999999999   99999999999999999999999999875432211     112345799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++|+|++ |..||......      ... .....         ......+...+..+.+++.
T Consensus       170 ~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~~-~~~~~---------~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVV-PRVEK---------GYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             HHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHhc---------CCCCCCCCCCCHHHHHHHH
Confidence            9988889999999999999999997 88887532111      000 00000         1111122334556889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||+.+|++|||+.++++.|++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         234 QCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHHhc
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=1.5e-27  Score=191.74  Aligned_cols=165  Identities=22%  Similarity=0.291  Sum_probs=125.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..++...++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|+||
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aP  175 (267)
T cd08228         101 RLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccCh
Confidence            45888999999999999999999999   99999999999999999999999999876543221  11123466789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+|+++|+|++|..||......    ........ ..        ..............+.+++.
T Consensus       176 E~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~li~  242 (267)
T cd08228         176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-EQ--------CDYPPLPTEHYSEKLRELVS  242 (267)
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-hc--------CCCCCCChhhcCHHHHHHHH
Confidence            9998888899999999999999999999997432111    01111100 00        00011112234466899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.+|++||++.+|++.+++.
T Consensus       243 ~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         243 MCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHCCCCcccCcCHHHHHHHHHHh
Confidence            99999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.95  E-value=1.6e-27  Score=193.82  Aligned_cols=162  Identities=27%  Similarity=0.414  Sum_probs=121.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.................+..|+|||
T Consensus       126 ~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (288)
T cd05050         126 PLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE  202 (288)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHH
Confidence            5788999999999999999999999   9999999999999999999999999987543222111111123356799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++|+|++ |..||......      +.. .....+..         ...+...+..+.+++.
T Consensus       203 ~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------~~~-~~~~~~~~---------~~~~~~~~~~l~~li~  266 (288)
T cd05050         203 SIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------EVI-YYVRDGNV---------LSCPDNCPLELYNLMR  266 (288)
T ss_pred             HHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHhcCCC---------CCCCCCCCHHHHHHHH
Confidence            9988889999999999999999997 77776422111      000 00111111         1112234456999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||+.||++|||+.+|++.|+.
T Consensus       267 ~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         267 LCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHcccCcccCCCHHHHHHHhhC
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=1.7e-27  Score=190.87  Aligned_cols=162  Identities=28%  Similarity=0.396  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  173 (261)
T cd05072          98 GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP  173 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCH
Confidence            46788899999999999999999999   999999999999999999999999999765432211 11112335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||........       .....+.         .........+..+.+++
T Consensus       174 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~~~li  237 (261)
T cd05072         174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-------MSALQRG---------YRMPRMENCPDELYDIM  237 (261)
T ss_pred             HHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH-------HHHHHcC---------CCCCCCCCCCHHHHHHH
Confidence            99988888999999999999999998 8888753221110       0001111         01111122345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||..+|++||++++|.+.|+.
T Consensus       238 ~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         238 KTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHccCCcccCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00284 protein kinase; Provisional

Probab=99.95  E-value=7.1e-28  Score=208.74  Aligned_cols=176  Identities=19%  Similarity=0.208  Sum_probs=121.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCC----------------CeEEcccccceeecCC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEM----------------NPKISDFEMARIFGGN   65 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~----------------~~~l~d~~~~~~~~~~   65 (230)
                      ...+++..+..++.||+.||+|||+ .|   |+||||||+|||++.++                .+||+|||.+......
T Consensus       225 ~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~  301 (467)
T PTZ00284        225 HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS  301 (467)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc
Confidence            4578999999999999999999998 48   99999999999998765                4899999987542211


Q ss_pred             CCCccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh-------hHHHHh-hhh
Q 026939           66 QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY-------TWKLWC-EGE  137 (230)
Q Consensus        66 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~-------~~~~~~-~~~  137 (230)
                           .....++..|+|||++.+..++.++|||||||++|+|++|..||..............       .+.... ...
T Consensus       302 -----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~  376 (467)
T PTZ00284        302 -----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEE  376 (467)
T ss_pred             -----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchh
Confidence                 1224678899999999999999999999999999999999999965332211100000       000000 000


Q ss_pred             hhhhhc------hhh---------c--chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          138 ALELME------PVL---------K--QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       138 ~~~~~~------~~~---------~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ...+..      +..         .  ..........+.+|+.+||+.||++|||++++++  ++...
T Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        377 ARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             HHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            000000      000         0  0000112356889999999999999999999997  55443

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=1.1e-27  Score=203.45  Aligned_cols=166  Identities=26%  Similarity=0.347  Sum_probs=126.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       232 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         232 EGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            46899999999999999999999999   999999999999999999999999998765332222222223445679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++|+|++ |..||........      ....         +........+...+..+.+++
T Consensus       309 E~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~l~~li  373 (400)
T cd05105         309 ESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------FYNK---------IKSGYRMAKPDHATQEVYDIM  373 (400)
T ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------HHHH---------HhcCCCCCCCccCCHHHHHHH
Confidence            99988889999999999999999997 8888753211100      0000         011111112234456789999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.||++||++.+|.+.|+...
T Consensus       374 ~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         374 VKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHCccCHhHCcCHHHHHHHHHHHc
Confidence            9999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.95  E-value=1.3e-27  Score=195.43  Aligned_cols=164  Identities=26%  Similarity=0.288  Sum_probs=123.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .......+..|++||
T Consensus       115 ~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE  188 (297)
T cd05089         115 TLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIE  188 (297)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCch
Confidence            5889999999999999999999999   9999999999999999999999999875322110   111112244699999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      ...+..++.++|||||||++|+|++ |..||.......      .. ..         .........+...+..+.+++.
T Consensus       189 ~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~-~~---------~~~~~~~~~~~~~~~~~~~li~  252 (297)
T cd05089         189 SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LY-EK---------LPQGYRMEKPRNCDDEVYELMR  252 (297)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HH---------HhcCCCCCCCCCCCHHHHHHHH
Confidence            9988889999999999999999997 888885322111      00 00         0111111122234456889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      +||+.+|.+||++++|++.|++.....
T Consensus       253 ~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         253 QCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            999999999999999999987765543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.95  E-value=4e-27  Score=194.35  Aligned_cols=156  Identities=26%  Similarity=0.248  Sum_probs=119.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++.++..++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a  164 (316)
T cd05620          90 KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIA  164 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccC
Confidence            347889999999999999999999999   99999999999999999999999999864321111  1122456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......      .. .....      .    ...++......+.+++
T Consensus       165 PE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~------~~-~~~~~------~----~~~~~~~~~~~~~~li  227 (316)
T cd05620         165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE------LF-ESIRV------D----TPHYPRWITKESKDIL  227 (316)
T ss_pred             HHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HH-HHHHh------C----CCCCCCCCCHHHHHHH
Confidence            999998899999999999999999999999985332110      00 00000      0    0111222345688899


Q ss_pred             hhhcCCCCCCCCCHH-HHH
Q 026939          163 LLCVQADSADRPTMS-SVV  180 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~-~i~  180 (230)
                      .+||+.||++||++. +++
T Consensus       228 ~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         228 EKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHccCCHHHcCCChHHHH
Confidence            999999999999984 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=1.2e-27  Score=194.18  Aligned_cols=180  Identities=24%  Similarity=0.314  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-cccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-STNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.|++.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.......... ......+...|+|
T Consensus       103 ~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  179 (284)
T cd05081         103 ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA  179 (284)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeC
Confidence            35899999999999999999999999   9999999999999999999999999987653322111 1111122346999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++++|++|..++...........................+........+...+..+.+++
T Consensus       180 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (284)
T cd05081         180 PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIM  259 (284)
T ss_pred             HHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHH
Confidence            99998888999999999999999999987765322111000000000000000001111111111112223345699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.+|++|||+.+|++.|+..
T Consensus       260 ~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         260 KECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHccCChhhCCCHHHHHHHHHhc
Confidence            999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.95  E-value=3.7e-27  Score=189.05  Aligned_cols=161  Identities=29%  Similarity=0.456  Sum_probs=123.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|++||
T Consensus        98 ~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe  173 (260)
T cd05069          98 YLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPE  173 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHH
Confidence            4789999999999999999999999   999999999999999999999999998765332211 111123356799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      ...+..++.++|+||||+++|+|++ |..||....+..      . ....         ........+...+..+.+++.
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~-~~~~---------~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05069         174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------V-LEQV---------ERGYRMPCPQGCPESLHELMK  237 (260)
T ss_pred             HhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHH---------HcCCCCCCCcccCHHHHHHHH
Confidence            9988889999999999999999999 888875322110      0 0000         000111222334567899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||..||++||++++|++.|++
T Consensus       238 ~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         238 LCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHccCCcccCcCHHHHHHHHhc
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=1.2e-27  Score=196.45  Aligned_cols=164  Identities=30%  Similarity=0.358  Sum_probs=123.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.................+..|+||
T Consensus       135 ~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  211 (307)
T cd05098         135 EQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  211 (307)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence            35889999999999999999999999   999999999999999999999999998654322111111111224579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+|||||++|+|++ |..||......      ..          ...+........+......+.+++
T Consensus       212 E~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~~~li  275 (307)
T cd05098         212 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------EL----------FKLLKEGHRMDKPSNCTNELYMMM  275 (307)
T ss_pred             HHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HH----------HHHHHcCCCCCCCCcCCHHHHHHH
Confidence            99988889999999999999999998 77887432111      00          001111111122334456788999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||..+|++|||+.+|++.|+..
T Consensus       276 ~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         276 RDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHcccChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.95  E-value=1.4e-27  Score=184.09  Aligned_cols=174  Identities=21%  Similarity=0.223  Sum_probs=128.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...|+..++.+++.+++.|++|||++.   |+||||||.|++++.+|.+|++|||+++.++.........  +-+.+|.|
T Consensus        95 ~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRWYRA  169 (318)
T KOG0659|consen   95 NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRWYRA  169 (318)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc--eeeeeccC
Confidence            346888999999999999999999999   9999999999999999999999999999987655443332  44789999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh--------HHHHhhh---hhhhhhchhhcchh
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT--------WKLWCEG---EALELMEPVLKQSC  150 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~~~  150 (230)
                      ||++.+. .|...+|+||.||++.||+-|.+-|....+.+....+...        |..+..-   ...+..........
T Consensus       170 PELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~l  249 (318)
T KOG0659|consen  170 PELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNL  249 (318)
T ss_pred             hHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccc
Confidence            9999876 6999999999999999999988877654443332222111        1111100   00010111111113


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .........+++..||..||.+|.++.+.++
T Consensus       250 f~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  250 FPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            3445556799999999999999999999875

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=3.9e-27  Score=192.45  Aligned_cols=170  Identities=25%  Similarity=0.357  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.................+..|++|
T Consensus       125 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            35788899999999999999999999   999999999999999999999999998754322211111112335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh--cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |...+..++.++|+|||||++|+|++  |..||.......   ........+... .....     ...+..++..+.++
T Consensus       202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~l  272 (296)
T cd05095         202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---VIENTGEFFRDQ-GRQVY-----LPKPALCPDSLYKL  272 (296)
T ss_pred             HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---HHHHHHHHHhhc-ccccc-----CCCCCCCCHHHHHH
Confidence            99888889999999999999999998  566764322111   000000000000 00000     01122334568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+||+.||.+||++.+|++.|++
T Consensus       273 i~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         273 MLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHcCCCcccCCCHHHHHHHHhC
Confidence            999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=1.9e-27  Score=195.11  Aligned_cols=164  Identities=25%  Similarity=0.350  Sum_probs=123.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++||
T Consensus       105 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (303)
T cd05110         105 NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE  181 (303)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHH
Confidence            5789999999999999999999999   9999999999999999999999999997654322211111223356899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+||||+++|+|++ |..||.......      . ....         ........+......+.+++.
T Consensus       182 ~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~------~-~~~~---------~~~~~~~~~~~~~~~~~~li~  245 (303)
T cd05110         182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------I-PDLL---------EKGERLPQPPICTIDVYMVMV  245 (303)
T ss_pred             HhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHH---------HCCCCCCCCCCCCHHHHHHHH
Confidence            9988889999999999999999997 888875321110      0 0011         111111112223446888999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .||..+|++||++.++++.|+...
T Consensus       246 ~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         246 KCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999997753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=8.9e-28  Score=199.26  Aligned_cols=174  Identities=24%  Similarity=0.299  Sum_probs=126.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...|++.++..+++||+.||+|+|++|   ++|||||.+|||++.+|.+||+|||+++++........... +-+.+|.|
T Consensus       212 ~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~r-VvTLWYRp  287 (560)
T KOG0600|consen  212 GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSR-VVTLWYRP  287 (560)
T ss_pred             CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccc-eEEeeccC
Confidence            347899999999999999999999999   99999999999999999999999999998765443322222 34789999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHhhhhhh--hhh------chhhcc
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWCEGEAL--ELM------EPVLKQ  148 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~--~~~------~~~~~~  148 (230)
                      ||++.+. .|+.+.|+||.||++.||+.|++.|....+......+.-.     ...|...++.  ..+      .+.+..
T Consensus       288 PELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E  367 (560)
T KOG0600|consen  288 PELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRE  367 (560)
T ss_pred             hHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHH
Confidence            9999986 6999999999999999999999998655443322222110     0111111111  111      111111


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      . ....+...++|+..+|..||.+|.|+.++++
T Consensus       368 ~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  368 T-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             H-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1 1222345778899999999999999998874

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=5.9e-27  Score=201.66  Aligned_cols=175  Identities=19%  Similarity=0.238  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||.|||++|   |+||||||+||+++.++.++|+|||++................++..|++|
T Consensus       255 ~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~AP  331 (461)
T PHA03211        255 RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP  331 (461)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCH
Confidence            46899999999999999999999999   999999999999999999999999998765332222222234578899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCC-CCCccccccchhhhhHHHHhhhhh-----hh-----hhch-------h
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNS-GFYLSELGQSLLSYTWKLWCEGEA-----LE-----LMEP-------V  145 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~-----~~-----~~~~-------~  145 (230)
                      |.+.+..++.++|||||||++|+|++|..++ ........................     ..     +...       .
T Consensus       332 E~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  411 (461)
T PHA03211        332 EVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN  411 (461)
T ss_pred             HHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcc
Confidence            9999989999999999999999999987653 222111111110101111100000     00     0000       0


Q ss_pred             hcchh-------hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSC-------VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .....       .......+.+|+.+||+.||.+|||+.++++
T Consensus       412 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        412 RRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             cCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            00000       0012235788999999999999999999986

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=3.6e-27  Score=194.65  Aligned_cols=156  Identities=26%  Similarity=0.266  Sum_probs=119.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||+|||+.+   |+||||+|+||+++.++.++|+|||++.......  .......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~a  164 (316)
T cd05592          90 SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIA  164 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccC
Confidence            346889999999999999999999999   9999999999999999999999999987543222  11222457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......      ..... ..          ....++......+.+++
T Consensus       165 PE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i-~~----------~~~~~~~~~~~~~~~ll  227 (316)
T cd05592         165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSI-LN----------DRPHFPRWISKEAKDCL  227 (316)
T ss_pred             HHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHH-Hc----------CCCCCCCCCCHHHHHHH
Confidence            999998889999999999999999999999986432110      00000 00          01122233445678899


Q ss_pred             hhhcCCCCCCCCCHH-HHH
Q 026939          163 LLCVQADSADRPTMS-SVV  180 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~-~i~  180 (230)
                      .+||+.||.+||++. +++
T Consensus       228 ~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         228 SKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHccCCHHHcCCChHHHH
Confidence            999999999999875 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.95  E-value=1.8e-27  Score=195.25  Aligned_cols=162  Identities=28%  Similarity=0.402  Sum_probs=122.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      +++.++++++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++................++..|+|||.
T Consensus       138 l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  214 (302)
T cd05055         138 LTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES  214 (302)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhh
Confidence            899999999999999999999999   99999999999999999999999999875433221111112234567999999


Q ss_pred             hhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           86 AMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        86 ~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      +.+..++.++|+||+||++|+|++ |..||........               .............+......+.+++.+
T Consensus       215 ~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~  279 (302)
T cd05055         215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---------------FYKLIKEGYRMAQPEHAPAEIYDIMKT  279 (302)
T ss_pred             hccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---------------HHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            988889999999999999999998 8888753221100               000111111111122234568999999


Q ss_pred             hcCCCCCCCCCHHHHHHHhhc
Q 026939          165 CVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      ||..+|++|||+.+|++.|+.
T Consensus       280 cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         280 CWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             HcCCCchhCcCHHHHHHHHHh
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=2.7e-27  Score=196.73  Aligned_cols=166  Identities=33%  Similarity=0.355  Sum_probs=124.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       129 ~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (334)
T cd05100         129 EQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP  205 (334)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence            45888999999999999999999999   999999999999999999999999998765432211111111224579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      . ......         ......+......+.+++
T Consensus       206 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~-~~~~~~---------~~~~~~~~~~~~~l~~li  269 (334)
T cd05100         206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------L-FKLLKE---------GHRMDKPANCTHELYMIM  269 (334)
T ss_pred             HHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------H-HHHHHc---------CCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 777764321110      0 011111         111112223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .+||+.+|++||++.+|++.|+....
T Consensus       270 ~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         270 RECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHcccChhhCcCHHHHHHHHHHHhh
Confidence            99999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=4.8e-27  Score=188.75  Aligned_cols=163  Identities=26%  Similarity=0.419  Sum_probs=124.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||.+......... ......++..|++|
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~P  172 (262)
T cd05071          97 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP  172 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCH
Confidence            35788999999999999999999999   999999999999999999999999998765432211 11122345679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |...+..++.++|+||||+++|+|++ |..||.......      .. ..         .........+...+..+.+++
T Consensus       173 E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~-~~---------~~~~~~~~~~~~~~~~l~~li  236 (262)
T cd05071         173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VL-DQ---------VERGYRMPCPPECPESLHDLM  236 (262)
T ss_pred             hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HH-HH---------HhcCCCCCCccccCHHHHHHH
Confidence            99988889999999999999999999 777775322110      00 00         000111122334556789999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++||++.++++.|++.
T Consensus       237 ~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         237 CQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHccCCcccCCCHHHHHHHHHHh
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.3e-27  Score=188.12  Aligned_cols=162  Identities=28%  Similarity=0.334  Sum_probs=121.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.+++.||++||+++   ++|+||+|+||+++.++.++|+|||++....................|++|
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~P  164 (251)
T cd05041          88 NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP  164 (251)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCCh
Confidence            46788999999999999999999999   999999999999999999999999998754322111111111224569999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++++|++ |..||........      . .         .+........+...+..+.+++
T Consensus       165 E~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~------~-~---------~~~~~~~~~~~~~~~~~~~~li  228 (251)
T cd05041         165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT------R-E---------RIESGYRMPAPQLCPEEIYRLM  228 (251)
T ss_pred             HhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH------H-H---------HHhcCCCCCCCccCCHHHHHHH
Confidence            99988889999999999999999999 7777753321110      0 0         0011111112233445699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.+|.+|||+.+|++.|+
T Consensus       229 ~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         229 LQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHhccChhhCcCHHHHHHHhh
Confidence            9999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.95  E-value=3.2e-27  Score=189.13  Aligned_cols=161  Identities=25%  Similarity=0.357  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......... ......++..|++|
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~p  170 (256)
T cd05113          95 KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPP  170 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCH
Confidence            36899999999999999999999999   999999999999999999999999988754332111 11112334679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |...+..++.++|+||||+++|+|++ |..||.......      .. ....++.         ....+......+.+++
T Consensus       171 e~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~-~~~~~~~---------~~~~~~~~~~~~~~li  234 (256)
T cd05113         171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TV-EKVSQGL---------RLYRPHLASEKVYAIM  234 (256)
T ss_pred             HHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HH-HHHhcCC---------CCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 888875322110      00 0001110         1111222346789999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.||.+||++.+|++.|+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHhhC
Confidence            9999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=197.39  Aligned_cols=159  Identities=21%  Similarity=0.215  Sum_probs=120.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        87 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a  161 (312)
T cd05585          87 EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLA  161 (312)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCC
Confidence            457899999999999999999999999   99999999999999999999999999865322111  1222457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||......      ..... ....          ...++......+.+++
T Consensus       162 PE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~-~~~~----------~~~~~~~~~~~~~~li  224 (312)
T cd05585         162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRK-ILQE----------PLRFPDGFDRDAKDLL  224 (312)
T ss_pred             HHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHH-HHcC----------CCCCCCcCCHHHHHHH
Confidence            99999889999999999999999999999998532211      00000 0000          0112333445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHh
Q 026939          163 LLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      .+||+.||.+||++..+.+.|
T Consensus       225 ~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         225 IGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHcCCCHHHcCCCCCHHHHH
Confidence            999999999998654443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.5e-27  Score=192.69  Aligned_cols=169  Identities=25%  Similarity=0.334  Sum_probs=120.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       125 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  201 (295)
T cd05097         125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE  201 (295)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence            4788999999999999999999999   9999999999999999999999999987543222111111223356899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh--cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      .+.+..++.++|+||||+++++|++  +..||.......   ........+...      ........+...+..+.+++
T Consensus       202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li  272 (295)
T cd05097         202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLM  272 (295)
T ss_pred             hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHH
Confidence            9988889999999999999999998  445554321111   000000000000      00000011122335699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||++||++++|++.|++
T Consensus       273 ~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         273 MRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHcCCCchhCcCHHHHHHHHhC
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=4.3e-27  Score=197.40  Aligned_cols=169  Identities=22%  Similarity=0.206  Sum_probs=120.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++...+..++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++........   .....++..|+|||
T Consensus       119 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE  192 (359)
T cd07876         119 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPE  192 (359)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCcc---CCCCcccCCCCCch
Confidence            5788899999999999999999999   99999999999999999999999999865422111   11235678899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccccc---------chhhhhHHHHhhhhhhhhhch--hhc------
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ---------SLLSYTWKLWCEGEALELMEP--VLK------  147 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~--~~~------  147 (230)
                      .+.+..++.++|+|||||++|+|++|..||.........         ....+.....  .........  ...      
T Consensus       193 ~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  270 (359)
T cd07876         193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ--PTVRNYVENRPQYPGISFEE  270 (359)
T ss_pred             hccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH--HHHHHHHhhCCCCCCcchhh
Confidence            999889999999999999999999999999643221100         0000000000  000000000  000      


Q ss_pred             ----------chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 ----------QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 ----------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                                ..........+.+++.+||..||++|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         271 LFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             hccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                      0001112356889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.95  E-value=2.2e-27  Score=196.83  Aligned_cols=159  Identities=25%  Similarity=0.311  Sum_probs=119.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+++   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a  164 (327)
T cd05617          90 QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIA  164 (327)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCC
Confidence            457999999999999999999999999   99999999999999999999999999865322111  1122456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......................          ...+...+..+.+++
T Consensus       165 PE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~~~~~~~~~li  234 (327)
T cd05617         165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIPRFLSVKASHVL  234 (327)
T ss_pred             HHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCCCCCCHHHHHHH
Confidence            9999988999999999999999999999999964332222111112111111110          112233345688999


Q ss_pred             hhhcCCCCCCCCCH
Q 026939          163 LLCVQADSADRPTM  176 (230)
Q Consensus       163 ~~cl~~dP~~RPs~  176 (230)
                      .+||+.||++|+++
T Consensus       235 ~~~L~~dP~~R~~~  248 (327)
T cd05617         235 KGFLNKDPKERLGC  248 (327)
T ss_pred             HHHhccCHHHcCCC
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=1.3e-27  Score=198.26  Aligned_cols=157  Identities=22%  Similarity=0.211  Sum_probs=120.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+++   ++||||+|+||+++.++.++|+|||++.......  .......++..|+|
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~a  163 (328)
T cd05593          89 ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLA  163 (328)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccC
Confidence            457899999999999999999999999   9999999999999999999999999986432111  11122357889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......      .. ......          ...++......+.+++
T Consensus       164 PE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~-~~~~~~----------~~~~p~~~~~~~~~li  226 (328)
T cd05593         164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LF-ELILME----------DIKFPRTLSADAKSLL  226 (328)
T ss_pred             hhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HH-HHhccC----------CccCCCCCCHHHHHHH
Confidence            999988889999999999999999999999985322110      00 000000          0112233345688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||+.||++|+     ++.++++
T Consensus       227 ~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         227 SGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHcCCCHHHcCCCCCCCHHHHhc
Confidence            999999999997     8898875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.95  E-value=3e-27  Score=189.09  Aligned_cols=161  Identities=25%  Similarity=0.320  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......... ......++..|+||
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aP  170 (256)
T cd05114          95 GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPP  170 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCCh
Confidence            35889999999999999999999999   999999999999999999999999988754322211 11112334579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||......      +.... ...+.         ....+......+.+++
T Consensus       171 E~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~-i~~~~---------~~~~~~~~~~~~~~li  234 (256)
T cd05114         171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEM-ISRGF---------RLYRPKLASMTVYEVM  234 (256)
T ss_pred             hhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHCCC---------CCCCCCCCCHHHHHHH
Confidence            99988889999999999999999999 88887532211      01000 11110         0111222345689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.+|++||++.++++.|.
T Consensus       235 ~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HHHccCCcccCcCHHHHHHhhC
Confidence            9999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=4.3e-27  Score=192.92  Aligned_cols=171  Identities=20%  Similarity=0.224  Sum_probs=117.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..++...+..++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||++........  ......++..|+||
T Consensus        98 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP  172 (303)
T cd07869          98 GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPP  172 (303)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCCh
Confidence            46889999999999999999999999   99999999999999999999999999865432211  11123457889999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh---------hhhhh--------chh
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE---------ALELM--------EPV  145 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~--------~~~  145 (230)
                      |++.+. .++.++|+||+||++|+|++|..||....+...  .............         .....        ...
T Consensus       173 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (303)
T cd07869         173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKN  250 (303)
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhccccccccccccCCcc
Confidence            998754 578899999999999999999999964322110  0000000000000         00000        000


Q ss_pred             hcchhh-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSCV-AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +..... ......+.+++.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         251 LRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000 011245778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.95  E-value=3.5e-27  Score=188.63  Aligned_cols=164  Identities=28%  Similarity=0.360  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++......... .......++..|++
T Consensus        92 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  168 (257)
T cd05040          92 GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA  168 (257)
T ss_pred             ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecC
Confidence            36899999999999999999999999   999999999999999999999999998765432111 11112234568999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+|||||++|+|++ |..||.......      .........         .....+...+..+.++
T Consensus       169 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~l  233 (257)
T cd05040         169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEG---------ERLERPEACPQDIYNV  233 (257)
T ss_pred             HHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC---------CcCCCCccCCHHHHHH
Confidence            999988889999999999999999998 999974321110      000000000         0011122334568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+||+.+|++||++.+|++.|.+
T Consensus       234 i~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         234 MLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHHHhcC
Confidence            999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=6.1e-27  Score=186.89  Aligned_cols=159  Identities=27%  Similarity=0.338  Sum_probs=123.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|+|
T Consensus        95 ~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~a  169 (256)
T cd08529          95 GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLS  169 (256)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccC
Confidence            357889999999999999999999999   999999999999999999999999998765432221  122356778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||...+..++.++|+||||+++++|++|..||.......      .... ...         ......+......+.+++
T Consensus       170 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~---------~~~~~~~~~~~~~~~~~i  233 (256)
T cd08529         170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILK-IIR---------GVFPPVSQMYSQQLAQLI  233 (256)
T ss_pred             HHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHc---------CCCCCCccccCHHHHHHH
Confidence            999998889999999999999999999999986432110      0000 000         111112223455689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+||+.+|++||++.++++.
T Consensus       234 ~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         234 DQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHccCCcccCcCHHHHhhC
Confidence            99999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2e-27  Score=208.26  Aligned_cols=163  Identities=21%  Similarity=0.183  Sum_probs=126.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc-----c--ccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-----T--NRIVG   76 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-----~--~~~~~   76 (230)
                      ..|++.++++|++|+++|+++||... .+|+|||||.+|||++.+|..||+|||.+.-.-.......     .  -....
T Consensus       139 ~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~T  217 (738)
T KOG1989|consen  139 TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYT  217 (738)
T ss_pred             ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhC
Confidence            45999999999999999999999985 7799999999999999999999999999864322211110     0  01245


Q ss_pred             ccCccChhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH
Q 026939           77 TYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA  153 (230)
Q Consensus        77 ~~~~~aPe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (230)
                      ++.|.+||.+.   +...++|+|||+|||++|-|+....||+....                   ..++...+.-.-.+.
T Consensus       218 Tp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------------laIlng~Y~~P~~p~  278 (738)
T KOG1989|consen  218 TPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------------LAILNGNYSFPPFPN  278 (738)
T ss_pred             CccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------------eeEEeccccCCCCcc
Confidence            78999999886   55789999999999999999999999964311                   112222221122245


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ....|.+||+.||+.||.+||++-+|+..+-+.
T Consensus       279 ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  279 YSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             HHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence            667799999999999999999999999988543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.1e-27  Score=189.06  Aligned_cols=160  Identities=26%  Similarity=0.337  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus        95 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~P  170 (256)
T cd05059          95 GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPP  170 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCH
Confidence            46889999999999999999999999   999999999999999999999999988765322111 11111223579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      ....          +........+...+..+.+++
T Consensus       171 e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~----------~~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVES----------VSAGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHH----------HHcCCcCCCCCCCCHHHHHHH
Confidence            99988889999999999999999999 788875322111      0000          001111112223455699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHh
Q 026939          163 LLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      .+||..+|++|||+.+|++.|
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHHh
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=3.5e-27  Score=190.23  Aligned_cols=163  Identities=21%  Similarity=0.304  Sum_probs=122.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++...+++++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++||
T Consensus       109 ~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05074         109 TLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE  185 (273)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence            5788899999999999999999999   9999999999999999999999999887653322111111223356799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++|+|++ |..||.......      . .........         ...+...+..+.+++.
T Consensus       186 ~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~-~~~~~~~~~---------~~~~~~~~~~~~~l~~  249 (273)
T cd05074         186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------I-YNYLIKGNR---------LKQPPDCLEDVYELMC  249 (273)
T ss_pred             HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------H-HHHHHcCCc---------CCCCCCCCHHHHHHHH
Confidence            9988888999999999999999999 778775322110      0 000111100         0111223456999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.+|++||++.++++.|++.
T Consensus       250 ~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         250 QCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=1.8e-27  Score=199.39  Aligned_cols=172  Identities=22%  Similarity=0.201  Sum_probs=121.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++..+++.++.|++.||+|||+.|   ++||||+|+||+++.++.++|+|||++........   .....++..|+|||
T Consensus       115 ~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE  188 (355)
T cd07874         115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPE  188 (355)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHH
Confidence            4788899999999999999999999   99999999999999999999999999876433211   11235678999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccch-hhh------hHHHHhhhhhhhhhch-------------
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL-LSY------TWKLWCEGEALELMEP-------------  144 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~~~~-------------  144 (230)
                      .+.+..++.++|+|||||++|+|++|..||........... ...      ..............+.             
T Consensus       189 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (355)
T cd07874         189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF  268 (355)
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhc
Confidence            99988899999999999999999999999864321110000 000      0000000000000000             


Q ss_pred             --h-h--cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          145 --V-L--KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       145 --~-~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                        . .  ...........+.+++.+||+.||++|||+.++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence              0 0  000111224567899999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-27  Score=181.87  Aligned_cols=171  Identities=22%  Similarity=0.227  Sum_probs=126.0

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-------ccccc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-------STNRI   74 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------~~~~~   74 (230)
                      ++.-+++.+++.++.+|..||++||+.. .++.|+||||.||+++..+.+++.|||.+......-...       .....
T Consensus       120 kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e  198 (302)
T KOG2345|consen  120 KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEE  198 (302)
T ss_pred             cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHH
Confidence            4557899999999999999999999986 469999999999999999999999999987543111100       00112


Q ss_pred             ccccCccChhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh
Q 026939           75 VGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV  151 (230)
Q Consensus        75 ~~~~~~~aPe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (230)
                      .++..|.|||.+.   +...++++|||||||++|.|+.|..||+.... .+.......            ....+.-...
T Consensus       199 ~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaLAv------------~n~q~s~P~~  265 (302)
T KOG2345|consen  199 RCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLALAV------------QNAQISIPNS  265 (302)
T ss_pred             hCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEEee------------eccccccCCC
Confidence            4578999999986   34578999999999999999999999864333 111111100            0101100111


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          152 AAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ...++.+.+++..|++.||.+||++.+++..++..
T Consensus       266 ~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  266 SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            12455689999999999999999999999988653

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.95  E-value=3e-27  Score=190.65  Aligned_cols=160  Identities=24%  Similarity=0.302  Sum_probs=120.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .......+..|+|||
T Consensus       108 ~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE  181 (270)
T cd05047         108 TLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE  181 (270)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChH
Confidence            5889999999999999999999999   9999999999999999999999999875321110   111112245699999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+||||+++|+|++ |..||......      ... ..         +........+......+.+++.
T Consensus       182 ~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~-~~---------~~~~~~~~~~~~~~~~~~~li~  245 (270)
T cd05047         182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY-EK---------LPQGYRLEKPLNCDDEVYDLMR  245 (270)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHH-HH---------HhCCCCCCCCCcCCHHHHHHHH
Confidence            9988889999999999999999997 88887432110      000 00         0111111112233456889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||..||.+|||+.+++..|+..
T Consensus       246 ~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         246 QCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             HHcccChhhCCCHHHHHHHHHHh
Confidence            99999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.95  E-value=1.7e-27  Score=197.15  Aligned_cols=158  Identities=26%  Similarity=0.265  Sum_probs=120.6

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +...+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++........  ......++..|+
T Consensus        94 ~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~  168 (324)
T cd05589          94 HTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFL  168 (324)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCcccc
Confidence            3457899999999999999999999999   99999999999999999999999998764321111  112245688999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||.+.+..++.++|+|||||++|+|++|..||.......      .. .......          ..++......+.++
T Consensus       169 aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~-~~i~~~~----------~~~p~~~~~~~~~l  231 (324)
T cd05589         169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VF-DSIVNDE----------VRYPRFLSREAISI  231 (324)
T ss_pred             CHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCC----------CCCCCCCCHHHHHH
Confidence            9999998889999999999999999999999986432111      00 0000100          01222334568899


Q ss_pred             HhhhcCCCCCCCC-----CHHHHHH
Q 026939          162 GLLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +.+||+.||.+||     ++.++++
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            9999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=8.9e-27  Score=187.06  Aligned_cols=164  Identities=24%  Similarity=0.313  Sum_probs=125.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.+++.||++||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....+...|.||
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~ap  175 (267)
T cd08224         101 RLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSP  175 (267)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCH
Confidence            45889999999999999999999999   999999999999999999999999998765432211  1123456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH-HHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA-AELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++|..||......    ..... ..         .........+. .....+.+++
T Consensus       176 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~---------~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KK---------IEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             HHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHH-hh---------hhcCCCCCCChhhcCHHHHHHH
Confidence            9998888999999999999999999999997432210    00000 00         00001111122 3445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||..+|++|||+.+|++.|++.
T Consensus       242 ~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             HHHcCCCcccCCCHHHHHHHHHHh
Confidence            999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=4.3e-27  Score=188.05  Aligned_cols=164  Identities=26%  Similarity=0.348  Sum_probs=121.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||++||+.+   ++|+||+|+||+++.++.++|+|||.+......  ........++..|.|
T Consensus        92 ~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~a  166 (260)
T PF00069_consen   92 NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNPFVGTPEYMA  166 (260)
T ss_dssp             HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSSSSSSGGGSC
T ss_pred             ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--ccccccccccccccc
Confidence            467899999999999999999999999   999999999999999999999999998764111  112222355778999


Q ss_pred             hhhhh-cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAM-EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~-~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+. +..++.++|+||||+++++|++|..||............   .    . ...........  ........+.++
T Consensus       167 PE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~----~-~~~~~~~~~~~--~~~~~~~~l~~l  236 (260)
T PF00069_consen  167 PEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---E----K-ILKRPLPSSSQ--QSREKSEELRDL  236 (260)
T ss_dssp             HHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---H----H-HHHTHHHHHTT--SHTTSHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhh---h----h-ccccccccccc--ccchhHHHHHHH
Confidence            99998 778999999999999999999999998644111110000   0    0 00000000000  001112679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +..||+.||++||++.++++
T Consensus       237 i~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            99999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.95  E-value=5.8e-27  Score=187.81  Aligned_cols=162  Identities=27%  Similarity=0.433  Sum_probs=123.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|++|
T Consensus        97 ~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~p  172 (260)
T cd05067          97 IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP  172 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCH
Confidence            46889999999999999999999999   999999999999999999999999998765422211 11122345689999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||++++++++ |..||.......      .          ...+........+...+..+.+++
T Consensus       173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~----------~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------V----------IQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------H----------HHHHHcCCCCCCCCCCCHHHHHHH
Confidence            99988888999999999999999998 899985322110      0          000111111112223345699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||..+|++||++++|++.|+.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         237 RLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHccCChhhCCCHHHHHHHhhc
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-27  Score=203.62  Aligned_cols=150  Identities=27%  Similarity=0.301  Sum_probs=124.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.++..++..|+.||.|||++|   |+|||||.+||++|..|.+||+|||++...-..  ......+.|++.|+|
T Consensus       462 ~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g~~TsTfCGTpey~a  536 (694)
T KOG0694|consen  462 TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--GDRTSTFCGTPEFLA  536 (694)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC--CCccccccCChhhcC
Confidence            468999999999999999999999999   999999999999999999999999999753211  123334688999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhh--cchhhHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVL--KQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  160 (230)
                      ||++.+..|+.++|.|+|||++||||.|+.||....++..                   .+..+  ...||.-.+.+...
T Consensus       537 PEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------------------FdsI~~d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  537 PEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------------------FDSIVNDEVRYPRFLSKEAIA  597 (694)
T ss_pred             hhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------------------HHHHhcCCCCCCCcccHHHHH
Confidence            9999999999999999999999999999999974433211                   11111  12456677778999


Q ss_pred             HHhhhcCCCCCCCCCH
Q 026939          161 IGLLCVQADSADRPTM  176 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~  176 (230)
                      ||+++|..+|++|.-+
T Consensus       598 il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhccCcccccCC
Confidence            9999999999999865

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=3e-27  Score=194.72  Aligned_cols=111  Identities=28%  Similarity=0.474  Sum_probs=91.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe----CCCCCeEEcccccceeecCCCCC-cccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL----DHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~   78 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||++    +.++.++|+|||++......... .......++.
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~  179 (317)
T cd07867         103 MQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF  179 (317)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecc
Confidence            35889999999999999999999999   9999999999999    45678999999999765433211 1112235678


Q ss_pred             CccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCC
Q 026939           79 GYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFY  117 (230)
Q Consensus        79 ~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~  117 (230)
                      .|+|||.+.+. .++.++|||||||++|+|++|..||...
T Consensus       180 ~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            89999998764 5789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.95  E-value=1.5e-27  Score=198.05  Aligned_cols=162  Identities=23%  Similarity=0.246  Sum_probs=120.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..+..++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++......... ......++..|+|
T Consensus        99 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~a  174 (332)
T cd05614          99 RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMA  174 (332)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccC
Confidence            457899999999999999999999999   999999999999999999999999998754322211 1122457889999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+. .++.++|||||||++|+|++|..||..........  ......      .. .+    ..++......+.++
T Consensus       175 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~------~~-~~----~~~~~~~~~~~~~l  241 (332)
T cd05614         175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRI------LK-CD----PPFPSFIGPEAQDL  241 (332)
T ss_pred             HHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHH------hc-CC----CCCCCCCCHHHHHH
Confidence            9999765 47889999999999999999999985332211110  010000      00 01    11222344568889


Q ss_pred             HhhhcCCCCCCCC-----CHHHHHH
Q 026939          162 GLLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +.+||+.||++||     +++++++
T Consensus       242 i~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         242 LHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            9999999999999     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=1.9e-27  Score=196.61  Aligned_cols=152  Identities=29%  Similarity=0.318  Sum_probs=117.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  ......+++.|+|
T Consensus        90 ~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~a  164 (320)
T cd05590          90 SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIA  164 (320)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccC
Confidence            457899999999999999999999999   99999999999999999999999999865322111  1122456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......      . .....+..          ...+......+.+++
T Consensus       165 PE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~-~~~i~~~~----------~~~~~~~~~~~~~li  227 (320)
T cd05590         165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------L-FEAILNDE----------VVYPTWLSQDAVDIL  227 (320)
T ss_pred             HHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------H-HHHHhcCC----------CCCCCCCCHHHHHHH
Confidence            999998889999999999999999999999986432111      0 01111110          011222345688999


Q ss_pred             hhhcCCCCCCCCCH
Q 026939          163 LLCVQADSADRPTM  176 (230)
Q Consensus       163 ~~cl~~dP~~RPs~  176 (230)
                      .+||+.||++||++
T Consensus       228 ~~~L~~dP~~R~~~  241 (320)
T cd05590         228 KAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHcccCHHHCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=3.2e-27  Score=195.98  Aligned_cols=164  Identities=24%  Similarity=0.282  Sum_probs=121.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+++   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~a  164 (329)
T cd05588          90 QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIA  164 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccccccCCccccC
Confidence            457999999999999999999999999   99999999999999999999999998864221111  1122456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccc--ccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL--GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......  ................          ...+......+.+
T Consensus       165 PE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~~~~~~~~~  234 (329)
T cd05588         165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKASS  234 (329)
T ss_pred             HHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------CCCCCCCCHHHHH
Confidence            999998889999999999999999999999986432211  1111111111111110          0122233456889


Q ss_pred             HHhhhcCCCCCCCCC------HHHHHH
Q 026939          161 IGLLCVQADSADRPT------MSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs------~~~i~~  181 (230)
                      ++.+||+.||.+|++      ++++++
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         235 VLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            999999999999998      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.94  E-value=3.6e-27  Score=196.73  Aligned_cols=166  Identities=28%  Similarity=0.364  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|.||+++.++.++|+|||++................++..|++|
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  250 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  250 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence            45889999999999999999999999   999999999999999999999999998764322111111112234579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......     .. ......+..         ...+......+.+++
T Consensus       251 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~-~~~~~~~~~---------~~~~~~~~~~~~~~~  315 (343)
T cd05103         251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EF-CRRLKEGTR---------MRAPDYTTPEMYQTM  315 (343)
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HH-HHHHhccCC---------CCCCCCCCHHHHHHH
Confidence            99988889999999999999999997 888875321110     00 011111110         111112234588999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      ..||+.||++|||+.+|++.|+...
T Consensus       316 ~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         316 LDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=3.2e-27  Score=195.99  Aligned_cols=159  Identities=26%  Similarity=0.307  Sum_probs=118.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~a  164 (329)
T cd05618          90 QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIA  164 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccC
Confidence            357899999999999999999999999   99999999999999999999999999864321111  1122456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccc--cchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG--QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||........  ...............          ..++......+.+
T Consensus       165 PE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~~~~~~~  234 (329)
T cd05618         165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAAS  234 (329)
T ss_pred             HHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCCCCCCHHHHH
Confidence            9999988899999999999999999999999853221111  111111111111110          1123334556889


Q ss_pred             HHhhhcCCCCCCCCCH
Q 026939          161 IGLLCVQADSADRPTM  176 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~  176 (230)
                      ++.+||+.||++||++
T Consensus       235 ll~~~L~~dP~~R~~~  250 (329)
T cd05618         235 VLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhcCCHHHcCCC
Confidence            9999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=5.5e-27  Score=187.97  Aligned_cols=163  Identities=28%  Similarity=0.302  Sum_probs=119.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGYMA   82 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~a   82 (230)
                      .+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .......++..|+|
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  170 (262)
T cd05058          94 NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA  170 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccC
Confidence            4677888999999999999999999   999999999999999999999999998654321110  00111233567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCC-CCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKK-NSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++||||||+++|+|++|+. ||.....      ....... ..+         .....+...+..+.++
T Consensus       171 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~-~~~---------~~~~~~~~~~~~~~~l  234 (262)
T cd05058         171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYL-LQG---------RRLLQPEYCPDPLYEV  234 (262)
T ss_pred             hhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH-hcC---------CCCCCCCcCCHHHHHH
Confidence            999988889999999999999999999654 4432110      0110000 000         0011112223468899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +..||+.+|++||++.+|++.|++.
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=1e-27  Score=198.64  Aligned_cols=157  Identities=21%  Similarity=0.223  Sum_probs=120.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||+|||+ .+   ++||||+|+||+++.++.++|+|||++........  ......++..|+
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~  163 (325)
T cd05594          89 ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYL  163 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccC
Confidence            4578999999999999999999997 78   99999999999999999999999999865322111  112235788999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||.+.+..++.++|+|||||++|+|++|..||........       ........          ..++......+.++
T Consensus       164 aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~----------~~~p~~~~~~~~~l  226 (325)
T cd05594         164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEE----------IRFPRTLSPEAKSL  226 (325)
T ss_pred             CHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCC----------CCCCCCCCHHHHHH
Confidence            99999988999999999999999999999999853221100       00000000          01122334568899


Q ss_pred             HhhhcCCCCCCCC-----CHHHHHH
Q 026939          162 GLLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +.+||+.||++|+     ++.++++
T Consensus       227 i~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         227 LSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            9999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.94  E-value=3.8e-27  Score=193.30  Aligned_cols=160  Identities=25%  Similarity=0.301  Sum_probs=120.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.......   .......+..|++||
T Consensus       120 ~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE  193 (303)
T cd05088         120 TLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE  193 (303)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHH
Confidence            6889999999999999999999999   9999999999999999999999999885321110   111112245799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++|+|++ |..||......      +....          .........+...+..+.+++.
T Consensus       194 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~li~  257 (303)
T cd05088         194 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK----------LPQGYRLEKPLNCDDEVYDLMR  257 (303)
T ss_pred             HHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHH----------HhcCCcCCCCCCCCHHHHHHHH
Confidence            9988888999999999999999998 88887432111      00000          0000111112223446889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.+|++||++.++++.|+..
T Consensus       258 ~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         258 QCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.1e-27  Score=196.97  Aligned_cols=172  Identities=24%  Similarity=0.279  Sum_probs=120.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +...+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......     ....++..|+
T Consensus       111 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~  182 (343)
T cd07878         111 KCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYR  182 (343)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCCc-----CCcccccccc
Confidence            3457899999999999999999999999   9999999999999999999999999987653321     1235678899


Q ss_pred             Chhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh-hh-------hHHHHhhhhhhhhhchh--hcc--
Q 026939           82 APEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL-SY-------TWKLWCEGEALELMEPV--LKQ--  148 (230)
Q Consensus        82 aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~--~~~--  148 (230)
                      |||.+.+ ..++.++|||||||++|+|++|..||............ ..       .................  ...  
T Consensus       183 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (343)
T cd07878         183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQD  262 (343)
T ss_pred             CchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchh
Confidence            9999876 46889999999999999999999998543211100000 00       00000000000000000  000  


Q ss_pred             --hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 --SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 --~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        .........+.+++.+||+.||++|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         263 LKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              000112234788999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.94  E-value=9.2e-27  Score=186.07  Aligned_cols=158  Identities=25%  Similarity=0.342  Sum_probs=122.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|+|
T Consensus        96 ~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~a  170 (257)
T cd08223          96 GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMS  170 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccC
Confidence            346899999999999999999999999   99999999999999999999999999876643222  1122356778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||...+..++.++|+||+|+++++|++|..||......      ..... ...+.         ....+...+..+.+++
T Consensus       171 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~-~~~~~---------~~~~~~~~~~~~~~li  234 (257)
T cd08223         171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYR-IIEGK---------LPPMPKDYSPELGELI  234 (257)
T ss_pred             hhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhcC---------CCCCccccCHHHHHHH
Confidence            99998888899999999999999999999997532211      00000 11111         1122334455689999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||++||++.++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         235 ATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHHhccCcccCCCHHHHhc
Confidence            9999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=1.9e-27  Score=196.64  Aligned_cols=157  Identities=24%  Similarity=0.240  Sum_probs=120.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~a  164 (321)
T cd05591          90 SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIA  164 (321)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccC
Confidence            456889999999999999999999999   99999999999999999999999999875322211  1122356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||........      . .......          ..++......+.+++
T Consensus       165 PE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~-~~i~~~~----------~~~p~~~~~~~~~ll  227 (321)
T cd05591         165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------F-ESILHDD----------VLYPVWLSKEAVSIL  227 (321)
T ss_pred             HHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------H-HHHHcCC----------CCCCCCCCHHHHHHH
Confidence            9999988899999999999999999999999864321110      0 0011100          011222345688999


Q ss_pred             hhhcCCCCCCCC-------CHHHHHH
Q 026939          163 LLCVQADSADRP-------TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-------s~~~i~~  181 (230)
                      ..||+.||++||       ++.++++
T Consensus       228 ~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         228 KAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            999999999999       7787765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=8e-27  Score=186.39  Aligned_cols=157  Identities=25%  Similarity=0.314  Sum_probs=121.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........     .......|++||
T Consensus        96 ~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~y~~pe  167 (254)
T cd05083          96 LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPE  167 (254)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC-----CCCCCceecCHH
Confidence            5789999999999999999999999   99999999999999999999999999865432111     112345799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+||||+++|+|++ |..||.......      .. ...         ........+...+..+.+++.
T Consensus       168 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~---------~~~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VK-ECV---------EKGYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             HhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HH-HHH---------hCCCCCCCCCcCCHHHHHHHH
Confidence            9988889999999999999999998 888875322111      00 000         111111112233456889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||+.+|++||++.+|++.|++
T Consensus       232 ~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         232 SCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHcCCChhhCcCHHHHHHHHcc
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=186.33  Aligned_cols=146  Identities=26%  Similarity=0.283  Sum_probs=118.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .+++++..+..++.+|+.||+|||+.+   |++||+||+|||+|++|-+|+.|||++.......     ....|++.|+|
T Consensus       138 ~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT-----~TlCGTPeYLA  209 (355)
T KOG0616|consen  138 SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT-----WTLCGTPEYLA  209 (355)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcE-----EEecCCccccC
Confidence            468999999999999999999999999   9999999999999999999999999998765432     23578999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||+++..++..++|.|+|||++|||+.|.+||....+..       ...        +++...+  .+|......+.+|+
T Consensus       210 PEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~--------KI~~~~v--~fP~~fs~~~kdLl  272 (355)
T KOG0616|consen  210 PEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYE--------KILEGKV--KFPSYFSSDAKDLL  272 (355)
T ss_pred             hHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHH--------HHHhCcc--cCCcccCHHHHHHH
Confidence            999999999999999999999999999999997554311       011        1111111  23444455577788


Q ss_pred             hhhcCCCCCCC
Q 026939          163 LLCVQADSADR  173 (230)
Q Consensus       163 ~~cl~~dP~~R  173 (230)
                      ...|+.|-.+|
T Consensus       273 ~~LL~vD~t~R  283 (355)
T KOG0616|consen  273 KKLLQVDLTKR  283 (355)
T ss_pred             HHHHhhhhHhh
Confidence            88888888888

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.94  E-value=5e-27  Score=197.87  Aligned_cols=175  Identities=23%  Similarity=0.323  Sum_probs=121.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++.......... .....++..|+|
T Consensus        97 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~a  172 (372)
T cd07853          97 PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVTQYYRA  172 (372)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcccc-CCCCCcCCCcCC
Confidence            457899999999999999999999999   9999999999999999999999999987653322111 112245678999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhchhhcc-----
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEPVLKQ-----  148 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----  148 (230)
                      ||.+.+. .++.++||||+||++|+|++|..||....+......+..        ............+.......     
T Consensus       173 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (372)
T cd07853         173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPV  252 (372)
T ss_pred             HHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHH
Confidence            9998764 478999999999999999999999864432211100000        00000000000000000000     


Q ss_pred             --hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 --SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 --~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        .........+.+++.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         253 LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence              011123456889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=1.9e-27  Score=196.81  Aligned_cols=157  Identities=22%  Similarity=0.235  Sum_probs=120.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++.......  .......++..|+|
T Consensus        89 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~a  163 (323)
T cd05595          89 ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLA  163 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCC
Confidence            346899999999999999999999999   9999999999999999999999999886432111  11122356889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......       .........          ..++...+..+.+++
T Consensus       164 PE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~----------~~~p~~~~~~~~~li  226 (323)
T cd05595         164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEE----------IRFPRTLSPEAKSLL  226 (323)
T ss_pred             cccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC----------CCCCCCCCHHHHHHH
Confidence            999988889999999999999999999999985322110       000000000          012223345688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||+.||++|+     ++.++++
T Consensus       227 ~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         227 AGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHccCCHHHhCCCCCCCHHHHHc
Confidence            999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.94  E-value=2.7e-27  Score=195.48  Aligned_cols=156  Identities=28%  Similarity=0.242  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+||
T Consensus        91 ~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aP  165 (318)
T cd05570          91 GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAP  165 (318)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCH
Confidence            47899999999999999999999999   99999999999999999999999999865321111  11123567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+|||||++|+|++|..||.......      .. .......          ..++......+.+++.
T Consensus       166 E~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~-~~i~~~~----------~~~~~~~~~~~~~li~  228 (318)
T cd05570         166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LF-QSILEDE----------VRYPRWLSKEAKSILK  228 (318)
T ss_pred             HHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HH-HHHHcCC----------CCCCCcCCHHHHHHHH
Confidence            99998899999999999999999999999985332110      00 0010100          1122233456889999


Q ss_pred             hhcCCCCCCCCCH-----HHHHH
Q 026939          164 LCVQADSADRPTM-----SSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~-----~~i~~  181 (230)
                      +||+.||.+||++     .++++
T Consensus       229 ~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         229 SFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHccCCHHHcCCCCCCCHHHHhc
Confidence            9999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-27  Score=190.68  Aligned_cols=108  Identities=33%  Similarity=0.520  Sum_probs=96.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC------CCeEEcccccceeecCCCCCcccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE------MNPKISDFEMARIFGGNQSEASTNRIVG   76 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~   76 (230)
                      +..+++.++..++.||+.||++||+++   |+||||||.|||++.+      ..+||+|||+++......   ......|
T Consensus       103 ~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~tlcG  176 (429)
T KOG0595|consen  103 RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS---MAETLCG  176 (429)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh---HHHHhhC
Confidence            458999999999999999999999999   9999999999999865      458999999999876433   2334588


Q ss_pred             ccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCC
Q 026939           77 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGF  116 (230)
Q Consensus        77 ~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~  116 (230)
                      ++.|||||+++...|+.|+|+||+|+++|++++|..||..
T Consensus       177 SplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  177 SPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            9999999999999999999999999999999999999864

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=9.2e-27  Score=187.18  Aligned_cols=165  Identities=22%  Similarity=0.282  Sum_probs=124.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|+||
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ap  175 (267)
T cd08229         101 RLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSP  175 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCH
Confidence            46899999999999999999999999   999999999999999999999999988765432211  1123567789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||......    ...... .     ......+   ..........+.+++.
T Consensus       176 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~-----~~~~~~~---~~~~~~~~~~~~~li~  242 (267)
T cd08229         176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-K-----IEQCDYP---PLPSDHYSEELRQLVN  242 (267)
T ss_pred             HHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-h-----hhcCCCC---CCCcccccHHHHHHHH
Confidence            9998888999999999999999999999997432111    000000 0     0000000   0111234556889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||..||.+|||+.+|++.+++.
T Consensus       243 ~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         243 MCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HhcCCCcccCCCHHHHHHHHhhh
Confidence            99999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=4.8e-27  Score=195.06  Aligned_cols=172  Identities=23%  Similarity=0.323  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..+..++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++.......    .....++..|+|
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~a  170 (331)
T cd06649          98 KRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS  170 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCC
Confidence            4688999999999999999999985 5   9999999999999999999999999986543221    122356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh---------------------------HHHHhh
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT---------------------------WKLWCE  135 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~---------------------------~~~~~~  135 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||...............                           ......
T Consensus       171 PE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T cd06649         171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPA  250 (331)
T ss_pred             HhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccc
Confidence            99999888999999999999999999999998543221100000000                           000000


Q ss_pred             hhhhhhhchhhc---chh-hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          136 GEALELMEPVLK---QSC-VAAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       136 ~~~~~~~~~~~~---~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .......+....   ... .......+.+++.+||+.||++|||+.+|++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         251 MAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             hhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000110000   000 11234568999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=8.4e-27  Score=195.55  Aligned_cols=106  Identities=28%  Similarity=0.396  Sum_probs=90.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..++.++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++.......   ......++..|+|
T Consensus       151 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~a  224 (357)
T PHA03209        151 SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNA  224 (357)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccC
Confidence            457899999999999999999999999   9999999999999999999999999986432211   1112356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCC
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNS  114 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~  114 (230)
                      ||.+.+..++.++|+|||||++|+|+++..++
T Consensus       225 PE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            99999889999999999999999999866554

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.94  E-value=4.8e-27  Score=187.72  Aligned_cols=159  Identities=21%  Similarity=0.305  Sum_probs=122.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++...++.++.||+.||.+||+.+   ++|+||+|+||+++.++.++++|||.+.........  .....+...|+|
T Consensus        94 ~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~a  168 (255)
T cd08219          94 GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVP  168 (255)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc--cccccCCccccC
Confidence            346889999999999999999999999   999999999999999999999999998765432221  112356778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++|+|++|..||......      ..... ..++.         ....+......+.+++
T Consensus       169 PE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~-~~~~~---------~~~~~~~~~~~~~~li  232 (255)
T cd08219         169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK-VCQGS---------YKPLPSHYSYELRSLI  232 (255)
T ss_pred             HHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH-HhcCC---------CCCCCcccCHHHHHHH
Confidence            99998888999999999999999999999998532111      00000 00111         1112233445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+||+.||++||++.+|+.+
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=4.3e-27  Score=196.98  Aligned_cols=159  Identities=28%  Similarity=0.364  Sum_probs=116.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..+..++.||+.||+|||+.+   ++|+||+++||+++.++.++|+|||++.........  .....++..|+|||
T Consensus       164 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE  238 (353)
T PLN00034        164 IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPE  238 (353)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccc--ccccccCccccCcc
Confidence            4567788899999999999999999   999999999999999999999999998765322111  11235688999999


Q ss_pred             hhhcC-----CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           85 YAMEG-----LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        85 ~~~~~-----~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      .+...     ....++|||||||++|+|++|..||........   .......          ........+......+.
T Consensus       239 ~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAI----------CMSQPPEAPATASREFR  305 (353)
T ss_pred             ccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHH----------hccCCCCCCCccCHHHH
Confidence            87532     234689999999999999999999863221110   0000000          00001112234455689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.+|++
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.5e-27  Score=193.33  Aligned_cols=154  Identities=23%  Similarity=0.214  Sum_probs=119.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.||+.||+|||++|   ++|+||+|+||+++.++.++|+|||++.......     ....++..|+|
T Consensus        95 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~a  166 (291)
T cd05612          95 SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLA  166 (291)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----ccccCChhhcC
Confidence            357889999999999999999999999   9999999999999999999999999987543221     12356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|||||||++|+|++|..||.......      .. .....+.          ..++......+.+++
T Consensus       167 PE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~-~~i~~~~----------~~~~~~~~~~~~~li  229 (291)
T cd05612         167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IY-EKILAGK----------LEFPRHLDLYAKDLI  229 (291)
T ss_pred             HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCC----------cCCCccCCHHHHHHH
Confidence            999998889999999999999999999999985422110      00 0000100          112223345688999


Q ss_pred             hhhcCCCCCCCCC-----HHHHHH
Q 026939          163 LLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      .+||+.||.+||+     +.++++
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhc
Confidence            9999999999995     888775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=5.1e-27  Score=190.14  Aligned_cols=162  Identities=26%  Similarity=0.278  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........   .....++..|+||
T Consensus        90 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aP  163 (277)
T cd05607          90 RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAP  163 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCH
Confidence            35889999999999999999999999   99999999999999999999999999876543221   1123567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+||++|+|++|..||........  ........     .    ..... .........+.+++.
T Consensus       164 E~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~-----~----~~~~~-~~~~~~~~~~~~li~  231 (277)
T cd05607         164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRT-----L----EDEVK-FEHQNFTEESKDICR  231 (277)
T ss_pred             HHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHh-----h----ccccc-cccccCCHHHHHHHH
Confidence            999888899999999999999999999999864322111  00000000     0    00000 001123445889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHh
Q 026939          164 LCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L  183 (230)
                      .||+.||++||+++++++.+
T Consensus       232 ~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         232 LFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHhccCHhhCCCCccchhhh
Confidence            99999999999998766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=8.4e-27  Score=188.83  Aligned_cols=165  Identities=24%  Similarity=0.351  Sum_probs=124.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.................+..|++|
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         104 DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCH
Confidence            46899999999999999999999999   999999999999999999999999998765432221111111224579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+....++.++|+||||+++|++++ |..||.......      ..          ..+........+..+...+.+++
T Consensus       181 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~~~~  244 (279)
T cd05057         181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IP----------DLLEKGERLPQPPICTIDVYMVL  244 (279)
T ss_pred             HHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HH----------HHHhCCCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 999975432111      11          01111111111222344688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||..||.+||++.++++.|....
T Consensus       245 ~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         245 VKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             HHHcCCChhhCCCHHHHHHHHHHHH
Confidence            9999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=5.7e-27  Score=190.16  Aligned_cols=160  Identities=26%  Similarity=0.277  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus        92 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aP  166 (280)
T cd05608          92 PGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAP  166 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCH
Confidence            46899999999999999999999999   999999999999999999999999998765432221  1223567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+|||||++|+|++|..||.........  ....         .......  ..++...+..+.+++.
T Consensus       167 E~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~---------~~~~~~~--~~~~~~~~~~~~~li~  233 (280)
T cd05608         167 ELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELK---------QRILNDS--VTYPDKFSPASKSFCE  233 (280)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHH---------HhhcccC--CCCcccCCHHHHHHHH
Confidence            9999989999999999999999999999998643211100  0000         0000000  1122334556889999


Q ss_pred             hhcCCCCCCCC-----CHHHHHH
Q 026939          164 LCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +||+.||++||     +++++++
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         234 ALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHhc
Confidence            99999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.94  E-value=1e-26  Score=195.44  Aligned_cols=170  Identities=24%  Similarity=0.225  Sum_probs=120.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++........   .....++..|+|||
T Consensus       122 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE  195 (364)
T cd07875         122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPE  195 (364)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHH
Confidence            4788899999999999999999999   99999999999999999999999999876432211   11235678999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhch------------
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEP------------  144 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~------------  144 (230)
                      ++.+..++.++|||||||++|+|++|..||...........+..        ..... ..........            
T Consensus       196 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  274 (364)
T cd07875         196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKL  274 (364)
T ss_pred             HHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh-hHHHHHHHhhCCCcCCCChHhh
Confidence            99998999999999999999999999999864332111000000        00000 0000000000            


Q ss_pred             ---hh---cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          145 ---VL---KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       145 ---~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                         ..   ...........+.+++.+||+.||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               00   00001112346789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=5.1e-27  Score=190.65  Aligned_cols=175  Identities=21%  Similarity=0.304  Sum_probs=124.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......+...|+|
T Consensus       104 ~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  180 (284)
T cd05079         104 NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA  180 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccC
Confidence            35899999999999999999999999   999999999999999999999999998765432211 11122344567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccccc----chhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ----SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      ||.+.+..++.++|+||||+++|+|+++..|+.........    ........     .....+........+...+..+
T Consensus       181 pE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  255 (284)
T cd05079         181 PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-----RLVRVLEEGKRLPRPPNCPEEV  255 (284)
T ss_pred             HHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-----HHHHHHHcCccCCCCCCCCHHH
Confidence            99998888999999999999999999987664221110000    00000000     0000111111111122345579


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          159 IHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+++.+||+.+|++|||+.+|++.|+..
T Consensus       256 ~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         256 YQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=1e-26  Score=187.06  Aligned_cols=164  Identities=26%  Similarity=0.386  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccc-cccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST-NRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~a   82 (230)
                      ..+++.+++.++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++............ ........|++
T Consensus       102 ~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  178 (268)
T cd05063         102 GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA  178 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecC
Confidence            46899999999999999999999999   999999999999999999999999998765432211111 11112346999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+|||||++|+|++ |..||......      ... .....         ......+...+..+.++
T Consensus       179 PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~-~~i~~---------~~~~~~~~~~~~~~~~l  242 (268)
T cd05063         179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVM-KAIND---------GFRLPAPMDCPSAVYQL  242 (268)
T ss_pred             HHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHH-HHHhc---------CCCCCCCCCCCHHHHHH
Confidence            999988889999999999999999997 99997432211      000 11111         01111122334568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.+|++||++.+|++.|++.
T Consensus       243 i~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         243 MLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=8.3e-27  Score=186.85  Aligned_cols=162  Identities=28%  Similarity=0.421  Sum_probs=122.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||++......... ..........|++|
T Consensus        98 ~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~P  173 (261)
T cd05034          98 KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAP  173 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCH
Confidence            46889999999999999999999999   999999999999999999999999998765432111 11112234579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||+|++++++++ |..||......      .....          .........+...+..+.+++
T Consensus       174 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQ----------VERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH----------HHcCCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 88887432110      00000          011111111222345689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.+|++||++.++++.|+.
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHcccCcccCCCHHHHHHHHhc
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=4e-27  Score=190.70  Aligned_cols=178  Identities=26%  Similarity=0.331  Sum_probs=126.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aP   83 (230)
                      .+++..++.++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||.+......... ...........|++|
T Consensus       105 ~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         105 QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCc
Confidence            4899999999999999999999999   999999999999999999999999998776422211 111112334569999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++++|++|..|+............ ..............+........+..++..+.+++.
T Consensus       182 e~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  260 (284)
T cd05038         182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG-IAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMK  260 (284)
T ss_pred             HHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc-cccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHH
Confidence            9998888999999999999999999999887432211100000 000000011111111111222223344567999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.+|++|||+.+|++.|+..
T Consensus       261 ~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         261 LCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHhccChhhCCCHHHHHHHHhhc
Confidence            99999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.1e-27  Score=197.31  Aligned_cols=163  Identities=20%  Similarity=0.150  Sum_probs=122.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.++..++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++.....     ......++..|+|
T Consensus        95 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~a  166 (333)
T cd05600          95 LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMA  166 (333)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccC
Confidence            346889999999999999999999999   99999999999999999999999999875432     1122456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|||||||++|+|++|..||.........      ... ..  ....+...............+.+++
T Consensus       167 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i-~~--~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENL-KY--WKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             hhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHH-Hh--ccccccCCCCCccccccCHHHHHHH
Confidence            99999889999999999999999999999998643221110      000 00  0000000000000013345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+||..+|.+||++.++++.
T Consensus       238 ~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHhhChhhhcCCHHHHHhC
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.94  E-value=9.4e-27  Score=189.52  Aligned_cols=165  Identities=28%  Similarity=0.384  Sum_probs=122.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++...++.++.||+.||+|||+++   ++|+||+|+||+++.++.++|+|||++................++..|++||
T Consensus       115 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE  191 (288)
T cd05061         115 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHH
Confidence            4567788999999999999999999   9999999999999999999999999887543222111111123356799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+|||||++|+|++ |..||......      +.. .....+..         ...+......+.+++.
T Consensus       192 ~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~-~~~~~~~~---------~~~~~~~~~~~~~li~  255 (288)
T cd05061         192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVL-KFVMDGGY---------LDQPDNCPERVTDLMR  255 (288)
T ss_pred             HhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHcCCC---------CCCCCCCCHHHHHHHH
Confidence            9988889999999999999999998 67777432111      000 00111100         0112233457999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      +||+.||++|||+.++++.|++...
T Consensus       256 ~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         256 MCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHcCCChhHCcCHHHHHHHHHhhcC
Confidence            9999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.94  E-value=1.2e-26  Score=184.70  Aligned_cols=161  Identities=28%  Similarity=0.301  Sum_probs=121.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......... ..........|+||
T Consensus        88 ~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aP  163 (250)
T cd05085          88 DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAP  163 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCH
Confidence            46789999999999999999999999   999999999999999999999999998654322111 11111224579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|++++ |..||.......      .. .....         ......+...+..+.+++
T Consensus       164 E~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~------~~-~~~~~---------~~~~~~~~~~~~~~~~li  227 (250)
T cd05085         164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ------AR-EQVEK---------GYRMSCPQKCPDDVYKVM  227 (250)
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH------HH-HHHHc---------CCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 888875322111      00 00000         111112223445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.+|++||++.++++.|.
T Consensus       228 ~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         228 QRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHcccCcccCCCHHHHHHHhc
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.6e-27  Score=187.91  Aligned_cols=161  Identities=21%  Similarity=0.269  Sum_probs=121.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc-ccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~a   82 (230)
                      ..++...++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++........... .....+...|+|
T Consensus        99 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  175 (263)
T cd06625          99 GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS  175 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccC
Confidence            46788899999999999999999999   99999999999999999999999999875432211111 012345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++|+|++|..||......      .....         ..........+......+.+++
T Consensus       176 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~---------~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFK---------IATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             cceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHH---------HhccCCCCCCCccCCHHHHHHH
Confidence            99999888999999999999999999999997532111      00000         0011111223334455688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+||..+|.+|||+.++++.
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhC
Confidence            99999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=4e-27  Score=194.85  Aligned_cols=152  Identities=26%  Similarity=0.281  Sum_probs=117.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  ......+++.|+|
T Consensus        95 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~a  169 (323)
T cd05616          95 VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIA  169 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcC
Confidence            356889999999999999999999999   99999999999999999999999999865322111  1122356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......      .... ....          ...++......+.+++
T Consensus       170 PE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~-i~~~----------~~~~p~~~s~~~~~li  232 (323)
T cd05616         170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQS-IMEH----------NVAYPKSMSKEAVAIC  232 (323)
T ss_pred             HHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHH-HHhC----------CCCCCCcCCHHHHHHH
Confidence            999998899999999999999999999999986432111      0000 0010          0112333455688999


Q ss_pred             hhhcCCCCCCCCCH
Q 026939          163 LLCVQADSADRPTM  176 (230)
Q Consensus       163 ~~cl~~dP~~RPs~  176 (230)
                      .+||+.||++|++.
T Consensus       233 ~~~l~~~p~~R~~~  246 (323)
T cd05616         233 KGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHcccCHHhcCCC
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=3.7e-27  Score=195.12  Aligned_cols=157  Identities=27%  Similarity=0.270  Sum_probs=119.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        95 ~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~a  169 (324)
T cd05587          95 VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIA  169 (324)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccC
Confidence            346889999999999999999999999   99999999999999999999999999864322111  1122356889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||+||++|+|++|..||.......      .... ....          ...++......+.+++
T Consensus       170 PE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~-i~~~----------~~~~~~~~~~~~~~li  232 (324)
T cd05587         170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQS-IMEH----------NVSYPKSLSKEAVSIC  232 (324)
T ss_pred             hhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHH-HHcC----------CCCCCCCCCHHHHHHH
Confidence            999998889999999999999999999999985332110      0000 0000          0112223345688999


Q ss_pred             hhhcCCCCCCCCCH-----HHHHH
Q 026939          163 LLCVQADSADRPTM-----SSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~-----~~i~~  181 (230)
                      .+||..||.+|++.     +++++
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         233 KGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhc
Confidence            99999999999986     55554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=4.9e-27  Score=193.87  Aligned_cols=156  Identities=26%  Similarity=0.278  Sum_probs=119.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.++..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  ......++..|+||
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  165 (316)
T cd05619          91 HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAP  165 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCH
Confidence            46899999999999999999999999   99999999999999999999999999865322111  11223567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+||++|+|++|..||......      ...... ..      .    ...++......+.+++.
T Consensus       166 E~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i-~~------~----~~~~~~~~~~~~~~li~  228 (316)
T cd05619         166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSI-RM------D----NPCYPRWLTREAKDILV  228 (316)
T ss_pred             HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHH-Hh------C----CCCCCccCCHHHHHHHH
Confidence            9999888999999999999999999999998543211      000000 00      0    01122233456888999


Q ss_pred             hhcCCCCCCCCCHH-HHHH
Q 026939          164 LCVQADSADRPTMS-SVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~-~i~~  181 (230)
                      +||+.||++||++. ++.+
T Consensus       229 ~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         229 KLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHhccCHhhcCCChHHHHc
Confidence            99999999999997 6643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=6.8e-27  Score=193.31  Aligned_cols=153  Identities=20%  Similarity=0.184  Sum_probs=117.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++..++..++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++.......  .......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~a  164 (321)
T cd05603          90 ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLA  164 (321)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCC
Confidence            456888999999999999999999999   9999999999999999999999999886432111  11222356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||......      ..... ....          ....+......+.+++
T Consensus       165 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~-i~~~----------~~~~~~~~~~~~~~li  227 (321)
T cd05603         165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDN-ILHK----------PLQLPGGKTVAACDLL  227 (321)
T ss_pred             HHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHH-HhcC----------CCCCCCCCCHHHHHHH
Confidence            99998888999999999999999999999998532210      00000 0000          0112233445688999


Q ss_pred             hhhcCCCCCCCCCHH
Q 026939          163 LLCVQADSADRPTMS  177 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~  177 (230)
                      .+||+.||.+||++.
T Consensus       228 ~~~l~~~p~~R~~~~  242 (321)
T cd05603         228 VGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHccCCHhhcCCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=4.5e-27  Score=194.54  Aligned_cols=153  Identities=23%  Similarity=0.200  Sum_probs=117.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||.|||++|   ++||||+|+||+++.++.++|+|||++.......  .......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~a  164 (323)
T cd05575          90 ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLA  164 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcC
Confidence            457889999999999999999999999   9999999999999999999999999886432111  11222356889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||......      +.... .....          ...+......+.+++
T Consensus       165 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~-i~~~~----------~~~~~~~~~~~~~li  227 (323)
T cd05575         165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDN-ILNKP----------LRLKPNISVSARHLL  227 (323)
T ss_pred             hhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHH-HHcCC----------CCCCCCCCHHHHHHH
Confidence            99999888999999999999999999999998532211      00000 00100          011122345688999


Q ss_pred             hhhcCCCCCCCCCHH
Q 026939          163 LLCVQADSADRPTMS  177 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~  177 (230)
                      .+||+.||.+||++.
T Consensus       228 ~~~l~~~p~~R~~~~  242 (323)
T cd05575         228 EGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHhhcCHHhCCCCC
Confidence            999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=5.3e-27  Score=194.18  Aligned_cols=157  Identities=22%  Similarity=0.222  Sum_probs=120.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+.+..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        94 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a  168 (323)
T cd05584          94 EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMA  168 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccC
Confidence            345788889999999999999999999   99999999999999999999999999865322211  1122356889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|||||||++|+|++|..||.......      .. .....+.          ...+......+.+++
T Consensus       169 PE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~-~~~~~~~----------~~~~~~~~~~~~~li  231 (323)
T cd05584         169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TI-DKILKGK----------LNLPPYLTPEARDLL  231 (323)
T ss_pred             hhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCC----------CCCCCCCCHHHHHHH
Confidence            999988888999999999999999999999986432110      00 0000100          112223345688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||+.||++||     ++.++++
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhc
Confidence            999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.94  E-value=1.3e-26  Score=185.22  Aligned_cols=161  Identities=26%  Similarity=0.321  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||.+......... .......+..|++|
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aP  170 (256)
T cd05112          95 GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSP  170 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCH
Confidence            46889999999999999999999999   999999999999999999999999988765332111 11112234679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      .... ...         ......+......+.+++
T Consensus       171 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~~---------~~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVET-INA---------GFRLYKPRLASQSVYELM  234 (256)
T ss_pred             hHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHH-HhC---------CCCCCCCCCCCHHHHHHH
Confidence            99988889999999999999999998 888875322110      0000 000         000011112345689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.+|++||++.++++.|.
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHcccChhhCCCHHHHHHhhC
Confidence            9999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.5e-27  Score=196.99  Aligned_cols=162  Identities=22%  Similarity=0.233  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCC-----------------
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ-----------------   66 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----------------   66 (230)
                      ..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.......                 
T Consensus        96 ~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (350)
T cd05573          96 DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN  172 (350)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccc
Confidence            57899999999999999999999999   9999999999999999999999999987654322                 


Q ss_pred             ----------CCccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh
Q 026939           67 ----------SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG  136 (230)
Q Consensus        67 ----------~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  136 (230)
                                .........++..|+|||.+.+..++.++|||||||++|+|++|..||.......      ...... . 
T Consensus       173 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~------~~~~i~-~-  244 (350)
T cd05573         173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE------TYNKII-N-  244 (350)
T ss_pred             ccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH------HHHHHh-c-
Confidence                      0011122356889999999999999999999999999999999999986433111      000000 0 


Q ss_pred             hhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 026939          137 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT-MSSVVVM  182 (230)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~i~~~  182 (230)
                          .. ...........+..+.+++.+||. ||.+||+ +.++++.
T Consensus       245 ----~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         245 ----WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ----cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                00 000000011134568889999997 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=7.4e-27  Score=192.00  Aligned_cols=173  Identities=22%  Similarity=0.273  Sum_probs=120.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus        99 ~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aP  173 (309)
T cd07872          99 NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPP  173 (309)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCC
Confidence            35788999999999999999999999   999999999999999999999999998764322211  1122457789999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhhhhhhhhhc-hhhcc----h
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCEGEALELME-PVLKQ----S  149 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~----~  149 (230)
                      |.+.+ ..++.++|+|||||++|+|++|..||.............        ..+..+.........+ +....    .
T Consensus       174 E~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (309)
T cd07872         174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLIN  253 (309)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhh
Confidence            99865 457899999999999999999999986443221110000        0010000000000000 00000    0


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ........+.+++.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         254 HAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            01123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=2e-26  Score=185.65  Aligned_cols=163  Identities=24%  Similarity=0.280  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......... .........|+||
T Consensus       102 ~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aP  177 (270)
T cd05056         102 YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAP  177 (270)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccCh
Confidence            35899999999999999999999999   9999999999999999999999999987654322111 1111234579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+....++.++|+||||++++++++ |..||.......      .... ..++.         ....+...+..+.+++
T Consensus       178 E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~-~~~~~---------~~~~~~~~~~~~~~li  241 (270)
T cd05056         178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIGR-IENGE---------RLPMPPNCPPTLYSLM  241 (270)
T ss_pred             hhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHH-HHcCC---------cCCCCCCCCHHHHHHH
Confidence            99988889999999999999999996 999985332110      0000 00111         1112233445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||..+|++|||+.++++.|++.
T Consensus       242 ~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         242 TKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=201.78  Aligned_cols=164  Identities=23%  Similarity=0.325  Sum_probs=138.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++..|+......+++||..||+|||++.   +|||||..+||++....-+||+|||+++........... ...-+..|+
T Consensus       484 nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWm  559 (974)
T KOG4257|consen  484 NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWM  559 (974)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeec
Confidence            3557899999999999999999999998   999999999999999999999999999987665444333 223367899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +||.+....++.++|||.|||++||+++ |..||..-                .+.++..-++.+-+..+|+.|+..|+.
T Consensus       560 aPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv----------------kNsDVI~~iEnGeRlP~P~nCPp~LYs  623 (974)
T KOG4257|consen  560 APESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV----------------KNSDVIGHIENGERLPCPPNCPPALYS  623 (974)
T ss_pred             CccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----------------cccceEEEecCCCCCCCCCCCChHHHH
Confidence            9999999999999999999999999886 88997532                233344445556667788899999999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      ||.+||.++|.+||++.+|...|.+
T Consensus       624 lmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  624 LMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             HHHHHhccCcccCCcHHHHHHHHHH
Confidence            9999999999999999999887744

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.94  E-value=1.1e-26  Score=187.28  Aligned_cols=159  Identities=26%  Similarity=0.356  Sum_probs=118.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus       105 ~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~a  179 (272)
T cd06637         105 GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMA  179 (272)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccC
Confidence            346899999999999999999999999   99999999999999999999999999875432211  1122356778999


Q ss_pred             hhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||.+.     +..++.++|+||+||++|+|++|..||....+...     . .... ...     ..   ..........
T Consensus       180 PE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~-~~~~-~~~-----~~---~~~~~~~~~~  244 (272)
T cd06637         180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----L-FLIP-RNP-----AP---RLKSKKWSKK  244 (272)
T ss_pred             HhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----H-HHHh-cCC-----CC---CCCCCCcCHH
Confidence            99986     23578899999999999999999999853221100     0 0000 000     00   0011123346


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||..||.+|||+.+|++
T Consensus       245 ~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         245 FQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhh
Confidence            889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=4.8e-27  Score=194.57  Aligned_cols=157  Identities=22%  Similarity=0.212  Sum_probs=118.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~a  164 (325)
T cd05604          90 ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLA  164 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCC
Confidence            457899999999999999999999999   99999999999999999999999999864321111  1122456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||......      ...... ....        .  .........+.+++
T Consensus       165 PE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~-~~~~--------~--~~~~~~~~~~~~ll  227 (325)
T cd05604         165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNI-LHKP--------L--VLRPGASLTAWSIL  227 (325)
T ss_pred             HHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHH-HcCC--------c--cCCCCCCHHHHHHH
Confidence            99999989999999999999999999999998532211      000000 0100        0  11122344588899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+|++.||.+||++++.++
T Consensus       228 ~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         228 EELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             HHHhccCHHhcCCCCCCHH
Confidence            9999999999998864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.94  E-value=1.1e-26  Score=198.06  Aligned_cols=171  Identities=23%  Similarity=0.220  Sum_probs=124.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC--CeEEcccccceeecCCCCCccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM--NPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      -..|+.+.+..++.||+.||.+||+.+   |||+||||+|||+...+  .+||+|||++.+......     ....+..|
T Consensus       283 f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfY  354 (586)
T KOG0667|consen  283 FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFY  354 (586)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeecccc
Confidence            357899999999999999999999999   99999999999997543  689999999987653322     24668899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHH-hhhhhhhhh------------
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLW-CEGEALELM------------  142 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~------------  142 (230)
                      .|||++.+.+|+.+.|||||||++.||++|.+-|....+.+....+...     ...+ ...+....+            
T Consensus       355 RAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~  434 (586)
T KOG0667|consen  355 RAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVE  434 (586)
T ss_pred             ccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeee
Confidence            9999999999999999999999999999998777544332211111000     0000 000000000            


Q ss_pred             --------------------ch--------hhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          143 --------------------EP--------VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       143 --------------------~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                                          ..        .+.......+...|.+++.+||+.||.+|+|..+.++
T Consensus       435 ~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  435 TSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             ecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                                00        0001122255677999999999999999999999987

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.94  E-value=1e-26  Score=197.47  Aligned_cols=165  Identities=25%  Similarity=0.324  Sum_probs=124.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.++++++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++|
T Consensus       234 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         234 PALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            46788999999999999999999998   999999999999999999999999998754322111111122446789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      ....         .+........+......+.+++
T Consensus       311 E~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~~~---------~~~~~~~~~~p~~~~~~l~~li  375 (401)
T cd05107         311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QFYN---------AIKRGYRMAKPAHASDEIYEIM  375 (401)
T ss_pred             HHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HHHH---------HHHcCCCCCCCCCCCHHHHHHH
Confidence            99988888999999999999999998 788875321110      0000         0111111112233455789999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||..+|.+||++++|++.|+..
T Consensus       376 ~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         376 QKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.7e-26  Score=184.65  Aligned_cols=157  Identities=29%  Similarity=0.356  Sum_probs=121.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........     .......|++||
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape  169 (256)
T cd05039          98 VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPE  169 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCch
Confidence            6899999999999999999999999   99999999999999999999999999876532211     123355799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+||||++++++++ |..||.......      . ....         ........+...+..+.+++.
T Consensus       170 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~~~~---------~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------V-VPHV---------EKGYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             hhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH------H-HHHH---------hcCCCCCCccCCCHHHHHHHH
Confidence            9988888999999999999999997 888875321110      0 0000         000111112233456899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||..+|++||++.++++.|+.
T Consensus       234 ~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         234 DCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHhccChhhCcCHHHHHHHHhc
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.94  E-value=1.1e-26  Score=186.05  Aligned_cols=174  Identities=23%  Similarity=0.209  Sum_probs=124.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      +.++...+..+++||+.||+|||+++   |+||||||.|++++.+|.+||+|||+++.+........  ....+..|.||
T Consensus       115 ~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt--~evvTlWYRaP  189 (323)
T KOG0594|consen  115 QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYT--PEVVTLWYRAP  189 (323)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccccc--ccEEEeeccCH
Confidence            45777899999999999999999999   99999999999999999999999999987653333222  23457789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHhhhh---hhhhhchhh--cchhhH
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWCEGE---ALELMEPVL--KQSCVA  152 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~--~~~~~~  152 (230)
                      |++.+. .|+...||||+||++.||+++..-|....+......+...     ...|....   ..+..-+..  ......
T Consensus       190 EvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~  269 (323)
T KOG0594|consen  190 EVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSS  269 (323)
T ss_pred             HHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHH
Confidence            999987 6999999999999999999999888655442221111100     01111111   111100000  001111


Q ss_pred             ---HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          153 ---AELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       153 ---~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                         .......+++.+|++++|.+|.|+...++.
T Consensus       270 ~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  270 ILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             hccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               112468889999999999999999999874

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=2e-26  Score=185.64  Aligned_cols=163  Identities=26%  Similarity=0.384  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcccccc---ccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI---VGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~---~~~~~~   80 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++...............   .....|
T Consensus       101 ~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y  177 (269)
T cd05065         101 GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW  177 (269)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceee
Confidence            46889999999999999999999999   999999999999999999999999988654332211111001   113469


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ++||.+.+..++.++|+|||||++|++++ |..||......      ....          .+........+...+..+.
T Consensus       178 ~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~~~~----------~i~~~~~~~~~~~~~~~~~  241 (269)
T cd05065         178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVIN----------AIEQDYRLPPPMDCPTALH  241 (269)
T ss_pred             cCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------HHHH----------HHHcCCcCCCcccCCHHHH
Confidence            99999988889999999999999999886 88887432211      0000          0001111111233445688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +++..||+.+|.+||++.+|+..|+.
T Consensus       242 ~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         242 QLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=5.8e-27  Score=193.26  Aligned_cols=160  Identities=24%  Similarity=0.289  Sum_probs=123.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC---CccccccccccCccC
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---EASTNRIVGTYGYMA   82 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~~a   82 (230)
                      |++.++++++++++.||+|||.+|   |+||||||+|+|++.+|.+||+|||.+..+.....   ........|++.|+|
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A  283 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA  283 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccc
Confidence            889999999999999999999999   99999999999999999999999999987743322   122234588999999


Q ss_pred             hhhhhcCC----CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           83 PEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        83 Pe~~~~~~----~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      ||...+..    ...+.||||+||++|-|+.|+.||-.......               ..+++...+.-...++..+.+
T Consensus       284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l---------------~~KIvn~pL~fP~~pe~~e~~  348 (576)
T KOG0585|consen  284 PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL---------------FDKIVNDPLEFPENPEINEDL  348 (576)
T ss_pred             hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH---------------HHHHhcCcccCCCcccccHHH
Confidence            99998743    34788999999999999999999843221100               111111111111123456778


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHHh
Q 026939          159 IHIGLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      .+|+.+||++||++|.++.+|....
T Consensus       349 kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  349 KDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHHHHHhhcChhheeehhhheecc
Confidence            9999999999999999999997543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1.6e-27  Score=196.73  Aligned_cols=154  Identities=23%  Similarity=0.208  Sum_probs=118.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        92 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~a  166 (318)
T cd05582          92 EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMA  166 (318)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcC
Confidence            456899999999999999999999999   99999999999999999999999999875432211  1122456789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......      .... ....        .  ...+......+.+++
T Consensus       167 PE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~-i~~~--------~--~~~p~~~~~~~~~li  229 (318)
T cd05582         167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTM-ILKA--------K--LGMPQFLSPEAQSLL  229 (318)
T ss_pred             HHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHH-HHcC--------C--CCCCCCCCHHHHHHH
Confidence            999988888999999999999999999999985422110      0000 0000        0  112223345688999


Q ss_pred             hhhcCCCCCCCCCHHH
Q 026939          163 LLCVQADSADRPTMSS  178 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~  178 (230)
                      .+||+.||++||++.+
T Consensus       230 ~~~l~~~P~~R~~a~~  245 (318)
T cd05582         230 RALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHhhcCHhHcCCCCC
Confidence            9999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=2.2e-26  Score=190.96  Aligned_cols=154  Identities=23%  Similarity=0.207  Sum_probs=119.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++.......     ....+++.|+|
T Consensus       112 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~a  183 (329)
T PTZ00263        112 AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLA  183 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcC
Confidence            356889999999999999999999999   9999999999999999999999999987653221     12356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||......      .. ......+.          ..++......+.+++
T Consensus       184 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~-~~~i~~~~----------~~~p~~~~~~~~~li  246 (329)
T PTZ00263        184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RI-YEKILAGR----------LKFPNWFDGRARDLV  246 (329)
T ss_pred             HHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HH-HHHHhcCC----------cCCCCCCCHHHHHHH
Confidence            99999888999999999999999999999998532211      00 01111110          011222334578999


Q ss_pred             hhhcCCCCCCCCC-----HHHHHH
Q 026939          163 LLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      .+||+.||.+|++     +++++.
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999997     577764

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.94  E-value=1.5e-26  Score=189.11  Aligned_cols=160  Identities=24%  Similarity=0.352  Sum_probs=120.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|+|
T Consensus       110 ~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a  184 (296)
T cd06654         110 ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA  184 (296)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccC
Confidence            346789999999999999999999999   999999999999999999999999987654322111  112245678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||....+...  ..    ......      .+  ....+......+.+++
T Consensus       185 PE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~----~~~~~~------~~--~~~~~~~~~~~l~~li  250 (296)
T cd06654         185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATNG------TP--ELQNPEKLSAIFRDFL  250 (296)
T ss_pred             HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HH----HHhcCC------CC--CCCCccccCHHHHHHH
Confidence            9999888889999999999999999999999853321110  00    000000      00  0011223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||..+|++||++.+|++
T Consensus       251 ~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         251 NRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHCcCCcccCcCHHHHhh
Confidence            9999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=5.1e-27  Score=195.20  Aligned_cols=159  Identities=25%  Similarity=0.322  Sum_probs=130.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.-++++++++++.|++.|+.|||++.   |+|||||..|||+++++.++|+|||++........  ......|++.|++
T Consensus       100 ~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~Ymc  174 (426)
T KOG0589|consen  100 GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMC  174 (426)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccC
Confidence            456899999999999999999999888   99999999999999999999999999988765431  2223588999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+.+|..++|||||||++|||.+-+++|....-...               +.++.. ......+......+..++
T Consensus       175 PEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---------------i~ki~~-~~~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  175 PEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---------------ILKINR-GLYSPLPSMYSSELRSLV  238 (426)
T ss_pred             HHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---------------HHHHhh-ccCCCCCccccHHHHHHH
Confidence            9999999999999999999999999999999854321110               111111 112345667777899999


Q ss_pred             hhhcCCCCCCCCCHHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~  182 (230)
                      ..|++.+|..||++.+++..
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhC
Confidence            99999999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-27  Score=198.85  Aligned_cols=153  Identities=22%  Similarity=0.233  Sum_probs=119.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe-CCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL-DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      .++.....+..|+.+|+.|+.|||++|   ++|||+||+|||+ +..+.++|+|||.+......   ...  ..-+..|+
T Consensus       409 ~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~t--p~~t~~y~  480 (612)
T KOG0603|consen  409 SKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDT--PALTLQYV  480 (612)
T ss_pred             hcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---hcc--cchhhccc
Confidence            344455677789999999999999999   9999999999999 58889999999998765433   111  12256899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++....|++++|+||||+++|+|++|..||......                  ..+..+...+.+....+....+|
T Consensus       481 APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~i~~~~~s~~vS~~AKdL  542 (612)
T KOG0603|consen  481 APEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTRIQMPKFSECVSDEAKDL  542 (612)
T ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHhhcCCccccccCHHHHHH
Confidence            999999889999999999999999999999998543222                  11112222222334555668889


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||.+||++.++..
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHhccCChhhCcChhhhcc
Confidence            99999999999999999864

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=8.4e-27  Score=193.46  Aligned_cols=158  Identities=21%  Similarity=0.227  Sum_probs=116.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   |+||||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~a  164 (330)
T cd05586          90 EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLA  164 (330)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccC
Confidence            457899999999999999999999999   99999999999999999999999999865322111  1122356889999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+. .++.++|||||||++|+|++|..||......      .. ......+.. ...        .......+.++
T Consensus       165 PE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~-~~~i~~~~~-~~~--------~~~~~~~~~~l  228 (330)
T cd05586         165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QM-YRNIAFGKV-RFP--------KNVLSDEGRQF  228 (330)
T ss_pred             HHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HH-HHHHHcCCC-CCC--------CccCCHHHHHH
Confidence            9998754 4789999999999999999999998532211      00 011111100 000        01123457889


Q ss_pred             HhhhcCCCCCCCCC----HHHHHH
Q 026939          162 GLLCVQADSADRPT----MSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs----~~~i~~  181 (230)
                      +.+||+.||.+||+    +.++++
T Consensus       229 i~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         229 VKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHcCCCHHHCCCCCCCHHHHhc
Confidence            99999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.94  E-value=3.6e-26  Score=183.30  Aligned_cols=162  Identities=27%  Similarity=0.409  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+......... ......++..|++|
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~P  172 (260)
T cd05073          97 SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP  172 (260)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCH
Confidence            35788899999999999999999999   999999999999999999999999998765432211 11112335679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+....++.++|+|||||+++++++ |..||.......      . .....++         .....+...+..+.+++
T Consensus       173 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~-~~~~~~~---------~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------V-IRALERG---------YRMPRPENCPEELYNIM  236 (260)
T ss_pred             hHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH------H-HHHHhCC---------CCCCCcccCCHHHHHHH
Confidence            99988888999999999999999999 888875322110      0 0000011         01111223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.+|++||++.++.+.|+.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         237 MRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1e-26  Score=194.85  Aligned_cols=154  Identities=23%  Similarity=0.324  Sum_probs=121.3

Q ss_pred             HHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhhhcC
Q 026939           10 RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEG   89 (230)
Q Consensus        10 ~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~   89 (230)
                      .+..+.+|++.|+.++|+.|   |||.||||.|+++- .|.+||+|||.+................|++.||+||.+...
T Consensus       461 ~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~  536 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM  536 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence            78889999999999999999   99999999998876 468999999999887666665555667899999999998732


Q ss_pred             -----------CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH-
Q 026939           90 -----------LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK-  157 (230)
Q Consensus        90 -----------~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  157 (230)
                                 +..+++|||||||++|+|+.|+.||+....              .-.++..+.++...-.|+..-... 
T Consensus       537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------------~~aKl~aI~~P~~~Iefp~~~~~~~  602 (677)
T KOG0596|consen  537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------------QIAKLHAITDPNHEIEFPDIPENDE  602 (677)
T ss_pred             cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------------HHHHHHhhcCCCccccccCCCCchH
Confidence                       256899999999999999999999863221              112344444544433333211112 


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.++|..||++||.+||++.++++
T Consensus       603 li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  603 LIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHHHHHHhcCcccCCCcHHHhc
Confidence            999999999999999999999986

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=1.5e-26  Score=188.14  Aligned_cols=162  Identities=30%  Similarity=0.420  Sum_probs=120.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..+..++.|++.||+|||+. +   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+
T Consensus       101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~  174 (288)
T cd06616         101 KSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYM  174 (288)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---ccccCccCcc
Confidence            35789999999999999999999975 7   999999999999999999999999998654322111   1124567899


Q ss_pred             ChhhhhcC---CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           82 APEYAMEG---LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        82 aPe~~~~~---~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      +||.+.+.   .++.++|+||+||++|+|++|..||.....     ......... ...     .+.+........+..+
T Consensus       175 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~l  243 (288)
T cd06616         175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGD-----PPILSNSEEREFSPSF  243 (288)
T ss_pred             CHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCC-----CCcCCCcCCCccCHHH
Confidence            99998766   688999999999999999999999864321     000000000 000     0111111112345568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.||++|||+.+|+.
T Consensus       244 ~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         244 VNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.94  E-value=2.7e-26  Score=185.98  Aligned_cols=162  Identities=26%  Similarity=0.393  Sum_probs=120.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......    .....++..|+|||
T Consensus        91 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE  163 (279)
T cd06619          91 KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPE  163 (279)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCce
Confidence            4678899999999999999999999   9999999999999999999999999987653221    11235677899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      .+.+..++.++|+||||+++|+|++|..||.......................     ....   ........+.+++.+
T Consensus       164 ~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~li~~  235 (279)
T cd06619         164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL---PVGQFSEKFVHFITQ  235 (279)
T ss_pred             eecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC---CCCcCCHHHHHHHHH
Confidence            99888899999999999999999999999864332221111100001110000     0000   011223458899999


Q ss_pred             hcCCCCCCCCCHHHHHH
Q 026939          165 CVQADSADRPTMSSVVV  181 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~  181 (230)
                      ||+.+|++||+++++++
T Consensus       236 ~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         236 CMRKQPKERPAPENLMD  252 (279)
T ss_pred             HhhCChhhCCCHHHHhc
Confidence            99999999999999986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=6e-27  Score=193.99  Aligned_cols=157  Identities=22%  Similarity=0.177  Sum_probs=118.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++...+..++.||+.||+|||+.|   ++||||||+||+++.++.++|+|||++........  ......++..|+|
T Consensus        90 ~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~a  164 (325)
T cd05602          90 ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLA  164 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccC
Confidence            346788899999999999999999999   99999999999999999999999999865322111  1222457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|||||||++|+|++|..||.......      .. .......          ..........+.+++
T Consensus       165 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~-~~i~~~~----------~~~~~~~~~~~~~li  227 (325)
T cd05602         165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MY-DNILNKP----------LQLKPNITNSARHLL  227 (325)
T ss_pred             HHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HH-HHHHhCC----------cCCCCCCCHHHHHHH
Confidence            999998889999999999999999999999985322110      00 0000000          011223344688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||.+|+++.+.+.
T Consensus       228 ~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         228 EGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHHcccCHHHCCCCCCCHH
Confidence            9999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=7.4e-26  Score=171.27  Aligned_cols=156  Identities=18%  Similarity=0.163  Sum_probs=114.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.+++.++.||+.||+|||+.+         ||+||+++.++.+++  ||++.......       ..++..|+|
T Consensus        11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~a   72 (176)
T smart00750       11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMA   72 (176)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccC
Confidence            457999999999999999999999864         999999999999999  99887653321       145789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHH--HHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL--LKFIH  160 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~  160 (230)
                      ||++.+..++.++|||||||++|+|++|..||.......  ....    ....... . ..+.. ...+....  ..+.+
T Consensus        73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~----~~~~~~~-~-~~~~~-~~~~~~~~~~~~~~~  143 (176)
T smart00750       73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILE----ILLNGMP-A-DDPRD-RSNLESVSAARSFAD  143 (176)
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHH----HHHHHhc-c-CCccc-cccHHHHHhhhhHHH
Confidence            999999999999999999999999999999985322110  0000    0000000 0 00000 01112222  26899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      ++.+||..+|++||++.++++.+..
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHH
Confidence            9999999999999999999987754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.94  E-value=2.4e-26  Score=185.09  Aligned_cols=162  Identities=22%  Similarity=0.307  Sum_probs=123.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.|++.+|.+||+ .+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..|+
T Consensus       107 ~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~  180 (269)
T cd08528         107 KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS  180 (269)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCc
Confidence            3468899999999999999999996 66   9999999999999999999999999987654322   122235677899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      +||.+.+..++.++|+||||+++|+|++|..||.......      .. ....+...        ...........+.++
T Consensus       181 ~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~-~~~~~~~~--------~~~~~~~~~~~l~~l  245 (269)
T cd08528         181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LA-TKIVEAVY--------EPLPEGMYSEDVTDV  245 (269)
T ss_pred             ChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HH-HHHhhccC--------CcCCcccCCHHHHHH
Confidence            9999988888999999999999999999999975322110      00 00001100        000011234568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+||+.||++||++.++..++++
T Consensus       246 i~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         246 ITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HHHHCCCCCccCCCHHHHHHHhcC
Confidence            999999999999999999998853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=3.9e-26  Score=182.26  Aligned_cols=160  Identities=26%  Similarity=0.358  Sum_probs=122.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++........  ......+...|++
T Consensus        93 ~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~  167 (256)
T cd06612          93 NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMA  167 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccC
Confidence            457899999999999999999999999   99999999999999999999999999876543221  1122345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++|+|++|..||....+.....       ....     ....  ....+......+.+++
T Consensus       168 PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~-----~~~~--~~~~~~~~~~~~~~~i  233 (256)
T cd06612         168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPN-----KPPP--TLSDPEKWSPEFNDFV  233 (256)
T ss_pred             HHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhcc-----CCCC--CCCchhhcCHHHHHHH
Confidence            999988889999999999999999999999986432211100       0000     0000  0111233345689999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||++|||+.+|++
T Consensus       234 ~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHhcChhhCcCHHHHhc
Confidence            9999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.94  E-value=1.9e-26  Score=187.09  Aligned_cols=172  Identities=20%  Similarity=0.204  Sum_probs=118.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus        93 ~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~a  167 (284)
T cd07839          93 NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRP  167 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcC
Confidence            346899999999999999999999999   999999999999999999999999998755322111  111244678999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh------hhhhhhchhhc--------
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG------EALELMEPVLK--------  147 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~--------  147 (230)
                      ||.+.+. .++.++|+|||||++|+|++|..|+....+...  ............      ......+....        
T Consensus       168 PE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd07839         168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTS  245 (284)
T ss_pred             hHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcch
Confidence            9998765 468899999999999999999988532221110  000000000000      00000000000        


Q ss_pred             -chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 -QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 -~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                       ..........+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         246 LVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             0111223456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.3e-26  Score=187.01  Aligned_cols=159  Identities=25%  Similarity=0.273  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........   .....++..|++|
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aP  170 (285)
T cd05605          97 PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAP  170 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCc
Confidence            46899999999999999999999999   99999999999999999999999999876532221   1123567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+||++|+|++|..||........   .    ..     ....+.. ....++...+..+.+++.
T Consensus       171 E~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~----~~-----~~~~~~~-~~~~~~~~~~~~~~~li~  237 (285)
T cd05605         171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---R----EE-----VERRVKE-DQEEYSEKFSEAARSICR  237 (285)
T ss_pred             HHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---H----HH-----HHHHhhh-cccccCcccCHHHHHHHH
Confidence            999888899999999999999999999999864221100   0    00     0000000 011223344556889999


Q ss_pred             hhcCCCCCCCC-----CHHHHHH
Q 026939          164 LCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .||..||++||     +++++++
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         238 QLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHccCCHHHhcCCCCCCHHHHhc
Confidence            99999999999     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=2.5e-26  Score=184.69  Aligned_cols=159  Identities=25%  Similarity=0.376  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC----ccccccccccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE----ASTNRIVGTYG   79 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~   79 (230)
                      ..++...+..++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||.+.........    .......+...
T Consensus       101 ~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (267)
T cd06628         101 GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF  177 (267)
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcC
Confidence            46888999999999999999999999   999999999999999999999999988765421111    01112245678


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |++||.+.+..++.++|+||||+++|+|++|..||.......         ..      ..... ......+......+.
T Consensus       178 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~------~~~~~-~~~~~~~~~~~~~~~  241 (267)
T cd06628         178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---------AI------FKIGE-NASPEIPSNISSEAI  241 (267)
T ss_pred             ccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---------HH------HHHhc-cCCCcCCcccCHHHH
Confidence            999999988888999999999999999999999986321100         00      00000 111222334456688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||.+||++.+|++
T Consensus       242 ~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         242 DFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhh
Confidence            9999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.94  E-value=7.4e-27  Score=187.27  Aligned_cols=170  Identities=21%  Similarity=0.245  Sum_probs=124.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++.++.-.+..+.+||..||+|||+.|   |+||||||.|+|+|.+ |.+||+|||.+.........   .....+..|.
T Consensus       119 ~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYR  192 (364)
T KOG0658|consen  119 NQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYR  192 (364)
T ss_pred             CCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEecccc
Confidence            467777788889999999999999999   9999999999999965 88999999999886543322   2235588999


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHh----------hhhhhhhhchhhc---
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWC----------EGEALELMEPVLK---  147 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~---  147 (230)
                      |||.+.+. .|+.+.||||.||++.||+-|++-|......+.  +.+. .+.+.          +.+....-.+.+.   
T Consensus       193 aPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eI-ik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~  269 (364)
T KOG0658|consen  193 APELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEI-IKVLGTPTREDIKSMNPNYTEFKFPQIKAHP  269 (364)
T ss_pred             CHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHH-HHHhCCCCHHHHhhcCcccccccCccccccc
Confidence            99999986 699999999999999999999999865332221  1111 11111          0010011111111   


Q ss_pred             --chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 --QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 --~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        .-+......+.++++.++|+++|.+|.++.+++.
T Consensus       270 ~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  270 WHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence              1133455667899999999999999999998764

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.94  E-value=2.3e-26  Score=186.57  Aligned_cols=173  Identities=23%  Similarity=0.222  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|+||
T Consensus        96 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  170 (285)
T cd07861          96 QYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAP  170 (285)
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccCh
Confidence            56899999999999999999999999   99999999999999999999999999876532211  11112446789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchh--------hhhHHHHhhhhhhh-hhchhhc---chh
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL--------SYTWKLWCEGEALE-LMEPVLK---QSC  150 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~~~~---~~~  150 (230)
                      |.+.+. .++.++|+|||||++++|++|..||............        ...+.......... .......   ...
T Consensus       171 E~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (285)
T cd07861         171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSA  250 (285)
T ss_pred             HHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHh
Confidence            988654 4788999999999999999999998643221100000        00000000000000 0000000   001


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .......+.+++.+||+.||++|||+.+|++
T Consensus       251 ~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         251 VKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            1123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=4.1e-26  Score=182.09  Aligned_cols=158  Identities=32%  Similarity=0.402  Sum_probs=120.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      +++.+++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++............ ...++..|++||.
T Consensus       100 ~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~  175 (258)
T smart00219      100 LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPES  175 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHH
Confidence            899999999999999999999999   999999999999999999999999998766443222111 1224578999999


Q ss_pred             hhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           86 AMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        86 ~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      +.+..++.++|+|+||+++++|++ |..||.....      ......          .........+...+..+.+++.+
T Consensus       176 ~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~----------~~~~~~~~~~~~~~~~~~~~i~~  239 (258)
T smart00219      176 LKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEY----------LKKGYRLPKPENCPPEIYKLMLQ  239 (258)
T ss_pred             hccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH----------HhcCCCCCCCCcCCHHHHHHHHH
Confidence            988889999999999999999998 6777643111      001000          00011111222345568999999


Q ss_pred             hcCCCCCCCCCHHHHHHHh
Q 026939          165 CVQADSADRPTMSSVVVML  183 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~~L  183 (230)
                      ||..||++|||+.++++.|
T Consensus       240 ~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      240 CWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HCcCChhhCcCHHHHHhhC
Confidence            9999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.94  E-value=3.8e-26  Score=185.26  Aligned_cols=160  Identities=24%  Similarity=0.300  Sum_probs=118.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++
T Consensus        97 ~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a  171 (282)
T cd06643          97 ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMA  171 (282)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccC
Confidence            357899999999999999999999999   99999999999999999999999999865432211  1122345778999


Q ss_pred             hhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||.+.     +..++.++|+||+||++|+|++|..||....+..      ...... ......       ...+......
T Consensus       172 PE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~-~~~~~~-------~~~~~~~~~~  237 (282)
T cd06643         172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIA-KSEPPT-------LAQPSRWSSE  237 (282)
T ss_pred             HhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHh-hcCCCC-------CCCccccCHH
Confidence            99984     3457789999999999999999999975322110      000000 000000       0112223456


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.||.+||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc
Confidence            889999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=1.8e-26  Score=185.50  Aligned_cols=155  Identities=23%  Similarity=0.302  Sum_probs=114.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC-------eEEcccccceeecCCCCCccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-------PKISDFEMARIFGGNQSEASTNRIV   75 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~   75 (230)
                      ...+++..+++++.||+.||+|||+++   ++|+||+|+||+++.++.       ++++|||++......      ....
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~  169 (262)
T cd05077          99 SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECV  169 (262)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------cccc
Confidence            346899999999999999999999999   999999999999986654       899999987644221      1124


Q ss_pred             cccCccChhhhh-cCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH
Q 026939           76 GTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA  153 (230)
Q Consensus        76 ~~~~~~aPe~~~-~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (230)
                      ++..|+|||.+. +..++.++|||||||++|+|++ |..|+........        ..+..... .     .    ...
T Consensus       170 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~~~~~-~-----~----~~~  231 (262)
T cd05077         170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFYEGQC-M-----L----VTP  231 (262)
T ss_pred             ccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHHhcCc-c-----C----CCC
Confidence            567899999886 4568899999999999999984 7777643211100        00001000 0     0    111


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      ....+.+++.+||+.||.+||++.+|++.|+
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            2346889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.94  E-value=8.4e-26  Score=182.05  Aligned_cols=165  Identities=25%  Similarity=0.353  Sum_probs=116.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus        96 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  172 (269)
T cd05087          96 TPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE  172 (269)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHh
Confidence            4567788899999999999999999   9999999999999999999999999886433222111222234567899999


Q ss_pred             hhhcC-------CCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           85 YAMEG-------LFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        85 ~~~~~-------~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      ++.+.       .++.++|+||||+++|+|++ |..||........   ...    ...........+.+.    .....
T Consensus       173 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~~~~~~~~~~~----~~~~~  241 (269)
T cd05087         173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY----TVREQQLKLPKPRLK----LPLSD  241 (269)
T ss_pred             HhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HhhcccCCCCCCccC----CCCCh
Confidence            98642       35789999999999999996 9989854322111   000    001111111111111    12233


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+.+++..|| .+|++|||+++|+..|+
T Consensus       242 ~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         242 RWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            4778889999 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=1.7e-26  Score=191.58  Aligned_cols=160  Identities=23%  Similarity=0.259  Sum_probs=118.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus        97 ~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aP  172 (330)
T cd05601          97 DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAP  172 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCH
Confidence            47899999999999999999999999   999999999999999999999999999765432221 11123567899999


Q ss_pred             hhhh------cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           84 EYAM------EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        84 e~~~------~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      |++.      ...++.++|||||||++|+|++|..||.......      ..............       .........
T Consensus       173 E~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~-------~~~~~~~~~  239 (330)
T cd05601         173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKF-------PEDPKVSSD  239 (330)
T ss_pred             HHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCC-------CCCCCCCHH
Confidence            9987      3457789999999999999999999985432111      00000000000000       001123445


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++..||+ +|.+||++.++++
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhC
Confidence            7888899997 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.3e-26  Score=184.79  Aligned_cols=157  Identities=29%  Similarity=0.395  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++|
T Consensus        93 ~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P  167 (274)
T cd06609          93 GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAP  167 (274)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccCh
Confidence            47899999999999999999999999   99999999999999999999999999977653321  11223556789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH-HHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA-ELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++|..||....+..      ... .....         .....+.. .+..+.+++
T Consensus       168 E~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~-~~~~~---------~~~~~~~~~~~~~~~~~l  231 (274)
T cd06609         168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLF-LIPKN---------NPPSLEGNKFSKPFKDFV  231 (274)
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHH-Hhhhc---------CCCCCcccccCHHHHHHH
Confidence            99988889999999999999999999999985332110      000 00000         01111111 344588899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||..+|++|||++++++
T Consensus       232 ~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         232 SLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHHhhCChhhCcCHHHHhh
Confidence            9999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.94  E-value=2.9e-26  Score=191.56  Aligned_cols=189  Identities=18%  Similarity=0.175  Sum_probs=132.9

Q ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCC---------------
Q 026939            1 MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN---------------   65 (230)
Q Consensus         1 ~~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---------------   65 (230)
                      |+...|++..+..++.+++.|+..||+.|   ++||||||+|+|+|..|.+||+||||+......               
T Consensus       233 ~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~  309 (550)
T KOG0605|consen  233 MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQIN  309 (550)
T ss_pred             HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhh
Confidence            46778999999999999999999999999   999999999999999999999999998532110               


Q ss_pred             -----CC-Cc-------c-----------------ccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCC
Q 026939           66 -----QS-EA-------S-----------------TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSG  115 (230)
Q Consensus        66 -----~~-~~-------~-----------------~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~  115 (230)
                           .. ..       .                 ....+|++-|+|||++.+.+|...+|.|||||++||||.|.+||.
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~  389 (550)
T KOG0605|consen  310 LSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFC  389 (550)
T ss_pred             hccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence                 00 00       0                 012368899999999999999999999999999999999999997


Q ss_pred             CCccccc-cchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH--HhhcCCCC
Q 026939          116 FYLSELG-QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT---MSSVVV--MLASDNVT  189 (230)
Q Consensus       116 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~i~~--~L~~~~~~  189 (230)
                      ...+... .....|.. .+      .       .........+..+||.+|+. ||++|-.   ++||.+  ++++..+.
T Consensus       390 s~tp~~T~rkI~nwr~-~l------~-------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  390 SETPQETYRKIVNWRE-TL------K-------FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             CCCHHHHHHHHHHHhh-hc------c-------CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            5544322 11111110 00      0       00111223568889999999 9999975   666654  44554443


Q ss_pred             CCCCCCCCCccCccCCCC
Q 026939          190 LPQPTEPAFSVGRNVARP  207 (230)
Q Consensus       190 ~~~~~~p~~~~~~~~~~~  207 (230)
                      =-.-..|+|.+.-+.+.|
T Consensus       455 ~l~~~~apfvP~v~~~~D  472 (550)
T KOG0605|consen  455 HLREMPAPFVPQVNSELD  472 (550)
T ss_pred             hhhcCCCCCCCCCCCccc
Confidence            222233555555544443

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.94  E-value=1.7e-26  Score=179.19  Aligned_cols=159  Identities=28%  Similarity=0.372  Sum_probs=121.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..|++....+|++|+.++++|||..+   |+|||+||+||+++.+..++|+|||++.......   ......|++.|+||
T Consensus       118 VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAP  191 (411)
T KOG0599|consen  118 VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAP  191 (411)
T ss_pred             eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccCh
Confidence            46889999999999999999999999   9999999999999999999999999998764332   22335789999999


Q ss_pred             hhhhc------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           84 EYAME------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        84 e~~~~------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      |++.-      ..|+..+|+|++||++|.|+.|.+||-.....       ...+.+.+++..      +....=.+....
T Consensus       192 EtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------lMLR~ImeGkyq------F~speWadis~~  258 (411)
T KOG0599|consen  192 ETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------LMLRMIMEGKYQ------FRSPEWADISAT  258 (411)
T ss_pred             hheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------HHHHHHHhcccc------cCCcchhhcccc
Confidence            99872      35889999999999999999999997321100       011111111100      000111233456


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..+|+.+||+.||.+|-|+++.+.
T Consensus       259 ~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  259 VKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHHeeCchhcccHHHHhc
Confidence            788999999999999999999875

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=5.7e-26  Score=182.94  Aligned_cols=164  Identities=21%  Similarity=0.265  Sum_probs=114.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      .++...+.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||+
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05042          97 AQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL  173 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHH
Confidence            467788999999999999999999   99999999999999999999999998864322111111122234567999999


Q ss_pred             hhc-------CCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           86 AME-------GLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        86 ~~~-------~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      +..       ..++.++|+|||||++|+|++ |..||....+..      ...... .........+    ..+......
T Consensus       174 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~-~~~~~~~~~~----~~~~~~~~~  242 (269)
T cd05042         174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVV-REQDIKLPKP----QLDLKYSDR  242 (269)
T ss_pred             HhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHh-hccCccCCCC----cccccCCHH
Confidence            753       346789999999999999999 677775332111      000100 1111111111    122233445


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      +.+++..|| .||++|||+++|++.|.
T Consensus       243 ~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         243 WYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            677888898 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=7e-26  Score=183.32  Aligned_cols=160  Identities=28%  Similarity=0.386  Sum_probs=124.0

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++..++..++.|++.||++||+.+   ++|+||+|+||+++.++.++++|||++.........  .....+...|+
T Consensus        94 ~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~  168 (277)
T cd06640          94 RAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWM  168 (277)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--cccccCccccc
Confidence            3457889999999999999999999999   999999999999999999999999998765432211  11234567899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||.+.+..++.++|+|||||++|+|++|..||....+...                ................+..+.++
T Consensus       169 apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l  232 (277)
T cd06640         169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------------LFLIPKNNPPTLTGEFSKPFKEF  232 (277)
T ss_pred             CHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH----------------hhhhhcCCCCCCchhhhHHHHHH
Confidence            99999888889999999999999999999999753221100                00111111123344556678999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      +.+||+.+|++||++.++++.
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         233 IDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHcccCcccCcCHHHHHhC
Confidence            999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.94  E-value=1.2e-25  Score=181.08  Aligned_cols=165  Identities=18%  Similarity=0.258  Sum_probs=114.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++...++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++||
T Consensus        95 ~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  171 (268)
T cd05086          95 NSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE  171 (268)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCch
Confidence            4567788899999999999999999   9999999999999999999999999875422111111112234567899999


Q ss_pred             hhhc-------CCCCccccchhhHHHHHHHHhc-CCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           85 YAME-------GLFSVKSDVFSFGVLLLEIISG-KKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        85 ~~~~-------~~~~~~~DiwslG~ll~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      ++..       ..++.++|+||||+++|+|+++ ..||....+.      ... ............++.+...    ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~----~~~  240 (268)
T cd05086         172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVL-NHVIKDQQVKLFKPQLELP----YSE  240 (268)
T ss_pred             hcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHhhcccccCCCccCCC----CcH
Confidence            8753       2357899999999999999975 5566422111      001 1111112222222222222    334


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+.+++..|| .+|++||++++|++.|.
T Consensus       241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         241 RWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            5777888999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.94  E-value=4.6e-26  Score=183.35  Aligned_cols=163  Identities=26%  Similarity=0.398  Sum_probs=122.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccc-cccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST-NRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~a   82 (230)
                      ..+++.+++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++............ .....+..|++
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  177 (267)
T cd05066         101 GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA  177 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecC
Confidence            46889999999999999999999999   999999999999999999999999998765432211111 11122357999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++|++++ |..||.......   ..    ....+         ......+...+..+.++
T Consensus       178 pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~---------~~~~~~~~~~~~~~~~l  241 (267)
T cd05066         178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEE---------GYRLPAPMDCPAALHQL  241 (267)
T ss_pred             HhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhC---------CCcCCCCCCCCHHHHHH
Confidence            999988889999999999999999886 999875322110   00    00000         01111122334568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+||+.+|.+||++.++++.|+.
T Consensus       242 i~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         242 MLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             HHHHcccCchhCCCHHHHHHHHHh
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.94  E-value=3.2e-26  Score=186.25  Aligned_cols=159  Identities=25%  Similarity=0.320  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+||
T Consensus        97 ~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~g~~~y~aP  170 (285)
T cd05630          97 AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYMAP  170 (285)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc---cCCCCCccccCh
Confidence            46889999999999999999999999   999999999999999999999999998654322211   123567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+|+++|+|++|..||.........   ....         ..... ....++......+.+++.
T Consensus       171 E~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~---------~~~~~-~~~~~~~~~~~~~~~li~  237 (285)
T cd05630         171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVE---------RLVKE-VQEEYSEKFSPDARSLCK  237 (285)
T ss_pred             HHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHH---------hhhhh-hhhhcCccCCHHHHHHHH
Confidence            9999888999999999999999999999998643211100   0000         00000 001122233445889999


Q ss_pred             hhcCCCCCCCCC-----HHHHHH
Q 026939          164 LCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs-----~~~i~~  181 (230)
                      .||+.||++|||     +.++++
T Consensus       238 ~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         238 MLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHhhcCHHHccCCCCCchHHHHc
Confidence            999999999999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.93  E-value=2.8e-26  Score=185.99  Aligned_cols=159  Identities=26%  Similarity=0.325  Sum_probs=117.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus       115 ~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~a  189 (282)
T cd06636         115 GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMA  189 (282)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccC
Confidence            346888899999999999999999999   99999999999999999999999998765432111  1122356778999


Q ss_pred             hhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||.+.     +..++.++|+|||||++|+|++|..||....+.....       .     ........   ......+..
T Consensus       190 PE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-------~-----~~~~~~~~---~~~~~~~~~  254 (282)
T cd06636         190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-------L-----IPRNPPPK---LKSKKWSKK  254 (282)
T ss_pred             HhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-------h-----HhhCCCCC---CcccccCHH
Confidence            99875     3457889999999999999999999985322111000       0     00000000   011223456


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.||.+||++.+|++
T Consensus       255 ~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         255 FIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHHHHHHHhCCChhhCcCHHHHhc
Confidence            999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.93  E-value=1.7e-26  Score=192.45  Aligned_cols=155  Identities=22%  Similarity=0.206  Sum_probs=120.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......     ....+++.|+|
T Consensus       125 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~a  196 (340)
T PTZ00426        125 NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIA  196 (340)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-----ceecCChhhcC
Confidence            457899999999999999999999999   9999999999999999999999999987653221     12356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||....+..       .......+.          ..++......+.+++
T Consensus       197 PE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~----------~~~p~~~~~~~~~li  259 (340)
T PTZ00426        197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGI----------IYFPKFLDNNCKHLM  259 (340)
T ss_pred             HHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC----------CCCCCCCCHHHHHHH
Confidence            999998889999999999999999999999986432110       011111110          011222334578899


Q ss_pred             hhhcCCCCCCCC-----CHHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~~  182 (230)
                      .+||+.||++|+     +++++++.
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHcC
Confidence            999999999995     89988763

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=4e-26  Score=182.88  Aligned_cols=154  Identities=21%  Similarity=0.302  Sum_probs=114.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC--------eEEcccccceeecCCCCCccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN--------PKISDFEMARIFGGNQSEASTNRIV   75 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~   75 (230)
                      ..+++..++.++.||+.||+|||+++   ++|+||+|+||+++.++.        ++++|||++......      ....
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~  165 (258)
T cd05078          95 NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILL  165 (258)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhcc
Confidence            35899999999999999999999999   999999999999987655        588999887543221      1134


Q ss_pred             cccCccChhhhhcC-CCCccccchhhHHHHHHHHhcC-CCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH
Q 026939           76 GTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA  153 (230)
Q Consensus        76 ~~~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (230)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|. .|+........        .....        .  ....+..
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--------~~~~~--------~--~~~~~~~  227 (258)
T cd05078         166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--------LQFYE--------D--RHQLPAP  227 (258)
T ss_pred             ccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--------HHHHH--------c--cccCCCC
Confidence            56789999998764 5789999999999999999985 44432111100        00000        0  1112222


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      ...++.+++.+||+.||++|||+++|++.|+
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         228 KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            3356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.93  E-value=5.5e-26  Score=181.91  Aligned_cols=158  Identities=23%  Similarity=0.288  Sum_probs=123.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhH-----hCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLH-----EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT   77 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh-----~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~   77 (230)
                      ..++++..++.++.||+.||++||     +.+   ++|+||+|+||+++.++.++|+|||++.........  .....+.
T Consensus        99 ~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~  173 (265)
T cd08217          99 RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGT  173 (265)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccC
Confidence            357899999999999999999999     777   999999999999999999999999998776433221  1123567


Q ss_pred             cCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           78 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        78 ~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ..|++||.+.+..++.++|+||||+++++|++|..||......      ... ..         +........+......
T Consensus       174 ~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~---------~~~~~~~~~~~~~~~~  237 (265)
T cd08217         174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLA-SK---------IKEGKFRRIPYRYSSE  237 (265)
T ss_pred             CCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHH-HH---------HhcCCCCCCccccCHH
Confidence            7899999998888899999999999999999999998643211      000 01         1111111233345567


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.+|++||++.+|++
T Consensus       238 ~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         238 LNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhh
Confidence            899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.93  E-value=4.8e-26  Score=183.16  Aligned_cols=159  Identities=21%  Similarity=0.298  Sum_probs=117.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus       101 ~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (266)
T cd06651         101 GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS  177 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccC
Confidence            46889999999999999999999999   999999999999999999999999998654321111 11112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||+||++|+|++|..||.......     .          ............++......+..++
T Consensus       178 PE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~li  242 (266)
T cd06651         178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A----------IFKIATQPTNPQLPSHISEHARDFL  242 (266)
T ss_pred             HHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H----------HHHHhcCCCCCCCchhcCHHHHHHH
Confidence            999988888999999999999999999999985321100     0          0001111111222333344566666


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                       +||..+|++||++++|++
T Consensus       243 -~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         243 -GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -HHhcCChhhCcCHHHHhc
Confidence             688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.93  E-value=5.6e-26  Score=183.83  Aligned_cols=159  Identities=28%  Similarity=0.392  Sum_probs=122.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..++++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|+
T Consensus        94 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~  168 (277)
T cd06642          94 KPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWM  168 (277)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCccccc
Confidence            3457899999999999999999999999   99999999999999999999999999876432211  111234567899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      +||.+.+..++.++|+||||+++|+|++|..|+....+...      ..          ..............+..+.++
T Consensus       169 aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~l  232 (277)
T cd06642         169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF----------LIPKNSPPTLEGQYSKPFKEF  232 (277)
T ss_pred             CHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh----------hhhcCCCCCCCcccCHHHHHH
Confidence            99999888889999999999999999999999753221110      00          000011111222344568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.+|++||++.+|++
T Consensus       233 i~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=3.5e-26  Score=189.33  Aligned_cols=151  Identities=26%  Similarity=0.301  Sum_probs=116.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++........  ......++..|+||
T Consensus        96 ~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  170 (323)
T cd05615          96 GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAP  170 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCH
Confidence            57899999999999999999999999   99999999999999999999999999865322111  11223568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+||++|+|++|..||.......      ..... ...          ...++......+.+++.
T Consensus       171 E~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i-~~~----------~~~~p~~~~~~~~~li~  233 (323)
T cd05615         171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSI-MEH----------NVSYPKSLSKEAVSICK  233 (323)
T ss_pred             HHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhC----------CCCCCccCCHHHHHHHH
Confidence            99988889999999999999999999999986432110      00000 000          01122333456888999


Q ss_pred             hhcCCCCCCCCCH
Q 026939          164 LCVQADSADRPTM  176 (230)
Q Consensus       164 ~cl~~dP~~RPs~  176 (230)
                      +||+.+|.+|++.
T Consensus       234 ~~l~~~p~~R~~~  246 (323)
T cd05615         234 GLMTKHPSKRLGC  246 (323)
T ss_pred             HHcccCHhhCCCC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=3.2e-26  Score=190.28  Aligned_cols=107  Identities=31%  Similarity=0.455  Sum_probs=91.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..+..++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++......    ......++..|+|
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~a  170 (333)
T cd06650          98 GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS  170 (333)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccC
Confidence            4688899999999999999999974 6   999999999999999999999999988654221    1112356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCC
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY  117 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~  117 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       171 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             HHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            99998888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.93  E-value=5.4e-26  Score=185.57  Aligned_cols=160  Identities=21%  Similarity=0.314  Sum_probs=120.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus       112 ~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~a  186 (292)
T cd06658         112 HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMA  186 (292)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccC
Confidence            456889999999999999999999999   99999999999999999999999998865432211  1122356778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++++|++|..||........      .. .     ...........  .......+.+++
T Consensus       187 PE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~-~-----~~~~~~~~~~~--~~~~~~~~~~li  252 (292)
T cd06658         187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MR-R-----IRDNLPPRVKD--SHKVSSVLRGFL  252 (292)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-H-----HHhcCCCcccc--ccccCHHHHHHH
Confidence            9999888889999999999999999999999853221100      00 0     00011111110  112334578889


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||..||.+|||+.+|++
T Consensus       253 ~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         253 DLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             HHHccCChhHCcCHHHHhh
Confidence            9999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=3.9e-26  Score=183.63  Aligned_cols=164  Identities=22%  Similarity=0.312  Sum_probs=119.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++..+..++.|++.||.|||+.+   ++|+|++|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       100 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~  174 (267)
T cd06646         100 TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMA  174 (267)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccc--cCccccCccccC
Confidence            357889999999999999999999999   999999999999999999999999998765322111  112345678999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.   ...++.++|+||+||++|+|++|..||....+.......       ....   ...+..  ......+..+.
T Consensus       175 PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~~~~~--~~~~~~~~~~~  242 (267)
T cd06646         175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQPPKL--KDKTKWSSTFH  242 (267)
T ss_pred             HhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CCCCCC--ccccccCHHHH
Confidence            99875   334778999999999999999999997432211100000       0000   000000  00112345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHh
Q 026939          160 HIGLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +++.+||+.+|++|||+++|++.|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCC
Confidence            999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.93  E-value=2.5e-26  Score=193.51  Aligned_cols=162  Identities=20%  Similarity=0.188  Sum_probs=119.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..++...+..++.||+.||+|||+.+   |+||||+|+||+++.++.++|+|||++......... ......+++.|+|
T Consensus       136 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~a  211 (370)
T cd05596         136 NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYIS  211 (370)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeEC
Confidence            456888999999999999999999999   999999999999999999999999998765322211 1122357889999


Q ss_pred             hhhhhcC----CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           83 PEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        83 Pe~~~~~----~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      ||++.+.    .++.++|+|||||++|+|++|..||......      ............       +.-......+..+
T Consensus       212 PE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~-------~~~~~~~~~s~~~  278 (370)
T cd05596         212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNS-------LTFPDDIEISKQA  278 (370)
T ss_pred             HHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCc-------CCCCCcCCCCHHH
Confidence            9998753    3788999999999999999999998643211      000000000000       0000011234568


Q ss_pred             HHHHhhhcCCCCCC--CCCHHHHHH
Q 026939          159 IHIGLLCVQADSAD--RPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~--RPs~~~i~~  181 (230)
                      .+++..||+.+|++  |+++.++++
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHHHccChhhccCCCCHHHHhc
Confidence            88999999999987  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=196.99  Aligned_cols=163  Identities=25%  Similarity=0.341  Sum_probs=136.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..++.-..+.++.||.+|++||..++   +|||||..+|+|+..+..+|++|||+++.+.......- .....++.|.|
T Consensus       359 r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH-AGAKFPIKWTA  434 (1157)
T KOG4278|consen  359 RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTA  434 (1157)
T ss_pred             hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecc-cCccCcccccC
Confidence            445666778889999999999999998   99999999999999999999999999998754333221 12234678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||-+....++.++|||+|||++||+.| |..||..-                .-..++.+++..++..-|..|++++++|
T Consensus       435 PEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----------------dlSqVY~LLEkgyRM~~PeGCPpkVYeL  498 (1157)
T KOG4278|consen  435 PESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYGLLEKGYRMDGPEGCPPKVYEL  498 (1157)
T ss_pred             cccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----------------cHHHHHHHHhccccccCCCCCCHHHHHH
Confidence            999999999999999999999999998 67776421                1224677888888888899999999999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      |+.||+++|..||++++|.+.++.
T Consensus       499 MraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  499 MRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             HHHHhcCCcccCccHHHHHHHHHH
Confidence            999999999999999999998854

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=5.3e-26  Score=198.36  Aligned_cols=171  Identities=22%  Similarity=0.285  Sum_probs=116.2

Q ss_pred             CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhh
Q 026939            7 DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYA   86 (230)
Q Consensus         7 ~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~   86 (230)
                      ...+++.++.||+.||+|||+++   |+||||||+|||++.++.++|+|||++..+...... ......++..|++||.+
T Consensus       265 ~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~  340 (501)
T PHA03210        265 LLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEIL  340 (501)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhh
Confidence            35667889999999999999999   999999999999999999999999999766432221 11224578899999999


Q ss_pred             hcCCCCccccchhhHHHHHHHHhcCCC-CCCCccccccchhhhhHHH-Hhhh-------hhhhhhchhhc----chh---
Q 026939           87 MEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYTWKL-WCEG-------EALELMEPVLK----QSC---  150 (230)
Q Consensus        87 ~~~~~~~~~DiwslG~ll~~ll~g~~p-~~~~~~~~~~~~~~~~~~~-~~~~-------~~~~~~~~~~~----~~~---  150 (230)
                      .+..++.++|||||||++|+|++|..+ ++................. ....       ...+.++....    ...   
T Consensus       341 ~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~  420 (501)
T PHA03210        341 AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPL  420 (501)
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhH
Confidence            998999999999999999999998754 4322211111111110000 0000       00011100000    000   


Q ss_pred             --hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 --VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 --~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        .......+.+++.+||+.||.+|||+.+++.
T Consensus       421 ~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        421 IRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence              0012234677889999999999999999986

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.3e-25  Score=179.87  Aligned_cols=161  Identities=24%  Similarity=0.316  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..++...++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|++|
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P  170 (262)
T cd06613          96 GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAP  170 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCc
Confidence            57899999999999999999999999   99999999999999999999999998875432211  11123456789999


Q ss_pred             hhhhcC---CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           84 EYAMEG---LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        84 e~~~~~---~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |.+.+.   .++.++|+||||+++|+|++|..||.........  .     ......    +.. .........+..+.+
T Consensus       171 e~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~-----~~~~~~----~~~-~~~~~~~~~~~~~~~  238 (262)
T cd06613         171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--F-----LISKSN----FPP-PKLKDKEKWSPVFHD  238 (262)
T ss_pred             hhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--H-----HHHhcc----CCC-ccccchhhhhHHHHH
Confidence            998776   7889999999999999999999998532211100  0     000000    000 000112334566899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||+.+|.+|||+.+|+.
T Consensus       239 li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhc
Confidence            999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.93  E-value=4.8e-26  Score=186.24  Aligned_cols=160  Identities=23%  Similarity=0.326  Sum_probs=120.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|++
T Consensus       109 ~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a  183 (296)
T cd06655         109 ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA  183 (296)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccC
Confidence            346899999999999999999999999   999999999999999999999999987654322111  112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||....+....      .... ...     .+.  ...+......+.+++
T Consensus       184 PE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~-~~~-----~~~--~~~~~~~~~~~~~li  249 (296)
T cd06655         184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIA-TNG-----TPE--LQNPEKLSPIFRDFL  249 (296)
T ss_pred             cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hcC-----Ccc--cCCcccCCHHHHHHH
Confidence            99998888899999999999999999999998543221110      0000 000     000  011223344688899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||..||.+||++.+|++
T Consensus       250 ~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         250 NRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHhhcChhhCCCHHHHhh
Confidence            9999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=5.9e-26  Score=181.48  Aligned_cols=153  Identities=20%  Similarity=0.323  Sum_probs=116.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-------CeEEcccccceeecCCCCCccccccccc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-------NPKISDFEMARIFGGNQSEASTNRIVGT   77 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~   77 (230)
                      .+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++       .++|+|||++.....      .....+.
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~  167 (259)
T cd05037          97 NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVER  167 (259)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccC
Confidence            5889999999999999999999999   99999999999999877       799999999876432      1112345


Q ss_pred             cCccChhhhhcC--CCCccccchhhHHHHHHHHhc-CCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           78 YGYMAPEYAMEG--LFSVKSDVFSFGVLLLEIISG-KKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        78 ~~~~aPe~~~~~--~~~~~~DiwslG~ll~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      ..|++||.+.+.  .++.++|+||||+++|+|++| ..|+.........       ..+....           ..+...
T Consensus       168 ~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~~~~-----------~~~~~~  229 (259)
T cd05037         168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQH-----------RLPMPD  229 (259)
T ss_pred             CCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHhcCC-----------CCCCCC
Confidence            679999998876  788999999999999999994 6665432211000       0000000           000111


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      ...+.+++.+||..+|.+|||+.+|++.|+
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4e-27  Score=199.06  Aligned_cols=167  Identities=29%  Similarity=0.350  Sum_probs=130.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++..+++.++.+.+.||+|||+++   ++||||.++|+|++.++.+|++|||++.....  .........-+..|+|||
T Consensus       258 ~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPE  332 (474)
T KOG0194|consen  258 SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPE  332 (474)
T ss_pred             CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc--eeeccccccCcceecChh
Confidence            4999999999999999999999999   99999999999999999999999999865431  111111112357999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+....|+.++|||||||++||+++ |..||......      +...         ++.....+...+...+..+..++.
T Consensus       333 tl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~---------kI~~~~~r~~~~~~~p~~~~~~~~  397 (474)
T KOG0194|consen  333 TLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKA---------KIVKNGYRMPIPSKTPKELAKVMK  397 (474)
T ss_pred             hhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHH---------HHHhcCccCCCCCCCHHHHHHHHH
Confidence            9999999999999999999999998 78887543222      1111         111223333444466667888889


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      +||..+|+.||+|.++.+.|+.......
T Consensus       398 ~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  398 QCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HhccCChhhccCHHHHHHHHHHHHhccc
Confidence            9999999999999999999988766544

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=4e-26  Score=189.86  Aligned_cols=178  Identities=23%  Similarity=0.263  Sum_probs=121.9

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGY   80 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~   80 (230)
                      +.+.+++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|
T Consensus        99 ~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y  175 (336)
T cd07849          99 KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY  175 (336)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCc
Confidence            3467899999999999999999999999   999999999999999999999999998765332211 111223557789


Q ss_pred             cChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh-h-------hhHHHHhhhhhhhhhch---hhc-
Q 026939           81 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL-S-------YTWKLWCEGEALELMEP---VLK-  147 (230)
Q Consensus        81 ~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~---~~~-  147 (230)
                      +|||.+.+ ..++.++|+||+||++|+|++|..||............ .       .................   ... 
T Consensus       176 ~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T cd07849         176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKV  255 (336)
T ss_pred             cChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcc
Confidence            99998765 46889999999999999999999998542211000000 0       00000000000000000   000 


Q ss_pred             --chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          148 --QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       148 --~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                        ....+.....+.+++.+||+.||++|||+.++++.
T Consensus       256 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         256 PWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             cHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              00112235568899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.93  E-value=1.2e-25  Score=182.35  Aligned_cols=158  Identities=23%  Similarity=0.249  Sum_probs=120.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........    ....++..|+|
T Consensus        91 ~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~a  163 (279)
T cd05633          91 HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMA  163 (279)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----cCcCCCcCccC
Confidence            356899999999999999999999999   99999999999999999999999999865432211    12356789999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+ ..++.++|+||+||++++|++|..||.........    ......      .    ......+......+.++
T Consensus       164 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~------~----~~~~~~~~~~~~~~~~l  229 (279)
T cd05633         164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMT------L----TVNVELPDSFSPELKSL  229 (279)
T ss_pred             HHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHh------h----cCCcCCccccCHHHHHH
Confidence            999864 45789999999999999999999998543221110    000000      0    00112233345568899


Q ss_pred             HhhhcCCCCCCCC-----CHHHHHH
Q 026939          162 GLLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +.+||..||++||     ++.++++
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         230 LEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            9999999999999     5988877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.93  E-value=4.1e-26  Score=186.85  Aligned_cols=173  Identities=19%  Similarity=0.222  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus        99 ~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~P  173 (301)
T cd07873          99 NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPP  173 (301)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCc
Confidence            46889999999999999999999999   999999999999999999999999998654322111  1112446789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchh--------hhhHHHHhhh-hhhhhhchhhcch----
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL--------SYTWKLWCEG-EALELMEPVLKQS----  149 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~----  149 (230)
                      |.+.+. .++.++|+|||||++|+|++|..||............        ...+...... .....-.+.....    
T Consensus       174 E~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (301)
T cd07873         174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHN  253 (301)
T ss_pred             HHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHh
Confidence            998754 4788999999999999999999998643321110000        0000000000 0000000000000    


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ........+.+++.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         254 HAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            01122345788999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.93  E-value=1.7e-25  Score=177.70  Aligned_cols=190  Identities=25%  Similarity=0.263  Sum_probs=133.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      +++...++.-+..|++.|++|||.++   |+|||||++|+|++..|.+|++|||+++.++......+.  .+=+.+|.||
T Consensus       172 q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~--lVVTLWYRaP  246 (419)
T KOG0663|consen  172 QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTP--LVVTLWYRAP  246 (419)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcccCcc--eEEEeeecCH
Confidence            78999999999999999999999999   999999999999999999999999999988765332222  2337799999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhh------hhhchhhcc
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEAL------ELMEPVLKQ  148 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~  148 (230)
                      |++.+. .|+...|+||+||++.||+++.+-|......+....+..        .|..+..-...      ...-..++.
T Consensus       247 ELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~  326 (419)
T KOG0663|consen  247 ELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRK  326 (419)
T ss_pred             HHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhh
Confidence            999986 589999999999999999999998865443322221110        11111111100      111111111


Q ss_pred             hhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCC-CCCCCCCCCCccC
Q 026939          149 SCVAA-ELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV-TLPQPTEPAFSVG  201 (230)
Q Consensus       149 ~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~-~~~~~~~p~~~~~  201 (230)
                      .+... ....-.+++..+|.+||++|.|+.+.++   ..++ ..|.|..|.+...
T Consensus       327 kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~---h~~F~e~P~p~~P~~~Pt  378 (419)
T KOG0663|consen  327 KFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK---HEYFRETPLPIDPSMFPT  378 (419)
T ss_pred             hccccccchhHHHHHHHHhccCccccccHHHhhc---ccccccCCCCCChhhcCC
Confidence            22222 3355678889999999999999998765   3322 2344555555443

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=9.1e-26  Score=183.56  Aligned_cols=159  Identities=26%  Similarity=0.314  Sum_probs=119.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........   .....++..|+||
T Consensus        97 ~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aP  170 (285)
T cd05632          97 PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAP  170 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccCh
Confidence            46899999999999999999999999   99999999999999999999999998865432211   1123567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+|+++|+|++|..||............        .......     ...++......+.+++.
T Consensus       171 E~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--------~~~~~~~-----~~~~~~~~~~~~~~li~  237 (285)
T cd05632         171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--------DRRVLET-----EEVYSAKFSEEAKSICK  237 (285)
T ss_pred             HHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HHhhhcc-----ccccCccCCHHHHHHHH
Confidence            9998888999999999999999999999998643221110000        0000000     01122233445788999


Q ss_pred             hhcCCCCCCCCC-----HHHHHH
Q 026939          164 LCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs-----~~~i~~  181 (230)
                      .||+.||++||+     +.+++.
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHc
Confidence            999999999999     667765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=9.5e-26  Score=182.13  Aligned_cols=161  Identities=25%  Similarity=0.319  Sum_probs=120.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++++|||++........ .......++..|++||
T Consensus       113 ~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE  188 (275)
T cd05046         113 PLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPE  188 (275)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChh
Confidence            6899999999999999999999999   99999999999999999999999998764322111 1111224456799999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|+||||+++++|++ |..||.......      ... ....+...        ...+...+..+.+++.
T Consensus       189 ~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~-~~~~~~~~--------~~~~~~~~~~l~~~i~  253 (275)
T cd05046         189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLN-RLQAGKLE--------LPVPEGCPSRLYKLMT  253 (275)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHH-HHHcCCcC--------CCCCCCCCHHHHHHHH
Confidence            9988888899999999999999998 777874321110      000 00001100        0111223346889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhh
Q 026939          164 LCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      +||+.+|.+||++.+++..|.
T Consensus       254 ~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         254 RCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCCcccCCCHHHHHHHhc
Confidence            999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-25  Score=182.22  Aligned_cols=173  Identities=21%  Similarity=0.242  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.+++.++.||+.||++||+.+   ++|+||+|+||+++.++.++|+|||.+........  ......+...|++|
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~P  167 (283)
T cd05118          93 RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAP  167 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCc
Confidence            47899999999999999999999999   99999999999999999999999999876643321  11112456789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhh---hhhhhhhchh--hcch
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCE---GEALELMEPV--LKQS  149 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~--~~~~  149 (230)
                      |.+.+. .++.++|+||||+++|+|++|+.||.............        ..+..+.+   .......+..  ....
T Consensus       168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (283)
T cd05118         168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPK  247 (283)
T ss_pred             HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHH
Confidence            998876 68899999999999999999999885432211000000        00000000   0000000000  0011


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .....+..+.+++..||+.||.+||++.+++.
T Consensus       248 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         248 LFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            12345667999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.93  E-value=1.5e-25  Score=179.03  Aligned_cols=158  Identities=25%  Similarity=0.391  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.+|+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++|
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ap  170 (256)
T cd08221          96 QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSP  170 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCH
Confidence            46899999999999999999999999   99999999999999999999999999876543321  12223567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||......      +..... ..+..         ...+...+..+.+++.
T Consensus       171 e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~---------~~~~~~~~~~~~~~i~  234 (256)
T cd08221         171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI-VQGNY---------TPVVSVYSSELISLVH  234 (256)
T ss_pred             hhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCC---------CCCccccCHHHHHHHH
Confidence            9998888889999999999999999999998532211      111010 11110         1112333456889999


Q ss_pred             hhcCCCCCCCCCHHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~  182 (230)
                      +||+.+|++||++.++++.
T Consensus       235 ~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHcccCcccCCCHHHHhhC
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=1.5e-25  Score=182.75  Aligned_cols=159  Identities=25%  Similarity=0.309  Sum_probs=117.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++|
T Consensus       105 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  179 (292)
T cd06644         105 RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAP  179 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCc
Confidence            46899999999999999999999999   99999999999999999999999998765432211  11223456789999


Q ss_pred             hhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           84 EYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        84 e~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |.+.     ...++.++|+|||||++|+|++|..||.......      .. .......     .+.  ...+......+
T Consensus       180 E~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~-----~~~--~~~~~~~~~~~  245 (292)
T cd06644         180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VL-LKIAKSE-----PPT--LSQPSKWSMEF  245 (292)
T ss_pred             eeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HH-HHHhcCC-----Ccc--CCCCcccCHHH
Confidence            9885     3446789999999999999999999985422110      00 0000000     000  01122334568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.+|++||++.+|++
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhc
Confidence            89999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-25  Score=181.25  Aligned_cols=160  Identities=27%  Similarity=0.375  Sum_probs=119.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus       107 ~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~a  181 (275)
T cd06608         107 GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMA  181 (275)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccC
Confidence            457899999999999999999999999   99999999999999999999999999876533221  1122346778999


Q ss_pred             hhhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||.+..     ..++.++|+||||+++++|++|..||.......      .... ....     ..+.  ...+......
T Consensus       182 PE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~-----~~~~--~~~~~~~~~~  247 (275)
T cd06608         182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFK-IPRN-----PPPT--LKSPENWSKK  247 (275)
T ss_pred             HhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHH-hhcc-----CCCC--CCchhhcCHH
Confidence            998753     346788999999999999999999985321110      0000 0000     0000  1112234557


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||..||++|||+.+|++
T Consensus       248 ~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         248 FNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHHHHHHhhcChhhCcCHHHHhc
Confidence            889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-26  Score=196.91  Aligned_cols=161  Identities=26%  Similarity=0.310  Sum_probs=132.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      +..|.......++.||+.|+.||.+++   +||||+..+|+++.....+||+|||+.+..+..... .......-.+.||
T Consensus       206 ~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWC  282 (1039)
T KOG0199|consen  206 KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWC  282 (1039)
T ss_pred             ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCccccc
Confidence            346777888899999999999999998   999999999999999889999999999877544332 2222233367899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+....++.++|+|++||.+||||+ |..||-.-                ....+.+.+|...+...+..|++.+++
T Consensus       283 aPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----------------~g~qIL~~iD~~erLpRPk~csedIY~  346 (1039)
T KOG0199|consen  283 APESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----------------RGIQILKNIDAGERLPRPKYCSEDIYQ  346 (1039)
T ss_pred             CHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----------------CHHHHHHhccccccCCCCCCChHHHHH
Confidence            9999999999999999999999999999 66776321                122355556666666678899999999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      +|..||..+|++|||+..|.+.
T Consensus       347 imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  347 IMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HHHHhccCCccccccHHHHHHh
Confidence            9999999999999999999743

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=6.1e-26  Score=201.46  Aligned_cols=163  Identities=31%  Similarity=0.380  Sum_probs=132.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcccccc-ccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI-VGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~-~~~~~~~aP   83 (230)
                      .|.....+.++.||+.|++||++..   ++|||+..+||++..+..+|++|||+++.............. .-+..|+||
T Consensus       414 ~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  414 ALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP  490 (609)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence            4889999999999999999999998   999999999999999999999999999854433332211111 125579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+....|+.++||||+|+++||+++ |..||....               ...++.+.+..+.+...|..+..+++++|
T Consensus       491 Esl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~---------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM  555 (609)
T KOG0200|consen  491 ESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP---------------PTEELLEFLKEGNRMEQPEHCSDEIYDLM  555 (609)
T ss_pred             HHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC---------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            99999999999999999999999999 777774311               01122334555555566777888899999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.||+.+|++||++.++.+.++.
T Consensus       556 ~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  556 KSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             HHHhCCCcccCCCHHHHHHHHHH
Confidence            99999999999999999999987

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.93  E-value=1.2e-25  Score=182.37  Aligned_cols=173  Identities=21%  Similarity=0.269  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|++|
T Consensus        95 ~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aP  169 (286)
T cd07847          95 RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAP  169 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCH
Confidence            46899999999999999999999999   99999999999999999999999999876543221  11123456789999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh-----h---HHHHhhhhhh---hhhchhhcc---
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY-----T---WKLWCEGEAL---ELMEPVLKQ---  148 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~-----~---~~~~~~~~~~---~~~~~~~~~---  148 (230)
                      |.+.+ ..++.++|+||+|+++|+|++|..||..............     .   ...+......   .........   
T Consensus       170 E~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (286)
T cd07847         170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLE  249 (286)
T ss_pred             HHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHH
Confidence            99876 4578899999999999999999999864332211100000     0   0000000000   000000000   


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .........+.+++.+||+.+|++||++.+++.
T Consensus       250 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         250 SKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            001122456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.93  E-value=1.3e-25  Score=182.05  Aligned_cols=158  Identities=26%  Similarity=0.385  Sum_probs=117.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||+|||++ +   ++|+||+|+||+++.++.++|+|||++........   .....++..|++
T Consensus        98 ~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a  171 (283)
T cd06617          98 LTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMA  171 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccC
Confidence            4689999999999999999999997 7   99999999999999999999999999876432211   111245678999


Q ss_pred             hhhhhc----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           83 PEYAME----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        83 Pe~~~~----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      ||.+.+    ..++.++|+|||||++|+|++|..||......     ........ ....     ....   ....+..+
T Consensus       172 PE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~-----~~~~---~~~~~~~l  237 (283)
T cd06617         172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVV-EEPS-----PQLP---AEKFSPEF  237 (283)
T ss_pred             hhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHH-hcCC-----CCCC---ccccCHHH
Confidence            998864    34688999999999999999999998532111     00000000 0000     0000   11234568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||..+|++||++.+|++
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            89999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.93  E-value=1.3e-25  Score=179.46  Aligned_cols=157  Identities=22%  Similarity=0.343  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.|+++||+.+   ++|+||+|+||+++.++.++++|||++.........  .....+...|+||
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p  170 (256)
T cd08218          96 VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSP  170 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCH
Confidence            36789999999999999999999999   999999999999999999999999998765432211  1123456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+|||||++++|++|..||......      ...... ..+.         ....+......+.+++.
T Consensus       171 e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~---------~~~~~~~~~~~~~~li~  234 (256)
T cd08218         171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKI-IRGS---------YPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             HHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHH-hcCC---------CCCCcccCCHHHHHHHH
Confidence            9998888899999999999999999999997532111      000000 0110         01122334556899999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.+|++||++.+|++
T Consensus       235 ~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         235 QLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHhhCChhhCcCHHHHhh
Confidence            999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=3e-25  Score=179.96  Aligned_cols=169  Identities=20%  Similarity=0.220  Sum_probs=121.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.........   ....+...|++||
T Consensus       103 ~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE  176 (287)
T cd07838         103 GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPE  176 (287)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChH
Confidence            5899999999999999999999999   999999999999999999999999998765432211   1123567899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhh---------hhhhchhh---cchhhH
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEA---------LELMEPVL---KQSCVA  152 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~  152 (230)
                      .+.+..++.++|+||+||++|+|++|..||..........  ............         ........   ......
T Consensus       177 ~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T cd07838         177 VLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVP  254 (287)
T ss_pred             HhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChHhcCCCcccchhhcccccccchhhhhh
Confidence            9998889999999999999999999988876432211100  000000000000         00000000   011122


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .....+.+++.+||+.||++||++.++++
T Consensus       255 ~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         255 EICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            34567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.93  E-value=1.1e-25  Score=184.13  Aligned_cols=160  Identities=19%  Similarity=0.314  Sum_probs=120.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       111 ~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~a  185 (297)
T cd06659         111 QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMA  185 (297)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccceecCccccC
Confidence            456889999999999999999999999   999999999999999999999999988654322111  112356778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++++|++|..||........      ... .....     ...  ..........+.+++
T Consensus       186 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~-----~~~--~~~~~~~~~~l~~~i  251 (297)
T cd06659         186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKR-LRDSP-----PPK--LKNAHKISPVLRDFL  251 (297)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HhccC-----CCC--ccccCCCCHHHHHHH
Confidence            9999888899999999999999999999999853221110      000 00000     000  001112234588899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.+|++||++.+|++
T Consensus       252 ~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         252 ERMLTREPQERATAQELLD  270 (297)
T ss_pred             HHHhcCCcccCcCHHHHhh
Confidence            9999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.93  E-value=1.1e-25  Score=183.50  Aligned_cols=173  Identities=23%  Similarity=0.229  Sum_probs=121.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus       101 ~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aP  175 (293)
T cd07843         101 QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAP  175 (293)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCc
Confidence            35899999999999999999999999   999999999999999999999999998766443211  1122456789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhh------hhhhhhhchhhcc
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCE------GEALELMEPVLKQ  148 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~------~~~~~~~~~~~~~  148 (230)
                      |.+.+. .++.++|+||+|+++|+|++|..||.............        ..|..+..      ..........+..
T Consensus       176 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (293)
T cd07843         176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK  255 (293)
T ss_pred             hhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhc
Confidence            998754 46889999999999999999999986433221110000        00000000      0000000011111


Q ss_pred             hhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAA-ELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .++.. ....+.+++.+||+.+|++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         256 KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            12222 3566889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.93  E-value=1e-25  Score=184.33  Aligned_cols=160  Identities=23%  Similarity=0.325  Sum_probs=120.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|++
T Consensus       109 ~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~a  183 (297)
T cd06656         109 ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA  183 (297)
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccC
Confidence            356788999999999999999999999   999999999999999999999999998764322211  112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||....+.....  ..    ...+      .+  ....+......+.+++
T Consensus       184 PE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~~----~~~~------~~--~~~~~~~~~~~~~~li  249 (297)
T cd06656         184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LI----ATNG------TP--ELQNPERLSAVFRDFL  249 (297)
T ss_pred             HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--ee----ccCC------CC--CCCCccccCHHHHHHH
Confidence            999988888999999999999999999999985432211100  00    0000      00  0011223344578899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.+|++||++.+|++
T Consensus       250 ~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=1.6e-25  Score=180.04  Aligned_cols=162  Identities=22%  Similarity=0.323  Sum_probs=118.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.|++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus       100 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~a  174 (267)
T cd06645         100 TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMA  174 (267)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccC
Confidence            357899999999999999999999999   99999999999999999999999999876532211  1122356788999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.   ...++.++|+|||||++|+|++|..||....+...     . .. .....   ...+....  .......+.
T Consensus       175 PE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-----~-~~-~~~~~---~~~~~~~~--~~~~~~~~~  242 (267)
T cd06645         175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----L-FL-MTKSN---FQPPKLKD--KMKWSNSFH  242 (267)
T ss_pred             hhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----H-Hh-hhccC---CCCCcccc--cCCCCHHHH
Confidence            99875   44578899999999999999999999743221110     0 00 00000   00000000  011234588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.+|++||++.+|++
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhc
Confidence            8999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=1.6e-25  Score=184.07  Aligned_cols=173  Identities=24%  Similarity=0.281  Sum_probs=119.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..........  ........|+||
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~~~~~~~y~aP  177 (309)
T cd07845         103 TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAP  177 (309)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCCC--CcccccccccCh
Confidence            56899999999999999999999999   9999999999999999999999999987654322111  112335679999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhh---hhhhchhhc--ch
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEA---LELMEPVLK--QS  149 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~~~--~~  149 (230)
                      |.+.+ ..++.++|+|||||++|+|++|..||....+.........        .+........   .........  ..
T Consensus       178 E~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (309)
T cd07845         178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKH  257 (309)
T ss_pred             hhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHH
Confidence            99875 4578999999999999999999999864332211000000        0000000000   000000000  00


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ........+.+++.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         258 KFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00113556789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.93  E-value=1.9e-25  Score=183.78  Aligned_cols=174  Identities=21%  Similarity=0.248  Sum_probs=120.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC----CCCeEEcccccceeecCCCC-CccccccccccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH----EMNPKISDFEMARIFGGNQS-EASTNRIVGTYG   79 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~----~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~   79 (230)
                      .++...++.++.||+.||.|||+.+   ++|+||+|+||+++.    ++.++|+|||++........ ........++..
T Consensus       104 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  180 (316)
T cd07842         104 SIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW  180 (316)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcccccc
Confidence            6889999999999999999999999   999999999999999    89999999999876543322 111222345678


Q ss_pred             ccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccc-hhhh-----hHHHHh-----------h-hhhhh
Q 026939           80 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS-LLSY-----TWKLWC-----------E-GEALE  140 (230)
Q Consensus        80 ~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~-~~~~-----~~~~~~-----------~-~~~~~  140 (230)
                      |+|||.+.+. .++.++|+|||||++++|++|..||.......... ....     ....+.           . .....
T Consensus       181 y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (316)
T cd07842         181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT  260 (316)
T ss_pred             ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchh
Confidence            9999988764 57899999999999999999999986443322000 0000     000000           0 00000


Q ss_pred             hhch---------hhcchhhH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          141 LMEP---------VLKQSCVA--AELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       141 ~~~~---------~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..+.         .+...+..  .....+.+++.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         261 LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             hhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000         00000111  33456899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.93  E-value=9.5e-26  Score=183.11  Aligned_cols=174  Identities=22%  Similarity=0.282  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+++||+++.++.++|+|||++......... ......+...|+||
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~P  170 (288)
T cd07833          95 GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAP  170 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCC
Confidence            46889999999999999999999999   999999999999999999999999998765433221 11123456789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhh---hhhch----hhc
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEAL---ELMEP----VLK  147 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~---~~~~~----~~~  147 (230)
                      |.+.+. .++.++|+||||+++|+|++|..||..............        ....+......   .....    ...
T Consensus       171 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (288)
T cd07833         171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLE  250 (288)
T ss_pred             chhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHH
Confidence            999887 788999999999999999999999864322110000000        00000000000   00000    001


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..++...+..+.+++.+||..+|++||+++++++
T Consensus       251 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         251 RRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            1122234677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-25  Score=173.79  Aligned_cols=161  Identities=26%  Similarity=0.393  Sum_probs=120.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .+++++...=++...+++||.||-.+.  .|+|||+||+|||++..|.+||+|||.+.+........   ...|-+.|+|
T Consensus       185 k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht---rsAGC~~YMa  259 (391)
T KOG0983|consen  185 KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT---RSAGCAAYMA  259 (391)
T ss_pred             cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc---cccCCccccC
Confidence            357888889999999999999998753  39999999999999999999999999998765433222   2345678999


Q ss_pred             hhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.-   ..|+.++||||||+.++||.||+.||..-..+     .+..... .+.+-     +.+..  ....+..|.
T Consensus       260 PERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkv-ln~eP-----P~L~~--~~gFSp~F~  326 (391)
T KOG0983|consen  260 PERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKV-LNEEP-----PLLPG--HMGFSPDFQ  326 (391)
T ss_pred             ccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHH-HhcCC-----CCCCc--ccCcCHHHH
Confidence            999863   46899999999999999999999998632211     0011111 11110     11111  111345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++..||..|+.+||...++++
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhc
Confidence            9999999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.93  E-value=3.6e-27  Score=204.10  Aligned_cols=165  Identities=25%  Similarity=0.383  Sum_probs=141.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCC-CCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ-SEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~~   81 (230)
                      +..+.+-+...+++.|+.|++||-+++   +|||||.++|||++.+..+|++|||+++...... .........-+.+|.
T Consensus       725 DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWT  801 (996)
T KOG0196|consen  725 DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWT  801 (996)
T ss_pred             CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeec
Confidence            345778889999999999999999999   9999999999999999999999999999764332 111111123357999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+...+++.++||||+|+++||.++ |.+||-                .+.++++.+.++..++...|.+++..|++
T Consensus       802 APEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW----------------dmSNQdVIkaIe~gyRLPpPmDCP~aL~q  865 (996)
T KOG0196|consen  802 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW----------------DMSNQDVIKAIEQGYRLPPPMDCPAALYQ  865 (996)
T ss_pred             ChhHhhhcccCchhhccccceEEEEecccCCCccc----------------ccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence            9999999999999999999999999887 888862                24577788888888888889999999999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ||..||++|-..||.+.+|+..|...
T Consensus       866 LMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  866 LMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             HHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            99999999999999999999999764

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.93  E-value=1.1e-25  Score=189.68  Aligned_cols=161  Identities=19%  Similarity=0.172  Sum_probs=117.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++...+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++......... ......++..|+|
T Consensus       136 ~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~a  211 (370)
T cd05621         136 NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYIS  211 (370)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce-ecccCCCCcccCC
Confidence            456889999999999999999999999   999999999999999999999999998765322211 1123457889999


Q ss_pred             hhhhhcCC----CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh--HHHHH
Q 026939           83 PEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV--AAELL  156 (230)
Q Consensus        83 Pe~~~~~~----~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  156 (230)
                      ||++.+..    ++.++|+||+||++|+|++|..||.......      ...         .+........++  .....
T Consensus       212 PE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~---------~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYS---------KIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             HHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHH---------HHHhCCcccCCCCcccCCH
Confidence            99997643    7789999999999999999999985332110      000         011100000111  12344


Q ss_pred             HHHHHHhhhcCCCCC--CCCCHHHHHHH
Q 026939          157 KFIHIGLLCVQADSA--DRPTMSSVVVM  182 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~--~RPs~~~i~~~  182 (230)
                      .+.+++..|+..++.  .|+++.++++.
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            577788888875554  38899999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=2.6e-25  Score=180.52  Aligned_cols=160  Identities=25%  Similarity=0.295  Sum_probs=118.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+||
T Consensus       119 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  193 (286)
T cd06638         119 ERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAP  193 (286)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccCh
Confidence            46888999999999999999999999   99999999999999999999999999876533221  11123567889999


Q ss_pred             hhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           84 EYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        84 e~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |.+..     ..++.++|+||+||++|+|++|..||........     ..  .....     .....  ..+......+
T Consensus       194 E~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-----~~--~~~~~-----~~~~~--~~~~~~~~~~  259 (286)
T cd06638         194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-----LF--KIPRN-----PPPTL--HQPELWSNEF  259 (286)
T ss_pred             hhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----Hh--hcccc-----CCCcc--cCCCCcCHHH
Confidence            98753     3478899999999999999999999854321110     00  00000     00000  0111223468


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+++.+||+.||++|||+.+|++.
T Consensus       260 ~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         260 NDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhc
Confidence            899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.93  E-value=2.8e-25  Score=186.03  Aligned_cols=170  Identities=25%  Similarity=0.249  Sum_probs=120.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      ++..++..++.|++.||+|||+.|   ++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  188 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEV  188 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHH
Confidence            788899999999999999999999   99999999999999999999999999876533211   111245678999999


Q ss_pred             hhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccc---------hhhhh------HHHHhhh-h------hhhhhc
Q 026939           86 AMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS---------LLSYT------WKLWCEG-E------ALELME  143 (230)
Q Consensus        86 ~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~---------~~~~~------~~~~~~~-~------~~~~~~  143 (230)
                      +.+..++.++|+|||||++++|++|..||..........         ...+.      ....... .      ......
T Consensus       189 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
T cd07850         189 ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFP  268 (353)
T ss_pred             HhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCc
Confidence            999899999999999999999999999985432111000         00000      0000000 0      000000


Q ss_pred             hhh----cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          144 PVL----KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       144 ~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...    ...........+.+++.+||+.||++|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         269 DVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             ccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000    00001133556889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.93  E-value=3.2e-25  Score=182.15  Aligned_cols=155  Identities=28%  Similarity=0.357  Sum_probs=118.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......      ...+...|+|
T Consensus       109 ~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~------~~~~~~~y~a  179 (307)
T cd06607         109 KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMA  179 (307)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCC------CccCCccccC
Confidence            457899999999999999999999999   9999999999999999999999999886543211      1345678999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.   ...++.++|+||||+++|+|++|..||........      ... .....        ............+.
T Consensus       180 PE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~-~~~~~--------~~~~~~~~~~~~~~  244 (307)
T cd06607         180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQND--------SPTLSSNDWSDYFR  244 (307)
T ss_pred             ceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHH-HhcCC--------CCCCCchhhCHHHH
Confidence            99874   34578899999999999999999999743221110      000 00000        00011223455789


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++||++.+|+.
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhc
Confidence            9999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.93  E-value=2.6e-25  Score=181.11  Aligned_cols=160  Identities=27%  Similarity=0.317  Sum_probs=118.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|++
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a  196 (291)
T cd06639         122 GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMA  196 (291)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccC
Confidence            457899999999999999999999999   999999999999999999999999998754322211  112345678999


Q ss_pred             hhhhhcC-----CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAMEG-----LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~~~-----~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||.+...     .++.++|+|||||++|+|++|..||........      ... .........       ..+......
T Consensus       197 PE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~~-------~~~~~~~~~  262 (291)
T cd06639         197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------LFK-IPRNPPPTL-------LHPEKWCRS  262 (291)
T ss_pred             hhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------HHH-HhcCCCCCC-------CcccccCHH
Confidence            9987643     367899999999999999999999853221100      000 000000000       011223346


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.+|++||++.+|++
T Consensus       263 l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         263 FNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHHHHHhhcChhhCcCHHHHhc
Confidence            889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=8.5e-26  Score=189.76  Aligned_cols=162  Identities=20%  Similarity=0.199  Sum_probs=117.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-------------   69 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------------   69 (230)
                      +..+++..+..++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++..........             
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~  171 (364)
T cd05599          95 KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF  171 (364)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccc
Confidence            456899999999999999999999999   9999999999999999999999999986542211000             


Q ss_pred             -----------------------cccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh
Q 026939           70 -----------------------STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL  126 (230)
Q Consensus        70 -----------------------~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~  126 (230)
                                             ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~-----  246 (364)
T cd05599         172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE-----  246 (364)
T ss_pred             cccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH-----
Confidence                                   0011247889999999998899999999999999999999999986432211     


Q ss_pred             hhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 026939          127 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT---MSSVVV  181 (230)
Q Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~i~~  181 (230)
                       ................       .......+.+++.+|+. +|.+|++   +.++++
T Consensus       247 -~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         247 -TYRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             -HHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence             0000000000000000       01123457788888986 9999998   888776

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=1.8e-25  Score=185.97  Aligned_cols=176  Identities=24%  Similarity=0.256  Sum_probs=123.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++...++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~y~a  176 (337)
T cd07858         102 SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRA  176 (337)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCccc--ccccccccCccC
Confidence            357899999999999999999999999   999999999999999999999999998765332111  112345678999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHH-----------HHhhhhhhhhhchhh---c
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWK-----------LWCEGEALELMEPVL---K  147 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~---~  147 (230)
                      ||.+.. ..++.++|+|||||++|+|++|..||.......   .......           ..........+....   .
T Consensus       177 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (337)
T cd07858         177 PELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPR  253 (337)
T ss_pred             hHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccc
Confidence            998865 458899999999999999999999985432110   0000000           000001111000000   0


Q ss_pred             ---chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--hhcC
Q 026939          148 ---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM--LASD  186 (230)
Q Consensus       148 ---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~--L~~~  186 (230)
                         ..........+.+++.+||+.+|++|||++++++.  ++..
T Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         254 QSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               00112345668899999999999999999999874  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.93  E-value=1.8e-25  Score=181.84  Aligned_cols=159  Identities=21%  Similarity=0.314  Sum_probs=119.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||.+........  ......++..|++|
T Consensus       110 ~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aP  184 (285)
T cd06648         110 TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAP  184 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCH
Confidence            46888999999999999999999999   99999999999999999999999998764432211  11123467789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+|+++++|++|..||....+.      .... .....     ..+...  .+......+.+++.
T Consensus       185 E~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~-~~~~~-----~~~~~~--~~~~~~~~l~~li~  250 (285)
T cd06648         185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMK-RIRDN-----LPPKLK--NLHKVSPRLRSFLD  250 (285)
T ss_pred             HHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHH-HHHhc-----CCCCCc--ccccCCHHHHHHHH
Confidence            9998888999999999999999999999997532211      0000 00000     000110  11123456899999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.+|++||++.++++
T Consensus       251 ~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         251 RMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHcccChhhCcCHHHHcc
Confidence            999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-25  Score=186.83  Aligned_cols=162  Identities=19%  Similarity=0.271  Sum_probs=131.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceE-eCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVL-LDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil-~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..|.+..+.+++.||+.|+.|+|+..   +|||||||+|+. +.+-|-+||.|||++..+......   ....|+..|.|
T Consensus       113 ~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSA  186 (864)
T KOG4717|consen  113 EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSA  186 (864)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchh---hcccchhhccC
Confidence            46889999999999999999999987   999999999975 467788999999999887544332   22467889999


Q ss_pred             hhhhhcCCCC-ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~-~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..|+ +++|||||||++|.|++|+.||....+..               .+..+++...  ..|.....++.+|
T Consensus       187 PEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCKY--tvPshvS~eCrdL  249 (864)
T KOG4717|consen  187 PEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCKY--TVPSHVSKECRDL  249 (864)
T ss_pred             chhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcccc--cCchhhhHHHHHH
Confidence            9999999986 67899999999999999999997554332               2334444433  4467778889999


Q ss_pred             HhhhcCCCCCCCCCHHHHHH--HhhcCCC
Q 026939          162 GLLCVQADSADRPTMSSVVV--MLASDNV  188 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~--~L~~~~~  188 (230)
                      |..||..||.+|.+.++|..  .|+....
T Consensus       250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHHHhcCchhhccHHHHhccccccCCCC
Confidence            99999999999999999985  4444433

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2e-25  Score=184.93  Aligned_cols=192  Identities=24%  Similarity=0.254  Sum_probs=130.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      .++++..++.++.||+.||++||+.|   ++|+||+|.||+++.++.++|+|||++......... .......++..|++
T Consensus        98 ~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  174 (330)
T cd07834          98 QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA  174 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCC
Confidence            47899999999999999999999999   999999999999999999999999999876443210 11122345778999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhch---hh---c
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEP---VL---K  147 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~---~  147 (230)
                      ||.+.+. .++.++|+||||+++|+|++|..||...........+..        .+...........+..   ..   .
T Consensus       175 PE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (330)
T cd07834         175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPL  254 (330)
T ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchh
Confidence            9999887 789999999999999999999999864432111000000        0000000000000000   00   0


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCC-CCCCCCCCCC
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNV-TLPQPTEPAF  198 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~-~~~~~~~p~~  198 (230)
                      ..........+.+++.+||+.+|++||++.++++  .+++... ..+.+...++
T Consensus       255 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~  308 (330)
T cd07834         255 SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPF  308 (330)
T ss_pred             HHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcc
Confidence            0111224566899999999999999999999998  4554422 2334444444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.93  E-value=4e-26  Score=183.83  Aligned_cols=170  Identities=21%  Similarity=0.255  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC--------------------CCCeEEcccccceeec
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--------------------EMNPKISDFEMARIFG   63 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~--------------------~~~~~l~d~~~~~~~~   63 (230)
                      .+++..++..+++|++.++++||+.+   ++|.||||+||++..                    +..++++|||.+.+..
T Consensus       187 ~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~  263 (415)
T KOG0671|consen  187 IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH  263 (415)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec
Confidence            57899999999999999999999999   999999999999821                    2347999999998754


Q ss_pred             CCCCCccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh-----hHHH------
Q 026939           64 GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY-----TWKL------  132 (230)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~-----~~~~------  132 (230)
                      ...     ..++.+..|.|||++.+.+++..+||||+||+++|+.+|...|...........-+.     ...+      
T Consensus       264 e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~  338 (415)
T KOG0671|consen  264 EHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRK  338 (415)
T ss_pred             cCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhh
Confidence            333     224668899999999999999999999999999999999988865443221111111     0011      


Q ss_pred             ---Hhhhhh--------------hhhhchhh-cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          133 ---WCEGEA--------------LELMEPVL-KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       133 ---~~~~~~--------------~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                         +..+.+              .+..++.. .......+...|.+|++.||..||.+|+|+.|++.
T Consensus       339 ~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  339 EKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence               111100              00000000 00123456677999999999999999999999875

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=1.5e-25  Score=183.73  Aligned_cols=174  Identities=21%  Similarity=0.289  Sum_probs=118.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGYMA   82 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~a   82 (230)
                      .+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .......++..|+|
T Consensus       115 ~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  191 (310)
T cd07865         115 KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP  191 (310)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccC
Confidence            6899999999999999999999999   999999999999999999999999998765432211  11112345678999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH-----HHHhhhhhhhhhch-----hhcchh-
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW-----KLWCEGEALELMEP-----VLKQSC-  150 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-----~~~~~~-  150 (230)
                      ||.+.+. .++.++|+||||+++|+|++|..||................     ..+.........+.     ...... 
T Consensus       192 PE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (310)
T cd07865         192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVK  271 (310)
T ss_pred             cHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhH
Confidence            9988654 46789999999999999999999986433221110000000     00000000000000     000000 


Q ss_pred             ----hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 ----VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ----~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                          +......+.+++.+||..||++|||++++++
T Consensus       272 ~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         272 ERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                0012345778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3e-25  Score=182.83  Aligned_cols=160  Identities=20%  Similarity=0.193  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--------------
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--------------   69 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--------------   69 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..........              
T Consensus        98 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (316)
T cd05574          98 KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN  174 (316)
T ss_pred             CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccccccc
Confidence            57899999999999999999999999   9999999999999999999999999886543211100              


Q ss_pred             -------------cccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh
Q 026939           70 -------------STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG  136 (230)
Q Consensus        70 -------------~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  136 (230)
                                   ......++..|++||.+.+..++.++|+||||+++|+|++|..||........              
T Consensus       175 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--------------  240 (316)
T cd05574         175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET--------------  240 (316)
T ss_pred             ccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH--------------
Confidence                         01122456789999999888899999999999999999999999853321100              


Q ss_pred             hhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHH
Q 026939          137 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT----MSSVVV  181 (230)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~i~~  181 (230)
                       ....................+.+++.+||+.||++||+    +++++.
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 -FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence             00011111100011113566999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.7e-25  Score=179.70  Aligned_cols=159  Identities=26%  Similarity=0.386  Sum_probs=119.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus        95 ~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~a  169 (277)
T cd06917          95 AGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMA  169 (277)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeC
Confidence            347899999999999999999999999   99999999999999999999999999877643321  1122356778999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+. .++.++|+||||+++|+|++|..||..........       .....     ..+.+...   .....+.++
T Consensus       170 PE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-----~~~~~~~~---~~~~~~~~~  234 (277)
T cd06917         170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-----KPPRLEDN---GYSKLLREF  234 (277)
T ss_pred             HHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-----CCCCCCcc---cCCHHHHHH
Confidence            9998654 46889999999999999999999986432111000       00000     00001000   133468899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++||++.++++
T Consensus       235 i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         235 VAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHHHcCCCcccCcCHHHHhh
Confidence            99999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.93  E-value=1.4e-25  Score=180.09  Aligned_cols=160  Identities=27%  Similarity=0.388  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++...++.++.|++.||++||+ .+   ++|+||+|+||+++.++.++|+|||.+.........    ...+...|++
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~  167 (265)
T cd06605          95 GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMA  167 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccCChhccC
Confidence            578899999999999999999999 88   999999999999999999999999987654221111    1355678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH-HHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA-ELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++++|++|..||........ ......... ....         ....+.. ....+.++
T Consensus       168 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~l  236 (265)
T cd06605         168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYI-VNEP---------PPRLPSGKFSPDFQDF  236 (265)
T ss_pred             HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHH-hcCC---------CCCCChhhcCHHHHHH
Confidence            9999888899999999999999999999999854321111 011111000 0000         0111111 45568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||..||++|||+.+++.
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhh
Confidence            99999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.93  E-value=1.8e-25  Score=179.53  Aligned_cols=161  Identities=24%  Similarity=0.276  Sum_probs=119.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC----CccccccccccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS----EASTNRIVGTYG   79 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~   79 (230)
                      .++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........    ........++..
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (265)
T cd06631          97 GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY  173 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCcc
Confidence            46889999999999999999999999   99999999999999999999999998865421111    111112345778


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||.+.+..++.++|+||||+++++|++|..||........     . ... ...   .    ......+......+.
T Consensus       174 ~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~-~~~-~~~---~----~~~~~~~~~~~~~~~  239 (265)
T cd06631         174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----M-FYI-GAH---R----GLMPRLPDSFSAAAI  239 (265)
T ss_pred             ccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----H-HHh-hhc---c----CCCCCCCCCCCHHHH
Confidence            9999999888889999999999999999999999853211100     0 000 000   0    001112223445688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.+|++||++.++++
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.93  E-value=1.8e-25  Score=182.22  Aligned_cols=170  Identities=22%  Similarity=0.229  Sum_probs=117.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++. ++.++|+|||++..........  ....+...|+|
T Consensus       105 ~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~a  179 (295)
T cd07837         105 RPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRA  179 (295)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCcccc--CCcccccCCCC
Confidence            46899999999999999999999999   999999999999998 8899999999987543221111  11234678999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh------hhhhhc----hhhcc---
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE------ALELME----PVLKQ---  148 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~----~~~~~---  148 (230)
                      ||.+.+ ..++.++|+||||+++|+|++|..||....+....  .... .......      ......    +....   
T Consensus       180 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (295)
T cd07837         180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIF-KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDL  256 (295)
T ss_pred             hHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHH-HHhCCCChhhCcchhhccchhhcCcccchhH
Confidence            998865 45789999999999999999999998643221100  0000 0000000      000000    00000   


Q ss_pred             -hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 -SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 -~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                       .........+.+++.+||.+||.+||++.+++.
T Consensus       257 ~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         257 SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             001123456889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=2.3e-25  Score=180.35  Aligned_cols=170  Identities=20%  Similarity=0.196  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++. +.++|+|||++.........   ....++..|++|
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aP  167 (282)
T cd07831          95 RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAP  167 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCCh
Confidence            46899999999999999999999999   999999999999999 99999999998765332221   113456789999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccc---------hhhhhHHHHhhhhhhhhhchh-hc---ch
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS---------LLSYTWKLWCEGEALELMEPV-LK---QS  149 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~-~~---~~  149 (230)
                      |.+.. ..++.++|+||+||++|+|++|..||..........         ...+ ..............+. ..   ..
T Consensus       168 E~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  246 (282)
T cd07831         168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHMNYNFPSKKGTGLRK  246 (282)
T ss_pred             hHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccccccCcccccccHHH
Confidence            97654 456889999999999999999999985432211000         0000 0000000000000000 00   01


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .....+..+.+++.+||+.+|++||++.++++
T Consensus       247 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         247 LLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            11234677999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=4.7e-25  Score=175.86  Aligned_cols=155  Identities=25%  Similarity=0.286  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||++||+.|   ++|+||+|+||+++.++.++|+|||++........    ....+...|++|
T Consensus        98 ~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~P  170 (256)
T cd08530          98 KLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----KTQIGTPHYMAP  170 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCc----ccccCCccccCH
Confidence            56889999999999999999999999   99999999999999999999999999876543311    112456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++++|++|..||.......      ...          ..........+......+.+++.
T Consensus       171 e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~----------~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LRY----------KVQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             HHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH----------HHhcCCCCCCchhhCHHHHHHHH
Confidence            99988888999999999999999999999985332110      000          00111111223345566999999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.+|++||++.++++
T Consensus       235 ~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         235 SMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHcCCCcccCCCHHHHhc
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=3.6e-25  Score=176.29  Aligned_cols=160  Identities=24%  Similarity=0.336  Sum_probs=124.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+................+...|.+||
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE  173 (260)
T cd06606          97 KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE  173 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHh
Confidence            7899999999999999999999999   9999999999999999999999999988765443211122235677899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      .+.+...+.++|+|+||+++++|++|..||.....     .....+         ...........+......+.+++.+
T Consensus       174 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY---------KIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH---------hccccCCCcCCCcccCHHHHHHHHH
Confidence            99888899999999999999999999999864330     000111         1111111112333345679999999


Q ss_pred             hcCCCCCCCCCHHHHHH
Q 026939          165 CVQADSADRPTMSSVVV  181 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~  181 (230)
                      ||+.||++||++.++++
T Consensus       240 ~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         240 CLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hCcCChhhCCCHHHHhh
Confidence            99999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=192.91  Aligned_cols=165  Identities=27%  Similarity=0.378  Sum_probs=129.4

Q ss_pred             cCCC--CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQL--DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l--~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ..|+  ++.+.-.+.+||++||.|||.+.   |||||||-+|++++ -.|.+|++|||-+......  ..+...+.|+..
T Consensus       667 WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQ  741 (1226)
T KOG4279|consen  667 WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQ  741 (1226)
T ss_pred             cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Cccccccccchh
Confidence            3466  77888889999999999999998   99999999999997 4688999999988765432  334445788999


Q ss_pred             ccChhhhhcC--CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           80 YMAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        80 ~~aPe~~~~~--~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      |||||++..+  .|..++|||||||.+.||.||++||-.......         .+...-+.     ...+..|.+...+
T Consensus       742 YMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AMFkVGmy-----KvHP~iPeelsae  807 (1226)
T KOG4279|consen  742 YMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AMFKVGMY-----KVHPPIPEELSAE  807 (1226)
T ss_pred             hhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hhhhhcce-----ecCCCCcHHHHHH
Confidence            9999999865  589999999999999999999999853322111         00011111     1234667888889


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ...++.+|+.+||..||++.++++  +|+..
T Consensus       808 ak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  808 AKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            999999999999999999999987  55443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-26  Score=183.49  Aligned_cols=168  Identities=21%  Similarity=0.265  Sum_probs=137.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      +.+.-.+...++.|++.|++|||..+   ++|.||..+|+.++....+||+|=.+++-.-......-++..-.+..|+++
T Consensus       391 qtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl  467 (563)
T KOG1024|consen  391 QTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL  467 (563)
T ss_pred             cchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCH
Confidence            45666788899999999999999999   999999999999999999999998887654333333333333456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+++..|+.++|+|||||++|||+| |+.|+..-++                -++...++.+.+-..|.+++.+|..+|
T Consensus       468 Eal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----------------fEm~~ylkdGyRlaQP~NCPDeLf~vM  531 (563)
T KOG1024|consen  468 EALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----------------FEMEHYLKDGYRLAQPFNCPDELFTVM  531 (563)
T ss_pred             HHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----------------HHHHHHHhccceecCCCCCcHHHHHHH
Confidence            99999999999999999999999998 8888753222                134455566666667888888999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      .-||..+|++||+++++..-|.+...++
T Consensus       532 acCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  532 ACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             HHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            9999999999999999999998765543

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.93  E-value=2.2e-25  Score=177.95  Aligned_cols=157  Identities=24%  Similarity=0.288  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.||+.||++||+.+   ++|+||+|+||+++.++.++|+|||++.......   ......++..|++|
T Consensus        97 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~p  170 (258)
T cd06632          97 GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAP  170 (258)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCH
Confidence            45889999999999999999999999   9999999999999999999999999987653322   11223567789999


Q ss_pred             hhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.... ++.++|+||||+++|+|++|..||......      ..........         .....+......+.+++
T Consensus       171 e~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~~li  235 (258)
T cd06632         171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSK---------ELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             HHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcc---------cCCCcCCCcCHHHHHHH
Confidence            9987766 889999999999999999999998643211      0000000000         01112233445688899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.+|++||++.++++
T Consensus       236 ~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         236 LKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHhhcCcccCcCHHHHhc
Confidence            9999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=176.37  Aligned_cols=164  Identities=22%  Similarity=0.230  Sum_probs=119.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ++.++++++-.|.+||..|+.|||+.+   |.||||||+|+|+..   |..+||+|||++..........+   ...++.
T Consensus       155 ~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~T---Pc~TPy  228 (400)
T KOG0604|consen  155 DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMT---PCFTPY  228 (400)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCccccC---Cccccc
Confidence            457999999999999999999999999   999999999999964   45689999999977543322222   244789


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++...+|+...|+||+||++|.|++|.+||....   +.. +.-..+.....--+.+.++     -=...++...
T Consensus       229 YvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h---g~a-ispgMk~rI~~gqy~FP~p-----EWs~VSe~aK  299 (400)
T KOG0604|consen  229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLA-ISPGMKRRIRTGQYEFPEP-----EWSCVSEAAK  299 (400)
T ss_pred             ccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC---Ccc-CChhHHhHhhccCccCCCh-----hHhHHHHHHH
Confidence            999999988899999999999999999999999984211   100 0000000000000111111     0123456677


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++++.+|..+|.+|.|+.+++.
T Consensus       300 dlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  300 DLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHhcCCchhheeHHHhhc
Confidence            8889999999999999999886

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.93  E-value=4.1e-25  Score=177.88  Aligned_cols=156  Identities=26%  Similarity=0.377  Sum_probs=115.4

Q ss_pred             CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            7 DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         7 ~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      +...++.++.||+.||+|||+.+   ++|+||+|+||+++. ++.++|+|||++.........  .....++..|++||.
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~  180 (268)
T cd06624         106 NEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEV  180 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhh
Confidence            78888999999999999999999   999999999999976 678999999998765322211  112245778999999


Q ss_pred             hhcCC--CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           86 AMEGL--FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        86 ~~~~~--~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      +.+..  ++.++|+||+|+++|+|++|..||........     ..+..         .........+......+.+++.
T Consensus       181 ~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKV---------GMFKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             hccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhh---------hhhccCCCCCcccCHHHHHHHH
Confidence            86543  78899999999999999999999753221100     00000         0000111223344556889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.+|++|||+.+|++
T Consensus       247 ~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHcCCCchhCCCHHHHHh
Confidence            999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.93  E-value=2.7e-25  Score=178.23  Aligned_cols=160  Identities=23%  Similarity=0.267  Sum_probs=122.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++...+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ......+...|++
T Consensus        87 ~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~  160 (262)
T cd05572          87 RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVA  160 (262)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccC
Confidence            346889999999999999999999999   9999999999999999999999999987654332   1112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|++|+++|+|++|..||.......    .....         ..........++......+.+++
T Consensus       161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~~~~~~~~i  227 (262)
T cd05572         161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYN---------DILKGNGKLEFPNYIDKAAKDLI  227 (262)
T ss_pred             hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHH---------HHhccCCCCCCCcccCHHHHHHH
Confidence            999988888999999999999999999999986443210    00000         01111111223334466799999


Q ss_pred             hhhcCCCCCCCCC-----HHHHHH
Q 026939          163 LLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      .+||+.+|++||+     +.++++
T Consensus       228 ~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         228 KQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHccCChhhCcCCcccCHHHHhc
Confidence            9999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.93  E-value=4e-25  Score=177.32  Aligned_cols=163  Identities=28%  Similarity=0.434  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--cccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--STNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (230)
                      ..+++..++.++.|++.||++||+.|   ++|+||+|+||+++.++.++|+|||++..........  ......++..|+
T Consensus        97 ~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~  173 (267)
T cd06610          97 GGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM  173 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhc
Confidence            35889999999999999999999999   9999999999999999999999999886554322211  112234677899


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchh-hHHHHHHHH
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC-VAAELLKFI  159 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~  159 (230)
                      +||.+... .++.++|+||||+++++|++|..||.......      ...... ...     ........ ....+..+.
T Consensus       174 ~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~  241 (267)
T cd06610         174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTL-QND-----PPSLETGADYKKYSKSFR  241 (267)
T ss_pred             ChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHh-cCC-----CCCcCCccccccccHHHH
Confidence            99998877 78899999999999999999999985332210      000000 000     00010000 113345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++||++.+|++
T Consensus       242 ~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         242 KMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHcCCChhhCcCHHHHhh
Confidence            9999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.92  E-value=2.3e-25  Score=180.79  Aligned_cols=173  Identities=23%  Similarity=0.305  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|++|
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aP  169 (286)
T cd07846          95 NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAP  169 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--cCcccceeeccCc
Confidence            35899999999999999999999999   999999999999999999999999998765332211  1123457789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhhhhhh-hhhchhhcc-----
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCEGEAL-ELMEPVLKQ-----  148 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~-----  148 (230)
                      |.+.+. .++.++|+||||+++|+|++|..||.............        .....+...... ....+....     
T Consensus       170 E~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (286)
T cd07846         170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE  249 (286)
T ss_pred             HHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHH
Confidence            998753 46789999999999999999998885332211000000        000000000000 000000000     


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......+..+.+++.+||+.+|++||++.+|++
T Consensus       250 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         250 KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            011233566899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.92  E-value=4.2e-25  Score=177.53  Aligned_cols=159  Identities=19%  Similarity=0.242  Sum_probs=119.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      ..++...++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (265)
T cd06652         101 GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS  177 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccC
Confidence            46788899999999999999999999   999999999999999999999999988754321111 11112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++|+|++|..||.......     ..          ............+......+.+++
T Consensus       178 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~----------~~~~~~~~~~~~~~~~~~~~~~~i  242 (265)
T cd06652         178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AI----------FKIATQPTNPVLPPHVSDHCRDFL  242 (265)
T ss_pred             hhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HH----------HHHhcCCCCCCCchhhCHHHHHHH
Confidence            999988888999999999999999999999985321110     00          000011111223445556788888


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||. +|++||++++|++
T Consensus       243 ~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         243 KRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHhc-ChhhCCCHHHHhc
Confidence            99985 8999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.92  E-value=3.4e-25  Score=187.39  Aligned_cols=163  Identities=20%  Similarity=0.242  Sum_probs=115.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC---------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---------------   67 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   67 (230)
                      ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++..+.....               
T Consensus        95 ~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~  171 (381)
T cd05626          95 MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM  171 (381)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccccccccc
Confidence            356889999999999999999999999   99999999999999999999999998753211000               


Q ss_pred             ------------------------------CccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCC
Q 026939           68 ------------------------------EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY  117 (230)
Q Consensus        68 ------------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~  117 (230)
                                                    ........|+..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  251 (381)
T cd05626         172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP  251 (381)
T ss_pred             CcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCC
Confidence                                          00011235788999999998888999999999999999999999998643


Q ss_pred             ccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh--hcCCCCCCCCCHHHHHH
Q 026939          118 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL--CVQADSADRPTMSSVVV  181 (230)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~~i~~  181 (230)
                      ......      ...........       ..........+.+++.+  |+..++..||++.+|+.
T Consensus       252 ~~~~~~------~~i~~~~~~~~-------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         252 TPTETQ------LKVINWENTLH-------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             CHHHHH------HHHHccccccC-------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            221110      00000000000       00011123346666666  55667777999999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.92  E-value=3.7e-25  Score=176.26  Aligned_cols=158  Identities=22%  Similarity=0.336  Sum_probs=122.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.+++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|++
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~  171 (258)
T cd08215          97 GKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLS  171 (258)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecccC
Confidence            467899999999999999999999999   99999999999999999999999999876544321  1222356778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||...+..++.++|+|++|+++++|++|..||......      ..... .....         ....+......+.+++
T Consensus       172 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~---------~~~~~~~~~~~~~~~i  235 (258)
T cd08215         172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALK-ILKGQ---------YPPIPSQYSSELRNLV  235 (258)
T ss_pred             hhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHH-HhcCC---------CCCCCCCCCHHHHHHH
Confidence            99998888999999999999999999999997533211      00000 00100         1112223445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||..+|++|||+.++++
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHcCCChhhCcCHHHHhc
Confidence            9999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.92  E-value=3.8e-25  Score=177.16  Aligned_cols=160  Identities=28%  Similarity=0.349  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.|++.|+++||+ .+   ++|+||+|+||+++.++.++|+|||++..........  ....+...|++
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~  168 (264)
T cd06623          94 GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMS  168 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccC
Confidence            568999999999999999999999 99   9999999999999999999999999987654332221  12345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH-HHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA-ELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l  161 (230)
                      ||.+.+..++.++|+|+||+++|+|++|..||........   ........          .......+.. .+..+.++
T Consensus       169 pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~----------~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAIC----------DGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             HhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHh----------cCCCCCCCcccCCHHHHHH
Confidence            9999888889999999999999999999999864432100   00000000          0001111222 45679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||..+|++||++.++++
T Consensus       236 i~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHHHccCChhhCCCHHHHHh
Confidence            99999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=4.6e-25  Score=177.85  Aligned_cols=164  Identities=24%  Similarity=0.322  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..++...+..++.||+.||.+||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++|
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~P  179 (272)
T cd06629         103 GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP  179 (272)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCH
Confidence            46888999999999999999999999   999999999999999999999999998654322111111123456789999


Q ss_pred             hhhhcCC--CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           84 EYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        84 e~~~~~~--~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |.+....  ++.++|+||||+++|++++|..||......      ....... .......+.    .......+..+.++
T Consensus       180 E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~l  248 (272)
T cd06629         180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLG-NKRSAPPIP----PDVSMNLSPVALDF  248 (272)
T ss_pred             HHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhh-ccccCCcCC----ccccccCCHHHHHH
Confidence            9987654  789999999999999999999997422110      0000000 000000001    11112235668899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||..+|++||++.+|++
T Consensus       249 i~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         249 LNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHhcCChhhCCCHHHHhh
Confidence            99999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.92  E-value=4.3e-25  Score=176.19  Aligned_cols=156  Identities=26%  Similarity=0.370  Sum_probs=118.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.+++.+|++||+++   ++|+||+|+||+++.++ .++|+|||.+........   .....++..|+|
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~a  169 (256)
T cd08220          96 SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYIS  169 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccC
Confidence            35889999999999999999999999   99999999999998654 579999999876543221   112355778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||+|+++|+|++|..||.......      ..... ....         ....+......+.+++
T Consensus       170 PE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~-~~~~---------~~~~~~~~~~~l~~li  233 (256)
T cd08220         170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKI-MSGT---------FAPISDRYSPDLRQLI  233 (256)
T ss_pred             chhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHH-HhcC---------CCCCCCCcCHHHHHHH
Confidence            999988888999999999999999999999975322110      00000 0000         0111223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.+|++|||+.++++
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHHccCChhhCCCHHHHhh
Confidence            9999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=3e-25  Score=183.90  Aligned_cols=168  Identities=20%  Similarity=0.256  Sum_probs=116.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-----cccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-----ASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~   78 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+++.||+...........     .......+..
T Consensus        96 ~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (327)
T cd08227          96 DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL  172 (327)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccccccccccccccee
Confidence            35899999999999999999999999   999999999999999999999999764332111100     0011123456


Q ss_pred             CccChhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhc-------------
Q 026939           79 GYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELME-------------  143 (230)
Q Consensus        79 ~~~aPe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  143 (230)
                      .|+|||.+.+  ..++.++|+|||||++|+|++|..||........  ..    . ...+......+             
T Consensus       173 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~----~-~~~~~~~~~~~~~~~~~~~~~~~~  245 (327)
T cd08227         173 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LL----E-KLNGTVPCLLDTTTIPAEELTMKP  245 (327)
T ss_pred             cccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HH----H-HhcCCccccccccchhhhhcccCC
Confidence            7999999976  3588999999999999999999999864221110  00    0 00000000000             


Q ss_pred             -----------------------hhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          144 -----------------------PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       144 -----------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                                             ..............+.+++.+||+.||++|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         246 SRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                   00000112233457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=2.1e-25  Score=180.49  Aligned_cols=155  Identities=21%  Similarity=0.292  Sum_probs=114.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-------CeEEcccccceeecCCCCCccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-------NPKISDFEMARIFGGNQSEASTNRIV   75 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~   75 (230)
                      ...+++..++.++.||+.||+|||+++   ++|+||+|+||+++..+       .++++|||++.......      ...
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~  181 (274)
T cd05076         111 KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERV  181 (274)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCcccccccccc------ccc
Confidence            346899999999999999999999999   99999999999997543       37999999875432111      123


Q ss_pred             cccCccChhhhhc-CCCCccccchhhHHHHHHHH-hcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH
Q 026939           76 GTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEII-SGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA  153 (230)
Q Consensus        76 ~~~~~~aPe~~~~-~~~~~~~DiwslG~ll~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (230)
                      ++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||....+....       ...         ...  ...+..
T Consensus       182 ~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~---------~~~--~~~~~~  243 (274)
T cd05076         182 ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-------RFY---------EKK--HRLPEP  243 (274)
T ss_pred             cCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-------HHH---------Hhc--cCCCCC
Confidence            4677999998865 45889999999999999985 688887532211100       000         000  001111


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHhh
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       244 ~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         244 SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            2235889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.92  E-value=6.3e-25  Score=176.48  Aligned_cols=163  Identities=25%  Similarity=0.381  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCC--ccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSE--ASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   80 (230)
                      .++++..++.++.||+.||.+||++|   ++|+||+|+||+++.++ .++|+|||.+.........  .......++..|
T Consensus        98 ~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  174 (268)
T cd06630          98 GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF  174 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccce
Confidence            56889999999999999999999999   99999999999998776 5899999998765432111  111223567789


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ++||.+.+..++.++|+|++|+++++|++|..||........   .....         ...........+......+.+
T Consensus       175 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06630         175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIF---------KIASATTAPSIPEHLSPGLRD  242 (268)
T ss_pred             eCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHH---------HHhccCCCCCCchhhCHHHHH
Confidence            999999888889999999999999999999999853221100   00000         000111112334445567889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||..+|++||++.++++
T Consensus       243 ~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         243 VTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHcCCCcccCcCHHHHhc
Confidence            999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.92  E-value=2.7e-25  Score=180.14  Aligned_cols=174  Identities=21%  Similarity=0.231  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||++||+.+   ++|+||+|+||+++.++.++|+|||++.......... .....+...|++|
T Consensus        95 ~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~P  170 (287)
T cd07840          95 VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRPP  170 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc-ccccccccccCCc
Confidence            47899999999999999999999999   9999999999999999999999999987664332111 1112346689999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh--------HHHH------hhhhhhhhhchhhcc
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT--------WKLW------CEGEALELMEPVLKQ  148 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~~~~~~~  148 (230)
                      |.+.+ ..++.++|+||||+++|+|++|..||...............        +...      ............+..
T Consensus       171 E~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T cd07840         171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE  250 (287)
T ss_pred             eeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHH
Confidence            98765 35789999999999999999999998643322110000000        0000      000000000001111


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+...+...+.+++.+||+.+|.+||++.++++
T Consensus       251 ~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         251 FFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111112567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-25  Score=169.97  Aligned_cols=157  Identities=22%  Similarity=0.254  Sum_probs=117.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .++..+-....||++||.|+|.++   |+|||++|+|+++..   ..-+||+|||++....   .........|++.|++
T Consensus       107 ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fma  180 (355)
T KOG0033|consen  107 YSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLS  180 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccC
Confidence            355667788999999999999999   999999999999853   3458999999998775   2233445688999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||+++..+|+..+|||+.||++|-|+.|..||....   ....+    +.+..+. +++..     .+-....++..+|+
T Consensus       181 PEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rly----e~I~~g~-yd~~~-----~~w~~is~~Ak~Lv  247 (355)
T KOG0033|consen  181 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY----EQIKAGA-YDYPS-----PEWDTVTPEAKSLI  247 (355)
T ss_pred             HHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHH----HHHhccc-cCCCC-----cccCcCCHHHHHHH
Confidence            999999999999999999999999999999985311   11111    1111111 11111     11223344577889


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++||..||++|-|+.|.++
T Consensus       248 rrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  248 RRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHhccChhhhccHHHHhC
Confidence            9999999999999988764

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.92  E-value=2e-25  Score=188.43  Aligned_cols=163  Identities=21%  Similarity=0.235  Sum_probs=115.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC---------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---------------   67 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   67 (230)
                      ...++...+..++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++..+.....               
T Consensus        95 ~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  171 (376)
T cd05598          95 LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM  171 (376)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccc
Confidence            346788999999999999999999999   99999999999999999999999998743210000               


Q ss_pred             --------------------------CccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccc
Q 026939           68 --------------------------EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL  121 (230)
Q Consensus        68 --------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~  121 (230)
                                                ........|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  251 (376)
T cd05598         172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE  251 (376)
T ss_pred             cccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHH
Confidence                                      000012357889999999998899999999999999999999999986443221


Q ss_pred             ccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCC---CHHHHHHH
Q 026939          122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP---TMSSVVVM  182 (230)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~~i~~~  182 (230)
                      ...      .......       .............+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       252 ~~~------~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         252 TQL------KVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             HHH------HHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            100      0000000       0000001122344667777766 5999999   88888763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.92  E-value=3.8e-25  Score=183.82  Aligned_cols=176  Identities=22%  Similarity=0.281  Sum_probs=122.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--cccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--STNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~   80 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..........  ......++..|
T Consensus       101 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y  177 (334)
T cd07855         101 DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY  177 (334)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccc
Confidence            456899999999999999999999999   9999999999999999999999999987654322111  11123567789


Q ss_pred             cChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhchhh-cc--
Q 026939           81 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEPVL-KQ--  148 (230)
Q Consensus        81 ~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-~~--  148 (230)
                      ++||.+.+ ..++.++|+|||||++|+|++|..||..............        ..............+... ..  
T Consensus       178 ~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (334)
T cd07855         178 RAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPV  257 (334)
T ss_pred             cChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCC
Confidence            99999865 4578999999999999999999999854322110000000        000000000001110000 00  


Q ss_pred             ---hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                         ......+..+.+++.+||+.+|.+||++.+++.
T Consensus       258 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         258 PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             CHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               011233567999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=8.5e-25  Score=177.58  Aligned_cols=168  Identities=24%  Similarity=0.310  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .++++..+..++.+++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......    .....++..|++
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~a  170 (284)
T cd06620          98 GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMS  170 (284)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCC
Confidence            468899999999999999999997 57   9999999999999999999999999876432211    112356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH-HHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA-AELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+|||||++|++++|..||...................    ........ ....+. ..+..+.++
T Consensus       171 PE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~l  245 (284)
T cd06620         171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL----LQQIVQEP-PPRLPSSDFPEDLRDF  245 (284)
T ss_pred             HHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH----HHHHhhcc-CCCCCchhcCHHHHHH
Confidence            999988888999999999999999999999986433221100000000000    00000000 001111 234568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHh
Q 026939          162 GLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +.+||+.||++|||+.++++..
T Consensus       246 i~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         246 VDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHHhcCCcccCcCHHHHhcCc
Confidence            9999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.92  E-value=6.7e-25  Score=179.23  Aligned_cols=172  Identities=23%  Similarity=0.200  Sum_probs=119.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||++||+|||+++   ++|+||+|+||+++.++.++|+|||++..........  ....+...|+|||
T Consensus        98 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE  172 (298)
T cd07841          98 VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVVTRWYRAPE  172 (298)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc--cccccceeeeCHH
Confidence            6899999999999999999999999   9999999999999999999999999987654332111  1123456799999


Q ss_pred             hhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHhhh-hhhhhhchhhcc-----hhhH
Q 026939           85 YAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWCEG-EALELMEPVLKQ-----SCVA  152 (230)
Q Consensus        85 ~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~-----~~~~  152 (230)
                      .+.+ ..++.++|+|||||++++|++|..+|....+..........     ...+... ............     ....
T Consensus       173 ~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T cd07841         173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFP  252 (298)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcc
Confidence            8865 35788999999999999999997776532221100000000     0000000 000000000000     1112


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .....+.+++.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         253 AASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            34567899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.92  E-value=1e-24  Score=179.46  Aligned_cols=173  Identities=21%  Similarity=0.251  Sum_probs=118.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-----cccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-----ASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~   78 (230)
                      ..+++.....++.|++.||+|||+++   |+|+||+|+||+++.++.++++||+.+.........     .......+..
T Consensus        96 ~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (314)
T cd08216          96 EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL  172 (314)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccc
Confidence            45888999999999999999999999   999999999999999999999999988654321110     0111223456


Q ss_pred             CccChhhhhcC--CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH-----------HHHhhhhhhh----h
Q 026939           79 GYMAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW-----------KLWCEGEALE----L  141 (230)
Q Consensus        79 ~~~aPe~~~~~--~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~----~  141 (230)
                      .|+|||.+...  .++.++|+||+||++|+|++|..||........  ..+...           ..........    .
T Consensus       173 ~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            79999998753  578899999999999999999999864321110  000000           0000000000    0


Q ss_pred             hch----hhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          142 MEP----VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       142 ~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...    .............+.+++.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000    0011122233456888999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.92  E-value=5.8e-25  Score=174.41  Aligned_cols=158  Identities=27%  Similarity=0.390  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||++||..+   ++|+||+|+||+++.++.++|+|||.+........   .....+...|++|
T Consensus        93 ~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~P  166 (253)
T cd05122          93 QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAP  166 (253)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCH
Confidence            47899999999999999999999999   99999999999999999999999998876543321   1223557789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++++|++|..||........      ... .........       .........+.+++.
T Consensus       167 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~-------~~~~~~~~~~~~~i~  232 (253)
T cd05122         167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFK-IATNGPPGL-------RNPEKWSDEFKDFLK  232 (253)
T ss_pred             HHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHH-HHhcCCCCc-------CcccccCHHHHHHHH
Confidence            999888889999999999999999999999753221100      000 000000000       001112456899999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.||++|||+.++++
T Consensus       233 ~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.92  E-value=2e-25  Score=185.69  Aligned_cols=175  Identities=21%  Similarity=0.234  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC---ccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE---ASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   80 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........   .......++..|
T Consensus       102 ~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y  178 (337)
T cd07852         102 NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY  178 (337)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccc
Confidence            36788999999999999999999999   999999999999999999999999988765432211   122223567789


Q ss_pred             cChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhchh---hc-
Q 026939           81 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEPV---LK-  147 (230)
Q Consensus        81 ~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~-  147 (230)
                      ++||.+.+ ..++.++|+||||+++|+|++|..||..............        ............+++..   .. 
T Consensus       179 ~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (337)
T cd07852         179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRK  258 (337)
T ss_pred             cCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhccccccc
Confidence            99998765 4578899999999999999999999854332211000000        00000000000011100   00 


Q ss_pred             --chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 --QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 --~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        ..........+.+++.+||+.||++|||+.++++
T Consensus       259 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         259 PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             chhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence              0011123556899999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=4.5e-25  Score=181.45  Aligned_cols=173  Identities=23%  Similarity=0.309  Sum_probs=119.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......    .....++..|+
T Consensus        93 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~  165 (308)
T cd06615          93 AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYM  165 (308)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCcc
Confidence            3568899999999999999999997 47   9999999999999999999999999876542211    12235677899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhh-----------------hhhhhhhch
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCE-----------------GEALELMEP  144 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~  144 (230)
                      +||.+.+..++.++|+||||+++|+|++|..||.....................                 .......+.
T Consensus       166 aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06615         166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDY  245 (308)
T ss_pred             ChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHH
Confidence            999998888899999999999999999999998532211110000000000000                 000000000


Q ss_pred             hh---cchhh-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          145 VL---KQSCV-AAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       145 ~~---~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      ..   ....+ ......+.+++.+||..||++||++.+|++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         246 IVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             HhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   00000 1134458899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=3.4e-25  Score=186.19  Aligned_cols=111  Identities=27%  Similarity=0.341  Sum_probs=94.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--------------   68 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------   68 (230)
                      ...+++..+..++.||+.||+|||++|   |+||||||+||+++.++.++|+|||++.........              
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~  171 (363)
T cd05628          95 KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF  171 (363)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccc
Confidence            467899999999999999999999999   999999999999999999999999998653211000              


Q ss_pred             -------------------ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCC
Q 026939           69 -------------------ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGF  116 (230)
Q Consensus        69 -------------------~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~  116 (230)
                                         .......|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                               000123578899999999988999999999999999999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.92  E-value=3e-25  Score=187.06  Aligned_cols=162  Identities=20%  Similarity=0.181  Sum_probs=116.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++...+..++.||+.||+|||+.+   |+||||+|+||+++.++.++|+|||++......... ......+++.|+|
T Consensus       136 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~a  211 (371)
T cd05622         136 NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYIS  211 (371)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccC
Confidence            456888999999999999999999999   999999999999999999999999998765432211 1122457889999


Q ss_pred             hhhhhcCC----CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           83 PEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        83 Pe~~~~~~----~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      ||++.+..    ++.++|+|||||++|+|++|..||......      ...............       .........+
T Consensus       212 PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~-------~~~~~~s~~~  278 (371)
T cd05622         212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTF-------PDDNDISKEA  278 (371)
T ss_pred             HHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcccC-------CCcCCCCHHH
Confidence            99987543    788999999999999999999998643211      000111100000000       1112334557


Q ss_pred             HHHHhhhcCCCCCC---CCCHHHHHHH
Q 026939          159 IHIGLLCVQADSAD---RPTMSSVVVM  182 (230)
Q Consensus       159 ~~l~~~cl~~dP~~---RPs~~~i~~~  182 (230)
                      .+++..|+. +|..   |+++.+|++.
T Consensus       279 ~~li~~~L~-~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         279 KNLICAFLT-DREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHcC-ChhhhcCCCCHHHHhcC
Confidence            888899998 4444   6788888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=5.6e-25  Score=178.14  Aligned_cols=159  Identities=25%  Similarity=0.335  Sum_probs=118.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++|
T Consensus        98 ~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P  172 (280)
T cd06611          98 RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAP  172 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCH
Confidence            46899999999999999999999999   99999999999999999999999998765432211  11223567789999


Q ss_pred             hhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           84 EYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        84 e~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |.+..     ..++.++|+||||+++|+|++|..||.......      .... .....     .+.+  ..+......+
T Consensus       173 E~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~--~~~~~~~~~~  238 (280)
T cd06611         173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLK-ILKSE-----PPTL--DQPSKWSSSF  238 (280)
T ss_pred             HHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHH-HhcCC-----CCCc--CCcccCCHHH
Confidence            99752     346789999999999999999999985432110      0000 00000     0000  1122334568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.+|++||++.+|++
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhc
Confidence            89999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.92  E-value=5.6e-25  Score=178.30  Aligned_cols=158  Identities=24%  Similarity=0.267  Sum_probs=120.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........    ....++..|+|
T Consensus        91 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~a  163 (278)
T cd05606          91 HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMA  163 (278)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----cCcCCCcCCcC
Confidence            456899999999999999999999999   99999999999999999999999999865432211    12356789999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+. .++.++|+||+|+++|+|++|..||.........   ... ...      ...    ....+...+..+.++
T Consensus       164 PE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~~~-~~~------~~~----~~~~~~~~s~~~~~l  229 (278)
T cd05606         164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EID-RMT------LTM----AVELPDSFSPELRSL  229 (278)
T ss_pred             cHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---HHH-HHh------hcc----CCCCCCcCCHHHHHH
Confidence            9998754 5889999999999999999999998543211110   000 000      000    111222335678999


Q ss_pred             HhhhcCCCCCCCC-----CHHHHHH
Q 026939          162 GLLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +.+||..+|.+||     ++.++++
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         230 LEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHhhcCHHhccCCCCCCHHHHHh
Confidence            9999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=189.98  Aligned_cols=159  Identities=22%  Similarity=0.308  Sum_probs=125.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.+|.+.++.-+++|++.||.|||+++   |+||||+..|||++.+|.++|+|||.+.....  .....+.+.|+++|||
T Consensus       124 ~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMA  198 (1187)
T KOG0579|consen  124 GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMA  198 (1187)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCccccc
Confidence            467899999999999999999999999   99999999999999999999999998765321  1223345789999999


Q ss_pred             hhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhh-cchhhHHHHH
Q 026939           83 PEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVL-KQSCVAAELL  156 (230)
Q Consensus        83 Pe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  156 (230)
                      ||+..     ..+|+.++||||||+.+.+|..+.+|.....+...               +.++.+... ..-.|..+..
T Consensus       199 PEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV---------------llKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  199 PEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---------------LLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             chheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH---------------HHHHhhcCCCcccCcchhhh
Confidence            99876     45799999999999999999999998543222111               011111000 0123678888


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .|.+++.+||..||..||++.++++
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhh
Confidence            9999999999999999999999876

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.92  E-value=4.6e-25  Score=178.94  Aligned_cols=174  Identities=20%  Similarity=0.205  Sum_probs=118.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|+|
T Consensus        94 ~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~a  168 (284)
T cd07860          94 LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRA  168 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccC
Confidence            356899999999999999999999999   999999999999999999999999998755322111  111234678999


Q ss_pred             hhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchh--------hhhHHHHhhh-hhhhhhchhhcc---h
Q 026939           83 PEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL--------SYTWKLWCEG-EALELMEPVLKQ---S  149 (230)
Q Consensus        83 Pe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~---~  149 (230)
                      ||.+.+.. ++.++|+||||+++|+|++|..||............        ...+...... .....+......   .
T Consensus       169 PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (284)
T cd07860         169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK  248 (284)
T ss_pred             CeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH
Confidence            99876544 578899999999999999999998643221110000        0000000000 000000000000   0


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ........+.+++.+||+.||++|||++++++
T Consensus       249 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         249 VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            01122345788999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=1.7e-24  Score=176.18  Aligned_cols=166  Identities=27%  Similarity=0.287  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..++...++.++.||+.||+|||+.+   ++|+||+++||+++.++.++|+|||++........    ....+...|++|
T Consensus       100 ~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~p  172 (287)
T cd06621         100 GRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAP  172 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCH
Confidence            46788899999999999999999999   99999999999999999999999999765432211    122456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+|+||+++|+|++|..||........ ...+.... ........+... .  .........+.+++.
T Consensus       173 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~-~--~~~~~~~~~~~~li~  247 (287)
T cd06621         173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSY-IVNMPNPELKDE-P--GNGIKWSEEFKDFIK  247 (287)
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHH-HhcCCchhhccC-C--CCCCchHHHHHHHHH
Confidence            999888899999999999999999999999864422100 01111100 000010010000 0  000123456889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.+|++|||+.+|++
T Consensus       248 ~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         248 QCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHcCCCcccCCCHHHHHh
Confidence            999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.92  E-value=1e-24  Score=181.19  Aligned_cols=163  Identities=17%  Similarity=0.171  Sum_probs=114.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++........ .......++..|+||
T Consensus        97 ~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aP  172 (332)
T cd05623          97 DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISP  172 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCH
Confidence            56889999999999999999999999   99999999999999999999999999865432211 111223578899999


Q ss_pred             hhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           84 EYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        84 e~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |++..     ..++.++|+|||||++|+|++|..||......      ..............      ...........+
T Consensus       173 E~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~------~p~~~~~~s~~~  240 (332)
T cd05623         173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ------FPAQVTDVSEDA  240 (332)
T ss_pred             HHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc------CCCccccCCHHH
Confidence            99863     45788999999999999999999998532211      11111100000000      001112234567


Q ss_pred             HHHHhhhcCCCCC--CCCCHHHHHHH
Q 026939          159 IHIGLLCVQADSA--DRPTMSSVVVM  182 (230)
Q Consensus       159 ~~l~~~cl~~dP~--~RPs~~~i~~~  182 (230)
                      .+++.+|+..++.  .|++++++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCC
Confidence            7888888865444  36888888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-24  Score=177.32  Aligned_cols=171  Identities=19%  Similarity=0.236  Sum_probs=116.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..........  ....++..|+||
T Consensus        98 ~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aP  172 (291)
T cd07844          98 GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY--SNEVVTLWYRPP  172 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccc--cccccccccCCc
Confidence            36789999999999999999999999   9999999999999999999999999886543221111  112346789999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh--hh----------hhhh-----chh
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG--EA----------LELM-----EPV  145 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~----------~~~~-----~~~  145 (230)
                      |.+.+ ..++.++|+||+|+++|+|++|..||........ . ....+......  ..          ....     ...
T Consensus       173 E~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (291)
T cd07844         173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-Q-LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRP  250 (291)
T ss_pred             HHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-H-HHHHHHhcCCCChhhhhhhhhccccccccccccCChh
Confidence            99875 4578899999999999999999999854321100 0 00000000000  00          0000     000


Q ss_pred             hcchhh-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSCV-AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +..... ......+.+++.+||+.+|++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         251 LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000 001256788999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=7.1e-25  Score=176.76  Aligned_cols=156  Identities=23%  Similarity=0.268  Sum_probs=119.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++.+++.++.||+.||.+||+.+   ++|+||+|+||+++.++ .++|+|||++.......      ...++..|+|
T Consensus       104 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~a  174 (267)
T PHA03390        104 GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFS  174 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCCCCcccC
Confidence            37899999999999999999999999   99999999999999988 89999999987653221      1245778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||+|+++|+|++|..||.......    ..  ...+...     ...  ....+...+..+.+++
T Consensus       175 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~----~~--~~~~~~~-----~~~--~~~~~~~~~~~~~~li  241 (267)
T PHA03390        175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE----LD--LESLLKR-----QQK--KLPFIKNVSKNANDFV  241 (267)
T ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch----hh--HHHHHHh-----hcc--cCCcccccCHHHHHHH
Confidence            999988889999999999999999999999986332211    00  0000000     000  0112224556689999


Q ss_pred             hhhcCCCCCCCCC-HHHHHH
Q 026939          163 LLCVQADSADRPT-MSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs-~~~i~~  181 (230)
                      .+||+.+|.+||+ ++++++
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHhccChhhCCchHHHHhc
Confidence            9999999999996 588874

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=9.2e-25  Score=179.58  Aligned_cols=156  Identities=28%  Similarity=0.349  Sum_probs=118.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..+++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++......      ....++..|+|
T Consensus       109 ~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~a  179 (308)
T cd06634         109 KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMA  179 (308)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccC
Confidence            456899999999999999999999999   999999999999999999999999988654321      12345678999


Q ss_pred             hhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.+   ..++.++|+|||||++|+|++|..||........      ..         ..................+.
T Consensus       180 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~---------~~~~~~~~~~~~~~~~~~~~  244 (308)
T cd06634         180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY---------HIAQNESPALQSGHWSEYFR  244 (308)
T ss_pred             HHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HH---------HHhhcCCCCcCcccccHHHH
Confidence            999753   4578899999999999999999999743211100      00         00000000111223455688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      +++.+||+.+|++||++.++++.
T Consensus       245 ~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         245 NFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHHhhCCcccCCCHHHHhhC
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.92  E-value=3.5e-25  Score=183.85  Aligned_cols=176  Identities=25%  Similarity=0.268  Sum_probs=120.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   80 (230)
                      ...+++..++.++.||+.||+|||++|   ++|+||+|+||+++.++.++|+|||++.........  .......++..|
T Consensus        99 ~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y  175 (332)
T cd07857          99 GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY  175 (332)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccc
Confidence            457899999999999999999999999   999999999999999999999999998765422111  111223567789


Q ss_pred             cChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccc-hh-------hhhHHHHhhhhhhhhhc---hhhcc
Q 026939           81 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS-LL-------SYTWKLWCEGEALELME---PVLKQ  148 (230)
Q Consensus        81 ~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~---~~~~~  148 (230)
                      +|||.+.+ ..++.++|+||+|+++|+|++|..||.......... ..       .................   .....
T Consensus       176 ~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
T cd07857         176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKK  255 (332)
T ss_pred             cCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCc
Confidence            99998765 468899999999999999999999986432110000 00       00000000000000000   00000


Q ss_pred             ---hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                         .........+.+++.+||+.||.+|||+.+++.
T Consensus       256 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         256 PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             chHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               001112456889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.92  E-value=2.5e-25  Score=188.23  Aligned_cols=162  Identities=20%  Similarity=0.216  Sum_probs=113.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC---------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---------------   67 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   67 (230)
                      ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++..+.....               
T Consensus        95 ~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~  171 (382)
T cd05625          95 MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM  171 (382)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccc
Confidence            346889999999999999999999999   99999999999999999999999998753210000               


Q ss_pred             ------------------------------CccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCC
Q 026939           68 ------------------------------EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY  117 (230)
Q Consensus        68 ------------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~  117 (230)
                                                    ........|+..|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             cccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence                                          00011235778999999999889999999999999999999999998643


Q ss_pred             ccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 026939          118 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT---MSSVVV  181 (230)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~i~~  181 (230)
                      .+...      .......       ...............+.+++.+|+ .+|.+|++   +.+|++
T Consensus       252 ~~~~~------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         252 TPLET------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             CHHHH------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            22110      0000000       000000001112334666666665 59999997   777765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=9.5e-25  Score=177.32  Aligned_cols=158  Identities=23%  Similarity=0.326  Sum_probs=117.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..+..++.||+.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++........    ....+...|++
T Consensus        97 ~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~a  169 (286)
T cd06622          97 EGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMA  169 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----ccCCCccCccC
Confidence            378999999999999999999997 47   99999999999999999999999998865432211    11245668999


Q ss_pred             hhhhhcC------CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           83 PEYAMEG------LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        83 Pe~~~~~------~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      ||.+.+.      .++.++|+|||||++|+|++|..||.......   ....         ...... ......+.....
T Consensus       170 PE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~---------~~~~~~-~~~~~~~~~~~~  236 (286)
T cd06622         170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQ---------LSAIVD-GDPPTLPSGYSD  236 (286)
T ss_pred             cchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHH---------HHHHhh-cCCCCCCcccCH
Confidence            9998543      35789999999999999999999985321110   0000         000000 111123344566


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhc
Confidence            6889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.3e-25  Score=180.95  Aligned_cols=155  Identities=26%  Similarity=0.271  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.+|+.||++||..+   ||+||+||+|||+|..|.++|+|+|++..+........   ..|+..||||
T Consensus       282 ~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~---rvGT~GYMAP  355 (591)
T KOG0986|consen  282 PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG---RVGTVGYMAP  355 (591)
T ss_pred             CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcccc---ccCcccccCH
Confidence            47899999999999999999999998   99999999999999999999999999987754433221   3789999999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++++..|+..+|.|+|||++|+|+.|..||..........            ++.+... .....++..-++....|++
T Consensus       356 Evl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e------------Evdrr~~-~~~~ey~~kFS~eakslc~  422 (591)
T KOG0986|consen  356 EVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE------------EVDRRTL-EDPEEYSDKFSEEAKSLCE  422 (591)
T ss_pred             HHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH------------HHHHHHh-cchhhcccccCHHHHHHHH
Confidence            99999999999999999999999999999985322211110            0111000 0012344555666788888


Q ss_pred             hhcCCCCCCCCCHH
Q 026939          164 LCVQADSADRPTMS  177 (230)
Q Consensus       164 ~cl~~dP~~RPs~~  177 (230)
                      ..|+.||++|...+
T Consensus       423 ~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  423 GLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHccCHHHhccCC
Confidence            99999999997554

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.92  E-value=1e-24  Score=179.93  Aligned_cols=157  Identities=29%  Similarity=0.352  Sum_probs=118.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......      ....++..|++
T Consensus       119 ~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~a  189 (317)
T cd06635         119 KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMA  189 (317)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccC
Confidence            456899999999999999999999999   999999999999999999999999987643221      12345678999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.   ...++.++|+|||||++|+|++|..||........      . .        ..................+.
T Consensus       190 PE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~-~--------~~~~~~~~~~~~~~~~~~l~  254 (317)
T cd06635         190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-Y--------HIAQNESPTLQSNEWSDYFR  254 (317)
T ss_pred             hhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------H-H--------HHHhccCCCCCCccccHHHH
Confidence            99974   34578899999999999999999999753211100      0 0        00000000111223345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHh
Q 026939          160 HIGLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +++.+||+.+|.+||++.+|++.+
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhCh
Confidence            999999999999999999999755

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.92  E-value=9.3e-25  Score=175.04  Aligned_cols=160  Identities=28%  Similarity=0.393  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc--ccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS--TNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~~   81 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+++||+++.++.++|+|||++...........  .....+...|+
T Consensus        94 ~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T cd06626          94 RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM  170 (264)
T ss_pred             CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCcc
Confidence            45889999999999999999999999   99999999999999999999999999876543322111  11234567899


Q ss_pred             ChhhhhcCC---CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH--HHHH
Q 026939           82 APEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA--AELL  156 (230)
Q Consensus        82 aPe~~~~~~---~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  156 (230)
                      +||.+.+..   ++.++|+|+||++++++++|..||.......     ....... ..         .....+.  ....
T Consensus       171 ~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~---------~~~~~~~~~~~~~  235 (264)
T cd06626         171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG-AG---------HKPPIPDSLQLSP  235 (264)
T ss_pred             ChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh-cC---------CCCCCCcccccCH
Confidence            999988765   8899999999999999999999985322110     0000000 00         0011111  1245


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+.+++.+||+.+|++||++.+|+.
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhc
Confidence            6789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=7e-25  Score=179.15  Aligned_cols=160  Identities=28%  Similarity=0.395  Sum_probs=117.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .++++..+..++.||+.||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+|
T Consensus       109 ~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~a  182 (296)
T cd06618         109 GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA  182 (296)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccC
Confidence            468899999999999999999997 47   999999999999999999999999998654322211   11235678999


Q ss_pred             hhhhhcCC----CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           83 PEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        83 Pe~~~~~~----~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      ||.+.+..    ++.++|+||||+++|+|++|..||......     .+...... ....     ....  ........+
T Consensus       183 PE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~~~-----~~~~--~~~~~~~~l  249 (296)
T cd06618         183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKIL-QEEP-----PSLP--PNEGFSPDF  249 (296)
T ss_pred             HhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHh-cCCC-----CCCC--CCCCCCHHH
Confidence            99987543    788999999999999999999998532111     00000100 0000     0000  001234468


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+++.+||..||++||++.++++.
T Consensus       250 ~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         250 CSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHHccCChhhCCCHHHHhcC
Confidence            999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.92  E-value=4.7e-25  Score=180.88  Aligned_cols=174  Identities=23%  Similarity=0.306  Sum_probs=118.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc---------cccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS---------TNRI   74 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---------~~~~   74 (230)
                      ..+++.+++.++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||++...........         ....
T Consensus       110 ~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (311)
T cd07866         110 VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL  186 (311)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccc
Confidence            47899999999999999999999999   99999999999999999999999999875432211110         0112


Q ss_pred             ccccCccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhh------hh
Q 026939           75 VGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGE------AL  139 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~------~~  139 (230)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|..||..............        .+..+....      ..
T Consensus       187 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (311)
T cd07866         187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSF  266 (311)
T ss_pred             eeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccC
Confidence            345679999988654 578899999999999999999999854332211110000        000000000      00


Q ss_pred             hhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          140 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....+.... ........+.+++.+||+.||++|||+.+++.
T Consensus       267 ~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         267 TNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000000 01122356889999999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.8e-25  Score=187.58  Aligned_cols=163  Identities=19%  Similarity=0.189  Sum_probs=115.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC------------c-
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE------------A-   69 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------------~-   69 (230)
                      ...+++..+..++.|++.||+|||+.|   |+||||||+||+++.++.++|+|||++..+......            . 
T Consensus        95 ~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~  171 (377)
T cd05629          95 YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN  171 (377)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccc
Confidence            456889999999999999999999999   999999999999999999999999998532110000            0 


Q ss_pred             --------------------------------cccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCC
Q 026939           70 --------------------------------STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY  117 (230)
Q Consensus        70 --------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~  117 (230)
                                                      ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             ccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCC
Confidence                                            000134778899999999888999999999999999999999998543


Q ss_pred             ccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHHH
Q 026939          118 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR---PTMSSVVVM  182 (230)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~~i~~~  182 (230)
                      .....      ..............+       .......+.+++.+|+. +|.+|   +++.++++.
T Consensus       252 ~~~~~------~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         252 NSHET------YRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CHHHH------HHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            22110      000000000000000       01123457888899997 77765   589888863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=5.9e-25  Score=183.39  Aligned_cols=171  Identities=23%  Similarity=0.271  Sum_probs=119.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..++.++.|++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.......     ....++..|++
T Consensus       112 ~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~a  183 (343)
T cd07851         112 CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA  183 (343)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccccc-----cCCcccccccC
Confidence            357899999999999999999999999   9999999999999999999999999987653221     11244678999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccch-hhh-------hHHHHhhhhhhhhhch---hhcchh
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL-LSY-------TWKLWCEGEALELMEP---VLKQSC  150 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~---~~~~~~  150 (230)
                      ||.+.+. .++.++|+||||+++|+|++|..||........... ...       ....+........+..   .....+
T Consensus       184 PE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (343)
T cd07851         184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDF  263 (343)
T ss_pred             HHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCH
Confidence            9998653 678899999999999999999999854322110000 000       0000000000000000   000001


Q ss_pred             ---hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 ---VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ---~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                         .......+.+++.+||+.||++|||+.+|++
T Consensus       264 ~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         264 KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence               1123567999999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.92  E-value=2.9e-25  Score=179.98  Aligned_cols=172  Identities=22%  Similarity=0.222  Sum_probs=118.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....+...|+|||
T Consensus        95 ~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE  169 (283)
T cd07835          95 GLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPE  169 (283)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCc
Confidence            5899999999999999999999998   999999999999999999999999998654322111  11123467899999


Q ss_pred             hhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchh-h-------hhHHHHhh-hhhhhhhchh---hcchhh
Q 026939           85 YAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL-S-------YTWKLWCE-GEALELMEPV---LKQSCV  151 (230)
Q Consensus        85 ~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~-~-------~~~~~~~~-~~~~~~~~~~---~~~~~~  151 (230)
                      .+.+. .++.++|+||||+++|+|++|..||....+....... .       ..+..... ..........   ......
T Consensus       170 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T cd07835         170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVV  249 (283)
T ss_pred             eeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhc
Confidence            87654 4688999999999999999999998643321110000 0       00000000 0000000000   000111


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          152 AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            222356889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=8.5e-25  Score=200.34  Aligned_cols=157  Identities=15%  Similarity=0.135  Sum_probs=108.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-------------------CCeEEcccccceeecC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-------------------MNPKISDFEMARIFGG   64 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-------------------~~~~l~d~~~~~~~~~   64 (230)
                      .++++.+++.+++||+.||+|||++|   |+||||||+|||++..                   +.+|++|||++.....
T Consensus        75 ~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~  151 (793)
T PLN00181         75 RSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI  151 (793)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccc
Confidence            46899999999999999999999999   9999999999999654                   4455666666543211


Q ss_pred             CCC---------C-----ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH
Q 026939           65 NQS---------E-----ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW  130 (230)
Q Consensus        65 ~~~---------~-----~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~  130 (230)
                      ...         .     .......+++.|+|||++.+..++.++|||||||++|||++|..|+......         .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---------~  222 (793)
T PLN00181        152 LSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---------M  222 (793)
T ss_pred             ccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---------H
Confidence            000         0     0000124567799999999999999999999999999999988775311100         0


Q ss_pred             HHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....    .....     ............++.+||+.+|.+||++.+|++
T Consensus       223 ~~~~----~~~~~-----~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        223 SSLR----HRVLP-----PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHH----HhhcC-----hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            0000    00000     001112234567888999999999999999976

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.92  E-value=1.2e-24  Score=176.85  Aligned_cols=158  Identities=24%  Similarity=0.341  Sum_probs=119.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||++||+.|   ++|+||+|+||+++.++.++|+|||++........  ......+...|++||
T Consensus       112 ~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE  186 (286)
T cd06614         112 RMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPE  186 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHh
Confidence            7899999999999999999999999   99999999999999999999999998765432211  111224567899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      .+.+..++.++|+||||+++|+|++|..||....+...      . ..........       ..........+.+++.+
T Consensus       187 ~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~-------~~~~~~~~~~l~~li~~  252 (286)
T cd06614         187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------L-FLITTKGIPP-------LKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             HhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhcCCCC-------CcchhhCCHHHHHHHHH
Confidence            99888889999999999999999999999753222110      0 0000000000       01112234568899999


Q ss_pred             hcCCCCCCCCCHHHHHH
Q 026939          165 CVQADSADRPTMSSVVV  181 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~  181 (230)
                      ||+.+|.+||++.+|++
T Consensus       253 ~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         253 CLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HhccChhhCcCHHHHhh
Confidence            99999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.92  E-value=6.7e-25  Score=175.59  Aligned_cols=164  Identities=27%  Similarity=0.283  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC------Cccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS------EASTNRIVGT   77 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~   77 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........      ........+.
T Consensus        88 ~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (265)
T cd05579          88 GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT  164 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccC
Confidence            46899999999999999999999999   99999999999999999999999998865432211      0111223456


Q ss_pred             cCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH--HH
Q 026939           78 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA--EL  155 (230)
Q Consensus        78 ~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  155 (230)
                      ..|++||.......+.++|+||||++++++++|..||.......      .... ...+.        .  ..+..  ..
T Consensus       165 ~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~--------~--~~~~~~~~~  227 (265)
T cd05579         165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQN-ILNGK--------I--EWPEDVEVS  227 (265)
T ss_pred             ccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HhcCC--------c--CCCccccCC
Confidence            78999999988888999999999999999999999985332110      0000 00000        0  11111  25


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          156 LKFIHIGLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       156 ~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      ..+.+++.+||+.+|++|||+..+.+.|+...
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~  259 (265)
T cd05579         228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF  259 (265)
T ss_pred             HHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence            56889999999999999999977777665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=3.2e-25  Score=188.29  Aligned_cols=163  Identities=22%  Similarity=0.373  Sum_probs=126.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      |.++++.+...+|++||+.||.|||++ +.||+|||||-+|||++.+ |.+||+|+|++.........    ...|++.|
T Consensus       136 k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak----svIGTPEF  210 (632)
T KOG0584|consen  136 KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK----SVIGTPEF  210 (632)
T ss_pred             HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccccc----eeccCccc
Confidence            456889999999999999999999998 5789999999999999876 88999999999876433322    25789999


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcc-hhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ-SCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~  159 (230)
                      ||||... ..|++.+||||||++++||+|+..||..     +...          -.+++-+-.++++ .+..-....+.
T Consensus       211 MAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~----------AQIYKKV~SGiKP~sl~kV~dPevr  274 (632)
T KOG0584|consen  211 MAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNP----------AQIYKKVTSGIKPAALSKVKDPEVR  274 (632)
T ss_pred             cChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCH----------HHHHHHHHcCCCHHHhhccCCHHHH
Confidence            9999985 7899999999999999999999999742     1111          1122222222221 12222344588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          160 HIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ++|.+|+.. ...|||+.+++.  +|...
T Consensus       275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            899999999 999999999997  55543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.92  E-value=5.5e-25  Score=183.49  Aligned_cols=176  Identities=19%  Similarity=0.207  Sum_probs=117.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCC-ccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~   80 (230)
                      ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++. ++.++|+|||.+......... .......++..|
T Consensus       108 ~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y  184 (342)
T cd07854         108 QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY  184 (342)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccc
Confidence            356899999999999999999999999   999999999999974 557899999998764322111 111112456789


Q ss_pred             cChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhchhhcc---
Q 026939           81 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEPVLKQ---  148 (230)
Q Consensus        81 ~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~---  148 (230)
                      +|||.+.. ..++.++|+|||||++|+|++|..||....+.........        ....................   
T Consensus       185 ~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (342)
T cd07854         185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP  264 (342)
T ss_pred             cCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCC
Confidence            99998754 4578899999999999999999999854322111000000        00000000000000000000   


Q ss_pred             --hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 --SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 --~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        .........+.+++.+||+.||++|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         265 LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence              011123456889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=5e-25  Score=178.69  Aligned_cols=171  Identities=20%  Similarity=0.261  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  169 (286)
T cd07832          94 RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LYSHQVATRWYRAP  169 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-ccccccCcccccCc
Confidence            56899999999999999999999999   999999999999999999999999998765433211 11123457789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh------hhhhh------hchhh----
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG------EALEL------MEPVL----  146 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~------~~~~~----  146 (230)
                      |.+.+. .++.++|+||+|+++++|++|.++|....+...   ...........      ....+      ..+..    
T Consensus       170 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (286)
T cd07832         170 ELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIP  246 (286)
T ss_pred             eeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcch
Confidence            988654 468899999999999999999777753222110   00000000000      00000      00000    


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...........+.+++.+||..+|.+||+++++++
T Consensus       247 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         247 LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00111223467899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=7.9e-25  Score=182.54  Aligned_cols=173  Identities=22%  Similarity=0.243  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......     ....++..|+||
T Consensus       112 ~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aP  183 (342)
T cd07879         112 HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAP  183 (342)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccCh
Confidence            46889999999999999999999999   9999999999999999999999999986532211     122446789999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHH--hhhhhhh---------hh---chhhcc
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLW--CEGEALE---------LM---EPVLKQ  148 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~---------~~---~~~~~~  148 (230)
                      |.+.+ ..++.++|+|||||++|+|++|..||........   ........  ......+         ..   ......
T Consensus       184 E~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (342)
T cd07879         184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK  260 (342)
T ss_pred             hhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccc
Confidence            99876 4588999999999999999999999864321110   00000000  0000000         00   000000


Q ss_pred             h---hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCC
Q 026939          149 S---CVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDN  187 (230)
Q Consensus       149 ~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~  187 (230)
                      .   ..+.....+.+++.+||+.||++||++.+++.  .+++..
T Consensus       261 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         261 DFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0   01123456889999999999999999999984  465543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=5.6e-25  Score=176.24  Aligned_cols=160  Identities=21%  Similarity=0.203  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....      .....+...|++|
T Consensus        92 ~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~p  162 (260)
T cd05611          92 GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAP  162 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccCh
Confidence            46899999999999999999999999   99999999999999999999999998865432      1123456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||+|+++++|++|..||.......       ..........      ..........+..+.+++.
T Consensus       163 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~~~~~~i~  229 (260)
T cd05611         163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRI------NWPEEVKEFCSPEAVDLIN  229 (260)
T ss_pred             hhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc------CCCCcccccCCHHHHHHHH
Confidence            99988788999999999999999999999985322110       0011111000      0011112234556899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||+.+|++||++..+.+.|..
T Consensus       230 ~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         230 RLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             HHccCCHHHccCCCcHHHHHcC
Confidence            9999999999988766665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.92  E-value=1.2e-24  Score=176.08  Aligned_cols=158  Identities=27%  Similarity=0.375  Sum_probs=121.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++++|||++........  ......+...|++
T Consensus        95 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~  169 (277)
T cd06641          95 PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMA  169 (277)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccC
Confidence            456889999999999999999999999   99999999999999999999999998865532211  1112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||+||++|+|++|..||.......      ... ..         ........+...+..+.+++
T Consensus       170 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~-~~---------~~~~~~~~~~~~~~~~~~~i  233 (277)
T cd06641         170 PEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLF-LI---------PKNNPPTLEGNYSKPLKEFV  233 (277)
T ss_pred             hhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHH-HH---------hcCCCCCCCcccCHHHHHHH
Confidence            999988888899999999999999999999975322110      000 00         00001112233445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.+|.+||++.++++
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         234 EACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             HHHccCChhhCcCHHHHHh
Confidence            9999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.92  E-value=1.3e-24  Score=177.47  Aligned_cols=161  Identities=22%  Similarity=0.318  Sum_probs=120.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|++
T Consensus       109 ~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~  183 (293)
T cd06647         109 ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA  183 (293)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcC
Confidence            346788999999999999999999999   999999999999999999999999987654322211  112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++|++++|..||..........  ..    ...+.      +.  ...+......+.+++
T Consensus       184 PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~~----~~~~~------~~--~~~~~~~~~~l~~li  249 (293)
T cd06647         184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LI----ATNGT------PE--LQNPEKLSAIFRDFL  249 (293)
T ss_pred             chhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--eh----hcCCC------CC--CCCccccCHHHHHHH
Confidence            999988888999999999999999999999986432211100  00    00000      00  011122344588899


Q ss_pred             hhhcCCCCCCCCCHHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+||..+|++||++.+++..
T Consensus       250 ~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         250 NRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHccCChhhCcCHHHHhcC
Confidence            99999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.7e-24  Score=179.73  Aligned_cols=163  Identities=19%  Similarity=0.188  Sum_probs=113.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.||+.||+|||+++   ++||||+|+||+++.++.++|+|||++.......... .....++..|+||
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aP  172 (331)
T cd05597          97 DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISP  172 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc-ccceeccccccCH
Confidence            46889999999999999999999999   9999999999999999999999999987653322211 1123568899999


Q ss_pred             hhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           84 EYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        84 e~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |++..     ..++.++|+||+||++|+|++|..||......      +...............      ......+..+
T Consensus       173 E~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~------~~~~~~~~~~  240 (331)
T cd05597         173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQFP------PDVTDVSEEA  240 (331)
T ss_pred             HHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccCC------CccCCCCHHH
Confidence            99873     34678999999999999999999998532211      1000111110000100      0011134456


Q ss_pred             HHHHhhhcCC--CCCCCCCHHHHHHH
Q 026939          159 IHIGLLCVQA--DSADRPTMSSVVVM  182 (230)
Q Consensus       159 ~~l~~~cl~~--dP~~RPs~~~i~~~  182 (230)
                      .+++.+|+..  ++..|+++.++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcC
Confidence            7777777654  33347888888874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.7e-24  Score=180.76  Aligned_cols=171  Identities=25%  Similarity=0.269  Sum_probs=118.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......     .....++..|+|
T Consensus       114 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~a  185 (345)
T cd07877         114 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA  185 (345)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccC
Confidence            356899999999999999999999999   999999999999999999999999998654221     112345678999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhh---hchhhcch-
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALEL---MEPVLKQS-  149 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~-  149 (230)
                      ||.+.+ ..++.++|+|||||++++|++|..||..............        .............   +....... 
T Consensus       186 PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (345)
T cd07877         186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF  265 (345)
T ss_pred             HHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch
Confidence            999876 4678899999999999999999999854322110000000        0000000000000   00000000 


Q ss_pred             --hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 --CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 --~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        ........+.+++.+||+.||.+||++.++++
T Consensus       266 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         266 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence              00112446889999999999999999999886

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.92  E-value=1.5e-24  Score=179.88  Aligned_cols=175  Identities=22%  Similarity=0.275  Sum_probs=117.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-----cccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-----ASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~   78 (230)
                      ..+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.+++.||+.+.........     .......+..
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (328)
T cd08226          96 EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL  172 (328)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCcc
Confidence            45888999999999999999999999   999999999999999999999998755332111100     0001112345


Q ss_pred             CccChhhhhcC--CCCccccchhhHHHHHHHHhcCCCCCCCcccccc-chhh-------------hhHHHHhhh------
Q 026939           79 GYMAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ-SLLS-------------YTWKLWCEG------  136 (230)
Q Consensus        79 ~~~aPe~~~~~--~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~-~~~~-------------~~~~~~~~~------  136 (230)
                      .|++||.+.+.  .++.++|+||+||++|+|++|..||......... ....             .....+...      
T Consensus       173 ~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (328)
T cd08226         173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS  252 (328)
T ss_pred             CccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhc
Confidence            69999998763  4789999999999999999999998643211100 0000             000000000      


Q ss_pred             -----hh-----hhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          137 -----EA-----LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       137 -----~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                           ..     .......+...........+.+++++||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                 00     0011111122233456678999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.92  E-value=2.7e-25  Score=186.57  Aligned_cols=111  Identities=27%  Similarity=0.342  Sum_probs=93.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--------------   68 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------   68 (230)
                      ...+++..+..++.|++.||+|||+.|   ++||||||+||+++.++.++|+|||++.........              
T Consensus        95 ~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~  171 (360)
T cd05627          95 KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF  171 (360)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccc
Confidence            457899999999999999999999999   999999999999999999999999987643211000              


Q ss_pred             -------------------ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCC
Q 026939           69 -------------------ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGF  116 (230)
Q Consensus        69 -------------------~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~  116 (230)
                                         .......|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                               000123578899999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.92  E-value=2.3e-24  Score=201.59  Aligned_cols=176  Identities=22%  Similarity=0.464  Sum_probs=127.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.++.+++.|++.||+|||..+...++||||+|+||+++.++..++. ++........      ....++..|+|||
T Consensus       776 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE  848 (968)
T PLN00113        776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPE  848 (968)
T ss_pred             cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcc
Confidence            47899999999999999999995432339999999999999988877664 4433221111      1124567899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcc--hhhHHHHHHHHHHH
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ--SCVAAELLKFIHIG  162 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~  162 (230)
                      ++.+..++.++|||||||++|||++|+.||..... .......+.............+++.+..  ..+..+...+.+++
T Consensus       849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  927 (968)
T PLN00113        849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA  927 (968)
T ss_pred             cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHH
Confidence            99988999999999999999999999999843221 1222333333322222333334443322  23456667889999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .+||+.||++|||+.+|++.|+....
T Consensus       928 ~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        928 LHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            99999999999999999999987644

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=2.2e-24  Score=175.63  Aligned_cols=171  Identities=20%  Similarity=0.227  Sum_probs=116.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus        98 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aP  172 (291)
T cd07870          98 GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPP  172 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCC
Confidence            45788889999999999999999999   999999999999999999999999988654322111  1112346789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh---------hhhhhhchhh----cch
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG---------EALELMEPVL----KQS  149 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~----~~~  149 (230)
                      |.+.+. .++.++|+||||+++|+|++|..||........ . ....+..+...         ..........    ...
T Consensus       173 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (291)
T cd07870         173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-Q-LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQ  250 (291)
T ss_pred             ceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-H-HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcc
Confidence            998754 578899999999999999999999864332100 0 00000000000         0000000000    000


Q ss_pred             hh-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CV-----AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..     ......+.+++.+|+..||.+|||+.+++.
T Consensus       251 ~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         251 LRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00     011346788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.91  E-value=1.1e-24  Score=178.14  Aligned_cols=170  Identities=22%  Similarity=0.278  Sum_probs=118.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......... .........|++|
T Consensus       111 ~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~P  186 (302)
T cd07864         111 VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPP  186 (302)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcccc-cccceeccCccCh
Confidence            46899999999999999999999999   9999999999999999999999999987653322111 1112346689999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh---hhhhh--------------hchh
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG---EALEL--------------MEPV  145 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--------------~~~~  145 (230)
                      |.+.+. .++.++|+|||||++++|++|..||........   ...........   ....+              ..+.
T Consensus       187 E~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd07864         187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRR  263 (302)
T ss_pred             HHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhhcccccccccccccccccccccc
Confidence            988653 468899999999999999999999864322110   00000000000   00000              0000


Q ss_pred             hcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .... ....+..+.+++.+||+.||.+||++.+|++
T Consensus       264 ~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         264 LREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000 0112456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=2.1e-24  Score=175.52  Aligned_cols=178  Identities=21%  Similarity=0.203  Sum_probs=135.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCC-----------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN-----------------   65 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-----------------   65 (230)
                      ++.+++..+..++..++.||+|||..|   ||+|||||+|||+..+|.+.|+||.++......                 
T Consensus       173 ~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~  249 (459)
T KOG0610|consen  173 GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPS  249 (459)
T ss_pred             CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcc
Confidence            467899999999999999999999999   999999999999999999999999886432100                 


Q ss_pred             ---------------CCC----------------------ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHH
Q 026939           66 ---------------QSE----------------------ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII  108 (230)
Q Consensus        66 ---------------~~~----------------------~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll  108 (230)
                                     ...                      .....++|+-.|+|||++.+.....++|.|+||+++|||+
T Consensus       250 ~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmL  329 (459)
T KOG0610|consen  250 CRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEML  329 (459)
T ss_pred             cccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHH
Confidence                           000                      0011235677899999999999999999999999999999


Q ss_pred             hcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHH--H
Q 026939          109 SGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT----MSSVVV--M  182 (230)
Q Consensus       109 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~i~~--~  182 (230)
                      .|.-||.......               ....++...+.-.-.+...-.+.+||++.|.+||.+|-.    +.||.+  +
T Consensus       330 yG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF  394 (459)
T KOG0610|consen  330 YGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF  394 (459)
T ss_pred             hCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence            9999995433221               122222222221112245567899999999999999998    999987  7


Q ss_pred             hhcCCCCCCCCCCCCC
Q 026939          183 LASDNVTLPQPTEPAF  198 (230)
Q Consensus       183 L~~~~~~~~~~~~p~~  198 (230)
                      +++.+++|-.-.+|++
T Consensus       395 F~gVnWaLir~~~PP~  410 (459)
T KOG0610|consen  395 FEGVNWALIRCARPPE  410 (459)
T ss_pred             ccCCChhheeccCCCc
Confidence            8999998764444444

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.91  E-value=2e-24  Score=177.95  Aligned_cols=155  Identities=28%  Similarity=0.362  Sum_probs=116.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++.+++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.....      .....++..|++
T Consensus       115 ~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~a  185 (313)
T cd06633         115 KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMA  185 (313)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccC
Confidence            457899999999999999999999999   99999999999999999999999998754221      112355778999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.   ...++.++|+|||||++|+|++|..||........      ..... ......        .........+.
T Consensus       186 PE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~--------~~~~~~~~~l~  250 (313)
T cd06633         186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNDSPT--------LQSNEWTDSFR  250 (313)
T ss_pred             hhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHH-hcCCCC--------CCccccCHHHH
Confidence            99984   35678899999999999999999999743221100      00000 000000        01112234588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.+|.+||++.+++.
T Consensus       251 ~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         251 GFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            8999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=1.6e-24  Score=175.63  Aligned_cols=173  Identities=23%  Similarity=0.259  Sum_probs=119.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|++|
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~P  169 (284)
T cd07836          95 GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAP  169 (284)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--cccccccccccCh
Confidence            46899999999999999999999999   999999999999999999999999998654322111  1112346789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchh--------hhhHHHHhhhhh-hhhhc---hhhcchh
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL--------SYTWKLWCEGEA-LELME---PVLKQSC  150 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~---~~~~~~~  150 (230)
                      |.+.+. .++.++|+|+||+++|+|++|..||............        ...+........ .....   .......
T Consensus       170 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (284)
T cd07836         170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQL  249 (284)
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHH
Confidence            988664 4688999999999999999999998643321110000        000000000000 00000   0000111


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....+..+.+++.+||+.||.+||++.+|++
T Consensus       250 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         250 FPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2233566889999999999999999999974

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.91  E-value=1.5e-24  Score=176.79  Aligned_cols=154  Identities=24%  Similarity=0.246  Sum_probs=119.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...++...++.++.||+.||++||+.+   ++|+||+|.||+++.++.++|+|||++......     .....++..|++
T Consensus        95 ~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~a  166 (290)
T cd05580          95 SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLA  166 (290)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccC
Confidence            357899999999999999999999999   999999999999999999999999998765433     112345778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+...+.++|+||||+++|+|++|..||......       ........+.          ..++......+.+++
T Consensus       167 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~----------~~~~~~~~~~l~~li  229 (290)
T cd05580         167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGK----------VRFPSFFSPDAKDLI  229 (290)
T ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC----------ccCCccCCHHHHHHH
Confidence            99998888889999999999999999999998543211       0000000100          112223355688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||..||.+|+     +++++++
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHc
Confidence            999999999999     6677663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.91  E-value=2.3e-24  Score=176.06  Aligned_cols=160  Identities=22%  Similarity=0.320  Sum_probs=119.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||+|||+.|   ++|+||+|+||+++.++.++|+|||++........  ......++..|++
T Consensus       110 ~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~  184 (292)
T cd06657         110 HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMA  184 (292)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccC
Confidence            346889999999999999999999999   99999999999999999999999998765432211  1122345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||+|+++|+|++|..||........      . ....     ......+.  ........+.+++
T Consensus       185 pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~------~-~~~~-----~~~~~~~~--~~~~~~~~l~~li  250 (292)
T cd06657         185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------M-KMIR-----DNLPPKLK--NLHKVSPSLKGFL  250 (292)
T ss_pred             HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHH-----hhCCcccC--CcccCCHHHHHHH
Confidence            9998877889999999999999999999999853221100      0 0000     00000000  1122344578899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.+|.+||++.++++
T Consensus       251 ~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         251 DRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHhCCcccCcCHHHHhc
Confidence            9999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-25  Score=201.55  Aligned_cols=159  Identities=27%  Similarity=0.323  Sum_probs=121.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCC--CCccccccccccCccCh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ--SEASTNRIVGTYGYMAP   83 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~~aP   83 (230)
                      .++..-.-+..|++.|++|||..|   ||||||||.||+++.+|.+|++|||.+.......  .........|++.||||
T Consensus      1331 ~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1331 EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred             hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCc
Confidence            445555567799999999999999   9999999999999999999999999998765442  12233345789999999


Q ss_pred             hhhhcCC---CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           84 EYAMEGL---FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        84 e~~~~~~---~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |++.+..   -..++|||||||++.||+||+.||.....+         |..+.+      +..+..+++|......-.+
T Consensus      1408 Evit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy~------V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1408 EVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMYH------VAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred             hhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHhH------HhccCCCCCchhhhHhHHH
Confidence            9998643   457899999999999999999998643322         122111      1222234556666666778


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      ++.+||+.||+.|-++.++++.
T Consensus      1473 Fle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHHHHHhcCchhhhHHHHHHHh
Confidence            8899999999999888877653

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=1.9e-24  Score=174.90  Aligned_cols=158  Identities=27%  Similarity=0.293  Sum_probs=118.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........   .....+...|++||
T Consensus        91 ~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~PE  164 (277)
T cd05577          91 GFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPE  164 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCcCCHH
Confidence            6899999999999999999999999   99999999999999999999999998865432111   11234567899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      .+.+..++.++|+||+|+++++|++|..||..........       ........      .....+......+.+++.+
T Consensus       165 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~------~~~~~~~~~~~~~~~li~~  231 (277)
T cd05577         165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------ELKRRTLE------MAVEYPDKFSPEAKDLCEA  231 (277)
T ss_pred             HhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------HHHhcccc------ccccCCccCCHHHHHHHHH
Confidence            9988888999999999999999999999985433211100       00000000      0111223335568899999


Q ss_pred             hcCCCCCCCC-----CHHHHHH
Q 026939          165 CVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       165 cl~~dP~~RP-----s~~~i~~  181 (230)
                      ||+.||++||     ++.++++
T Consensus       232 ~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         232 LLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HccCChhHccCCCcccHHHHHh
Confidence            9999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.91  E-value=2.1e-24  Score=195.39  Aligned_cols=165  Identities=22%  Similarity=0.278  Sum_probs=119.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC----------------C
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS----------------E   68 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----------------~   68 (230)
                      .+++..+++++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++........                .
T Consensus       109 ~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~  185 (932)
T PRK13184        109 KTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM  185 (932)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccccccc
Confidence            4567788999999999999999999   99999999999999999999999999876521100                0


Q ss_pred             ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcc
Q 026939           69 ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ  148 (230)
Q Consensus        69 ~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (230)
                      .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.......      ....    ...   ..+.. .
T Consensus       186 t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k------i~~~----~~i---~~P~~-~  251 (932)
T PRK13184        186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK------ISYR----DVI---LSPIE-V  251 (932)
T ss_pred             ccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh------hhhh----hhc---cChhh-c
Confidence            01112357889999999998899999999999999999999999985321110      0000    000   00000 0


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHhhcC
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRP-TMSSVVVMLASD  186 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~i~~~L~~~  186 (230)
                      ......+..+.+++.+||..||++|+ +++++++.|+..
T Consensus       252 ~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        252 APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00112334588899999999999996 566677666543

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=1.8e-24  Score=173.04  Aligned_cols=157  Identities=28%  Similarity=0.288  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .+++...++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ......+...|++|
T Consensus        95 ~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~P  168 (258)
T cd05578          95 VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAP  168 (258)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCH
Confidence            37899999999999999999999999   9999999999999999999999999887654322   11223456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||........   ....          ..... .....+...+..+.+++.
T Consensus       169 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~----------~~~~~-~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---DQIR----------AKQET-ADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             HHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH---HHHH----------HHhcc-ccccCcccCcHHHHHHHH
Confidence            999888889999999999999999999999864332100   0000          00000 112233344567999999


Q ss_pred             hhcCCCCCCCCCH--HHHH
Q 026939          164 LCVQADSADRPTM--SSVV  180 (230)
Q Consensus       164 ~cl~~dP~~RPs~--~~i~  180 (230)
                      +||+.||.+||++  .+++
T Consensus       235 ~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHccCChhHcCCccHHHHh
Confidence            9999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=4.3e-24  Score=172.73  Aligned_cols=172  Identities=25%  Similarity=0.257  Sum_probs=120.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.........  .........|+||
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aP  167 (282)
T cd07829          93 GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAP  167 (282)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCCh
Confidence            47899999999999999999999999   999999999999999999999999998765432211  1112345679999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchh--------hhhHHHHhhh-----hhhhhhchhhcch
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL--------SYTWKLWCEG-----EALELMEPVLKQS  149 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-----~~~~~~~~~~~~~  149 (230)
                      |.+.+. .++.++|+|+||++++++++|..||............        ...+..+..-     .............
T Consensus       168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (282)
T cd07829         168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKV  247 (282)
T ss_pred             HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHh
Confidence            998766 7889999999999999999999988543321110000        0000000000     0000000000000


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                       .......+.+++..||+.||++||++.+++.
T Consensus       248 -~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         248 -LPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             -cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             1112556999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=3.6e-24  Score=173.51  Aligned_cols=172  Identities=24%  Similarity=0.235  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+||
T Consensus        94 ~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aP  167 (283)
T cd07830          94 KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAP  167 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCcccccCc
Confidence            47899999999999999999999999   999999999999999999999999998765432221   113456789999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh-h----hhHHHHhhhh-hhhhhchhh-------cch
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL-S----YTWKLWCEGE-ALELMEPVL-------KQS  149 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~-~----~~~~~~~~~~-~~~~~~~~~-------~~~  149 (230)
                      |.+.. ..++.++|+||||+++++|++|..||............ .    .....+.... .....+...       ...
T Consensus       168 E~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (283)
T cd07830         168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQ  247 (283)
T ss_pred             eeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHH
Confidence            98754 45789999999999999999999988543221110000 0    0000000000 000000000       001


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ........+.+++.+||+.||++|||+.+++.
T Consensus       248 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         248 LIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             HcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            11112456889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=1.3e-24  Score=197.65  Aligned_cols=159  Identities=23%  Similarity=0.314  Sum_probs=115.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCC----CCeeecCCCCCceEeCC-----------------CCCeEEcccccceee
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSR----LRIIHRDLKASNVLLDH-----------------EMNPKISDFEMARIF   62 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~----~~i~H~di~~~nil~~~-----------------~~~~~l~d~~~~~~~   62 (230)
                      ..+++..++.|+.||+.||+|||+.+.    ..|+|+||+|+|||++.                 .+.++|+|||++...
T Consensus       113 g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l  192 (1021)
T PTZ00266        113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI  192 (1021)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccc
Confidence            468999999999999999999998431    23999999999999954                 234899999998765


Q ss_pred             cCCCCCccccccccccCccChhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhh
Q 026939           63 GGNQSEASTNRIVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALE  140 (230)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~aPe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (230)
                      .....   .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||......     .... ......    
T Consensus       193 ~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~-----~qli-~~lk~~----  259 (1021)
T PTZ00266        193 GIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF-----SQLI-SELKRG----  259 (1021)
T ss_pred             ccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH-----HHHH-HHHhcC----
Confidence            32211   122356889999999864  35789999999999999999999998532211     0010 000000    


Q ss_pred             hhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          141 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       141 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                         +.+   .....+..+.+||..||+.+|.+||++.+++.
T Consensus       260 ---p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        260 ---PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             ---CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence               000   00122456889999999999999999999984

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=1e-24  Score=172.83  Aligned_cols=144  Identities=18%  Similarity=0.135  Sum_probs=111.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||.+........     ....+..|++|
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~y~aP  151 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVENMYCAP  151 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCccccCC
Confidence            46889999999999999999999999   99999999999999999999999998755432211     12335579999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |...+..++.++|+||+|+++|+|++|..|+........            .         ......+......+.+++.
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~---------~~~~~~~~~~~~~~~~li~  210 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T---------HTTLNIPEWVSEEARSLLQ  210 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c---------ccccCCcccCCHHHHHHHH
Confidence            998877889999999999999999999987642111000            0         0000112223456889999


Q ss_pred             hhcCCCCCCCCCH
Q 026939          164 LCVQADSADRPTM  176 (230)
Q Consensus       164 ~cl~~dP~~RPs~  176 (230)
                      +||+.||++||++
T Consensus       211 ~~l~~dp~~R~~~  223 (237)
T cd05576         211 QLLQFNPTERLGA  223 (237)
T ss_pred             HHccCCHHHhcCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=2.6e-24  Score=176.52  Aligned_cols=168  Identities=19%  Similarity=0.173  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-------------cc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-------------AS   70 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------~~   70 (230)
                      ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........             ..
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (305)
T cd05609          96 GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL  172 (305)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhcc
Confidence            46889999999999999999999999   999999999999999999999999987532110000             00


Q ss_pred             ccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchh
Q 026939           71 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC  150 (230)
Q Consensus        71 ~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (230)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......      ..... .....   ...+.    .
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~-~~~~~---~~~~~----~  238 (305)
T cd05609         173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ-VISDD---IEWPE----G  238 (305)
T ss_pred             ccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhcc---cCCCC----c
Confidence            01124466899999998888999999999999999999999998532110      01000 00000   00000    0


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      ....+..+.+++.+||+.||++||++..+.+.|+...+
T Consensus       239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~  276 (305)
T cd05609         239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF  276 (305)
T ss_pred             cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence            11234458899999999999999998888877776544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=5.5e-24  Score=170.46  Aligned_cols=157  Identities=25%  Similarity=0.304  Sum_probs=119.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++........  ......+...|++
T Consensus       100 ~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~  173 (260)
T cd08222         100 GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMS  173 (260)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccC
Confidence            356899999999999999999999999   999999999999975 5699999998876533221  1112345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||...+..++.++|+||+|+++|+|++|..||.....      ...... ...         ......+......+.+++
T Consensus       174 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~-~~~---------~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR-IVE---------GPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HHc---------CCCCCCcchhcHHHHHHH
Confidence            9999888888999999999999999999999752211      000000 000         111122334456789999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||..+|++||++.+|++
T Consensus       238 ~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHhcCChhhCcCHHHHhh
Confidence            9999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.91  E-value=7e-24  Score=176.12  Aligned_cols=162  Identities=19%  Similarity=0.196  Sum_probs=114.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++......... ......++..|+||
T Consensus        97 ~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aP  172 (331)
T cd05624          97 DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISP  172 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCH
Confidence            57889999999999999999999999   999999999999999999999999998765432221 11223578899999


Q ss_pred             hhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           84 EYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        84 e~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |.+.+     ..++.++|+||+||++|+|++|..||......      ..............      .+......+..+
T Consensus       173 E~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~------~p~~~~~~~~~~  240 (331)
T cd05624         173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ------FPSHITDVSEEA  240 (331)
T ss_pred             HHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc------CCCccccCCHHH
Confidence            99875     45788999999999999999999998532211      00001100000000      001111234568


Q ss_pred             HHHHhhhcCCCCCC--CCCHHHHHH
Q 026939          159 IHIGLLCVQADSAD--RPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~--RPs~~~i~~  181 (230)
                      .+++.+|+..++..  |++++++++
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhc
Confidence            88888888865543  457777765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.91  E-value=2.8e-24  Score=171.64  Aligned_cols=156  Identities=24%  Similarity=0.351  Sum_probs=117.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC-eEEcccccceeecCCCCCccccccccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-PKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++. ++|+|||.+.........  .....++..|+||
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ap  171 (257)
T cd08225          97 LFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSP  171 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccCH
Confidence            5789999999999999999999999   999999999999998864 699999988765432211  1112457789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |...+..++.++|+||||+++++|++|..||......      ..... .....        . ..........+.+++.
T Consensus       172 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~--------~-~~~~~~~~~~~~~~i~  235 (257)
T cd08225         172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK-ICQGY--------F-APISPNFSRDLRSLIS  235 (257)
T ss_pred             HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-Hhccc--------C-CCCCCCCCHHHHHHHH
Confidence            9998888999999999999999999999997532111      01100 00100        0 0111223346889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||..+|++|||+.+|+.
T Consensus       236 ~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         236 QLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHhccChhhCcCHHHHhh
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3e-24  Score=170.95  Aligned_cols=157  Identities=24%  Similarity=0.332  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.+||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....+...|++|
T Consensus        94 ~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~p  168 (254)
T cd06627          94 GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAP  168 (254)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCH
Confidence            57899999999999999999999999   999999999999999999999999999876433221  1223457789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |...+..++.++|+|++|+++++|++|..||......      ...+... ..         .....+......+.+++.
T Consensus       169 e~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~---------~~~~~~~~~~~~~~~~i~  232 (254)
T cd06627         169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIV-QD---------DHPPLPEGISPELKDFLM  232 (254)
T ss_pred             hhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cc---------CCCCCCCCCCHHHHHHHH
Confidence            9998877889999999999999999999997532210      0011110 00         011122233456889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||..+|++||++.+++.
T Consensus       233 ~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHhCChhhCcCHHHHhc
Confidence            999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.91  E-value=3.2e-24  Score=174.46  Aligned_cols=169  Identities=22%  Similarity=0.234  Sum_probs=124.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......+...|++
T Consensus        99 ~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~a  174 (288)
T cd05583          99 REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMA  174 (288)
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccC
Confidence            356889999999999999999999999   999999999999999999999999988764332211 1112345778999


Q ss_pred             hhhhhcCC--CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~~--~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||.+.+..  .+.++|+||||+++++|++|..||........  ........      ...     ....+......+.+
T Consensus       175 PE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~------~~~-----~~~~~~~~~~~l~~  241 (288)
T cd05583         175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRI------LKS-----KPPFPKTMSAEARD  241 (288)
T ss_pred             HHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHH------Hcc-----CCCCCcccCHHHHH
Confidence            99987654  67899999999999999999999853221110  00010000      000     01122233455888


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      ++.+||+.||++|||+.++.+.|+....
T Consensus       242 li~~~l~~~p~~R~t~~~~~~~l~~~~~  269 (288)
T cd05583         242 FIQKLLEKDPKKRLGANGADEIKNHPFF  269 (288)
T ss_pred             HHHHHhcCCHhhccCcchHHHHhcCccc
Confidence            9999999999999999999888766543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.91  E-value=9.2e-25  Score=172.22  Aligned_cols=111  Identities=31%  Similarity=0.428  Sum_probs=95.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC----CCeEEcccccceeecCCCCC-ccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE----MNPKISDFEMARIFGGNQSE-ASTNRIVGT   77 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~   77 (230)
                      .+.++...+.+|+.||+.|+.|||++.   ++|||+||.||++..+    |.+|++|+|+++.+.+.... ...+..+-+
T Consensus       126 ~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVT  202 (438)
T KOG0666|consen  126 AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVT  202 (438)
T ss_pred             hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEE
Confidence            457889999999999999999999999   9999999999999877    88999999999987654322 233344557


Q ss_pred             cCccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCC
Q 026939           78 YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGF  116 (230)
Q Consensus        78 ~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~  116 (230)
                      ..|.|||++.+. .|+.+.|+|+.||++.||++..+-|..
T Consensus       203 iWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  203 IWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             EEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            899999999986 599999999999999999998887743

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.6e-24  Score=172.08  Aligned_cols=159  Identities=21%  Similarity=0.247  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC-CccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS-EASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ ........++..|+|
T Consensus       101 ~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (264)
T cd06653         101 GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS  177 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccC
Confidence            45788999999999999999999999   99999999999999999999999999876432111 111112346778999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+|||||++++|++|..||......      .         ...+..........+......+.+++
T Consensus       178 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~---------~~~~~~~~~~~~~~p~~~~~~~~~~i  242 (264)
T cd06653         178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------A---------AIFKIATQPTKPMLPDGVSDACRDFL  242 (264)
T ss_pred             HhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------H---------HHHHHHcCCCCCCCCcccCHHHHHHH
Confidence            99998888899999999999999999999998532111      0         00111111111233445556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+ +|..||++.+++.
T Consensus       243 ~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         243 KQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHhc-CcccCccHHHHhc
Confidence            99999 4799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=3e-24  Score=193.36  Aligned_cols=155  Identities=26%  Similarity=0.409  Sum_probs=112.9

Q ss_pred             CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeec--------------CC--CCCcc
Q 026939            7 DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG--------------GN--QSEAS   70 (230)
Q Consensus         7 ~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~--------------~~--~~~~~   70 (230)
                      .-..+|+++++|++||+|+|++|   ++||||||.|||++.+..+||+|||++....              ..  .....
T Consensus       695 ~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~  771 (1351)
T KOG1035|consen  695 QRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGD  771 (1351)
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcc
Confidence            35689999999999999999999   9999999999999999999999999987510              00  00111


Q ss_pred             ccccccccCccChhhhhcCC---CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhc
Q 026939           71 TNRIVGTYGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK  147 (230)
Q Consensus        71 ~~~~~~~~~~~aPe~~~~~~---~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (230)
                      .....|+.-|+|||++.+..   |+.++|+||||++++||+.   ||+...+...              .+..+.+..+.
T Consensus       772 ~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~--------------iL~~LR~g~iP  834 (1351)
T KOG1035|consen  772 LTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS--------------ILTNLRKGSIP  834 (1351)
T ss_pred             cccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHH--------------HHHhcccCCCC
Confidence            22347788999999998654   9999999999999999986   3543221100              01111111111


Q ss_pred             --chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 --QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 --~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        ..+..+....=..++++|++.||.+||||.+++.
T Consensus       835 ~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  835 EPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             CCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence              1223344444567889999999999999999985

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.91  E-value=3.3e-24  Score=178.91  Aligned_cols=171  Identities=22%  Similarity=0.242  Sum_probs=119.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.......     ....++..|++
T Consensus       112 ~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~a  183 (343)
T cd07880         112 HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRA  183 (343)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccC
Confidence            467899999999999999999999999   9999999999999999999999999987543211     11244678999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh-h-------hhHHHHhhhhhhhhhc---hhhc---
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL-S-------YTWKLWCEGEALELME---PVLK---  147 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~---~~~~---  147 (230)
                      ||.+.+ ..++.++|+||||++++++++|..||............ .       ................   ....   
T Consensus       184 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (343)
T cd07880         184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF  263 (343)
T ss_pred             HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH
Confidence            999876 35788999999999999999999998643221000000 0       0000000000000000   0000   


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..........+.+++.+|++.||++|||+.+++.
T Consensus       264 ~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         264 RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0111233445889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.91  E-value=3.9e-24  Score=172.76  Aligned_cols=158  Identities=29%  Similarity=0.330  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC---------------
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE---------------   68 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------------   68 (230)
                      ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.........               
T Consensus        97 ~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (280)
T cd05581          97 GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE  173 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccc
Confidence            36899999999999999999999999   999999999999999999999999998765432210               


Q ss_pred             ---ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchh
Q 026939           69 ---ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPV  145 (230)
Q Consensus        69 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (230)
                         .......+...|++||......++.++|+|+||++++++++|..||.......      .....         .  .
T Consensus       174 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~---------~--~  236 (280)
T cd05581         174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------TFQKI---------L--K  236 (280)
T ss_pred             ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH---------H--h
Confidence               11122345678999999888888999999999999999999999986432110      00000         0  0


Q ss_pred             hcchhhHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHH
Q 026939          146 LKQSCVAAELLKFIHIGLLCVQADSADRPTM----SSVVV  181 (230)
Q Consensus       146 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~~i~~  181 (230)
                      .....+...+..+.+++.+||+.+|++||++    +++++
T Consensus       237 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1112233335668999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.91  E-value=1e-23  Score=171.94  Aligned_cols=172  Identities=23%  Similarity=0.243  Sum_probs=115.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .+++..++.++.||+.||+|||+++   ++|+||+|+||+++. ++.++|+|||++.........  .....++..|++|
T Consensus        98 ~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~P  172 (294)
T PLN00009         98 AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAP  172 (294)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCH
Confidence            3578888999999999999999999   999999999999985 456899999998765332111  1112446789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchh--------hhhHHHHhhhhhhhhhchhhcc----hh
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL--------SYTWKLWCEGEALELMEPVLKQ----SC  150 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~----~~  150 (230)
                      |.+.+. .++.++|+||+|+++|+|++|..||............        ...|..+..-.......+....    ..
T Consensus       173 E~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (294)
T PLN00009        173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATV  252 (294)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHh
Confidence            988764 5788999999999999999999998643221110000        0000000000000000000000    01


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .......+.+++.+||+.+|++||++.++++
T Consensus       253 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        253 VPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1223455889999999999999999999986

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.91  E-value=3e-24  Score=181.16  Aligned_cols=168  Identities=27%  Similarity=0.361  Sum_probs=131.0

Q ss_pred             CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhh
Q 026939            7 DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYA   86 (230)
Q Consensus         7 ~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~   86 (230)
                      .-....+++.||++|++||.+-+   +||||+.++|+|++.++.+|++|||.++-.-.......+...+-+.+|+|+|.+
T Consensus       635 ~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsi  711 (807)
T KOG1094|consen  635 ETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESI  711 (807)
T ss_pred             ccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHH
Confidence            34566789999999999999998   999999999999999999999999999865555555566566668899999999


Q ss_pred             hcCCCCccccchhhHHHHHHHHh--cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           87 MEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        87 ~~~~~~~~~DiwslG~ll~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      ..++++.++|+|+||+.+||+++  ...||+...+++.   .+.....+..+      .+......|+.++.+++++|.+
T Consensus       712 llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~------~~~~~l~~P~~cp~~lyelml~  782 (807)
T KOG1094|consen  712 LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQ------GRQVVLSRPPACPQGLYELMLR  782 (807)
T ss_pred             HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCC------CcceeccCCCcCcHHHHHHHHH
Confidence            99999999999999999999875  6788754332221   11111111111      1111224466777889999999


Q ss_pred             hcCCCCCCCCCHHHHHHHhhcC
Q 026939          165 CVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ||.++-++||+++++...|++.
T Consensus       783 Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  783 CWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HhchhhhcCCCHHHHHHHHHHh
Confidence            9999999999999999998764

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.91  E-value=5.3e-24  Score=178.33  Aligned_cols=157  Identities=24%  Similarity=0.227  Sum_probs=123.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC----CCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE----MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +++..+..++.|++.+++|||+.|   ++|||+||+|+|+...    +.++++|||++.....   ........|++.|+
T Consensus       132 ~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~  205 (382)
T KOG0032|consen  132 YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYV  205 (382)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCcccc
Confidence            788999999999999999999999   9999999999999643    4799999999988754   22333468899999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++....|+..+|+||+|+++|.|++|..||..........       ....++.      .+....-........++
T Consensus       206 APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~------~f~~~~w~~is~~akd~  272 (382)
T KOG0032|consen  206 APEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF------DFTSEPWDDISESAKDF  272 (382)
T ss_pred             CchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC------CCCCCCccccCHHHHHH
Confidence            9999988999999999999999999999999985433211100       1111111      11112223346678889


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +..|+..||.+|+|+.++++
T Consensus       273 i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  273 IRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHhcccCcccCCCHHHHhc
Confidence            99999999999999999998

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.91  E-value=4.8e-24  Score=177.20  Aligned_cols=173  Identities=21%  Similarity=0.247  Sum_probs=119.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC------------Ccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS------------EAS   70 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------~~~   70 (230)
                      ...++...++.++.|++.||++||+.+   ++|+||+++||+++.++.++|+|||.+........            ...
T Consensus       113 ~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  189 (335)
T PTZ00024        113 KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE  189 (335)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccc
Confidence            346889999999999999999999999   99999999999999999999999999876541110            001


Q ss_pred             ccccccccCccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhh-----------
Q 026939           71 TNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEA-----------  138 (230)
Q Consensus        71 ~~~~~~~~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------  138 (230)
                      .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||....+...   .............           
T Consensus       190 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~  266 (335)
T PTZ00024        190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPL  266 (335)
T ss_pred             ccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhccc
Confidence            1112345689999998764 468899999999999999999999864432211   0000000000000           


Q ss_pred             hhhhchhhc---chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          139 LELMEPVLK---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       139 ~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .........   ..........+.+++.+||+.+|++||++++++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        267 YTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             ccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            000000000   0011223456889999999999999999999986

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=1.8e-24  Score=176.09  Aligned_cols=157  Identities=20%  Similarity=0.285  Sum_probs=123.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .+.|+++++..+++||++|+.|+|.++   ++|||||.+|||++.|+++|++|||++..+....   ....+.|++-|..
T Consensus       147 r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYAS  220 (668)
T KOG0611|consen  147 RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYAS  220 (668)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCC
Confidence            468999999999999999999999999   9999999999999999999999999998764332   2334678999999


Q ss_pred             hhhhhcCCCC-ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~-~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+.+|. +.+|.||||+++|.|+.|..||......                .+.+.+......  -++.+-...-|
T Consensus       221 PEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----------------~lvrQIs~GaYr--EP~~PSdA~gL  282 (668)
T KOG0611|consen  221 PEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----------------RLVRQISRGAYR--EPETPSDASGL  282 (668)
T ss_pred             ccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------------HHHHHhhccccc--CCCCCchHHHH
Confidence            9999998885 7899999999999999999998643311                111111111100  11112235567


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHh
Q 026939          162 GLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +++||-.||+.|.|+.+|....
T Consensus       283 IRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhhh
Confidence            8999999999999999998754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.91  E-value=8.3e-24  Score=175.48  Aligned_cols=173  Identities=25%  Similarity=0.320  Sum_probs=120.3

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++......++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......     ....+...|+
T Consensus       101 ~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~  172 (328)
T cd07856         101 TSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTRYYR  172 (328)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCccccccc
Confidence            3457888899999999999999999999   9999999999999999999999999886542211     1124467899


Q ss_pred             Chhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh--------hhhHHHHhhhhhhhhhchhhc-chhh
Q 026939           82 APEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL--------SYTWKLWCEGEALELMEPVLK-QSCV  151 (230)
Q Consensus        82 aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-~~~~  151 (230)
                      +||.+.+ ..++.++|+||||+++++|++|..||............        .............+....... ...+
T Consensus       173 aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (328)
T cd07856         173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVP  252 (328)
T ss_pred             CceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCc
Confidence            9998765 46889999999999999999999998543321110000        000000001111111111000 0011


Q ss_pred             -----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          152 -----AAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       152 -----~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                           ......+.+++.+||+.+|++||++.+++..
T Consensus       253 ~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         253 FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 1234678999999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.91  E-value=5.5e-25  Score=173.05  Aligned_cols=162  Identities=24%  Similarity=0.337  Sum_probs=131.3

Q ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            1 MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         1 ~~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      +|+++|.+.++..++++-+.||+|||...   -+|||||..||+++.+|..||+|||.+........  ..+...|++.|
T Consensus       121 ~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFW  195 (502)
T KOG0574|consen  121 ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFW  195 (502)
T ss_pred             HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhCccccCccc
Confidence            47889999999999999999999999988   99999999999999999999999999977644332  22346789999


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++....|..++||||||+...||..|.+||..-.+......+.            -...+.+  .-|..++..|.+
T Consensus       196 MAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP------------T~PPPTF--~KPE~WS~~F~D  261 (502)
T KOG0574|consen  196 MAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP------------TKPPPTF--KKPEEWSSEFND  261 (502)
T ss_pred             ccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc------------CCCCCCC--CChHhhhhHHHH
Confidence            99999999999999999999999999999999986433221111000            0001111  126778888999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.||-.+|++|.|+-.+++
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhh
Confidence            999999999999999998876

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.5e-23  Score=166.71  Aligned_cols=153  Identities=27%  Similarity=0.280  Sum_probs=117.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+...|++|
T Consensus        88 ~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~P  162 (250)
T cd05123          88 GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAP  162 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccCh
Confidence            36899999999999999999999999   99999999999999999999999999876543221  11223456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |...+...+.++|+|+||+++|++++|..||......      ......         ..  ....++......+.+++.
T Consensus       163 e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~---------~~--~~~~~~~~~~~~l~~~i~  225 (250)
T cd05123         163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYEKI---------LK--DPLRFPEFLSPEARDLIS  225 (250)
T ss_pred             HHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH---------hc--CCCCCCCCCCHHHHHHHH
Confidence            9998888889999999999999999999998543210      000000         00  011222233556889999


Q ss_pred             hhcCCCCCCCCCHHH
Q 026939          164 LCVQADSADRPTMSS  178 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~  178 (230)
                      +||..||++||++.+
T Consensus       226 ~~l~~~p~~R~~~~~  240 (250)
T cd05123         226 GLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHhcCCHhhCCCccc
Confidence            999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7e-24  Score=161.55  Aligned_cols=155  Identities=23%  Similarity=0.290  Sum_probs=124.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++...+.+.+|++.|+.|+|.++   ++||||+|+|+|++..+.+|++|||-+....+...    ....|+.-|.+
T Consensus       118 ~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR----~tlcgt~dyl~  190 (281)
T KOG0580|consen  118 MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKR----KTLCGTLDYLP  190 (281)
T ss_pred             cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCCCc----eeeecccccCC
Confidence            457889999999999999999999999   99999999999999999999999998876542222    12467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||...+...+..+|+|++|++.||++.|.+||.....                ++.++-+.. ..-.+|........+++
T Consensus       191 pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----------------~etYkrI~k-~~~~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  191 PEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH----------------SETYKRIRK-VDLKFPSTISGGAADLI  253 (281)
T ss_pred             HhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh----------------HHHHHHHHH-ccccCCcccChhHHHHH
Confidence            9999999999999999999999999999999863221                011111100 11123455556688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+|+..+|.+|.+..+++.
T Consensus       254 ~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             HHHhccCccccccHHHHhh
Confidence            9999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=2.1e-23  Score=183.79  Aligned_cols=163  Identities=19%  Similarity=0.190  Sum_probs=106.0

Q ss_pred             HHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCCccccccccccCccChhhh
Q 026939            8 WKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYA   86 (230)
Q Consensus         8 ~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~   86 (230)
                      ...+..++.||+.||+|||+.+   |+||||||+|||++. ++.+||+|||++......... ......+++.|+|||.+
T Consensus       254 ~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~  329 (566)
T PLN03225        254 NKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQY  329 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHh
Confidence            3456689999999999999999   999999999999985 578999999999754322111 11224567899999976


Q ss_pred             hcC----------------------CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh----hhhh
Q 026939           87 MEG----------------------LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG----EALE  140 (230)
Q Consensus        87 ~~~----------------------~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~  140 (230)
                      ...                      .+..++||||+||++|+|+++..++....       ..+.......+    ....
T Consensus       330 ~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~  402 (566)
T PLN03225        330 IMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRK  402 (566)
T ss_pred             hccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHH
Confidence            422                      23446699999999999998766542110       00000000000    0000


Q ss_pred             hhchhh----cc--hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          141 LMEPVL----KQ--SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       141 ~~~~~~----~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......    ..  .....+.....+|+.+||+.||.+|||+.++++
T Consensus       403 ~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        403 LVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             hhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence            011100    00  001112234568999999999999999999986

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.5e-24  Score=180.01  Aligned_cols=155  Identities=31%  Similarity=0.382  Sum_probs=122.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +++|.+-.+..|+.+.+.||+|||+.+   .||||||..||+++..|.+||+|||.+-....      .+.++|+++|||
T Consensus       120 kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMA  190 (948)
T KOG0577|consen  120 KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMA  190 (948)
T ss_pred             hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccc
Confidence            578889999999999999999999999   99999999999999999999999999865432      234688999999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||++.   .+.|+-++||||||+...+|...++|.-...   ...   ..+.      +...-.+.+   ...+++..|.
T Consensus       191 PEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---AMS---ALYH------IAQNesPtL---qs~eWS~~F~  255 (948)
T KOG0577|consen  191 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMS---ALYH------IAQNESPTL---QSNEWSDYFR  255 (948)
T ss_pred             hhHheeccccccCCccceeeccchhhhhhhcCCCccCch---HHH---HHHH------HHhcCCCCC---CCchhHHHHH
Confidence            99987   4679999999999999999999998842110   000   0000      011111111   1467888899


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .++..||+.-|.+|||.++++.
T Consensus       256 ~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHHHHhhCcccCCcHHHHhh
Confidence            9999999999999999998765

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.3e-24  Score=177.24  Aligned_cols=158  Identities=22%  Similarity=0.268  Sum_probs=125.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..++..+...++..+++|++|||++|   |++|||||+|++++.+|-+||.|||++...+....   .-.+.|++.|.|
T Consensus       514 Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVA  587 (732)
T KOG0614|consen  514 RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVA  587 (732)
T ss_pred             cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCccccc
Confidence            457888899999999999999999999   99999999999999999999999999987654322   223578999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+...+.++|.|+||+++|||++|.+||....+...-+.            +.+.++   .-.+|....+...+|+
T Consensus       588 PEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------------ILkGid---~i~~Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  588 PEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------------ILKGID---KIEFPRRITKTATDLI  652 (732)
T ss_pred             chhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------------HHhhhh---hhhcccccchhHHHHH
Confidence            9999999999999999999999999999999975543322111            111111   1234455556678888


Q ss_pred             hhhcCCCCCCCCC-----HHHHHH
Q 026939          163 LLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      ++....+|.+|..     +.+|.+
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHh
Confidence            8999999999976     555554

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-23  Score=171.63  Aligned_cols=185  Identities=26%  Similarity=0.364  Sum_probs=131.7

Q ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHhHhCC------CCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcccccc
Q 026939            1 MRSVQLDWKRRISIINGIARGLLYLHEDS------RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI   74 (230)
Q Consensus         1 ~~~~~l~~~~~~~i~~qi~~al~~Lh~~~------~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   74 (230)
                      |+...++|....+++..++.||+|||+.-      +.+|+|||||+.|||+..++++.|+|||++..+............
T Consensus       299 L~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~q  378 (534)
T KOG3653|consen  299 LKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQ  378 (534)
T ss_pred             HHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhh
Confidence            35668899999999999999999999854      458999999999999999999999999999988655444444446


Q ss_pred             ccccCccChhhhhcCC-CC-----ccccchhhHHHHHHHHhcCCCCC--------CCcc-c-cccchhhhhHHHHhhhh-
Q 026939           75 VGTYGYMAPEYAMEGL-FS-----VKSDVFSFGVLLLEIISGKKNSG--------FYLS-E-LGQSLLSYTWKLWCEGE-  137 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~-~~-----~~~DiwslG~ll~~ll~g~~p~~--------~~~~-~-~~~~~~~~~~~~~~~~~-  137 (230)
                      +|+.+|||||++.+.. +.     .+.||||+|.++|||++.-.-+.        ..+. + ..+...+..+......+ 
T Consensus       379 VGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~  458 (534)
T KOG3653|consen  379 VGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQ  458 (534)
T ss_pred             hhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhcc
Confidence            8999999999998753 22     36799999999999998644321        1111 0 11111122222111111 


Q ss_pred             hhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      ...+.+....    ......+.+.+..||..|++.|.|+.=+.+++.+..-.
T Consensus       459 RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  459 RPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            1111111111    13345588889999999999999999999999887653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.90  E-value=4.6e-23  Score=162.31  Aligned_cols=155  Identities=28%  Similarity=0.299  Sum_probs=118.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      +++.+++.++.+++.++.+||+.+   ++|+||+|.||+++.++.++++|||.+.......   ......+...|++||.
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~  157 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence            789999999999999999999999   9999999999999999999999999988764332   1112345678999999


Q ss_pred             hhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH--HHHHHHHHHh
Q 026939           86 AMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA--ELLKFIHIGL  163 (230)
Q Consensus        86 ~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~  163 (230)
                      +.+..++.++|+|++|++++++++|..||.......      .         ..+.............  ....+.+++.
T Consensus       158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~---------~~~~~~~~~~~~~~~~~~~~~~~~~~i~  222 (244)
T smart00220      158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------E---------LFKKIGKPKPPFPPPEWKISPEAKDLIR  222 (244)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------H---------HHHHHhccCCCCccccccCCHHHHHHHH
Confidence            988888999999999999999999999975421110      0         0000000000000000  3456889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||..+|++||++.++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHccCCchhccCHHHHhh
Confidence            999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=182.17  Aligned_cols=165  Identities=26%  Similarity=0.342  Sum_probs=138.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.+|.....+.|++||++|+.|||.+.   ++||||..+|||+.....+|+.|||++................-.+.|+|
T Consensus       792 r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwma  868 (1177)
T KOG1025|consen  792 RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMA  868 (1177)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHH
Confidence            457788899999999999999999988   99999999999999999999999999987654333333323344668999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      -|.+....|+.++||||+||.+||++| |..|+..                +...++.++++...+...|+.+...++.+
T Consensus       869 le~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g----------------i~~~eI~dlle~geRLsqPpiCtiDVy~~  932 (1177)
T KOG1025|consen  869 LESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG----------------IPAEEIPDLLEKGERLSQPPICTIDVYMV  932 (1177)
T ss_pred             HHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC----------------CCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence            999999999999999999999999998 8888642                22345666777777778889999999999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      |.+||-.|++.||+++++..++.+.
T Consensus       933 mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  933 MVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             HHHHhccCcccCccHHHHHHHHHHH
Confidence            9999999999999999999888654

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.89  E-value=3e-23  Score=168.88  Aligned_cols=162  Identities=21%  Similarity=0.232  Sum_probs=117.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......+...|++
T Consensus        99 ~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~a  174 (290)
T cd05613          99 RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMA  174 (290)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCC
Confidence            346889999999999999999999999   999999999999999999999999998765332211 1112345778999


Q ss_pred             hhhhhcC--CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~--~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||.+.+.  .++.++|+||||+++|+|++|..||........  ...........           ...++......+.+
T Consensus       175 PE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~~  241 (290)
T cd05613         175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS-----------EPPYPQEMSALAKD  241 (290)
T ss_pred             hhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc-----------CCCCCccCCHHHHH
Confidence            9998753  467899999999999999999999853221111  00111000000           01122334456889


Q ss_pred             HHhhhcCCCCCCCC-----CHHHHHH
Q 026939          161 IGLLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      ++.+||+.||++||     ++.+++.
T Consensus       242 ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         242 IIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            99999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.5e-23  Score=159.19  Aligned_cols=176  Identities=22%  Similarity=0.322  Sum_probs=123.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   80 (230)
                      .++++..++.+++.++.+||.|+|.+.   |+|||+|+.|++++++|.++|+|||+++.+......  ......+-+..|
T Consensus       118 ~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwY  194 (376)
T KOG0669|consen  118 KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWY  194 (376)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeec
Confidence            468999999999999999999999999   999999999999999999999999999876433221  111112336789


Q ss_pred             cChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh-----hhHHHHhhhhhhhhhchh-----hcch
Q 026939           81 MAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS-----YTWKLWCEGEALELMEPV-----LKQS  149 (230)
Q Consensus        81 ~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~  149 (230)
                      .+||.+.+. .|.+..|+|..||++.+|+++.+-+...........+.     .....|.+.+-..+....     ....
T Consensus       195 rppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~  274 (376)
T KOG0669|consen  195 RPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQ  274 (376)
T ss_pred             CCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcch
Confidence            999999875 68999999999999999999998875433222111111     111222222222221111     0000


Q ss_pred             h--------hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 C--------VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +        +..-.....+|+..++..||.+|+++++++.
T Consensus       275 ~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  275 KRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            0        1111225778899999999999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-22  Score=166.22  Aligned_cols=184  Identities=23%  Similarity=0.260  Sum_probs=132.1

Q ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHhHh-----CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC--Cccccc
Q 026939            1 MRSVQLDWKRRISIINGIARGLLYLHE-----DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS--EASTNR   73 (230)
Q Consensus         1 ~~~~~l~~~~~~~i~~qi~~al~~Lh~-----~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~   73 (230)
                      |++..++-+..++++..+++||++||.     +|+..|.|||||+.|||+.+++.+.++|+|++........  ....+.
T Consensus       300 L~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~  379 (513)
T KOG2052|consen  300 LNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNP  379 (513)
T ss_pred             HhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCC
Confidence            456789999999999999999999995     4567899999999999999999999999999987654422  122334


Q ss_pred             cccccCccChhhhhcCC------CCccccchhhHHHHHHHHhc----------CCCCCCCccccccchhhhhHHHHhhhh
Q 026939           74 IVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISG----------KKNSGFYLSELGQSLLSYTWKLWCEGE  137 (230)
Q Consensus        74 ~~~~~~~~aPe~~~~~~------~~~~~DiwslG~ll~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~  137 (230)
                      .+|+.+|||||++...-      --..+||||||+++||+...          +.||...-+.  +...+...+...-.+
T Consensus       380 rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~--DPs~eeMrkVVCv~~  457 (513)
T KOG2052|consen  380 RVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS--DPSFEEMRKVVCVQK  457 (513)
T ss_pred             ccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC--CCCHHHHhcceeecc
Confidence            58899999999997532      12578999999999999753          2344322211  111122222222211


Q ss_pred             hhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      ....+...   =...+....+.+||+.||..+|+.|-|+--|.+.|.+....
T Consensus       458 ~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  458 LRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             cCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            11111111   12346778899999999999999999999999999887653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.88  E-value=9.3e-24  Score=163.33  Aligned_cols=165  Identities=25%  Similarity=0.322  Sum_probs=121.3

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++..+++...-+|....+.||.||-..-  .|+|||+||+|||++..|.+||+|||.+......-...   .-.|-..|+
T Consensus       160 q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT---~daGCrpYm  234 (361)
T KOG1006|consen  160 QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT---VDAGCRPYM  234 (361)
T ss_pred             HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh---hccCCcccc
Confidence            3567888888888888999999997643  59999999999999999999999999987653322111   124556899


Q ss_pred             Chhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           82 APEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        82 aPe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |||.+..  ..|+.++|+||||+.++|+.||..|+..|.....+      ......++...+.....    ..+....+.
T Consensus       235 APERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq------l~~Vv~gdpp~l~~~~~----~~~~s~~~~  304 (361)
T KOG1006|consen  235 APERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ------LCQVVIGDPPILLFDKE----CVHYSFSMV  304 (361)
T ss_pred             ChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH------HHHHHcCCCCeecCccc----ccccCHHHH
Confidence            9999874  35899999999999999999999998766542111      11122222222222111    122345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .++..|+..|-..||.+.++.+
T Consensus       305 ~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  305 RFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHHhhcccccCcchhhhhc
Confidence            8999999999999999999876

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=8.9e-22  Score=176.56  Aligned_cols=185  Identities=20%  Similarity=0.198  Sum_probs=130.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      ++++.-+..++..|+.||.-||+.|   +|||||||+|||++..|.++|+|||.|..+...+.- .....+|+|-|.+||
T Consensus       171 ~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPE  246 (1317)
T KOG0612|consen  171 RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPE  246 (1317)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHH
Confidence            5899999999999999999999999   999999999999999999999999999877533321 122348899999999


Q ss_pred             hhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           85 YAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        85 ~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      +++.     +.|...+|.||+||++|||+.|.-||....-...     + .++..+.+...+.+       ....+....
T Consensus       247 vLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT-----Y-~KIm~hk~~l~FP~-------~~~VSeeak  313 (1317)
T KOG0612|consen  247 VLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET-----Y-GKIMNHKESLSFPD-------ETDVSEEAK  313 (1317)
T ss_pred             HHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH-----H-HHHhchhhhcCCCc-------ccccCHHHH
Confidence            9983     4588999999999999999999999853211100     0 11111111222111       133455566


Q ss_pred             HHHhhhcCCCCCCCCC---HHHHHH--HhhcCCCCCCCCCCCCCccCccCCCC
Q 026939          160 HIGLLCVQADSADRPT---MSSVVV--MLASDNVTLPQPTEPAFSVGRNVARP  207 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs---~~~i~~--~L~~~~~~~~~~~~p~~~~~~~~~~~  207 (230)
                      +||+..+. +|+.|..   +++|..  ++.+..+.--.-..|+|.+.-+++.|
T Consensus       314 dLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~D  365 (1317)
T KOG0612|consen  314 DLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDD  365 (1317)
T ss_pred             HHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCc
Confidence            77776554 6889988   888876  55666554222344455555444443

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-22  Score=160.68  Aligned_cols=150  Identities=24%  Similarity=0.234  Sum_probs=115.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .+.+++.+...+-..|+.||.|||+.+   ||+||+|.+|.+++++|.+|+.|||+|...-.  .......+.|++.|+|
T Consensus       262 er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLA  336 (516)
T KOG0690|consen  262 ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLA  336 (516)
T ss_pred             hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc--ccceeccccCChhhcC
Confidence            456788888899999999999999999   99999999999999999999999999964311  1222334678999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++....|..++|.|.+||++|||++|..||......                ++..++-- -.-.+|.....+...|+
T Consensus       337 PEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----------------kLFeLIl~-ed~kFPr~ls~eAktLL  399 (516)
T KOG0690|consen  337 PEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----------------KLFELILM-EDLKFPRTLSPEAKTLL  399 (516)
T ss_pred             chhhccccccceeehhhhhHHHHHHHhccCcccccchh----------------HHHHHHHh-hhccCCccCCHHHHHHH
Confidence            99999999999999999999999999999998532211                11111000 00123444445567778


Q ss_pred             hhhcCCCCCCCC
Q 026939          163 LLCVQADSADRP  174 (230)
Q Consensus       163 ~~cl~~dP~~RP  174 (230)
                      ...|..||.+|.
T Consensus       400 sGLL~kdP~kRL  411 (516)
T KOG0690|consen  400 SGLLKKDPKKRL  411 (516)
T ss_pred             HHHhhcChHhhc
Confidence            889999999995

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=157.61  Aligned_cols=177  Identities=23%  Similarity=0.291  Sum_probs=125.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      -+.|+...+.-+++||+.||+|||+.+   |+||||||.|.+++.|-.+|++|||+++............. +-+-.|.|
T Consensus       150 PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqE-VVTQYYRA  225 (449)
T KOG0664|consen  150 PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHE-VVTQYYRA  225 (449)
T ss_pred             CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHH-HHHHHhcc
Confidence            467888899999999999999999999   99999999999999999999999999987654333322222 22568999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhchhhcc-----
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEPVLKQ-----  148 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----  148 (230)
                      ||++++. .|+.+.||||.||++.||+...--|....+......+..        ..+.-+++....++....+.     
T Consensus       226 PEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v  305 (449)
T KOG0664|consen  226 PELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR  305 (449)
T ss_pred             HHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc
Confidence            9999986 599999999999999999987777765444433222211        01111222222222222221     


Q ss_pred             ----hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHh
Q 026939          149 ----SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       149 ----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                          ..+...-..-+.+++.++..||++|.+-.+.+..+
T Consensus       306 LYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  306 LYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             eeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                11122334466777889999999999999888755

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.86  E-value=3.2e-22  Score=169.79  Aligned_cols=154  Identities=25%  Similarity=0.313  Sum_probs=122.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.+.....+..++.|+++|++|||+++   |+|||||++|++++.+.++||+|||++.++....   ......|++.|.|
T Consensus       149 ~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAa  222 (596)
T KOG0586|consen  149 HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAA  222 (596)
T ss_pred             cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc---cccccCCCCCccC
Confidence            445666889999999999999999999   9999999999999999999999999999886432   2333578899999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcc--hhhHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ--SCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  159 (230)
                      ||++.+..| .+.+|+|++|+++|.|+.|..||....-.                   .+-++.+..  ..+.....++.
T Consensus       223 PEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~rvl~gk~rIp~~ms~dce  283 (596)
T KOG0586|consen  223 PELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPRVLRGKYRIPFYMSCDCE  283 (596)
T ss_pred             hHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccchheeeeecccceeechhH
Confidence            999998876 48999999999999999999998632211                   111111111  12333344588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++++++-.+|.+|+++++|.+
T Consensus       284 ~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  284 DLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             HHHHHhhccCccccCCHHHhhh
Confidence            8999999999999999999986

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.86  E-value=4.9e-22  Score=148.78  Aligned_cols=113  Identities=27%  Similarity=0.367  Sum_probs=94.9

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++..+++...=+++..++.||.|||++-  .++|||+||+|||++..|.+|++|||.+....+......   -.|-..|+
T Consensus       141 ~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~---daGCkpYm  215 (282)
T KOG0984|consen  141 KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM---DAGCKPYM  215 (282)
T ss_pred             cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH---hcCCCccC
Confidence            4667889999999999999999999964  599999999999999999999999999987654432221   13456799


Q ss_pred             Chhhhhc----CCCCccccchhhHHHHHHHHhcCCCCCCCcc
Q 026939           82 APEYAME----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLS  119 (230)
Q Consensus        82 aPe~~~~----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~  119 (230)
                      |||.+..    ..|+.++||||||+.+.||.++..||..+..
T Consensus       216 aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  216 APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            9999863    3689999999999999999999999876543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.6e-21  Score=154.50  Aligned_cols=196  Identities=24%  Similarity=0.324  Sum_probs=136.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .+.|+++.+..+...|+.||.|||+.|   |++||+|.+|++++..|.+||.|||.+..--..  ......+.|++.|.|
T Consensus       345 qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyia  419 (593)
T KOG0695|consen  345 QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIA  419 (593)
T ss_pred             hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccc
Confidence            458999999999999999999999999   999999999999999999999999998653222  223334688999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccc-ccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL-GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..|...+|.|+|||+++||+.|..||..-...+ ..+..++..+.+....+          ..|...+.+...+
T Consensus       420 peilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----------riprslsvkas~v  489 (593)
T KOG0695|consen  420 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----------RIPRSLSVKASHV  489 (593)
T ss_pred             hhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----------cccceeehhhHHH
Confidence            999999999999999999999999999999996432222 22222233232222211          1233344455667


Q ss_pred             HhhhcCCCCCCCCC------HHHHHH--Hhhc------CCCCCCCCCCCCCccCccCCC-CCCCCCC
Q 026939          162 GLLCVQADSADRPT------MSSVVV--MLAS------DNVTLPQPTEPAFSVGRNVAR-PSQFSSG  213 (230)
Q Consensus       162 ~~~cl~~dP~~RPs------~~~i~~--~L~~------~~~~~~~~~~p~~~~~~~~~~-~~~~~~~  213 (230)
                      +..-|+.||.+|..      ++++.+  +++.      +..++.+|-.|++....-+.- ++++-.+
T Consensus       490 lkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e  556 (593)
T KOG0695|consen  490 LKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSE  556 (593)
T ss_pred             HHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccC
Confidence            77788999998853      233321  1221      122334567777776655532 3344433

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-21  Score=159.64  Aligned_cols=149  Identities=28%  Similarity=0.304  Sum_probs=119.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+.+..+..++..|+.||-+||++|   |++||||.+|||++..|.+||+|||++..--.  ...+.....|++.|.|||
T Consensus       446 kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~--~~~TTkTFCGTPdYiAPE  520 (683)
T KOG0696|consen  446 KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF--DGVTTKTFCGTPDYIAPE  520 (683)
T ss_pred             ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc--CCcceeeecCCCcccccc
Confidence            5667888999999999999999999   99999999999999999999999999864211  122233467899999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      ++...+|...+|.||+||++|||+.|++||....+...               ...+.+.  .-.||...+.+.+.++..
T Consensus       521 Ii~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---------------F~aI~eh--nvsyPKslSkEAv~ickg  583 (683)
T KOG0696|consen  521 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---------------FQAIMEH--NVSYPKSLSKEAVAICKG  583 (683)
T ss_pred             eEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHHHHc--cCcCcccccHHHHHHHHH
Confidence            99999999999999999999999999999965432211               0011111  225667777788888899


Q ss_pred             hcCCCCCCCCC
Q 026939          165 CVQADSADRPT  175 (230)
Q Consensus       165 cl~~dP~~RPs  175 (230)
                      .|...|.+|..
T Consensus       584 ~ltK~P~kRLG  594 (683)
T KOG0696|consen  584 LLTKHPGKRLG  594 (683)
T ss_pred             HhhcCCccccC
Confidence            99999999853

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.85  E-value=5e-22  Score=173.50  Aligned_cols=153  Identities=29%  Similarity=0.437  Sum_probs=113.6

Q ss_pred             HHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---C--CCeEEcccccceeecCCCCC-ccccccccccCccCh
Q 026939           10 RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---E--MNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMAP   83 (230)
Q Consensus        10 ~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~--~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aP   83 (230)
                      ..+.++.|+++||++||+-+   |+||||||.|||++.   +  ..++|+|||++......... .......|+..|.||
T Consensus       607 ~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  607 DPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             cHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCH
Confidence            35778999999999999999   999999999999976   3  45799999999887544332 222344678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhc-CCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISG-KKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+....-+.++||||+||++|..++| .+||+.....+..        +.........+.+      ..++  ...+||
T Consensus       684 E~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il~~~~~L~~L~~------~~d~--eA~dLI  747 (903)
T KOG1027|consen  684 EQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------ILTGNYTLVHLEP------LPDC--EAKDLI  747 (903)
T ss_pred             HHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hhcCccceeeecc------CchH--HHHHHH
Confidence            999988888899999999999998885 8999854322211        1111111111111      1111  577899


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+|+..+|..||++.+|+.
T Consensus       748 ~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  748 SRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHhcCCCcccCCCHHHHhC
Confidence            9999999999999999863

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-21  Score=153.99  Aligned_cols=171  Identities=22%  Similarity=0.203  Sum_probs=117.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++-.+...+++|++.|++|||+.|   |+||||||+||++..+..+|+.|||++...+..   .....++.+..|.|||
T Consensus       114 elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrape  187 (369)
T KOG0665|consen  114 ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPE  187 (369)
T ss_pred             hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCch
Confidence            4566788999999999999999999   999999999999999999999999999865432   1111134467899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccc---------ccchhhhhHHHHh-------hhhhh--hhhchhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL---------GQSLLSYTWKLWC-------EGEAL--ELMEPVL  146 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~---------~~~~~~~~~~~~~-------~~~~~--~~~~~~~  146 (230)
                      ++.+-.+.+.+||||+||++.||++|..-|......+         +.....+..+...       +.+-+  -...+.+
T Consensus       188 vil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~f  267 (369)
T KOG0665|consen  188 VILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELF  267 (369)
T ss_pred             heeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhC
Confidence            9999899999999999999999999987664211110         0000000000000       00000  0000000


Q ss_pred             cc-------hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          147 KQ-------SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       147 ~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..       ....-......+++.+||..||++|-+++++++
T Consensus       268 pD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  268 PDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            00       001122334677899999999999999999987

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.84  E-value=8.9e-21  Score=150.35  Aligned_cols=174  Identities=21%  Similarity=0.210  Sum_probs=117.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC---eEEcccccceeecCCCCC-----cccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN---PKISDFEMARIFGGNQSE-----ASTNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~-----~~~~~~   74 (230)
                      ++-+++.++..+.++|+.||.|||.+|   |.|||+||+|||-.....   +||+||.+.-........     ...-..
T Consensus       170 ~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tP  246 (463)
T KOG0607|consen  170 RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTP  246 (463)
T ss_pred             hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCc
Confidence            456788999999999999999999999   999999999999865543   799999876433211111     111223


Q ss_pred             ccccCccChhhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcch
Q 026939           75 VGTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS  149 (230)
Q Consensus        75 ~~~~~~~aPe~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (230)
                      .|+..|||||+..-     ..|+.+.|.||||+++|.|++|++||......+.-=.... -...++..+..-+..... .
T Consensus       247 vGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe-~Cr~CQ~~LFesIQEGkY-e  324 (463)
T KOG0607|consen  247 VGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE-VCRVCQNKLFESIQEGKY-E  324 (463)
T ss_pred             ccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC-ccHHHHHHHHHHHhccCC-c
Confidence            67789999998762     2488999999999999999999999955443221000000 001112222222222211 1


Q ss_pred             hhH----HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          150 CVA----AELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       150 ~~~----~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ||.    ..+....+++...+..|+.+|-++..+++
T Consensus       325 FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  325 FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            222    22344667888889999999999999886

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.83  E-value=2.1e-21  Score=162.66  Aligned_cols=111  Identities=32%  Similarity=0.410  Sum_probs=96.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC---CCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +.+|+++.-..++.||+.||+|||.++   |+|+|+||+||++...   -.+||+|||+++..+...   .....+|++.
T Consensus       658 kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPA  731 (888)
T KOG4236|consen  658 KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPA  731 (888)
T ss_pred             cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCcc
Confidence            357888899999999999999999999   9999999999999765   358999999999876432   2233588999


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcc
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS  119 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~  119 (230)
                      |+|||++++..|...-|+||.||++|.-++|..||....+
T Consensus       732 YLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd  771 (888)
T KOG4236|consen  732 YLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED  771 (888)
T ss_pred             ccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence            9999999999999999999999999999999999965443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.83  E-value=8.8e-21  Score=147.36  Aligned_cols=187  Identities=18%  Similarity=0.224  Sum_probs=125.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC--CCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .+-+.-..+++.|+++|+.|||+++   +||||||.+|||+-.  ...+||+|||+....+.....     ......|.+
T Consensus       117 GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~  188 (378)
T KOG1345|consen  117 GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHA  188 (378)
T ss_pred             cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceehh-----hhhhcccCC
Confidence            4556778899999999999999999   999999999999842  247999999998765432111     222457899


Q ss_pred             hhhhhcC-----CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAMEG-----LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~~~-----~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||.....     ...+.+|+|.||+++|..++|..||......+   ..-+.|..|..+......+...      ....+
T Consensus       189 pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~~~~P~~F~------~fs~~  259 (378)
T KOG1345|consen  189 PELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKNPALPKKFN------PFSEK  259 (378)
T ss_pred             cHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccCccCchhhc------ccCHH
Confidence            9987643     24678999999999999999999997433332   2334455565555554333211      12334


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCC--CCCCCCCCCccCccCCCCC
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVVMLASDNVT--LPQPTEPAFSVGRNVARPS  208 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~--~~~~~~p~~~~~~~~~~~~  208 (230)
                      +..+.++-|..+++.|--..++.+........  +-+.++|...+-.|.+.++
T Consensus       260 a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~S  312 (378)
T KOG1345|consen  260 ALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTAS  312 (378)
T ss_pred             HHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCcc
Confidence            77788889999999996655555544222111  2233444455555555444

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.83  E-value=6e-20  Score=158.93  Aligned_cols=165  Identities=17%  Similarity=0.124  Sum_probs=109.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++......... .......++.|++||
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE  380 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence            4678889999999999999999999   999999999999999999999999998654322111 111123367899999


Q ss_pred             hhhcCC----------------------CCccccchhhHHHHHHHHhcCC-CCCCCcccccc----chhhhhHHHHhhhh
Q 026939           85 YAMEGL----------------------FSVKSDVFSFGVLLLEIISGKK-NSGFYLSELGQ----SLLSYTWKLWCEGE  137 (230)
Q Consensus        85 ~~~~~~----------------------~~~~~DiwslG~ll~~ll~g~~-p~~~~~~~~~~----~~~~~~~~~~~~~~  137 (230)
                      .+....                      .....|+||+||++++|++|.. |+.........    ......|...... 
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~-  459 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ-  459 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc-
Confidence            875322                      1134699999999999999875 54321100000    0000001111000 


Q ss_pred             hhhhhchhhcchhhHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHH
Q 026939          138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADS---ADRPTMSSVVV  181 (230)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~~i~~  181 (230)
                             ...-...........+++.+||..+|   .+|+|+.++++
T Consensus       460 -------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 -------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                   01111122345668889999999766   68999999975

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.82  E-value=4.5e-20  Score=166.12  Aligned_cols=54  Identities=37%  Similarity=0.585  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccce
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      ..+++..++.++.||+.||+|||..+   |+|+||+|+|||++.++.++|+|||++.
T Consensus        99 ~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          99 GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            45788999999999999999999999   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=5.3e-20  Score=157.18  Aligned_cols=118  Identities=25%  Similarity=0.330  Sum_probs=97.4

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-------------
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-------------   68 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------   68 (230)
                      |-.-+++..+..++..+.+|+++.|..|   +|||||||+|||||.+|.+||.|||||.-+......             
T Consensus       722 rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDS  798 (1034)
T KOG0608|consen  722 RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDS  798 (1034)
T ss_pred             HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCcccccc
Confidence            3456788889999999999999999999   999999999999999999999999999754211000             


Q ss_pred             ---------------------------ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccc
Q 026939           69 ---------------------------ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL  121 (230)
Q Consensus        69 ---------------------------~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~  121 (230)
                                                 ......+|+..|+|||++....|+..+|.|+.||++|+|+.|+.||-...+..
T Consensus       799 mep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  799 MEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             CCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence                                       00112367889999999999999999999999999999999999996555444


Q ss_pred             c
Q 026939          122 G  122 (230)
Q Consensus       122 ~  122 (230)
                      .
T Consensus       879 t  879 (1034)
T KOG0608|consen  879 T  879 (1034)
T ss_pred             c
Confidence            3

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=1.6e-19  Score=138.63  Aligned_cols=125  Identities=36%  Similarity=0.589  Sum_probs=107.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++...++.++.+++.++.+||+.+   ++|+||++.||+++. ++.++|+||+.+........  ......+...|.+|
T Consensus        88 ~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p  162 (215)
T cd00180          88 KLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAP  162 (215)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccCh
Confidence            6889999999999999999999999   999999999999998 88999999999877643321  11113446789999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |..... ..+.+.|+|++|++++++                                                ..+.+++
T Consensus       163 e~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~~~l  194 (215)
T cd00180         163 EVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PELKDLI  194 (215)
T ss_pred             hHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHHHHHH
Confidence            998876 788999999999999998                                                4588899


Q ss_pred             hhhcCCCCCCCCCHHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~  182 (230)
                      ..|++.+|++||++.++++.
T Consensus       195 ~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         195 RKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHhhCCcccCcCHHHHhhC
Confidence            99999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=156.89  Aligned_cols=172  Identities=20%  Similarity=0.275  Sum_probs=120.0

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC--CCCC--eEEcccccceeecCCCCCccccccccc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMN--PKISDFEMARIFGGNQSEASTNRIVGT   77 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~--~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~   77 (230)
                      +...|++.+.+.++.++..||.|||.+|   |+||||||.||++.  .+|.  .||+|||.++......   .-...+|+
T Consensus       113 N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT  186 (732)
T KOG4250|consen  113 NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGT  186 (732)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCc
Confidence            3457999999999999999999999999   99999999999884  3343  5999999998765433   22336889


Q ss_pred             cCccChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhh--chhh--------
Q 026939           78 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELM--EPVL--------  146 (230)
Q Consensus        78 ~~~~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--------  146 (230)
                      ..|++||.+.. ..|+..+|.|||||++|+..||..||-....  .+.+.+..+...........+  .+..        
T Consensus       187 ~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~--pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~  264 (732)
T KOG4250|consen  187 EEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG--PKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSS  264 (732)
T ss_pred             hhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC--ccccchhhhhhhccCCCceeEeeecccCCceeeec
Confidence            99999999984 7899999999999999999999999843221  122233333333222111111  0000        


Q ss_pred             ----cchhhHHHHHHHHHHHhhhcCCCCCCCC--CHHHHHH
Q 026939          147 ----KQSCVAAELLKFIHIGLLCVQADSADRP--TMSSVVV  181 (230)
Q Consensus       147 ----~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~~i~~  181 (230)
                          ...........+...+..+|..+|.+|-  .+.+..-
T Consensus       265 ~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa  305 (732)
T KOG4250|consen  265 TLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFA  305 (732)
T ss_pred             cCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHH
Confidence                0112234445566677778888888888  4444333

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.81  E-value=3.7e-20  Score=136.19  Aligned_cols=173  Identities=20%  Similarity=0.171  Sum_probs=119.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..++...+.+++.|++.||.++|+.+   ++|||+||.|.+++.+|.+||+|||+++.++........  .+-+..|.+|
T Consensus        96 g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcysa--evvtlwyrpp  170 (292)
T KOG0662|consen   96 GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA--EVVTLWYRPP  170 (292)
T ss_pred             CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec--eeeeeeccCc
Confidence            46788999999999999999999999   999999999999999999999999999988754433222  2336789999


Q ss_pred             hhhhcCC-CCccccchhhHHHHHHHHhcCCC-CCCCccccccchhhhhHHHHhhh---hhhhhhchhhcchhh-------
Q 026939           84 EYAMEGL-FSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYTWKLWCEG---EALELMEPVLKQSCV-------  151 (230)
Q Consensus        84 e~~~~~~-~~~~~DiwslG~ll~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-------  151 (230)
                      .++-+.+ |+...|+||.||++.|+.....| |......+..-.+.+......+.   .+.++.+-...+.++       
T Consensus       171 dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsq  250 (292)
T KOG0662|consen  171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQ  250 (292)
T ss_pred             ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHH
Confidence            9998775 78889999999999999985555 44332221111111100000000   112222222222222       


Q ss_pred             --HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          152 --AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       152 --~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        +.....=.++++..+.-+|..|.++++.++
T Consensus       251 ivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  251 IVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             HhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence              122223456778888999999999998875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.81  E-value=8.3e-20  Score=160.44  Aligned_cols=161  Identities=26%  Similarity=0.347  Sum_probs=127.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++.++.+..+.-|++.++.|+.+||.+.   ++||||+-.||+++.+|.+||.|||++...+....  ......|+++||
T Consensus       116 ~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WM  190 (953)
T KOG0587|consen  116 KGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWM  190 (953)
T ss_pred             cccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecccc--cccCcCCCcccc
Confidence            4678899999999999999999999998   99999999999999999999999999876643322  222357899999


Q ss_pred             Chhhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           82 APEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        82 aPe~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      |||++.-     ..|+..+|+||||++..||-.|.+|+....+......            +.....+  ..-.+..+.+
T Consensus       191 APEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------------IpRNPPP--kLkrp~kWs~  256 (953)
T KOG0587|consen  191 APEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------IPRNPPP--KLKRPKKWSK  256 (953)
T ss_pred             cceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------------CCCCCCc--cccchhhHHH
Confidence            9999873     2478899999999999999999999754332211110            1111111  1123678899


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +|.+++..||..|-++||+..++++
T Consensus       257 ~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  257 KFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             HHHHHHHHHHhhccccCcchhhhcc
Confidence            9999999999999999999998875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.80  E-value=3e-20  Score=155.48  Aligned_cols=106  Identities=25%  Similarity=0.299  Sum_probs=89.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..|....+..++.|+..||..|-.-|   ++|.||||+|||++.. ..+||+|||.+.+.......+    ++-+..|.
T Consensus       530 nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYR  602 (752)
T KOG0670|consen  530 NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYR  602 (752)
T ss_pred             ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccccH----HHHHHhcc
Confidence            456777889999999999999999988   9999999999999865 457999999998765433221    12256899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCC
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSG  115 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~  115 (230)
                      |||++.+..|+...|+||.||++|||.||+--|.
T Consensus       603 aPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  603 APEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             CcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            9999999999999999999999999999987664

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=4.5e-19  Score=146.23  Aligned_cols=166  Identities=29%  Similarity=0.351  Sum_probs=118.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC---CCCCeEEcccccceeecCCCCCcc-----cccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEAS-----TNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~-----~~~~   74 (230)
                      ++-+++.++.+|+.||+.||.||.... .||+|.||||.|||+.   .-|.+|+.|||++..+........     ....
T Consensus       562 hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQg  640 (775)
T KOG1151|consen  562 HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQG  640 (775)
T ss_pred             hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeeccc
Confidence            456788999999999999999999884 6799999999999985   347899999999987754332211     2234


Q ss_pred             ccccCccChhhhhcC----CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchh
Q 026939           75 VGTYGYMAPEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC  150 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~----~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (230)
                      .|+.+|++||.+.-+    +.+.++||||+||++|..+.|..||+.......         ......+.+.-+-.+  ..
T Consensus       641 AGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---------ILqeNTIlkAtEVqF--P~  709 (775)
T KOG1151|consen  641 AGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---------ILQENTILKATEVQF--PP  709 (775)
T ss_pred             CceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---------HHhhhchhcceeccC--CC
Confidence            678899999988744    478899999999999999999999986543221         111111111111100  00


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVV  180 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~  180 (230)
                      -+.......+++++||++.-+.|....++.
T Consensus       710 KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  710 KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            122333467788999999999988766553

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.78  E-value=1.2e-18  Score=132.69  Aligned_cols=169  Identities=18%  Similarity=0.230  Sum_probs=114.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      |+.-.+.-.+.+++.||.|+|++|   |.|||+||.|++++.. -.++|+|+|++.+.........   .+.+..|--||
T Consensus       129 l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPE  202 (338)
T KOG0668|consen  129 LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPE  202 (338)
T ss_pred             hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCceeee---eeehhhcCCch
Confidence            444566778999999999999999   9999999999999954 5699999999998755443322   24456778899


Q ss_pred             hhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH--------------HHHhhhhhhhhhchhhcc-
Q 026939           85 YAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW--------------KLWCEGEALELMEPVLKQ-  148 (230)
Q Consensus        85 ~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~-  148 (230)
                      ++... .|+...|+|||||++..|+..+.||-...++ .+++...+.              .....+....++....+. 
T Consensus       203 LLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~  281 (338)
T KOG0668|consen  203 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKP  281 (338)
T ss_pred             heeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccccc
Confidence            88764 5888999999999999999999998432222 222221110              011111111211111110 


Q ss_pred             --hhhH-----HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 --SCVA-----AELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 --~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        .+..     -...+..+++...|.+|-.+|+|+.|.+.
T Consensus       282 w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  282 WSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence              0000     01245778889999999999999998764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=9.9e-19  Score=145.29  Aligned_cols=105  Identities=19%  Similarity=0.225  Sum_probs=70.4

Q ss_pred             ccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccc----ccchhh-------hhHHHHhhhh-hhhhhch
Q 026939           77 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL----GQSLLS-------YTWKLWCEGE-ALELMEP  144 (230)
Q Consensus        77 ~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~----~~~~~~-------~~~~~~~~~~-~~~~~~~  144 (230)
                      +..|.+||++.+..|...+||||++|++|||.||...|....-..    .+.+..       ..+.....++ ..+++.+
T Consensus       414 TRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr  493 (590)
T KOG1290|consen  414 TRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNR  493 (590)
T ss_pred             hhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhcc
Confidence            446999999999999999999999999999999998874322111    111111       1111111111 0111100


Q ss_pred             -----------------hhc--chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          145 -----------------VLK--QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       145 -----------------~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                                       .+.  =.++.++..+|.+++.-||+.+|++||||.+.++
T Consensus       494 ~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  494 RGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             ccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence                             000  1346788999999999999999999999999885

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2.5e-19  Score=158.09  Aligned_cols=166  Identities=22%  Similarity=0.227  Sum_probs=125.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGYMA   82 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~a   82 (230)
                      .+....+--+++|++.|++|||+.|   +.|||+|++|+++..+|.+|++|||.+..+......  .......|+..|+|
T Consensus       416 ~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~a  492 (601)
T KOG0590|consen  416 KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLA  492 (601)
T ss_pred             ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcC
Confidence            6777888899999999999999999   999999999999999999999999999877554333  44556788999999


Q ss_pred             hhhhhcCCCCc-cccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSV-KSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~-~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..|.+ ..||||.|+++..|.+|+.||.............       ........... ........++....+
T Consensus       493 pE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~lp~~~~~~  564 (601)
T KOG0590|consen  493 PEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSDQRNIFEG-PNRLLSLLPRETRII  564 (601)
T ss_pred             cccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------ccccccccccC-hHHHHHhchhhHHHH
Confidence            99999988875 5699999999999999999986544332221000       00000000000 011223444557788


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      |.+||+.||.+|.|+++|++
T Consensus       565 ~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  565 IYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHccCChhheecHHHHhh
Confidence            89999999999999999986

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.72  E-value=6.9e-18  Score=135.36  Aligned_cols=139  Identities=20%  Similarity=0.257  Sum_probs=96.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      +....++.+..|++..+++||+.|   ++|+||+++|++++.+|.+.|+||+.....+.....     ......|.+||.
T Consensus       142 l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~  213 (288)
T PF14531_consen  142 LAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPEL  213 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhh
Confidence            345567788899999999999999   999999999999999999999999887765432211     122467899998


Q ss_pred             hhcC--------CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           86 AMEG--------LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        86 ~~~~--------~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ....        .++.+.|.|+||+++|.|+++..||+...+......                    .-..|. +.++.
T Consensus       214 ~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~  272 (288)
T PF14531_consen  214 ESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEP  272 (288)
T ss_dssp             HHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------------------GGTTSS----HH
T ss_pred             hhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------------------cchhcC-CcCHH
Confidence            7542        478899999999999999999999975443322111                    112344 66677


Q ss_pred             HHHHHhhhcCCCCCCC
Q 026939          158 FIHIGLLCVQADSADR  173 (230)
Q Consensus       158 l~~l~~~cl~~dP~~R  173 (230)
                      +..|+..+|++||.+|
T Consensus       273 v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  273 VQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHccCCcccC
Confidence            8999999999999988

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.1e-17  Score=130.61  Aligned_cols=157  Identities=19%  Similarity=0.253  Sum_probs=121.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEc--ccccceeecCCCCCccccccccccCccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKIS--DFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .++-.++.+++.+++.|++|||+.... |.-.-+++.+++++.+.+.++.  |-.++...         ......+.|++
T Consensus       285 vvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfqe---------~gr~y~pawms  354 (448)
T KOG0195|consen  285 VVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQE---------VGRAYSPAWMS  354 (448)
T ss_pred             EEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeeec---------cccccCcccCC
Confidence            467789999999999999999998633 5556789999999998776654  43332211         11133678999


Q ss_pred             hhhhhcCC---CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~~~---~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.++..+   ..+++|+|||++++|||.|...||....+...               ..++.-..++...|+..+..+.
T Consensus       355 pealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialeglrv~ippgis~hm~  419 (448)
T KOG0195|consen  355 PEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEGLRVHIPPGISRHMN  419 (448)
T ss_pred             HHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhccccccCCCCccHHHH
Confidence            99998654   44789999999999999999999987655433               2334445566667778888899


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ++|.-|+..||.+||.++.|+-.|+..
T Consensus       420 klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            999999999999999999999998753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.71  E-value=5.3e-18  Score=143.58  Aligned_cols=106  Identities=27%  Similarity=0.399  Sum_probs=92.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      .+.++++..+..|++|++.|+++||++|   |+|||||-+|+.++.+|-+||+|||.+.......-    +.+.|+..|.
T Consensus       663 ~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf----d~f~gtv~~a  735 (772)
T KOG1152|consen  663 FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYA  735 (772)
T ss_pred             ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCCc----ceeeeecccc
Confidence            3568899999999999999999999999   99999999999999999999999999876543322    2357899999


Q ss_pred             ChhhhhcCCCCc-cccchhhHHHHHHHHhcCCCC
Q 026939           82 APEYAMEGLFSV-KSDVFSFGVLLLEIISGKKNS  114 (230)
Q Consensus        82 aPe~~~~~~~~~-~~DiwslG~ll~~ll~g~~p~  114 (230)
                      |||++.+.+|-- .-|||+||+++|.++....||
T Consensus       736 apevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  736 APEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             chhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999999888754 459999999999998877775

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.70  E-value=3.2e-17  Score=134.06  Aligned_cols=109  Identities=27%  Similarity=0.404  Sum_probs=86.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecC--------------C-C--
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGG--------------N-Q--   66 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~--------------~-~--   66 (230)
                      .++..++..+++.++.||+++|.+|   |+||||||.|++++.. +.-.|.|||++.....              . .  
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~  204 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAM  204 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccc
Confidence            5678899999999999999999999   9999999999999854 5678999999872100              0 0  


Q ss_pred             -------------------------CCccccccccccCccChhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCC
Q 026939           67 -------------------------SEASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGF  116 (230)
Q Consensus        67 -------------------------~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~  116 (230)
                                               .........|+++|.|||++...+ .+.+.||||.||++..++++..||-.
T Consensus       205 g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  205 GKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             cCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccccc
Confidence                                     000001124678899999998654 67889999999999999999999843

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.67  E-value=2.5e-16  Score=122.74  Aligned_cols=106  Identities=31%  Similarity=0.442  Sum_probs=90.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      +++..++.++.+++.++.+||+.+   ++|+|+++.||+++.++.++|+|||.+......... ......+...|++||.
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~  170 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEV  170 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhH
Confidence            788999999999999999999998   999999999999999999999999998876443200 1122345678999999


Q ss_pred             h-hcCCCCccccchhhHHHHHHHHhcCCCCC
Q 026939           86 A-MEGLFSVKSDVFSFGVLLLEIISGKKNSG  115 (230)
Q Consensus        86 ~-~~~~~~~~~DiwslG~ll~~ll~g~~p~~  115 (230)
                      + ....++.++|+|+||+++++|++|..||.
T Consensus       171 ~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      171 LLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             hcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            8 56677889999999999999999999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.66  E-value=1.1e-15  Score=126.66  Aligned_cols=171  Identities=20%  Similarity=0.181  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-----CeEEcccccceeec--CCC------CCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-----NPKISDFEMARIFG--GNQ------SEAS   70 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-----~~~l~d~~~~~~~~--~~~------~~~~   70 (230)
                      +.++..+++.++.|++.+|++||+.|   ++||||||.|+++....     .+.|.|||+++.+.  ...      ....
T Consensus       117 ~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~  193 (322)
T KOG1164|consen  117 GRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQ  193 (322)
T ss_pred             CCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCC
Confidence            67899999999999999999999999   99999999999998653     58999999998322  111      1111


Q ss_pred             ccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchh
Q 026939           71 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC  150 (230)
Q Consensus        71 ~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (230)
                      .....|+..|+++....+...+++.|+||++.++.+++.|..||............       ...........     +
T Consensus       194 ~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~-------~~~~~~~~~~~-----~  261 (322)
T KOG1164|consen  194 KGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF-------EKDPRKLLTDR-----F  261 (322)
T ss_pred             ccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH-------HHHhhhhcccc-----c
Confidence            22345889999999999999999999999999999999999887433221110000       00000000000     1


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      .......+.+++..+-..+...+|....+...|++....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  262 GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            111223355555555568999999999999988665444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.65  E-value=5.9e-16  Score=131.81  Aligned_cols=177  Identities=22%  Similarity=0.330  Sum_probs=123.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCe-eecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRI-IHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i-~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++.+...+.++|+.||+|||..-   | .|+.+++.|++++.+-.+|+.|||+....................-|.
T Consensus        42 ~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~  118 (484)
T KOG1023|consen   42 DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWT  118 (484)
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhcc
Confidence            467899999999999999999999865   5 999999999999999999999999986643211111111112345799


Q ss_pred             ChhhhhcCC-------CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           82 APEYAMEGL-------FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        82 aPe~~~~~~-------~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      |||.+....       .+.+.|+||+|++++|+++...||.........  .+.......  .....+.+.+...  .+.
T Consensus       119 aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~--~e~  192 (484)
T KOG1023|consen  119 APELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELL--NEL  192 (484)
T ss_pred             CHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh--HHHHHHHHh--cCCCCcCcchhhh--hhc
Confidence            999998642       467799999999999999999998653332221  111111111  1111111111110  123


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      ...+..++..||..+|.+||+++.|...++....
T Consensus       193 ~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  193 PPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             chHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            3368899999999999999999999988876554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.65  E-value=7.3e-16  Score=138.97  Aligned_cols=163  Identities=18%  Similarity=0.169  Sum_probs=109.6

Q ss_pred             CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccc-ccc----ccccCcc
Q 026939            7 DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST-NRI----VGTYGYM   81 (230)
Q Consensus         7 ~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~----~~~~~~~   81 (230)
                      ..-++.=|+.||+.||..+|..|   |+|||||.+|||++.=.++.|.||......--..+.+.. ..+    ....+|.
T Consensus       118 ~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYi  194 (1431)
T KOG1240|consen  118 VLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYI  194 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeec
Confidence            34567778999999999999999   999999999999999889999999765332111111110 001    1234899


Q ss_pred             ChhhhhcC----------C-CCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcch
Q 026939           82 APEYAMEG----------L-FSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS  149 (230)
Q Consensus        82 aPe~~~~~----------~-~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (230)
                      |||.+...          . .+++=||||+||++.||++ |.++|...+-      ..+  +...    .......+.  
T Consensus       195 APERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~aY--r~~~----~~~~e~~Le--  260 (1431)
T KOG1240|consen  195 APERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LAY--RSGN----ADDPEQLLE--  260 (1431)
T ss_pred             ChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------HhH--hccC----ccCHHHHHH--
Confidence            99988642          1 5677899999999999998 5666642210      000  0000    000011111  


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                        ..+...+..|+..|++.||++|-++++.++--++..+
T Consensus       261 --~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  261 --KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             --hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence              1112247788999999999999999999998766544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.64  E-value=1.6e-16  Score=136.62  Aligned_cols=161  Identities=22%  Similarity=0.272  Sum_probs=117.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .+|++-+....++..+.+++|||++|   -+|||||-.||+++..|.+|++|||.+...+...  .....+.|++.|+||
T Consensus       107 gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmap  181 (829)
T KOG0576|consen  107 GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAP  181 (829)
T ss_pred             ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccch
Confidence            36788899999999999999999999   9999999999999999999999999876543221  122236789999999


Q ss_pred             hhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           84 EYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        84 e~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |+..   ...|...+|+|++|+...|+-..++|--...+   ...+...     ....   +++. ...-...+...|.+
T Consensus       182 Evaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr~l~Lm-----TkS~---~qpp-~lkDk~kws~~fh~  249 (829)
T KOG0576|consen  182 EVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MRALFLM-----TKSG---FQPP-TLKDKTKWSEFFHN  249 (829)
T ss_pred             hHHHHHhcccccccccccccccchhhhhhcCCcccccch---HHHHHHh-----hccC---CCCC-cccCCccchHHHHH
Confidence            9875   45799999999999999999877776211100   0000000     0000   0100 00113456677999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.|+..+|++||+++.+++
T Consensus       250 fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHhcCCCccCCChhhhee
Confidence            999999999999999987654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=5.1e-15  Score=121.12  Aligned_cols=164  Identities=18%  Similarity=0.171  Sum_probs=112.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC--CC--CeEEcccccceeecCCCCC----ccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--EM--NPKISDFEMARIFGGNQSE----ASTNRIV   75 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~--~~--~~~l~d~~~~~~~~~~~~~----~~~~~~~   75 (230)
                      +..+.....-++.|+++|+.|||.+|   +.|||+|++||++.-  ++  .+.++|||.+-........    .-.....
T Consensus       336 ~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~G  412 (598)
T KOG4158|consen  336 RHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLG  412 (598)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCC
Confidence            34566778889999999999999999   999999999999943  32  4689999988654332211    1111234


Q ss_pred             cccCccChhhhhcCC------CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcch
Q 026939           76 GTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS  149 (230)
Q Consensus        76 ~~~~~~aPe~~~~~~------~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (230)
                      |....+|||+....+      .-.++|.|+.|.+.||++....||........ ....     ..+...         +.
T Consensus       413 GNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~-----Yqe~qL---------Pa  477 (598)
T KOG4158|consen  413 GNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT-----YQESQL---------PA  477 (598)
T ss_pred             CcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh-----hhhhhC---------CC
Confidence            566889999987532      23689999999999999999999853111100 0000     011111         12


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+..++..+.+++...|++||.+|++..-....|+-
T Consensus       478 lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  478 LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             CcccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence            334445557888899999999999998776666543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.60  E-value=7.8e-16  Score=129.50  Aligned_cols=149  Identities=22%  Similarity=0.371  Sum_probs=105.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCC----CCccccccccccCc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ----SEASTNRIVGTYGY   80 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~   80 (230)
                      ..++...+.++.|++.|++|   ++   .+|+|++|.||++..+..++|+|||+........    .........++..|
T Consensus       355 ~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~Y  428 (516)
T KOG1033|consen  355 ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLY  428 (516)
T ss_pred             ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhccccccc
Confidence            45677889999999999999   77   9999999999999999999999999987654433    11112234778999


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhc-CCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISG-KKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ++||.+.+..|+.++|||+||++++|++.- .-.+.               .   .....++.+..+.+. ...+...=.
T Consensus       429 msPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------------r---~~t~~d~r~g~ip~~-~~~d~p~e~  489 (516)
T KOG1033|consen  429 MSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------------R---IATLTDIRDGIIPPE-FLQDYPEEY  489 (516)
T ss_pred             CCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------------H---HHhhhhhhcCCCChH-HhhcCcHHH
Confidence            999999999999999999999999999872 11110               0   001111111111111 111122235


Q ss_pred             HHHhhhcCCCCCCCCCHHH
Q 026939          160 HIGLLCVQADSADRPTMSS  178 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~  178 (230)
                      .|+.+++...|.+||++.+
T Consensus       490 ~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  490 TLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HHHHHhcCCCcccCchHHH
Confidence            6788999999999995443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.55  E-value=8.8e-14  Score=113.21  Aligned_cols=171  Identities=29%  Similarity=0.326  Sum_probs=119.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCc----cccccccccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEA----STNRIVGTYG   79 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~   79 (230)
                      .++......++.|++.++.++|+.+   ++|||++|+|++++..+ .+++.|||.+..........    ......++..
T Consensus        97 ~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~  173 (384)
T COG0515          97 PLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG  173 (384)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccc
Confidence            6888999999999999999999999   99999999999999988 69999999987554332211    2234567889


Q ss_pred             ccChhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           80 YMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        80 ~~aPe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      |.+||.+.+   ..+....|+|++|++++++++|..||......   ................ ................
T Consensus       174 ~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  249 (384)
T COG0515         174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSNPELISK  249 (384)
T ss_pred             cCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCccccchhhH
Confidence            999999987   57889999999999999999999996543321   0000000110000000 0000000000022235


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      .+.+++..|+..+|..|.+.......
T Consensus       250 ~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         250 AASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            67888889999999999999887764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.48  E-value=1.3e-13  Score=106.12  Aligned_cols=173  Identities=17%  Similarity=0.152  Sum_probs=125.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC---CCeEEcccccceeecCCCC-----Ccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQS-----EASTNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~-----~~~~~~~   74 (230)
                      .+.++..+++.++-|++.-++|+|..+   ++||||||+|+++.-+   ..+.|+|||++..+.....     .......
T Consensus       105 ~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l  181 (341)
T KOG1163|consen  105 SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL  181 (341)
T ss_pred             hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence            357889999999999999999999999   9999999999999754   4588999999986533221     1222334


Q ss_pred             ccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           75 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .|+.+|.+-....+...+...|+-|+|.++..+--|..||........++.++...+......+.     .+...+|.+ 
T Consensus       182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie-----~LC~G~P~E-  255 (341)
T KOG1163|consen  182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE-----VLCKGFPAE-  255 (341)
T ss_pred             ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH-----HHhCCCcHH-
Confidence            67888888777777777889999999999998889999998766666555554433222222221     122234443 


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                         |.-.+.-|-...-++-|+..-+.+.+.-..
T Consensus       256 ---F~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  256 ---FAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             ---HHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence               666666787888888888877777664443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.46  E-value=5.8e-14  Score=120.52  Aligned_cols=150  Identities=24%  Similarity=0.225  Sum_probs=116.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.....+...++-+++++|+.+   ++|+|+|++||+++.+|.+++.|||+....-....      ..|+..|+||
T Consensus        92 ~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymAp  162 (612)
T KOG0603|consen   92 VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAP  162 (612)
T ss_pred             CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhh
Confidence            34566677888899999999999999   99999999999999999999999999875432211      1568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |+..  .....+|.|++|++.++|++|..||+.          +         ....++..  ....|.+.......++.
T Consensus       163 EI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~---------~~~~Il~~--~~~~p~~l~~~a~~~~~  219 (612)
T KOG0603|consen  163 EIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------D---------TMKRILKA--ELEMPRELSAEARSLFR  219 (612)
T ss_pred             Hhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------H---------HHHHHhhh--ccCCchhhhHHHHHHHH
Confidence            9997  567899999999999999999999863          0         11111111  12345666666778888


Q ss_pred             hhcCCCCCCCCCH--HHHHHHhhc
Q 026939          164 LCVQADSADRPTM--SSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~--~~i~~~L~~  185 (230)
                      .++..+|.+|.-.  ..+.++.+.
T Consensus       220 ~l~~r~p~nrLg~~~~~~~eik~h  243 (612)
T KOG0603|consen  220 QLFKRNPENRLGAGPDGVDEIKQH  243 (612)
T ss_pred             HHHhhCHHHHhccCcchhHHHhcc
Confidence            9999999999866  566665544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.46  E-value=4.6e-13  Score=107.40  Aligned_cols=169  Identities=17%  Similarity=0.181  Sum_probs=118.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-----CeEEcccccceeecCCCCC-----cccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-----NPKISDFEMARIFGGNQSE-----ASTN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-----~~~l~d~~~~~~~~~~~~~-----~~~~   72 (230)
                      ++.++..+++.+++|++.-++++|++.   +|+|||||+|+||...+     .+.++|||++.......+.     ....
T Consensus       118 gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~K  194 (449)
T KOG1165|consen  118 GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHK  194 (449)
T ss_pred             cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccc
Confidence            467899999999999999999999999   99999999999997543     4789999999866433221     1222


Q ss_pred             ccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH
Q 026939           73 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA  152 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (230)
                      ...|+.+||+.....+...+...|+-|||-+++..+-|..||.......-+..++-.-.......+..+     ...+|.
T Consensus       195 SLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L-----c~g~P~  269 (449)
T KOG1165|consen  195 SLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL-----CEGFPE  269 (449)
T ss_pred             ccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH-----HhcCHH
Confidence            346788999998888888999999999999999999999999766555544444332222112222221     222333


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHh
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +    |..-|.-.-..+-.+-|..+-+..-+
T Consensus       270 e----fa~Yl~yvR~L~F~E~PDYdylr~Lf  296 (449)
T KOG1165|consen  270 E----FATYLRYVRRLDFFETPDYDYLRKLF  296 (449)
T ss_pred             H----HHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            2    44444444456667777776555443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.41  E-value=1.9e-13  Score=123.27  Aligned_cols=147  Identities=20%  Similarity=0.190  Sum_probs=102.1

Q ss_pred             HHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-------------ccccccccccCccCh
Q 026939           17 GIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-------------ASTNRIVGTYGYMAP   83 (230)
Q Consensus        17 qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~~~~~~~~~~aP   83 (230)
                      +++.+++|||+.+   |+|||++++|.+++.-|.+|+.|||+..........             ....+..+++.|.||
T Consensus       151 dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  151 DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence            3478999999999   999999999999999999999999988653221110             111234778999999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++....|...+|.|++|+++|+.+.|..||...-++..       ...+    +.+.+..   ..-......+..+++.
T Consensus       228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-------fg~v----isd~i~w---pE~dea~p~Ea~dli~  293 (1205)
T KOG0606|consen  228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-------FGQV----ISDDIEW---PEEDEALPPEAQDLIE  293 (1205)
T ss_pred             hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-------Hhhh----hhhhccc---cccCcCCCHHHHHHHH
Confidence            999999999999999999999999999999854322211       0000    0000000   0001222234677788


Q ss_pred             hhcCCCCCCCCCHHHHH
Q 026939          164 LCVQADSADRPTMSSVV  180 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~  180 (230)
                      +.|+.+|..|--...-+
T Consensus       294 ~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  294 QLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             HHHHhChHhhcccchhh
Confidence            88999999996433333

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.1e-11  Score=113.13  Aligned_cols=107  Identities=19%  Similarity=0.115  Sum_probs=87.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-------CCCCeEEcccccceeecCCCCCcccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-------HEMNPKISDFEMARIFGGNQSEASTNRIVG   76 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~   76 (230)
                      +..++..++.+.+|++..+++||..+   |||+||||+|+|+.       .+..++|+|||.+.-+.--.....-...++
T Consensus       789 ~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~  865 (974)
T KOG1166|consen  789 KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWH  865 (974)
T ss_pred             CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeec
Confidence            46788899999999999999999999   99999999999994       235689999998864322111112222455


Q ss_pred             ccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCC
Q 026939           77 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN  113 (230)
Q Consensus        77 ~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p  113 (230)
                      +-.+-++|...+..++..+|.|.|+.+++.|+.|+.-
T Consensus       866 td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  866 TDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            6788999999999999999999999999999998754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.17  E-value=4.6e-11  Score=99.87  Aligned_cols=74  Identities=23%  Similarity=0.314  Sum_probs=58.5

Q ss_pred             HHHHHHHHHHHHHhHhCCCCCeeecCC-CCCceEeCCCCCeEEcccccceeecCCCCCcc------ccccccccCccChh
Q 026939           12 ISIINGIARGLLYLHEDSRLRIIHRDL-KASNVLLDHEMNPKISDFEMARIFGGNQSEAS------TNRIVGTYGYMAPE   84 (230)
Q Consensus        12 ~~i~~qi~~al~~Lh~~~~~~i~H~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~------~~~~~~~~~~~aPe   84 (230)
                      ..++.+++.||+|||+.|   |+|||| ||+||+++.++.++|+|||++..+........      .....+.+.|.+||
T Consensus       114 ~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             HHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            578899999999999999   999999 99999999999999999999987643321111      01234566789999


Q ss_pred             hhhc
Q 026939           85 YAME   88 (230)
Q Consensus        85 ~~~~   88 (230)
                      .+..
T Consensus       191 ~~~~  194 (365)
T PRK09188        191 ALTP  194 (365)
T ss_pred             cCCh
Confidence            8764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.16  E-value=6.9e-11  Score=90.89  Aligned_cols=100  Identities=18%  Similarity=0.179  Sum_probs=72.3

Q ss_pred             HHHHHHHHHHHHHhHhCCCCCeeecCC-CCCceEeCCCCCeEEcccccceeecCCCCC----cc-------ccccccccC
Q 026939           12 ISIINGIARGLLYLHEDSRLRIIHRDL-KASNVLLDHEMNPKISDFEMARIFGGNQSE----AS-------TNRIVGTYG   79 (230)
Q Consensus        12 ~~i~~qi~~al~~Lh~~~~~~i~H~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~-------~~~~~~~~~   79 (230)
                      ..++.|++.+|+++|+.|   ++|+|| +|.||+++.++.++|+|||++.........    ..       .......+.
T Consensus        94 ~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~  170 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA  170 (218)
T ss_pred             HHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence            467899999999999999   999999 799999999999999999999865432211    00       001122445


Q ss_pred             ccChhhhhcC--CCCccccchhhHHHHHHHHhcCCCC
Q 026939           80 YMAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNS  114 (230)
Q Consensus        80 ~~aPe~~~~~--~~~~~~DiwslG~ll~~ll~g~~p~  114 (230)
                      ++.|+-..-.  .--...+.++.|+.+|.++|+..+.
T Consensus       171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            5666543321  2225667788899999999988774

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=3.8e-10  Score=93.78  Aligned_cols=172  Identities=15%  Similarity=0.159  Sum_probs=113.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      .+|...++.++.|+.+.+-||..|   .+-+|++++|+|++.++.+.|.|-+......+.....   +.++...|++||.
T Consensus       114 ~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~---cpVg~~eftPPEl  187 (637)
T COG4248         114 CAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHL---CPVGVSEFTPPEL  187 (637)
T ss_pred             cccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCceEe---cccCccccCCHHH
Confidence            578899999999999999999999   8899999999999999999999866555443332222   2467889999998


Q ss_pred             hh-----cCCCCccccchhhHHHHHHHHhc-CCCCCCCcc-ccccchhhhhHHHHhhhhhhhhhc------hhhcchhhH
Q 026939           86 AM-----EGLFSVKSDVFSFGVLLLEIISG-KKNSGFYLS-ELGQSLLSYTWKLWCEGEALELME------PVLKQSCVA  152 (230)
Q Consensus        86 ~~-----~~~~~~~~DiwslG~ll~~ll~g-~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~  152 (230)
                      -.     +-.-+...|.|.||+++++++.| .+||..-.. .......+.   .+..+......+      +-....-..
T Consensus       188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~g~f~ya~~~~~g~~p~P~~~P~~  264 (637)
T COG4248         188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAHGRFAYASDQRRGLKPPPRSIPLS  264 (637)
T ss_pred             hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhcceeeechhccCCCCCCCCCCChh
Confidence            65     23456788999999999999886 888743111 111111110   001111111111      000111112


Q ss_pred             HHHHHHHHHHhhhcCCC--CCCCCCHHHHHHHhhcC
Q 026939          153 AELLKFIHIGLLCVQAD--SADRPTMSSVVVMLASD  186 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~d--P~~RPs~~~i~~~L~~~  186 (230)
                      .....+..|..+|+...  +.-|||++..+..|...
T Consensus       265 ~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         265 MLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            33445677778888654  56899999998887553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=8.8e-12  Score=110.54  Aligned_cols=162  Identities=24%  Similarity=0.316  Sum_probs=117.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhH-hCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecC-CCCCcccccccc-ccCc
Q 026939            5 QLDWKRRISIINGIARGLLYLH-EDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGG-NQSEASTNRIVG-TYGY   80 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh-~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~-~~~~~~~~~~~~-~~~~   80 (230)
                      ..+...+-..+.|+..++.|+| ..+   +.|+|++|+|.+++.++ .++.+|||++..+.. ...........+ ++.|
T Consensus       119 ~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y  195 (601)
T KOG0590|consen  119 GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPY  195 (601)
T ss_pred             CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCC
Confidence            3455667788999999999999 888   99999999999999999 899999999988765 444444444566 8899


Q ss_pred             cChhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      .|||...+.. .....|+||.|+++..+++|..|+............      +......      ..............
T Consensus       196 ~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~------~~~~~~~------~~~~~~~~~~~~~~  263 (601)
T KOG0590|consen  196 GAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS------WKSNKGR------FTQLPWNSISDQAH  263 (601)
T ss_pred             CCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee------ecccccc------cccCccccCChhhh
Confidence            9999998754 356789999999999999999998655444321111      1111100      00011112223466


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++..++..+|..|.+.+++..
T Consensus       264 ~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  264 DLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             hcccccccCCchhccccccccc
Confidence            7778888899999999988753

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.14  E-value=6.7e-11  Score=90.63  Aligned_cols=56  Identities=16%  Similarity=0.173  Sum_probs=50.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHh-HhCCCCCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939            3 SVQLDWKRRISIINGIARGLLYL-HEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~L-h~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      ..+++....+.++.|++.+|.++ |+.|   ++||||||+||+++ ++.++|+|||++...
T Consensus       111 ~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         111 DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            45788999999999999999999 7888   99999999999998 478999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.11  E-value=1.2e-10  Score=89.18  Aligned_cols=57  Identities=21%  Similarity=0.307  Sum_probs=51.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeec
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG   63 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   63 (230)
                      ..+++...+..++.|++.++.+||+ .|   ++|+||+|+||+++ ++.++|+|||++....
T Consensus       111 ~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         111 DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            3467788999999999999999999 99   99999999999999 7899999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.08  E-value=5.5e-11  Score=93.01  Aligned_cols=78  Identities=17%  Similarity=0.275  Sum_probs=59.0

Q ss_pred             HHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhhhcCCCC
Q 026939           13 SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFS   92 (230)
Q Consensus        13 ~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~   92 (230)
                      ....+++.++..+|..|   ++|+|++|+|++++.+| ++|+|||........   ...           ..++....+.
T Consensus       139 ~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~---~a~-----------d~~vler~y~  200 (232)
T PRK10359        139 DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR---KAK-----------DRIDLERHYG  200 (232)
T ss_pred             HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccch---hhH-----------HHHHHHhHhc
Confidence            35679999999999999   99999999999999888 999999977543111   000           1133344566


Q ss_pred             ccccchhhHHHHHHHH
Q 026939           93 VKSDVFSFGVLLLEII  108 (230)
Q Consensus        93 ~~~DiwslG~ll~~ll  108 (230)
                      .++|+|+||+.+..+.
T Consensus       201 ~~~di~~lg~~~~~~~  216 (232)
T PRK10359        201 IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ccccccceeEeehHHH
Confidence            7999999999876554

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=5e-09  Score=84.53  Aligned_cols=159  Identities=21%  Similarity=0.204  Sum_probs=100.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccc--ccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF--EMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~--~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +.+....-.+|+-||++||.|||+- ..+++|+++.-+.+++..+|-+|++--  ...................+.++|.
T Consensus       171 ~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~  249 (458)
T KOG1266|consen  171 KALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFS  249 (458)
T ss_pred             hhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccc
Confidence            4566667788999999999999997 578999999999999999887777532  1111111111122222335567899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      +|+.-...+.+..+|||++|....+|..+.--...     .........  ... .....+...+..           .+
T Consensus       250 a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tn-----seS~~~~ee--~ia-~~i~~len~lqr-----------~~  310 (458)
T KOG1266|consen  250 APESGTTTNTTGASDIYKFGMCALEMAILEIQSTN-----SESKVEVEE--NIA-NVIIGLENGLQR-----------GS  310 (458)
T ss_pred             cCCcCcccccccchhhhhhhHHHHHHHHheeccCC-----Ccceeehhh--hhh-hheeeccCcccc-----------Cc
Confidence            99986666778899999999999999876543211     111110000  000 011111111111           23


Q ss_pred             HhhhcCCCCCCCCCHHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      +..|++..|..||++++++..
T Consensus       311 i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  311 ITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             CcccccCCCCCCcchhhhhcC
Confidence            446999999999999987653

>smart00090 RIO RIO-like kinase

Probab=98.77  E-value=1.3e-08  Score=80.68  Aligned_cols=56  Identities=18%  Similarity=0.289  Sum_probs=48.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      ..+...++..++.||+.++.+||+.|  .++|+||+|+||+++ ++.++|+|||.+...
T Consensus       143 ~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      143 VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            45566677899999999999999876  499999999999999 788999999987654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.71  E-value=3.9e-09  Score=92.34  Aligned_cols=152  Identities=22%  Similarity=0.332  Sum_probs=99.3

Q ss_pred             HHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccc-------cccccccCccChhhhh
Q 026939           15 INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST-------NRIVGTYGYMAPEYAM   87 (230)
Q Consensus        15 ~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-------~~~~~~~~~~aPe~~~   87 (230)
                      +.+++.|+.++|..-  .+||+.|.|++|.++.++..|++.|+++............       ........|.+||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345668999999754  4999999999999999999999999887654321111111       0112244799999998


Q ss_pred             cCCCCccccchhhHHHHHHHHhcCCC-CCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhc
Q 026939           88 EGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV  166 (230)
Q Consensus        88 ~~~~~~~~DiwslG~ll~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  166 (230)
                      +...+.++|++|+||++|.+..|..+ +.....     ......        ....+..-...+..+.+.++.+-+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-----~~~~~~--------~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-----LLSYSF--------SRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCC-----cchhhh--------hhcccccccccccccCcHHHHHHHHHHh
Confidence            87888999999999999999865554 221100     000000        0000100011222344455777778899


Q ss_pred             CCCCCCCCCHHHHHH
Q 026939          167 QADSADRPTMSSVVV  181 (230)
Q Consensus       167 ~~dP~~RPs~~~i~~  181 (230)
                      ..++..||++..+..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999997776654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.68  E-value=2.7e-08  Score=78.95  Aligned_cols=46  Identities=26%  Similarity=0.397  Sum_probs=42.0

Q ss_pred             HHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939           14 IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus        14 i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      .+.+|+.+|.+||+.|   |+|+||+|.|||++.++.++|+|||.+...
T Consensus       147 ~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        147 QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            4678999999999999   999999999999998889999999987653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.67  E-value=3.8e-08  Score=75.84  Aligned_cols=52  Identities=21%  Similarity=0.286  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeec
Q 026939            9 KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG   63 (230)
Q Consensus         9 ~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   63 (230)
                      .....++.+++.++.++|+.+   ++|+||+|.||+++.++.++|+|||.+....
T Consensus       125 ~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         125 EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            345678999999999999999   9999999999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.61  E-value=5.6e-08  Score=83.76  Aligned_cols=156  Identities=22%  Similarity=0.292  Sum_probs=107.4

Q ss_pred             CCHHHHHHHHHHHHH----HHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccc---cccccc
Q 026939            6 LDWKRRISIINGIAR----GLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEAST---NRIVGT   77 (230)
Q Consensus         6 l~~~~~~~i~~qi~~----al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~---~~~~~~   77 (230)
                      ++....+..+.+...    ||.++|+.+   ++|-|+++.|++...+ ...+++||+++..++........   ....+.
T Consensus       215 ~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~  291 (524)
T KOG0601|consen  215 LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGD  291 (524)
T ss_pred             CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCC
Confidence            667788888899999    999999998   9999999999999999 78899999999877654432221   122456


Q ss_pred             cCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           78 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        78 ~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ..|++||.. +.-++...|++++|.++.+-..+...+.....        -.|..+.+.        .+...+...-...
T Consensus       292 ~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~r~~--------~ip~e~~~~~s~~  354 (524)
T KOG0601|consen  292 CIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQLRQG--------YIPLEFCEGGSSS  354 (524)
T ss_pred             ceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccccccc--------cCchhhhcCcchh
Confidence            689999987 45567899999999999998887665321100        001111000        0111122222223


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +...+..|++.+|-.|++++.+..
T Consensus       355 l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  355 LRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhhHHHHhcCcchhhhhHHHHHhc
Confidence            444677899999999998887753

>PRK10345 hypothetical protein; Provisional

Probab=98.57  E-value=7.9e-08  Score=74.66  Aligned_cols=48  Identities=21%  Similarity=0.383  Sum_probs=38.6

Q ss_pred             CCCHHHHHHHHHHHHHHH-HHhHhCCCCCeeecCCCCCceEeCCC----CCeEEcccc
Q 026939            5 QLDWKRRISIINGIARGL-LYLHEDSRLRIIHRDLKASNVLLDHE----MNPKISDFE   57 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al-~~Lh~~~~~~i~H~di~~~nil~~~~----~~~~l~d~~   57 (230)
                      .+++.  ..++.+++.++ +|||+++   |+||||||+||+++..    +.++|+|++
T Consensus       102 ~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        102 RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            34444  35678888888 9999999   9999999999999743    379999944

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.56  E-value=8.5e-08  Score=72.97  Aligned_cols=50  Identities=22%  Similarity=0.241  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939            9 KRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus         9 ~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      .....++.+++.++.++|. .+   ++|+||+|+||+++ ++.++|+|||.+...
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            5678899999999999999 88   99999999999999 889999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.48  E-value=2.1e-07  Score=72.19  Aligned_cols=48  Identities=31%  Similarity=0.434  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           10 RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        10 ~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .+..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            56789999999999999999   99999999999999 78899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.44  E-value=2.8e-07  Score=70.89  Aligned_cols=45  Identities=27%  Similarity=0.482  Sum_probs=42.1

Q ss_pred             HHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           13 SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        13 ~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++.+++.+|++||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        94 ~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            78999999999999999   99999999999999 78999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.41  E-value=5.2e-07  Score=69.14  Aligned_cols=56  Identities=16%  Similarity=0.105  Sum_probs=47.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHh-HhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeec
Q 026939            4 VQLDWKRRISIINGIARGLLYL-HEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG   63 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~L-h~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   63 (230)
                      ..++..+...++.+++.+|..| |..|   ++|+|+++.||++. ++.+.++||+.+....
T Consensus       119 ~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         119 AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            3455566778899999999988 8888   99999999999997 4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.36  E-value=3.8e-07  Score=80.77  Aligned_cols=47  Identities=21%  Similarity=0.412  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           11 RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        11 ~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ...++.+++.+|.+||+.+   ++|||++|+||++ .++.++|+|||++..
T Consensus       430 ~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            5678999999999999999   9999999999999 577899999999865

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.24  E-value=2.9e-06  Score=74.54  Aligned_cols=96  Identities=17%  Similarity=0.263  Sum_probs=68.9

Q ss_pred             HHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhhhc
Q 026939            9 KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAME   88 (230)
Q Consensus         9 ~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~   88 (230)
                      ..+.--+.||+.||.|||..+  .++|++|.-..|+++..|.-+|++|.++........  ..........|..|+.+..
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence            345556899999999998655  499999999999999999999999998865432211  0111111224555654432


Q ss_pred             CCCCccccchhhHHHHHHHHhc
Q 026939           89 GLFSVKSDVFSFGVLLLEIISG  110 (230)
Q Consensus        89 ~~~~~~~DiwslG~ll~~ll~g  110 (230)
                      ..  -..|.|.|||++++++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  356999999999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.20  E-value=3.2e-06  Score=61.18  Aligned_cols=55  Identities=29%  Similarity=0.316  Sum_probs=46.6

Q ss_pred             CHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939            7 DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus         7 ~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      +......++.+++.+++.||......++|+|+++.|++++..+.++++||+.+..
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            3467788999999999999985322399999999999999988999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.13  E-value=1.6e-06  Score=74.92  Aligned_cols=151  Identities=21%  Similarity=0.239  Sum_probs=100.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCcc--
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM--   81 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~--   81 (230)
                      -+++..++++..|++.++.++|++.   ++|.|++|+||++..+ +..++.||+....+.....  .   ..+..++.  
T Consensus       362 ~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--~---~~~~~r~~p~  433 (524)
T KOG0601|consen  362 MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--V---FHHIDRLYPI  433 (524)
T ss_pred             hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc--c---cccccccccc
Confidence            4567788999999999999999999   9999999999999886 6778899887753211111  0   11122333  


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ++.+.....+..++|+++||.-+.+..++..-..     .+...+.             +.....  .........+..+
T Consensus       434 ~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-----~~~~~~~-------------i~~~~~--p~~~~~~~~~q~~  493 (524)
T KOG0601|consen  434 AEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-----SGVQSLT-------------IRSGDT--PNLPGLKLQLQVL  493 (524)
T ss_pred             chhhccccccccccccccccccccccccCcccCc-----cccccee-------------eecccc--cCCCchHHhhhhh
Confidence            4444445678899999999999999888765421     1111000             000000  0011222456777


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHh
Q 026939          162 GLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      ...+...++..||.+.++....
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             hhhhcCCccccchhhhhhcccc
Confidence            7788899999999998876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.06  E-value=7.7e-06  Score=63.47  Aligned_cols=53  Identities=32%  Similarity=0.481  Sum_probs=47.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC---CeEEccccccee
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM---NPKISDFEMARI   61 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~   61 (230)
                      .+......++.+++..++-||..|   ++|+|+++.|||++.++   .+.++||+.+..
T Consensus       115 ~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  115 LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            456678899999999999999999   99999999999999886   789999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.05  E-value=3e-06  Score=77.78  Aligned_cols=152  Identities=19%  Similarity=0.162  Sum_probs=101.1

Q ss_pred             HHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCC---------------------CC
Q 026939            9 KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN---------------------QS   67 (230)
Q Consensus         9 ~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---------------------~~   67 (230)
                      .-.......+..++++||...   +.|+|+++.+.+...++..++.+|+.....+..                     ..
T Consensus       904 epaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~  980 (1205)
T KOG0606|consen  904 EPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSER  980 (1205)
T ss_pred             ccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccc
Confidence            344456667788999999987   899999999999999999999998633211100                     00


Q ss_pred             ---C-----ccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhh
Q 026939           68 ---E-----ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEAL  139 (230)
Q Consensus        68 ---~-----~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (230)
                         .     .......+++.|.+||...+......+|.|++|+++++.++|.+||....+...          +.+--..
T Consensus       981 ~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~----------f~ni~~~ 1050 (1205)
T KOG0606|consen  981 RPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI----------FENILNR 1050 (1205)
T ss_pred             ccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh----------hhccccC
Confidence               0     012234667889999999998888999999999999999999999864332211          1110001


Q ss_pred             hhhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 026939          140 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMS  177 (230)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  177 (230)
                      ++..    ..-+........+++...+..+|.+|-.+.
T Consensus      1051 ~~~~----p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1051 DIPW----PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCC----CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            1111    111223333455666677788888887766

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.05  E-value=8.1e-06  Score=65.80  Aligned_cols=54  Identities=24%  Similarity=0.307  Sum_probs=46.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-------CCCeEEccccccee
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-------EMNPKISDFEMARI   61 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-------~~~~~l~d~~~~~~   61 (230)
                      +.+...+..++.+++..++-||..|   ++|+|++++|||++.       +..+.|+||+.+..
T Consensus       134 ~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        134 PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            3455677889999999999999999   999999999999975       35689999997753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.03  E-value=7e-06  Score=61.22  Aligned_cols=49  Identities=33%  Similarity=0.352  Sum_probs=40.6

Q ss_pred             HHHHHHHHHHHHHhHhCC--CCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           12 ISIINGIARGLLYLHEDS--RLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        12 ~~i~~qi~~al~~Lh~~~--~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ..++.+++.+|+.||+.+  ...++|+|+++.||+++ ++.++++||+.+..
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            456789999999999987  12249999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.98  E-value=8.3e-06  Score=47.30  Aligned_cols=44  Identities=45%  Similarity=0.714  Sum_probs=40.3

Q ss_pred             CCCCCCCCCCCCccCccCCCCCCCCCCC--cccccceeeecccCCC
Q 026939          187 NVTLPQPTEPAFSVGRNVARPSQFSSGA--EVCSVNEVTLSNVSPR  230 (230)
Q Consensus       187 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  230 (230)
                      ...|+.|++|+|..++...+..+.+..+  ..+++|+|+++-+.||
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            4569999999999999999999888888  8999999999999887

; GO: 0004674 protein serine/threonine kinase activity

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.84  E-value=2.9e-05  Score=58.40  Aligned_cols=46  Identities=26%  Similarity=0.419  Sum_probs=40.4

Q ss_pred             HHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           12 ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        12 ~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ..++..+=..+.-||..|   |+|+|+.++|+++.... +.++|||++.+
T Consensus        95 ~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          95 PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            457778888889999999   99999999999998764 99999999864

>PRK09902 hypothetical protein; Provisional

Probab=97.83  E-value=3.5e-05  Score=59.56  Aligned_cols=54  Identities=15%  Similarity=0.155  Sum_probs=47.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC--eEEccccccee
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN--PKISDFEMARI   61 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~   61 (230)
                      +.+..++..++.+++.+++-||+.|   +.|+|+.+.||+++.++.  +.++||..++.
T Consensus       124 ~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        124 PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            4467778899999999999999999   999999999999986666  89999986643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.76  E-value=5.7e-05  Score=65.29  Aligned_cols=49  Identities=20%  Similarity=0.282  Sum_probs=41.8

Q ss_pred             HHHHHHHHH-HHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeec
Q 026939           12 ISIINGIAR-GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG   63 (230)
Q Consensus        12 ~~i~~qi~~-al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   63 (230)
                      .+++..++. .+..+|..|   ++|+|++|.||+++.++.++++|||++....
T Consensus       259 ~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       259 KALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            456666666 468899999   9999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.66  E-value=0.00066  Score=58.69  Aligned_cols=89  Identities=19%  Similarity=0.331  Sum_probs=68.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..++++..|.++.||..||.++|+.|   +.-+-+.+.+|+++++.++++...|..........               
T Consensus       387 ~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------  448 (655)
T KOG3741|consen  387 NLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------  448 (655)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------
Confidence            456788999999999999999999999   88899999999999988888887665443322110               


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCC
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKN  113 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p  113 (230)
                       +.+..   ..+-|.-.||.+++.|.+|...
T Consensus       449 -~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  449 -EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             -cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence             11111   2467899999999999998554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.64  E-value=0.00015  Score=55.36  Aligned_cols=50  Identities=28%  Similarity=0.405  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHHHHHH-hHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939            9 KRRISIINGIARGLLY-LHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus         9 ~~~~~i~~qi~~al~~-Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      .....++.+++..+.. +|..|   ++|+|++..||+++.+ .+.++||+.+...
T Consensus       106 ~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  106 EEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             STHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             hhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence            3456778888886655 67998   9999999999999877 8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.48  E-value=0.00026  Score=53.43  Aligned_cols=48  Identities=33%  Similarity=0.531  Sum_probs=41.0

Q ss_pred             HHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC---eEEcccccceee
Q 026939           12 ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN---PKISDFEMARIF   62 (230)
Q Consensus        12 ~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~   62 (230)
                      ..++..|=+.+.-||..+   ++|+||..+||++..++.   +.++|||++...
T Consensus       116 ~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            678889999999999999   999999999999865543   589999998653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.23  E-value=0.00046  Score=53.70  Aligned_cols=42  Identities=21%  Similarity=0.336  Sum_probs=36.3

Q ss_pred             HHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccc
Q 026939           14 IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA   59 (230)
Q Consensus        14 i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~   59 (230)
                      ++..+++++.-||..|   ++|+|++|.|++++.+ .++++|++.-
T Consensus       140 ~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k  181 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGK  181 (229)
T ss_pred             HHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccc
Confidence            5567888999999999   9999999999999855 5999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.04  E-value=0.0012  Score=52.72  Aligned_cols=53  Identities=23%  Similarity=0.293  Sum_probs=43.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccce
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      +++....-.++..|+.-+..+-..|   ++|+|++.-||+++.+|.+.++||-.+.
T Consensus       198 r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         198 RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCcccc
Confidence            3445566677888888887777778   9999999999999999999999986554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.88  E-value=0.0024  Score=50.53  Aligned_cols=59  Identities=20%  Similarity=0.352  Sum_probs=49.6

Q ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeec
Q 026939            1 MRSVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG   63 (230)
Q Consensus         1 ~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   63 (230)
                      |+..++.......+..+++..+.-|-. .+   +||+||+.-|||+. ++.+.++|++.+....
T Consensus       158 LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         158 LKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            456666677788899999999988877 66   99999999999999 7789999998876543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=96.82  E-value=0.002  Score=56.99  Aligned_cols=38  Identities=16%  Similarity=0.308  Sum_probs=32.7

Q ss_pred             HHhHhCCCCCeeecCCCCCceEeCCCC----CeEEcccccceeec
Q 026939           23 LYLHEDSRLRIIHRDLKASNVLLDHEM----NPKISDFEMARIFG   63 (230)
Q Consensus        23 ~~Lh~~~~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~   63 (230)
                      ..+...|   ++|+|++|.||+++.++    .++++|||++....
T Consensus       274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            4566778   99999999999999887    89999999987653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.69  E-value=0.0055  Score=57.93  Aligned_cols=147  Identities=22%  Similarity=0.227  Sum_probs=93.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCC---ceEeCCCCCeEEc--ccccceeecCCCCCcccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKAS---NVLLDHEMNPKIS--DFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      ..++..+.+.+..++++|++++|+..   ..|.-+..+   +...+..+.....  ||+.............   .....
T Consensus       281 ~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~  354 (1351)
T KOG1035|consen  281 GSIPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAE  354 (1351)
T ss_pred             cccCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCcc
Confidence            36788899999999999999999986   666666665   3333444555554  7776655433222111   12234


Q ss_pred             CccChhhhhcCCCC--ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           79 GYMAPEYAMEGLFS--VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        79 ~~~aPe~~~~~~~~--~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      .+.+++........  ...|+|.+|.+...+..|..+.....                      .+...+...+..    
T Consensus       355 ~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~----------------------~~~~~l~~~~~~----  408 (1351)
T KOG1035|consen  355 IRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA----------------------VPVSLLDVLSTS----  408 (1351)
T ss_pred             ccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc----------------------chhhhhccccch----
Confidence            56677766655444  44699999999999998877632111                      011111111111    


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                      ...+....|+..++++|+++.+++..
T Consensus       409 ~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  409 ELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhhhhhhcchhhhhccchhhhhhc
Confidence            35566678999999999999999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.67  E-value=0.0044  Score=47.35  Aligned_cols=57  Identities=18%  Similarity=0.159  Sum_probs=49.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .-+|.++.+++.+++..+.+++..-...+.-+|++++|+-++.++.++++|.+.+..
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            358999999999999999999885444488999999999999999999999876643

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=96.56  E-value=0.0063  Score=47.08  Aligned_cols=31  Identities=26%  Similarity=0.440  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCceEeCC--CCCeEEccccccee
Q 026939           31 LRIIHRDLKASNVLLDH--EMNPKISDFEMARI   61 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~   61 (230)
                      ..++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            35899999999999998  56678999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.94  E-value=0.051  Score=45.67  Aligned_cols=53  Identities=26%  Similarity=0.370  Sum_probs=46.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ..++++++++.+.+..+.-+..+  ++.-||++.-.||+++ +|.+.|+||.+++.
T Consensus       318 ~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence            45789999999999988888763  5789999999999999 99999999999873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.88  E-value=0.043  Score=43.09  Aligned_cols=29  Identities=28%  Similarity=0.457  Sum_probs=25.3

Q ss_pred             CeeecCCCCCceEeCC-CCCeEEcccccce
Q 026939           32 RIIHRDLKASNVLLDH-EMNPKISDFEMAR   60 (230)
Q Consensus        32 ~i~H~di~~~nil~~~-~~~~~l~d~~~~~   60 (230)
                      .++|+|+.+.||+++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            4999999999999997 5779999998664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.75  E-value=0.08  Score=43.33  Aligned_cols=30  Identities=33%  Similarity=0.466  Sum_probs=25.9

Q ss_pred             CCeeecCCCCCceEeCCC----CCeEEcccccce
Q 026939           31 LRIIHRDLKASNVLLDHE----MNPKISDFEMAR   60 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~~----~~~~l~d~~~~~   60 (230)
                      ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            459999999999999975    789999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.27  E-value=0.05  Score=42.90  Aligned_cols=30  Identities=23%  Similarity=0.341  Sum_probs=24.9

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.|++++..+...++||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            489999999999998765567999987643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.04  E-value=0.085  Score=43.39  Aligned_cols=29  Identities=38%  Similarity=0.503  Sum_probs=25.4

Q ss_pred             CeeecCCCCCceEeCCCCCeEEcccccce
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      .++|+|+++.|++++.++...++||+.+.
T Consensus       188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            39999999999999988767899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.87  E-value=0.15  Score=41.90  Aligned_cols=28  Identities=25%  Similarity=0.414  Sum_probs=24.1

Q ss_pred             CeeecCCCCCceEeCCCCCeEEcccccce
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      .++|+|+++.|++++. +.+.++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            3899999999999987 578899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=93.86  E-value=0.12  Score=45.60  Aligned_cols=47  Identities=19%  Similarity=0.311  Sum_probs=35.8

Q ss_pred             HHHHHHHHH-HHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeec
Q 026939           14 IINGIARGL-LYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG   63 (230)
Q Consensus        14 i~~qi~~al-~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   63 (230)
                      ++..++.+. ..+-..|   +.|.|.+|.||+++.+|.+.+.|||......
T Consensus       269 ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         269 LAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            333333333 4444567   9999999999999999999999999886553

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.81  E-value=0.072  Score=41.80  Aligned_cols=39  Identities=21%  Similarity=0.290  Sum_probs=32.3

Q ss_pred             HHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccc
Q 026939           19 ARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEM   58 (230)
Q Consensus        19 ~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~   58 (230)
                      +++|...|+.. ...+|+|.+|+|||-++.|-+||.|-+.
T Consensus       151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence            35677788653 4599999999999999999999999654

The function of this family is unknown.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=93.78  E-value=0.061  Score=41.72  Aligned_cols=31  Identities=39%  Similarity=0.481  Sum_probs=20.9

Q ss_pred             CCeeecCCCCCceEeC-CCCCeEEccccccee
Q 026939           31 LRIIHRDLKASNVLLD-HEMNPKISDFEMARI   61 (230)
Q Consensus        31 ~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~   61 (230)
                      ..++|+|+.+.||+++ .++.+.++||+.+..
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             cEEEEeccccccceeeeccceeEEEecccceE
Confidence            3499999999999999 556668999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.64  E-value=0.14  Score=41.41  Aligned_cols=50  Identities=26%  Similarity=0.312  Sum_probs=36.3

Q ss_pred             HHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           11 RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        11 ~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ..+.+..+-.++.-.+.. ...++|+|+.+.|++.+..+.++|+||..+..
T Consensus       134 ~~~~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         134 LRKKLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            334555555555555543 02489999999999999989999999987643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.56  E-value=0.11  Score=42.28  Aligned_cols=28  Identities=39%  Similarity=0.517  Sum_probs=25.0

Q ss_pred             eeecCCCCCceEeCCCCCeEEcccccce
Q 026939           33 IIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        33 i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      ++|+|+++.|++++.++.+.|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999987777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=93.26  E-value=0.07  Score=41.96  Aligned_cols=28  Identities=14%  Similarity=0.147  Sum_probs=24.7

Q ss_pred             CeeecCCCCCceEeCCCCCeEEcccccce
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      .++|+|+.+.|++++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999887 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.05  E-value=0.077  Score=41.07  Aligned_cols=30  Identities=33%  Similarity=0.547  Sum_probs=20.9

Q ss_pred             CeeecCCCCCceEe-CCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLL-DHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~-~~~~~~~l~d~~~~~~   61 (230)
                      .+.|+|+.+.||++ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 7888999999987643

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK05231 homoserine kinase; Provisional

Probab=93.00  E-value=0.19  Score=41.47  Aligned_cols=28  Identities=36%  Similarity=0.472  Sum_probs=24.4

Q ss_pred             eeecCCCCCceEeCCCCCeEEcccccce
Q 026939           33 IIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        33 i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      ++|+|+.+.||+++.+....++||+.+.
T Consensus       189 liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        189 VIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCCCCCCCcEEEECCceEEEEeccccc
Confidence            9999999999999866556899998764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=92.58  E-value=0.088  Score=41.63  Aligned_cols=30  Identities=20%  Similarity=0.221  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCceEeCCCCCeEEcccccce
Q 026939           31 LRIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            349999999999999987777899998664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.43  E-value=0.095  Score=41.85  Aligned_cols=28  Identities=29%  Similarity=0.401  Sum_probs=24.5

Q ss_pred             CeeecCCCCCceEeCCCCCeEEcccccce
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      .++|+|+.+.||+++.++ +.++||+.+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            489999999999999876 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=91.91  E-value=0.04  Score=54.19  Aligned_cols=109  Identities=13%  Similarity=-0.025  Sum_probs=76.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCC--CCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDS--RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~--~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      .+++...+.....+.+.+..-+|+..  +-.-+|.+++.-|.++..+-.++++++|+.....+  .....+...+++.|+
T Consensus      1330 ~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v 1407 (2724)
T KOG1826|consen 1330 PDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYV 1407 (2724)
T ss_pred             CcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHH
Confidence            34444555555555466665555432  23478999999999999999999999999873211  112222235567788


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCC
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNS  114 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~  114 (230)
                      .+++...-.++.++|+|..|+.+|..-.|..+|
T Consensus      1408 ~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1408 LQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            888888888888899999999999988777764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=91.90  E-value=0.29  Score=40.34  Aligned_cols=30  Identities=27%  Similarity=0.375  Sum_probs=26.8

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            499999999999999998999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK10271 thiK thiamine kinase; Provisional

Probab=91.67  E-value=0.15  Score=38.89  Aligned_cols=29  Identities=24%  Similarity=0.305  Sum_probs=24.8

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ..+|+|+.|.|++++.++ ++++|++.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            479999999999998776 89999987643

>PLN02236 choline kinase

Probab=91.36  E-value=0.33  Score=40.73  Aligned_cols=29  Identities=31%  Similarity=0.509  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceEeCC-CCCeEEcccccce
Q 026939           32 RIIHRDLKASNVLLDH-EMNPKISDFEMAR   60 (230)
Q Consensus        32 ~i~H~di~~~nil~~~-~~~~~l~d~~~~~   60 (230)
                      .++|+|+++.||+++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            4899999999999975 4679999998764

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.29  E-value=0.17  Score=38.74  Aligned_cols=29  Identities=24%  Similarity=0.462  Sum_probs=23.9

Q ss_pred             CeeecCCCCCceEeCCCC-----CeEEcccccce
Q 026939           32 RIIHRDLKASNVLLDHEM-----NPKISDFEMAR   60 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~-----~~~l~d~~~~~   60 (230)
                      .++|||+.+.|+++..++     .+.++||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            489999999999997543     57899998764

subfamily of choline kinases

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=90.98  E-value=0.69  Score=38.63  Aligned_cols=28  Identities=43%  Similarity=0.679  Sum_probs=24.6

Q ss_pred             eeecCCCCCceEeCCCCC-eEEcccccce
Q 026939           33 IIHRDLKASNVLLDHEMN-PKISDFEMAR   60 (230)
Q Consensus        33 i~H~di~~~nil~~~~~~-~~l~d~~~~~   60 (230)
                      ++|+|+.+.||+++.+.. +.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998874 8899998663

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=90.82  E-value=0.42  Score=39.86  Aligned_cols=45  Identities=16%  Similarity=0.329  Sum_probs=36.4

Q ss_pred             HHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccce
Q 026939           13 SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        13 ~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      .+...+..-+--|-..|   +||+|.+--||+++.++.++++||-.+.
T Consensus       206 ~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  206 TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             HHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHhh
Confidence            34555555566777888   9999999999999999999999996544

>COG4499 Predicted membrane protein [Function unknown]

Probab=90.37  E-value=2.4  Score=35.72  Aligned_cols=84  Identities=15%  Similarity=0.101  Sum_probs=58.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      ++....+++++.+.+..|..+...    -.|.-+.|+||+++.++.+.+.-+|+-...              +|.=+.||
T Consensus        81 ~~~k~~Klr~a~~~I~~l~e~~~t----r~~~~laPeNilf~~~l~p~~vH~Glk~~l--------------pPye~tee  142 (434)
T COG4499          81 RKEKTRKLRLALQNIATLSELNNT----RYTFFLAPENILFDGGLTPFFVHRGLKNSL--------------PPYEMTEE  142 (434)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhcc----ceeEEecchheEEcCCCceEEEecchhccC--------------CCCCCCHH
Confidence            345567888888888888665433    567788999999999998888888765322              12224455


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCC
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGF  116 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~  116 (230)
                      .+.          -.+-+++..++.|..+|..
T Consensus       143 ~f~----------~~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         143 RFL----------KEYKALAIYAFNGKFSFES  164 (434)
T ss_pred             HHH----------HHHHHHHHHHHcCCccHHH
Confidence            442          2456777888889998753

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=89.59  E-value=0.64  Score=39.86  Aligned_cols=31  Identities=26%  Similarity=0.418  Sum_probs=25.8

Q ss_pred             CCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           30 RLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        30 ~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ...++|+|+.+.||++..+ .++++|+.++..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            3459999999999999766 589999987654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=89.51  E-value=0.27  Score=39.88  Aligned_cols=30  Identities=23%  Similarity=0.576  Sum_probs=24.7

Q ss_pred             CeeecCCCCCceEeCCCCC-eEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMN-PKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~-~~l~d~~~~~~   61 (230)
                      .++|+|+++.|++++.++. ..|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 46999987754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=88.25  E-value=0.89  Score=40.43  Aligned_cols=55  Identities=13%  Similarity=0.234  Sum_probs=37.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHH-HHhHhCCCCCeeecCCCCCceEeCC----CCCeEEcccccceeec
Q 026939            3 SVQLDWKRRISIINGIARGL-LYLHEDSRLRIIHRDLKASNVLLDH----EMNPKISDFEMARIFG   63 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al-~~Lh~~~~~~i~H~di~~~nil~~~----~~~~~l~d~~~~~~~~   63 (230)
                      +..++..   .++..+..+. ..|-..|   ++|+|-+|.||++..    ++.+.+.|+|+.....
T Consensus       297 ~~gi~~~---~i~~~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  297 KRGISPH---DILNKLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HcCCCHH---HHHHHHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            3344444   3444444444 3345566   999999999999984    5678999999986543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=88.00  E-value=0.3  Score=43.12  Aligned_cols=81  Identities=20%  Similarity=0.146  Sum_probs=42.6

Q ss_pred             ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHH-hhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCCCC
Q 026939           93 VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLW-CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA  171 (230)
Q Consensus        93 ~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  171 (230)
                      +++|||++|.++.++.-|..-+.........   ....... ..+....+.-.   ..+.-++...+.++...|+-..|.
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l---~~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~  183 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYL---EILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPI  183 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHH---HHHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccc
Confidence            6999999999999988775543211000000   0000000 00000000000   023345666788888889988888


Q ss_pred             CCCCHHHH
Q 026939          172 DRPTMSSV  179 (230)
Q Consensus       172 ~RPs~~~i  179 (230)
                      .||...+.
T Consensus       184 ir~l~~~~  191 (725)
T KOG1093|consen  184 IRPLPMEL  191 (725)
T ss_pred             cccchhHH
Confidence            88855444

>PHA03111 Ser/Thr kinase; Provisional

Probab=87.84  E-value=0.76  Score=38.39  Aligned_cols=36  Identities=25%  Similarity=0.167  Sum_probs=22.2

Q ss_pred             HHHHHHHHHHHHHHh-HhCCCCCeeecCCCCCceEeC
Q 026939           11 RISIINGIARGLLYL-HEDSRLRIIHRDLKASNVLLD   46 (230)
Q Consensus        11 ~~~i~~qi~~al~~L-h~~~~~~i~H~di~~~nil~~   46 (230)
                      +..+..||+--.-.+ .-.+-...+|.||||+|||+-
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            344556665544223 222223499999999999983

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=87.52  E-value=0.51  Score=39.14  Aligned_cols=33  Identities=21%  Similarity=0.402  Sum_probs=28.6

Q ss_pred             CCCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939           30 RLRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus        30 ~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      ..+++|+|+.+.|++++..+.+-+.||+++...
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            356999999999999998888999999988653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=87.27  E-value=0.36  Score=43.57  Aligned_cols=92  Identities=25%  Similarity=0.270  Sum_probs=65.9

Q ss_pred             HHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhhhcCCC
Q 026939           12 ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF   91 (230)
Q Consensus        12 ~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~   91 (230)
                      ..+++.-+.++++||+..   -+|+|    ||+.+ ++..++.+|+.........   ......++..+++||+.....+
T Consensus       339 ~~~~r~et~~l~~l~~~~---~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~  407 (829)
T KOG0576|consen  339 AYPLRKETRPLAELHSSY---KVHRD----NILGS-EEEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTI  407 (829)
T ss_pred             hhhhhhhccccccccccc---ccCcc----ccccc-ccccccccccCCcccCccc---ccccCCCCCCCCCchhhccccc
Confidence            344555667888898864   57887    55444 3678889988776543322   1222456789999999999999


Q ss_pred             CccccchhhHHHHHHHHhcCCCC
Q 026939           92 SVKSDVFSFGVLLLEIISGKKNS  114 (230)
Q Consensus        92 ~~~~DiwslG~ll~~ll~g~~p~  114 (230)
                      ....|.|++|+-..++--|.+|-
T Consensus       408 ~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  408 DGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCCCccCCCcchhhcCCCCCCC
Confidence            99999999998767777776663

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=87.17  E-value=0.54  Score=39.22  Aligned_cols=30  Identities=30%  Similarity=0.423  Sum_probs=25.2

Q ss_pred             CeeecCCCCCceEeCC-CCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDH-EMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~-~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||+++. ++.++++||..+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4899999999999974 56899999987643

>PRK11768 serine/threonine protein kinase; Provisional

Probab=87.02  E-value=1  Score=37.50  Aligned_cols=26  Identities=31%  Similarity=0.572  Sum_probs=22.3

Q ss_pred             eeecCCCCCceEeCCCCCeEEcccccce
Q 026939           33 IIHRDLKASNVLLDHEMNPKISDFEMAR   60 (230)
Q Consensus        33 i~H~di~~~nil~~~~~~~~l~d~~~~~   60 (230)
                      ++|+|+.+.||+++ + .+.++||+-+.
T Consensus       198 liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        198 RLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            89999999999995 4 57899998764

>PRK06148 hypothetical protein; Provisional

Probab=86.69  E-value=1  Score=43.41  Aligned_cols=29  Identities=31%  Similarity=0.409  Sum_probs=24.2

Q ss_pred             eeecCCCCCceEeCCCC--Ce-EEccccccee
Q 026939           33 IIHRDLKASNVLLDHEM--NP-KISDFEMARI   61 (230)
Q Consensus        33 i~H~di~~~nil~~~~~--~~-~l~d~~~~~~   61 (230)
                      ++|+|+++.||+++.++  .+ -|+|||-+..
T Consensus       205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        205 VIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            99999999999999775  44 5999987654

>PRK12396 5-methylribose kinase; Reviewed

Probab=86.64  E-value=1.1  Score=38.48  Aligned_cols=31  Identities=29%  Similarity=0.452  Sum_probs=26.0

Q ss_pred             CCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           30 RLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        30 ~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ...++|+|+.+.|||++.+ ..+++|..++.+
T Consensus       226 ~~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy  256 (409)
T PRK12396        226 AQALIHGDLHTGSVFVKND-STKVIDPEFAFY  256 (409)
T ss_pred             chhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence            4469999999999999976 589999877754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=86.35  E-value=1.1  Score=36.49  Aligned_cols=30  Identities=27%  Similarity=0.443  Sum_probs=24.2

Q ss_pred             CCeeecCCCCCceEeCCC--C---CeEEcccccce
Q 026939           31 LRIIHRDLKASNVLLDHE--M---NPKISDFEMAR   60 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~~--~---~~~l~d~~~~~   60 (230)
                      ..++|||++..|||+..+  |   .+++.||..+.
T Consensus       215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence            359999999999999654  3   58899987664

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=84.84  E-value=1.6  Score=36.89  Aligned_cols=30  Identities=23%  Similarity=0.419  Sum_probs=24.7

Q ss_pred             CCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           31 LRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ..++|+|+.+.||+++.+ .++++|+..+..
T Consensus       192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence            459999999999999765 477999887654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=83.92  E-value=2  Score=37.05  Aligned_cols=41  Identities=20%  Similarity=0.293  Sum_probs=28.9

Q ss_pred             HHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           20 RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        20 ~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ..|++.-......++|+|+.+.||+++.++ .+++|..++.+
T Consensus       219 ~~Lk~~f~~~~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~  259 (418)
T PLN02756        219 AELKSMFCERAQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY  259 (418)
T ss_pred             HHHHHHHHhcccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence            334333333345699999999999999875 88888766644

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=83.86  E-value=0.71  Score=38.72  Aligned_cols=14  Identities=43%  Similarity=0.821  Sum_probs=13.1

Q ss_pred             CeeecCCCCCceEe
Q 026939           32 RIIHRDLKASNVLL   45 (230)
Q Consensus        32 ~i~H~di~~~nil~   45 (230)
                      ..+|.||||+|||+
T Consensus       299 nF~H~DLKPdNILi  312 (434)
T PF05445_consen  299 NFLHVDLKPDNILI  312 (434)
T ss_pred             eeeecccCcCcEEE
Confidence            49999999999998

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK06149 hypothetical protein; Provisional

Probab=83.81  E-value=1.4  Score=42.31  Aligned_cols=28  Identities=21%  Similarity=0.312  Sum_probs=23.0

Q ss_pred             eeecCCCCCceEeCCCC--C---eEEcccccce
Q 026939           33 IIHRDLKASNVLLDHEM--N---PKISDFEMAR   60 (230)
Q Consensus        33 i~H~di~~~nil~~~~~--~---~~l~d~~~~~   60 (230)
                      ++|+|+++.||+++.+.  .   ..|+|||-+.
T Consensus       210 ~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        210 AVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             ccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            99999999999998652  3   3789998664

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=82.63  E-value=2.3  Score=36.26  Aligned_cols=58  Identities=19%  Similarity=0.240  Sum_probs=48.7

Q ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939            1 MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus         1 ~~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ||..+++...+..+..+++..+..|.+.+  ++||.||+--|+|+- +|.+.++|.+.+.-
T Consensus       256 LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  256 LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEEEEEcccccc
Confidence            56778888889999999999999999887  599999999998775 56789999765543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	230
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-29
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-28
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-22
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		5e-04
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  123 bits (309), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 72/188 (38%), Positives = 105/188 (55%), Gaps = 7/188 (3%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LDW +R  I  G ARGL YLH+    +IIHRD+KA+N+LLD E    + DF +A++    
Sbjct: 136 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 195
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS- 124
                   + GT G++APEY   G  S K+DVF +GV+LLE+I+G++   F L+ L    
Sbjct: 196 DXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR--AFDLARLANDD 252
Query: 125 ---LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
              LL +   L  E +   L++  L+ +    E+ + I + LLC Q+   +RP MS VV 
Sbjct: 253 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 312
Query: 182 MLASDNVT 189
           ML  D + 
Sbjct: 313 MLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 104/188 (55%), Gaps = 7/188 (3%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LDW +R  I  G ARGL YLH+    +IIHRD+KA+N+LLD E    + DF +A++    
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS- 124
                   + G  G++APEY   G  S K+DVF +GV+LLE+I+G++   F L+ L    
Sbjct: 188 DXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR--AFDLARLANDD 244
Query: 125 ---LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
              LL +   L  E +   L++  L+ +    E+ + I + LLC Q+   +RP MS VV 
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 182 MLASDNVT 189
           ML  D + 
Sbjct: 305 MLEGDGLA 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/179 (34%), Positives = 98/179 (54%), Gaps = 5/179 (2%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
           ++ + W++R+ I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DF +++  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK- 188
Query: 63  GGNQSEASTNRIV-GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           G    +     +V GT GY+ PEY ++G  + KSDV+SFGV+L E++  +      L   
Sbjct: 189 GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
             +L  +  +    G+  ++++P L        L KF    + C+   S DRP+M  V+
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/179 (34%), Positives = 98/179 (54%), Gaps = 5/179 (2%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
           ++ + W++R+ I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DF +++  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK- 188
Query: 63  GGNQSEASTNRIV-GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           G    +     +V GT GY+ PEY ++G  + KSDV+SFGV+L E++  +      L   
Sbjct: 189 GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
             +L  +  +    G+  ++++P L        L KF    + C+   S DRP+M  V+
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 51/105 (48%), Positives = 66/105 (62%), Gaps = 4/105 (3%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDF +AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                 +RIVGT  YMAPE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 187 AQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 51/105 (48%), Positives = 65/105 (61%), Gaps = 4/105 (3%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDF +AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                  RIVGT  YMAPE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 187 AQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 51/105 (48%), Positives = 65/105 (61%), Gaps = 4/105 (3%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDF +AR     
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                  RIVGT  YMAPE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 181 AQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/105 (47%), Positives = 65/105 (61%), Gaps = 4/105 (3%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDF +AR     
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                 +RIVGT  Y APE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 178 AQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/102 (40%), Positives = 62/102 (60%), Gaps = 12/102 (11%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--------KISDFEMARIFGGNQSEA 69
           IARG+ YLH+++ + IIHRDLK+SN+L+  ++          KI+DF +AR         
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRT 169
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +     G Y +MAPE     +FS  SDV+S+GVLL E+++G+
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 23/187 (12%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A G+ Y+    R+  IHRDL+++N+L+ + +  KI+DF +AR+   N+  A        
Sbjct: 114 VAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-P 169
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             + APE A+ G F++KSDV+SFG+LL E+++  +     +   G +            E
Sbjct: 170 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR-----VPYPGMN----------NRE 214
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPA 197
            LE +E   +  C     +    + + C + D  +RPT   +   L  D  T    TEP 
Sbjct: 215 VLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFL-EDYFTA---TEPQ 270
Query: 198 FSVGRNV 204
           +  G N+
Sbjct: 271 YQPGENL 277

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 106 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 162
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 163 GAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 219
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 220 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 262
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 263 T---STEPQYQPGENL 275

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 108 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 164
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 165 GAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 221
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 222 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 264
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 265 T---STEPQYQPGENL 277

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 41/111 (36%), Positives = 69/111 (62%), Gaps = 3/111 (2%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLD +RR+S+   +A+G+ YLH +    I+HR+LK+ N+L+D +   K+ DF ++R+   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSG 115
             +  S+    GT  +MAPE   +   + KSDV+SFGV+L E+ + ++  G
Sbjct: 192 --TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/111 (36%), Positives = 67/111 (60%), Gaps = 3/111 (2%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLD +RR+S+   +A+G+ YLH +    I+HRDLK+ N+L+D +   K+ DF ++R+   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSG 115
                 +    GT  +MAPE   +   + KSDV+SFGV+L E+ + ++  G
Sbjct: 192 --XFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 174 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 230
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 231 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 273
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 274 T---STEPQYQPGENL 286

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 107 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ 163
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 164 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 220
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + +  +RPT   +   L  D  
Sbjct: 221 GYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYF 263
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 264 T---STEPQYQPGENL 276

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 110 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 166
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 167 GAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 223
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + +  +RPT   +   L  D  
Sbjct: 224 GYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYF 266
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 267 T---STEPQYQPGENL 279

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 29/190 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A        
Sbjct: 120 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 175
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT---WKLWC 134
             + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L      +++ C
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPC 233
Query: 135 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPT 194
             E  E +  ++ Q                C + +  +RPT   +   L  D  T    T
Sbjct: 234 PPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYFT---ST 273
Query: 195 EPAFSVGRNV 204
           EP +  G N+
Sbjct: 274 EPQYQPGENL 283

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 29/190 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A        
Sbjct: 120 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-P 175
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT---WKLWC 134
             + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L      +++ C
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPC 233
Query: 135 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPT 194
             E  E +  ++ Q                C + +  +RPT   +   L  D  T    T
Sbjct: 234 PPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYFT---ST 273
Query: 195 EPAFSVGRNV 204
           EP +  G N+
Sbjct: 274 EPQYQPGENL 283

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 340 GAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 396
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + +  +RPT   +   L  D  
Sbjct: 397 GYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYF 439
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP +  G N+
Sbjct: 440 T---STEPQYQPGENL 452

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF + R+   N+  A  
Sbjct: 284 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ 340
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 341 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 397
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + D  +RPT   +   L  D  
Sbjct: 398 GYRMPCPPECPESLHDLMCQ----------------CWRKDPEERPTFEYLQAFL-EDYF 440
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP    G N+
Sbjct: 441 T---STEPQXQPGENL 453

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 366 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 423 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 479
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + +  +RPT   +   L  D  
Sbjct: 480 GYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYF 522
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP    G N+
Sbjct: 523 T---STEPQXQPGENL 535

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 340 GAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 396
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + +  +RPT   +   L  D  
Sbjct: 397 GYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYF 439
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP    G N+
Sbjct: 440 T---STEPQXQPGENL 452

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-- 129
                   + APE A+ G F++KSDV+SFG+LL E+ +  K    Y   + + +L     
Sbjct: 340 GAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVER 396
Query: 130 -WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV 188
            +++ C  E  E +  ++ Q                C + +  +RPT   +   L  D  
Sbjct: 397 GYRMPCPPECPESLHDLMCQ----------------CWRKEPEERPTFEYLQAFL-EDYF 439
Query: 189 TLPQPTEPAFSVGRNV 204
           T    TEP    G N+
Sbjct: 440 T---STEPQXQPGENL 452

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/115 (37%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 8   WKRRISIINGIARGLLYLHED-------SRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           W     I   +ARGL YLHED        +  I HRD+K+ NVLL + +   I+DF +A 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVF------SFGVLLLEIIS 109
            F   +S   T+  VGT  YMAPE  +EG  + + D F      + G++L E+ S
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 63/122 (51%), Gaps = 16/122 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q  W +R+S    IA G+ YLH    + IIHRDL + N L+    N  ++DF +AR+   
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160
Query: 65  NQSEASTNR------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
            +++    R            +VG   +MAPE      +  K DVFSFG++L EII G+ 
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRV 219
Query: 113 NS 114
           N+
Sbjct: 220 NA 221

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 110 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 166
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK--NSGFYLSEL 121
            N+  A          + APE    G F++KSDV+SFG+LL EI++  +    G    E+
Sbjct: 167 DNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 225
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q+L               ++ P    +C   EL + +    LC +    DRPT   +  
Sbjct: 226 IQNL----------ERGYRMVRP---DNC-PEELYQLMR---LCWKERPEDRPTFDYLRS 268
Query: 182 ML-----ASDNVTLPQP 193
           +L     A++    PQP
Sbjct: 269 VLEDFFTATEGQYQPQP 285

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 112 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 168
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK--NSGFYLSEL 121
            N+  A          + APE    G F++KSDV+SFG+LL EI++  +    G    E+
Sbjct: 169 DNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 227
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q+L               ++ P    +C   EL + +    LC +    DRPT   +  
Sbjct: 228 IQNL----------ERGYRMVRP---DNC-PEELYQLMR---LCWKERPEDRPTFDYLRS 270
Query: 182 ML-----ASDNVTLPQP 193
           +L     A++    PQP
Sbjct: 271 VLEDFFTATEGQYQPQP 287

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ Y+    R   IHRDL+A+NVL+   +  KI+DF +AR+   N+  A        
Sbjct: 119 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 175
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + APE    G F++KSDV+SFG+LL EI++  K
Sbjct: 176 -KWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGK 209

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 28/197 (14%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK--NSGFYLSEL 121
            N+  A          + APE    G F++KSDV+SFG+LL EI++  +    G    E+
Sbjct: 161 DNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q+              LE    +++      EL + +    LC +    DRPT   +  
Sbjct: 220 IQN--------------LERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRS 262
Query: 182 ML-----ASDNVTLPQP 193
           +L     A++    PQP
Sbjct: 263 VLEDFFTATEGQYQPQP 279

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 113 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 169
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK--NSGFYLSEL 121
            N+  A          + APE    G F++KSDV+SFG+LL EI++  +    G    E+
Sbjct: 170 DNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 228
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q+L               ++ P    +C   EL + +    LC +    DRPT   +  
Sbjct: 229 IQNL----------ERGYRMVRP---DNC-PEELYQLMR---LCWKERPEDRPTFDYLRS 271
Query: 182 ML-----ASDNVTLPQP 193
           +L     A++    PQP
Sbjct: 272 VLEDFFTATEGQFQPQP 288

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 114 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 170
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK--NSGFYLSEL 121
            N+  A          + APE    G F++KSDV+SFG+LL EI++  +    G    E+
Sbjct: 171 DNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 229
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q+L               ++ P    +C   EL + +    LC +    DRPT   +  
Sbjct: 230 IQNL----------ERGYRMVRP---DNC-PEELYQLMR---LCWKERPEDRPTFDYLRS 272
Query: 182 ML-----ASDNVTLPQP 193
           +L     A++    PQP
Sbjct: 273 VLEDFFTATEGQYQPQP 289

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 106 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 162
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 163 DNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 161 DNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 105 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 161
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 162 DNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 110 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 166
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 167 DNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 109 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 165
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 166 DNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 66/115 (57%), Gaps = 14/115 (12%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF----EMA 59
            + + K+ I I    ARG+ YLH  S   IIHRDLK++N+ L  +   KI DF    E +
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 60  RIFGGNQSEASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
           R  G +Q E    ++ G+  +MAPE         +S +SDV++FG++L E+++G+
Sbjct: 172 RWSGSHQFE----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 66/115 (57%), Gaps = 14/115 (12%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF----EMA 59
            + + K+ I I    ARG+ YLH  S   IIHRDLK++N+ L  +   KI DF    E +
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 60  RIFGGNQSEASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
           R  G +Q E    ++ G+  +MAPE         +S +SDV++FG++L E+++G+
Sbjct: 172 RWSGSHQFE----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 62/111 (55%), Gaps = 6/111 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
            + + K+ I I    ARG+ YLH  S   IIHRDLK++N+ L  +   KI DF +A +  
Sbjct: 103 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKS 159
Query: 64  GNQSEASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
                    ++ G+  +MAPE         +S +SDV++FG++L E+++G+
Sbjct: 160 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 161 DNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 99  IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 155
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 156 DNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 5/99 (5%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           +I+  I +GL YLH +   R IHRD+KA+NVLL  + + K++DF +A      Q     N
Sbjct: 120 TILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 174
Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 175 XFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E   S  SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 203 IDXXKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 262 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ Y+    R   IHRDL+A+NVL+   +  KI+DF +AR+   N+  A        
Sbjct: 118 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 174
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + APE    G F++KS+V+SFG+LL EI++  K
Sbjct: 175 -KWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGK 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 64/111 (57%), Gaps = 5/111 (4%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R+   D  +  +++  I +GL YLH + +   IHRD+KA+NVLL  + + K++DF +A 
Sbjct: 112 LRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG 168
Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                 ++   N  VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 169 QL--TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 135 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 191
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 192 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 250
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 251 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 292

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 203 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 262 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 131 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 188 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 247 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 288

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 187 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 244 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 303 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 344

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           G++YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N++ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 81  MAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
           +APE      F  +  DV+S G++L  +++G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 139 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 195
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 196 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 254
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 255 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 296

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 138 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 194
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 195 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 253
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 254 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 295

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 203 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 262 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           QL  K  +S    +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 202
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
            +  + +TN  +    +MAPE   + +++ +SDV+SFGVLL EI +  G    G  + EL
Sbjct: 203 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                   +KL  EG  ++      K S    EL   +     C  A  + RPT   +V
Sbjct: 262 --------FKLLKEGHRMD------KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DF +A      
Sbjct: 116 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Q     N  VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 173 Q--IKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DF +A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Q     N  VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 158 Q--IKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DF +A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Q     N  VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 158 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +          
Sbjct: 107 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
            ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DF +A      
Sbjct: 121 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Q     N  VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 178 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 9/101 (8%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--AS 70
           +I+    +GL YLH    +R IHRD+KA N+LL+ E + K++DF +A    G  ++  A 
Sbjct: 129 TILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDXMAK 181
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N ++GT  +MAPE   E  ++  +D++S G+  +E+  GK
Sbjct: 182 RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +          
Sbjct: 107 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
            ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +          
Sbjct: 109 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
            ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +          
Sbjct: 134 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 190
Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
            ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 191 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +          
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
            ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 28/197 (14%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+  
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK--NSGFYLSEL 121
             +  A          + APE    G F++KSDV+SFG+LL EI++  +    G    E+
Sbjct: 161 DAEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
            Q+L               ++ P    +C   EL + +    LC +    DRPT   +  
Sbjct: 220 IQNL----------ERGYRMVRP---DNC-PEELYQLMR---LCWKERPEDRPTFDYLRS 262
Query: 182 ML-----ASDNVTLPQP 193
           +L     A++    PQP
Sbjct: 263 VLEDFFTATEGQYQPQP 279

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 64/107 (59%), Gaps = 14/107 (13%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF----EMARIFGGNQS 67
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF    E +R  G +Q 
Sbjct: 127 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 68  EASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
           E    ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 184 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +          
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
            ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 63/106 (59%), Gaps = 4/106 (3%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHR+L+A+N+L+   ++ KI+DF +AR+  
Sbjct: 100 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIE 156
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N+  A          + APE    G F++KSDV+SFG+LL EI++
Sbjct: 157 DNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +          
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 191
Query: 72  NRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
            ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 76/176 (43%), Gaps = 21/176 (11%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           IS    +ARG+ +L   S  + IHRDL A N+LL      KI DF +AR    N      
Sbjct: 202 ISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSLLSYT 129
                   +MAPE   + ++S KSDV+S+GVLL EI S  G    G  + E   S L   
Sbjct: 259 GDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREG 318
Query: 130 WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
            ++     A E   P + Q            I L C   D  +RP  + +V  L  
Sbjct: 319 MRM----RAPEYSTPEIYQ------------IMLDCWHRDPKERPRFAELVEKLGD 358

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 64/107 (59%), Gaps = 14/107 (13%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF----EMARIFGGNQS 67
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF    E +R  G +Q 
Sbjct: 107 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 163
Query: 68  EASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
           E    ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 164 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 64/107 (59%), Gaps = 14/107 (13%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDF----EMARIFGGNQS 67
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF    E +R  G +Q 
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 191
Query: 68  EASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
           E    ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+
Sbjct: 192 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 315 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 356

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 142 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 198
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 199 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 257
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 258 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 299

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 57/92 (61%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DF +AR+   N+  A        
Sbjct: 120 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE    G F++KSDV+SFG+LL+EI++
Sbjct: 177 -KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 140 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINN 196
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 255
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 256 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 297

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 26/189 (13%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           +S  LD     +I+  +  GL YLH++ +   IHRD+KA N+LL  + + +I+DF ++  
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAF 170
Query: 62  F--GGNQSEASTNR-IVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGF 116
              GG+ +     +  VGT  +MAPE  ME +  +  K+D++SFG+  +E+ +G   +  
Sbjct: 171 LATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATG---AAP 226
Query: 117 YLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK-----FIHIGLLCVQADSA 171
           Y       +L  T         L+   P L+      E+LK     F  +  LC+Q D  
Sbjct: 227 YHKYPPMKVLMLT---------LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE 277
Query: 172 DRPTMSSVV 180
            RPT + ++
Sbjct: 278 KRPTAAELL 286

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                +T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+L+      K+ DF +AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              T  ++GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE   E      SD+++ G ++ ++++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 62/106 (58%), Gaps = 5/106 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G++YL E    R++HRDL A NVL+    + KI+DF +AR+  G++ E + +     
Sbjct: 149 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 205
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
             +MA E      F+ +SDV+S+GV + E+++  GK   G    E+
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 26/189 (13%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           +S  LD     +I+  +  GL YLH++ +   IHRD+KA N+LL  + + +I+DF ++  
Sbjct: 109 KSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAF 165
Query: 62  F--GGNQSEASTNR-IVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGF 116
              GG+ +     +  VGT  +MAPE  ME +  +  K+D++SFG+  +E+ +G   +  
Sbjct: 166 LATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATG---AAP 221
Query: 117 YLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK-----FIHIGLLCVQADSA 171
           Y       +L  T         L+   P L+      E+LK     F  +  LC+Q D  
Sbjct: 222 YHKYPPMKVLMLT---------LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE 272
Query: 172 DRPTMSSVV 180
            RPT + ++
Sbjct: 273 KRPTAAELL 281

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 15/118 (12%)
Query: 6   LDWKRRISIINGIARGLLYLHED--------SRLRIIHRDLKASNVLLDHEMNPKISDFE 57
           + W     +   ++RGL YLHED         +  I HRD K+ NVLL  ++   ++DF 
Sbjct: 109 ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFG 168
Query: 58  MARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVF------SFGVLLLEIIS 109
           +A  F   +    T+  VGT  YMAPE  +EG  + + D F      + G++L E++S
Sbjct: 169 LAVRFEPGKPPGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 145 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 201
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 202 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 260
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 261 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 302

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 57/92 (61%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DF +AR+   N+  A        
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 349
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE    G F++KSDV+SFG+LL+EI++
Sbjct: 350 -KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 34/77 (44%), Positives = 48/77 (62%), Gaps = 2/77 (2%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFS 92
           ++HRDLK +NV LD + N K+ DF +ARI   + S A T   VGT  YM+PE      ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYN 194
Query: 93  VKSDVFSFGVLLLEIIS 109
            KSD++S G LL E+ +
Sbjct: 195 EKSDIWSLGCLLYELCA 211

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 5/109 (4%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           +S + D  R       I   L++LH+     II+RDLK  NVLLDHE + K++DF M + 
Sbjct: 117 KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK- 172
Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             G  +  +T    GT  Y+APE   E L+    D ++ GVLL E++ G
Sbjct: 173 -EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DF +AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              T  ++GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DF +AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              T  ++GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 62/106 (58%), Gaps = 5/106 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G++YL E    R++HRDL A NVL+    + KI+DF +AR+  G++ E + +     
Sbjct: 126 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
             +MA E      F+ +SDV+S+GV + E+++  GK   G    E+
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DF +AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              T  ++GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DF +AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              T  ++GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   S    +HRDL A NVL+ H    KI DF +AR    + +          
Sbjct: 181 VAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   EG++++KSDV+S+G+LL EI S
Sbjct: 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF +AR+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/77 (42%), Positives = 46/77 (59%), Gaps = 2/77 (2%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFS 92
           ++HRDLK +NV LD + N K+ DF +ARI   N  E      VGT  YM+PE      ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVGTPYYMSPEQMNRMSYN 194
Query: 93  VKSDVFSFGVLLLEIIS 109
            KSD++S G LL E+ +
Sbjct: 195 EKSDIWSLGCLLYELCA 211

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DF +AR I     S
Sbjct: 133 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              T  ++GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + RGL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 118 KVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 169
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YMAPE      +SV+SD++S G+ L+E+  G+
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HRDL A N ++ H+   KI DF M R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      +I+DF +AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINN 209
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELG 122
                 T        +MAPE   + +++ +SDV+SFGVL+ EI +  G    G  + EL 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +KL  EG  ++      K +    EL   +     C  A  + RPT   +V
Sbjct: 269 -------FKLLKEGHRMD------KPANCTNELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HRDL A N ++ H+   KI DF M R           
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HRDL A N ++ H+   KI DF M R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I+  N I  G+ + H+   +RI+HRD+K  N+L+D     KI DF +A+      S   T
Sbjct: 114 INFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQT 169
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           N ++GT  Y +PE A        +D++S G++L E++ G+
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 60/107 (56%), Gaps = 14/107 (13%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA----RIFGGNQS 67
           I I    A+G+ YLH  +   IIHRD+K++N+ L   +  KI DF +A    R  G  Q 
Sbjct: 135 IDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 68  EASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
           E  T    G+  +MAPE         FS +SDV+S+G++L E+++G+
Sbjct: 192 EQPT----GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD  +A      Q++ 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            T    GT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 148 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 205 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDVIKAV- 261
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 262 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 234
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 235 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD  +A      Q++ 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            T    GT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 234
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 235 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD  +A      Q++ 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            T    GT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD  +A      Q++ 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            T    GT G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 138 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 251
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 252 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/101 (38%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEA 69
           ++++ I+  L YLHE+   RIIHRDLK  N++L      +  KI D   A+    +Q E 
Sbjct: 126 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGEL 180
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            T   VGT  Y+APE   +  ++V  D +SFG L  E I+G
Sbjct: 181 CTE-FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/101 (38%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEA 69
           ++++ I+  L YLHE+   RIIHRDLK  N++L      +  KI D   A+    +Q E 
Sbjct: 125 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGEL 179
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            T   VGT  Y+APE   +  ++V  D +SFG L  E I+G
Sbjct: 180 CTE-FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF + R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + +PE      F+  SDV+S+G++L E++S  +   + +S   Q ++    
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q D  +RP    +V +L
Sbjct: 264 -----DEGYRLPPPM---DCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/77 (42%), Positives = 47/77 (61%), Gaps = 2/77 (2%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFS 92
           ++HRDLK +NV LD + N K+ DF +ARI   + S A     VGT  YM+PE      ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYN 194
Query: 93  VKSDVFSFGVLLLEIIS 109
            KSD++S G LL E+ +
Sbjct: 195 EKSDIWSLGCLLYELCA 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 170 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 221
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 222 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DF M +    
Sbjct: 114 KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--EN 168
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQ 123
              +A TN   GT  Y+APE  +   ++   D +SFGVLL E++ G+    G    EL  
Sbjct: 169 MLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
Query: 124 SLL--SYTWKLWCEGEALELM 142
           S+   +  +  W E EA +L+
Sbjct: 229 SIRMDNPFYPRWLEKEAKDLL 249

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 27/177 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ G+  G+ YL   S L  +HRDL A NVL+D  +  K+SDF ++R+   +   A T
Sbjct: 154 VGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 72  NRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL 126
                T G     + APE      FS  SDV+SFGV++ E+++  +    Y +   + ++
Sbjct: 211 T----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNRDVI 264
Query: 127 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           S         E   L  P+    C  A       + L C   D A RP  S +V +L
Sbjct: 265 SSV------EEGYRLPAPM---GCPHA----LHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DF M +    
Sbjct: 115 KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--EN 169
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQ 123
              +A TN   GT  Y+APE  +   ++   D +SFGVLL E++ G+    G    EL  
Sbjct: 170 MLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 229
Query: 124 SLL--SYTWKLWCEGEALELM 142
           S+   +  +  W E EA +L+
Sbjct: 230 SIRMDNPFYPRWLEKEAKDLL 250

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HRDL A N ++ H+   KI DF M R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GI  G+ YL   S +  +HRDL A N+L++  +  K+SDF M+R+   +   A T
Sbjct: 134 VGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + APE      F+  SDV+S+G+++ E++S  +   + +S   Q ++    
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAI- 247
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C  A       + L C Q + +DRP    +V ML
Sbjct: 248 -----EEGYRLPPPM---DCPIA----LHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GI  G+ YL   S +  +HRDL A N+L++  +  K+SDF M+R+   +   A T
Sbjct: 119 VGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + APE      F+  SDV+S+G+++ E++S  +   + +S   Q ++    
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAI- 232
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C  A       + L C Q + +DRP    +V ML
Sbjct: 233 -----EEGYRLPPPM---DCPIA----LHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 135 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 186
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 159
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 159
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HRDL A N ++ H+   KI DF M R           
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 57/94 (60%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++  N  VGT
Sbjct: 132 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 185
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 186 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 159
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HRDL A N ++ H+   KI DF M R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 159
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   ++ 
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 159
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 27/177 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ G+  G+ YL   S L  +HRDL A NVL+D  +  K+SDF ++R+   +   A T
Sbjct: 154 VGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 72  NRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL 126
                T G     + APE      FS  SDV+SFGV++ E+++  +    Y +   + ++
Sbjct: 211 T----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNRDVI 264
Query: 127 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           S         E   L  P+    C  A       + L C   D A RP  S +V +L
Sbjct: 265 SSV------EEGYRLPAPM---GCPHA----LHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 160 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 266

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GI  G+ YL   S +  +HRDL A N+L++  +  K+SDF M+R+   +   A T
Sbjct: 113 VGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 169
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + APE      F+  SDV+S+G+++ E++S  +   + +S   Q ++    
Sbjct: 170 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAI- 226
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C  A       + L C Q + +DRP    +V ML
Sbjct: 227 -----EEGYRLPPPM---DCPIA----LHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 136 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 242

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 120 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 60/101 (59%), Gaps = 8/101 (7%)
Query: 11  RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS 70
           ++SI   + +GL YL E  + +I+HRD+K SN+L++     K+ DF ++    G   +  
Sbjct: 111 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEM 162
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 163 ANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 127 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 132 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 127 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 130 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 59/99 (59%), Gaps = 5/99 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEAS 70
           + ++  IA G+ YL   S   ++H+DL   NVL+  ++N KISD  + R ++  +  +  
Sbjct: 148 VHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 204
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N ++    +MAPE  M G FS+ SD++S+GV+L E+ S
Sbjct: 205 GNSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 24/173 (13%)
Query: 8   WKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS 67
           WK  + + + +       H  SR R++HRD+K +NV +      K+ D  + R F    +
Sbjct: 139 WKYFVQLCSALE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS 127
            A +  +VGT  YM+PE   E  ++ KSD++S G LL E+ + +  S FY  ++  +L S
Sbjct: 192 AAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKM--NLYS 245
Query: 128 YTWKL-WCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
              K+  C+        P L     + EL + ++   +C+  D   RP ++ V
Sbjct: 246 LCKKIEQCD-------YPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD  +A  F   +  AS    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           +GYMAPE   +G+ +   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 59/99 (59%), Gaps = 5/99 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEAS 70
           + ++  IA G+ YL   S   ++H+DL   NVL+  ++N KISD  + R ++  +  +  
Sbjct: 131 VHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            N ++    +MAPE  M G FS+ SD++S+GV+L E+ S
Sbjct: 188 GNSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD  +A  F   +  AS    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           +GYMAPE   +G+ +   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 151 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD  +A  F   +  AS    VGT
Sbjct: 300 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 352
Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           +GYMAPE   +G+ +   +D FS G +L +++ G
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD  +A  F   +  AS    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 110
           +GYMAPE   +G+ +   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/115 (37%), Positives = 62/115 (53%), Gaps = 10/115 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           IA GL +L       II+RDLK  NV+LD E + KI+DF M +  I+ G     +T    
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 503
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYT 129
           GT  Y+APE      +    D ++FGVLL E+++G+    G    EL QS++ + 
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 19/173 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GI+ G+ YL   S +  +HRDL A N+L++  +  K+SDF ++R+   +   A T
Sbjct: 127 VGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 72  NRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW 130
            R       + APE      F+  SDV+S+G+++ E++S  +    Y     Q ++    
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP--YWEMTNQDVIKAV- 240
Query: 131 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 E   L  P+    C AA       + L C Q +   RP    +V ML
Sbjct: 241 -----EEGYRLPSPM---DCPAA----LYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ ST  +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 181
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ YL ED RL  +HRDL A NVL+    + KI+DF +A++ G  + E         
Sbjct: 123 IAEGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF  A++ G  + E         
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF  A++ G  + E         
Sbjct: 130 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/115 (37%), Positives = 62/115 (53%), Gaps = 10/115 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           IA GL +L       II+RDLK  NV+LD E + KI+DF M +  I+ G     +T    
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 182
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYT 129
           GT  Y+APE      +    D ++FGVLL E+++G+    G    EL QS++ + 
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
            ++ I  G+LYLH      I+HRDL  SN+LL   MN KI+DF +A        +  T  
Sbjct: 117 FMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-- 171
Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           + GT  Y++PE A      ++SDV+S G +   ++ G+
Sbjct: 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF  A++ G  + E         
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF  A++ G  + E         
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF  A++ G  + E         
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HR+L A N ++ H+   KI DF M R           
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 191 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DF  A++ G  + E         
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL 125
             +MA E  +  +++ +SDV+S+GV + E+++   K   G   SE+   L
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           I +   IA G+ YL+     + +HR+L A N ++ H+   KI DF M R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + +    +MAPE   +G+F+  SD++SFGV+L EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 19  ARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVGT 77
           ++G+ YLH      +IHRDLK  N+LL       KI DF  A      Q+  + N+  G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GS 166
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE      +S K DVFS+G++L E+I+ +K       E+G       W +     
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAV----- 217
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEP 196
                 P++K      E L        C   D + RP+M  +V ++       P   EP
Sbjct: 218 HNGTRPPLIKNLPKPIESLM-----TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 19  ARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVGT 77
           ++G+ YLH      +IHRDLK  N+LL       KI DF  A      Q+  + N+  G+
Sbjct: 113 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GS 167
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE      +S K DVFS+G++L E+I+ +K       E+G       W +     
Sbjct: 168 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAV----- 218
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEP 196
                 P++K      E L        C   D + RP+M  +V ++       P   EP
Sbjct: 219 HNGTRPPLIKNLPKPIESLM-----TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 17/113 (15%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           KRR ++    AR        G+ YLH +   R+IHRDLK  N+ L+ +M+ KI DF +A 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 61  I--FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              F G + +     + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 191 KIEFDGERKKT----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 159 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 216 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 26  HEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY 85
           H    L+IIHRD+K SN+LLD   N K+ DF ++   G      +  R  G   YMAPE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPER 196
Query: 86  ----AMEGLFSVKSDVFSFGVLLLEIISGK 111
               A    + V+SDV+S G+ L E+ +G+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 194 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL  LH   R RI++RDLK  N+LLD   + +ISD  +A      Q+       VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGT 348
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GYMAPE      ++   D ++ G LL E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 3/108 (2%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           +++ + +A G++YL   + L  +HRDL   N L+   +  KI DF M+R           
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
            R +    +M PE  +   F+ +SDV+SFGV+L EI +  K   + LS
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 242

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 57/98 (58%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           IS    I++G+ YL E   ++++HRDL A N+L+      KISDF ++R      S    
Sbjct: 153 ISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKR 209
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 10/115 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I+ GL +LH+     II+RDLK  NV+LD E + KI+DF M +  +  G     +T    
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG----VTTREFC 181
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYT 129
           GT  Y+APE      +    D +++GVLL E+++G+    G    EL QS++ + 
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 236

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 17/113 (15%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           KRR ++    AR        G+ YLH +   R+IHRDLK  N+ L+ +M+ KI DF +A 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 61  I--FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              F G + +     + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 191 KIEFDGERKKX----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 3/108 (2%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           +++ + +A G++YL   + L  +HRDL   N L+   +  KI DF M+R           
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
            R +    +M PE  +   F+ +SDV+SFGV+L EI +  K   + LS
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 236

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A GL +LH    L II+RDLK  N+LLD E + K++DF +++    ++ +A +    GT
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGT 193
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             YMAPE       S  +D +S+GVL+ E+++G
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRDL A N+LL H    KI DF +AR    + +          
Sbjct: 170 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE     +++ +SDV+S+G+ L E+ S    S  Y    G  + S  +K+  EG 
Sbjct: 227 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPY---PGMPVDSKFYKMIKEG- 280
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
              ++ P        AE+   +     C  AD   RPT   +V ++
Sbjct: 281 -FRMLSP----EHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 318

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL  LH   R RI++RDLK  N+LLD   + +ISD  +A      Q+       VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGT 348
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GYMAPE      ++   D ++ G LL E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 57/92 (61%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL +   +R++HRDL A NVL+    + KI+DF +AR+   +++E   +     
Sbjct: 128 IAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MA E  +   F+ +SDV+S+GV + E+++
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRDL A N+LL H    KI DF +AR    + +          
Sbjct: 172 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE     +++ +SDV+S+G+ L E+ S    S  Y    G  + S  +K+  EG 
Sbjct: 229 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPY---PGMPVDSKFYKMIKEG- 282
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
              ++ P        AE+   +     C  AD   RPT   +V ++
Sbjct: 283 -FRMLSP----EHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 320

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRDL A N+LL H    KI DF +AR    + +          
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE     +++ +SDV+S+G+ L E+ S    S  Y    G  + S  +K+  EG 
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPY---PGMPVDSKFYKMIKEG- 287
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
              ++ P        AE+   +     C  AD   RPT   +V ++
Sbjct: 288 -FRMLSP----EHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 325

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRDL A N+LL H    KI DF +AR    + +          
Sbjct: 154 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE     +++ +SDV+S+G+ L E+ S    S  Y    G  + S  +K+  EG 
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPY---PGMPVDSKFYKMIKEG- 264
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
              ++ P        AE+   +     C  AD   RPT   +V ++
Sbjct: 265 -FRMLSP----EHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 302

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRDL A N+LL H    KI DF +AR    + +          
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             +MAPE     +++ +SDV+S+G+ L E+ S    S  Y    G  + S  +K+  EG 
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSSPY---PGMPVDSKFYKMIKEG- 287
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
              ++ P        AE+   +     C  AD   RPT   +V ++
Sbjct: 288 -FRMLSP----EHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 325

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 57/98 (58%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           IS    I++G+ YL E   ++++HRDL A N+L+      KISDF ++R      S    
Sbjct: 153 ISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 12/111 (10%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
            +LD  R +   + I +G+ YL   SR R +HRDL A N+L++ E + KI+DF +A++  
Sbjct: 122 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 64  GNQS-----EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            ++      E   + I     + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 179 LDKDYYVVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 12/111 (10%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
            +LD  R +   + I +G+ YL   SR R +HRDL A N+L++ E + KI+DF +A++  
Sbjct: 110 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 166
Query: 64  GNQS-----EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            ++      E   + I     + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 167 LDKDYYVVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR    +            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 17/113 (15%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           KRR ++    AR        G+ YLH +   R+IHRDLK  N+ L+ +M+ KI DF +A 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 61  I--FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              F G + +     + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 191 KIEFDGERKKD----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL E   +  +HRDL A N+L++  +  K+SDF ++R    N S+ + 
Sbjct: 119 VGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 72  NRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +G      + APE      F+  SD +S+G+++ E++S
Sbjct: 176 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 3/108 (2%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           +++ + +A G++YL   + L  +HRDL   N L+   +  KI DF M+R           
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
            R +    +M PE  +   F+ +SDV+SFGV+L EI +  K   + LS
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 12/111 (10%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
            +LD  R +   + I +G+ YL   SR R +HRDL A N+L++ E + KI+DF +A++  
Sbjct: 109 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 165
Query: 64  GNQS-----EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            ++      E   + I     + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 166 LDKDYYVVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 90/186 (48%), Gaps = 26/186 (13%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMNP---KISDFEMAR 60
           + W  ++ ++  IA G+ Y+ ++    I+HRDL++ N+ L    E  P   K++DF +++
Sbjct: 119 IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177
Query: 61  IFGGNQSEASTNRIVGTYGYMAPEY--AMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYL 118
                QS  S + ++G + +MAPE   A E  ++ K+D +SF ++L  I++G+       
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----F 228
Query: 119 SELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSS 178
            E     + +   +  EG     + P + + C      +  ++  LC   D   RP  S 
Sbjct: 229 DEYSYGKIKFINMIREEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSY 279
Query: 179 VVVMLA 184
           +V  L+
Sbjct: 280 IVKELS 285

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 6/108 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
            +LD  R +   + I +G+ YL   SR R +HRDL A N+L++ E + KI+DF +A++  
Sbjct: 106 ARLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLP 162
Query: 64  GNQSEASTNRIVGTYG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            ++ +    R  G     + APE   + +FS +SDV+SFGV+L E+ +
Sbjct: 163 LDK-DXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 17/113 (15%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           KRR ++    AR        G+ YLH +   R+IHRDLK  N+ L+ +M+ KI DF +A 
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 174
Query: 61  I--FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              F G + +     + GT  Y+APE   +   S + D++S G +L  ++ GK
Sbjct: 175 KIEFDGERKKD----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 54/102 (52%), Gaps = 12/102 (11%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           ++ +G  +GL YLH  +   +IHRD+KA N+LL      K+ DF  A I       A  N
Sbjct: 158 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 208
Query: 73  RIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
             VGT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 209 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL E   +  +HRDL A N+L++  +  K+SDF ++R    N S+ + 
Sbjct: 121 VGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 72  NRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +G      + APE      F+  SD +S+G+++ E++S
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 129 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL E S   +IHRDL A N L+      K+SDF M R    +Q  +ST      
Sbjct: 112 VCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + +PE      +S KSDV+SFGVL+ E+ S  K
Sbjct: 169 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 54/102 (52%), Gaps = 12/102 (11%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           ++ +G  +GL YLH  +   +IHRD+KA N+LL      K+ DF  A I       A  N
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169
Query: 73  RIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGK 111
             VGT  +MAPE  +   EG +  K DV+S G+  +E+   K
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 470 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 526
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
                   T+G     + APE      FS KSDV+SFGVL+ E  S            GQ
Sbjct: 527 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----------YGQ 571
Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 ++     E   ++E   +  C A    +   +  LC   D  +RP  ++V + L
Sbjct: 572 K----PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 627

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 194
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 135 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 186
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 187 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 194
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 56/92 (60%), Gaps = 14/92 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DF +AR+  G +           
Sbjct: 287 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--GAKFPIK------- 334
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE    G F++KSDV+SFG+LL+EI++
Sbjct: 335 --WTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 469 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
                   T+G     + APE      FS KSDV+SFGVL+ E  S            GQ
Sbjct: 526 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----------YGQ 570
Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 ++     E   ++E   +  C A    +   +  LC   D  +RP  ++V + L
Sbjct: 571 K----PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 626

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL +   +  +HRDL A N+L++  +  K+SDF ++R    + S+ + 
Sbjct: 138 VGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 72  NRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +G      + APE      F+  SDV+S+G+++ E++S
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ S   +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--EMVGTPY 181
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHR++K+ N+LL  + + K++DF         QS+ ST  +VGT  
Sbjct: 128 QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 182
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 111 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELG 122
                   T+G     + APE      FS KSDV+SFGVL+ E  S G+K    Y    G
Sbjct: 168 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKG 220
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
                         E   ++E   +  C A    +   +  LC   D  +RP  ++V + 
Sbjct: 221 -------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 267
Query: 183 L 183
           L
Sbjct: 268 L 268

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 160 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 211
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 212 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 209
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 92/190 (48%), Gaps = 26/190 (13%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMNP---KISDF 56
           ++  + W  ++ ++  IA G+ Y+ ++    I+HRDL++ N+ L    E  P   K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 57  EMARIFGGNQSEASTNRIVGTYGYMAPEY--AMEGLFSVKSDVFSFGVLLLEIISGKKNS 114
            +++     QS  S + ++G + +MAPE   A E  ++ K+D +SF ++L  I++G+   
Sbjct: 174 GLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP- 227
Query: 115 GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP 174
                E     + +   +  EG     + P + + C      +  ++  LC   D   RP
Sbjct: 228 ---FDEYSYGKIKFINMIREEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRP 275
Query: 175 TMSSVVVMLA 184
             S +V  L+
Sbjct: 276 HFSYIVKELS 285

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R         
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 195
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 209
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ S   +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPY 181
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 195
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            V+L+ ++  ++   + + L YLH      +IHRD+K+ ++LL  +   K+SDF     F
Sbjct: 135 QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFG----F 187
Query: 63  GGNQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
               S+    R  +VGT  +MAPE     L++ + D++S G++++E++ G+
Sbjct: 188 CAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 150 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 201
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 202 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ S   +VGT  
Sbjct: 128 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPY 182
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 3/98 (3%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           IS    I++G+ YL E   + ++HRDL A N+L+      KISDF ++R      S    
Sbjct: 153 ISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKR 209
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 170 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 221
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 222 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y+H+ +   I+HRDLK  N+LL   + + + KI DF ++  F   Q+   
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM 180
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            +RI GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y+H+ +   I+HRDLK  N+LL   + + + KI DF ++  F   Q+   
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM 180
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            +RI GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 111 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELG 122
                   T+G     + APE      FS KSDV+SFGVL+ E  S G+K    Y    G
Sbjct: 168 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKG 220
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
                         E   ++E   +  C A    +   +  LC   D  +RP  ++V + 
Sbjct: 221 -------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 267
Query: 183 L 183
           L
Sbjct: 268 L 268

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/106 (41%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR    +  
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIY 209
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 33/167 (19%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I + L +LH  S+L +IHRD+K SNVL++     K+ DF ++   G    + + +   G 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGC 172
Query: 78  YGYMAPEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLW 133
             YMAPE     L    +SVKSD++S G+ ++E+                ++L + +  W
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIEL----------------AILRFPYDSW 216
Query: 134 CE-----GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
                   + +E   P L     +AE + F      C++ +S +RPT
Sbjct: 217 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPT 260

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 125 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
                   T+G     + APE      FS KSDV+SFGVL+ E  S            GQ
Sbjct: 182 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----------YGQ 226
Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 ++     E   ++E   +  C A    +   +  LC   D  +RP  ++V + L
Sbjct: 227 K----PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 282

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 6/98 (6%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +++ ++ G+ YL E +    +HRDL A NVLL +    KISDF +++  G + S   T R
Sbjct: 115 LLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTAR 170
Query: 74  IVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             G +   + APE      FS +SDV+S+GV + E +S
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 107 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELG 122
                   T+G     + APE      FS KSDV+SFGVL+ E  S G+K    Y    G
Sbjct: 164 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKG 216
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
                         E   ++E   +  C A    +   +  LC   D  +RP  ++V + 
Sbjct: 217 -------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 263
Query: 183 L 183
           L
Sbjct: 264 L 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 9/79 (11%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTY--GYMAPEYAMEGL 90
            +HRDL A NVL+  +   K+SDF + +       EAS+ +  G     + APE   E  
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAA 181
Query: 91  FSVKSDVFSFGVLLLEIIS 109
           FS KSDV+SFG+LL EI S
Sbjct: 182 FSTKSDVWSFGILLWEIYS 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 127 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
                   T+G     + APE      FS KSDV+SFGVL+ E  S            GQ
Sbjct: 184 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----------YGQ 228
Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 ++     E   ++E   +  C A    +   +  LC   D  +RP  ++V + L
Sbjct: 229 K----PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 284

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 127 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
                   T+G     + APE      FS KSDV+SFGVL+ E  S            GQ
Sbjct: 184 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----------YGQ 228
Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 ++     E   ++E   +  C A    +   +  LC   D  +RP  ++V + L
Sbjct: 229 K----PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 284

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 105 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELG 122
                   T+G     + APE      FS KSDV+SFGVL+ E  S G+K    Y    G
Sbjct: 162 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKG 214
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
                         E   ++E   +  C A    +   +  LC   D  +RP  ++V + 
Sbjct: 215 -------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 261
Query: 183 L 183
           L
Sbjct: 262 L 262

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDF +++    +++ 
Sbjct: 117 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 69  ASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELG 122
                   T+G     + APE      FS KSDV+SFGVL+ E  S G+K    Y    G
Sbjct: 174 YKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKG 226
Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
                         E   ++E   +  C A    +   +  LC   D  +RP  ++V + 
Sbjct: 227 -------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 273
Query: 183 L 183
           L
Sbjct: 274 L 274

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL E     +IHRDL A N L+      K+SDF M R    +Q  +ST      
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + +PE      +S KSDV+SFGVL+ E+ S  K
Sbjct: 170 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA 69
           + I +   IA G+ YL+ +   + +HRDL A N  +  +   KI DF M R         
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              + +    +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL E     +IHRDL A N L+      K+SDF M R    +Q  +ST      
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 171
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + +PE      +S KSDV+SFGVL+ E+ S  K
Sbjct: 172 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 69/139 (49%), Gaps = 15/139 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +ARG+ YL   S+ + IHRDL A N+L+      KI+DF ++R       E    + +G 
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 192
Query: 78  YG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL---LSYTW 130
               +MA E     +++  SDV+S+GVLL EI+S  G    G   +EL + L        
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 252
Query: 131 KLWCEGEALELMEPVLKQS 149
            L C+ E  +LM    ++ 
Sbjct: 253 PLNCDDEVYDLMRQCWREK 271

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 69/139 (49%), Gaps = 15/139 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +ARG+ YL   S+ + IHRDL A N+L+      KI+DF ++R       E    + +G 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 202
Query: 78  YG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL---LSYTW 130
               +MA E     +++  SDV+S+GVLL EI+S  G    G   +EL + L        
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 262
Query: 131 KLWCEGEALELMEPVLKQS 149
            L C+ E  +LM    ++ 
Sbjct: 263 PLNCDDEVYDLMRQCWREK 281

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 87/176 (49%), Gaps = 25/176 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL   + +  +HRDL A N+L++  +  K+SDF ++R+   +  EA+ 
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATY 205
Query: 72  NRIVGTYG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS--ELGQSLLS 127
               G     + APE      F+  SDV+SFG+++ E+++  +   + LS  E+ +++  
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-- 263
Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                    +   L  P+    C +A       + + C Q + A RP  + +V +L
Sbjct: 264 --------NDGFRLPTPM---DCPSA----IYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y+H++   +I+HRDLK  N+LL+    + N +I DF ++  F   ++   
Sbjct: 137 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 190
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 191 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRD+ A NVLL +    KI DF +AR    + +          
Sbjct: 173 VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++V+SDV+S+G+LL EI S
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 91/190 (47%), Gaps = 26/190 (13%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMNP---KISDF 56
           ++  + W  ++ ++  IA G+ Y+ ++    I+HRDL++ N+ L    E  P   K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 57  EMARIFGGNQSEASTNRIVGTYGYMAPEY--AMEGLFSVKSDVFSFGVLLLEIISGKKNS 114
             ++     QS  S + ++G + +MAPE   A E  ++ K+D +SF ++L  I++G+   
Sbjct: 174 GTSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP- 227
Query: 115 GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP 174
                E     + +   +  EG     + P + + C      +  ++  LC   D   RP
Sbjct: 228 ---FDEYSYGKIKFINMIREEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRP 275
Query: 175 TMSSVVVMLA 184
             S +V  L+
Sbjct: 276 HFSYIVKELS 285

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y+H+ +   I+HRDLK  N+LL   + + + KI DF ++  F   Q+   
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM 180
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            +RI GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL E     +IHRDL A N L+      K+SDF M R    +Q  +ST      
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + +PE      +S KSDV+SFGVL+ E+ S  K
Sbjct: 169 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRD+ A NVLL +    KI DF +AR    + +          
Sbjct: 173 VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++V+SDV+S+G+LL EI S
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL E     +IHRDL A N L+      K+SDF M R    +Q  +ST      
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + +PE      +S KSDV+SFGVL+ E+ S  K
Sbjct: 167 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRD+ A NVLL +    KI DF +AR    + +          
Sbjct: 161 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++V+SDV+S+G+LL EI S
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRD+ A NVLL +    KI DF +AR    + +          
Sbjct: 167 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 223
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++V+SDV+S+G+LL EI S
Sbjct: 224 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGG 64
           L    ++ I   +A G+ YL E    + +HRDL   N L+   M  KI+DF ++R I+  
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +  +A  N  +    +M PE      ++ +SDV+++GV+L EI S      + ++   + 
Sbjct: 228 DYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--EE 284
Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
           ++ Y      +G  L         +C     L+  ++  LC     ADRP+  S+
Sbjct: 285 VIYYVR----DGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSI 326

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  L +LH    L II+RDLK  N+LLD E + K++DF +++    ++ +A +    GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  L +LH    L II+RDLK  N+LLD E + K++DF +++    ++ +A +    GT
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 190
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 139 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 134 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 3/115 (2%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +L   + + I + IA G++YL   +    +HRDL   N L+   +  KI DF M+R    
Sbjct: 129 ELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
                     +    +M PE  M   F+ +SDV+SFGV+L EI +  K   F LS
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QL  +  +   + +A+G+ +L   +    IHRD+ A NVLL +    KI DF +AR    
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           + +            +MAPE   + +++V+SDV+S+G+LL EI S
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 161 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 35/168 (20%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI-VG 76
           I + L +LH  S+L +IHRD+K SNVL++     K+ DF ++    G   ++    I  G
Sbjct: 162 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDSVAKTIDAG 215
Query: 77  TYGYMAPEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKL 132
              YMAPE     L    +SVKSD++S G+ ++E+                ++L + +  
Sbjct: 216 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL----------------AILRFPYDS 259
Query: 133 WCE-----GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
           W        + +E   P L     +AE + F      C++ +S +RPT
Sbjct: 260 WGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPT 304

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y+H++   +I+HRDLK  N+LL+    + N +I DF ++  F   ++   
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 137 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 160 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  L +LH    L II+RDLK  N+LLD E + K++DF +++    ++ +A +    GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             YMAPE       +  +D +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y+H++   +I+HRDLK  N+LL+    + N +I DF ++  F   ++   
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 207
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 208 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 9/79 (11%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTY--GYMAPEYAMEGL 90
            +HRDL A NVL+  +   K+SDF + +       EAS+ +  G     + APE   E  
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 362
Query: 91  FSVKSDVFSFGVLLLEIIS 109
           FS KSDV+SFG+LL EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ YL   +  + +HRDL A N +LD +   K++DF +AR     +  +  N+    
Sbjct: 140 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 9/79 (11%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTY--GYMAPEYAMEGL 90
            +HRDL A NVL+  +   K+SDF + +       EAS+ +  G     + APE   E  
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 175
Query: 91  FSVKSDVFSFGVLLLEIIS 109
           FS KSDV+SFG+LL EI S
Sbjct: 176 FSTKSDVWSFGILLWEIYS 194

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMAR-IFGGNQ 66
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR I+    
Sbjct: 161 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAGY 216
Query: 67  SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                  ++    +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 217 YRKGGCAMLPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMAR-IFGGNQ 66
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MAR I+    
Sbjct: 184 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAGY 239
Query: 67  SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                  ++    +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 240 YRKGGCAMLPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y+H++   +I+HRDLK  N+LL+    + N +I DF ++  F   ++   
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 208
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 209 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 9/79 (11%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTY--GYMAPEYAMEGL 90
            +HRDL A NVL+  +   K+SDF + +       EAS+ +  G     + APE   E  
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 190
Query: 91  FSVKSDVFSFGVLLLEIIS 109
           FS KSDV+SFG+LL EI S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ YL E     +IHRDL A N L+      K+SDF M R    +Q  +ST      
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 188
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             + +PE      +S KSDV+SFGVL+ E+ S  K
Sbjct: 189 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +    IHRD+ A NVLL +    KI DF +AR    + +          
Sbjct: 169 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             +MAPE   + +++V+SDV+S+G+LL EI S
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L YLHE     II+RDLK  NVLLD E + K++D+ M +   G +   +T+   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 62/123 (50%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+    RI+HRDLKA N+LLD +MN KI+DF  +  F  G + +A       
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG---- 175
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
                AP YA   LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 176 -----APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 130 WKL 132
           +++
Sbjct: 231 YRI 233

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L YLHE     II+RDLK  NVLLD E + K++D+ M +   G +   +T+   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L YLHE     II+RDLK  NVLLD E + K++D+ M +   G +   +T+   GT
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 169
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L YLHE     II+RDLK  NVLLD E + K++D+ M +   G +   +T+   GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 173
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR     + ++  N+    
Sbjct: 140 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 59/97 (60%), Gaps = 8/97 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + +G+ YLH     +IIHRD+K SN+L+  + + KI+DF ++  F G  S+A  +  VGT
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGT 200
Query: 78  YGYMAPEYAME--GLFSVKS-DVFSFGVLLLEIISGK 111
             +MAPE   E   +FS K+ DV++ GV L   + G+
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR     + ++  N+    
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR     + ++  N+    
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/124 (36%), Positives = 63/124 (50%), Gaps = 22/124 (17%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF--GGNQSEASTNRIV 75
           I   + Y H+    RI+HRDLKA N+LLD +MN KI+DF  +  F  GG       +   
Sbjct: 120 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-----KLDTFC 171
Query: 76  GTYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSY 128
           G+  Y APE     LF  K       DV+S GV+L  ++SG     G  L EL + +L  
Sbjct: 172 GSPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 226
Query: 129 TWKL 132
            +++
Sbjct: 227 KYRI 230

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 22/167 (13%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVG 76
           I  GL YLH++   +I+HRD+K  NVL++ +    KISDF  ++   G      T    G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTG 185
Query: 77  TYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWC 134
           T  YMAPE   +G   +   +D++S G  ++E+ +GK    FY  ELG+   +  +K+  
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFY--ELGEPQAA-MFKV-- 238
Query: 135 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
               +  + P + +S ++AE   FI   L C + D   R   + ++V
Sbjct: 239 ---GMFKVHPEIPES-MSAEAKAFI---LKCFEPDPDKRACANDLLV 278

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR     + ++  N+    
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 7/129 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           ++S QL        +  I RGL Y+H  +   ++HRDLK SN+L++   + KI DF +AR
Sbjct: 136 LKSQQLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLAR 192
Query: 61  IFGGNQSEAS-TNRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGF 116
           I              V T  Y APE  +      KS D++S G +L E++S +       
Sbjct: 193 IADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252
Query: 117 YLSELGQSL 125
           YL +L   L
Sbjct: 253 YLDQLNHIL 261

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR     + ++  N+    
Sbjct: 201 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR     + ++  N+    
Sbjct: 147 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEAS 70
           II  +  G+ Y H++   +I+HRDLK  N+LL+    + N +I DF ++  F  ++    
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKD 187
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 188 K---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/106 (40%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           + +   IA G  YL E+     IHRD+ A N LL     P    KI DF MA+    +  
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAQ----DIY 195
Query: 68  EASTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            AS  R  G       +M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 196 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 2   RSVQLDWKRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKI 53
           RS+    KRR ++    AR        G  YLH   R R+IHRDLK  N+ L+ ++  KI
Sbjct: 102 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 158
Query: 54  SDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 113
            DF +A     +     T  + GT  Y+APE   +   S + DV+S G ++  ++ GK  
Sbjct: 159 GDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK-- 214
Query: 114 SGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR 173
             F  S L ++ L      +   + +         + VAA L++ +      +Q D   R
Sbjct: 215 PPFETSCLKETYLRIKKNEYSIPKHI---------NPVAASLIQKM------LQTDPTAR 259
Query: 174 PTMSSVV 180
           PT++ ++
Sbjct: 260 PTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 2   RSVQLDWKRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKI 53
           RS+    KRR ++    AR        G  YLH   R R+IHRDLK  N+ L+ ++  KI
Sbjct: 106 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 162
Query: 54  SDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            DF +A     +     T  + GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 163 GDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR     + ++  N+    
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 78  Y--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 2   RSVQLDWKRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKI 53
           RS+    KRR ++    AR        G  YLH   R R+IHRDLK  N+ L+ ++  KI
Sbjct: 102 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 158
Query: 54  SDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            DF +A     +     T  + GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 159 GDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I + L YL E  +  +IHRD+K SN+LLD     K+ DF ++   G    + + +R  G 
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGC 187
Query: 78  YGYMAPEY-----AMEGLFSVKSDVFSFGVLLLEIISGK 111
             YMAPE        +  + +++DV+S G+ L+E+ +G+
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 22/167 (13%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVG 76
           I  GL YLH++   +I+HRD+K  NVL++ +    KISDF  ++   G      T    G
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTG 171
Query: 77  TYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWC 134
           T  YMAPE   +G   +   +D++S G  ++E+ +GK    FY  ELG+   +  +K+  
Sbjct: 172 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFY--ELGEPQAA-MFKV-- 224
Query: 135 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
               +  + P + +S ++AE   FI   L C + D   R   + ++V
Sbjct: 225 ---GMFKVHPEIPES-MSAEAKAFI---LKCFEPDPDKRACANDLLV 264

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 139 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 130 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + +GL + HE+   +I+HRDLK  N+L++     K+ DF +AR FG   +  S+   V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVT 171
Query: 78  YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGK 111
             Y AP+  M    +S   D++S G +L E+I+GK
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 141 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 62/123 (50%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DF  +  F  GN+ +A       
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---- 174
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
                AP YA   LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 175 -----APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 130 WKL 132
           +++
Sbjct: 230 YRI 232

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 29/178 (16%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL +   +  +HRDL A N+L++  +  K+SDF ++R+      E   
Sbjct: 148 VGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-----EDDP 199
Query: 72  NRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
             +  T G      + APE      F+  SDV+S+G+++ E++S  +   + +S   Q +
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDV 257
Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           +          E   L  P+    C A        + L C Q + A+RP    +V +L
Sbjct: 258 IKAI------EEGYRLPAPM---DCPAG----LHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 141 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 198 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++NGIA    Y H+    R++HRDLK  N+L++ E   KI+DF +AR F G      T
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYT 158
Query: 72  NRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG 110
           + IV T  Y AP+  M    +S   D++S G +  E+++G
Sbjct: 159 HEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 108 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 164
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 165 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 109 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 165
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 166 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 114 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 170
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 171 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 167 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 113 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 113 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVG 76
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +          V 
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 77  TYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
           T  Y APE  +      KS D++S G +L E++S +       YL +L   L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 116 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 172
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 173 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 113 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 117 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 173
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 174 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 167 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 6/107 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +++ K+++     I +G+ YL   SR + +HRDL A NVL++ E   KI DF + +    
Sbjct: 122 KINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 65  NQSEAST--NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++   +   +R    + Y APE  M+  F + SDV+SFGV L E+++
Sbjct: 179 DKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 15/139 (10%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +ARG+ YL   S+ + IHR+L A N+L+      KI+DF ++R       E    + +G 
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 199
Query: 78  YG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSELGQSL---LSYTW 130
               +MA E     +++  SDV+S+GVLL EI+S  G    G   +EL + L        
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 259
Query: 131 KLWCEGEALELMEPVLKQS 149
            L C+ E  +LM    ++ 
Sbjct: 260 PLNCDDEVYDLMRQCWREK 278

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 115 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 171
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 172 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 7/102 (6%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +++ ++ G+ YL E +    +HR+L A NVLL +    KISDF +++  G + S   T R
Sbjct: 441 LLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTAR 496
Query: 74  IVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK 112
             G +   + APE      FS +SDV+S+GV + E +S G+K
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RG+ + H+    RI+HRDLK  N+L++ +   K++DF +AR F G    + T+ +V T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-T 182
Query: 78  YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
             Y AP+  M    +S   D++S G +  E+I+GK
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++ GIA G+ YL +   +  +HR L A N+L++  +  K+SDF ++R    + S+ + 
Sbjct: 112 VGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 72  NRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +G      + APE      F+  SDV+S+G+++ E++S
Sbjct: 169 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RG+ + H+    RI+HRDLK  N+L++ +   K++DF +AR F G    + T+ +V T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-T 182
Query: 78  YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
             Y AP+  M    +S   D++S G +  E+I+GK
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 128 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 128 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 65  NQSEASTNRI-VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++              + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RGL +LH     R++HRDLK  N+L+      K++DF +ARI+    +  S   +V T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVT 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  ++  ++   D++S G +  E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 6/107 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +++ K+++     I +G+ YL   SR + +HRDL A NVL++ E   KI DF + +    
Sbjct: 110 KINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 166
Query: 65  NQSEAST--NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++   +   +R    + Y APE  M+  F + SDV+SFGV L E+++
Sbjct: 167 DKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RGL +LH     R++HRDLK  N+L+      K++DF +ARI+    +  S   +V T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVT 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  ++  ++   D++S G +  E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RGL +LH     R++HRDLK  N+L+      K++DF +ARI+    +  S   +V T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVT 182
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  ++  ++   D++S G +  E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 88/189 (46%), Gaps = 34/189 (17%)
Query: 2   RSVQLDWKRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKI 53
           RS+    KRR ++    AR        G  YLH   R R+IHRDLK  N+ L+ ++  KI
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 182
Query: 54  SDFEMARI--FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            DF +A    + G + +     + GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 183 GDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 112 KNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 171
               F  S L ++ L      +   + +         + VAA L++ +      +Q D  
Sbjct: 239 --PPFETSCLKETYLRIKKNEYSIPKHI---------NPVAASLIQKM------LQTDPT 281
Query: 172 DRPTMSSVV 180
            RPT++ ++
Sbjct: 282 ARPTINELL 290

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 12/110 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 65  NQ-----SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++      E   + I     + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 167 DKEFFKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++NGIA    Y H+    R++HRDLK  N+L++ E   KI+DF +AR F G      T
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYT 158
Query: 72  NRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG 110
           + +V T  Y AP+  M    +S   D++S G +  E+++G
Sbjct: 159 HEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 88/189 (46%), Gaps = 34/189 (17%)
Query: 2   RSVQLDWKRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKI 53
           RS+    KRR ++    AR        G  YLH   R R+IHRDLK  N+ L+ ++  KI
Sbjct: 124 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 180
Query: 54  SDFEMARI--FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            DF +A    + G + +     + GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 181 GDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236
Query: 112 KNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 171
               F  S L ++ L      +   + +         + VAA L++ +      +Q D  
Sbjct: 237 --PPFETSCLKETYLRIKKNEYSIPKHI---------NPVAASLIQKM------LQTDPT 279
Query: 172 DRPTMSSVV 180
            RPT++ ++
Sbjct: 280 ARPTINELL 288

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++  + RGL Y+H      IIHRDLK SNV ++ +   +I DF +AR     Q++     
Sbjct: 128 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTG 179
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + ++NGIA    Y H+    R++HRDLK  N+L++ E   KI+DF +AR F G      T
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYT 158
Query: 72  NRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG 110
           + +V T  Y AP+  M    +S   D++S G +  E+++G
Sbjct: 159 HEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 23/178 (12%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I  G+ YLH       IHRDL A NVLLD++   KI DF +A+ +  G++          
Sbjct: 143 ICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII----SGKKNSGFYLSELG-----QSLLS 127
              + APE   E  F   SDV+SFGV L E++    S +     +L  +G      ++L 
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
            T       E LE  E + +     AE+    H+   C + +++ RPT  +++ +L +
Sbjct: 260 LT-------ELLERGERLPRPDKCPAEV---YHLMKNCWETEASFRPTFENLIPILKT 307

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DF  +  F  GN+ +       G
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT----FCG 175
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
           +  Y APE     LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 176 SPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 130 WKL 132
           +++
Sbjct: 231 YRI 233

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 210
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + +++  D++S G ++ E+++G+
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   +  G+ +L      + IHRDL A N L+D ++  K+SDF M R    +Q  +S 
Sbjct: 107 LEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS- 162
Query: 72  NRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              VGT     + APE      +S KSDV++FG+L+ E+ S
Sbjct: 163 ---VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 61/120 (50%), Gaps = 17/120 (14%)
Query: 2   RSVQLDWKRRISIINGIAR--------GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKI 53
           RS+    KRR ++    AR        G  YLH   R R+IHRDLK  N+ L+ ++  KI
Sbjct: 100 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 156
Query: 54  SDFEMARI--FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            DF +A    + G + +     + GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 157 GDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 180
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 181 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQS 67
           K  IS    +ARG+ YL E    + +HRDL A N +LD     K++DF +AR I      
Sbjct: 124 KDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 68  EASTNRIVG-TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +R       + A E      F+ KSDV+SFGVLL E+++
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 180
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 181 SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++  + RGL Y+H      IIHRDLK SNV ++ +   +I DF +AR     Q++     
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTG 187
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 121 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 171
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 172 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 106 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 156
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 157 SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 107 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 157
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 158 SVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 109 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 159
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 160 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++  + RGL Y+H      IIHRDLK SNV ++ +   +I DF +AR     Q++     
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTG 187
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E++ GK
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 107 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 157
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 158 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 109 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 159
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 160 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DF  +  F  GN+     +   G
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCG 174
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
           +  Y APE     LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 175 SPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 130 WKL 132
           +++
Sbjct: 230 YRI 232

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 7/107 (6%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +LD K    +   I  G+ Y H   R  ++HRDLK  NVLLD  MN KI+DF ++ +   
Sbjct: 112 RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFS-VKSDVFSFGVLLLEIISG 110
            +    +    G+  Y APE     L++  + D++S GV+L  ++ G
Sbjct: 169 GEFLRXS---CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 105 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 155
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 156 SVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 105 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 155
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 156 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 139 ISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI 195
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 196 -KWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH +    I+HRDLK  N+L+      K++DF +ARI+    + A    +V T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVVTLW 176
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH +    I+HRDLK  N+L+      K++DF +ARI+     + + + +V T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTLW 176
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 10/102 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I   I RGL +LH+    ++IHRD+K  NVLL      K+ DF ++     +++    N 
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNT 188
Query: 74  IVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISG 110
            +GT  +MAPE        +  +  KSD++S G+  +E+  G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 109 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 159
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 160 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DF  +  F  GN+ +       G
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCG 174
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
           +  Y APE     LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 175 SPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 130 WKL 132
           +++
Sbjct: 230 YRI 232

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 103 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 153
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 154 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DF  +  F  GN+ +       G
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCG 174
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
           +  Y APE     LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 175 SPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 130 WKL 132
           +++
Sbjct: 230 YRI 232

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 3/116 (2%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
            +L   + + I   IA G++YL   +    +HRDL   N L+   +  KI DF M+R   
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 179
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
                      +    +M PE  M   F+ +SDV+S GV+L EI +  K   + LS
Sbjct: 180 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 118 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 175 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 181
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 108 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 158
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 159 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DF  +  F  GN+ +       G
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCG 174
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
           +  Y APE     LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 175 SPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 130 WKL 132
           +++
Sbjct: 230 YRI 232

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAS 70
           II  +  G+ YLH   +  I+HRDLK  N+LL+ +      KI DF ++ +F   +++  
Sbjct: 141 IIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKK 194
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               +GT  Y+APE  +   +  K DV+S GV+L  +++G
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 121 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 177
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 178 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 118 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 175 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 107 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 157
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 158 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 107 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 157
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 158 SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 192
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 109 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 159
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 160 SVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 101 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 151
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 152 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 33/167 (19%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I + L +LH  S+L +IHRD+K SNVL++     K  DF ++   G    + + +   G 
Sbjct: 145 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS---GYLVDDVAKDIDAGC 199
Query: 78  YGYMAPEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLW 133
             Y APE     L    +SVKSD++S G+  +E+                ++L + +  W
Sbjct: 200 KPYXAPERINPELNQKGYSVKSDIWSLGITXIEL----------------AILRFPYDSW 243
Query: 134 CE-----GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
                   + +E   P L     +AE + F      C++ +S +RPT
Sbjct: 244 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPT 287

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 107 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 157
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 158 SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 179
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 180
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 188
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH +    I+HRDLK  N+L+      K++DF +ARI+     + +   +V T  
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLW 184
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 191
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 21/182 (11%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEA 69
           +I+  I  G+ YLH   +  I+HRD+K  N+LL+++   +N KI DF ++  F     + 
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDY 203
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-----KNSGFYLSELGQS 124
                +GT  Y+APE  ++  ++ K DV+S GV++  ++ G      +N    + ++ + 
Sbjct: 204 KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262
Query: 125 LLSYTWKLW--CEGEALELMEPVL----KQSCVAAELLKFIHIGLLCVQADSADRPTMSS 178
              + +  W     EA EL++ +L     + C A E L    I       + +D+ T+  
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCG 322
Query: 179 VV 180
            +
Sbjct: 323 AL 324

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 192
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 124 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 181 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DF  +  F  GN+ +       G
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCG 167
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
           +  Y APE     LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 168 SPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 222
Query: 130 WKL 132
           +++
Sbjct: 223 YRI 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 204
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  + ++   A G+ YL        IHRDL A N L+  +   KISDF M+R        
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXA 269
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           AS         + APE    G +S +SDV+SFG+LL E  S
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 121 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 177
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 178 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L YLH      II+RDLK  N+LLD   + KI+DF  A+          T  + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 81  MAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +APE      ++   D +SFG+L+ E+++G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+DF       G
Sbjct: 105 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF-------G 154
Query: 65  NQSEASTNR---IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
               A ++R   + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 WSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 179 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 125 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 177
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 178
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 179 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 179 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 183
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 133 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 189
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 190 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/123 (34%), Positives = 61/123 (49%), Gaps = 20/123 (16%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-GNQSEASTNRIVG 76
           I   + Y H+     I+HRDLKA N+LLD + N KI+DF  +  F  GN+ +A       
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCG---- 174
Query: 77  TYGYMAPEYAMEGLFSVKS------DVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYT 129
                AP YA   LF  K       DV+S GV+L  ++SG     G  L EL + +L   
Sbjct: 175 -----APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 130 WKL 132
           +++
Sbjct: 230 YRI 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 187
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 12/110 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHR+L   N+L+++E   KI DF + ++   
Sbjct: 111 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ 167
Query: 65  NQ-----SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++      E   + I     + APE   E  FSV SDV+SFGV+L E+ +
Sbjct: 168 DKEYYKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 204
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE 68
           K  + ++   A G+ YL        IHRDL A N L+  +   KISDF M+R        
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           AS         + APE    G +S +SDV+SFG+LL E  S
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHRDL A N L+      K++DF ++R+  G+   A        
Sbjct: 118 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + APE      FS+KSDV++FGVLL EI +
Sbjct: 175 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      ++     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 201
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 109 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD------FGW 159
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE         K D++S GVL  E + GK
Sbjct: 160 SVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IV 75
           + R L YLH      +IHRD+K+ ++LL  +   K+SDF     F    S+    R  +V
Sbjct: 150 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLV 202
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           GT  +MAPE      +  + D++S G++++E+I G+
Sbjct: 203 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I+  L +LH+     II+RDLK  N++L+H+ + K++DF + +  I  G      T+   
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG----TVTHXFC 182
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           GT  YMAPE  M    +   D +S G L+ ++++G
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I+  L +LH+     II+RDLK  N++L+H+ + K++DF + +  I  G      T+   
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG----TVTHTFC 182
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           GT  YMAPE  M    +   D +S G L+ ++++G
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I  G+ YLH       IHR+L A NVLLD++   KI DF +A+ +  G++          
Sbjct: 126 ICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL--------GQSLLSY 128
              + APE   E  F   SDV+SFGV L E+++   +S    ++         GQ  +  
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 242
Query: 129 TWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
             +L   GE L   +   K  C    L+K       C + +++ RPT  +++ +L +
Sbjct: 243 LTELLERGERLPRPD---KCPCEVYHLMKN------CWETEASFRPTFENLIPILKT 290

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      +      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      +      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+DF      G 
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADF------GW 154
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 155 SVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      +      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I  G+ YLH       IHR+L A NVLLD++   KI DF +A+ +  G++          
Sbjct: 126 ICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL--------GQSLLSY 128
              + APE   E  F   SDV+SFGV L E+++   +S    ++         GQ  +  
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 242
Query: 129 TWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
             +L   GE L   +   K  C    L+K       C + +++ RPT  +++ +L +
Sbjct: 243 LTELLERGERLPRPD---KCPCEVYHLMKN------CWETEASFRPTFENLIPILKT 290

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI++F      G 
Sbjct: 106 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANF------GW 156
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 157 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+ +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH +    I+HRDLK  N+L+      K++DF +ARI+     + +   +V T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTLW 176
Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           R  +LD    + +   I +G+ Y+H     ++IHRDLK SN+ L      KI DF +   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
               +++    R  GT  YM+PE      +  + D+++ G++L E++
Sbjct: 186 L---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 9/112 (8%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DF +AR
Sbjct: 120 MKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
                Q+++     V T  Y APE  +  + ++   D++S G ++ E+I+GK
Sbjct: 177 -----QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 58/108 (53%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S GV++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L YLH++   +IIHRDLKA N+L   + + K++DF ++      ++    +  +GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYW 201
Query: 81  MAPEYAM-----EGLFSVKSDVFSFGVLLLEI 107
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI++F      G 
Sbjct: 107 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANF------GW 157
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 158 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 108 RFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIAD------FGW 158
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + G
Sbjct: 159 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 23/178 (12%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I  G+ YLH       IHR L A NVLLD++   KI DF +A+ +  G++          
Sbjct: 121 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS---GKKNSGFYLSEL-----GQ-SLLS 127
              + APE   E  F   SDV+SFGV L E+++     ++     +EL     GQ ++L 
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR 237
Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
            T       E LE  E + +      E+    H+   C + +++ RPT  ++V +L +
Sbjct: 238 LT-------ELLERGERLPRPDRCPCEI---YHLMKNCWETEASFRPTFQNLVPILQT 285

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 58/108 (53%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S GV++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 23/178 (12%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I  G+ YLH       IHR L A NVLLD++   KI DF +A+ +  G++          
Sbjct: 120 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS---GKKNSGFYLSEL-----GQ-SLLS 127
              + APE   E  F   SDV+SFGV L E+++     ++     +EL     GQ ++L 
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR 236
Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
            T       E LE  E + +      E+    H+   C + +++ RPT  ++V +L +
Sbjct: 237 LT-------ELLERGERLPRPDRCPCEI---YHLMKNCWETEASFRPTFQNLVPILQT 284

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+D      FG 
Sbjct: 108 RFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIAD------FGW 158
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +    S+ R  + GT  Y+ PE     +   K D++S GVL  E + G
Sbjct: 159 SVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 13/120 (10%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISD 55
           ++S  LD K  + +      GL +LH +      +  I HRDLK+ N+L+       I+D
Sbjct: 126 LKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185
Query: 56  FEMARIF--GGNQSEASTNRIVGTYGYMAPEYAMEGLFS------VKSDVFSFGVLLLEI 107
             +A  F    N+ +   N  VGT  YM PE   E L        + +D++SFG++L E+
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY--AMEG 89
           RIIHRD+K  N+LLD   +  I+DF +A +      E     + GT  YMAPE   + +G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKG 191
Query: 90  L-FSVKSDVFSFGVLLLEIISGKK 112
             +S   D +S GV   E++ G++
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF + R      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  S   +++RDLK  N++LD + + KI+DF + +   G +  A+     GT
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 315
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  S   +++RDLK  N++LD + + KI+DF + +   G +  A+     GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 312
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LDW  +I +       L ++H+    +I+HRD+K+ N+ L  +   ++ DF +AR+   N
Sbjct: 128 LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--N 176
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            +       +GT  Y++PE      ++ KSD+++ G +L E+ + K
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHR+L A N L+      K++DF ++R+  G+   A        
Sbjct: 327 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             + APE      FS+KSDV++FGVLL EI +      + +S      LS         +
Sbjct: 384 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLS---------Q 427
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
             EL+E   +         K   +   C Q + +DRP+ + +
Sbjct: 428 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 9/101 (8%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
           ++I  +   + YLH   R+ I+HRDLK  N+L    D E    ISDF ++++ G     +
Sbjct: 124 TLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS 180
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +     GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 181 TA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IVGTYGYMAPEYAMEGL 90
           +IHRD+K+ ++LL H+   K+SDF     F    S+    R  +VGT  +MAPE      
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 201
Query: 91  FSVKSDVFSFGVLLLEIISGK 111
           +  + D++S G++++E++ G+
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGE 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 G--TSFMMTPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  + YL + +    IHR+L A N L+      K++DF ++R+  G+   A        
Sbjct: 366 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 422
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             + APE      FS+KSDV++FGVLL EI +      + +S      LS  ++L  +  
Sbjct: 423 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDY 475
Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
            +E  E   ++     EL++       C Q + +DRP+ + +
Sbjct: 476 RMERPEGCPEK---VYELMR------ACWQWNPSDRPSFAEI 508

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IVGTYGYMAPEYAMEGL 90
           +IHRD+K+ ++LL H+   K+SDF     F    S+    R  +VGT  +MAPE      
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 323
Query: 91  FSVKSDVFSFGVLLLEIISGK 111
           +  + D++S G++++E++ G+
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGE 344

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L YLH++   +IIHRDLKA N+L   + + K++DF ++      +     +  +GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYW 201
Query: 81  MAPEYAM-----EGLFSVKSDVFSFGVLLLEI 107
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L YLH++   +IIHRDLKA N+L   + + K++DF ++      +     +  +GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYW 201
Query: 81  MAPEYAM-----EGLFSVKSDVFSFGVLLLEI 107
           MAPE  M     +  +  K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IVGTYGYMAPEYAMEGL 90
           +IHRD+K+ ++LL H+   K+SDF     F    S+    R  +VGT  +MAPE      
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 203
Query: 91  FSVKSDVFSFGVLLLEIISGK 111
           +  + D++S G++++E++ G+
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGE 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IVGTYGYMAPEYAMEGL 90
           +IHRD+K+ ++LL H+   K+SDF     F    S+    R  +VGT  +MAPE      
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 192
Query: 91  FSVKSDVFSFGVLLLEIISGK 111
           +  + D++S G++++E++ G+
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGE 213

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  S   +++RDLK  N++LD + + KI+DF + +   G +  A+     GT
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 172
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  S   +++RDLK  N++LD + + KI+DF + +   G +  A+     GT
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 174
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 175 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IVGTYGYMAPEYAMEGL 90
           +IHRD+K+ ++LL H+   K+SDF     F    S+    R  +VGT  +MAPE      
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 196
Query: 91  FSVKSDVFSFGVLLLEIISGK 111
           +  + D++S G++++E++ G+
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGE 217

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  S   +++RDLK  N++LD + + KI+DF + +   G +  A+     GT
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 173
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR--IVGTYGYMAPEYAMEGL 90
           +IHRD+K+ ++LL H+   K+SDF     F    S+    R  +VGT  +MAPE      
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 246
Query: 91  FSVKSDVFSFGVLLLEIISGK 111
           +  + D++S G++++E++ G+
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGE 267

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 55/90 (61%), Gaps = 6/90 (6%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           +GL YLH+     I+HRDLK +N+LLD     K++DF +A+ F G+ + A  +++V T  
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRW 177
Query: 80  YMAPEYAMEG-LFSVKSDVFSFGVLLLEII 108
           Y APE      ++ V  D+++ G +L E++
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 59/122 (48%), Gaps = 21/122 (17%)
Query: 7   DWKRRISIINGIARGLLYLH------EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           DW     + + + RGL YLH      +  +  I HRDL + NVL+ ++    ISDF ++ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 61  IFGGNQ----SEASTNRI--VGTYGYMAPEYAMEGLFSVKS--------DVFSFGVLLLE 106
              GN+     E     I  VGT  YMAPE  +EG  +++         D+++ G++  E
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 107 II 108
           I 
Sbjct: 228 IF 229

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 178 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  F +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 60/115 (52%), Gaps = 11/115 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DF +AR      ++A    
Sbjct: 149 LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 200
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
            V T  Y APE  +  + ++   D++S G ++ E+++GK       YL +L Q L
Sbjct: 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 50/84 (59%), Gaps = 6/84 (7%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTNRIVGTYGYMAPEYAME 88
           R +I+HRDLK  N+LLD  +N KI+DF ++ I   GN  + S     G+  Y APE    
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVING 181
Query: 89  GLFS-VKSDVFSFGVLLLEIISGK 111
            L++  + DV+S G++L  ++ G+
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 60/115 (52%), Gaps = 11/115 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DF +AR      ++A    
Sbjct: 131 LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 182
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKK--NSGFYLSELGQSL 125
            V T  Y APE  +  + ++   D++S G ++ E+++GK       YL +L Q L
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 16/110 (14%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--EMNP-KISDFEMAR--IFGGNQSE 68
           ++  +A  L +LH      I HRDLK  N+L +H  +++P KI DF++       G+ S 
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 69  ASTNRIV---GTYGYMAPE----YAMEG-LFSVKSDVFSFGVLLLEIISG 110
            ST  ++   G+  YMAPE    ++ E  ++  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L +LH     RIIHRDLKA NVL+  E + +++DF ++      ++    +  +GT  +
Sbjct: 121 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYW 175
Query: 81  MAPEYAM-----EGLFSVKSDVFSFGVLLLEI 107
           MAPE  M     +  +  K+D++S G+ L+E+
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL E     ++HR+L A NVLL      +++DF +A +   +  +   +     
Sbjct: 142 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
             +MA E    G ++ +SDV+S+GV + E+++   +  +G  L+E+
Sbjct: 199 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 244

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA+G+ YL E     ++HR+L A NVLL      +++DF +A +   +  +   +     
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNSGFYLSEL 121
             +MA E    G ++ +SDV+S+GV + E+++   +  +G  L+E+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 162
Query: 73  RIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 EVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
            L +LH     RIIHRDLKA NVL+  E + +++DF ++      ++    +  +GT  +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYW 183
Query: 81  MAPEYAM-----EGLFSVKSDVFSFGVLLLEI 107
           MAPE  M     +  +  K+D++S G+ L+E+
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D  +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 114 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 169
Query: 73  RIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIIS 109
            +V T  Y APE  +    +S   D++S G +  E+++
Sbjct: 170 EVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 177 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 46/77 (59%), Gaps = 6/77 (7%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTNRIVGTYGYMAPEYAME 88
           R +I+HRDLK  N+LLD  +N KI+DF ++ I   GN  + S     G+  Y APE    
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISG 185
Query: 89  GLFS-VKSDVFSFGVLL 104
            L++  + DV+S GV+L
Sbjct: 186 KLYAGPEVDVWSCGVIL 202

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D  +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 46/77 (59%), Gaps = 6/77 (7%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTNRIVGTYGYMAPEYAME 88
           R +I+HRDLK  N+LLD  +N KI+DF ++ I   GN  + S     G+  Y APE    
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISG 186
Query: 89  GLFS-VKSDVFSFGVLL 104
            L++  + DV+S GV+L
Sbjct: 187 KLYAGPEVDVWSCGVIL 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 46/77 (59%), Gaps = 6/77 (7%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTNRIVGTYGYMAPEYAME 88
           R +I+HRDLK  N+LLD  +N KI+DF ++ I   GN  + S     G+  Y APE    
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISG 176
Query: 89  GLFS-VKSDVFSFGVLL 104
            L++  + DV+S GV+L
Sbjct: 177 KLYAGPEVDVWSCGVIL 193

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG---GNQSEAS 70
           ++  +  GL Y+H   R +I+HRD+KA+NVL+  +   K++DF +AR F     +Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 71  TNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEI-----ISGKKNSGFYLSELGQS 124
            NR+V T  Y  PE  + E  +    D++  G ++ E+     I         L+ + Q 
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 125 LLSYTWKLWCEGEALELME 143
             S T ++W   +  EL E
Sbjct: 246 CGSITPEVWPNVDNYELYE 264

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 46/77 (59%), Gaps = 6/77 (7%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTNRIVGTYGYMAPEYAME 88
           R +I+HRDLK  N+LLD  +N KI+DF ++ I   GN  + S     G+  Y APE    
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISG 180
Query: 89  GLFS-VKSDVFSFGVLL 104
            L++  + DV+S GV+L
Sbjct: 181 KLYAGPEVDVWSCGVIL 197

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 12/114 (10%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            V L  K   SI+  +   + +LH ++   I+HRDLK  N+LLD  M  ++SDF  +   
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISG 110
              +       + GT GY+APE     +      +  + D+++ GV+L  +++G
Sbjct: 251 EPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--- 68
           + I   IA  + +LH      ++HRDLK SN+    +   K+ DF +      ++ E   
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 69  -------ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                  A+    VGT  YM+PE      +S K D+FS G++L E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 12/114 (10%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            V L  K    I+  +   +  LH   +L I+HRDLK  N+LLD +MN K++DF  +   
Sbjct: 118 KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISG 110
              +   S   + GT  Y+APE     +      +  + D++S GV++  +++G
Sbjct: 175 DPGEKLRS---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 114 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 169
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 170 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D  +AR      ++     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTG 181
Query: 74  IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            V T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 14/111 (12%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR   
Sbjct: 119 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-- 173
Query: 64  GNQSEASTNRIVGTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                ASTN ++  Y     Y APE  +   +    D++S G ++ E++ G
Sbjct: 174 -----ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 12  ISIINGIARGLLYLH-----EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG--G 64
           + I+  IA GL +LH        +  I HRDLK+ N+L+       I+D  +A +     
Sbjct: 137 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 196
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGL----FSV--KSDVFSFGVLLLEI 107
           NQ +   N  VGT  YMAPE   E +    F    + D+++FG++L E+
Sbjct: 197 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 163
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 164 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 12  ISIINGIARGLLYLH-----EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG--G 64
           + I+  IA GL +LH        +  I HRDLK+ N+L+       I+D  +A +     
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGL----FSV--KSDVFSFGVLLLEI 107
           NQ +   N  VGT  YMAPE   E +    F    + D+++FG++L E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 111 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 166
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 167 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF 91
           + +HRDL A N L++ +   K+SDF ++R    ++  +S         +  PE  M   F
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPV-RWSPPEVLMYSKF 198
Query: 92  SVKSDVFSFGVLLLEIIS 109
           S KSD+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 12/114 (10%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            V L  K    I+  +   +  LH   +L I+HRDLK  N+LLD +MN K++DF  +   
Sbjct: 105 KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 161
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISG 110
              +       + GT  Y+APE     +      +  + D++S GV++  +++G
Sbjct: 162 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 14/111 (12%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 64  GNQSEASTNRIVGTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                A TN ++  Y     Y APE  +   ++   D++S G ++ E++ G
Sbjct: 176 -----ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG---GNQSEAS 70
           ++  +  GL Y+H   R +I+HRD+KA+NVL+  +   K++DF +AR F     +Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 71  TNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEI-----ISGKKNSGFYLSELGQS 124
            NR+V T  Y  PE  + E  +    D++  G ++ E+     I         L+ + Q 
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 125 LLSYTWKLWCEGEALELME 143
             S T ++W   +  EL E
Sbjct: 246 CGSITPEVWPNVDNYELYE 264

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 12  ISIINGIARGLLYLH-----EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG--G 64
           + I+  IA GL +LH        +  I HRDLK+ N+L+       I+D  +A +     
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGL----FSV--KSDVFSFGVLLLEI 107
           NQ +   N  VGT  YMAPE   E +    F    + D+++FG++L E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 113 QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA 169
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 170 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 12/114 (10%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            V L  K    I+  +   +  LH   +L I+HRDLK  N+LLD +MN K++DF  +   
Sbjct: 118 KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISG 110
              +       + GT  Y+APE     +      +  + D++S GV++  +++G
Sbjct: 175 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG---GNQSEAS 70
           ++  +  GL Y+H   R +I+HRD+KA+NVL+  +   K++DF +AR F     +Q    
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 71  TNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEI-----ISGKKNSGFYLSELGQS 124
            NR+V T  Y  PE  + E  +    D++  G ++ E+     I         L+ + Q 
Sbjct: 186 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 125 LLSYTWKLWCEGEALELME 143
             S T ++W   +  EL E
Sbjct: 245 CGSITPEVWPNVDNYELYE 263

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG---GNQSEAS 70
           ++  +  GL Y+H   R +I+HRD+KA+NVL+  +   K++DF +AR F     +Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 71  TNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEI-----ISGKKNSGFYLSELGQS 124
            NR+V T  Y  PE  + E  +    D++  G ++ E+     I         L+ + Q 
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 125 LLSYTWKLWCEGEALELME 143
             S T ++W   +  EL E
Sbjct: 246 CGSITPEVWPNVDNYELYE 264

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 27/179 (15%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-----EMNPKISDFEMARIFG-GN 65
           I+++     GL +LH    L I+HRDLK  N+L+       ++   ISDF + +    G 
Sbjct: 121 ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLF---SVKSDVFSFGVLLLEIIS-GKKNSGFYLSEL 121
            S +  + + GT G++APE   E      +   D+FS G +   +IS G    G  L   
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
              LL           +L+ + P   +  +A EL++ +      +  D   RP+   V+
Sbjct: 238 ANILLGAC--------SLDCLHPEKHEDVIARELIEKM------IAMDPQKRPSAKHVL 282

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 13/107 (12%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--- 68
           + I   IA  + +LH      ++HRDLK SN+    +   K+ DF +      ++ E   
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 69  -------ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                  A     VGT  YM+PE      +S K D+FS G++L E++
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 47/82 (57%), Gaps = 4/82 (4%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEG 89
           R  ++HRDLK  NVLLD  MN KI+DF ++ +    +   ++    G+  Y APE     
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGR 185
Query: 90  LFS-VKSDVFSFGVLLLEIISG 110
           L++  + D++S GV+L  ++ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG 207

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI 74
           +  I   L +LH   +L II+RD+K  N+LLD   +  ++DF +++ F  +++E + +  
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-F 220
Query: 75  VGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISG 110
            GT  YMAP+    G        D +S GVL+ E+++G
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF 91
           + +HRDL A N L++ +   K+SDF ++R    ++  +S         +  PE  M   F
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKF 182
Query: 92  SVKSDVFSFGVLLLEIIS 109
           S KSD+++FGVL+ EI S
Sbjct: 183 SSKSDIWAFGVLMWEIYS 200

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   K++DF +A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF 91
           + +HRDL A N L++ +   K+SDF ++R    ++  +S         +  PE  M   F
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKF 198
Query: 92  SVKSDVFSFGVLLLEIIS 109
           S KSD+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR F G      T+
Sbjct: 107 SYLFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTH 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
            +V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  G
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215
Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 216 --TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF 91
           + +HRDL A N L++ +   K+SDF ++R    ++  +S         +  PE  M   F
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKF 183
Query: 92  SVKSDVFSFGVLLLEIIS 109
           S KSD+++FGVL+ EI S
Sbjct: 184 SSKSDIWAFGVLMWEIYS 201

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 46/228 (20%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK--ISDFEMAR 60
            + LD  +   I   I +G+ YLH      I+H+DLK+ NV  D   N K  I+DF +  
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD---NGKVVITDFGLFS 177
Query: 61  IFGGNQSEASTNRIVGTYGY-----------MAPEYAMEGL-FSVKSDVFSFGVLLLEII 108
           I G  Q+    +++    G+           ++P+   + L FS  SDVF+ G +  E+ 
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 109 SGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 168
           +       + ++  +++      +W  G     M+P L Q  +  E+   +   L C   
Sbjct: 238 A---REWPFKTQPAEAI------IWQMGTG---MKPNLSQIGMGKEISDIL---LFCWAF 282
Query: 169 DSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRNVARPSQFSSGAEV 216
           +  +RPT + ++ ML      LP+         R ++ P  F   AE+
Sbjct: 283 EQEERPTFTKLMDMLEK----LPKRN-------RRLSHPGHFWKSAEL 319

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF 91
           + +HRDL A N L++ +   K+SDF ++R    ++  +S         +  PE  M   F
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKF 189
Query: 92  SVKSDVFSFGVLLLEIIS 109
           S KSD+++FGVL+ EI S
Sbjct: 190 SSKSDIWAFGVLMWEIYS 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF 91
           + +HRDL A N L++ +   K+SDF ++R    ++  +S         +  PE  M   F
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKF 178
Query: 92  SVKSDVFSFGVLLLEIIS 109
           S KSD+++FGVL+ EI S
Sbjct: 179 SSKSDIWAFGVLMWEIYS 196

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 11/96 (11%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGN---QSEASTNR 73
           IA G+ YL   S    IHRDL A N +L  +M   ++DF ++R I+ G+   Q  AS   
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +     ++A E   + L++V SDV++FGV + EI++
Sbjct: 203 V----KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNR-IVGTYG 79
           YLHE+    IIHRDLK  NVLL  +      KI+DF  ++I G    E S  R + GT  
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCGTPT 181
Query: 80  YMAPEYAME---GLFSVKSDVFSFGVLLLEIISG 110
           Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNR-IVGTYG 79
           YLHE+    IIHRDLK  NVLL  +      KI+DF  ++I G    E S  R + GT  
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCGTPT 187
Query: 80  YMAPEYAME---GLFSVKSDVFSFGVLLLEIISG 110
           Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNR-IVGTYG 79
           YLHE+    IIHRDLK  NVLL  +      KI+DF  ++I G    E S  R + GT  
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCGTPT 181
Query: 80  YMAPEYAME---GLFSVKSDVFSFGVLLLEIISG 110
           Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNR-IVGTYG 79
           YLHE+    IIHRDLK  NVLL  +      KI+DF  ++I G    E S  R + GT  
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCGTPT 181
Query: 80  YMAPEYAME---GLFSVKSDVFSFGVLLLEIISG 110
           Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNR-IVGTYG 79
           YLHE+    IIHRDLK  NVLL  +      KI+DF  ++I G    E S  R + GT  
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCGTPT 180
Query: 80  YMAPEYAME---GLFSVKSDVFSFGVLLLEIISG 110
           Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 158 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 215 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS--TNRIVGT 77
           RGL Y+H     ++IHRDLK SN+L++     KI DF MAR    + +E        V T
Sbjct: 170 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 78  YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKK 112
             Y APE  +    ++   D++S G +  E+++ ++
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           IA  L YLH    L I++RDLK  N+LLD + +  ++DF + +     +  ++T+   GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGT 202
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y+APE   +  +    D +  G +L E++ G
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 170 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 119 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 175
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 176 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 178 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 46/82 (56%), Gaps = 4/82 (4%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEG 89
           R  ++HRDLK  NVLLD  MN KI+DF ++ +    +    +    G+  Y APE     
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGR 185
Query: 90  LFS-VKSDVFSFGVLLLEIISG 110
           L++  + D++S GV+L  ++ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 32  RIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLF 91
           + +HRDL A N L++ +   K+SDF ++R    ++  +S         +  PE  M   F
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKF 183
Query: 92  SVKSDVFSFGVLLLEIIS 109
           S KSD+++FGVL+ EI S
Sbjct: 184 SSKSDIWAFGVLMWEIYS 201

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 170
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 171 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 178 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 170
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 171 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           R  +LD    + +   I +G+ Y+H     ++I+RDLK SN+ L      KI DF +   
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
               +++    R  GT  YM+PE      +  + D+++ G++L E++
Sbjct: 172 L---KNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G     +T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAP 228
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 59/118 (50%), Gaps = 17/118 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
           I +I  I  G+ YLH+++   I+H DLK  N+LL   + P    KI DF M+R  G    
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG---H 186
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS------GKKNSGFYLS 119
                 I+GT  Y+APE       +  +D+++ G++   +++      G+ N   YL+
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--EMNP-KISDFEMAR--IFGGNQSE 68
           ++  +A  L +LH      I HRDLK  N+L +H  +++P KI DF +       G+ S 
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSP 172
Query: 69  ASTNRIV---GTYGYMAPE----YAMEG-LFSVKSDVFSFGVLLLEIISG 110
            ST  ++   G+  YMAPE    ++ E  ++  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   K++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 14/102 (13%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIF--GGNQSE 68
           I+  +  G  YLH+ +   I+HRDLK  N+LL+ +      KI DF ++  F  GG   E
Sbjct: 126 IMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 182
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                 +GT  Y+APE  +   +  K DV+S GV+L  ++ G
Sbjct: 183 R-----LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 122 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 178
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           G   +       V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 179 G---TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNR-IVGTYG 79
           YLHE+    IIHRDLK  NVLL  +      KI+DF  ++I G    E S  R + GT  
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCGTPT 306
Query: 80  YMAPEYAME---GLFSVKSDVFSFGVLLLEIISG 110
           Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNR-IVGTYG 79
           YLHE+    IIHRDLK  NVLL  +      KI+DF  ++I G    E S  R + GT  
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCGTPT 320
Query: 80  YMAPEYAME---GLFSVKSDVFSFGVLLLEIISG 110
           Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVL-LDHEMNPKI--SDFEMARIFGGNQSEAS 70
           +I  +   + YLHE+    I+HRDLK  N+L L  E N KI  +DF ++++    +    
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGI 163
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            +   GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS--TNRIVGT 77
           RGL Y+H     ++IHRDLK SN+L++     KI DF MAR    + +E        V T
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 78  YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKK 112
             Y APE  +    ++   D++S G +  E+++ ++
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 202
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 228
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 125 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 181
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 182 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 170
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S   T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 171 GT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 228
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 200
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAP 208
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 160
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 200
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  SR  +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 119 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 173
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 160
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  SR  +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 114 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 164
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 164
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 163
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 163
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 164
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 164
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIIS 109
             V T  Y APE  +    +S   D++S G +  E+++
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAP 193
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 14/102 (13%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIF--GGNQSE 68
           I+  +  G  YLH+ +   I+HRDLK  N+LL+ +      KI DF ++  F  GG   E
Sbjct: 109 IMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 165
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                 +GT  Y+APE  +   +  K DV+S GV+L  ++ G
Sbjct: 166 R-----LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 164
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIIS 109
             V T  Y APE  +    +S   D++S G +  E+++
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   +++DF +A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 111 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 165
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIIS 109
             V T  Y APE  +    +S   D++S G +  E+++
Sbjct: 166 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 163
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYX 164
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 194
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYX 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYX 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYX 163
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYX 161
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG      +  
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYX 162
Query: 73  RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             V T  Y APE  +    +S   D++S G +  E+++ +
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + +  +A  L Y HE    ++IHRD+K  N+L+ ++   KI+D      FG 
Sbjct: 110 RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIAD------FGW 160
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +    S  R  + GT  Y+ PE         K D++  GVL  E + G
Sbjct: 161 SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 117 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 171
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      +++RD+K  N++LD + + KI+DF + +   G    A+     GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168
Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D +R  + +  +A  L Y HE    ++IHRD+K  N+L+ ++   KI+D      FG 
Sbjct: 111 RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIAD------FGW 161
Query: 65  NQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +    S  R  + GT  Y+ PE         K D++  GVL  E + G
Sbjct: 162 SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 57/124 (45%), Gaps = 25/124 (20%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL--------DHEMNPK-----ISDFEM 58
           IS++  IA G+ +LH    L+IIHRDLK  N+L+        D +   +     ISDF +
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 59  ARIFGGNQSEAST--NRIVGTYGYMAPEYAMEG-------LFSVKSDVFSFGVLLLEIIS 109
            +     QS   T  N   GT G+ APE   E          +   D+FS G +   I+S
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 110 GKKN 113
             K+
Sbjct: 235 KGKH 238

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIV 75
           +A G+ YL      R IHRDL A N+LL      KI DF + R    N        +R V
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + + APE      FS  SD + FGV L E+ +
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--STNRIV 75
           +A G+ YL      R IHRDL A N+LL      KI DF + R    N        +R V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + + APE      FS  SD + FGV L E+ +
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--STNRIV 75
           +A G+ YL      R IHRDL A N+LL      KI DF + R    N        +R V
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + + APE      FS  SD + FGV L E+ +
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 12/101 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQSEA 69
           ++  +   L Y H      ++H+DLK  N+L   + +P    KI DF +A +F  +  E 
Sbjct: 129 LMKQMMNALAYFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD--EH 182
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           STN   GT  YMAPE     + + K D++S GV++  +++G
Sbjct: 183 STN-AAGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTG 221

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S      +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMEPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+++D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIV 75
           +A G+ YL      R IHRDL A N+LL      KI DF + R    N        +R V
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + + APE      FS  SD + FGV L E+ +
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIV 75
           +A G+ YL      R IHRDL A N+LL      KI DF + R    N        +R V
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + + APE      FS  SD + FGV L E+ +
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIV 75
           +A G+ YL      R IHRDL A N+LL      KI DF + R    N        +R V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + + APE      FS  SD + FGV L E+ +
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIV 75
           +A G+ YL      R IHRDL A N+LL      KI DF + R    N        +R V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             + + APE      FS  SD + FGV L E+ +
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNRI 74
           I   L Y H+++   IIHRD+K  NVLL  + N    K+ DF +A   G  +S       
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGR 193
Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           VGT  +MAPE      +    DV+  GV+L  ++SG
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL--------DHEMNPK-----ISDFEM 58
           IS++  IA G+ +LH    L+IIHRDLK  N+L+        D +   +     ISDF +
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 59  ARIFGGNQS--EASTNRIVGTYGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKN 113
            +     Q     + N   GT G+ APE   E      +   D+FS G +   I+S  K+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL--------DHEMNPK-----ISDFEM 58
           IS++  IA G+ +LH    L+IIHRDLK  N+L+        D +   +     ISDF +
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 59  ARIFGGNQS--EASTNRIVGTYGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKN 113
            +     Q     + N   GT G+ APE   E      +   D+FS G +   I+S  K+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-PKISDFEMARIF---GGN 65
           R +  +     GL YLH     RI+H D+KA NVLL  + +   + DF  A      G  
Sbjct: 167 RALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +S  + + I GT  +MAPE  M      K D++S   ++L +++G
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-PKISDFEMARIF---GGN 65
           R +  +     GL YLH     RI+H D+KA NVLL  + +   + DF  A      G  
Sbjct: 151 RALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +S  + + I GT  +MAPE  M      K D++S   ++L +++G
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 6/109 (5%)
Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           G   S      +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 GT--SFMMEPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-PKISDFEMARIF---GGN 65
           R +  +     GL YLH     RI+H D+KA NVLL  + +   + DF  A      G  
Sbjct: 165 RALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +S  + + I GT  +MAPE  M      K D++S   ++L +++G
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 56/111 (50%), Gaps = 11/111 (9%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           +S   D +R  +I+  +A  L+Y H     ++IHRD+K  N+LL  +   KI+D      
Sbjct: 116 KSCTFDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIAD------ 166
Query: 62  FGGNQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           FG +    S  R  + GT  Y+ PE     + + K D++  GVL  E++ G
Sbjct: 167 FGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 24  YLHEDSRLRIIHRDLKASNVL---LDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY 80
           YLH+   L I+HRDLK  N+L   LD +    ISDF ++++       +  +   GT GY
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 81  MAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +APE   +  +S   D +S GV+   ++ G
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           II  +     Y+H +    I HRD+K SN+L+D     K+SDF  +      + + S   
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR-- 211
Query: 74  IVGTYGYMAPE-YAMEGLFS-VKSDVFSFGVLL 104
             GTY +M PE ++ E  ++  K D++S G+ L
Sbjct: 212 --GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVL---LDHEMNPKISDFEMARIFGGNQSEAS 70
           +I  +   + YLH+   L I+HRDLK  N+L   LD +    ISDF ++++       + 
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            +   GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVL---LDHEMNPKISDFEMARIFGGNQSEAS 70
           +I  +   + YLH+   L I+HRDLK  N+L   LD +    ISDF ++++       + 
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            +   GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVL---LDHEMNPKISDFEMARIFGGNQSEAS 70
           +I  +   + YLH+   L I+HRDLK  N+L   LD +    ISDF ++++       + 
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            +   GT GY+APE   +  +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
              +   ++   D ++ GVL+ E+ +G
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIF---GGN 65
           R +  +     GL YLH  SR RI+H D+KA NVLL  +  +  + DF  A      G  
Sbjct: 186 RALYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +S  + + I GT  +MAPE  +      K DV+S   ++L +++G
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIF---GGNQSEASTNR-----IVGTYGYMAPE 84
           +IHRDLK SN+L++   + K+ DF +ARI      + SE +  +      V T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 85  YAM-EGLFSVKSDVFSFGVLLLEII 108
             +    +S   DV+S G +L E+ 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEAST 71
           +  I   + YLHE+    I+HRDLK  N+L      +   KI+DF +++I    + +   
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLM 207
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             + GT GY APE      +  + D++S G++   ++ G
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 160 YMEDSTXXKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 19  ARGLLYLH-----EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF--GGNQSEAST 71
           A GL +LH        +  I HRD K+ NVL+   +   I+D  +A +   G +  +   
Sbjct: 115 ACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGN 174
Query: 72  NRIVGTYGYMAPEYAMEGLFS------VKSDVFSFGVLLLEI 107
           N  VGT  YMAPE   E + +        +D+++FG++L EI
Sbjct: 175 NPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 27/172 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I + + YL     +  +HRD+   N+L+      K+ DF ++R I   +  +AS  R+  
Sbjct: 118 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-- 172
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG 136
              +M+PE      F+  SDV+ F V + EI+S  K   F+L    + ++    K    G
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE--NKDVIGVLEK----G 226
Query: 137 EAL---ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
           + L   +L  PVL              +   C   D +DRP  + +V  L+ 
Sbjct: 227 DRLPKPDLCPPVLYT------------LMTRCWDYDPSDRPRFTELVCSLSD 266

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEASTNRIVGTY 78
           G+ Y H    ++I HRDLK  N LLD    P  KI DF  ++    +    ST   VGT 
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 181
Query: 79  GYMAPEYAMEGLFSVK-SDVFSFGVLLLEIISG 110
            Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 16/104 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA----------RIFGGNQS 67
           I   L Y+H      IIHRDLK  N+ +D   N KI DF +A          ++   N  
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 68  EASTN--RIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEII 108
            +S N    +GT  Y+A E     G ++ K D++S G++  E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 16/104 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA----------RIFGGNQS 67
           I   L Y+H      IIHRDLK  N+ +D   N KI DF +A          ++   N  
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 68  EASTN--RIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEII 108
            +S N    +GT  Y+A E     G ++ K D++S G++  E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 22/176 (12%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA-RIFGGNQSEASTNRIVG 76
           IA G+ YL   S    +HRDL A N +L  +M   ++DF ++ +I+ G+       RI  
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG--RIAK 210
Query: 77  T-YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCE 135
               ++A E   + +++ KSDV++FGV + EI +  +    Y       +  Y       
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYDYL----LH 264
Query: 136 GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLP 191
           G  L+  E  L +            I   C + D  DRPT S + + L     +LP
Sbjct: 265 GHRLKQPEDCLDE---------LYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I + + YL     +  +HRD+   N+L+      K+ DF ++R I   +  +AS  R+  
Sbjct: 134 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-- 188
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYL 118
              +M+PE      F+  SDV+ F V + EI+S  K   F+L
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 230

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 27/172 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           I + + YL     +  +HRD+   N+L+      K+ DF ++R I   +  +AS  R+  
Sbjct: 122 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-- 176
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG 136
              +M+PE      F+  SDV+ F V + EI+S  K   F+L    + ++    K    G
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE--NKDVIGVLEK----G 230
Query: 137 EAL---ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
           + L   +L  PVL              +   C   D +DRP  + +V  L+ 
Sbjct: 231 DRLPKPDLCPPVLYT------------LMTRCWDYDPSDRPRFTELVCSLSD 270

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIF---GGNQSEASTNR-----IVGTYGYMAPE 84
           +IHRDLK SN+L++   + K+ DF +ARI      + SE +  +      V T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 85  YAM-EGLFSVKSDVFSFGVLLLEII 108
             +    +S   DV+S G +L E+ 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIF---GGNQSEASTNR-----IVGTYGYMAPE 84
           +IHRDLK SN+L++   + K+ DF +ARI      + SE +  +      V T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 85  YAM-EGLFSVKSDVFSFGVLLLEII 108
             +    +S   DV+S G +L E+ 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVL-LDHEMNP---KISDFEMARIFGGNQSEA 69
           +++ I + + YLH      ++HRDLK SN+L +D   NP   +I DF  A+         
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            T     T  ++APE      +    D++S G+LL  +++G
Sbjct: 183 MTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 131 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 187
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 188 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 103 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 160 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 105 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 161
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 162 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 11/117 (9%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-----KISDF 56
           + VQL      S++  I  G+ YLH +    ++HRDLK +N+L+  E  P     KI+D 
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADM 176
Query: 57  EMARIFGGN-QSEASTNRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
             AR+F    +  A  + +V T+ Y APE  +      K+ D+++ G +  E+++ +
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 103 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 160 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 108 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 165 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 106 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 162
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 163 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 24  YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
           YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT   +AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEALAP 207
Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISG 110
           E  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 100 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 157 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 56/124 (45%), Gaps = 25/124 (20%)
Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL--------DHEMNPK-----ISDFEM 58
           IS++  IA G+ +LH    L+IIHRDLK  N+L+        D +   +     ISDF +
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 59  ARIFGGNQS--EASTNRIVGTYGYMAPEYAMEG-------LFSVKSDVFSFGVLLLEIIS 109
            +     Q     + N   GT G+ APE   E          +   D+FS G +   I+S
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 110 GKKN 113
             K+
Sbjct: 235 KGKH 238

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 9/102 (8%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVL-LDHEMNP---KISDFEMARIFGGNQSE 68
           +++  I + + YLH      ++HRDLK SN+L +D   NP   +I DF  A+        
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             T     T  ++APE      +    D++S GVLL  +++G
Sbjct: 177 LMTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 15/104 (14%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVL-LDHEMNP---KISDFEMARIFGGNQSEA 69
           +++ I + + YLH      ++HRDLK SN+L +D   NP   +I DF  A+     Q  A
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRA 177
Query: 70  STNRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               ++    T  ++APE      +    D++S G+LL  +++G
Sbjct: 178 ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR 159
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 160 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I  I   +L+ H+   + ++HRDLK  N+LL  +      K++DF +A    G+Q   + 
Sbjct: 109 IQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ--AW 163
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               GT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 164 FGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEASTNRIVGTY 78
           G+ Y H    +++ HRDLK  N LLD    P  KI DF  ++    +    ST   VGT 
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 180
Query: 79  GYMAPEYAMEGLFSVK-SDVFSFGVLLLEIISG 110
            Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEASTNRIVGTY 78
           G+ Y H    +++ HRDLK  N LLD    P  KI DF  ++    +    ST   VGT 
Sbjct: 126 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 179
Query: 79  GYMAPEYAMEGLFSVK-SDVFSFGVLLLEIISG 110
            Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 10  RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIF---GGN 65
           R +  +     GL YLH  SR RI+H D+KA NVLL  +  +  + DF  A      G  
Sbjct: 167 RALYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +   + + I GT  +MAPE  +      K DV+S   ++L +++G
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + RGL Y H   R +++HRDLK  N+L++     K++DF +AR      ++   N +V T
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVV-T 163
Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
             Y  P+  +    +S + D++  G +  E+ +G+
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL  LHE     ++HRDL   N+LL    +  I DF +AR    + ++A+    V  
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTH 196
Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK---KNSGFY 117
             Y APE  M+   F+   D++S G ++ E+ + K   + S FY
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 9/102 (8%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVL-LDHEMNP---KISDFEMARIFGGNQSE 68
           +++  I + + YLH      ++HRDLK SN+L +D   NP   +I DF  A+        
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
             T     T  ++APE      +    D++S GVLL   ++G
Sbjct: 177 LXTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL  LHE     ++HRDL   N+LL    +  I DF +AR    + ++A+    V  
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTH 196
Query: 78  YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK---KNSGFY 117
             Y APE  M+   F+   D++S G ++ E+ + K   + S FY
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I  I   + Y H +    I+HR+LK  N+LL  +      K++DF +A     N SEA  
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 164
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +   GT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I  I   + Y H +    I+HR+LK  N+LL  +      K++DF +A     N SEA  
Sbjct: 110 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 163
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +   GT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 164 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I  I   + Y H +    I+HR+LK  N+LL  +      K++DF +A     N SEA  
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 164
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +   GT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 540 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE----YAME 88
           +IHRD+K  N+LLD   + K++DF               +  VGT  Y++PE       +
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 89  GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           G +  + D +S GV L E++ G  ++ FY   L
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVG--DTPFYADSL 284

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE--YAM 87
           +L  +HRD+K  NVLLD   + +++DF    +   +     ++  VGT  Y++PE   AM
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 88  E---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           E   G +  + D +S GV + E++ G+  + FY   L ++
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 289

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I  I   + Y H +    I+HR+LK  N+LL  +      K++DF +A     N SEA  
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-W 187
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +   GT GY++PE   +  +S   D+++ GV+L  ++ G
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 61/115 (53%), Gaps = 15/115 (13%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNV-LLDHEM-NPKIS--DFEMA-RIFGGNQSEASTN 72
           I  G+ YLH     RI H DLK  N+ LLD  + NP+I   DF +A +I  GN+ +    
Sbjct: 117 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---- 169
Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS 127
            I GT  ++APE        +++D++S GV+   ++SG   +  +L E  Q  L+
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGETKQETLT 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I  I   +L+ H+   + ++HRDLK  N+LL  ++     K++DF +A    G Q   + 
Sbjct: 127 IQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AW 181
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               GT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 182 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEASTNRIVGTY 78
           G+ Y H    +++ HRDLK  N LLD    P  KI+DF  ++    +   +     VGT 
Sbjct: 127 GVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTP 180
Query: 79  GYMAPEYAMEGLFSVK-SDVFSFGVLLLEIISG 110
            Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 60/115 (52%), Gaps = 15/115 (13%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNV-LLDHEM-NPKIS--DFEMA-RIFGGNQSEASTN 72
           I  G+ YLH     RI H DLK  N+ LLD  + NP+I   DF +A +I  GN+      
Sbjct: 124 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FK 176
Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS 127
            I GT  ++APE        +++D++S GV+   ++SG   +  +L E  Q  L+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGETKQETLT 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +R   LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 61  IF-GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 108
                   +AS  ++     +MAPE      F+  SDV+ FGV + EI+
Sbjct: 540 YMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE--YAM 87
           +L  +HRD+K  NVLLD   + +++DF    +   +     ++  VGT  Y++PE   AM
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 88  E---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           E   G +  + D +S GV + E++ G+  + FY   L ++
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 305

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 16/104 (15%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA----------RIFGGNQS 67
           I   L Y+H      IIHR+LK  N+ +D   N KI DF +A          ++   N  
Sbjct: 125 ILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 68  EASTN--RIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEII 108
            +S N    +GT  Y+A E     G ++ K D +S G++  E I
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 14/134 (10%)
Query: 30  RLRIIHRDLKASNVLLDHEMNPKISDF-EMARIFGGNQSEASTNRIVGTYGYMAPE--YA 86
           +L  +HRD+K  N+L+D   + +++DF    ++      ++S    VGT  Y++PE   A
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPEILQA 250
Query: 87  ME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELME 143
           ME   G +  + D +S GV + E++ G+  + FY     +SL+    K+    E  +   
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFY----AESLVETYGKIMNHKERFQFPT 304
Query: 144 PVLKQSCVAAELLK 157
            V   S  A +L++
Sbjct: 305 QVTDVSENAKDLIR 318

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 23/118 (19%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG-----NQSE 68
           ++  + + + YLH      ++HRD+K SN+LL+ E + K++DF ++R F       N   
Sbjct: 114 VVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 69  ASTNR--------------IVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 111
            S N                V T  Y APE  +      K  D++S G +L EI+ GK
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 61/115 (53%), Gaps = 15/115 (13%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNV-LLDHEM-NPKIS--DFEMA-RIFGGNQSEASTN 72
           I  G+ YLH     RI H DLK  N+ LLD  + NP+I   DF +A +I  GN+ +    
Sbjct: 138 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---- 190
Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS 127
            I GT  ++APE        +++D++S GV+   ++SG   +  +L E  Q  L+
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGETKQETLT 242

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE----YAME 88
            IHRD+K  N+LLD   + K++DF         +     +  VGT  Y++PE       +
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 89  GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           G +  + D +S GV L E++ G  ++ FY   L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG--DTPFYADSL 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE----YAME 88
            IHRD+K  N+LLD   + K++DF         +     +  VGT  Y++PE       +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 89  GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           G +  + D +S GV L E++ G  ++ FY   L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG--DTPFYADSL 283

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE----YAME 88
            IHRD+K  N+LLD   + K++DF         +     +  VGT  Y++PE       +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 89  GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
           G +  + D +S GV L E++ G  ++ FY   L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG--DTPFYADSL 283

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 175 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 175 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEAS 70
           I+  +   + ++H+   + ++HRDLK  N+L   E   +  KI DF  AR+   +     
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T     T  Y APE   +  +    D++S GV+L  ++SG+
Sbjct: 168 TPCF--TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSE 68
            +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLL--DHEMNP-KISDFEMARIFGGNQSEAS 70
           I+  +   + Y H   +L + HRDLK  N L   D   +P K+ DF +A  F   +   +
Sbjct: 111 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               VGT  Y++P+  +EGL+  + D +S GV++  ++ G
Sbjct: 168 K---VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQS 67
             +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ 
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +     I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 175 K----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQS 67
             +  I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ 
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           +     I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 175 K----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPK----ISDFEMA-RIFGGNQSEASTN 72
           I  G+ YLH    L+I H DLK  N++L     PK    I DF +A +I  GN+ +    
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---- 175
Query: 73  RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
            I GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLL--DHEMNP-KISDFEMARIFGGNQSEAS 70
           I+  +   + Y H   +L + HRDLK  N L   D   +P K+ DF +A  F   +   +
Sbjct: 128 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 184
Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               VGT  Y++P+  +EGL+  + D +S GV++  ++ G
Sbjct: 185 K---VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 7/86 (8%)
Query: 22  LLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM 81
           L +LH      ++H D+K +N+ L      K+ DF +    G   +  +     G   YM
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYM 223
Query: 82  APEYAMEGLFSVKSDVFSFGVLLLEI 107
           APE  ++G +   +DVFS G+ +LE+
Sbjct: 224 APEL-LQGSYGTAADVFSLGLTILEV 248

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I+ I   + ++H+     I+HRDLK  N+LL  +      K++DF +A    G Q   + 
Sbjct: 136 IHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ--AW 190
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               GT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 191 FGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---EASTNRIVGT 77
           G+ Y H    +++ HRDLK  N LLD    P++        FG ++S    +     VGT
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLK----ICAFGYSKSSVLHSQPKSTVGT 179
Query: 78  YGYMAPEYAMEGLFSVK-SDVFSFGVLLLEIISG 110
             Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 21  GLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---EASTNRIVGT 77
           G+ Y H    +++ HRDLK  N LLD    P++        FG ++S    +     VGT
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLK----ICAFGYSKSSVLHSQPKDTVGT 179
Query: 78  YGYMAPEYAMEGLFSVK-SDVFSFGVLLLEIISG 110
             Y+APE  ++  +  K +DV+S GV L  ++ G
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           I +GL +LH  +   IIHRDLK  N+ +       KI D  +A +   + ++A    ++G
Sbjct: 138 ILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIG 192
Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 106
           T  + APE   E  +    DV++FG   LE
Sbjct: 193 TPEFXAPE-XYEEKYDESVDVYAFGXCXLE 221

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 15  INGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEAST 71
           I  I   +L+ H+   + ++HR+LK  N+LL  ++     K++DF +A    G Q   + 
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AW 170
Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
               GT GY++PE   +  +    D+++ GV+L  ++ G
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 10/108 (9%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q+  K    IINGI  G  + H      IIHRD+K  N+L+      K+ DF  AR    
Sbjct: 124 QVVQKYLFQIINGI--GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
              E   +  V T  Y APE  +  + +    DV++ G L+ E+  G+
Sbjct: 177 -PGEVYDDE-VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           S +  + +GL + H  SR  ++HRDLK  N+L++     K++DF +AR FG      S  
Sbjct: 105 SFLFQLLKGLGFCH--SR-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161
Query: 73  RIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKK 112
             V T  Y  P+      L+S   D++S G +  E+ +  +
Sbjct: 162 --VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 16/110 (14%)
Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMNP-KISDFEMARIFGGNQS--- 67
           ++  +A  L +LH      I HRDLK  N+L +   +++P KI DF++      N S   
Sbjct: 116 VVRDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTP 172
Query: 68  --EASTNRIVGTYGYMAPEYA-----MEGLFSVKSDVFSFGVLLLEIISG 110
                     G+  YMAPE           +  + D++S GV+L  ++SG
Sbjct: 173 ITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 33  IIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEG 89
           I+HRDLK  N+LL  +      K++DF +A    G+Q   +     GT GY++PE   + 
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRKD 181
Query: 90  LFSVKSDVFSFGVLLLEIISG 110
            +    D+++ GV+L  ++ G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNRI 74
           I   L Y H+++   IIHRD+K   VLL  + N    K+  F +A   G  +S       
Sbjct: 141 ILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGR 195
Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           VGT  +MAPE      +    DV+  GV+L  ++SG
Sbjct: 196 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 33  IIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEG 89
           I+HRDLK  N+LL  +      K++DF +A    G+Q   +     GT GY++PE   + 
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRKD 181
Query: 90  LFSVKSDVFSFGVLLLEIISG 110
            +    D+++ GV+L  ++ G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNRI 74
           I   L Y H+++   IIHRD+K   VLL  + N    K+  F +A   G  +S       
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGR 193
Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
           VGT  +MAPE      +    DV+  GV+L  ++SG
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 19  ARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISDFEMA--RIFGGNQSEAST 71
           A GL +LH +      +  I HRDLK+ N+L+       I+D  +A       +  + + 
Sbjct: 136 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 195
Query: 72  NRIVGTYGYMAPEY-----AMEGLFSVK-SDVFSFGVLLLEI 107
           N  VGT  YMAPE       M+   S K +D+++ G++  EI
Sbjct: 196 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 19  ARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISDFEMA--RIFGGNQSEAST 71
           A GL +LH +      +  I HRDLK+ N+L+       I+D  +A       +  + + 
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 175
Query: 72  NRIVGTYGYMAPEY-----AMEGLFSVK-SDVFSFGVLLLEI 107
           N  VGT  YMAPE       M+   S K +D+++ G++  EI
Sbjct: 176 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 19  ARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISDFEMA--RIFGGNQSEAST 71
           A GL +LH +      +  I HRDLK+ N+L+       I+D  +A       +  + + 
Sbjct: 111 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 170
Query: 72  NRIVGTYGYMAPEY-----AMEGLFSVK-SDVFSFGVLLLEI 107
           N  VGT  YMAPE       M+   S K +D+++ G++  EI
Sbjct: 171 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 19  ARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISDFEMA--RIFGGNQSEAST 71
           A GL +LH +      +  I HRDLK+ N+L+       I+D  +A       +  + + 
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 72  NRIVGTYGYMAPEY-----AMEGLFSVK-SDVFSFGVLLLEI 107
           N  VGT  YMAPE       M+   S K +D+++ G++  EI
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 19  ARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISDFEMA--RIFGGNQSEAST 71
           A GL +LH +      +  I HRDLK+ N+L+       I+D  +A       +  + + 
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 72  NRIVGTYGYMAPEY-----AMEGLFSVK-SDVFSFGVLLLEI 107
           N  VGT  YMAPE       M+   S K +D+++ G++  EI
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 19  ARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISDFEMA--RIFGGNQSEAST 71
           A GL +LH +      +  I HRDLK+ N+L+       I+D  +A       +  + + 
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 172
Query: 72  NRIVGTYGYMAPEY-----AMEGLFSVK-SDVFSFGVLLLEI 107
           N  VGT  YMAPE       M+   S K +D+++ G++  EI
Sbjct: 173 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	230
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-85
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-69
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-48
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-37
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-33
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-23
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-20
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-19
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-19
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-18
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-17
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-16
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-14
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-13
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  256 bits (657), Expect = 4e-86
 Identities = 61/189 (32%), Positives = 92/189 (48%), Gaps = 8/189 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
            +  L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDF +AR 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
                    T+RIVGT  YMAPE  + G  + KSD++SFGV+LLEII+G      +    
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP- 240

Query: 122 GQSLLSYTWKLWCEGEALE-LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
            Q LL    ++  E + +E  ++  +  +     +     +   C+      RP +  V 
Sbjct: 241 -QLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQ 298

Query: 181 VMLASDNVT 189
            +L     +
Sbjct: 299 QLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  255 bits (655), Expect = 1e-85
 Identities = 70/186 (37%), Positives = 106/186 (56%), Gaps = 3/186 (1%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            LDW +R  I  G ARGL YLH+    +IIHRD+KA+N+LLD E    + DF +A++   
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN--SGFYLSELG 122
             +  +T  + GT G++APEY   G  S K+DVF +GV+LLE+I+G++        ++  
Sbjct: 187 KDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
             LL +   L  E +   L++  L+ +    E+ + I + LLC Q+   +RP MS VV M
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305

Query: 183 LASDNV 188
           L  D +
Sbjct: 306 LEGDGL 311

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  213 bits (544), Expect = 6e-69
 Identities = 63/179 (35%), Positives = 99/179 (55%), Gaps = 5/179 (2%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GG 64
           + W++R+ I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DF +++     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +Q+  ST  + GT GY+ PEY ++G  + KSDV+SFGV+L E++  +      L     +
Sbjct: 193 DQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           L  +  +    G+  ++++P L        L KF    + C+   S DRP+M  V+  L
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  194 bits (494), Expect = 2e-61
 Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 24/202 (11%)

Query: 5   QLDWKRRISIINGIARGLLYLHED-------SRLRIIHRDLKASNVLLDHEMNPKISDFE 57
            + W     I   +ARGL YLHED        +  I HRD+K+ NVLL + +   I+DF 
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 58  MARIFGGNQSEASTNRIVGTYGYMAPEYAMEGL-----FSVKSDVFSFGVLLLEIISGKK 112
           +A  F   +S   T+  VGT  YMAPE     +       ++ D+++ G++L E+ S   
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 113 NSGFYLSELGQSLLSYTWKLWCEGEALELME--------PVLKQSCVAAELLK-FIHIGL 163
            +   + E    +L +  ++       ++ E        PVL+        +        
Sbjct: 237 AADGPVDEY---MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293

Query: 164 LCVQADSADRPTMSSVVVMLAS 185
            C   D+  R +   V   +  
Sbjct: 294 ECWDHDAEARLSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  161 bits (408), Expect = 2e-48
 Identities = 40/226 (17%), Positives = 81/226 (35%), Gaps = 30/226 (13%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED------SRLRIIHRDLKASNVLLDHEMNPKIS 54
           +     DW     + + + RGL YLH +       +  I HRDL + NVL+ ++    IS
Sbjct: 103 LSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162

Query: 55  DFEMARIFGGN------QSEASTNRIVGTYGYMAPEYAMEGL-------FSVKSDVFSFG 101
           DF ++    GN      + + +    VGT  YMAPE     +          + D+++ G
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222

Query: 102 VLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ----------SCV 151
           ++  EI     +       + +  +++  ++       ++   V ++             
Sbjct: 223 LIYWEIFMRCTDLFPG-ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281

Query: 152 AAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPA 197
           +  +         C   D+  R T       +A   +   +    +
Sbjct: 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  134 bits (340), Expect = 1e-38
 Identities = 53/196 (27%), Positives = 81/196 (41%), Gaps = 20/196 (10%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-PKISDFEMAR 60
                     +S     ++G+ YLH      +IHRDLK  N+LL       KI DF  A 
Sbjct: 95  PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE 120
               +     TN   G+  +MAPE      +S K DVFS+G++L E+I+ +K    +  E
Sbjct: 155 ----DIQTHMTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PF-DE 205

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
           +G       W +   G    L++ + K       L+        C   D + RP+M  +V
Sbjct: 206 IGGPAFRIMWAV-HNGTRPPLIKNLPKP---IESLMT------RCWSKDPSQRPSMEEIV 255

Query: 181 VMLASDNVTLPQPTEP 196
            ++       P   EP
Sbjct: 256 KIMTHLMRYFPGADEP 271

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  132 bits (335), Expect = 8e-38
 Identities = 52/194 (26%), Positives = 78/194 (40%), Gaps = 29/194 (14%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
              Q  W +R+S    IA G+ YLH    + IIHRDL + N L+    N  ++DF +AR+
Sbjct: 101 MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARL 157

Query: 62  FGGNQSEASTNR------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               +++    R            +VG   +MAPE      +  K DVFSFG++L EII 
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

Query: 110 GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQAD 169
                  YL       L+              ++     +C  +    F  I + C   D
Sbjct: 218 RVNADPDYLPRTMDFGLNVR----------GFLDRYCPPNCPPS----FFPITVRCCDLD 263

Query: 170 SADRPTMSSVVVML 183
              RP+   +   L
Sbjct: 264 PEKRPSFVKLEHWL 277

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  128 bits (323), Expect = 3e-36
 Identities = 42/189 (22%), Positives = 86/189 (45%), Gaps = 26/189 (13%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-----HEMNPKISDF 56
           ++  + W  ++ ++  IA G+ Y+  +    I+HRDL++ N+ L        +  K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 57  EMARIFGGNQSEASTNRIVGTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEIISGKKNS 114
            +++        + +   +G + +MAPE   A E  ++ K+D +SF ++L  I++G+   
Sbjct: 174 GLSQQ----SVHSVSGL-LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-- 226

Query: 115 GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP 174
             +  E     + +   +  EG    +  P   + C      +  ++  LC   D   RP
Sbjct: 227 -PF-DEYSYGKIKFINMIREEGLRPTI--P---EDCPP----RLRNVIELCWSGDPKKRP 275

Query: 175 TMSSVVVML 183
             S +V  L
Sbjct: 276 HFSYIVKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  127 bits (321), Expect = 7e-36
 Identities = 44/188 (23%), Positives = 83/188 (44%), Gaps = 23/188 (12%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
              + + K+ I I    ARG+ YLH      IIHRDLK++N+ L  +   KI DF +A  
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169

Query: 62  FGGNQSEASTNRIVGTYGYMAPE---YAMEGLFSVKSDVFSFGVLLLEIISGK---KNSG 115
                      ++ G+  +MAPE         +S +SDV++FG++L E+++G+    N  
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-- 227

Query: 116 FYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
             ++   Q +      +     +L      ++ +C          +   C++    +RP+
Sbjct: 228 --INNRDQII----EMV--GRGSLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPS 275

Query: 176 MSSVVVML 183
              ++  +
Sbjct: 276 FPRILAEI 283

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  127 bits (320), Expect = 1e-35
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 33/202 (16%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QLD +RR+S+   +A+G+ YLH      I+HR+LK+ N+L+D +   K+ DF ++R+   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-- 189

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
             +  S+    GT  +MAPE   +   + KSDV+SFGV+L E+ + +             
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------------- 236

Query: 125 LLSYTWKLWCEGEALELMEPVLKQ-------SCVAAELLKFIHIGLLCVQADSADRPTMS 177
                 + W      +++  V  +         +  ++   I     C   +   RP+ +
Sbjct: 237 ------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE---GCWTNEPWKRPSFA 287

Query: 178 SVVVMLAS-DNVTLPQPTEPAF 198
           +++ +L       +P P     
Sbjct: 288 TIMDLLRPLIKSAVPPPNRSDL 309

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  123 bits (310), Expect = 2e-34
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 41/198 (20%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--------K 52
           +   ++     ++    IARG+ YLH+++ + IIHRDLK+SN+L+  ++          K
Sbjct: 97  LSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156

Query: 53  ISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
           I+DF +AR +      ++     G Y +MAPE     +FS  SDV+S+GVLL E+++G+ 
Sbjct: 157 ITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE- 211

Query: 113 NSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ-------SCVAAELLKFIHIGLLC 165
                               +   + L +   V          S       K +     C
Sbjct: 212 ------------------VPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLME---DC 250

Query: 166 VQADSADRPTMSSVVVML 183
              D   RP+ ++++  L
Sbjct: 251 WNPDPHSRPSFTNILDQL 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  120 bits (303), Expect = 2e-33
 Identities = 40/186 (21%), Positives = 79/186 (42%), Gaps = 28/186 (15%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
            +  +D  + +     +ARG+ +LH    L I    L + +V++D +M  +IS  ++   
Sbjct: 104 TNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFS 162

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNSGFY 117
           F        +   +    ++APE A++          +D++SF VLL E+++ +     +
Sbjct: 163 F-------QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREV---PF 211

Query: 118 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMS 177
                 S +    K+  EG    +  P      ++  + K + I   C+  D A RP   
Sbjct: 212 ---ADLSNMEIGMKVALEGLRPTI--P----PGISPHVSKLMKI---CMNEDPAKRPKFD 259

Query: 178 SVVVML 183
            +V +L
Sbjct: 260 MIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  119 bits (300), Expect = 1e-32
 Identities = 42/199 (21%), Positives = 78/199 (39%), Gaps = 41/199 (20%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             + LD  +   I   I +G+ YLH      I+H+DLK+ NV  D      I+DF +  I
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178

Query: 62  FGGNQSEASTNRI---VGTYGYMAPE---------YAMEGLFSVKSDVFSFGVLLLEIIS 109
            G  Q+    +++    G   ++APE            +  FS  SDVF+ G +  E+ +
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238

Query: 110 GKK-----NSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL 164
            +       +   + ++G  +     ++    E  +++                      
Sbjct: 239 REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL--------------------F 278

Query: 165 CVQADSADRPTMSSVVVML 183
           C   +  +RPT + ++ ML
Sbjct: 279 CWAFEQEERPTFTKLMDML 297

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  116 bits (293), Expect = 9e-32
 Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 30/209 (14%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLR-----IIHRDLKASNVLLDHEMNPKISD 55
           ++   LD    + I+  IA GL +LH +         I HRDLK+ N+L+       I+D
Sbjct: 97  LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156

Query: 56  FEMARIF--GGNQSEASTNRIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLLLEI 107
             +A +     NQ +   N  VGT  YMAPE               + D+++FG++L E+
Sbjct: 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

Query: 108 ISGKKNSGF-------YLSELG-QSLLSYTWKLWC-EGEALELMEPVLKQSCVA--AELL 156
                ++G        +   +          K+ C + +   +         +   A+L+
Sbjct: 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276

Query: 157 KFIHIGLLCVQADSADRPTMSSVVVMLAS 185
           K       C   + + R T   +   L  
Sbjct: 277 K------ECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 1e-31
 Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 32/210 (15%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLR-----IIHRDLKASNVLLDHEMNPKISD 55
           ++S  LD K  + +      GL +LH +         I HRDLK+ N+L+       I+D
Sbjct: 126 LKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185

Query: 56  FEMARIF--GGNQSEASTNRIVGTYGYMAPEYAMEGLFSV-------KSDVFSFGVLLLE 106
             +A  F    N+ +   N  VGT  YM PE  ++   +         +D++SFG++L E
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWE 244

Query: 107 IISGKKNSGF-------YLSELG-QSLLSYTWKLWC-EGEALELMEPVLKQSCVA--AEL 155
           +     + G        Y   +          ++ C +              C+    +L
Sbjct: 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304

Query: 156 LKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
           +        C   + A R T   V   LA 
Sbjct: 305 MT------ECWAHNPASRLTALRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (281), Expect = 1e-29
 Identities = 45/210 (21%), Positives = 84/210 (40%), Gaps = 32/210 (15%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISD 55
           +    +  +  I +    A GL +LH +      +  I HRDLK+ N+L+       I+D
Sbjct: 131 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190

Query: 56  FEMARIF--GGNQSEASTNRIVGTYGYMAPEYAMEGLFSV-------KSDVFSFGVLLLE 106
             +A       +  + + N  VGT  YMAPE  ++   ++       ++D+++ G++  E
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 249

Query: 107 IISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELME---------PVLKQSCVAAELLK 157
           I       G +        L Y + L     ++E M          P +     + E L+
Sbjct: 250 IARRCSIGGIH----EDYQLPY-YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 304

Query: 158 FIHIGLL--CVQADSADRPTMSSVVVMLAS 185
            +   ++  C  A+ A R T   +   L+ 
Sbjct: 305 VM-AKIMRECWYANGAARLTALRIKKTLSQ 333

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 97.4 bits (243), Expect = 1e-24
 Identities = 34/162 (20%), Positives = 65/162 (40%), Gaps = 27/162 (16%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I +G+ Y+H     ++I+RDLK SN+ L      KI DF +       +++    R  GT
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGT 184

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             YM+PE      +  + D+++ G++L E++     + F  S+                 
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETSKF---------------- 227

Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
             +L + ++       +    +      +     DRP  S +
Sbjct: 228 FTDLRDGII-SDIFDKKEKTLLQ---KLLSKKPEDRPNTSEI 265

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 98.1 bits (245), Expect = 2e-24
 Identities = 38/105 (36%), Positives = 51/105 (48%), Gaps = 3/105 (2%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +L  K  + ++   A G+ YL        IHRDL A N L+  +   KISDF M+R    
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               AS         + APE    G +S +SDV+SFG+LL E  S
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.0 bits (244), Expect = 3e-24
 Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 39/192 (20%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +   + +GL YL E    +I+HRD+K SN+L++     K+ DF ++       S A++  
Sbjct: 136 VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF- 190

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-----KNSGFYLSELGQSLLSY 128
            VGT  YM+PE      +SV+SD++S G+ L+E+  G+      ++       G  +   
Sbjct: 191 -VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

Query: 129 TWKLWCEGEA------------------LELME-------PVLKQSCVAAELLKFIHIGL 163
             +                          EL++       P L     + E   F++   
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN--- 306

Query: 164 LCVQADSADRPT 175
            C+  + A+R  
Sbjct: 307 KCLIKNPAERAD 318

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 95.8 bits (239), Expect = 6e-24
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 28/192 (14%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
           ++        V   G     + APE   E  FSV SDV+SFGV+L E+ +  + S    +
Sbjct: 167 DKEFFK----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222

Query: 120 ELGQSLLSYTWKLWCEGEALELME-------PVLKQSCVAAELLKFIH-IGLLCVQADSA 171
           E  + + +           +EL++       P     C        I+ I   C   +  
Sbjct: 223 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE-----IYMIMTECWNNNVN 274

Query: 172 DRPTMSSVVVML 183
            RP+   + + +
Sbjct: 275 QRPSFRDLALRV 286

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 96.3 bits (240), Expect = 6e-24
 Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 50/229 (21%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +LD  R +   + I +G+ YL      R +HRDL A N+L++ E + KI+DF +A++   
Sbjct: 123 RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
           ++       +V   G     + APE   + +FS +SDV+SFGV+L E+ +          
Sbjct: 180 DKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT---------- 225

Query: 120 ELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG----------------- 162
                      K          M    +     + LL+ +  G                 
Sbjct: 226 -YCD-------KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELM 277

Query: 163 LLCVQADSADRPTMSSVVVML---ASDNVTLPQPTEPAFSVGRNVARPS 208
            LC      DRP+ S++   L    S +         A   G++ +   
Sbjct: 278 KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSF 326

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 95.9 bits (239), Expect = 9e-24
 Identities = 45/207 (21%), Positives = 72/207 (34%), Gaps = 49/207 (23%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
               +   + +     I  G+ YLH       IHRDL A NVLLD++   KI DF +A+ 
Sbjct: 127 PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183

Query: 62  FGGNQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSG 115
                        V   G     + APE   E  F   SDV+SFGV L E+++    +  
Sbjct: 184 VPEGHEYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239

Query: 116 FYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG------------- 162
                L    ++                           L + +  G             
Sbjct: 240 PPTKFLELIGIAQ-------------------GQMTVLRLTELLERGERLPRPDKCPAEV 280

Query: 163 ----LLCVQADSADRPTMSSVVVMLAS 185
                 C + +++ RPT  +++ +L +
Sbjct: 281 YHLMKNCWETEASFRPTFENLIPILKT 307

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.4 bits (238), Expect = 9e-24
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 27/168 (16%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I   I + L +LH  S+L +IHRD+K SNVL++     K+ DF ++   G    + + + 
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDI 168

Query: 74  IVGTYGYMAPE----YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ--SLLS 127
             G   YMAPE       +  +SVKSD++S G+ ++E+   +    F     G     L 
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQLK 224

Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
                  E  +     P L     +AE + F      C++ +S +RPT
Sbjct: 225 QV----VEEPS-----PQLPADKFSAEFVDFTS---QCLKKNSKERPT 260

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 1e-23
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 28/192 (14%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++D  + +   + I +G+ YL      R IHRDL   N+L+++E   KI DF + ++   
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
           ++        V   G     + APE   E  FSV SDV+SFGV+L E+ +  + S    +
Sbjct: 198 DKEYYK----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253

Query: 120 ELGQSLLSYTWKLWCEGEALELME-------PVLKQSCVAAELLKFIH-IGLLCVQADSA 171
           E  + + +           +EL++       P     C        I+ I   C   +  
Sbjct: 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE-----IYMIMTECWNNNVN 305

Query: 172 DRPTMSSVVVML 183
            RP+   + + +
Sbjct: 306 QRPSFRDLALRV 317

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.1 bits (237), Expect = 2e-23
 Identities = 39/193 (20%), Positives = 80/193 (41%), Gaps = 31/193 (16%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +++ K+++     I +G+ YL      + +HRDL A NVL++ E   KI DF + +    
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYL 118
           ++   +    V         + APE  M+  F + SDV+SFGV L E+++    +S    
Sbjct: 179 DKEYYT----VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234

Query: 119 SELGQSLLSYTWKLWCEGEALELME-------PVLKQSCVAAELLKFIH-IGLLCVQADS 170
             L     ++          +  ++       P    +C        ++ +   C +   
Sbjct: 235 LFLKMIGPTHGQMTVT--RLVNTLKEGKRLPCP---PNCPDE-----VYQLMRKCWEFQP 284

Query: 171 ADRPTMSSVVVML 183
           ++R +  +++   
Sbjct: 285 SNRTSFQNLIEGF 297

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 95.3 bits (237), Expect = 2e-23
 Identities = 34/172 (19%), Positives = 60/172 (34%), Gaps = 31/172 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN----- 72
           IA  + +LH      ++HRDLK SN+    +   K+ DF +      ++ E +       
Sbjct: 173 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229

Query: 73  -----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS 127
                  VGT  YM+PE      +S K D+FS G++L E++              Q    
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS---------TQMERV 280

Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
                    +       +  Q     +    +      +     +RP  + +
Sbjct: 281 RIITDVRNLK----FPLLFTQKY--PQEHMMVQ---DMLSPSPTERPEATDI 323

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 93.9 bits (234), Expect = 2e-23
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 18  IARGLLYLHE--DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIV 75
           +   L   H   D    ++HRDLK +NV LD + N K+ DF +ARI   + S A T   V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FV 177

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCE 135
           GT  YM+PE      ++ KSD++S G LL E+ +      F       S      K+  E
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFT----AFSQKELAGKI-RE 230

Query: 136 GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
           G+   +          + EL + I      +      RP++  +
Sbjct: 231 GKFRRIP------YRYSDELNEIIT---RMLNLKDYHRPSVEEI 265

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 94.8 bits (236), Expect = 3e-23
 Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 21/162 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L ++H+    +I+HRD+K+ N+ L  +   ++ DF +AR+       A     +GT
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             Y++PE      ++ KSD+++ G +L E+ + K    F       S+ +   K+   G 
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH--AFE----AGSMKNLVLKI-ISGS 241

Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
                 PV      + +L   +       + +  DRP+++S+
Sbjct: 242 ----FPPV--SLHYSYDLRSLVS---QLFKRNPRDRPSVNSI 274

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 93.5 bits (233), Expect = 5e-23
 Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
               L +LH      ++H D+K +N+ L      K+ DF +     G           G 
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGD 219

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
             YMAPE  ++G +   +DVFS G+ +LE+    +
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 95.2 bits (237), Expect = 6e-23
 Identities = 37/108 (34%), Positives = 60/108 (55%), Gaps = 10/108 (9%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +    + I     IA G+ ++    +   IHRDL+A+N+L+   +  KI+DF +AR+   
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336

Query: 65  NQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           N+  A      G      + APE    G F++KSDV+SFG+LL+EI++
Sbjct: 337 NEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 92.8 bits (231), Expect = 1e-22
 Identities = 37/172 (21%), Positives = 62/172 (36%), Gaps = 31/172 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST------ 71
           IA  + +LH      ++HRDLK SN+    +   K+ DF +      ++ E +       
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 72  ----NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS 127
                  VGT  YM+PE      +S K D+FS G++L E++       F      Q    
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFS----TQMERV 234

Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
            T       +      P+  Q          +      +     +RP   ++
Sbjct: 235 RTLTDVRNLK----FPPLFTQKY--PCEYVMVQ---DMLSPSPMERPEAINI 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 92.4 bits (230), Expect = 1e-22
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 18/162 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   L ++H     R++HRD+K +NV +      K+ D  + R F    + A +  +VGT
Sbjct: 145 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE 137
             YM+PE   E  ++ KSD++S G LL E+ + +    FY  ++    L    K+  + +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCK--KI-EQCD 254

Query: 138 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
                 P L     + EL + ++   +C+  D   RP ++ V
Sbjct: 255 Y-----PPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 92.4 bits (230), Expect = 2e-22
 Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +  + +TN     +      +MAPE   + +++ +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 93.7 bits (233), Expect = 2e-22
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 4/105 (3%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++     + +   I+  + YL    +   IHR+L A N L+      K++DF ++R+  G
Sbjct: 314 EVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +   A          + APE      FS+KSDV++FGVLL EI +
Sbjct: 371 DTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 91.1 bits (227), Expect = 2e-22
 Identities = 37/111 (33%), Positives = 62/111 (55%), Gaps = 10/111 (9%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             ++L   + + +   IA G+ ++        IHRDL+A+N+L+   ++ KI+DF +AR+
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARL 158

Query: 62  FGGNQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              N+  A      G      + APE    G F++KSDV+SFG+LL EI++
Sbjct: 159 IEDNEYTARE----GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 93.4 bits (232), Expect = 3e-22
 Identities = 35/98 (35%), Positives = 59/98 (60%), Gaps = 4/98 (4%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 366 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422

Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                   + APE A+ G F++KSDV+SFG+LL E+ +
Sbjct: 423 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 91.6 bits (228), Expect = 3e-22
 Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 14/111 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q    + + ++ G+  G+ YL   S L  +HRDL A NVL+D  +  K+SDF ++R+   
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

Query: 65  NQSEASTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +   A T     T G      + APE      FS  SDV+SFGV++ E+++
Sbjct: 204 DPDAAYT-----TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 91.6 bits (228), Expect = 3e-22
 Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 5/106 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
               +  +   + +A+G+ +L   +    IHRD+ A NVLL +    KI DF +AR I  
Sbjct: 160 TASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +      N  +    +MAPE   + +++V+SDV+S+G+LL EI S
Sbjct: 217 DSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.8 bits (226), Expect = 4e-22
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 14/113 (12%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
              ++     + +   I+  + YL    +   IHRDL A N L+      K++DF ++R+
Sbjct: 104 NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

Query: 62  FGGNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             G+   A        +      + APE      FS+KSDV++FGVLL EI +
Sbjct: 161 MTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 92.9 bits (231), Expect = 4e-22
 Identities = 35/98 (35%), Positives = 59/98 (60%), Gaps = 4/98 (4%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+  A  
Sbjct: 283 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339

Query: 72  NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                   + APE A+ G F++KSDV+SFG+LL E+ +
Sbjct: 340 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 91.5 bits (228), Expect = 4e-22
 Identities = 34/114 (29%), Positives = 61/114 (53%), Gaps = 14/114 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            +  +  ++    IA+G+ YL      R++HRDL A NVL+    + KI+DF +A++ G 
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK 112
            + E          G     +MA E  +  +++ +SDV+S+GV + E+++ G K
Sbjct: 170 EEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 91.2 bits (227), Expect = 5e-22
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 9/102 (8%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I     + L +L E+  L+IIHRD+K SN+LLD   N K+ DF ++   G      +  R
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTR 184

Query: 74  IVGTYGYMAPE----YAMEGLFSVKSDVFSFGVLLLEIISGK 111
             G   YMAPE     A    + V+SDV+S G+ L E+ +G+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 91.2 bits (227), Expect = 5e-22
 Identities = 32/111 (28%), Positives = 59/111 (53%), Gaps = 14/111 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +    + + ++ GIA G+ YL   + +  +HRDL A N+L++  +  K+SDF ++R+   
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

Query: 65  NQSEASTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +     T     T G      + APE      F+  SDV+SFG+++ E+++
Sbjct: 200 DPEATYT-----TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 91.7 bits (228), Expect = 5e-22
 Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
           Q+ +K  +S    +ARG+ YL   +  + IHRDL A NVL+      KI+DF +AR I  
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +  + +TN     +      +MAPE   + +++ +SDV+SFGVL+ EI +
Sbjct: 256 IDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.4 bits (225), Expect = 6e-22
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 4/106 (3%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L     I+  N I  G+ + H    +RI+HRD+K  N+L+D     KI DF +A+     
Sbjct: 108 LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-E 163

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            S   TN ++GT  Y +PE A        +D++S G++L E++ G+
Sbjct: 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.8 bits (226), Expect = 7e-22
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 5/106 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
            LD +  +S    +A+G+ +L   +    IHRDL A N+LL H    KI DF +AR I  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +      N  +    +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 198 DSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 91.3 bits (227), Expect = 9e-22
 Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           Q    + + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDF + R+   
Sbjct: 143 QFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199

Query: 65  NQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +   A T R  G      + +PE      F+  SDV+S+G++L E++S
Sbjct: 200 DPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 10/103 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +   I + L YL E     +IHRD+K SN+LLD     K+ DF ++   G    + + +R
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDR 183

Query: 74  IVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 111
             G   YMAPE        +  + +++DV+S G+ L+E+ +G+
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 89.2 bits (222), Expect = 1e-21
 Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 14/111 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            +  K  I +++ ++ G+ YL        +HRDL A NVLL  +   KISDF +++    
Sbjct: 113 HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169

Query: 65  NQSEASTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +++                  + APE      FS KSDV+SFGVL+ E  S
Sbjct: 170 DENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 89.6 bits (223), Expect = 1e-21
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
            L  +  I     +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR I+ 
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                   +     +      +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 201 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 90.1 bits (224), Expect = 2e-21
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 15/98 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTN---- 72
           +A+G+ +L        +HRDL A NVL+ H    KI DF +AR I   +      N    
Sbjct: 181 VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237

Query: 73  -RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +      +MAPE   EG++++KSDV+S+G+LL EI S
Sbjct: 238 VK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 89.6 bits (223), Expect = 2e-21
 Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
            +  +  +  +  IA G+ YL   S    +HRDL A N +L  +M   ++DF +++ I+ 
Sbjct: 143 HIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           G+            +      ++A E   + +++ KSDV++FGV + EI +
Sbjct: 200 GDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 89.2 bits (222), Expect = 2e-21
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 10/108 (9%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +   ++ + +   +   + YL      + +HRDL A N L++ +   K+SDF ++R    
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172

Query: 65  NQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           ++  +S     G+     +  PE  M   FS KSD+++FGVL+ EI S
Sbjct: 173 DEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.5 bits (225), Expect = 2e-21
 Identities = 38/98 (38%), Positives = 58/98 (59%), Gaps = 15/98 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTN---- 72
           +ARG+ YL   +  + IHRDL A NVL+  +   KI+DF +AR I   +  + +TN    
Sbjct: 200 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256

Query: 73  -RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +      +MAPE   + +++ +SDV+SFGVLL EI +
Sbjct: 257 VK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.4 bits (220), Expect = 2e-21
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 10/108 (9%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L+  + + +   +  G+ +L      + IHRDL A N L+D ++  K+SDF M R    
Sbjct: 100 GLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156

Query: 65  NQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +Q  +S     GT     + APE      +S KSDV++FG+L+ E+ S
Sbjct: 157 DQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.8 bits (221), Expect = 2e-21
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 14/111 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++       +++ ++ G+ YL        +HRDL A NVLL +    KISDF +++  G 
Sbjct: 106 EIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

Query: 65  NQSEASTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           + S  +               + APE      FS +SDV+S+GV + E +S
Sbjct: 163 DDSYYTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 88.4 bits (220), Expect = 2e-21
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 10/101 (9%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST 71
           + +   +  G+ YL       +IHRDL A N L+      K+SDF M R    +Q  +ST
Sbjct: 107 LGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163

Query: 72  NRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
               GT     + +PE      +S KSDV+SFGVL+ E+ S
Sbjct: 164 ----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 89.2 bits (222), Expect = 2e-21
 Identities = 31/98 (31%), Positives = 57/98 (58%), Gaps = 15/98 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTN---- 72
           I++G+ YL   + ++++HRDL A N+L+      KISDF ++R ++  +     +     
Sbjct: 159 ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP 215

Query: 73  -RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +      +MA E   + +++ +SDV+SFGVLL EI++
Sbjct: 216 VK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 89.3 bits (222), Expect = 3e-21
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
            L  +  +  +  IA G+ YL   S    IHRDL A N +L  +M   ++DF ++R I+ 
Sbjct: 133 NLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           G+            +      ++A E   + L++V SDV++FGV + EI++
Sbjct: 190 GDYYRQGCASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 3e-21
 Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 5/107 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
               K  IS    +ARG+ YL   +  + +HRDL A N +LD     K++DF +AR    
Sbjct: 120 NPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176

Query: 65  NQSEASTNRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +  +            + A E      F+ KSDV+SFGVLL E+++
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 88.1 bits (219), Expect = 4e-21
 Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 13/111 (11%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
               K  I     +A+G+ YL      + +HRDL A N +LD +   K++DF +AR    
Sbjct: 124 NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-- 178

Query: 65  NQSEASTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +     +    G      +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 179 --YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 88.5 bits (220), Expect = 5e-21
 Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 13/110 (11%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L   + +++ + +A G++YL   + L  +HRDL   N L+   +  KI DF M+R    
Sbjct: 154 PLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR---- 206

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +       R VG        +M PE  +   F+ +SDV+SFGV+L EI +
Sbjct: 207 DIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.5 bits (220), Expect = 5e-21
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 13/110 (11%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            +  +  ++    IA+G+ YL      R++HRDL A NVL+    + KI+DF +A++ G 
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + E          G     +MA E  +  +++ +SDV+S+GV + E+++
Sbjct: 170 EEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 87.6 bits (218), Expect = 6e-21
 Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
            L+    + ++  IA G+ YL   S   ++H+DL   NVL+  ++N KISD  + R ++ 
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +  +   N     R      +MAPE  M G FS+ SD++S+GV+L E+ S
Sbjct: 181 ADYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.1 bits (219), Expect = 6e-21
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 4/107 (3%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           +  KR I +I    + L + H   +  IIHRD+K +N+++      K+ DF +AR    +
Sbjct: 113 MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

Query: 66  QSE-ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            +    T  ++GT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 89.3 bits (222), Expect = 6e-21
 Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 10/106 (9%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L     +     +   + YL        +HRDL A NVL+  +   K+SDF + +    
Sbjct: 285 VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---- 337

Query: 65  NQSEASTN-RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             S      ++     + APE   E  FS KSDV+SFG+LL EI S
Sbjct: 338 EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.1 bits (219), Expect = 7e-21
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 16/110 (14%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L  ++ +     +ARG+ YL   S+ + IHRDL A N+L+      KI+DF ++R  G 
Sbjct: 138 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ 192

Query: 65  NQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                 T      R      +MA E     +++  SDV+S+GVLL EI+S
Sbjct: 193 EVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 88.1 bits (219), Expect = 7e-21
 Identities = 35/111 (31%), Positives = 56/111 (50%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
            L    ++ I   +A G+ YL   S  + +HRDL   N L+   M  KI+DF ++R I+ 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +  +A  N     R      +M PE      ++ +SDV+++GV+L EI S
Sbjct: 227 ADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.3 bits (217), Expect = 9e-21
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 13/110 (11%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           +L   + + I + IA G++YL   +    +HRDL   N L+   +  KI DF M+R    
Sbjct: 129 ELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---- 181

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +       R VG +      +M PE  M   F+ +SDV+SFGV+L EI +
Sbjct: 182 DVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.3 bits (217), Expect = 1e-20
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 15/111 (13%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFG 63
                + I +   IA G+ YL+     + +HRDL A N ++  +   KI DF M R I+ 
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190

Query: 64  GNQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            +            R      +M+PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 191 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 89.2 bits (221), Expect = 1e-20
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 8/108 (7%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++       +++ ++ G+ YL        +HR+L A NVLL +    KISDF +++  G 
Sbjct: 432 EIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

Query: 65  NQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           + S  +            + APE      FS +SDV+S+GV + E +S
Sbjct: 489 DDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 86.9 bits (216), Expect = 1e-20
 Identities = 32/108 (29%), Positives = 41/108 (37%), Gaps = 8/108 (7%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
                        +A G+ YL      R IHRDL A N+LL      KI DF + R    
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

Query: 65  NQSEASTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           N               + + APE      FS  SD + FGV L E+ +
Sbjct: 174 NDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 86.5 bits (215), Expect = 1e-20
 Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 14/110 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R    
Sbjct: 112 SLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168

Query: 65  NQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +    ++      +      +MAPE      F+  SDV+ FGV + EI+ 
Sbjct: 169 STYYKASKGKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILM 212

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 86.6 bits (215), Expect = 1e-20
 Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 21/159 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVG 76
           I +GL +LH  +   IIHRDLK  N+ +     + KI D  +A +     S A    ++G
Sbjct: 138 ILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA--VIG 192

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG 136
           T  +MAPE   E  +    DV++FG+ +LE+ + +     Y      + +   ++    G
Sbjct: 193 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP---YSECQNAAQI---YRRVTSG 245

Query: 137 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
                 +P         E+ + I     C++ +  +R +
Sbjct: 246 V-----KPASFDKVAIPEVKEIIE---GCIRQNKDERYS 276

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 87.4 bits (217), Expect = 1e-20
 Identities = 28/110 (25%), Positives = 54/110 (49%), Gaps = 13/110 (11%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L  +  ++    IA+G+ YL       ++HR+L A NVLL      +++DF +A +   
Sbjct: 111 ALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +  +   +            +MA E    G ++ +SDV+S+GV + E+++
Sbjct: 168 DDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 86.6 bits (215), Expect = 1e-20
 Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 16/106 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST------ 71
           I   L Y+H      IIHRDLK  N+ +D   N KI DF +A+    +            
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 72  ------NRIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEIISG 110
                    +GT  Y+A E     G ++ K D++S G++  E+I  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 86.1 bits (214), Expect = 2e-20
 Identities = 34/110 (30%), Positives = 47/110 (42%), Gaps = 18/110 (16%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L     +     +   + YL        +HRDL A NVL+  +   K+SDF + +    
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---- 165

Query: 65  NQSEASTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
             S          +      + APE   E  FS KSDV+SFG+LL EI S
Sbjct: 166 EASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 86.5 bits (215), Expect = 2e-20
 Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 4/106 (3%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L   R ++I+  I   L   H        HRD+K  N+L+  +    + DF +A      
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +        VGT  YMAPE   E   + ++D+++   +L E ++G 
Sbjct: 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 87.9 bits (218), Expect = 2e-20
 Identities = 40/182 (21%), Positives = 73/182 (40%), Gaps = 29/182 (15%)

Query: 9   KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL-----DHEMNPKISDFEMARIFG 63
              I+++     GL +LH    L I+HRDLK  N+L+       ++   ISDF + +   
Sbjct: 118 LEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 64  GNQSE-ASTNRIVGTYGYMAPEY---AMEGLFSVKSDVFSFGVLLLEIISGKK--NSGFY 117
             +   +  + + GT G++APE      +   +   D+FS G +   +IS          
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 118 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMS 177
             +    L +          +L+ + P   +  +A EL++        +  D   RP+  
Sbjct: 235 QRQANILLGAC---------SLDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAK 279

Query: 178 SV 179
            V
Sbjct: 280 HV 281

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 87.1 bits (216), Expect = 2e-20
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 11/110 (10%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
               K  I     +A+G+ +L   +  + +HRDL A N +LD +   K++DF +AR    
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244

Query: 65  NQSEASTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
            + ++  N+   T       +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 245 KEFDSVHNK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 85.7 bits (213), Expect = 3e-20
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 16/111 (14%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L     +     I + + YL     +  +HRD+   N+L+      K+ DF ++R    
Sbjct: 109 SLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165

Query: 65  NQSEASTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
                ++              +M+PE      F+  SDV+ F V + EI+S
Sbjct: 166 EDYYKAS-------VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 87.6 bits (217), Expect = 3e-20
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 4/105 (3%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R    
Sbjct: 487 SLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
           +    ++   +    +MAPE      F+  SDV+ FGV + EI+ 
Sbjct: 544 STYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 86.8 bits (215), Expect = 6e-20
 Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 11/106 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L     I+ +  I   L YLH    + +++ DLK  N++L  E   K+ D          
Sbjct: 179 LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-- 232

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
               S   + GT G+ APE    G  +V +D+++ G  L  +    
Sbjct: 233 ----SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDL 273

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.6 bits (209), Expect = 2e-19
 Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 5/93 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR-IFGGNQSEASTNRIVG 76
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DF +AR I+         +  + 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257

Query: 77  TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +MAPE   + +++++SDV+SFGVLL EI S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 15/105 (14%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   +  +H+     I+H DLK +N L+  +   K+ DF +A     + +    +  VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 78  YGYMAPE-----------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
             YM PE              +   S KSDV+S G +L  +  GK
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 43/113 (38%), Positives = 51/113 (45%), Gaps = 16/113 (14%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARI 61
            L     + +   IA G  YL        IHRD+ A N LL         KI DF MAR 
Sbjct: 136 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 191

Query: 62  FGGNQSEASTNRIVGTYGY-----MAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +   AS  R  G         M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 192 ---DIYRASYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 83.6 bits (207), Expect = 3e-19
 Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 15/105 (14%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   +  +H+     I+H DLK +N L+  +   K+ DF +A     + +    +  VGT
Sbjct: 117 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 78  YGYMAPE-----------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
             YM PE              +   S KSDV+S G +L  +  GK
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 84.3 bits (208), Expect = 4e-19
 Identities = 19/111 (17%), Positives = 37/111 (33%), Gaps = 9/111 (8%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L    R+ +   + R L  LH      ++H  L+  +++LD      ++ FE      G 
Sbjct: 208 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GA 263

Query: 66  QSEASTNRIVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            + +   R        A            L +   D ++ G+ +  I    
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 84.6 bits (209), Expect = 4e-19
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 12/97 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL ++H      +++RDLK +N+LLD   + +ISD  +A  F   +     +  VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353

Query: 78  YGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGK 111
           +GYMAPE   +G+    S   D FS G +L +++ G 
Sbjct: 354 HGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 82.6 bits (205), Expect = 4e-19
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 11/97 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR---I 74
           I  G+LYLH      I+HRDL  SN+LL   MN KI+DF +A      Q +    +   +
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTL 172

Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GT  Y++PE A      ++SDV+S G +   ++ G+
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 83.7 bits (207), Expect = 4e-19
 Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 15/105 (14%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   +  +H+     I+H DLK +N L+  +   K+ DF +A     + +    +  VG 
Sbjct: 164 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

Query: 78  YGYMAPE-----------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
             YM PE              +   S KSDV+S G +L  +  GK
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.6 bits (207), Expect = 5e-19
 Identities = 42/113 (37%), Positives = 50/113 (44%), Gaps = 16/113 (14%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARI 61
            L     + +   IA G  YL        IHRD+ A N LL         KI DF MAR 
Sbjct: 177 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 232

Query: 62  FGGNQSEASTNRIVGTYGY-----MAPEYAMEGLFSVKSDVFSFGVLLLEIIS 109
              +   A   R  G         M PE  MEG+F+ K+D +SFGVLL EI S
Sbjct: 233 ---DIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 83.2 bits (206), Expect = 6e-19
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +     Y+H  +   I HRD+K SN+L+D     K+SDF  +      + + S     GT
Sbjct: 160 VLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----RGT 213

Query: 78  YGYMAPE-YAMEGLFS-VKSDVFSFGVLLLEIISGK 111
           Y +M PE ++ E  ++  K D++S G+ L  +    
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 82.2 bits (204), Expect = 7e-19
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 11/97 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR---I 74
           I  G  YLH   R R+IHRDLK  N+ L+ ++  KI DF +A      + E    R   +
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVL 175

Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 84.0 bits (207), Expect = 7e-19
 Identities = 36/97 (37%), Positives = 48/97 (49%), Gaps = 9/97 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEASTNRI 74
           I+  L YLHE    RIIHRDLK  N++L      +  KI D   A+         +    
Sbjct: 130 ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--F 183

Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           VGT  Y+APE   +  ++V  D +SFG L  E I+G 
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 82.4 bits (204), Expect = 9e-19
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 11/97 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR---I 74
           I  G  YLH   R R+IHRDLK  N+ L+ ++  KI DF +A      + E    R   +
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVL 201

Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GT  Y+APE   +   S + DV+S G ++  ++ GK
Sbjct: 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 82.4 bits (203), Expect = 1e-18
 Identities = 10/109 (9%), Positives = 25/109 (22%), Gaps = 10/109 (9%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
                    +   + R    L       ++H      N+ +  +    + D       G 
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245

Query: 65  NQSEASTNRIVGTYGYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISGK 111
                          Y   E+       F+   + +  G+ +  +    
Sbjct: 246 ----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 81.7 bits (202), Expect = 1e-18
 Identities = 32/98 (32%), Positives = 46/98 (46%), Gaps = 7/98 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNR--- 73
              GL YLH     RI+H D+KA NVLL  + +   + DF  A     +    S      
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           I GT  +MAPE  M      K D++S   ++L +++G 
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 82.0 bits (202), Expect = 2e-18
 Identities = 20/117 (17%), Positives = 40/117 (34%), Gaps = 20/117 (17%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L    R+ +   + R L  LH      ++H  L+  +++LD      ++ FE     G  
Sbjct: 203 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 257

Query: 66  QSEASTNRIVGTYGYMAPEY-----------AMEGLFSVKSDVFSFGVLLLEIISGK 111
               +      + G+  PE                L +   D ++ G+++  I    
Sbjct: 258 ----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL +LH+     II+RDLK  NVLLD + N +ISD  +A      Q++       GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            G+MAPE  +   +    D F+ GV L E+I+ +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.1 bits (203), Expect = 3e-18
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL  LH     RI++RDLK  N+LLD   + +ISD  +A      Q   +    VGT
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 348

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GYMAPE      ++   D ++ G LL E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.0 bits (198), Expect = 4e-18
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 12/101 (11%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I GI     YLH     +IIHRD+K SN+L+  + + KI+DF ++  F G+ +  S   
Sbjct: 146 LIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT- 197

Query: 74  IVGTYGYMAPE--YAMEGLFS-VKSDVFSFGVLLLEIISGK 111
            VGT  +MAPE       +FS    DV++ GV L   + G+
Sbjct: 198 -VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 79.6 bits (197), Expect = 6e-18
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 3/94 (3%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A++      +A  N  VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y++PE   E      SD+++ G ++ ++++G 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 79.8 bits (197), Expect = 7e-18
 Identities = 24/106 (22%), Positives = 45/106 (42%), Gaps = 18/106 (16%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLL----DHEMNPKISDFEMARIFGGNQSEASTNR 73
           +  G+ +L E     I+HR++K  N++     D +   K++DF  AR    ++   S   
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--- 174

Query: 74  IVGTYGYMAPE--------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
           + GT  Y+ P+           +  +    D++S GV      +G 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 80.2 bits (198), Expect = 9e-18
 Identities = 37/121 (30%), Positives = 51/121 (42%), Gaps = 25/121 (20%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-------------KISDFEM 58
           IS++  IA G+ +LH    L+IIHRDLK  N+L+                    ISDF +
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174

Query: 59  ARIFGGNQS--EASTNRIVGTYGYMAPEYAMEGLFSV-------KSDVFSFGVLLLEIIS 109
            +     QS    + N   GT G+ APE   E              D+FS G +   I+S
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

Query: 110 G 110
            
Sbjct: 235 K 235

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 79.9 bits (197), Expect = 1e-17
 Identities = 24/106 (22%), Positives = 45/106 (42%), Gaps = 18/106 (16%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLL----DHEMNPKISDFEMARIFGGNQSEASTNR 73
           +  G+ +L E     I+HR++K  N++     D +   K++DF  AR    ++   S   
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--- 174

Query: 74  IVGTYGYMAPE--------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
           + GT  Y+ P+           +  +    D++S GV      +G 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 28/111 (25%), Positives = 46/111 (41%), Gaps = 19/111 (17%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++ GI RGL  +H        HRDLK +N+LL  E  P + D         +   +    
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 74  IV-------GTYGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            +        T  Y APE      + +      ++DV+S G +L  ++ G+
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE 243

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 5/98 (5%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I+  I +GL YLH +   + IHRD+KA+NVLL      K++DF +A      Q + +T  
Sbjct: 124 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-- 178

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            VGT  +MAPE   +  +  K+D++S G+  +E+  G+
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 22/120 (18%), Positives = 45/120 (37%), Gaps = 30/120 (25%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--------KISDF 56
            ++   ++ +   +A  + +L       +IH ++ A N+LL  E +         K+SD 
Sbjct: 109 CINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 57  EMARIFGGNQSEASTNRIVGTYGY------MAPEYAMEG-LFSVKSDVFSFGVLLLEIIS 109
            ++              ++           + PE        ++ +D +SFG  L EI S
Sbjct: 166 GISIT------------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 78.6 bits (194), Expect = 2e-17
 Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 5/98 (5%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I+    +GL YLH     R IHRD+KA N+LL+ E + K++DF +A       ++ +T  
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-- 184

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           ++GT  +MAPE   E  ++  +D++S G+  +E+  GK
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 76.9 bits (190), Expect = 5e-17
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 13/97 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR---I 74
           +A  L Y H     R+IHRD+K  N+LL      KI+DF       G    A ++R   +
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF-------GWSVHAPSSRRTDL 167

Query: 75  VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 77.0 bits (190), Expect = 5e-17
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 10/98 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVG 76
           I  GL YLH++   +I+HRD+K  NVL++ +    KISDF  ++   G      T    G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185

Query: 77  TYGYMAPE---YAMEGLFSVKSDVFSFGVLLLEIISGK 111
           T  YMAPE       G +   +D++S G  ++E+ +GK
Sbjct: 186 TLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGK 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 76.6 bits (189), Expect = 8e-17
 Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 5/98 (5%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +     + L +LH +   ++IHRD+K+ N+LL  + + K++DF         QS+ ST  
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 175

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +VGT  +MAPE      +  K D++S G++ +E+I G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 76.2 bits (188), Expect = 8e-17
 Identities = 21/108 (19%), Positives = 39/108 (36%), Gaps = 17/108 (15%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI-------------FGG 64
           + RGL Y+H      ++H D+K SN+ +     P  +  E                  G 
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
               +S     G   ++A E   E      K+D+F+  + ++     +
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 74.5 bits (184), Expect = 3e-16
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 8/98 (8%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++ G+     YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N+
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 74  IVGTYGYMAPEYAMEGLFS-VKSDVFSFGVLLLEIISG 110
           + GT  Y+APE      F     DV+S G++L  +++G
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.8 bits (187), Expect = 3e-16
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 13/99 (13%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   L YL      RIIHRD+K  N+LLD   +  I+DF +A +            + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGT 177

Query: 78  YGYMAPE--YAMEGL---FSVKSDVFSFGVLLLEIISGK 111
             YMAPE   + +G    F+V  D +S GV   E++ G+
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 75.2 bits (185), Expect = 3e-16
 Identities = 45/222 (20%), Positives = 77/222 (34%), Gaps = 53/222 (23%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I     R + ++H   +  IIHRDLK  N+LL ++   K+ DF  A         + + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 74  I----------VGTYGYMAPEYAMEGLFS-----VKSDVFSFGVLLLEIISGKKNSGFYL 118
                        T  Y  PE  +  L+S      K D+++ G +L  +   +    F  
Sbjct: 200 RRALVEEEITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPFE- 254

Query: 119 SELGQSLL-----SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR 173
                + L      Y+              P   Q  V   L++        +Q +  +R
Sbjct: 255 ---DGAKLRIVNGKYSIP------------PHDTQYTVFHSLIRA------MLQVNPEER 293

Query: 174 PTMSSVV----VMLASDNVTLPQPTEPAFS--VGRNVARPSQ 209
            +++ VV     + A+ NV    P         G   A  S+
Sbjct: 294 LSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 75.1 bits (185), Expect = 3e-16
 Identities = 28/98 (28%), Positives = 55/98 (56%), Gaps = 5/98 (5%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +   + + L YLH      +IHRD+K+ ++LL  +   K+SDF        +  +  +  
Sbjct: 146 VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-- 200

Query: 74  IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +VGT  +MAPE     L++ + D++S G++++E++ G+
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 74.6 bits (184), Expect = 3e-16
 Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 7/94 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  L Y H     ++IHRD+K  N+L+ ++   KI+DF  +      +       + GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGT 175

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+ PE         K D++  GVL  E + G 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 10/103 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           I   I RGL +LH+    ++IHRD+K  NVLL      K+ DF ++          +T  
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188

Query: 74  IVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            +GT  +MAPE        +  +  KSD++S G+  +E+  G 
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 74.7 bits (184), Expect = 5e-16
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 8/98 (8%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           ++ G+     YLH    + I HRD+K  N+LLD   N KISDF +A +F  N  E   N+
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 74  IVGTYGYMAPEYAMEGLFS-VKSDVFSFGVLLLEIISG 110
           + GT  Y+APE      F     DV+S G++L  +++G
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 75.1 bits (185), Expect = 6e-16
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            II  +  G+ YLH+     I+HRDLK  N+LL   + +   KI DF ++ +F   +   
Sbjct: 140 VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--- 193

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                +GT  Y+APE  +   +  K DV+S GV+L  +++G 
Sbjct: 194 KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 75.1 bits (185), Expect = 6e-16
 Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 10/101 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            II  +  G+ Y+H+    +I+HRDLK  N+LL     + N +I DF ++  F  ++   
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--- 183

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 184 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 73.9 bits (182), Expect = 7e-16
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 7/103 (6%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEM-ARIFGGNQSEAST 71
           +I+  +  GL YLH++     IHRD+KA N+LL  + + +I+DF + A +  G     + 
Sbjct: 125 TILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181

Query: 72  NR--IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
            R   VGT  +MAPE   +   +  K+D++SFG+  +E+ +G 
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 74.6 bits (183), Expect = 8e-16
 Identities = 23/105 (21%), Positives = 45/105 (42%), Gaps = 10/105 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAST-- 71
           I+ G+ + L Y+H       +HR +KAS++L+  +    +S          +        
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 72  ---NRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGK 111
                 V    +++PE   + L  +  KSD++S G+   E+ +G 
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 74.4 bits (183), Expect = 9e-16
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 10/101 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
           +I+  I  G+ YLH+     I+HRD+K  N+LL   +  +N KI DF ++  F  +    
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--- 203

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                +GT  Y+APE  ++  ++ K DV+S GV++  ++ G
Sbjct: 204 KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 12/98 (12%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
            I+  +   +  LH+   L I+HRDLK  N+LLD +MN K++DF  +      +      
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 181

Query: 73  RIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLL 104
            + GT  Y+APE            +  + D++S GV++
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.5 bits (181), Expect = 1e-15
 Identities = 39/105 (37%), Positives = 55/105 (52%), Gaps = 23/105 (21%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTN 72
           I++ +     Y H   + RI+HRDLKA N+LLD +MN KI+DF  +  F  G + +A   
Sbjct: 123 IVSAVQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-- 173

Query: 73  RIVGTYGYMAPEYAMEGLFS------VKSDVFSFGVLLLEIISGK 111
              G   Y APE     LF        + DV+S GV+L  ++SG 
Sbjct: 174 --CGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 73.7 bits (181), Expect = 1e-15
 Identities = 30/105 (28%), Positives = 45/105 (42%), Gaps = 9/105 (8%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL--DHEMNPKISDFEMARIFGGNQSEAS 70
           +I+  I   L YLH      I HRD+K  N L   +     K+ DF +++ F    +   
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228

Query: 71  T--NRIVGTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEIISGK 111
                  GT  ++APE        +  K D +S GVLL  ++ G 
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 73.4 bits (181), Expect = 2e-15
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 8/96 (8%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS---TNRIVG 76
            GL Y+H +   +I+HRD+KA+NVL+  +   K++DF +AR F   ++      TNR+V 
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190

Query: 77  TYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 111
           T  Y  PE  + E  +    D++  G ++ E+ +  
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 28/124 (22%), Positives = 47/124 (37%), Gaps = 20/124 (16%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   + YL       IIHRD+K  N+++  +   K+ DF  A      +         GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGT 192

Query: 78  YGYMAPE-YAMEGLFSVKSDVFSFGVLL-------------LEIISGKKNSGFYLSELGQ 123
             Y APE          + +++S GV L              E +    +  + +S+   
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM 252

Query: 124 SLLS 127
           SL+S
Sbjct: 253 SLVS 256

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 73.6 bits (181), Expect = 2e-15
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 10/101 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            II  +  G+ Y+H+     I+HRDLK  N+LL   + + + KI DF ++  F  N    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.9 bits (177), Expect = 3e-15
 Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 9/100 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +I+G+     YLH      I+H+D+K  N+LL      KIS   +A       ++ +   
Sbjct: 118 LIDGLE----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 74  IVGTYGYMAPEYAM-EGLFS-VKSDVFSFGVLLLEIISGK 111
             G+  +  PE A     FS  K D++S GV L  I +G 
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 72.0 bits (177), Expect = 4e-15
 Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 10/103 (9%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +   +   L +LH     RIIHRDLKA NVL+  E + +++DF ++        +  +  
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176

Query: 74  IVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            +GT  +MAPE        +  +  K+D++S G+ L+E+   +
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 72.1 bits (177), Expect = 4e-15
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 12/98 (12%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           SI+  +   + +LH      I+HRDLK  N+LLD  M  ++SDF  +      +      
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLR 257

Query: 73  RIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLL 104
            + GT GY+APE            +  + D+++ GV+L
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 71.6 bits (176), Expect = 7e-15
 Identities = 31/95 (32%), Positives = 42/95 (44%), Gaps = 8/95 (8%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEA 69
             +  I   L Y H+     IIHRD+K   VLL  + N    K+  F +A   G +   A
Sbjct: 134 HYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                VGT  +MAPE      +    DV+  GV+L
Sbjct: 191 GG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 71.3 bits (175), Expect = 9e-15
 Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 12/101 (11%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           + +G  +GL YLH      +IHRD+KA N+LL      K+ DF  A       + A++  
Sbjct: 159 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS-- 209

Query: 74  IVGTYGYMAPE---YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            VGT  +MAPE      EG +  K DV+S G+  +E+   K
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 6/100 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L YLH  S   +++RDLK  N++LD + + KI+DF + +   G +  A+     GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 312

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY 117
             Y+APE   +  +    D +  GV++ E++ G+    FY
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 350

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 9/96 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL-DHEMNP---KISDFEMARIFGGNQSE 68
           +++  I + + YLH      ++HRDLK SN+L  D   NP   +I DF  A+        
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
             T     T  ++APE      +    D++S GVLL
Sbjct: 177 LMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 28/125 (22%), Positives = 46/125 (36%), Gaps = 22/125 (17%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVG 76
           +   + + H      ++HRD+K  N+L+D      K+ DF    +              G
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DG 210

Query: 77  TYGYMAPEYAMEGLFS-VKSDVFSFGVLL-------------LEIISGKKNSGFYLSELG 122
           T  Y  PE+     +    + V+S G+LL              EII G+      +S   
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 270

Query: 123 QSLLS 127
           Q L+ 
Sbjct: 271 QHLIR 275

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.7 bits (170), Expect = 4e-14
 Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 11/102 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           IA GL +L       II+RDLK  NV+LD E + KI+DF M +  I+ G      T    
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFC 503

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY 117
           GT  Y+APE      +    D ++FGVLL E+++G+  + F 
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFE 543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 69.2 bits (170), Expect = 5e-14
 Identities = 29/102 (28%), Positives = 47/102 (46%), Gaps = 18/102 (17%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           + R +  LH  S + + HRD+K  NVL++      K+ DF  A+    + SE +   I  
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICS 194

Query: 77  TYGYMAPE-------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            Y Y APE       Y      +   D++S G +  E++ G+
Sbjct: 195 RY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.7 bits (169), Expect = 5e-14
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 14/97 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RG+ + H+    RI+HRDLK  N+L++ +   K++DF +AR F G    + T+ +V T  
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLW 184

Query: 80  YMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           Y AP+     L   K      D++S G +  E+I+GK
Sbjct: 185 YRAPDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 68.9 bits (169), Expect = 5e-14
 Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 8/95 (8%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            I+  +   + ++H+   + ++HRDLK  N+L    +  +  KI DF  AR+   +    
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
            T     T  Y APE   +  +    D++S GV+L
Sbjct: 167 KT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.5 bits (168), Expect = 5e-14
 Identities = 25/125 (20%), Positives = 48/125 (38%), Gaps = 22/125 (17%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           +   + + H      ++HRD+K  N+L+D      K+ DF    +              G
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF----DG 200

Query: 77  TYGYMAPEYAMEGLFS-VKSDVFSFGVLL-------------LEIISGKKNSGFYLSELG 122
           T  Y  PE+     +  + + V+S G+LL              EI+  + +   ++S   
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDC 260

Query: 123 QSLLS 127
            +L+ 
Sbjct: 261 CALIR 265

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 68.4 bits (168), Expect = 6e-14
 Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 10/95 (10%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            I+  +   + Y H+   L + HRDLK  N L      +   K+ DF +A  F   +   
Sbjct: 110 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                VGT  Y++P+  +EGL+  + D +S GV++
Sbjct: 164 MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 69.3 bits (170), Expect = 6e-14
 Identities = 32/93 (34%), Positives = 44/93 (47%), Gaps = 12/93 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEASTNRI 74
           +   + YLHE     IIHRDLK  NVLL  +      KI+DF  ++I G          +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTL 301

Query: 75  VGTYGYMAPE---YAMEGLFSVKSDVFSFGVLL 104
            GT  Y+APE         ++   D +S GV+L
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.8 bits (169), Expect = 6e-14
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH     R++HRDLK  N+L+      K++DF +ARI+    +   T+ +V T  
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVV-TLW 184

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 68.4 bits (168), Expect = 6e-14
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 10/95 (10%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            II  +  G+ Y+H+     I+HRDLK  N+LL   + + + KI DF ++  F  N    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                +GT  Y+APE  + G +  K DV+S GV+L
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 68.0 bits (167), Expect = 7e-14
 Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 10/95 (10%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            ++  +   L Y H      ++H+DLK  N+L          KI DF +A +F  ++   
Sbjct: 128 ELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--- 181

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
            +    GT  YMAPE   +   + K D++S GV++
Sbjct: 182 HSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.4 bits (168), Expect = 8e-14
 Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 11/102 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I   L YLH      +++RD+K  N++LD + + KI+DF + +  I  G     +     
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 166

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY 117
           GT  Y+APE   +  +    D +  GV++ E++ G+    FY
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 206

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 68.0 bits (167), Expect = 8e-14
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL +LH +    I+HRDLK  N+L+      K++DF +ARI+    +   T  +V T  
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVV-TLW 184

Query: 80  YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           Y APE  ++  ++   D++S G +  E+   K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 8e-14
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L YLHE     II+RDLK  NVLLD E + K++D+ M +   G +   +T+   GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 173

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.0 bits (167), Expect = 9e-14
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 7/100 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +A  L +LH    L II+RDLK  N+LLD E + K++DF +++       E       GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGT 189

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY 117
             YMAPE       +  +D +SFGVL+ E+++G     F 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQ 227

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 10/97 (10%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
            S I  I  G+ YLH     +I H DLK  N++L  +  P    K+ DF +A        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV- 173

Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                 I GT  ++APE        +++D++S GV+ 
Sbjct: 174 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.0 bits (167), Expect = 1e-13
 Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 9/96 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           IA GL +L       II+RDLK  NV+LD E + KI+DF M +  I+ G      T    
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFC 182

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.0 bits (167), Expect = 1e-13
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I+  L +LH+     II+RDLK  N++L+H+ + K++DF + +          T+   GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGT 184

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             YMAPE  M    +   D +S G L+ ++++G 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.0 bits (167), Expect = 1e-13
 Identities = 39/100 (39%), Positives = 55/100 (55%), Gaps = 7/100 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L++LH+     II+RDLK  NVLLDHE + K++DF M +    N    +T    GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY 117
             Y+APE   E L+    D ++ GVLL E++ G   + F 
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH--APFE 225

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 67.2 bits (165), Expect = 1e-13
 Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 14/98 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           +GL + H      ++HRDLK  N+L++     K+++F +AR F G      +  +V T  
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLW 166

Query: 80  YMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGKK 112
           Y  P+     LF  K      D++S G +  E+ +  +
Sbjct: 167 YRPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGR 200

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I+  L YLHE     II+RDLK  NVLLD E + K++D+ M +  +  G+     T+   
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 214

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           GT  Y+APE      +    D ++ GVL+ E+++G+
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 39/102 (38%), Positives = 57/102 (55%), Gaps = 11/102 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           I  GL +LH      I++RDLK  N+LLD + + KI+DF M +  + G       TN   
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFC 179

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY 117
           GT  Y+APE  +   ++   D +SFGVLL E++ G+  S F+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH 219

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 10/97 (10%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
              +  I  G+ YLH    L+I H DLK  N++L     P    KI DF +A        
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 172

Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                 I GT  ++APE        +++D++S GV+ 
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 67.2 bits (165), Expect = 2e-13
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 10/97 (10%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
              +  I  G+ YLH     RI H DLK  N++L  +  P    K+ DF +A        
Sbjct: 111 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN- 166

Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                 I GT  ++APE        +++D++S GV+ 
Sbjct: 167 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 66.8 bits (164), Expect = 2e-13
 Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 9/95 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEA 69
             I  I   + Y H      I+HR+LK  N+LL  +      K++DF +A     ++   
Sbjct: 109 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--- 162

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
           + +   GT GY++PE   +  +S   D+++ GV+L
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.7 bits (166), Expect = 2e-13
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 11/102 (10%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR--IFGGNQSEASTNRIV 75
           IA  L YLH    L I++RDLK  N+LLD + +  ++DF + +  I   +    +T+   
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFC 200

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFY 117
           GT  Y+APE   +  +    D +  G +L E++ G     FY
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL--PPFY 240

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 10/97 (10%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGGNQS 67
            S I  I  G+ YLH     +I H DLK  N++L  +  P    K+ DF +A        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV- 173

Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                 I GT  ++APE        +++D++S GV+ 
Sbjct: 174 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 67.2 bits (165), Expect = 2e-13
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 14/97 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           +GL + HE+   +I+HRDLK  N+L++     K+ DF +AR F G      ++ +V T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLW 173

Query: 80  YMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           Y AP+     L   ++     D++S G +L E+I+GK
Sbjct: 174 YRAPDV----LMGSRTYSTSIDIWSCGCILAEMITGK 206

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 66.8 bits (164), Expect = 2e-13
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 10/94 (10%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEAS 70
           +I  +   + YLHE     I+HRDLK  N+L    +      I+DF ++++         
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---- 163

Query: 71  TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
            +   GT GY+APE   +  +S   D +S GV+ 
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 9/95 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEA 69
             I  I   + Y H      I+HR+LK  N+LL  +      K++DF +A     ++   
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--- 185

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
           + +   GT GY++PE   +  +S   D+++ GV+L
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.8 bits (164), Expect = 2e-13
 Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 14/97 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
            G+ Y H+    R++HRDLK  N+L++ E   KI+DF +AR F G      T+ IV T  
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLW 165

Query: 80  YMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           Y AP+     L   K      D++S G +  E+++G 
Sbjct: 166 YRAPDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 67.0 bits (164), Expect = 3e-13
 Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 8/95 (8%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEA 69
           I  +  I  G+ ++H+   + I+H DLK  N+L  +      KI DF +AR +   +   
Sbjct: 190 ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                 GT  ++APE       S  +D++S GV+ 
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 67.3 bits (165), Expect = 3e-13
 Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIFGGNQSEA 69
             I  I   +L+ H+   + ++HR+LK  N+LL  ++     K++DF +A    G Q   
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                 GT GY++PE   +  +    D+++ GV+L
Sbjct: 171 FG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 23/105 (21%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTN 72
           II  I     Y H   R +I+HRDLK  N+LLD  +N KI+DF ++ I   GN  + S  
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167

Query: 73  RIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
              G+  Y APE      YA       + DV+S G++L  ++ G+
Sbjct: 168 --CGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGR 205

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 14/97 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           RGL Y H     +++HRDLK  N+L++     K++DF +AR      ++   N +V T  
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLW 165

Query: 80  YMAPEYAMEGLF-----SVKSDVFSFGVLLLEIISGK 111
           Y  P+     L      S + D++  G +  E+ +G+
Sbjct: 166 YRPPDI----LLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.5 bits (163), Expect = 4e-13
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 12/104 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   L +LH+   L II+RD+K  N+LLD   +  ++DF +++ F  +++E       GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223

Query: 78  YGYMAPEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFY 117
             YMAP+    G      +V  D +S GVL+ E+++G   S F 
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFT 263

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 66.7 bits (163), Expect = 4e-13
 Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 8/95 (8%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEA 69
           I+ +     GL ++HE     I+H D+K  N++ + +     KI DF +A     ++   
Sbjct: 152 INYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                  T  + APE          +D+++ GVL 
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 66.2 bits (162), Expect = 5e-13
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 12/93 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEASTNRI 74
           +   + YLHE     IIHRDLK  NVLL   + +   KI+DF  ++I G          +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTL 176

Query: 75  VGTYGYMAPE---YAMEGLFSVKSDVFSFGVLL 104
            GT  Y+APE         ++   D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 66.1 bits (162), Expect = 5e-13
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 14/97 (14%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG 79
           +GL YLH+     I+HRDLK +N+LLD     K++DF +A+ F G+ + A T+++V T  
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRW 177

Query: 80  YMAPEYAMEGLF-----SVKSDVFSFGVLLLEIISGK 111
           Y APE     LF      V  D+++ G +L E++   
Sbjct: 178 YRAPEL----LFGARMYGVGVDMWAVGCILAELLLRV 210

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 65.7 bits (161), Expect = 5e-13
 Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 23/105 (21%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTN 72
           I++ +     Y H   R  ++HRDLK  NVLLD  MN KI+DF ++ +   G     S  
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 170

Query: 73  RIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
              G+  Y APE      YA  G    + D++S GV+L  ++ G 
Sbjct: 171 --CGSPNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 65.8 bits (161), Expect = 6e-13
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
             +  I   + YLHE     I+HRDLK  N+L      +   KI+DF +++I        
Sbjct: 152 DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--- 205

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
               + GT GY APE      +  + D++S G++ 
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 66.0 bits (161), Expect = 8e-13
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 17/102 (16%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDFEMARIFGG-NQSEASTNRI 74
            G+ YLH +    ++HRDLK +N+L+  E       KI+D   AR+F    +  A  + +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 75  VGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
           V T+ Y APE     L   +      D+++ G +  E+++ +
Sbjct: 196 VVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 65.4 bits (159), Expect = 9e-13
 Identities = 17/117 (14%), Positives = 34/117 (29%), Gaps = 14/117 (11%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-----------KIS 54
           +     IS    +   +  +H+     IIH D+K  N +L +                + 
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225

Query: 55  DFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           D   +                 T G+   E      ++ + D F     +  ++ G 
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 65.4 bits (160), Expect = 9e-13
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 9/96 (9%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSE 68
           I +I  I  G+ YLH+     I+H DLK  N+LL       + KI DF M+R  G     
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-- 188

Query: 69  ASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                I+GT  Y+APE       +  +D+++ G++ 
Sbjct: 189 -ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 65.5 bits (160), Expect = 9e-13
 Identities = 24/98 (24%), Positives = 48/98 (48%), Gaps = 9/98 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   +  +H+   L  +HRD+K  N+L+D   + +++DF        +     ++  VGT
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239

Query: 78  YGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE        +G +  + D +S GV + E++ G
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           + R + ++H    L I HRD+K  N+L++ + N  K+ DF  A+      SE S   I  
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICS 204

Query: 77  TYGYMAPEY---AMEGLFSVKSDVFSFGVLLLEIISGK 111
            + Y APE    A E  ++   D++S G +  E+I GK
Sbjct: 205 RF-YRAPELMLGATE--YTPSIDLWSIGCVFGELILGK 239

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 23/105 (21%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF-GGNQSEASTN 72
           I++G+     Y H   R  ++HRDLK  NVLLD  MN KI+DF ++ +   G     S  
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 175

Query: 73  RIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
              G+  Y APE      YA       + D++S GV+L  ++ G 
Sbjct: 176 --CGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGT 213

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 8/95 (8%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEA 69
           +  +  + +GL ++HE      +H DLK  N++   + +   K+ DF +       Q   
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
           S     GT  + APE A        +D++S GVL 
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 20/102 (19%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           + R L Y+H      I HRD+K  N+LLD +    K+ DF  A+     + E + + I  
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 219

Query: 77  TYGYMAPE-------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
            Y Y APE       Y      +   DV+S G +L E++ G+
Sbjct: 220 RY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 11/100 (11%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I   +  +H    L  +HRD+K  N+LLD   + +++DF        +     +   VGT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGT 226

Query: 78  YGYMAPE-------YAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE           G +  + D ++ GV   E+  G
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 64.9 bits (159), Expect = 1e-12
 Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 8/95 (8%)

Query: 12  ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEA 69
           +S ++ +   L +LH      I H D++  N++     +   KI +F  AR         
Sbjct: 105 VSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
           +   +     Y APE     + S  +D++S G L+
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 64.7 bits (158), Expect = 1e-12
 Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 10/95 (10%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            I+  I   + +LH      I HRD+K  N+L    + +   K++DF  A+    N    
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--- 185

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
                  T  Y+APE      +    D++S GV++
Sbjct: 186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.0 bits (159), Expect = 2e-12
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 16/100 (16%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-KISDFEMARIFGGNQSEASTNRIVG 76
           + R L Y+H    + I HRD+K  N+LLD      K+ DF  A+I      E + + I  
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICS 204

Query: 77  TYGYMAPEYAMEGLF-----SVKSDVFSFGVLLLEIISGK 111
            Y Y APE     +F     +   D++S G ++ E++ G+
Sbjct: 205 RY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 16/105 (15%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIF--GGNQS 67
            ++  +A  L +LH      I HRDLK  N+L +H       KI DF++       G+ S
Sbjct: 115 VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 68  EASTNR---IVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLL 104
             ST       G+  YMAPE          ++  + D++S GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  G   S   T   V T
Sbjct: 136 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY-VVT 189

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  +   +    D++S G ++ E+I G 
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 30/101 (29%), Positives = 44/101 (43%), Gaps = 18/101 (17%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  G+ + H      IIHRD+K  N+L+      K+ DF  AR       E   + +  T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-T 187

Query: 78  YGYMAPE-------YAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y APE       Y      +V  DV++ G L+ E+  G+
Sbjct: 188 RWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I     YLH    L +I+RDLK  N+L+D +   +++DF  A+   G      T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGT 201

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
              +APE  +   ++   D ++ GVL+ E+ +G
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 63.0 bits (154), Expect = 6e-12
 Identities = 28/104 (26%), Positives = 46/104 (44%), Gaps = 14/104 (13%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN 72
           SI     + + + H   +   IHRD+K  N+L+      K+ DF  AR+  G  S+   +
Sbjct: 106 SITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDD 161

Query: 73  RIVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
            +  T  Y +PE     L          DV++ G +  E++SG 
Sbjct: 162 EVA-TRWYRSPEL----LVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 63.2 bits (154), Expect = 6e-12
 Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 8/97 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   L  +H    +  IHRD+K  N+LLD   + K++DF               +  VGT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGT 232

Query: 78  YGYMAPE----YAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y++PE       +G +  + D +S GV L E++ G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 62.8 bits (153), Expect = 7e-12
 Identities = 33/99 (33%), Positives = 46/99 (46%), Gaps = 23/99 (23%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--EMNPKISDFEMARIFGGNQSEAST 71
           +++G++    Y H    ++I HRDLK  N LLD       KI DF  ++    +    ST
Sbjct: 125 LLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177

Query: 72  NRIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLL 104
              VGT  Y+APE      Y         +DV+S GV L
Sbjct: 178 ---VGTPAYIAPEVLLRQEYD-----GKIADVWSCGVTL 208

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.5 bits (153), Expect = 8e-12
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 20/99 (20%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +   L YLH      II+RDLK  N+LLD   + KI+DF  A+          T  + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 166

Query: 78  YGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISG 110
             Y+APE      Y      S+  D +SFG+L+ E+++G
Sbjct: 167 PDYIAPEVVSTKPYNK----SI--DWWSFGILIYEMLAG 199

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 62.8 bits (153), Expect = 8e-12
 Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 9/95 (9%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEA 69
            I+  I   + YLH    + I HRD+K  N+L          K++DF  A+    + S  
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221

Query: 70  STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 104
           +      T  Y+APE      +    D++S GV++
Sbjct: 222 T---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 62.7 bits (153), Expect = 9e-12
 Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 24/103 (23%)

Query: 20  RGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTY 78
           + L Y H  S   I+HRD+K  NV++DHE    ++ D+ +A     +  +    R+   Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY 195

Query: 79  GYMAPE---------YAMEGLFSVKSDVFSFGVLLLEIISGKK 112
            +  PE         Y++        D++S G +L  +I  K+
Sbjct: 196 -FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 62.3 bits (152), Expect = 9e-12
 Identities = 29/104 (27%), Positives = 43/104 (41%), Gaps = 19/104 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-----KISDFEMARIFGGNQSEASTN 72
           +  G+ + H     R +HRDLK  N+LL           KI DF +AR F G      T+
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196

Query: 73  RIVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
            I+ T  Y  PE     L   +      D++S   +  E++   
Sbjct: 197 EII-TLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 9/112 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DF +AR
Sbjct: 120 MKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
                 +       V T  Y APE  +    ++   D++S G ++ E+I+GK
Sbjct: 177 QADSEMTGY-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 62.2 bits (151), Expect = 1e-11
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  G   S   T   V T
Sbjct: 173 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY-VVT 226

Query: 78  YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  +   +    D++S G ++ E++  K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      +       V T
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-----VAT 192

Query: 78  YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  +    ++   D++S G ++ E+++G+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 9/95 (9%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + +GL Y+H      ++HRDLK  N+ ++ +   KI DF +AR      +       V T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVT 186

Query: 78  YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  +    ++   D++S G ++ E+++GK
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 20/107 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRI--- 74
             R +  LH  +   +IHRDLK SN+L++   + K+ DF +ARI   + ++ S       
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 75  -----VGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
                V T  Y APE     + +        DV+S G +L E+   +
Sbjct: 178 GMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 60.8 bits (148), Expect = 4e-11
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 15/101 (14%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS--TNRIV 75
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DF +AR+   +       T   V
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-V 192

Query: 76  GTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 111
            T  Y APE     + + K      D++S G +L E++S +
Sbjct: 193 ATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 7/95 (7%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           I  GL  LHE     ++HRDL   N+LL    +  I DF +AR          T+  V  
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHY-VTH 196

Query: 78  YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 111
             Y APE  M+   F+   D++S G ++ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 8/98 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEAS--TNRI 74
           + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DF +ARI   + S     +  +
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 75  VGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 111
           V T  Y +P   +    ++   D+++ G +  E+++GK
Sbjct: 186 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.1 bits (138), Expect = 7e-10
 Identities = 20/71 (28%), Positives = 33/71 (46%), Gaps = 3/71 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G+ Y+H  S   I+HRDLK +N L++ + + K+ DF +AR     ++  S   I   
Sbjct: 165 LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 78  YGYMAPEYAME 88
              M       
Sbjct: 222 EDDMNLVTFPH 232

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 17/110 (15%)

Query: 12  ISIINGIAR----GLLYLHEDSRLRIIHRDLKASNVLLDHEMNP------KISDFEMARI 61
           +  +  I++    GL Y+H   R  IIH D+K  NVL++   +P      KI+D   A  
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +  + +       + T  Y +PE  +   +   +D++S   L+ E+I+G 
Sbjct: 188 YDEHYTN-----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.8 bits (132), Expect = 4e-09
 Identities = 19/72 (26%), Positives = 32/72 (44%), Gaps = 3/72 (4%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           +  G  ++HE     IIHRDLK +N LL+ + + K+ DF +AR     +     N +   
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 78  YGYMAPEYAMEG 89
                    ++ 
Sbjct: 195 EEPGPHNKNLKK 206

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 54.7 bits (132), Expect = 5e-09
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 23/114 (20%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGT 77
           + + + YLH  S   ++HRD+K SN+LL+ E + K++DF ++R F   +   +   +   
Sbjct: 118 LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 78  YGYMAP--------EY-------AMEGLFSVKS-----DVFSFGVLLLEIISGK 111
                         +Y       A E L          D++S G +L EI+ GK
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 2e-07
 Identities = 28/148 (18%), Positives = 50/148 (33%), Gaps = 56/148 (37%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLL--------------------------- 45
            II  + +GL YLH  ++ RIIH D+K  N+LL                           
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 46  ----------------------DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP 83
                                   ++  KI+D   A     + +E      + T  Y + 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSL 262

Query: 84  EYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           E  +   ++  +D++S   +  E+ +G 
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 8/96 (8%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEASTNRIV 75
           +   LL+L     L IIH DLK  N+LL +      KI DF  +        +     I 
Sbjct: 166 MCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQ 220

Query: 76  GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             + Y +PE  +   + +  D++S G +L+E+ +G+
Sbjct: 221 SRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 4e-07
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 18/100 (18%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIFGGNQSEASTNRIV 75
           I + L  LH   + RIIH DLK  N+LL  +     K+ D      FG   S    ++ V
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID------FG---SSCYEHQRV 256

Query: 76  GTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
            TY     Y APE  +   + +  D++S G +L E+++G 
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 47.6 bits (112), Expect = 9e-07
 Identities = 17/83 (20%), Positives = 25/83 (30%), Gaps = 13/83 (15%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           MR+         SI++ +   L        LR  HRDL   NVLL      K+      +
Sbjct: 153 MRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

Query: 61  IFGGNQSEASTNRIVGTYGYMAP 83
                         + + G    
Sbjct: 211 SST-----------IPSCGLQVS 222

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 47.0 bits (112), Expect = 1e-06
 Identities = 10/106 (9%), Positives = 24/106 (22%), Gaps = 32/106 (30%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
                 I  +  +A      H   R  +       S V +  + +  ++           
Sbjct: 126 PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP--------- 173

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                          M          + + D+   G  L  ++  +
Sbjct: 174 -------------ATMPDA-------NPQDDIRGIGASLYALLVNR 199

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.1 bits (102), Expect = 3e-05
 Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 23/111 (20%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI-------------FGG 64
           +   L +LHE    ++ H DLK  N+L  +     + +   +               FG 
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 187

Query: 65  NQSEASTNRIVGTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             S    +    T      Y  PE  +E  ++   DV+S G +L E   G 
Sbjct: 188 --SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.6 bits (101), Expect = 4e-05
 Identities = 27/121 (22%), Positives = 44/121 (36%), Gaps = 27/121 (22%)

Query: 12  ISIINGIARGLL----YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI------ 61
           +  I  +A  +     +LH     ++ H DLK  N+L       +  + ++ R       
Sbjct: 117 LDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173

Query: 62  -------FGGNQSEASTNRIVGTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 110
                  FG   S    +    T      Y APE  +   +S   DV+S G +L+E   G
Sbjct: 174 PDIKVVDFG---SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

Query: 111 K 111
            
Sbjct: 231 F 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 42.7 bits (101), Expect = 5e-05
 Identities = 30/114 (26%), Positives = 43/114 (37%), Gaps = 23/114 (20%)

Query: 18  IARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR---- 73
           I + L YL +   + + H DLK  N+LLD     K          G       T      
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 74  ----------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                           I+ T  Y APE  +   + V SD++SFG +L E+ +G 
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 6/50 (12%)

Query: 13  SIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMA 59
            I+  I   + YLH    + I HRD+K  N+L   +      K++DF  A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	230
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.98
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.96
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.96
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.95
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.95
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.95
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.94
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.92
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.92
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.91
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.89
3uqc_A	286	Probable conserved transmembrane protein; structur	99.88
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.75
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.45
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.2
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.92
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.41
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.61
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.33
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	95.98
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.96
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	94.85
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.83
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.21
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	92.83
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.53
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.57
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.48
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	91.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	91.05
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	90.79
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.32
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	89.96
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	89.68
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.39
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.57
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	87.82
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.68
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	86.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.83

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=257.91  Aligned_cols=175  Identities=25%  Similarity=0.383  Sum_probs=128.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................|++.|+|
T Consensus       126 ~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymA  202 (307)
T 3omv_A          126 ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA  202 (307)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccC
Confidence            457999999999999999999999999   99999999999999999999999999976543222222233578999999


Q ss_pred             hhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||++.+   ..|+.++|||||||++|||+||..||.......      ........+.    ..+.+ ...+..++..+.
T Consensus       203 PE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~----~~p~~-~~~~~~~~~~l~  271 (307)
T 3omv_A          203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY----ASPDL-SKLYKNCPKAMK  271 (307)
T ss_dssp             HHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC----CCCCS-TTSCTTSCHHHH
T ss_pred             HHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC----CCCCc-ccccccchHHHH
Confidence            999974   358999999999999999999999986432111      0111111110    01100 122334456699


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      +|+.+||+.||++|||+.+|++.|+....+++
T Consensus       272 ~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          272 RLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             HHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            99999999999999999999999887665554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.7e-38  Score=258.34  Aligned_cols=164  Identities=26%  Similarity=0.360  Sum_probs=131.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..|++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................+++.|+||
T Consensus       140 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  216 (308)
T 4gt4_A          140 SALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP  216 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence            46999999999999999999999999   999999999999999999999999999765332222222234678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |++.+..|+.++|||||||++|||+| |..||......      +.          ...+........+..++..+.+||
T Consensus       217 E~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------~~----------~~~i~~~~~~~~p~~~~~~~~~li  280 (308)
T 4gt4_A          217 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV----------VEMIRNRQVLPCPDDCPAWVYALM  280 (308)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------HH----------HHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             HHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------HH----------HHHHHcCCCCCCcccchHHHHHHH
Confidence            99999999999999999999999998 88998643211      11          111111122233455666799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       281 ~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          281 IECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999999764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-38  Score=258.92  Aligned_cols=165  Identities=25%  Similarity=0.316  Sum_probs=131.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .+|++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................+++.|+||
T Consensus       123 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  199 (299)
T 4asz_A          123 TELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  199 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCH
Confidence            47999999999999999999999999   999999999999999999999999999765433222222334578899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |++.+..|+.++|||||||++|||+| |..||......      +..          ..+........|..++..+.+||
T Consensus       200 E~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~----------~~i~~~~~~~~p~~~~~~~~~li  263 (299)
T 4asz_A          200 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVI----------ECITQGRVLQRPRTCPQEVYELM  263 (299)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHH----------HHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             HHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHH----------HHHHcCCCCCCCccchHHHHHHH
Confidence            99999999999999999999999998 89998643211      111          11111111223444556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.||++|||+.+|++.|++..
T Consensus       264 ~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          264 LGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHH
Confidence            9999999999999999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=259.04  Aligned_cols=166  Identities=25%  Similarity=0.298  Sum_probs=125.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .+|++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................+++.|+||
T Consensus       153 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          153 GPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccCh
Confidence            47999999999999999999999999   999999999999999999999999999865433322223334678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |++.+..++.++|||||||++|||+| |..||......      +..          ..+....+...+..++..+.+||
T Consensus       230 E~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~----------~~i~~g~~~~~p~~~~~~~~~li  293 (329)
T 4aoj_A          230 ESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAI----------DCITQGRELERPRACPPEVYAIM  293 (329)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHH----------HHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             hhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHH----------HHHHcCCCCCCcccccHHHHHHH
Confidence            99999999999999999999999999 89998643211      111          11111112233444556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .+||+.||++|||+.+|++.|+....
T Consensus       294 ~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          294 RGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999999987643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.6e-38  Score=260.33  Aligned_cols=165  Identities=27%  Similarity=0.335  Sum_probs=131.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..|++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus       180 ~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          180 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             TCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence            46899999999999999999999999   999999999999999999999999999865443333333345678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |++.+..|+.++|||||||++|||+| |..||.......      .         +...+....+...|..++..+.++|
T Consensus       257 E~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------~---------~~~~i~~g~~~~~p~~~~~~~~~li  321 (353)
T 4ase_A          257 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------E---------FCRRLKEGTRMRAPDYTTPEMYQTM  321 (353)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------H---------HHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             HHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH------H---------HHHHHHcCCCCCCCccCCHHHHHHH
Confidence            99999999999999999999999998 899986432111      0         1111122222233444556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       322 ~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          322 LDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCcChhHCcCHHHHHHHHHHH
Confidence            999999999999999999998653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.8e-37  Score=248.98  Aligned_cols=185  Identities=22%  Similarity=0.212  Sum_probs=128.5

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCC-----CCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--cccccc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDS-----RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRI   74 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~-----~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~   74 (230)
                      ++.++++..+++++.|++.||+|||+++     ..+|+||||||+|||++.++.+||+|||++.........  ......
T Consensus        93 ~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~  172 (303)
T 3hmm_A           93 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR  172 (303)
T ss_dssp             HHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC----
T ss_pred             HhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccc
Confidence            4567899999999999999999999871     112999999999999999999999999999876543221  122234


Q ss_pred             ccccCccChhhhhcC------CCCccccchhhHHHHHHHHhcCCCCCCCccccccch----hhhhHHHHhhhhhhhhhch
Q 026939           75 VGTYGYMAPEYAMEG------LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL----LSYTWKLWCEGEALELMEP  144 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~------~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  144 (230)
                      .|++.|+|||++.+.      .++.++|||||||++|||+||..||+..........    ................+.+
T Consensus       173 ~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp  252 (303)
T 3hmm_A          173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP  252 (303)
T ss_dssp             -CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred             cccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCC
Confidence            689999999999764      367799999999999999999888754322111000    0000001111011111111


Q ss_pred             hhcch-hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          145 VLKQS-CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       145 ~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+... ...+....+.+||.+||+.||++|||+.+|++.|+..
T Consensus       253 ~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          253 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11111 1235667899999999999999999999999999764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.7e-36  Score=247.54  Aligned_cols=167  Identities=22%  Similarity=0.212  Sum_probs=127.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCC---Ccccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQS---EASTNRIVGTY   78 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~   78 (230)
                      ..++++.+++.++.||+.||+|||+++   |+||||||+|||++.+| .+||+|||++........   ........|++
T Consensus       144 ~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~  220 (336)
T 4g3f_A          144 MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE  220 (336)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCc
Confidence            357999999999999999999999999   99999999999999987 599999999987643221   11223346899


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      .|+|||++.+..|+.++|||||||++|+|++|..||........      ..........        ....+...+..+
T Consensus       221 ~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~~--------~~~~~~~~s~~~  286 (336)
T 4g3f_A          221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLKIASEPPP--------IREIPPSCAPLT  286 (336)
T ss_dssp             GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHHHHHSCCG--------GGGSCTTSCHHH
T ss_pred             cccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHcCCCC--------chhcCccCCHHH
Confidence            99999999999999999999999999999999999964322211      1111111000        011233445568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          159 IHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+++.+||+.||++|||+.||++.|...
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            8999999999999999999999887553

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.7e-36  Score=247.69  Aligned_cols=160  Identities=21%  Similarity=0.299  Sum_probs=125.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.++..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++.........  .....|++.|+|
T Consensus       164 ~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~YmA  238 (346)
T 4fih_A          164 HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMA  238 (346)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--ccccccCcCcCC
Confidence            467999999999999999999999999   999999999999999999999999999876433222  223578999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..|+.++|||||||++|+|++|..||.......      ... .....     ..+.+  ......+..+.+|+
T Consensus       239 PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~-~i~~~-----~~~~~--~~~~~~s~~~~dli  304 (346)
T 4fih_A          239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMK-MIRDN-----LPPRL--KNLHKVSPSLKGFL  304 (346)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHS-----SCCCC--SCGGGSCHHHHHHH
T ss_pred             HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHH-HHHcC-----CCCCC--CccccCCHHHHHHH
Confidence            999999999999999999999999999999986432111      110 11110     00000  11223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||++|||+.++++
T Consensus       305 ~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          305 DRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHcCCChhHCcCHHHHhc
Confidence            9999999999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-36  Score=249.40  Aligned_cols=157  Identities=21%  Similarity=0.339  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++.......  .......|++.|+||
T Consensus       120 ~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAP  194 (350)
T 4b9d_A          120 VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSP  194 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCH
Confidence            46789999999999999999999999   9999999999999999999999999997653211  112234689999999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..|+.++|||||||++|+|++|..||......      +..... .++..         ...+...+..+.+|+.
T Consensus       195 E~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i-~~~~~---------~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKI-ISGSF---------PPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH-HHTCC---------CCCCTTSCHHHHHHHH
T ss_pred             HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHH-HcCCC---------CCCCccCCHHHHHHHH
Confidence            9999999999999999999999999999999643211      111111 11111         1112233456889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.||++|||+.++++
T Consensus       259 ~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHTCSSGGGSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.3e-36  Score=243.57  Aligned_cols=157  Identities=25%  Similarity=0.293  Sum_probs=125.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................|++.|+|
T Consensus       126 ~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmA  202 (311)
T 4aw0_A          126 IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS  202 (311)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCC
Confidence            357999999999999999999999999   99999999999999999999999999987654333333334578999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..|+.++|||||||++|+|++|..||......      ..... ..+..          ..++...+..+.+|+
T Consensus       203 PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~-i~~~~----------~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAK-IIKLE----------YDFPEKFFPKARDLV  265 (311)
T ss_dssp             HHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHTC----------CCCCTTCCHHHHHHH
T ss_pred             HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCC----------CCCCcccCHHHHHHH
Confidence            99999999999999999999999999999999543211      11111 11111          012223345688999


Q ss_pred             hhhcCCCCCCCCCHHHH
Q 026939          163 LLCVQADSADRPTMSSV  179 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i  179 (230)
                      .+||+.||++|||++++
T Consensus       266 ~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             HHHSCSSGGGSTTSGGG
T ss_pred             HHHccCCHhHCcChHHH
Confidence            99999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-35  Score=238.06  Aligned_cols=156  Identities=22%  Similarity=0.283  Sum_probs=116.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.++..++.||+.||+|||++|   |+||||||+||+++.++.+||+|||++........   .....|++.|+|
T Consensus       106 ~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~Y~A  179 (275)
T 3hyh_A          106 RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAA  179 (275)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcccCC
Confidence            468999999999999999999999999   99999999999999999999999999976543221   123478999999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..+ +.++||||+||++|+|++|..||......      .. .....++.          ..++...+..+.++
T Consensus       180 PE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~-~~~i~~~~----------~~~p~~~s~~~~~l  242 (275)
T 3hyh_A          180 PEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VL-FKNISNGV----------YTLPKFLSPGAAGL  242 (275)
T ss_dssp             HHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHTC----------CCCCTTSCHHHHHH
T ss_pred             hhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHcCC----------CCCCCCCCHHHHHH
Confidence            999998876 57999999999999999999999642211      11 11111111          01122334568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||++++++
T Consensus       243 i~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHc
Confidence            99999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=248.44  Aligned_cols=161  Identities=20%  Similarity=0.288  Sum_probs=126.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +...+++.++..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++.........  .....|++.|+
T Consensus       240 ~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~Ym  314 (423)
T 4fie_A          240 THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWM  314 (423)
T ss_dssp             HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--BCCCEECTTTC
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--ccccccCcCcC
Confidence            3467999999999999999999999999   999999999999999999999999999876433222  22357899999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+..|+.++|||||||++|+|++|..||.......      .... ....     ..+.+  ......+..+.+|
T Consensus       315 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~-i~~~-----~~~~~--~~~~~~s~~~~dl  380 (423)
T 4fie_A          315 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKM-IRDN-----LPPRL--KNLHKVSPSLKGF  380 (423)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHS-----CCCCC--SCTTSSCHHHHHH
T ss_pred             CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHH-HHcC-----CCCCC--cccccCCHHHHHH
Confidence            9999999999999999999999999999999985432111      1111 1110     00000  1122334568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       381 i~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          381 LDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHhc
Confidence            99999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-35  Score=237.45  Aligned_cols=159  Identities=23%  Similarity=0.338  Sum_probs=120.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ..++++..+..++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||++......    ......|++.|+
T Consensus       123 ~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~Ym  197 (290)
T 3fpq_A          123 FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFM  197 (290)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCcccc
Confidence            457999999999999999999999875 3499999999999997 4789999999999753321    122357899999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+ .|+.++|||||||++|+|++|..||.......      ........+..        ...++...+..+.++
T Consensus       198 APE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~--------~~~~~~~~~~~~~~l  262 (290)
T 3fpq_A          198 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVK--------PASFDKVAIPEVKEI  262 (290)
T ss_dssp             CGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCC--------CGGGGGCCCHHHHHH
T ss_pred             CHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCC--------CCCCCccCCHHHHHH
Confidence            9999864 69999999999999999999999985322110      01111111110        011222233458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||++++++
T Consensus       263 i~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          263 IEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            99999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.9e-35  Score=238.62  Aligned_cols=157  Identities=23%  Similarity=0.229  Sum_probs=121.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.++..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++.........  .....|++.|+|
T Consensus       120 ~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmA  194 (304)
T 3ubd_A          120 EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMA  194 (304)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC--CCSCCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc--ccccccCcccCC
Confidence            357999999999999999999999999   999999999999999999999999999764332221  223478999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..|+.++|||||||++|+|++|..||.......      ..... .+..          ..++...+..+.+++
T Consensus       195 PE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i-~~~~----------~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMI-LKAK----------LGMPQFLSPEAQSLL  257 (304)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCC----------CCCCTTSCHHHHHHH
T ss_pred             HHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHH-HcCC----------CCCCCcCCHHHHHHH
Confidence            999999999999999999999999999999996432111      11111 1110          112233445688999


Q ss_pred             hhhcCCCCCCCCCH-----HHHHH
Q 026939          163 LLCVQADSADRPTM-----SSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~-----~~i~~  181 (230)
                      .+||+.||++|||+     +++++
T Consensus       258 ~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          258 RMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHcccCHHHCCCCCcCCHHHHHc
Confidence            99999999999985     56654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.9e-33  Score=228.00  Aligned_cols=180  Identities=33%  Similarity=0.573  Sum_probs=147.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          134 MSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP  210 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCH
Confidence            36899999999999999999999999   999999999999999999999999999765432222222234568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++||||||+++|+|++|..||....+........+.......+.....+++.............+.+++.
T Consensus       211 E~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  290 (321)
T 2qkw_B          211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAV  290 (321)
T ss_dssp             HHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHH
T ss_pred             HHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHH
Confidence            99999999999999999999999999999997655544444444444444455555556665555667888899999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.||++|||+.+|++.|+..
T Consensus       291 ~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          291 KCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHHHHHHH
Confidence            99999999999999999999765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-33  Score=230.29  Aligned_cols=161  Identities=20%  Similarity=0.314  Sum_probs=113.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc----------ccccc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA----------STNRI   74 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----------~~~~~   74 (230)
                      ..++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++..........          .....
T Consensus       114 ~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  190 (299)
T 4g31_A          114 ERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ  190 (299)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC-------------------------
T ss_pred             hhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCc
Confidence            3456778999999999999999999   9999999999999999999999999997654321111          11224


Q ss_pred             ccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           75 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .|++.|+|||++.+..|+.++|||||||++|+|++   ||....+        .. ..     ..... ....+......
T Consensus       191 ~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--------~~-~~-----~~~~~-~~~~p~~~~~~  252 (299)
T 4g31_A          191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--------RV-RT-----LTDVR-NLKFPPLFTQK  252 (299)
T ss_dssp             -CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--------HH-HH-----HHHHH-TTCCCHHHHHH
T ss_pred             ccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--------HH-HH-----HHHHh-cCCCCCCCccc
Confidence            68999999999999999999999999999999996   6532110        00 00     00000 00111223344


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ...+.+++.+||+.||++|||+.++++  .+++.
T Consensus       253 ~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          253 YPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            455778999999999999999999987  45443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-33  Score=235.14  Aligned_cols=179  Identities=21%  Similarity=0.243  Sum_probs=126.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC--CccccccccccC
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS--EASTNRIVGTYG   79 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~   79 (230)
                      ++.++++.++..+++||+.||+|||++|   |+||||||+|||++.++.+||+|||++..+.....  ........|++.
T Consensus       151 ~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~  227 (398)
T 4b99_A          151 SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW  227 (398)
T ss_dssp             SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCT
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChH
Confidence            4578999999999999999999999999   99999999999999999999999999976533211  112223578999


Q ss_pred             ccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh-----------hhhhhhch---
Q 026939           80 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG-----------EALELMEP---  144 (230)
Q Consensus        80 ~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~---  144 (230)
                      |+|||++.+. .++.++||||+||++|+|++|..||...........+   .......           ........   
T Consensus       228 Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  304 (398)
T 4b99_A          228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPSPAVIQAVGAERVRAYIQSLPP  304 (398)
T ss_dssp             TCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCGGGTC-----CHHHHHHSSCC
T ss_pred             hcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCChHHhhhhhhhhhhhhhhcCCC
Confidence            9999998876 4689999999999999999999999643322111100   0000000           00000000   


Q ss_pred             hhc---chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          145 VLK---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       145 ~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ...   .......+..+.+|+.+||+.||++|||+.++++  ++.+.
T Consensus       305 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          305 RQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             CCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             cCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            000   0011122456889999999999999999999986  45543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.98  E-value=3.8e-32  Score=223.40  Aligned_cols=182  Identities=38%  Similarity=0.625  Sum_probs=145.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhC---CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHED---SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~---~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      .++++..++.++.|++.||+|||+.   +   ++|+||+|+||+++.++.++|+|||++......... ......++..|
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y  201 (326)
T 3uim_A          126 PPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGH  201 (326)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCCcCc
Confidence            3599999999999999999999999   8   999999999999999999999999999876433222 22223578899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCcccc--ccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL--GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      +|||.+.+..++.++||||||+++|+|++|..||.......  ......+..............+......++......+
T Consensus       202 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  281 (326)
T 3uim_A          202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQL  281 (326)
T ss_dssp             CCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHH
T ss_pred             cCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHH
Confidence            99999998889999999999999999999999985322111  1122222223333444555556666667788889999


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          159 IHIGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      .+++.+||+.||.+|||+.+|++.|++....
T Consensus       282 ~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          282 IQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             HHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             HHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence            9999999999999999999999999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=5.2e-33  Score=229.09  Aligned_cols=165  Identities=23%  Similarity=0.365  Sum_probs=128.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++................++..|+|
T Consensus       111 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  187 (327)
T 3poz_A          111 KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  187 (327)
T ss_dssp             TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccC
Confidence            457899999999999999999999999   99999999999999999999999999987644333222222345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|+|++ |..||.......                ....+........+......+.++
T Consensus       188 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l  251 (327)
T 3poz_A          188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGERLPQPPICTIDVYMI  251 (327)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred             hHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HHHHHHcCCCCCCCccCCHHHHHH
Confidence            999999999999999999999999999 999986432211                111111111122233345568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||++|||+.+|++.|+..
T Consensus       252 i~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          252 MVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999998664

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=1.3e-31  Score=217.20  Aligned_cols=186  Identities=13%  Similarity=0.132  Sum_probs=136.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC-----eEEcccccceeecCCCCC-----cccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-----PKISDFEMARIFGGNQSE-----ASTN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~-----~~~~   72 (230)
                      +.++++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.     ++|+|||++.........     ....
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  176 (298)
T 1csn_A          100 GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK  176 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCcc
Confidence            346999999999999999999999999   999999999999987765     999999999876543221     1122


Q ss_pred             ccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH
Q 026939           73 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA  152 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (230)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||..................    .. ....+    ....
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~-~~~~~----~~~~  247 (298)
T 1csn_A          177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK----KQ-STPLR----ELCA  247 (298)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH----HH-HSCHH----HHTT
T ss_pred             CCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh----cc-CccHH----HHHh
Confidence            345788999999999989999999999999999999999999654322221111111000    00 00000    1111


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCCcc
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSV  200 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~~~~~p~~~~  200 (230)
                      ..+..+.+++.+||+.||++|||+.+|++.|++....+.......+.|
T Consensus       248 ~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            234568999999999999999999999999988755544444444544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=5.2e-32  Score=225.87  Aligned_cols=109  Identities=26%  Similarity=0.354  Sum_probs=91.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCc--------------
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEA--------------   69 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~--------------   69 (230)
                      .+++.++..++.||+.||+|||++|   |+||||||+|||++.+ +.+||+|||++..........              
T Consensus       113 ~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~  189 (361)
T 4f9c_A          113 SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCS  189 (361)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccc
Confidence            5899999999999999999999999   9999999999999876 789999999997653321110              


Q ss_pred             ------------cccccccccCccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCC
Q 026939           70 ------------STNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGF  116 (230)
Q Consensus        70 ------------~~~~~~~~~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~  116 (230)
                                  ......|++.|+|||++.+. .|+.++||||+||++|+|++|..||..
T Consensus       190 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             cccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence                        01123589999999999876 489999999999999999999999843

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=1.2e-31  Score=224.76  Aligned_cols=164  Identities=30%  Similarity=0.352  Sum_probs=128.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+++   |+||||+|+||+++.++.+||+|||++................++..|+||
T Consensus       198 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          198 EQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence            46899999999999999999999999   999999999999999999999999999865443322222223456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |++.+..++.++|||||||++|+|++ |..||.......      .          ...+........+......+.+++
T Consensus       275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~------~----------~~~~~~~~~~~~~~~~~~~l~~li  338 (370)
T 2psq_A          275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L----------FKLLKEGHRMDKPANCTNELYMMM  338 (370)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------H----------HHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------H----------HHHHhcCCCCCCCCCCCHHHHHHH
Confidence            99999999999999999999999999 999986432111      0          011111111222334455699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       339 ~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          339 RDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=2.6e-31  Score=215.20  Aligned_cols=177  Identities=18%  Similarity=0.172  Sum_probs=133.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe---CCCCCeEEcccccceeecCCCCC-----cccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSE-----ASTNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~   74 (230)
                      ..++++..++.++.||+.||+|||+.+   ++|+||+|+||++   +.++.++|+|||++.........     ......
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~  175 (296)
T 4hgt_A           99 SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL  175 (296)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCccccc
Confidence            457999999999999999999999999   9999999999999   68889999999999876443221     112234


Q ss_pred             ccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           75 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .++..|+|||.+.+..++.++|||||||++|+|++|..||.....................     ......    ....
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~----~~~~  246 (296)
T 4hgt_A          176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-----TPIEVL----CKGY  246 (296)
T ss_dssp             CSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-----SCHHHH----TTTS
T ss_pred             CCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-----chhhhh----hccC
Confidence            6788999999999989999999999999999999999999754433322222111111000     000001    1112


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      +..+.+++..||+.||++|||+.+|++.|++......
T Consensus       247 ~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          247 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            3468999999999999999999999999987654433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=3.2e-32  Score=223.90  Aligned_cols=181  Identities=28%  Similarity=0.350  Sum_probs=131.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC----------CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED----------SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~----------~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~   72 (230)
                      ...+++..++.++.||+.||+|||+.          +   ++|+||||+||+++.++.+||+|||++.............
T Consensus       115 ~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~  191 (322)
T 3soc_A          115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH  191 (322)
T ss_dssp             HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCT
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccc
Confidence            45689999999999999999999998          8   9999999999999999999999999998765443332333


Q ss_pred             ccccccCccChhhhhcC-----CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh-----hHHHHhhhhhhhhh
Q 026939           73 RIVGTYGYMAPEYAMEG-----LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY-----TWKLWCEGEALELM  142 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~-----~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~  142 (230)
                      ...++..|+|||.+.+.     .++.++|||||||++|+|++|..||..............     ..............
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (322)
T 3soc_A          192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK  271 (322)
T ss_dssp             TCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC
T ss_pred             cCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC
Confidence            34678899999999863     456788999999999999999999865433222111110     00000000001111


Q ss_pred             chhhcch-hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          143 EPVLKQS-CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       143 ~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+.+... ........+.+++.+||+.||++|||+.+|+++|+..
T Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111111 1234556799999999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=4.4e-31  Score=213.94  Aligned_cols=186  Identities=17%  Similarity=0.169  Sum_probs=137.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC---CCCCeEEcccccceeecCCCCCc-----ccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEA-----STNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~   74 (230)
                      +.++++.+++.++.||+.||+|||+++   ++|+||+|+||+++   .++.++|+|||++..........     .....
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  175 (296)
T 3uzp_A           99 SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL  175 (296)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccc
Confidence            457999999999999999999999999   99999999999995   78899999999998765432211     11234


Q ss_pred             ccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           75 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .++..|+|||.+.+..++.++|||||||++|+|++|..||..................    ... .....+    ....
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~-~~~~~~----~~~~  246 (296)
T 3uzp_A          176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KMS-TPIEVL----CKGY  246 (296)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HHH-SCHHHH----TTTS
T ss_pred             ccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----ccC-CchHHH----HhhC
Confidence            6788999999999989999999999999999999999999754333222222111111    000 000011    1222


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCCcc
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSV  200 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~~~~~p~~~~  200 (230)
                      +..+.+++.+||+.||++|||+.+|++.|+........+....+.|
T Consensus       247 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw  292 (296)
T 3uzp_A          247 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  292 (296)
T ss_dssp             CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred             CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence            3558999999999999999999999999988755544444444444

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.3e-32  Score=225.31  Aligned_cols=167  Identities=23%  Similarity=0.340  Sum_probs=123.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++................++..|+|
T Consensus       111 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~a  187 (327)
T 3lzb_A          111 KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  187 (327)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccC
Confidence            356899999999999999999999999   99999999999999999999999999987543322222222344668999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|+|++ |..||........                ...+........+......+.++
T Consensus       188 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~l  251 (327)
T 3lzb_A          188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSILEKGERLPQPPICTIDVYMI  251 (327)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHHHHTTCCCCCCTTBCHHHHHH
T ss_pred             HHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------------HHHHHcCCCCCCCccCCHHHHHH
Confidence            999999999999999999999999999 9999864322211                11111111112233344568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      +.+||+.||.+|||+.+|++.|+....
T Consensus       252 i~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          252 MRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            999999999999999999999987643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=3.9e-31  Score=220.91  Aligned_cols=190  Identities=16%  Similarity=0.163  Sum_probs=136.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC--CCCCeEEcccccceeecCCCCC-----ccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMNPKISDFEMARIFGGNQSE-----ASTNRIV   75 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~   75 (230)
                      ..++++.+++.++.||+.||+|||+.+   |+||||||+||+++  .++.++|+|||++.........     .......
T Consensus       146 ~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~  222 (364)
T 3op5_A          146 AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD  222 (364)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence            367999999999999999999999999   99999999999998  8899999999999765322111     1112234


Q ss_pred             cccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHH
Q 026939           76 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL  155 (230)
Q Consensus        76 ~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (230)
                      ++..|+|||.+.+..++.++|||||||++|+|++|..||........   ................++..+.   ....+
T Consensus       223 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~---~~~~~  296 (364)
T 3op5_A          223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK---YVRDSKIRYRENIASLMDKCFP---AANAP  296 (364)
T ss_dssp             CCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH---HHHHHHHHHHHCHHHHHHHHSC---TTCCC
T ss_pred             CCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH---HHHHHHHHhhhhHHHHHHHhcc---cccCH
Confidence            78899999999998999999999999999999999999864221110   0000111111122222222111   01224


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCCccC
Q 026939          156 LKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVG  201 (230)
Q Consensus       156 ~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~~~~~p~~~~~  201 (230)
                      ..+.+++..||+.||++||++.+|++.|++............++|.
T Consensus       297 ~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  342 (364)
T 3op5_A          297 GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS  342 (364)
T ss_dssp             HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred             HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence            5689999999999999999999999999876555444444444443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=1.7e-31  Score=235.80  Aligned_cols=158  Identities=23%  Similarity=0.214  Sum_probs=123.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++........    ....|++.|+|
T Consensus       286 ~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~----~t~~GTp~YmA  358 (689)
T 3v5w_A          286 HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMA  358 (689)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC----CSCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCCC----CCccCCcCccC
Confidence            357999999999999999999999999   99999999999999999999999999987643322    22478999999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+ ..|+.++|+|||||++|+|++|..||........   ....... ...          ...++...+..+.+|
T Consensus       359 PEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i-~~~----------~~~~p~~~S~~a~dL  424 (689)
T 3v5w_A          359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMT-LTM----------AVELPDSFSPELRSL  424 (689)
T ss_dssp             HHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHH-HHC----------CCCCCTTSCHHHHHH
T ss_pred             HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhh-cCC----------CCCCCccCCHHHHHH
Confidence            999974 5799999999999999999999999964322111   1111000 000          011233344568899


Q ss_pred             HhhhcCCCCCCCCC-----HHHHHH
Q 026939          162 GLLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      +.+||+.||.+|++     +++|++
T Consensus       425 I~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          425 LEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHccCCHhHCCCCCCCCHHHHhc
Confidence            99999999999998     677765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=1.5e-31  Score=220.06  Aligned_cols=166  Identities=22%  Similarity=0.281  Sum_probs=127.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.|   ++||||||+||+++.++.++|+|||++................++..|+||
T Consensus       110 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  186 (325)
T 3kex_A          110 GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL  186 (325)
T ss_dssp             GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccCh
Confidence            47889999999999999999999999   999999999999999999999999999876443332222334556789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||........                ...+........+......+.+++
T Consensus       187 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li  250 (325)
T 3kex_A          187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----------------PDLLEKGERLAQPQICTIDVYMVM  250 (325)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH----------------HHHHHTTCBCCCCTTBCTTTTHHH
T ss_pred             HHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH----------------HHHHHcCCCCCCCCcCcHHHHHHH
Confidence            99999999999999999999999999 9999864321111                111111111112222334588899


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .+||+.||.+|||+.+|++.|+....
T Consensus       251 ~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          251 VKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999977543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=2e-31  Score=224.05  Aligned_cols=167  Identities=30%  Similarity=0.323  Sum_probs=130.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++................++..|+||
T Consensus       186 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          186 EQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            46999999999999999999999999   999999999999999999999999999765443322222223456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++|+|++ |..||.......                ....+........+......+.+++
T Consensus       263 E~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li  326 (382)
T 3tt0_A          263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMMM  326 (382)
T ss_dssp             HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------HHHHHHTTCCCCCCSSCCHHHHHHH
T ss_pred             HHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCccCCHHHHHHH
Confidence            99999999999999999999999999 999985332111                1111111111122233445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      .+||+.||++|||+.+|++.|+.....
T Consensus       327 ~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          327 RDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            999999999999999999999876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=8.4e-32  Score=218.43  Aligned_cols=181  Identities=23%  Similarity=0.281  Sum_probs=127.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      .++++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  185 (295)
T 3ugc_A          109 ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA  185 (295)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCC
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeC
Confidence            35899999999999999999999999   999999999999999999999999999765432211 11112234567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++||||||+++|+|++|..|+...........................+........+...+..+.+++
T Consensus       186 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  265 (295)
T 3ugc_A          186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM  265 (295)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHH
Confidence            99999999999999999999999999999987543221100000000000000011111222222223444556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.||++|||+.+|++.|+...
T Consensus       266 ~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          266 TECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHHHHHHHHH
Confidence            9999999999999999999998653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=4.7e-31  Score=214.26  Aligned_cols=176  Identities=25%  Similarity=0.304  Sum_probs=128.6

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhH--------hCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--cc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLH--------EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--ST   71 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh--------~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~   71 (230)
                      +...+++..++.++.||+.||+|||        +.+   ++||||||+||+++.++.+||+|||++..........  ..
T Consensus        98 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  174 (301)
T 3q4u_A           98 QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN  174 (301)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCC
T ss_pred             hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccc
Confidence            4567999999999999999999999        888   9999999999999999999999999997654332211  11


Q ss_pred             cccccccCccChhhhhcC------CCCccccchhhHHHHHHHHhc----------CCCCCCCccccccchhhhhHHHHhh
Q 026939           72 NRIVGTYGYMAPEYAMEG------LFSVKSDVFSFGVLLLEIISG----------KKNSGFYLSELGQSLLSYTWKLWCE  135 (230)
Q Consensus        72 ~~~~~~~~~~aPe~~~~~------~~~~~~DiwslG~ll~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~  135 (230)
                      ....++..|+|||.+.+.      .++.++|||||||++|+|++|          ..||.........  ..........
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~~~~~~  252 (301)
T 3q4u_A          175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS--FEDMRKVVCV  252 (301)
T ss_dssp             CCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTT
T ss_pred             cccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc--hhhhhHHHhc
Confidence            223578899999999876      345789999999999999999          6666432221111  0111111100


Q ss_pred             hhhhhhhchhh-cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          136 GEALELMEPVL-KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       136 ~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                          ....+.. ...+.......+.+++.+||+.||++|||+.+|++.|++.
T Consensus       253 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          253 ----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             ----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                0001111 1123345677899999999999999999999999999763

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=1.5e-30  Score=214.48  Aligned_cols=186  Identities=15%  Similarity=0.133  Sum_probs=134.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC-----eEEcccccceeecCCCCCc-----ccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-----PKISDFEMARIFGGNQSEA-----STN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~~-----~~~   72 (230)
                      +..+++.+++.++.||+.||+|||+.+   ++||||+|+||+++.++.     ++|+|||++..........     ...
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~  175 (330)
T 2izr_A           99 DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK  175 (330)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccC
Confidence            467999999999999999999999999   999999999999998877     9999999998754332211     112


Q ss_pred             ccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH
Q 026939           73 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA  152 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (230)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|..||..............    ........ ........   
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~~-~~~~~~~~---  247 (330)
T 2izr_A          176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK----IGDTKRAT-PIEVLCEN---  247 (330)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH----HHHHHHHS-CHHHHTTT---
T ss_pred             CcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH----HHhhhccC-CHHHHhcc---
Confidence            34678999999999999999999999999999999999999965432211111111    00000000 00001111   


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCCccC
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVG  201 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~~~~~p~~~~~  201 (230)
                       .+ .+.+++..||+.||.+||++.+|.+.|++............++|.
T Consensus       248 -~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          248 -FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             -CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             -Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence             12 689999999999999999999999999765443333333344443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=1.7e-31  Score=224.16  Aligned_cols=164  Identities=29%  Similarity=0.345  Sum_probs=126.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+++   ++||||+|+||+++.++.+||+|||++................++..|+||
T Consensus       208 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aP  284 (377)
T 3cbl_A          208 ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP  284 (377)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCH
Confidence            46899999999999999999999999   999999999999999999999999998764332111111112235679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++|+|++ |..||.......                ....+........+..++..+.++|
T Consensus       285 E~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----------------TREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----------------HHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             hHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            99998899999999999999999998 888886432111                1111111112222333455689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       349 ~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=2.2e-31  Score=221.52  Aligned_cols=165  Identities=27%  Similarity=0.333  Sum_probs=127.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   |+|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       188 ~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          188 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeECh
Confidence            34999999999999999999999999   999999999999999999999999999765433322222334567789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||.......      ......         ........+......+.+++
T Consensus       265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRL---------KEGTRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHH---------HHTCCCCCCTTCCHHHHHHH
T ss_pred             hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHH---------HcCCCCCCCCCCCHHHHHHH
Confidence            99999999999999999999999998 999985432111      001111         11111112223345689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ..||+.||++|||+.+|++.|+..
T Consensus       330 ~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=5.6e-31  Score=215.11  Aligned_cols=170  Identities=30%  Similarity=0.490  Sum_probs=129.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS------------   70 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~------------   70 (230)
                      ...+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++...........            
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~  178 (310)
T 3s95_A          102 DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK  178 (310)
T ss_dssp             CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccc
Confidence            467899999999999999999999999   99999999999999999999999999987543222110            


Q ss_pred             ccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchh
Q 026939           71 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC  150 (230)
Q Consensus        71 ~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (230)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+...............          .....    ..
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~----------~~~~~----~~  244 (310)
T 3s95_A          179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR----------GFLDR----YC  244 (310)
T ss_dssp             -CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH----------HHHHH----TC
T ss_pred             ccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh----------ccccc----cC
Confidence            01235788899999999999999999999999999999999998654433222111110          01111    11


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      +...+..+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            223334588999999999999999999999999876433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=1.5e-30  Score=215.79  Aligned_cols=179  Identities=16%  Similarity=0.163  Sum_probs=130.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC--CeEEcccccceeecCCCC-----Ccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM--NPKISDFEMARIFGGNQS-----EASTNRIVG   76 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~-----~~~~~~~~~   76 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++||||+|+||+++.++  .++|+|||++........     ........+
T Consensus       146 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  222 (345)
T 2v62_A          146 GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG  222 (345)
T ss_dssp             GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCC
Confidence            37899999999999999999999999   99999999999998777  999999999976532211     111123467


Q ss_pred             ccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           77 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        77 ~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      +..|+|||.+.+..++.++|||||||++|+|++|..||........  ........ ........+.....   ....+.
T Consensus       223 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~  296 (345)
T 2v62_A          223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--AVQTAKTN-LLDELPQSVLKWAP---SGSSCC  296 (345)
T ss_dssp             CTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--HHHHHHHH-HHHTTTHHHHHHSC---TTSCCH
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--HHHHHHHh-hcccccHHHHhhcc---ccccHH
Confidence            8899999999998999999999999999999999999853211110  00000000 00001110000000   012344


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      .+.+++..||+.||++|||+.+|++.|+.....+.
T Consensus       297 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          297 EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence            69999999999999999999999999998776443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=4.8e-31  Score=216.56  Aligned_cols=164  Identities=23%  Similarity=0.298  Sum_probs=120.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE  209 (323)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence            6899999999999999999999999   9999999999999999999999999997654333222222234466899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|||||||++|+|++ |..||........      . .....         ......+...+..+.+++.
T Consensus       210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~-~~~~~---------~~~~~~~~~~~~~l~~li~  273 (323)
T 3qup_A          210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------Y-NYLIG---------GNRLKQPPECMEEVYDLMY  273 (323)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------H-HHHHT---------TCCCCCCTTCCHHHHHHHH
T ss_pred             hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH------H-HHHhc---------CCCCCCCCccCHHHHHHHH
Confidence            9999999999999999999999999 8899864322111      0 00001         0111222334456899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      +||+.||++|||+.++++.|++..
T Consensus       274 ~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          274 QCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999998753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=3.3e-31  Score=216.79  Aligned_cols=169  Identities=27%  Similarity=0.363  Sum_probs=121.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||+|||+.| .+++||||+|+||+++.++.++|+|||++........  ......++..|+|||
T Consensus       133 ~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE  209 (309)
T 3p86_A          133 QLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPE  209 (309)
T ss_dssp             HSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChh
Confidence            3899999999999999999999875 3499999999999999999999999999875432211  122245688999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      .+.+..++.++|||||||++|+|++|..||........      ......         .......+...+..+.+++.+
T Consensus       210 ~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~l~~li~~  274 (309)
T 3p86_A          210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGF---------KCKRLEIPRNLNPQVAAIIEG  274 (309)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHH---------SCCCCCCCTTSCHHHHHHHHH
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh---------cCCCCCCCccCCHHHHHHHHH
Confidence            99999999999999999999999999999864322111      000000         001112223344568999999


Q ss_pred             hcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          165 CVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      ||+.||++|||+.+|++.|+.......
T Consensus       275 ~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          275 CWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            999999999999999999988755544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=3.1e-30  Score=210.18  Aligned_cols=177  Identities=33%  Similarity=0.488  Sum_probs=134.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       128 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP  204 (307)
T 2nru_A          128 PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP  204 (307)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence            46999999999999999999999999   999999999999999999999999998875433222222334678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHh-hhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWC-EGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+ .++.++|+||||+++|+|++|..||........  ...+...... .......++..+ ...+......+.+++
T Consensus       205 E~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  280 (307)
T 2nru_A          205 EALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVA  280 (307)
T ss_dssp             HHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHH
T ss_pred             HHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHH
Confidence            98864 578999999999999999999999865433221  1111111111 111222222222 234566778899999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.||.+|||+.+|++.|++..
T Consensus       281 ~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          281 SQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHcCCCcccCcCHHHHHHHHHHHh
Confidence            9999999999999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=4.4e-31  Score=232.34  Aligned_cols=160  Identities=21%  Similarity=0.228  Sum_probs=124.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC--CCeEEcccccceeecCCCCCccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE--MNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ...+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||++........   .....|++.|
T Consensus       249 ~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y  322 (573)
T 3uto_A          249 HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEF  322 (573)
T ss_dssp             TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECccc
Confidence            357899999999999999999999999   9999999999999854  7899999999987643322   2234689999


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..|+.++|||||||++|+|++|..||........      ... .....      ...........+..+.+
T Consensus       323 ~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~-i~~~~------~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRN-VKSCD------WNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHH-HHTTC------CCCCSGGGTTSCHHHHH
T ss_pred             cCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHH-HHhCC------CCCCcccccCCCHHHHH
Confidence            999999999999999999999999999999999964332111      000 00100      00111112233456889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      |+.+||+.||.+|||+.++++
T Consensus       390 li~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4e-31  Score=218.82  Aligned_cols=168  Identities=28%  Similarity=0.386  Sum_probs=128.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       168 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  244 (344)
T 1rjb_A          168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  244 (344)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence            4899999999999999999999999   9999999999999999999999999997654332222223334567899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++||||||+++|+|++ |..||.......      ...         ..+........+...+..+.+++.
T Consensus       245 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~---------~~~~~~~~~~~~~~~~~~l~~li~  309 (344)
T 1rjb_A          245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------NFY---------KLIQNGFKMDQPFYATEEIYIIMQ  309 (344)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHH---------HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             HhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH------HHH---------HHHhcCCCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999998 999985432111      000         111111111222333456899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      +||+.||.+|||+.+|++.|+......
T Consensus       310 ~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          310 SCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            999999999999999999998876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=1.5e-30  Score=214.23  Aligned_cols=162  Identities=25%  Similarity=0.350  Sum_probs=122.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++................++..|+|
T Consensus        99 ~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  175 (323)
T 3tki_A           99 DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA  175 (323)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccC
Confidence            347999999999999999999999999   99999999999999999999999999976543222222223467889999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..+ +.++|||||||++|+|++|..||.........      ...+......        ..........+.++
T Consensus       176 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~--------~~~~~~~~~~~~~l  241 (323)
T 3tki_A          176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--------LNPWKKIDSAPLAL  241 (323)
T ss_dssp             HHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTCTT--------STTGGGSCHHHHHH
T ss_pred             cHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhccccc--------CCccccCCHHHHHH
Confidence            999987775 77899999999999999999998643322110      0111111000        00112233457889


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       242 i~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHccCChhhCcCHHHHhh
Confidence            99999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=1.2e-30  Score=212.28  Aligned_cols=160  Identities=23%  Similarity=0.332  Sum_probs=124.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++.+++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       110 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~a  184 (297)
T 3fxz_A          110 ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA  184 (297)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCC
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--cCCccCCcCccC
Confidence            356899999999999999999999999   999999999999999999999999998775433221  222467889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|||||||++|+|++|..||........      ........ ..       ....+...+..+.+++
T Consensus       185 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~-~~-------~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-TP-------ELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             HHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC-SC-------CCSCGGGSCHHHHHHH
T ss_pred             hhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-CC-------CCCCccccCHHHHHHH
Confidence            9999999999999999999999999999999864322111      00000000 00       0111233445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||++|||+.++++
T Consensus       251 ~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhh
Confidence            9999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=5.8e-31  Score=214.95  Aligned_cols=164  Identities=27%  Similarity=0.340  Sum_probs=127.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+++   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       145 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          145 RALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence            35899999999999999999999999   999999999999999999999999999876443322222223446789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||........       ...         +........+...+..+.+++
T Consensus       222 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~~~~~li  285 (314)
T 2ivs_A          222 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-------FNL---------LKTGHRMERPDNCSEEMYRLM  285 (314)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHH---------HHTTCCCCCCTTCCHHHHHHH
T ss_pred             hhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH---------hhcCCcCCCCccCCHHHHHHH
Confidence            99999889999999999999999999 9999854322110       011         111111122233445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       286 ~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          286 LQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=7.6e-31  Score=214.15  Aligned_cols=164  Identities=27%  Similarity=0.419  Sum_probs=127.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      ++++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       141 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  217 (313)
T 1t46_A          141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE  217 (313)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence            5999999999999999999999999   9999999999999999999999999997654433222222234567899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++||||||+++|+|++ |..||.......      ....         .+........+...+..+.+++.
T Consensus       218 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~l~~li~  282 (313)
T 1t46_A          218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFYK---------MIKEGFRMLSPEHAPAEMYDIMK  282 (313)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHHH---------HHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             HhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh------HHHH---------HhccCCCCCCcccCCHHHHHHHH
Confidence            9999999999999999999999999 999985432111      0001         11111111112233456899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.||.+|||+.+|++.|++.
T Consensus       283 ~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          283 TCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCchhCcCHHHHHHHHHHH
Confidence            99999999999999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=5.9e-31  Score=215.14  Aligned_cols=168  Identities=23%  Similarity=0.302  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       142 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          142 KHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCc
Confidence            56999999999999999999999999   999999999999999999999999998765433222222223456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||........      . .....+         .....+...+..+.+++
T Consensus       219 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~-~~~~~~---------~~~~~~~~~~~~l~~li  282 (313)
T 3brb_A          219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM------Y-DYLLHG---------HRLKQPEDCLDELYEIM  282 (313)
T ss_dssp             HHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------H-HHHHTT---------CCCCCBTTCCHHHHHHH
T ss_pred             hhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------H-HHHHcC---------CCCCCCccccHHHHHHH
Confidence            99999899999999999999999999 8888754322110      0 001111         11122233445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      .+||+.||++|||+.+|++.|+.....+
T Consensus       283 ~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          283 YSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999999998765443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=214.86  Aligned_cols=167  Identities=27%  Similarity=0.387  Sum_probs=127.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-cccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-STNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~   81 (230)
                      ...+++.+++.++.||+.||+|||+.+   |+|+||+|+||+++.++.++|+|||++.......... ......++..|+
T Consensus       145 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~  221 (325)
T 3kul_A          145 DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT  221 (325)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGS
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCccccc
Confidence            357899999999999999999999999   9999999999999999999999999998764332211 111223456799


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++||||||+++|+|++ |..||.......                ....+........+...+..+.+
T Consensus       222 aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~  285 (325)
T 3kul_A          222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----------------VISSVEEGYRLPAPMGCPHALHQ  285 (325)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----------------HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHHHHcCCCCCCCCCcCHHHHH
Confidence            9999998999999999999999999999 999985432111                11111111112223344556899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      ++..||+.||++|||+.+|++.|+....
T Consensus       286 li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          286 LMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999987643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=2.5e-30  Score=223.36  Aligned_cols=172  Identities=18%  Similarity=0.235  Sum_probs=130.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe---CCCCCeEEcccccceeecCCCCC-----cccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSE-----ASTNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~   74 (230)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+|||+   +.++.++|+|||++.........     ......
T Consensus        97 ~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~  173 (483)
T 3sv0_A           97 SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL  173 (483)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccccccccc
Confidence            457999999999999999999999999   9999999999999   57889999999999876543221     111234


Q ss_pred             ccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           75 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .++..|+|||.+.+..++.++|||||||++|+|++|..||...........+...    ........+..     .....
T Consensus       174 ~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----~~~~~~~~~~~-----l~~~~  244 (483)
T 3sv0_A          174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----SEKKVATSIEA-----LCRGY  244 (483)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH----HHHHHHSCHHH-----HHTTS
T ss_pred             CCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH----hhccccccHHH-----HhcCC
Confidence            6788999999999999999999999999999999999999654332222211111    11111111111     11122


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +..+.+++..||+.||++||++.+|++.|++.
T Consensus       245 p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          245 PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            45689999999999999999999999988664

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=5.6e-31  Score=220.34  Aligned_cols=164  Identities=30%  Similarity=0.332  Sum_probs=125.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC---CeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM---NPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++.+++.++.||+.||+|||++|   |+||||||+||+++.++   .++|+|||++................++..|
T Consensus       176 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y  252 (367)
T 3l9p_A          176 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW  252 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccE
Confidence            46899999999999999999999999   99999999999999655   4999999999754222222222233557789


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      +|||.+.+..++.++|||||||++|+|++ |..||.......      .          ...+........+...+..+.
T Consensus       253 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~----------~~~i~~~~~~~~~~~~~~~l~  316 (367)
T 3l9p_A          253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------V----------LEFVTSGGRMDPPKNCPGPVY  316 (367)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------H----------HHHHHTTCCCCCCTTCCHHHH
T ss_pred             ECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------H----------HHHHHcCCCCCCCccCCHHHH
Confidence            99999999999999999999999999998 889985432111      0          111111111122233345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +++.+||+.||++|||+.+|++.|+..
T Consensus       317 ~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          317 RIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            999999999999999999999999664

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=6.3e-31  Score=217.36  Aligned_cols=169  Identities=26%  Similarity=0.358  Sum_probs=128.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       169 ~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          169 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  245 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence            67999999999999999999999999   999999999999999999999999998765322221222223457789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      .. .....+.         ....+...+..+.+++
T Consensus       246 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~-~~~~~~~---------~~~~~~~~~~~l~~li  309 (343)
T 1luf_A          246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------VI-YYVRDGN---------ILACPENCPLELYNLM  309 (343)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH-HHHHTTC---------CCCCCTTCCHHHHHHH
T ss_pred             hhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH------HH-HHHhCCC---------cCCCCCCCCHHHHHHH
Confidence            99999999999999999999999999 888985332111      00 0111111         1112233445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      .+||+.||++|||+.+|++.|++......
T Consensus       310 ~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          310 RLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             HHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            99999999999999999999998766543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=1.5e-30  Score=223.46  Aligned_cols=169  Identities=25%  Similarity=0.414  Sum_probs=127.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+++   ++||||+|+||+++.++.+||+|||++......... ......++..|+||
T Consensus       275 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aP  350 (452)
T 1fmk_A          275 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP  350 (452)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCH
Confidence            45899999999999999999999999   999999999999999999999999999765432211 11122346789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||.......                ....+....+...+...+..+.++|
T Consensus       351 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~l~~li  414 (452)
T 1fmk_A          351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYRMPCPPECPESLHDLM  414 (452)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             hHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            99999999999999999999999999 888985332111                1111111122223344556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVTLPQ  192 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~~~~  192 (230)
                      .+||+.||++|||+++|++.|+......+.
T Consensus       415 ~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          415 CQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            999999999999999999999988765443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.9e-30  Score=213.80  Aligned_cols=177  Identities=26%  Similarity=0.297  Sum_probs=126.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC--------CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--ccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED--------SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--STN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~--------~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   72 (230)
                      ...+++..++.++.|++.||+|||+.        +   ++||||||+||+++.++.+||+|||++..........  ...
T Consensus       128 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  204 (337)
T 3mdy_A          128 STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN  204 (337)
T ss_dssp             HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCC
Confidence            45789999999999999999999998        8   9999999999999999999999999997654322211  112


Q ss_pred             ccccccCccChhhhhcCCCCcc------ccchhhHHHHHHHHhcC----------CCCCCCccccccchhhhhHHHHhhh
Q 026939           73 RIVGTYGYMAPEYAMEGLFSVK------SDVFSFGVLLLEIISGK----------KNSGFYLSELGQSLLSYTWKLWCEG  136 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~~~~~~------~DiwslG~ll~~ll~g~----------~p~~~~~~~~~~~~~~~~~~~~~~~  136 (230)
                      ...++..|+|||.+.+..+...      +|||||||++|+|++|.          .||........  .........   
T Consensus       205 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~---  279 (337)
T 3mdy_A          205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP--SYEDMREIV---  279 (337)
T ss_dssp             SSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHH---
T ss_pred             CCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC--chhhhHHHH---
Confidence            2357889999999987766655      99999999999999994          44432211111  011111111   


Q ss_pred             hhhhhhchhhcc-hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          137 EALELMEPVLKQ-SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       137 ~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                       ......+.... .........+.+++.+||+.||++|||+.+|++.|+....
T Consensus       280 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          280 -CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             -TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence             11111111111 1123667789999999999999999999999999987644

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=2.2e-30  Score=211.90  Aligned_cols=153  Identities=21%  Similarity=0.288  Sum_probs=118.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++........   .....+++.|+||
T Consensus       152 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aP  225 (311)
T 3p1a_A          152 ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAP  225 (311)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCH
Confidence            46999999999999999999999999   99999999999999999999999999876543222   1223568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+ .++.++|||||||++|+|++|..++.....          +.....        ......++......+.+++.
T Consensus       226 E~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~--------~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          226 ELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQ--------GYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             GGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTT--------TCCCHHHHTTSCHHHHHHHH
T ss_pred             hHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhc--------cCCCcccccCCCHHHHHHHH
Confidence            99875 789999999999999999999776532110          111111        11111223334566999999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.||++|||+.++++
T Consensus       287 ~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCChhhCcCHHHHHh
Confidence            999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=7.7e-31  Score=215.23  Aligned_cols=184  Identities=25%  Similarity=0.292  Sum_probs=135.3

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGY   80 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~   80 (230)
                      ++..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|
T Consensus       127 ~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y  203 (318)
T 3lxp_A          127 PRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW  203 (318)
T ss_dssp             GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGG
T ss_pred             hhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCcee
Confidence            4557899999999999999999999999   999999999999999999999999999876543221 112223456679


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||.+.+..++.++||||||+++|+|++|..||......... .................+........+...+..+.+
T Consensus       204 ~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  282 (318)
T 3lxp_A          204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYH  282 (318)
T ss_dssp             CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             eChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHHHHHhcccCCCCCccccHHHHH
Confidence            9999999989999999999999999999999997543211100 000000111111222333333333344455667999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      ++.+||+.||++|||+.++++.|+.....
T Consensus       283 li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          283 LMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999876443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=5.3e-30  Score=207.40  Aligned_cols=171  Identities=25%  Similarity=0.397  Sum_probs=118.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|
T Consensus       114 ~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  190 (289)
T 3og7_A          114 ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA  190 (289)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccC
Confidence            457899999999999999999999999   99999999999999999999999999876543222222223457889999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||.+.   +..++.++||||||+++|+|++|..||.......      ........+......     .......+..+.
T Consensus       191 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~-----~~~~~~~~~~l~  259 (289)
T 3og7_A          191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDL-----SKVRSNCPKRMK  259 (289)
T ss_dssp             HHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCT-----TSSCTTSCHHHH
T ss_pred             chhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcch-----hhccccCCHHHH
Confidence            99986   5568889999999999999999999986432211      011111111110000     011123345689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      +++.+||+.||.+|||+.+|++.|++..
T Consensus       260 ~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          260 RLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            9999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=3.1e-30  Score=206.33  Aligned_cols=165  Identities=25%  Similarity=0.326  Sum_probs=127.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......... .....++..|+||
T Consensus        99 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aP  174 (268)
T 3sxs_A           99 KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAP  174 (268)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCH
Confidence            46899999999999999999999999   9999999999999999999999999998654332211 1122345679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||........      .... ..         ......+...+..+.+++
T Consensus       175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~-~~---------~~~~~~~~~~~~~l~~li  238 (268)
T 3sxs_A          175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKV-SQ---------GHRLYRPHLASDTIYQIM  238 (268)
T ss_dssp             HHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHH-HT---------TCCCCCCTTSCHHHHHHH
T ss_pred             HHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHH-Hc---------CCCCCCCCcChHHHHHHH
Confidence            99998889999999999999999999 9999854322111      0000 00         001111122234588999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      ..||+.||++|||+.++++.|+....
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            99999999999999999999988654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=8.1e-31  Score=216.09  Aligned_cols=166  Identities=27%  Similarity=0.373  Sum_probs=126.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|
T Consensus       158 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  234 (333)
T 2i1m_A          158 NSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA  234 (333)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccC
Confidence            346899999999999999999999999   99999999999999999999999999976543322222222345678999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++||||||+++|+|++ |..||.......      ....         ..........+...+..+.++
T Consensus       235 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~l~~l  299 (333)
T 2i1m_A          235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFYK---------LVKDGYQMAQPAFAPKNIYSI  299 (333)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------HHHH---------HHHHTCCCCCCTTCCHHHHHH
T ss_pred             HHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------HHHH---------HHhcCCCCCCCCCCCHHHHHH
Confidence            999999999999999999999999998 888875422111      0001         111111111122234568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +..||+.||.+|||+.+|++.|++.
T Consensus       300 i~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          300 MQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhccChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=1.8e-30  Score=212.99  Aligned_cols=166  Identities=24%  Similarity=0.354  Sum_probs=127.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.||+.||.|||++|   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence            46789999999999999999999999   999999999999999999999999998754322221222223456789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||.......      .. .....+..         ...+...+..+.+++
T Consensus       210 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~-~~~~~~~~---------~~~~~~~~~~l~~li  273 (322)
T 1p4o_A          210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VL-RFVMEGGL---------LDKPDNCPDMLFELM  273 (322)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HH-HHHHTTCC---------CCCCTTCCHHHHHHH
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH------HH-HHHHcCCc---------CCCCCCCCHHHHHHH
Confidence            99999999999999999999999999 788875432111      00 01111110         111223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .+||+.||++|||+.++++.|++...
T Consensus       274 ~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          274 RMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            99999999999999999999988644

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=2.7e-30  Score=213.31  Aligned_cols=164  Identities=30%  Similarity=0.347  Sum_probs=127.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+||
T Consensus       152 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  228 (334)
T 2pvf_A          152 EQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  228 (334)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence            35899999999999999999999999   999999999999999999999999999876443222222223446789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||.......      .. ..         +........+......+.+++
T Consensus       229 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~~---------~~~~~~~~~~~~~~~~l~~li  292 (334)
T 2pvf_A          229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LF-KL---------LKEGHRMDKPANCTNELYMMM  292 (334)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HH-HH---------HHHTCCCCCCTTCCHHHHHHH
T ss_pred             HHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH------HH-HH---------HhcCCCCCCCccCCHHHHHHH
Confidence            99998889999999999999999999 999985432111      00 01         111111122233445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||.+|||+.+|++.|+..
T Consensus       293 ~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          293 RDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=2.3e-30  Score=207.26  Aligned_cols=165  Identities=29%  Similarity=0.420  Sum_probs=122.4

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC--------CCCeEEcccccceeecCCCCCccccc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--------EMNPKISDFEMARIFGGNQSEASTNR   73 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~   73 (230)
                      +++++++..++.++.|++.||+|||+++..+++|+||+|+||+++.        ++.++|+|||++.........    .
T Consensus        98 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~----~  173 (271)
T 3dtc_A           98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM----S  173 (271)
T ss_dssp             TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccccc----C
Confidence            4568999999999999999999999987445789999999999986        677999999998765432211    2


Q ss_pred             cccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH
Q 026939           74 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA  153 (230)
Q Consensus        74 ~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (230)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||.......      .....         .........+..
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~---------~~~~~~~~~~~~  238 (271)
T 3dtc_A          174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGV---------AMNKLALPIPST  238 (271)
T ss_dssp             --CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHH---------HTSCCCCCCCTT
T ss_pred             CCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhh---------hcCCCCCCCCcc
Confidence            356789999999999999999999999999999999999986432111      00000         001111122233


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            44568999999999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.96  E-value=1.2e-30  Score=216.25  Aligned_cols=161  Identities=23%  Similarity=0.346  Sum_probs=117.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.+   |+||||+|+||+++ ++.++|+|||++................+++.|+|
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  177 (343)
T 3dbq_A          102 KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP  177 (343)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCC
Confidence            357899999999999999999999999   99999999999997 67899999999976543332222233467899999


Q ss_pred             hhhhhc-----------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh
Q 026939           83 PEYAME-----------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV  151 (230)
Q Consensus        83 Pe~~~~-----------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (230)
                      ||++.+           ..++.++|||||||++|+|++|..||.......     .         .....++......++
T Consensus       178 PE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~---------~~~~~~~~~~~~~~~  243 (343)
T 3dbq_A          178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S---------KLHAIIDPNHEIEFP  243 (343)
T ss_dssp             HHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H---------HHHHHHCTTSCCCCC
T ss_pred             HHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----H---------HHHHHhcCCcccCCc
Confidence            999975           568899999999999999999999985322110     0         011111222222223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          152 AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          244 DIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            333456889999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=1.5e-30  Score=212.69  Aligned_cols=164  Identities=29%  Similarity=0.364  Sum_probs=126.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus       144 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (316)
T 2xir_A          144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  220 (316)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence            3899999999999999999999999   9999999999999999999999999997654333222222335567899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++||||||+++|+|++ |..||.......      ........+.         ....+......+.+++.
T Consensus       221 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~l~~li~  285 (316)
T 2xir_A          221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTML  285 (316)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHH
T ss_pred             hhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHHHhccCc---------cCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999998 999985432111      0001111110         11112223446889999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.||.+|||+.+|++.|+..
T Consensus       286 ~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          286 DCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=5.2e-30  Score=209.80  Aligned_cols=176  Identities=22%  Similarity=0.247  Sum_probs=124.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       113 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~a  187 (311)
T 3niz_A          113 KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRA  187 (311)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCcCC
Confidence            346899999999999999999999999   999999999999999999999999999876432221  122356889999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh----------------hhhhhchh
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE----------------ALELMEPV  145 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~  145 (230)
                      ||.+.+ ..++.++|||||||++|+|++|..||...........   .........                ........
T Consensus       188 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (311)
T 3niz_A          188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQELPLWKQRTFQVFEKK  264 (311)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCC
T ss_pred             HHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhhccchhhhcccccccCC
Confidence            999876 4689999999999999999999999864332221110   000000000                00000000


Q ss_pred             hcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          146 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       146 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ............+.+++.+||+.||++|||+.++++  .+++.
T Consensus       265 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          265 PWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             CHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             cHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence            000111223456889999999999999999999987  44443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=2.3e-30  Score=222.30  Aligned_cols=166  Identities=26%  Similarity=0.390  Sum_probs=129.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||+|||+++   ++||||+|+||+++.++.+||+|||++......... ......++..|+|||
T Consensus       280 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE  355 (454)
T 1qcf_A          280 KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPE  355 (454)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccCCCcccccccCHH
Confidence            6889999999999999999999999   999999999999999999999999999765321111 111123456899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+....++.++|||||||++|+|++ |..||.......      .          ...+........+...+..+.++|.
T Consensus       356 ~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~----------~~~i~~~~~~~~~~~~~~~l~~li~  419 (454)
T 1qcf_A          356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------V----------IRALERGYRMPRPENCPEELYNIMM  419 (454)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------H----------HHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             HhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------H----------HHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999999 999985432111      1          1111111122223344567999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      +||+.||++|||+.+|++.|+......
T Consensus       420 ~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          420 RCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            999999999999999999999876643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=2.2e-30  Score=208.76  Aligned_cols=163  Identities=23%  Similarity=0.266  Sum_probs=117.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......... .....++..|+||
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aP  186 (281)
T 1mp8_A          111 YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAP  186 (281)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccccc-cccCCCcccccCh
Confidence            46899999999999999999999999   9999999999999999999999999997654322211 1122345689999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||........      ... ...+         .....+...+..+.+++
T Consensus       187 E~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~------~~~-i~~~---------~~~~~~~~~~~~l~~li  250 (281)
T 1mp8_A          187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGR-IENG---------ERLPMPPNCPPTLYSLM  250 (281)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHH-HHTT---------CCCCCCTTCCHHHHHHH
T ss_pred             hhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH------HHH-HHcC---------CCCCCCCCCCHHHHHHH
Confidence            99999999999999999999999997 8889864322111      000 0011         01112233445688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       251 ~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          251 TKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.96  E-value=2e-30  Score=211.63  Aligned_cols=168  Identities=23%  Similarity=0.264  Sum_probs=123.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........   .....++..|+|||
T Consensus       116 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE  189 (308)
T 3g33_A          116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPE  189 (308)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCch
Confidence            4899999999999999999999999   99999999999999999999999999876543222   12246688999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhh---hhhh---h----hhch---hhcchhh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCE---GEAL---E----LMEP---VLKQSCV  151 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---~----~~~~---~~~~~~~  151 (230)
                      .+.+..++.++|||||||++|+|++|..||............   ......   ....   .    ....   .......
T Consensus       190 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (308)
T 3g33_A          190 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI---FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVV  266 (308)
T ss_dssp             HHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHS
T ss_pred             HHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhccchhhccccccCCCCCCcHHHhC
Confidence            999999999999999999999999999998643322111000   000000   0000   0    0000   0000111


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          152 AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......+.+++.+||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          267 PEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            233456889999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=5.8e-30  Score=207.55  Aligned_cols=170  Identities=27%  Similarity=0.272  Sum_probs=127.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC--CccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS--EASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   80 (230)
                      ...+++.+++.++.|++.||+|||+.|   ++|+||+|+||+++.++.++|+|||++........  ........++..|
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y  194 (298)
T 3pls_A          118 QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW  194 (298)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccc
Confidence            457899999999999999999999999   99999999999999999999999999875432211  1111223456789


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCC-CCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNS-GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      +|||.+.+..++.++||||||+++|+|++|..|+ .......      ..          ..+........+...+..+.
T Consensus       195 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~l~  258 (298)
T 3pls_A          195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------LT----------HFLAQGRRLPQPEYCPDSLY  258 (298)
T ss_dssp             SCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG------HH----------HHHHTTCCCCCCTTCCHHHH
T ss_pred             cChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH------HH----------HHhhcCCCCCCCccchHHHH
Confidence            9999999989999999999999999999966654 3221111      00          00111111112223345689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      +++.+||+.||.+|||+.++++.|++....+.
T Consensus       259 ~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          259 QVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999987644443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=5.4e-30  Score=212.99  Aligned_cols=180  Identities=14%  Similarity=0.146  Sum_probs=130.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC--CeEEcccccceeecCCCCC-----ccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM--NPKISDFEMARIFGGNQSE-----ASTNRIV   75 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~-----~~~~~~~   75 (230)
                      +..+++.+++.++.||+.||+|||+++   ++||||+|+||+++.++  .++|+|||++.........     .......
T Consensus       153 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~  229 (352)
T 2jii_A          153 KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE  229 (352)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccccccccc
Confidence            367999999999999999999999999   99999999999999988  8999999999765322111     1112236


Q ss_pred             cccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHH
Q 026939           76 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL  155 (230)
Q Consensus        76 ~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (230)
                      ++..|+|||.+.+..++.++|||||||++|+|++|..||........ ..... ...+ ......+......   ....+
T Consensus       230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~-~~~~-~~~~~~~~~~~~~---~~~~~  303 (352)
T 2jii_A          230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE-DIMKQ-KQKF-VDKPGPFVGPCGH---WIRPS  303 (352)
T ss_dssp             SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-HHHHH-HHHH-HHSCCCEECTTSC---EECCC
T ss_pred             CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH-HHHHH-HHhc-cCChhhhhhhccc---cCCCc
Confidence            78899999999998999999999999999999999999864321111 00000 0000 0011111110000   00123


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          156 LKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       156 ~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      ..+.+++.+||+.||++|||+.+|++.|++......
T Consensus       304 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          304 ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            458999999999999999999999999987654443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=4.2e-30  Score=215.52  Aligned_cols=164  Identities=24%  Similarity=0.390  Sum_probs=117.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++||||+|+||+++.++.+||+|||++......... .......++..|+|
T Consensus       142 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~a  218 (373)
T 2qol_A          142 AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS  218 (373)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccC
Confidence            47899999999999999999999999   999999999999999999999999999765432211 11111233567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++||||||+++|+|++ |..||.......                ....+........+...+..+.++
T Consensus       219 PE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~l~~l  282 (373)
T 2qol_A          219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------VIKAVDEGYRLPPPMDCPAALYQL  282 (373)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----------------HHHHHHTTEECCCCTTCBHHHHHH
T ss_pred             hhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCccccHHHHHH
Confidence            999999999999999999999999998 999985332110                111111111222233445569999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||++||++.+|++.|+..
T Consensus       283 i~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          283 MLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhCcChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999765

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=7.4e-30  Score=218.95  Aligned_cols=158  Identities=28%  Similarity=0.303  Sum_probs=125.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||+|||+++   ++||||+|+||+++.++.+||+|||++........     ...++..|+|||
T Consensus       285 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE  356 (450)
T 1k9a_A          285 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPE  356 (450)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccccc-----CCCCCcceeCHH
Confidence            4789999999999999999999999   99999999999999999999999999875432111     124467899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++||||||+++|+|++ |..||.......      ..          ..+....+...+..++..+.++|.
T Consensus       357 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~----------~~i~~~~~~~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VV----------PRVEKGYKMDAPDGCPPAVYDVMK  420 (450)
T ss_dssp             HHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------HH----------HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HH----------HHHHcCCCCCCCCcCCHHHHHHHH
Confidence            9999999999999999999999998 999986432111      11          111111122233445567999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.||++|||+.+|++.|+..
T Consensus       421 ~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          421 NCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHHHHHH
Confidence            99999999999999999999764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=2.8e-30  Score=206.82  Aligned_cols=163  Identities=27%  Similarity=0.318  Sum_probs=125.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  176 (269)
T 4hcu_A          101 GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASP  176 (269)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcccccccCCH
Confidence            46899999999999999999999999   999999999999999999999999998754322111 11112345679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      .....          ........+...+..+.+++
T Consensus       177 E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDI----------STGFRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHH----------HTTCCCCCCTTSCHHHHHHH
T ss_pred             HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHH----------hcCccCCCCCcCCHHHHHHH
Confidence            99999999999999999999999999 899986432111      00000          00111111222345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.++++.|++.
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.96  E-value=3.3e-30  Score=217.34  Aligned_cols=161  Identities=22%  Similarity=0.335  Sum_probs=117.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||.|||+.+   |+||||+|+||+++ ++.+||+|||++................+++.|+|
T Consensus       149 ~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  224 (390)
T 2zmd_A          149 KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP  224 (390)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccC
Confidence            347889999999999999999999999   99999999999995 57899999999976543322222223467899999


Q ss_pred             hhhhhc-----------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh
Q 026939           83 PEYAME-----------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV  151 (230)
Q Consensus        83 Pe~~~~-----------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (230)
                      ||++.+           ..++.++|||||||++|+|++|..||.......     ..         ....++......++
T Consensus       225 PE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~---------~~~~~~~~~~~~~~  290 (390)
T 2zmd_A          225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK---------LHAIIDPNHEIEFP  290 (390)
T ss_dssp             HHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HH---------HHHHHCTTSCCCCC
T ss_pred             hHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HH---------HHHHhCccccCCCC
Confidence            999875           368899999999999999999999985322110     00         11111111111122


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          152 AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......+.+++.+||+.||.+|||+.++++
T Consensus       291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          291 DIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            222446889999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=1.2e-30  Score=214.83  Aligned_cols=183  Identities=26%  Similarity=0.309  Sum_probs=131.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-cccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-STNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~a   82 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  198 (327)
T 3lxl_A          122 ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA  198 (327)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccC
Confidence            46899999999999999999999999   9999999999999999999999999998764332211 1122345667999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++||||||+++|+|++|..||............ ..............+........+...+..+.+++
T Consensus       199 PE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  277 (327)
T 3lxl_A          199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLELLEEGQRLPAPPACPAEVHELM  277 (327)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             HHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHHHhhcccCCCCCCcccHHHHHHH
Confidence            99999988999999999999999999999997532221100000 00000000111222222222233444556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      .+||+.||++|||+.+|++.|+......
T Consensus       278 ~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          278 KLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            9999999999999999999998875543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=3.5e-30  Score=207.19  Aligned_cols=167  Identities=27%  Similarity=0.398  Sum_probs=127.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++......... ......++..|+|||
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE  180 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE  180 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChh
Confidence            6899999999999999999999999   999999999999999999999999999876432211 111223466899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++||||||+++|+|++ |..||.......      ....          +........+...+..+.+++.
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~----------~~~~~~~~~~~~~~~~l~~li~  244 (279)
T 1qpc_A          181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQN----------LERGYRMVRPDNCPEELYQLMR  244 (279)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHH----------HHTTCCCCCCTTCCHHHHHHHH
T ss_pred             hhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHH----------HhcccCCCCcccccHHHHHHHH
Confidence            9998889999999999999999999 888885432111      0000          0111111122233456899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      +||+.||++|||+.+|++.|++......
T Consensus       245 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          245 LCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            9999999999999999999987654433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.9e-30  Score=207.34  Aligned_cols=169  Identities=25%  Similarity=0.342  Sum_probs=130.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+
T Consensus       104 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  180 (287)
T 1u59_A          104 REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY  180 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGC
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccccc
Confidence            356999999999999999999999999   999999999999999999999999999876433221 1111223467899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++|+||||+++|+|++ |..||.......      ..          ..+........+...+..+.+
T Consensus       181 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~----------~~i~~~~~~~~~~~~~~~l~~  244 (287)
T 1u59_A          181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VM----------AFIEQGKRMECPPECPPELYA  244 (287)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HH----------HHHHTTCCCCCCTTCCHHHHH
T ss_pred             CHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HH----------HHHhcCCcCCCCCCcCHHHHH
Confidence            9999998889999999999999999998 999985432211      00          011111112223344557999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      ++..||+.||++||++.+|++.|+....+.
T Consensus       245 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          245 LMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            999999999999999999999998765443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=2.7e-30  Score=217.58  Aligned_cols=174  Identities=21%  Similarity=0.236  Sum_probs=121.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC---------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---------------   67 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   67 (230)
                      ...+++..+..++.||+.||+|||+.|   |+||||||+||+++.++.+||+|||++........               
T Consensus       103 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  179 (388)
T 3oz6_A          103 ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN  179 (388)
T ss_dssp             HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-----
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccc
Confidence            457899999999999999999999999   99999999999999999999999999976532110               


Q ss_pred             ----CccccccccccCccChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh-----
Q 026939           68 ----EASTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE-----  137 (230)
Q Consensus        68 ----~~~~~~~~~~~~~~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  137 (230)
                          ........++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.   .......     
T Consensus       180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~p~~~~~~  256 (388)
T 3oz6_A          180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII---GVIDFPSNEDVE  256 (388)
T ss_dssp             ----------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCHHHHH
T ss_pred             cccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCCHHHHH
Confidence                011122367889999999986 578999999999999999999999996543221110000   0000000     


Q ss_pred             ------hhhhh----------chhhcchhh------------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 026939          138 ------ALELM----------EPVLKQSCV------------AAELLKFIHIGLLCVQADSADRPTMSSVVVM  182 (230)
Q Consensus       138 ------~~~~~----------~~~~~~~~~------------~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~  182 (230)
                            ....+          .......++            ......+.+|+.+||+.||++|||++++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          257 SIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             TSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence                  00000          000000000            0224568899999999999999999999863

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=4.2e-30  Score=211.96  Aligned_cols=183  Identities=22%  Similarity=0.219  Sum_probs=125.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC---------CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-----
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED---------SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-----   68 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~---------~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----   68 (230)
                      ...+++..++.++.||+.||+|||+.         +   ++||||||+||+++.++.+||+|||++.........     
T Consensus       105 ~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~  181 (336)
T 3g2f_A          105 LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE  181 (336)
T ss_dssp             HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-----
T ss_pred             hcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCcccc
Confidence            34568899999999999999999999         8   999999999999999999999999999875432211     


Q ss_pred             -ccccccccccCccChhhhhc-------CCCCccccchhhHHHHHHHHhcCCCCCCCccc-cccchhhhhHHHHh-hhhh
Q 026939           69 -ASTNRIVGTYGYMAPEYAME-------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE-LGQSLLSYTWKLWC-EGEA  138 (230)
Q Consensus        69 -~~~~~~~~~~~~~aPe~~~~-------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~  138 (230)
                       .......++..|+|||++.+       ..++.++|||||||++|+|++|..||...... .............. ....
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (336)
T 3g2f_A          182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM  261 (336)
T ss_dssp             ----CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred             ccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHH
Confidence             11112357889999999976       34567899999999999999997775322211 11111100000000 0000


Q ss_pred             hh-hhchhhcchh------hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          139 LE-LMEPVLKQSC------VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       139 ~~-~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      .. ......+..+      ....+..+.+++.+||+.||++|||+.++++.|++...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          262 QVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             HHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            00 0000011111      22356679999999999999999999999999987543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=6.9e-30  Score=221.55  Aligned_cols=166  Identities=25%  Similarity=0.319  Sum_probs=129.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+++   |+||||+|+||+++.++.+||+|||++......... ......++..|+|
T Consensus       312 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~a  387 (495)
T 1opk_A          312 RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA  387 (495)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeC
Confidence            356899999999999999999999999   999999999999999999999999999865432211 1112234568999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|+|++ |..||.......                ....+....+...+..++..+.++
T Consensus       388 PE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKDYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             HhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCCCCHHHHHH
Confidence            999999999999999999999999999 888885432111                111111122222334445679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      |.+||+.||++|||+.+|++.|+....
T Consensus       452 i~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            999999999999999999999987643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=4.7e-30  Score=206.83  Aligned_cols=164  Identities=24%  Similarity=0.319  Sum_probs=125.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+|
T Consensus       114 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~a  189 (283)
T 3gen_A          114 RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP  189 (283)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCC
Confidence            357999999999999999999999999   999999999999999999999999998765322111 1111234567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++|+|++ |..||........      ..          .+........+......+.++
T Consensus       190 PE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~~----------~~~~~~~~~~~~~~~~~l~~l  253 (283)
T 3gen_A          190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AE----------HIAQGLRLYRPHLASEKVYTI  253 (283)
T ss_dssp             HHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HH----------HHHTTCCCCCCTTCCHHHHHH
T ss_pred             HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------HH----------HHhcccCCCCCCcCCHHHHHH
Confidence            999999999999999999999999998 9999864322111      00          001111111122234568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||++|||+.++++.|++.
T Consensus       254 i~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          254 MYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.8e-29  Score=205.09  Aligned_cols=175  Identities=16%  Similarity=0.201  Sum_probs=130.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe----CCCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL----DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      .+++.+++.++.||+.||+|||+.+   ++|+||+|+||++    +.++.++|+|||++.........   ....++..|
T Consensus       108 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y  181 (319)
T 4euu_A          108 GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEY  181 (319)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce---eecccCCCc
Confidence            3999999999999999999999999   9999999999998    77778999999999876433221   123568899


Q ss_pred             cChhhhh--------cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhh----------
Q 026939           81 MAPEYAM--------EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELM----------  142 (230)
Q Consensus        81 ~aPe~~~--------~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  142 (230)
                      +|||++.        +..++.++|||||||++|+|++|..||.........  .......... ......          
T Consensus       182 ~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~-~p~~~~~~~~~~~~~~  258 (319)
T 4euu_A          182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG-KPSGAISGVQKAENGP  258 (319)
T ss_dssp             CCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHH-CCTTCCEEEECSTTCC
T ss_pred             cCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcC-CCcccchhhhcccCCc
Confidence            9999987        467889999999999999999999998543221111  1111111111 100000          


Q ss_pred             -----chhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          143 -----EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       143 -----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                           .-.............+.+++.+||+.||++|||++++++...+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             EEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence                 0001113456777789999999999999999999999999877654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=206.75  Aligned_cols=170  Identities=27%  Similarity=0.390  Sum_probs=123.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHh---CCCCCeeecCCCCCceEeCCCCC-eEEcccccceeecCCCCCccccccccccCc
Q 026939            5 QLDWKRRISIINGIARGLLYLHE---DSRLRIIHRDLKASNVLLDHEMN-PKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~---~~~~~i~H~di~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      .++...++.++.||+.||+|||+   ++   ++|+||+|+||+++.++. ++|+|||++.......     ....++..|
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y  169 (307)
T 2eva_A           98 YYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAW  169 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTS
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCce
Confidence            47889999999999999999999   67   999999999999988876 7999999987543221     123468899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||.+.+..++.++||||||+++|+|++|..||.......    ....+... .+         .....+...+..+.+
T Consensus       170 ~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-~~---------~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVH-NG---------TRPPLIKNLPKPIES  235 (307)
T ss_dssp             SCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHH-TT---------CCCCCBTTCCHHHHH
T ss_pred             EChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHh-cC---------CCCCcccccCHHHHH
Confidence            99999998899999999999999999999999986432111    11111110 00         111112233445889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEP  196 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~~~~~p  196 (230)
                      ++.+||+.||++|||+.+|++.|+.....++....|
T Consensus       236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            999999999999999999999998765555544433

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=5.6e-30  Score=206.28  Aligned_cols=163  Identities=21%  Similarity=0.259  Sum_probs=123.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......... .....++..|+||
T Consensus       108 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aP  183 (281)
T 3cc6_A          108 NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSP  183 (281)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccccc-cccCCCCcceeCc
Confidence            46899999999999999999999999   9999999999999999999999999987654322111 1122346689999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||........   .    .....+         .....+...+..+.+++
T Consensus       184 E~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~----~~~~~~---------~~~~~~~~~~~~l~~li  247 (281)
T 3cc6_A          184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---I----GVLEKG---------DRLPKPDLCPPVLYTLM  247 (281)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---H----HHHHHT---------CCCCCCTTCCHHHHHHH
T ss_pred             hhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---H----HHHhcC---------CCCCCCCCCCHHHHHHH
Confidence            99998999999999999999999998 9999854322111   0    000000         01111222345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.++++.|+..
T Consensus       248 ~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          248 TRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCCchhCcCHHHHHHHHHHH
Confidence            999999999999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=6e-30  Score=207.21  Aligned_cols=167  Identities=29%  Similarity=0.374  Sum_probs=128.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc-ccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-TNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........... .....++..|+|
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  188 (291)
T 1xbb_A          112 RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA  188 (291)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeC
Confidence            46899999999999999999999999   99999999999999999999999999987643322111 111233567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++|+|++ |..||.......                ....+........+...+..+.++
T Consensus       189 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~l  252 (291)
T 1xbb_A          189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERMGCPAGCPREMYDL  252 (291)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             hHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCCCCHHHHHH
Confidence            999998889999999999999999999 999986432211                001111111112233445569999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      +.+||+.||++|||+.+|++.|++....
T Consensus       253 i~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          253 MNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999875443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=1.2e-29  Score=204.91  Aligned_cols=164  Identities=24%  Similarity=0.430  Sum_probs=124.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC-----eEEcccccceeecCCCCCccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN-----PKISDFEMARIFGGNQSEASTNRIVGT   77 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~~~   77 (230)
                      ..++++..++.++.|++.||+|||+.+ .+++|+||+|+||+++.++.     ++|+|||++.....     ......++
T Consensus       116 ~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~  189 (287)
T 4f0f_A          116 AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGN  189 (287)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCC
T ss_pred             cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCC
Confidence            457999999999999999999999975 34999999999999987776     99999999864332     12224568


Q ss_pred             cCccChhhhh--cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHH
Q 026939           78 YGYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL  155 (230)
Q Consensus        78 ~~~~aPe~~~--~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (230)
                      ..|+|||.+.  ...++.++|||||||++|+|++|..||........    .....         ..........+...+
T Consensus       190 ~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~  256 (287)
T 4f0f_A          190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINM---------IREEGLRPTIPEDCP  256 (287)
T ss_dssp             CTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHH---------HHHSCCCCCCCTTSC
T ss_pred             ccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHH---------HhccCCCCCCCcccC
Confidence            8999999984  44578899999999999999999999864322111    00000         011111122233344


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          156 LKFIHIGLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       156 ~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      ..+.+++.+||+.||++|||+.+|++.|++
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          257 PRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            568999999999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=8.9e-30  Score=213.52  Aligned_cols=168  Identities=26%  Similarity=0.298  Sum_probs=118.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--cccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--STNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (230)
                      ..+++..++.++.||+.||+|||+++   ++||||+|+||+++.++.+||+|||++..........  ......++..|+
T Consensus       187 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~  263 (373)
T 3c1x_A          187 HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM  263 (373)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCccccc
Confidence            46889999999999999999999999   9999999999999999999999999997653222111  111224466899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++|||||||++|+|++ |.+||.......      .... ...+.         ....+...+..+.+
T Consensus       264 aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~------~~~~-~~~~~---------~~~~p~~~~~~l~~  327 (373)
T 3c1x_A          264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVY-LLQGR---------RLLQPEYCPDPLYE  327 (373)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC------HHHH-HHTTC---------CCCCCTTCCHHHHH
T ss_pred             ChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH------HHHH-HHcCC---------CCCCCCCCCHHHHH
Confidence            9999999999999999999999999999 566664322111      1100 01111         11112233456899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      ++.+||+.||++|||+.+|++.|+.....+
T Consensus       328 li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          328 VMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            999999999999999999999998764443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=1.2e-29  Score=204.18  Aligned_cols=161  Identities=22%  Similarity=0.326  Sum_probs=125.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+||
T Consensus       117 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aP  190 (284)
T 2a19_B          117 EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSP  190 (284)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccccc---cccCCcccccCh
Confidence            57899999999999999999999999   999999999999999999999999998776433221   123568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..|+....        . ...        ..........    .+..+.+++.
T Consensus       191 E~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~-~~~--------~~~~~~~~~~----~~~~~~~li~  249 (284)
T 2a19_B          191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------K-FFT--------DLRDGIISDI----FDKKEKTLLQ  249 (284)
T ss_dssp             HHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------H-HHH--------HHHTTCCCTT----SCHHHHHHHH
T ss_pred             hhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------H-HHH--------Hhhccccccc----CCHHHHHHHH
Confidence            99998889999999999999999999988852100        0 000        0011111112    2335788999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      +||+.||++|||+.++++.|........
T Consensus       250 ~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          250 KLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            9999999999999999999987765544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=1.5e-29  Score=205.33  Aligned_cols=169  Identities=26%  Similarity=0.281  Sum_probs=125.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   80 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .......++..|
T Consensus       122 ~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y  198 (298)
T 3f66_A          122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW  198 (298)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccc
Confidence            456899999999999999999999999   999999999999999999999999999765432211  111223445689


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhc-CCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISG-KKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      +|||.+.+..++.++|+||||+++|+|++| .+||.......      ..... ..+         .....+...+..+.
T Consensus       199 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~~~-~~~---------~~~~~~~~~~~~l~  262 (298)
T 3f66_A          199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYL-LQG---------RRLLQPEYCPDPLY  262 (298)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HHHHH-HTT---------CCCCCCTTCCHHHH
T ss_pred             cChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHH-hcC---------CCCCCCccCCHHHH
Confidence            999999999999999999999999999995 45553322111      11000 000         01111222334588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      +++.+||+.||++|||+.++++.|++....+
T Consensus       263 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          263 EVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999998765443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=206.41  Aligned_cols=160  Identities=23%  Similarity=0.248  Sum_probs=121.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..++++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+
T Consensus       130 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~  204 (298)
T 2zv2_A          130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFM  204 (298)
T ss_dssp             CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCcccc
Confidence            3467999999999999999999999999   99999999999999999999999999987643221  122246788999


Q ss_pred             ChhhhhcCC---CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           82 APEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        82 aPe~~~~~~---~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |||.+.+..   ++.++|||||||++|+|++|..||......      ... .......        .........+..+
T Consensus       205 aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~-~~~~~~~--------~~~~~~~~~~~~l  269 (298)
T 2zv2_A          205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM------CLH-SKIKSQA--------LEFPDQPDIAEDL  269 (298)
T ss_dssp             CGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCC--------CCCCSSSCCCHHH
T ss_pred             ChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH------HHH-HHHhccc--------CCCCCccccCHHH
Confidence            999987654   367899999999999999999998542211      000 0000000        0000011233458


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.||++|||+.+|++
T Consensus       270 ~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          270 KDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHhhcChhhCCCHHHHhc
Confidence            89999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=5.3e-30  Score=211.39  Aligned_cols=156  Identities=25%  Similarity=0.306  Sum_probs=122.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.+++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++.......   ......+++.|+|
T Consensus       108 ~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~a  181 (328)
T 3fe3_A          108 HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAA  181 (328)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeC
Confidence            357899999999999999999999999   9999999999999999999999999987653322   1223467889999


Q ss_pred             hhhhhcCCCC-ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~-~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..+. .++|||||||++|+|++|..||.......      ..... ..+.          ...+...+..+.++
T Consensus       182 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i-~~~~----------~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERV-LRGK----------YRIPFYMSTDCENL  244 (328)
T ss_dssp             HHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCC----------CCCCTTSCHHHHHH
T ss_pred             cccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCC----------CCCCCCCCHHHHHH
Confidence            9999988765 78999999999999999999986432111      11111 0100          01122234558899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||.+|||++++++
T Consensus       245 i~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=1.5e-29  Score=204.96  Aligned_cols=172  Identities=19%  Similarity=0.202  Sum_probs=122.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus        95 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~a  169 (292)
T 3o0g_A           95 NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRP  169 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--CCSCCSCGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--ccCCccccCCcC
Confidence            467999999999999999999999999   999999999999999999999999999876433221  122356788999


Q ss_pred             hhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh------hhhhhc---------hhh
Q 026939           83 PEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE------ALELME---------PVL  146 (230)
Q Consensus        83 Pe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~---------~~~  146 (230)
                      ||.+.+.. ++.++|||||||++|+|++|..||........  .............      .....+         ...
T Consensus       170 PE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T 3o0g_A          170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS  247 (292)
T ss_dssp             HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred             hHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcccccccccccccCCcc
Confidence            99998765 79999999999999999998888532211110  0000000000000      000000         000


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...........+.+++.+||+.||++|||++++++
T Consensus       248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00112234456889999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=3.1e-29  Score=206.07  Aligned_cols=161  Identities=22%  Similarity=0.332  Sum_probs=124.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..++++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+
T Consensus       134 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~  208 (321)
T 2c30_A          134 SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWM  208 (321)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGC
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCcccc
Confidence            3457999999999999999999999999   99999999999999999999999999876543222  122346788999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||.+.+..++.++||||||+++|+|++|..||.......      .... ...     ...+..  ......+..+.++
T Consensus       209 aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------~~~~-~~~-----~~~~~~--~~~~~~~~~l~~l  274 (321)
T 2c30_A          209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKR-LRD-----SPPPKL--KNSHKVSPVLRDF  274 (321)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHH-----SSCCCC--TTGGGSCHHHHHH
T ss_pred             CHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-Hhc-----CCCCCc--CccccCCHHHHHH
Confidence            9999998899999999999999999999999985432211      0000 000     000000  0112233458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       275 i~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          275 LERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.6e-29  Score=208.83  Aligned_cols=166  Identities=23%  Similarity=0.366  Sum_probs=121.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      ...+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++......... .......++..|+
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  217 (333)
T 1mqb_A          141 DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT  217 (333)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCcccccc
Confidence            357899999999999999999999999   999999999999999999999999999765432211 1111123456799


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++||||||+++|+|++ |..||.......      ..          ..+........+...+..+.+
T Consensus       218 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~l~~  281 (333)
T 1mqb_A          218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VM----------KAINDGFRLPTPMDCPSAIYQ  281 (333)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH----------HHHHTTCCCCCCTTCBHHHHH
T ss_pred             CchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HH----------HHHHCCCcCCCcccCCHHHHH
Confidence            9999998899999999999999999999 999985332110      00          011111111122234456899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      ++.+||+.||++||++.+|++.|+...
T Consensus       282 li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          282 LMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999997653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.96  E-value=4.9e-29  Score=214.59  Aligned_cols=172  Identities=22%  Similarity=0.211  Sum_probs=119.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.|   |+||||||+||+++.++.+||+|||++........   .....++..|+||
T Consensus       159 ~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aP  232 (464)
T 3ttj_A          159 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAP  232 (464)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CCC---C----CCCTTCCH
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCH
Confidence            35889999999999999999999999   99999999999999999999999999976543221   1224678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH----HHHh---hhhhh---------------hh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW----KLWC---EGEAL---------------EL  141 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~----~~~~---~~~~~---------------~~  141 (230)
                      |++.+..++.++|||||||++|+|++|..||...........+....    ..+.   .....               ..
T Consensus       233 E~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (464)
T 3ttj_A          233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL  312 (464)
T ss_dssp             HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHH
T ss_pred             HHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHh
Confidence            99999999999999999999999999999996533211100000000    0000   00000               00


Q ss_pred             hchhh---cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          142 MEPVL---KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       142 ~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .....   ...........+.+|+.+||+.||++|||++++++
T Consensus       313 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000   00111223567899999999999999999999987

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=1.5e-29  Score=205.42  Aligned_cols=169  Identities=25%  Similarity=0.315  Sum_probs=124.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++......... ......+++.|+||
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aP  181 (294)
T 4eqm_A          106 GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSP  181 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCH
Confidence            46899999999999999999999999   999999999999999999999999998765322211 12224578899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||.......      ........ ..     +..........+..+.+++.
T Consensus       182 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-~~-----~~~~~~~~~~~~~~l~~li~  249 (294)
T 4eqm_A          182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-SV-----PNVTTDVRKDIPQSLSNVIL  249 (294)
T ss_dssp             HHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-CC-----CCHHHHSCTTSCHHHHHHHH
T ss_pred             hHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-cC-----CCcchhcccCCCHHHHHHHH
Confidence            99999999999999999999999999999986432111      00011000 00     00011112233456889999


Q ss_pred             hhcCCCCCCCC-CHHHHHHHhhcCCC
Q 026939          164 LCVQADSADRP-TMSSVVVMLASDNV  188 (230)
Q Consensus       164 ~cl~~dP~~RP-s~~~i~~~L~~~~~  188 (230)
                      +||+.||++|| +++++.+.|+....
T Consensus       250 ~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          250 RATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             HHhcCCHhHccccHHHHHHHHHHHHh
Confidence            99999999998 99999999987644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.96  E-value=2.1e-29  Score=207.22  Aligned_cols=181  Identities=18%  Similarity=0.219  Sum_probs=124.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus        94 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~a  168 (324)
T 3mtl_A           94 GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYRP  168 (324)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--cccccCcccccC
Confidence            346899999999999999999999999   999999999999999999999999998764322211  122356789999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh---hhhhhhc---------hhh---
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG---EALELME---------PVL---  146 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---------~~~---  146 (230)
                      ||++.+ ..++.++|||||||++|+|++|..||..........   .........   .......         +..   
T Consensus       169 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
T 3mtl_A          169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAE  245 (324)
T ss_dssp             HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCC
T ss_pred             hhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHhchhhhcchhhcccccccccch
Confidence            999876 568999999999999999999999986543221110   000000000   0000000         000   


Q ss_pred             -cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCCCCC
Q 026939          147 -KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNVTLP  191 (230)
Q Consensus       147 -~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~~~~  191 (230)
                       ...........+.+++.+||+.||++|||++++++  .+.+......
T Consensus       246 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          246 ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             hhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence             00011123456889999999999999999999987  5666555443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=2e-30  Score=210.75  Aligned_cols=178  Identities=20%  Similarity=0.298  Sum_probs=128.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus       121 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  197 (302)
T 4e5w_A          121 NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA  197 (302)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccC
Confidence            46899999999999999999999999   999999999999999999999999999876543221 11222345667999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++|+|++|..|+............... ...........+........+...+..+.+++
T Consensus       198 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  276 (302)
T 4e5w_A          198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLM  276 (302)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC-GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             CeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc-cccCHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            99999999999999999999999999999885432111000000000 00000011111111122223344456799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhc
Q 026939          163 LLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      .+||+.||.+|||+.++++.|+.
T Consensus       277 ~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          277 RKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCHHHHHHHHHH
Confidence            99999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.96  E-value=8.4e-30  Score=205.76  Aligned_cols=164  Identities=26%  Similarity=0.331  Sum_probs=127.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ .......++..|+|
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~a  180 (288)
T 3kfa_A          105 RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTA  180 (288)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCC
T ss_pred             cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCC
Confidence            456899999999999999999999999   99999999999999999999999999876543222 11222344668999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++|+|++ |..||........                ...+........+...+..+.++
T Consensus       181 PE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~l  244 (288)
T 3kfa_A          181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELLEKDYRMERPEGCPEKVYEL  244 (288)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------HHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHhccCCCCCCCCCCHHHHHH
Confidence            999999999999999999999999999 8888854322111                11111111122233344568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||.+|||+.+|++.|+..
T Consensus       245 i~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          245 MRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhCCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999998754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.7e-30  Score=212.62  Aligned_cols=180  Identities=23%  Similarity=0.284  Sum_probs=128.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      ..+++.+++.++.||+.||++||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus       140 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  216 (326)
T 2w1i_A          140 ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA  216 (326)
T ss_dssp             TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEEC
Confidence            46899999999999999999999999   999999999999999999999999999876433221 11112234567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++||||||+++|+|++|..|+...........................+........+...+..+.+++
T Consensus       217 PE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  296 (326)
T 2w1i_A          217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM  296 (326)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             chhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHH
Confidence            99999888999999999999999999999887532111000000000000000011111111111222334456799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       297 ~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          297 TECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=6.1e-30  Score=223.82  Aligned_cols=168  Identities=26%  Similarity=0.424  Sum_probs=130.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+++   |+||||+|+|||++.++.+||+|||++........ .......++..|+||
T Consensus       358 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aP  433 (535)
T 2h8h_A          358 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP  433 (535)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcCcccccCH
Confidence            45899999999999999999999999   99999999999999999999999999875432111 011112345689999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++|+|++ |..||......      +          ....+....+...+..++..+.+||
T Consensus       434 E~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~----------~~~~i~~~~~~~~~~~~~~~l~~li  497 (535)
T 2h8h_A          434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E----------VLDQVERGYRMPCPPECPESLHDLM  497 (535)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------H----------HHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H----------HHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            99999999999999999999999999 88888533211      1          1111111112223344556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      .+||+.||++|||+.+|++.|+.......
T Consensus       498 ~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          498 CQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            99999999999999999999998776543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=8.6e-30  Score=226.07  Aligned_cols=168  Identities=24%  Similarity=0.341  Sum_probs=128.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      +..+++..++.++.||+.||+|||+++   |+||||+|+||+++.++.+||+|||++......... .......++..|+
T Consensus       430 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~  506 (613)
T 2ozo_A          430 REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY  506 (613)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCcccee
Confidence            456999999999999999999999999   999999999999999999999999999765322211 1111123356899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||++.+..++.++|||||||++|+|++ |..||.......                ....+....+...+..++..+.+
T Consensus       507 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~p~~~~~~l~~  570 (613)
T 2ozo_A          507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQGKRMECPPECPPELYA  570 (613)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCcCCHHHHH
Confidence            9999999999999999999999999998 999986432211                11111111222334445567999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      +|..||+.||++||++.+|++.|+.....
T Consensus       571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999999876443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.7e-29  Score=206.89  Aligned_cols=160  Identities=21%  Similarity=0.211  Sum_probs=122.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC----CeEEcccccceeecCCCCCcccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM----NPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++    .++|+|||++........   .....+++
T Consensus       108 ~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~  181 (326)
T 2y0a_A          108 KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP  181 (326)
T ss_dssp             SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCT
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCc
Confidence            457899999999999999999999999   99999999999998877    799999999987643222   12235788


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      .|+|||++.+..++.++|||||||++|+|++|..||.......      ..... ...      ............+..+
T Consensus       182 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~-~~~------~~~~~~~~~~~~~~~~  248 (326)
T 2y0a_A          182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANV-SAV------NYEFEDEYFSNTSALA  248 (326)
T ss_dssp             TTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHH-HHT------CCCCCHHHHTTSCHHH
T ss_pred             CcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHH-Hhc------CCCcCccccccCCHHH
Confidence            9999999998899999999999999999999999985322111      00000 000      0000111122334568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.||++|||+.++++
T Consensus       249 ~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          249 KDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            89999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=6.7e-29  Score=208.79  Aligned_cols=170  Identities=22%  Similarity=0.205  Sum_probs=125.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCC---------------------------------
Q 026939            4 VQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEM---------------------------------   49 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~---------------------------------   49 (230)
                      ..+++..++.++.||+.||+|||++ |   |+||||||+||+++.++                                 
T Consensus       141 ~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (397)
T 1wak_A          141 QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA  217 (397)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------C
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccc
Confidence            5699999999999999999999998 8   99999999999999775                                 


Q ss_pred             ----------------CeEEcccccceeecCCCCCccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCC
Q 026939           50 ----------------NPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN  113 (230)
Q Consensus        50 ----------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p  113 (230)
                                      .++|+|||++.......     ....++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       218 ~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  292 (397)
T 1wak_A          218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL  292 (397)
T ss_dssp             CTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCC
Confidence                            79999999997754321     123568899999999999999999999999999999999999


Q ss_pred             CCCCccccccchhhhhH---HH--------Hhhhhhh-hhhch-----------------h--hcchhhHHHHHHHHHHH
Q 026939          114 SGFYLSELGQSLLSYTW---KL--------WCEGEAL-ELMEP-----------------V--LKQSCVAAELLKFIHIG  162 (230)
Q Consensus       114 ~~~~~~~~~~~~~~~~~---~~--------~~~~~~~-~~~~~-----------------~--~~~~~~~~~~~~l~~l~  162 (230)
                      |................   ..        +..+... .....                 .  .....+......+.+|+
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  372 (397)
T 1wak_A          293 FEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL  372 (397)
T ss_dssp             CCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHH
T ss_pred             CCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHH
Confidence            96433222111000000   00        0000000 00000                 0  00123466778899999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||++|||+.++++
T Consensus       373 ~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          373 LPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGGGCSSGGGSCCHHHHHT
T ss_pred             HHHhccChhhcCCHHHHhh
Confidence            9999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=1.9e-29  Score=207.78  Aligned_cols=159  Identities=21%  Similarity=0.268  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.   ++.++|+|||++........   .....+++.|
T Consensus       126 ~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y  199 (327)
T 3lm5_A          126 EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEY  199 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCc
Confidence            57899999999999999999999999   999999999999987   78999999999987643222   1223578899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..++.++|+||||+++|+|++|..||........      ... ....      ...............+.+
T Consensus       200 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~-i~~~------~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLN-ISQV------NVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHT------CCCCCTTTTTTSCHHHHH
T ss_pred             cCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHH-HHhc------ccccCchhhcccCHHHHH
Confidence            999999989999999999999999999999999854322111      000 0000      000011112233456889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||+.||++|||++++++
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcCCChhhCcCHHHHhC
Confidence            999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.96  E-value=1.8e-29  Score=210.21  Aligned_cols=170  Identities=22%  Similarity=0.224  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-------------------------CCCeEEccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-------------------------EMNPKISDFEM   58 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-------------------------~~~~~l~d~~~   58 (230)
                      ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.                         ++.++|+|||+
T Consensus       132 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~  208 (360)
T 3llt_A          132 NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC  208 (360)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccC
Confidence            35899999999999999999999999   999999999999975                         78899999999


Q ss_pred             ceeecCCCCCccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh--------H
Q 026939           59 ARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT--------W  130 (230)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~--------~  130 (230)
                      +.......     ....++..|+|||++.+..++.++|||||||++|+|++|..||...............        .
T Consensus       209 a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~  283 (360)
T 3llt_A          209 ATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNML  283 (360)
T ss_dssp             CEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHH
T ss_pred             ceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHH
Confidence            97643221     1235688999999999999999999999999999999999999643322111100000        0


Q ss_pred             HHHhhhhhhhhhch-hh--------------------cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          131 KLWCEGEALELMEP-VL--------------------KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       131 ~~~~~~~~~~~~~~-~~--------------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .............. ..                    ...+.......+.+++.+||+.||++|||+.++++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          284 YEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000000000 00                    00111112256889999999999999999999974

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=2.2e-29  Score=202.47  Aligned_cols=157  Identities=27%  Similarity=0.299  Sum_probs=119.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      +++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........     ...++..|+|||.
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~y~aPE~  185 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEA  185 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccccc-----CCCccccccCHHH
Confidence            788999999999999999999999   99999999999999999999999999875432211     1244678999999


Q ss_pred             hhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           86 AMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        86 ~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                      +.+..++.++|+||||+++|+|++ |..||.......      .. ..         +........+...+..+.+++.+
T Consensus       186 ~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~-~~---------~~~~~~~~~~~~~~~~l~~li~~  249 (278)
T 1byg_A          186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VV-PR---------VEKGYKMDAPDGCPPAVYEVMKN  249 (278)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HH-HH---------HTTTCCCCCCTTCCHHHHHHHHH
T ss_pred             hCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HH---------HhcCCCCCCcccCCHHHHHHHHH
Confidence            999999999999999999999998 999986432111      00 00         11111112223344568999999


Q ss_pred             hcCCCCCCCCCHHHHHHHhhcC
Q 026939          165 CVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ||+.||++|||+.++++.|+..
T Consensus       250 ~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          250 CWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.3e-29  Score=208.60  Aligned_cols=162  Identities=25%  Similarity=0.288  Sum_probs=124.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ......++..|+||
T Consensus       137 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          137 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAI  210 (327)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccCh
Confidence            47999999999999999999999999   9999999999999999999999999986432111   11112346789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++||||||+++|+|++ |..||.......      ..          ..+........+...+..+.+++
T Consensus       211 E~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~l~~li  274 (327)
T 1fvr_A          211 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY----------EKLPQGYRLEKPLNCDDEVYDLM  274 (327)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH----------HHGGGTCCCCCCTTBCHHHHHHH
T ss_pred             hhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH----------HHhhcCCCCCCCCCCCHHHHHHH
Confidence            99998889999999999999999998 999985432111      00          00111111112223345689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.||.+|||+.++++.|+...
T Consensus       275 ~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          275 RQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=4.5e-30  Score=215.46  Aligned_cols=147  Identities=16%  Similarity=0.162  Sum_probs=114.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..++.++.||+.||+|||++|   |+||||||+||+++.++.+||+|||++.....     ......+ ..|+|||
T Consensus       202 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE  272 (377)
T 3byv_A          202 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPE  272 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHH
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChh
Confidence            3456888999999999999999999   99999999999999999999999999976322     1122355 8999999


Q ss_pred             hhhcC-----------CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH
Q 026939           85 YAMEG-----------LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA  153 (230)
Q Consensus        85 ~~~~~-----------~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (230)
                      ++.+.           .++.++|||||||++|+|++|..||...........               ... . ...    
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~---------------~~~-~-~~~----  331 (377)
T 3byv_A          273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW---------------IFR-S-CKN----  331 (377)
T ss_dssp             HHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG---------------GGS-S-CCC----
T ss_pred             hhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh---------------hhh-h-ccC----
Confidence            99987           799999999999999999999999854322111000               000 0 011    


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+..+.+++.+||+.||++|||+.++++
T Consensus       332 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          332 IPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            2345889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=2.5e-29  Score=206.17  Aligned_cols=170  Identities=24%  Similarity=0.280  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.|   ++||||+|+||+++.++.+||+|||++.........  .....++..|+||
T Consensus       103 ~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aP  177 (317)
T 2pmi_A          103 RGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAP  177 (317)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--CCCCcccccccCc
Confidence            46899999999999999999999999   999999999999999999999999999875432211  1123568899999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhh--hh----hhh--h------------h
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCE--GE----ALE--L------------M  142 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~----~~~--~------------~  142 (230)
                      |++.+. .++.++|||||||++|+|++|..||...........   .......  ..    ...  .            +
T Consensus       178 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (317)
T 2pmi_A          178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL  254 (317)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCS
T ss_pred             hHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChhHhhhhhhhhhcccccccccchhH
Confidence            999764 689999999999999999999999865432211100   0000000  00    000  0            0


Q ss_pred             chhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          143 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       143 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...+...........+.+++.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          255 RQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000000111123446899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=4.5e-30  Score=214.97  Aligned_cols=154  Identities=10%  Similarity=0.017  Sum_probs=113.9

Q ss_pred             HHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhhhhc--C
Q 026939           12 ISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEYAME--G   89 (230)
Q Consensus        12 ~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~--~   89 (230)
                      +.++.||+.||+|||++|   |+||||||+||+++.++.+||+|||++........     ...++..|+|||.+.+  .
T Consensus       197 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~  268 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTA  268 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEE
T ss_pred             HHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCC
Confidence            778899999999999999   99999999999999999999999999986532111     2344589999999987  6


Q ss_pred             CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhhhcCCC
Q 026939           90 LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQAD  169 (230)
Q Consensus        90 ~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  169 (230)
                      .++.++|||||||++|+|++|..||....+.........        ..................+..+.+++.+||+.|
T Consensus       269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP--------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBC--------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred             CcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhh--------hhhhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence            789999999999999999999999965432211110000        000000000001111233456889999999999


Q ss_pred             CCCCCCHHHHHH
Q 026939          170 SADRPTMSSVVV  181 (230)
Q Consensus       170 P~~RPs~~~i~~  181 (230)
                      |++|||+.++++
T Consensus       341 P~~Rpt~~e~l~  352 (371)
T 3q60_A          341 RRRRLLPLEAME  352 (371)
T ss_dssp             TTTCCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=9.4e-30  Score=210.52  Aligned_cols=156  Identities=22%  Similarity=0.265  Sum_probs=121.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.+++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++........   .....+++.|+|
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~a  175 (336)
T 3h4j_B          102 KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAA  175 (336)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCC
Confidence            457899999999999999999999999   99999999999999999999999999876543222   122357889999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..+ +.++|||||||++|+|++|..||............                ... ....+...+..+.++
T Consensus       176 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----------------~~~-~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----------------NSC-VYVMPDFLSPGAQSL  238 (336)
T ss_dssp             GGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------CSS-CCCCCTTSCHHHHHH
T ss_pred             HHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------HcC-CCCCcccCCHHHHHH
Confidence            999987765 68999999999999999999998643221111000                000 001122234458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||.+|||+.+|++
T Consensus       239 i~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHHh
Confidence            99999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=8.4e-30  Score=226.86  Aligned_cols=165  Identities=29%  Similarity=0.391  Sum_probs=126.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      +..+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......... .......++..|+
T Consensus       463 ~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~  539 (635)
T 4fl3_A          463 NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY  539 (635)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeee
Confidence            356899999999999999999999999   999999999999999999999999999765432211 1111223456899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||++.+..++.++|||||||++|+|++ |..||.......                ....+........+...+..+.+
T Consensus       540 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~p~~~~~~l~~  603 (635)
T 4fl3_A          540 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERMGCPAGCPREMYD  603 (635)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCCCCHHHHH
Confidence            9999999999999999999999999998 999985432211                11111222222334445567999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +|..||+.||++||++.+|++.|++.
T Consensus       604 li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          604 LMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            99999999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=1.4e-29  Score=204.77  Aligned_cols=171  Identities=22%  Similarity=0.277  Sum_probs=120.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||++|   ++|+||+|+||+++.++.+||+|||++.........  .....++..|+|
T Consensus        94 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~a  168 (288)
T 1ob3_A           94 EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRA  168 (288)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccccc--cccccccccccC
Confidence            357899999999999999999999999   999999999999999999999999998765432211  112356889999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh------hh--hhhchhh-------
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE------AL--ELMEPVL-------  146 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~--~~~~~~~-------  146 (230)
                      ||.+.+. .++.++|||||||++|+|++|..||..........   ..........      ..  ...++..       
T Consensus       169 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (288)
T 1ob3_A          169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP  245 (288)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred             chheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhchhhhcccccccccccccCcc
Confidence            9999764 58999999999999999999999986433211100   0000000000      00  0000000       


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...+.......+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00111223456889999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=207.16  Aligned_cols=180  Identities=27%  Similarity=0.350  Sum_probs=118.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC---CccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---EASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~   80 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++ ++.++|+|||++........   ........++..|
T Consensus       125 ~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y  200 (319)
T 2y4i_B          125 IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH  200 (319)
T ss_dssp             CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccc
Confidence            36899999999999999999999999   99999999999998 67999999998765432111   1111223467889


Q ss_pred             cChhhhhc---------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh
Q 026939           81 MAPEYAME---------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV  151 (230)
Q Consensus        81 ~aPe~~~~---------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (230)
                      +|||.+.+         ..++.++||||||+++|+|++|..||.......      ..+. ...+..     +...   .
T Consensus       201 ~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~-----~~~~---~  265 (319)
T 2y4i_B          201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQ-MGTGMK-----PNLS---Q  265 (319)
T ss_dssp             SCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHH-HHTTCC-----CCCC---C
T ss_pred             cChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-hccCCC-----CCCC---c
Confidence            99999874         347889999999999999999999986432211      1111 111110     0000   0


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCCccCc
Q 026939          152 AAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGR  202 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~~~~~p~~~~~~  202 (230)
                      ...+..+.+++.+||..||++|||+.+|++.|+...........|...+..
T Consensus       266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~  316 (319)
T 2y4i_B          266 IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS  316 (319)
T ss_dssp             SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence            112334889999999999999999999999999987776655666655543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=2.9e-29  Score=211.70  Aligned_cols=159  Identities=26%  Similarity=0.306  Sum_probs=119.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.|   |+||||||+||+++.++.+||+|||++........  ......+++.|+|
T Consensus       147 ~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~a  221 (396)
T 4dc2_A          147 QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIA  221 (396)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC--ccccccCCcccCC
Confidence            357899999999999999999999999   99999999999999999999999999875322211  1223467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccc--cchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG--QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||++.+..++.++|+|||||++|+|++|..||........  ..............          ...++...+..+.+
T Consensus       222 PE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~p~~~s~~~~~  291 (396)
T 4dc2_A          222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIRIPRSLSVKAAS  291 (396)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----------CCCCCTTSCHHHHH
T ss_pred             chhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----------ccCCCCcCCHHHHH
Confidence            9999999999999999999999999999999954322111  11111111111111          01223334456889


Q ss_pred             HHhhhcCCCCCCCCCH
Q 026939          161 IGLLCVQADSADRPTM  176 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~  176 (230)
                      ++.+||+.||.+||++
T Consensus       292 li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          292 VLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHTCSCTTTSTTC
T ss_pred             HHHHHhcCCHhHcCCC
Confidence            9999999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=4e-29  Score=208.66  Aligned_cols=160  Identities=21%  Similarity=0.207  Sum_probs=122.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC----CeEEcccccceeecCCCCCcccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM----NPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      ...+++..++.++.||+.||.|||+.|   |+|+||+|+||+++.++    .++|+|||++........   .....+++
T Consensus       109 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~  182 (361)
T 2yab_A          109 KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTP  182 (361)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCc
Confidence            457899999999999999999999999   99999999999998776    699999999987643221   12246788


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      .|+|||++.+..++.++|+|||||++|+|++|..||.......      .... .....      ......+....+..+
T Consensus       183 ~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~-i~~~~------~~~~~~~~~~~s~~~  249 (361)
T 2yab_A          183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN-ITAVS------YDFDEEFFSQTSELA  249 (361)
T ss_dssp             GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHH-HHTTC------CCCCHHHHTTSCHHH
T ss_pred             cEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcC------CCCCchhccCCCHHH
Confidence            9999999998899999999999999999999999985432111      0000 00000      000111112334568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||..||.+|||+.++++
T Consensus       250 ~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          250 KDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhc
Confidence            89999999999999999999885

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.3e-29  Score=202.39  Aligned_cols=163  Identities=27%  Similarity=0.309  Sum_probs=124.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ .......++..|+||
T Consensus        99 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aP  174 (267)
T 3t9t_A           99 GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP  174 (267)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccCh
Confidence            46899999999999999999999999   99999999999999999999999999875432111 111112345679999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|+||||+++|+|++ |..||.......      .... ...         ......+...+..+.+++
T Consensus       175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-i~~---------~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVED-IST---------GFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH-HHT---------TCCCCCCTTSCHHHHHHH
T ss_pred             hhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHH-Hhc---------CCcCCCCccCcHHHHHHH
Confidence            99998899999999999999999999 888885432111      0000 001         011111222345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.++++.|++.
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=2.6e-29  Score=205.58  Aligned_cols=172  Identities=20%  Similarity=0.237  Sum_probs=126.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc-------ccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS-------TNRIV   75 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-------~~~~~   75 (230)
                      +..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++...........       .....
T Consensus       128 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  204 (317)
T 2buj_A          128 GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR  204 (317)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccccccccc
Confidence            467999999999999999999999999   99999999999999999999999998865421111000       01124


Q ss_pred             cccCccChhhhhcCC---CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH
Q 026939           76 GTYGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA  152 (230)
Q Consensus        76 ~~~~~~aPe~~~~~~---~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (230)
                      ++..|+|||.+.+..   ++.++||||||+++|+|++|..||.........    ..          .............
T Consensus       205 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~----------~~~~~~~~~~~~~  270 (317)
T 2buj_A          205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS----VA----------LAVQNQLSIPQSP  270 (317)
T ss_dssp             SCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC----HH----------HHHHCC--CCCCT
T ss_pred             CCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch----hh----------HHhhccCCCCccc
Confidence            578899999987554   688999999999999999999998421111100    00          0000001111112


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTLP  191 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~~  191 (230)
                      ..+..+.+++.+||+.||.+|||+.+|++.|+......+
T Consensus       271 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            234568999999999999999999999999998766544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=1e-29  Score=205.35  Aligned_cols=159  Identities=25%  Similarity=0.329  Sum_probs=112.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++..++.++.||+.||+|||++ |   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~  176 (290)
T 3fme_A          103 GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYM  176 (290)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccccc---cccCCCcccc
Confidence            46799999999999999999999998 8   999999999999999999999999998765432221   1235678999


Q ss_pred             Chhhh----hcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           82 APEYA----MEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        82 aPe~~----~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      |||.+    .+..++.++|+||||+++|+|++|..||........     .....         .............+..
T Consensus       177 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~  242 (290)
T 3fme_A          177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQV---------VEEPSPQLPADKFSAE  242 (290)
T ss_dssp             CHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHH---------HHSCCCCCCTTTSCHH
T ss_pred             ChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHH---------hccCCCCcccccCCHH
Confidence            99996    455688999999999999999999999864221110     00000         0000001111223445


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.||++|||+.++++
T Consensus       243 ~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          243 FVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhhcChhhCcCHHHHHh
Confidence            889999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=2.7e-29  Score=207.91  Aligned_cols=157  Identities=21%  Similarity=0.223  Sum_probs=122.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||++|   |+||||||+||+++.+|.++|+|||++........  ......+++.|+|
T Consensus        99 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~a  173 (337)
T 1o6l_A           99 ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA  173 (337)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCC
Confidence            356899999999999999999999999   99999999999999999999999999875322211  1223467889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|+|||||++|+|++|..||.......      .. .......          ..++...+..+.+++
T Consensus       174 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~-~~i~~~~----------~~~p~~~s~~~~~li  236 (337)
T 1o6l_A          174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LF-ELILMEE----------IRFPRTLSPEAKSLL  236 (337)
T ss_dssp             GGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCC----------CCCCTTSCHHHHHHH
T ss_pred             hhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HH-HHHHcCC----------CCCCCCCCHHHHHHH
Confidence            999998899999999999999999999999985322110      00 0110100          112223345688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||+.||++||     ++.+|++
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHc
Confidence            999999999999     8999976

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.96  E-value=4.7e-29  Score=210.96  Aligned_cols=163  Identities=19%  Similarity=0.190  Sum_probs=118.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++.+++.++.||+.||.|||+.+   |+||||||+||+++.   ++.+||+|||++........   .....++..|
T Consensus       156 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y  229 (400)
T 1nxk_A          156 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYY  229 (400)
T ss_dssp             -CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCc
Confidence            36999999999999999999999999   999999999999997   78899999999986543221   1223568899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..++.++|||||||++|+|++|..||............   ......+.. ....     ......+..+.+
T Consensus       230 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~-~~~~-----~~~~~~s~~~~~  300 (400)
T 1nxk_A          230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY-EFPN-----PEWSEVSEEVKM  300 (400)
T ss_dssp             CCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCC-CCCT-----TTTTTSCHHHHH
T ss_pred             cCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCcc-cCCC-----cccccCCHHHHH
Confidence            9999998889999999999999999999999998643322111000   000111100 0000     001123456889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||+.||++|||+.+|++
T Consensus       301 li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          301 LIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999997

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=5.5e-29  Score=205.81  Aligned_cols=150  Identities=21%  Similarity=0.261  Sum_probs=121.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+|
T Consensus       124 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~a  197 (335)
T 3dls_A          124 HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYCA  197 (335)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCB---CEECSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCCce---eccCCCccccC
Confidence            347999999999999999999999999   999999999999999999999999999876433221   22357889999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..+ +.++|||||||++|+|++|..||........                     ...  ..+...+..+.++
T Consensus       198 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------------------~~~--~~~~~~~~~l~~l  254 (335)
T 3dls_A          198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE---------------------AAI--HPPYLVSKELMSL  254 (335)
T ss_dssp             HHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT---------------------TCC--CCSSCCCHHHHHH
T ss_pred             hhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh---------------------hcc--CCCcccCHHHHHH
Confidence            999988876 7899999999999999999999853211100                     000  0011123458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       255 i~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=7.2e-29  Score=203.78  Aligned_cols=156  Identities=22%  Similarity=0.330  Sum_probs=117.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC----------cccccc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE----------ASTNRI   74 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~   74 (230)
                      ..++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++.........          ......
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence            4566778999999999999999999   999999999999999999999999999876543211          111223


Q ss_pred             ccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           75 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .++..|+|||.+.+..++.++|||||||++|+|++|..|+...        .          ..................
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~----------~~~~~~~~~~~~~~~~~~  298 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------V----------RIITDVRNLKFPLLFTQK  298 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------H----------HHHHHHHTTCCCHHHHHH
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------H----------HHHHHhhccCCCcccccC
Confidence            5788999999999999999999999999999999987663100        0          000000111111223444


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...+.+++.+||+.||++|||+.++++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            556789999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=2.4e-29  Score=207.82  Aligned_cols=175  Identities=24%  Similarity=0.290  Sum_probs=126.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhH--------hCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--ccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLH--------EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--STN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh--------~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   72 (230)
                      +.++++.+++.++.||+.||+|||        +.+   ++|+||+|+||+++.++.++|+|||++..........  ...
T Consensus       133 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  209 (342)
T 1b6c_B          133 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN  209 (342)
T ss_dssp             HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCC
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccc
Confidence            356899999999999999999999        888   9999999999999999999999999998765432211  122


Q ss_pred             ccccccCccChhhhhcCC------CCccccchhhHHHHHHHHhc----------CCCCCCCccccccchhhhhHHHHhhh
Q 026939           73 RIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISG----------KKNSGFYLSELGQSLLSYTWKLWCEG  136 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~~------~~~~~DiwslG~ll~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~  136 (230)
                      ...++..|+|||.+.+..      ++.++||||||+++|+|++|          ..||........  ........... 
T Consensus       210 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~-  286 (342)
T 1b6c_B          210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCE-  286 (342)
T ss_dssp             SCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTT-
T ss_pred             cCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc--cHHHHHHHHHH-
Confidence            335688999999997652      33689999999999999999          556543221111  01111111111 


Q ss_pred             hhhhhhchhhcch-hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          137 EALELMEPVLKQS-CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       137 ~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                         ....+.+... ........+.+++.+||+.||++|||+.+|++.|+..
T Consensus       287 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          287 ---QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             ---SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence               1111111111 1235667899999999999999999999999999765

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=3.1e-28  Score=203.40  Aligned_cols=175  Identities=21%  Similarity=0.212  Sum_probs=123.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeC------CCCCeEEcccccceeecCCCCCccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLD------HEMNPKISDFEMARIFGGNQSEASTNRIV   75 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   75 (230)
                      ...+++..++.++.||+.||+|||++ |   |+|+||+|+||+++      ..+.++|+|||++........     ...
T Consensus       125 ~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~  196 (373)
T 1q8y_A          125 HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-----NSI  196 (373)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCC-----SCC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCCC-----CCC
Confidence            35699999999999999999999998 9   99999999999994      444799999999976543211     235


Q ss_pred             cccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHH-----------hhhhhh-----
Q 026939           76 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLW-----------CEGEAL-----  139 (230)
Q Consensus        76 ~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-----  139 (230)
                      ++..|+|||.+.+..++.++|||||||++|+|++|..||...................           ......     
T Consensus       197 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  276 (373)
T 1q8y_A          197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN  276 (373)
T ss_dssp             SCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBC
T ss_pred             CCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcC
Confidence            6889999999999999999999999999999999999996433211110000000000           000000     


Q ss_pred             -----hhh--------ch--hhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--Hhhc
Q 026939          140 -----ELM--------EP--VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLAS  185 (230)
Q Consensus       140 -----~~~--------~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~  185 (230)
                           ..+        ..  .....++......+.+++.+||+.||++|||+.++++  .+.+
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  339 (373)
T 1q8y_A          277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD  339 (373)
T ss_dssp             C--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred             CcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhc
Confidence                 000        00  0011245677888999999999999999999999987  4544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.5e-29  Score=206.77  Aligned_cols=163  Identities=18%  Similarity=0.255  Sum_probs=124.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC--CCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.  ++.++|+|||++........   .....+++.|+
T Consensus        97 ~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~  170 (321)
T 1tki_A           97 FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY  170 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhc
Confidence            46999999999999999999999999   999999999999987  78999999999987643221   22246788999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+..++.++|||||||++|+|++|..||.......      ..... ......      .........+..+.++
T Consensus       171 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~~~------~~~~~~~~~s~~~~~l  237 (321)
T 1tki_A          171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENI-MNAEYT------FDEEAFKEISIEAMDF  237 (321)
T ss_dssp             CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HHTCCC------CCHHHHTTSCHHHHHH
T ss_pred             CcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHH-HcCCCC------CChhhhccCCHHHHHH
Confidence            9999988888999999999999999999999985432111      00000 000000      0001111234568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH--Hhhc
Q 026939          162 GLLCVQADSADRPTMSSVVV--MLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~--~L~~  185 (230)
                      +.+||..||++|||+.++++  .+.+
T Consensus       238 i~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          238 VDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHcCCChhHCcCHHHHhcChhhcc
Confidence            99999999999999999998  4443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=2.6e-29  Score=206.74  Aligned_cols=164  Identities=29%  Similarity=0.333  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC---CCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.+   ..++|+|||++................++..|
T Consensus       135 ~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y  211 (327)
T 2yfx_A          135 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW  211 (327)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcce
Confidence            45899999999999999999999999   9999999999999844   45999999998754332222222233557789


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      +|||.+.+..++.++||||||+++|+|++ |..||.......      .. .....+         .....+...+..+.
T Consensus       212 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~~~~~~---------~~~~~~~~~~~~l~  275 (327)
T 2yfx_A          212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VL-EFVTSG---------GRMDPPKNCPGPVY  275 (327)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HH-HHHHTT---------CCCCCCTTCCHHHH
T ss_pred             eCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HH-HHHhcC---------CCCCCCCCCCHHHH
Confidence            99999999999999999999999999998 888885432110      00 001111         11112223345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +++.+||+.||.+|||+.+|++.|+..
T Consensus       276 ~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          276 RIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=3.3e-29  Score=209.61  Aligned_cols=177  Identities=24%  Similarity=0.275  Sum_probs=116.4

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +...+++..++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++......     .....++..|+
T Consensus       125 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~  196 (367)
T 2fst_X          125 KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYR  196 (367)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCcc
Confidence            4467999999999999999999999999   999999999999999999999999998764322     11235688999


Q ss_pred             Chhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHH---Hhhhhhhhhhchh---hcc-
Q 026939           82 APEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKL---WCEGEALELMEPV---LKQ-  148 (230)
Q Consensus        82 aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~~~~---~~~-  148 (230)
                      |||++.+ ..++.++|||||||++|+|++|..||...........+...     ...   .........+...   ... 
T Consensus       197 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (367)
T 2fst_X          197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN  276 (367)
T ss_dssp             CHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCC
T ss_pred             ChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCC
Confidence            9999987 57899999999999999999999998654322110000000     000   0000000000000   000 


Q ss_pred             --hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          149 --SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       149 --~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                        .........+.+|+.+||+.||++|||+.++++  .+++.
T Consensus       277 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          277 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence              011122456889999999999999999999987  44443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=6.6e-29  Score=208.83  Aligned_cols=159  Identities=24%  Similarity=0.340  Sum_probs=122.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.|   |+||||+|+||+++.++.++|+|||++........   .....+++.|+|
T Consensus       109 ~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~a  182 (384)
T 4fr4_A          109 NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMA  182 (384)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccC
Confidence            457999999999999999999999999   99999999999999999999999999987543221   222467889999


Q ss_pred             hhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||++.+   ..++.++|+|||||++|+|++|..||.............    ....          ....++...+..+.
T Consensus       183 PE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~----------~~~~~p~~~s~~~~  248 (384)
T 4fr4_A          183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----TFET----------TVVTYPSAWSQEMV  248 (384)
T ss_dssp             GGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----HHHH----------CCCCCCTTSCHHHH
T ss_pred             CeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhh----------cccCCCCcCCHHHH
Confidence            999874   458899999999999999999999986432221111100    0000          01122333455689


Q ss_pred             HHHhhhcCCCCCCCCC-HHHHHH
Q 026939          160 HIGLLCVQADSADRPT-MSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs-~~~i~~  181 (230)
                      +++.+||+.||++||+ +++|++
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHhcCCHhHhcccHHHHHc
Confidence            9999999999999998 777764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=211.71  Aligned_cols=161  Identities=27%  Similarity=0.276  Sum_probs=121.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||++|   |+||||||+||+++.++.++|+|||++........  ......+++.|+|
T Consensus       118 ~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~a  192 (353)
T 3txo_A          118 SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIA  192 (353)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc--cccccCCCcCeEC
Confidence            357899999999999999999999999   99999999999999999999999999875322211  1223467889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|+|||||++|+|++|..||.......      .... .....          ..++......+.+++
T Consensus       193 PE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~-i~~~~----------~~~p~~~~~~~~~li  255 (353)
T 3txo_A          193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEA-ILNDE----------VVYPTWLHEDATGIL  255 (353)
T ss_dssp             HHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCC----------CCCCTTSCHHHHHHH
T ss_pred             hhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHH-HHcCC----------CCCCCCCCHHHHHHH
Confidence            999998889999999999999999999999986432211      1111 11110          112223345688999


Q ss_pred             hhhcCCCCCCCCCH------HHHHH--Hhhc
Q 026939          163 LLCVQADSADRPTM------SSVVV--MLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RPs~------~~i~~--~L~~  185 (230)
                      .+||+.||.+||++      .+|++  ++++
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            99999999999998      77765  4444

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=5.7e-29  Score=208.18  Aligned_cols=178  Identities=23%  Similarity=0.230  Sum_probs=126.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+..++.||+.||+|||+.|   ++||||+|+||+++.++.+||+|||++.......     ....++..|+|
T Consensus       122 ~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~a  193 (367)
T 1cm8_A          122 HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRA  193 (367)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccccc-----CcCcCCCCcCC
Confidence            357899999999999999999999999   9999999999999999999999999998754321     12356789999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhhhhch---hh---c
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALELMEP---VL---K  147 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~---~  147 (230)
                      ||++.+ ..++.++|+||+||++++|++|..||...........+..        .............+..   ..   .
T Consensus       194 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (367)
T 1cm8_A          194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF  273 (367)
T ss_dssp             THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred             HHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH
Confidence            999987 6789999999999999999999999864332211000000        0000000000000000   00   0


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCC
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNV  188 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~  188 (230)
                      ..........+.+++.+||+.||++|||+.++++  .+++...
T Consensus       274 ~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          274 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            0111233456889999999999999999999988  5655433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.96  E-value=4.7e-29  Score=203.54  Aligned_cols=174  Identities=19%  Similarity=0.226  Sum_probs=119.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.|++.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus        96 ~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~a  170 (311)
T 4agu_A           96 QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRS  170 (311)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCC
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccC
Confidence            456899999999999999999999999   999999999999999999999999999875432221  112356788999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh--------hHHHHhhhhhhh---hhchhhc---
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY--------TWKLWCEGEALE---LMEPVLK---  147 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~---~~~~~~~---  147 (230)
                      ||.+.+ ..++.++|+||||+++|+|++|..||..............        ....+.......   ..++...   
T Consensus       171 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (311)
T 4agu_A          171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPL  250 (311)
T ss_dssp             HHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCH
T ss_pred             hHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchh
Confidence            999986 5689999999999999999999999865433221111000        000000000000   0000000   


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .......+..+.+++.+||+.||++|||++++++
T Consensus       251 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          251 ELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             hhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0001123445889999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=1.9e-28  Score=205.23  Aligned_cols=176  Identities=22%  Similarity=0.248  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||++|   ++||||+|+||+++.++.+||+|||++........   .....++..|+||
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aP  195 (371)
T 2xrw_A          122 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAP  195 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCH
T ss_pred             hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccccc---cCCceecCCccCH
Confidence            35889999999999999999999999   99999999999999999999999999976543211   1123568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh---------hhh------HHHHh-hh------hhhhh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL---------SYT------WKLWC-EG------EALEL  141 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~---------~~~------~~~~~-~~------~~~~~  141 (230)
                      |++.+..++.++|||||||++|+|++|..||............         ...      ...+. ..      .....
T Consensus       196 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (371)
T 2xrw_A          196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL  275 (371)
T ss_dssp             HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHH
T ss_pred             HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhh
Confidence            9999989999999999999999999999998653321110000         000      00000 00      00000


Q ss_pred             hchhh---cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--Hhhc
Q 026939          142 MEPVL---KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLAS  185 (230)
Q Consensus       142 ~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~  185 (230)
                      .....   ...........+.+++.+||+.||++|||++++++  .+..
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            00000   01112334667999999999999999999999987  5543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.96  E-value=5.8e-29  Score=199.51  Aligned_cols=162  Identities=25%  Similarity=0.355  Sum_probs=121.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++................++..|+|
T Consensus        99 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  175 (276)
T 2yex_A           99 DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA  175 (276)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccC
Confidence            347899999999999999999999999   99999999999999999999999999876532221112223456788999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..+ +.++|+||||+++|+|++|..||........      ....+......  .      ......+..+.++
T Consensus       176 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--~------~~~~~~~~~~~~l  241 (276)
T 2yex_A          176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--L------NPWKKIDSAPLAL  241 (276)
T ss_dssp             GGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTCTT--S------TTGGGSCHHHHHH
T ss_pred             hHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcccc--c------CchhhcCHHHHHH
Confidence            999987665 6789999999999999999999864332111      00111111000  0      0111223458889


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||.+|||+.+|++
T Consensus       242 i~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHCCCCchhCCCHHHHhc
Confidence            99999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=3.5e-29  Score=211.35  Aligned_cols=178  Identities=17%  Similarity=0.155  Sum_probs=125.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++..++.++.||+.||+|||+.|   |+||||||+||+++ .++.+||+|||++.........   ....++..|+
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~  208 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYR  208 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC---cccccCcCcc
Confidence            467899999999999999999999999   99999999999998 7899999999999875433221   1235688899


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHH--hhhhhhhh-----hchhhcc
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLW--CEGEALEL-----MEPVLKQ  148 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~-----~~~~~~~  148 (230)
                      |||++.+. .++.++|||||||++|+|++|..||...............     ...+  ........     .......
T Consensus       209 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (394)
T 4e7w_A          209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSK  288 (394)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHH
T ss_pred             CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHH
Confidence            99998765 5899999999999999999999998643322110000000     0000  00000000     0000001


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      .+....+..+.+++.+||+.||.+|||+.++++  ++++.
T Consensus       289 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          289 VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            112224456999999999999999999999987  34443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=2.9e-29  Score=214.01  Aligned_cols=107  Identities=24%  Similarity=0.274  Sum_probs=94.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC--eEEcccccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN--PKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.  ++|+|||++........     ...++..|+
T Consensus       195 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~-----~~~gt~~y~  266 (429)
T 3kvw_A          195 QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-----TYIQSRFYR  266 (429)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCC-----SSCSCGGGC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCccc-----ccCCCCCcc
Confidence            45899999999999999999999999   999999999999999887  99999999976432211     235678899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCc
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYL  118 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~  118 (230)
                      |||++.+..++.++|||||||++|+|++|..||....
T Consensus       267 aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999999999999986543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=1.7e-29  Score=206.25  Aligned_cols=169  Identities=21%  Similarity=0.265  Sum_probs=119.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~a  204 (310)
T 2wqm_A          130 KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMS  204 (310)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeC
Confidence            456899999999999999999999999   99999999999999999999999999876543221  1122356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++|+|++|..||......    ...... .........        .........+.+++
T Consensus       205 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~~~--------~~~~~~~~~l~~li  271 (310)
T 2wqm_A          205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEQCDYPP--------LPSDHYSEELRQLV  271 (310)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHH-HHHTTCSCC--------CCTTTSCHHHHHHH
T ss_pred             hHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHH-HhhcccCCC--------CcccccCHHHHHHH
Confidence            99999889999999999999999999999998532111    001110 010111000        00122334588999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCCCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDNVT  189 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~~~  189 (230)
                      .+||+.||++|||+.+|++.|+.....
T Consensus       272 ~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          272 NMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            999999999999999999999876544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=1.8e-28  Score=203.96  Aligned_cols=159  Identities=25%  Similarity=0.258  Sum_probs=121.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC---eEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN---PKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++..++.++.||+.||+|||+++   |+||||+|+||+++.++.   ++|+|||++........  ......+++.|
T Consensus       125 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y  199 (351)
T 3c0i_A          125 FVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHF  199 (351)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCc
Confidence            35899999999999999999999999   999999999999986654   99999999987654322  12224678899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..++.++|||||||++|+|++|..||......        .......+...  ..+    ......+..+.+
T Consensus       200 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~i~~~~~~--~~~----~~~~~~s~~~~~  265 (351)
T 3c0i_A          200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFEGIIKGKYK--MNP----RQWSHISESAKD  265 (351)
T ss_dssp             CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--------HHHHHHHTCCC--CCH----HHHTTSCHHHHH
T ss_pred             cCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--------HHHHHHcCCCC--CCc----cccccCCHHHHH
Confidence            9999999889999999999999999999999998642210        00111111000  000    011123456889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||+.||++|||+.++++
T Consensus       266 li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          266 LVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=1.8e-28  Score=211.34  Aligned_cols=172  Identities=27%  Similarity=0.381  Sum_probs=129.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++..++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++........   .....+++.|+|
T Consensus       110 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~a  183 (476)
T 2y94_A          110 NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAA  183 (476)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEC
Confidence            457999999999999999999999999   99999999999999999999999999987643222   112357889999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..+ +.++|||||||++|+|++|..||......      ... .....+.        .  ..+......+.++
T Consensus       184 PE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~-~~i~~~~--------~--~~p~~~s~~~~~L  246 (476)
T 2y94_A          184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLF-KKICDGI--------F--YTPQYLNPSVISL  246 (476)
T ss_dssp             HHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHH-HHHHTTC--------C--CCCTTCCHHHHHH
T ss_pred             hhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHH-HHHhcCC--------c--CCCccCCHHHHHH
Confidence            999988765 68999999999999999999998643211      010 1111110        0  1112233458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH--HhhcCCCCCCCCCCCC
Q 026939          162 GLLCVQADSADRPTMSSVVV--MLASDNVTLPQPTEPA  197 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~--~L~~~~~~~~~~~~p~  197 (230)
                      +.+||+.||++|||+.+|++  .+.........|..+.
T Consensus       247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~  284 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPS  284 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSC
T ss_pred             HHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcc
Confidence            99999999999999999997  5655433333333333

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.96  E-value=5.4e-29  Score=202.61  Aligned_cols=159  Identities=27%  Similarity=0.374  Sum_probs=124.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..++++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+
T Consensus       112 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~  186 (303)
T 3a7i_A          112 EPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWM  186 (303)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--BCCCCSCGGGC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccc--cCccCCCcCcc
Confidence            3467899999999999999999999999   999999999999999999999999999776433221  12235678899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||.+.+..++.++|+||||+++|+|++|..||........      .. .....         .....+...+..+.++
T Consensus       187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~---------~~~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LF-LIPKN---------NPPTLEGNYSKPLKEF  250 (303)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH-HHHHS---------CCCCCCSSCCHHHHHH
T ss_pred             CHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HH-HhhcC---------CCCCCccccCHHHHHH
Confidence            99999988999999999999999999999999864321110      00 00000         0111122233458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +..||+.||++|||+.+|++
T Consensus       251 i~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCChhhCcCHHHHhh
Confidence            99999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=2e-29  Score=203.73  Aligned_cols=167  Identities=24%  Similarity=0.253  Sum_probs=125.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-cccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-STNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|
T Consensus       116 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  192 (291)
T 1u46_A          116 GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA  192 (291)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCC
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeC
Confidence            46899999999999999999999999   9999999999999999999999999998764332211 1112244567999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|+||||+++|+|++ |..||.......      ........         ......+...+..+.++
T Consensus       193 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~l~~l  257 (291)
T 1u46_A          193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKE---------GERLPRPEDCPQDIYNV  257 (291)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTS---------CCCCCCCTTCCHHHHHH
T ss_pred             chhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHcc---------CCCCCCCcCcCHHHHHH
Confidence            999998889999999999999999999 999985432111      11111000         00111122334568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      +.+||+.||++|||+.++++.|++...
T Consensus       258 i~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          258 MVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=1.5e-28  Score=204.42  Aligned_cols=153  Identities=20%  Similarity=0.204  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.|   |+||||+|+||+++.++.++|+|||++.......     ....+++.|+||
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aP  207 (350)
T 1rdq_E          136 GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAP  207 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCc-----ccccCCccccCH
Confidence            56899999999999999999999999   9999999999999999999999999998754321     124578899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..++.++|+|||||++|+|++|..||......      ... .....+.          ..++...+..+.+++.
T Consensus       208 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~-~~i~~~~----------~~~p~~~~~~~~~li~  270 (350)
T 1rdq_E          208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIY-EKIVSGK----------VRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCC----------CCCCTTCCHHHHHHHH
T ss_pred             HHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHH-HHHHcCC----------CCCCCCCCHHHHHHHH
Confidence            9999999999999999999999999999998643211      110 1111111          1122233456899999


Q ss_pred             hhcCCCCCCCCC-----HHHHHH
Q 026939          164 LCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs-----~~~i~~  181 (230)
                      +||+.||.+||+     +++|++
T Consensus       271 ~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          271 NLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhhcCHHhccCCccCCHHHHHh
Confidence            999999999998     888876

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=1.3e-28  Score=202.74  Aligned_cols=170  Identities=20%  Similarity=0.233  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-------------------CCCeEEcccccceeecC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-------------------EMNPKISDFEMARIFGG   64 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-------------------~~~~~l~d~~~~~~~~~   64 (230)
                      .++++.+++.++.||+.||+|||+++   ++|+||+|+||+++.                   ++.++|+|||++.....
T Consensus       113 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          113 LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc
Confidence            36899999999999999999999999   999999999999987                   66799999999876432


Q ss_pred             CCCCccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHhhhh--
Q 026939           65 NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWCEGE--  137 (230)
Q Consensus        65 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~--  137 (230)
                      ..     ....++..|+|||.+.+..++.++|||||||++|+|++|..||...............     ........  
T Consensus       190 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  264 (339)
T 1z57_A          190 HH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKR  264 (339)
T ss_dssp             CC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCG
T ss_pred             cc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccch
Confidence            21     1235688999999999889999999999999999999999998654322211110000     00000000  


Q ss_pred             -------------------hhhhhchhh-cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          138 -------------------ALELMEPVL-KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       138 -------------------~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                                         ......+.. ...........+.+++.+||+.||.+|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          265 KYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence                               000000000 00112345677999999999999999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=8e-29  Score=212.05  Aligned_cols=161  Identities=19%  Similarity=0.213  Sum_probs=122.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC---CCCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +..+++..++.++.||+.||+|||++|   |+||||||+||+++   .++.+||+|||++.........  .....+++.
T Consensus       104 ~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~  178 (444)
T 3soa_A          104 REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPG  178 (444)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce--eecccCCcc
Confidence            356899999999999999999999999   99999999999998   4578999999999765432221  122467889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++.+..++.++|||||||++|+|++|..||.......      . ......+.. ....     ......+..+.
T Consensus       179 Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~-~~~i~~~~~-~~~~-----~~~~~~s~~~~  245 (444)
T 3soa_A          179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------L-YQQIKAGAY-DFPS-----PEWDTVTPEAK  245 (444)
T ss_dssp             GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-HHHHHHTCC-CCCT-----TTTTTSCHHHH
T ss_pred             cCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------H-HHHHHhCCC-CCCc-----cccccCCHHHH
Confidence            999999998899999999999999999999999985322110      0 011111100 0000     00112344588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999999999987

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=8e-29  Score=202.54  Aligned_cols=167  Identities=22%  Similarity=0.322  Sum_probs=117.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~a   82 (230)
                      .++++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  187 (311)
T 3ork_A          111 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS  187 (311)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCC
Confidence            46899999999999999999999999   999999999999999999999999999765432221 11222457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++||||||+++|+|++|..||.......      ...........    .   ........+..+.+++
T Consensus       188 PE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~----~---~~~~~~~~~~~l~~li  254 (311)
T 3ork_A          188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI----P---PSARHEGLSADLDAVV  254 (311)
T ss_dssp             HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC----C---HHHHSTTCCHHHHHHH
T ss_pred             HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC----C---cccccCCCCHHHHHHH
Confidence            999999999999999999999999999999986432211      11111100000    0   0001112345688999


Q ss_pred             hhhcCCCCCCCCCHHHHH-HHhhcC
Q 026939          163 LLCVQADSADRPTMSSVV-VMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~-~~L~~~  186 (230)
                      .+||+.||++||++.+++ ..|...
T Consensus       255 ~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          255 LKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHhcCHhhChhhHHHHHHHHHHH
Confidence            999999999999666555 455443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=2.1e-29  Score=207.52  Aligned_cols=168  Identities=21%  Similarity=0.223  Sum_probs=106.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC---CeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM---NPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +..+++.+++.++.||+.||+|||+.+   ++||||+|+||+++.++   .++|+|||++.........  .....++..
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~  174 (325)
T 3kn6_A          100 KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLH  174 (325)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--ccccCCCcC
Confidence            357899999999999999999999999   99999999999997665   7999999999765432221  112355789


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||.+.+..++.++|||||||++|+|++|..||.....................+..      ..........+..+.
T Consensus       175 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~s~~~~  248 (325)
T 3kn6_A          175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAWKNVSQEAK  248 (325)
T ss_dssp             ---------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHHHTSCHHHH
T ss_pred             ccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccccCCCHHHH
Confidence            99999999999999999999999999999999998643322111111111111111110      001111123455689


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       249 ~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          249 DLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHHHCCCChhHCCCHHHHhc
Confidence            9999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=5.3e-29  Score=213.37  Aligned_cols=161  Identities=20%  Similarity=0.209  Sum_probs=123.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||+|||+ .|   |+||||+|+||+++.++.++|+|||++........  ......+++.|+
T Consensus       242 ~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~  316 (446)
T 4ejn_A          242 ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYL  316 (446)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCcccc
Confidence            3578999999999999999999998 88   99999999999999999999999999865322111  122246788999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+..++.++|||||||++|+|++|..||.......      ..... ....          ..++......+.++
T Consensus       317 aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i-~~~~----------~~~p~~~~~~~~~l  379 (446)
T 4ejn_A          317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELI-LMEE----------IRFPRTLGPEAKSL  379 (446)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCC----------CCCCTTSCHHHHHH
T ss_pred             CHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHH-HhCC----------CCCCccCCHHHHHH
Confidence            9999999999999999999999999999999985432111      00000 0000          01222334568899


Q ss_pred             HhhhcCCCCCCCC-----CHHHHHH--Hhhc
Q 026939          162 GLLCVQADSADRP-----TMSSVVV--MLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RP-----s~~~i~~--~L~~  185 (230)
                      +.+||+.||.+||     +++++++  .+.+
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            9999999999999     9999986  4444

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=8.9e-30  Score=216.20  Aligned_cols=147  Identities=16%  Similarity=0.169  Sum_probs=114.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......     .....+ ..|+||
T Consensus       206 ~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aP  276 (413)
T 3dzo_A          206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPP  276 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCc
Confidence            35678899999999999999999999   999999999999999999999999998764322     122355 899999


Q ss_pred             hhh----------hcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHH
Q 026939           84 EYA----------MEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA  153 (230)
Q Consensus        84 e~~----------~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (230)
                      |++          .+..++.++|||||||++|+|++|..||..........               ..+..  ...+   
T Consensus       277 E~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~---------------~~~~~--~~~~---  336 (413)
T 3dzo_A          277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE---------------WIFRS--CKNI---  336 (413)
T ss_dssp             HHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---------------GGGSS--CCCC---
T ss_pred             hhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---------------HHHhh--cccC---
Confidence            999          44457889999999999999999999986433221100               00000  0112   


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 026939          154 ELLKFIHIGLLCVQADSADRPTMSSVV  180 (230)
Q Consensus       154 ~~~~l~~l~~~cl~~dP~~RPs~~~i~  180 (230)
                       +..+.+++.+||+.||++||++.+++
T Consensus       337 -~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          337 -PQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             -CHHHHHHHHHHccCChhhCcCHHHHH
Confidence             24589999999999999999976653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=208.04  Aligned_cols=168  Identities=19%  Similarity=0.177  Sum_probs=111.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc----------ccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA----------STN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----------~~~   72 (230)
                      ..++++.+++.++.||+.||+|||+.+ .+++|+||+|+||+++.++.++|+|||++..........          ...
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~  208 (337)
T 3ll6_A          130 RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI  208 (337)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhc
Confidence            357999999999999999999999875 249999999999999999999999999997654322111          011


Q ss_pred             ccccccCccChhhh---hcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcch
Q 026939           73 RIVGTYGYMAPEYA---MEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS  149 (230)
Q Consensus        73 ~~~~~~~~~aPe~~---~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (230)
                      ...++..|+|||.+   .+..++.++||||||+++|+|++|..||.......                   .........
T Consensus       209 ~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------------------~~~~~~~~~  269 (337)
T 3ll6_A          209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-------------------IVNGKYSIP  269 (337)
T ss_dssp             ---------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCC
T ss_pred             cccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-------------------hhcCcccCC
Confidence            23467889999998   45678899999999999999999999985322110                   000000000


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      ........+.+++.+||+.||++|||+.++++.|+......
T Consensus       270 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            01111223778999999999999999999999998765443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=2.7e-28  Score=198.43  Aligned_cols=164  Identities=19%  Similarity=0.167  Sum_probs=125.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++................++..|+|
T Consensus       103 ~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  179 (305)
T 2wtk_C          103 EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP  179 (305)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcC
Confidence            467999999999999999999999999   99999999999999999999999999987643222222223456889999


Q ss_pred             hhhhhcCC--CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~~--~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||.+.+..  ++.++||||||+++|+|++|..||......      ... .....+.          ...+......+.+
T Consensus       180 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~i~~~~----------~~~~~~~~~~l~~  242 (305)
T 2wtk_C          180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLF-ENIGKGS----------YAIPGDCGPPLSD  242 (305)
T ss_dssp             HHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH-HHHHHCC----------CCCCSSSCHHHHH
T ss_pred             hhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHH-HHHhcCC----------CCCCCccCHHHHH
Confidence            99997644  377999999999999999999998643211      000 0000100          0112233446889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ++.+||+.||++|||+.++++  .+.+.
T Consensus       243 li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          243 LLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             HHHHHccCChhhCCCHHHHhcCcccccC
Confidence            999999999999999999996  55544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=7.6e-29  Score=205.83  Aligned_cols=175  Identities=22%  Similarity=0.266  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (230)
                      ..+++.+++.++.||+.||+|||+.|   ++||||+|+||+++.++.++|+|||++.........  .......++..|+
T Consensus       119 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~  195 (351)
T 3mi9_A          119 VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR  195 (351)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCcc
Confidence            57899999999999999999999999   999999999999999999999999999876432211  1112235678899


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh--------HHHHhhhhhhhhhchhh--cchh
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT--------WKLWCEGEALELMEPVL--KQSC  150 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~--~~~~  150 (230)
                      |||++.+. .++.++|||||||++|+|++|..||...............        +................  ....
T Consensus       196 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (351)
T 3mi9_A          196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV  275 (351)
T ss_dssp             CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCH
T ss_pred             CchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCH
Confidence            99998764 5799999999999999999999998653322111100000        00000000000000000  0000


Q ss_pred             h-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 V-----AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~-----~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .     ......+.+++.+||+.||++|||+.++++
T Consensus       276 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          276 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0     011345889999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=4.3e-29  Score=208.52  Aligned_cols=181  Identities=21%  Similarity=0.223  Sum_probs=125.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      ...+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++......... .......+++.|+
T Consensus       122 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  198 (364)
T 3qyz_A          122 TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR  198 (364)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGC
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCC
Confidence            457899999999999999999999999   999999999999999999999999999865432211 1112246788999


Q ss_pred             Chhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh--------HHHHhhhhhhhhh----chhh--
Q 026939           82 APEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT--------WKLWCEGEALELM----EPVL--  146 (230)
Q Consensus        82 aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~----~~~~--  146 (230)
                      |||++.+ ..++.++|||||||++|+|++|..||...............        .............    ....  
T Consensus       199 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (364)
T 3qyz_A          199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP  278 (364)
T ss_dssp             CHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred             CCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCC
Confidence            9998765 45899999999999999999999998654322211110000        0000000000000    0000  


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ...........+.+++.+||+.||++|||+.++++  .+++.
T Consensus       279 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          279 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            00111223456889999999999999999999987  44443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=1e-28  Score=205.07  Aligned_cols=158  Identities=27%  Similarity=0.308  Sum_probs=118.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||++|   |+||||+|+||+++.++.++|+|||++........  ......+++.|+||
T Consensus       105 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aP  179 (345)
T 3a8x_A          105 RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAP  179 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCc
Confidence            57899999999999999999999999   99999999999999999999999999875322211  12234678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccc--cchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG--QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |++.+..++.++|+|||||++|+|++|..||........  ...............          ..++...+..+.++
T Consensus       180 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~l  249 (345)
T 3a8x_A          180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASV  249 (345)
T ss_dssp             HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----------CCCCTTSCHHHHHH
T ss_pred             cccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----------CCCCCCCCHHHHHH
Confidence            999999999999999999999999999999854221111  011111111111110          11223344568899


Q ss_pred             HhhhcCCCCCCCCCH
Q 026939          162 GLLCVQADSADRPTM  176 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~  176 (230)
                      +.+||+.||.+||++
T Consensus       250 i~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          250 LKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHTCSSTTTSTTC
T ss_pred             HHHHhcCCHhHCCCC
Confidence            999999999999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=5.2e-29  Score=211.92  Aligned_cols=171  Identities=20%  Similarity=0.174  Sum_probs=121.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++..++.++.||+.||+|||+.+   |+||||||+||+++.+ +.+||+|||++.........   ....++..|+
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~  223 (420)
T 1j1b_A          150 KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYR  223 (420)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcC
Confidence            467999999999999999999999999   9999999999999965 56899999999875432221   1235688999


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH-------HHHh--hhhhhhhhchh-----h
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW-------KLWC--EGEALELMEPV-----L  146 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~-------~~~~--~~~~~~~~~~~-----~  146 (230)
                      |||++.+. .++.++|||||||++|+|++|..||........  ......       ..+.  .........+.     .
T Consensus       224 aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~  301 (420)
T 1j1b_A          224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW  301 (420)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCH
T ss_pred             CHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCH
Confidence            99999765 689999999999999999999999864332111  111000       0000  00000000000     0


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...++......+.+|+.+||+.||++|||+.++++
T Consensus       302 ~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          302 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00112233456899999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=1.6e-28  Score=203.48  Aligned_cols=170  Identities=19%  Similarity=0.239  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe-------------------CCCCCeEEcccccceeecC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL-------------------DHEMNPKISDFEMARIFGG   64 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~-------------------~~~~~~~l~d~~~~~~~~~   64 (230)
                      .++++.+++.++.||+.||+|||+.+   |+|+||+|+||++                   +.++.++|+|||++.....
T Consensus       118 ~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          118 QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc
Confidence            47999999999999999999999999   9999999999999                   5678899999999976432


Q ss_pred             CCCCccccccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHhhhhhh
Q 026939           65 NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWCEGEAL  139 (230)
Q Consensus        65 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~  139 (230)
                      ..     ....++..|+|||++.+..++.++|||||||++|+|++|..||...............     ..........
T Consensus       195 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  269 (355)
T 2eu9_A          195 HH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ  269 (355)
T ss_dssp             CC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCG
T ss_pred             cc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccch
Confidence            21     1235688999999999989999999999999999999999999643322110000000     0000000000


Q ss_pred             h---------------------hhchhh-cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          140 E---------------------LMEPVL-KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       140 ~---------------------~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .                     ...+.. ...........+.+++.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          270 KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0                     000000 00112244567999999999999999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=2.6e-28  Score=209.64  Aligned_cols=106  Identities=27%  Similarity=0.429  Sum_probs=86.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--------------   68 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------   68 (230)
                      ...+++..++.++.||+.||+|||+.|   |+||||||+|||++.++.+||+|||++.........              
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~  226 (458)
T 3rp9_A          150 PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN  226 (458)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccc
Confidence            356999999999999999999999999   999999999999999999999999999765322110              


Q ss_pred             -----------ccccccccccCccChhhhh-cCCCCccccchhhHHHHHHHHhcC
Q 026939           69 -----------ASTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK  111 (230)
Q Consensus        69 -----------~~~~~~~~~~~~~aPe~~~-~~~~~~~~DiwslG~ll~~ll~g~  111 (230)
                                 .......++..|+|||++. +..++.++|||||||++|+|++|.
T Consensus       227 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             ------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence                       0112235688999999864 556999999999999999999943

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.95  E-value=8.1e-29  Score=209.68  Aligned_cols=110  Identities=28%  Similarity=0.470  Sum_probs=87.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe----CCCCCeEEcccccceeecCCCCC-ccccccccccC
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL----DHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYG   79 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~   79 (230)
                      .+++..++.++.||+.||+|||+.+   |+||||+|+||++    +.++.++|+|||++......... .......++..
T Consensus       124 ~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  200 (405)
T 3rgf_A          124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  200 (405)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCc
Confidence            5999999999999999999999999   9999999999999    67789999999999865432111 12223467889


Q ss_pred             ccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCC
Q 026939           80 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFY  117 (230)
Q Consensus        80 ~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~  117 (230)
                      |+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus       201 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             TCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999999874 4899999999999999999999999643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=1.2e-28  Score=198.33  Aligned_cols=154  Identities=24%  Similarity=0.333  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.......    .....++..|+||
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aP  176 (279)
T 3fdn_A          104 SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP  176 (279)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCH
Confidence            46899999999999999999999999   9999999999999999999999999875433221    1223568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++||||||+++|+|++|..||........       ......          ....++......+.+++.
T Consensus       177 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~----------~~~~~~~~~~~~~~~li~  239 (279)
T 3fdn_A          177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISR----------VEFTFPDFVTEGARDLIS  239 (279)
T ss_dssp             HHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHH----------TCCCCCTTSCHHHHHHHH
T ss_pred             hHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-------HHHHHh----------CCCCCCCcCCHHHHHHHH
Confidence            999988899999999999999999999999863321110       000000          011122223455889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.||++|||+.+|++
T Consensus       240 ~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          240 RLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHCCSSGGGSCCHHHHHH
T ss_pred             HHhccChhhCCCHHHHhh
Confidence            999999999999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.95  E-value=1.4e-28  Score=210.11  Aligned_cols=170  Identities=16%  Similarity=0.175  Sum_probs=125.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++......... ......|++.|+|
T Consensus       169 ~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~A  244 (437)
T 4aw2_A          169 EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYIS  244 (437)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeC
Confidence            357999999999999999999999999   999999999999999999999999999765432221 1222467899999


Q ss_pred             hhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||++.     ...++.++|+|||||++|+|++|..||........      .............      +......+..
T Consensus       245 PE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~------p~~~~~~s~~  312 (437)
T 4aw2_A          245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQF------PTQVTDVSEN  312 (437)
T ss_dssp             HHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHHCCC------CSSCCCSCHH
T ss_pred             hHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhhhhccccccC------CcccccCCHH
Confidence            99997     45689999999999999999999999864321111      1111100000000      0111123445


Q ss_pred             HHHHHhhhcCCCCCC--CCCHHHHHH--HhhcCCC
Q 026939          158 FIHIGLLCVQADSAD--RPTMSSVVV--MLASDNV  188 (230)
Q Consensus       158 l~~l~~~cl~~dP~~--RPs~~~i~~--~L~~~~~  188 (230)
                      +.+++.+||..+|+.  ||++++|++  ++++..+
T Consensus       313 ~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          313 AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             HHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence            888999999988888  999999987  5665543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=4.2e-29  Score=204.23  Aligned_cols=161  Identities=22%  Similarity=0.335  Sum_probs=116.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++ ++.++|+|||++................++..|+|
T Consensus       121 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  196 (313)
T 3cek_A          121 KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP  196 (313)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCC
Confidence            357899999999999999999999999   99999999999996 47899999999876543322222223456889999


Q ss_pred             hhhhhc-----------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh
Q 026939           83 PEYAME-----------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV  151 (230)
Q Consensus        83 Pe~~~~-----------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (230)
                      ||.+.+           ..++.++||||||+++|+|++|..||........     .         .....+......++
T Consensus       197 PE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~---------~~~~~~~~~~~~~~  262 (313)
T 3cek_A          197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----K---------LHAIIDPNHEIEFP  262 (313)
T ss_dssp             HHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----H---------HHHHHCTTSCCCCC
T ss_pred             HHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----H---------HHHHHhcccccCCc
Confidence            999875           4678899999999999999999999853221100     0         11111111111222


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          152 AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......+.+++.+||+.||++|||+.++++
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          263 DIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            222456889999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=4.7e-29  Score=207.28  Aligned_cols=155  Identities=31%  Similarity=0.403  Sum_probs=119.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......      ....+++.|+|
T Consensus       148 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~a  218 (348)
T 1u5q_A          148 KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMA  218 (348)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeC
Confidence            457899999999999999999999999   999999999999999999999999998764321      12356889999


Q ss_pred             hhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||++.   +..++.++|||||||++|+|++|..||.......      ...... ....     +..   .....+..+.
T Consensus       219 PE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~-~~~~-----~~~---~~~~~~~~l~  283 (348)
T 1u5q_A          219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNES-----PAL---QSGHWSEYFR  283 (348)
T ss_dssp             HHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCC-----CCC---CCTTSCHHHH
T ss_pred             HhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHH-hcCC-----CCC---CCCCCCHHHH
Confidence            99985   4578999999999999999999999985332111      111110 1100     000   1112334588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcccChhhCcCHHHHhh
Confidence            9999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=1.1e-28  Score=206.10  Aligned_cols=160  Identities=19%  Similarity=0.232  Sum_probs=121.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC---CeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM---NPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +..+++..++.++.||+.||+|||+.+   |+|+||+|+||+++.++   .++|+|||++........   .....+++.
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~  195 (362)
T 2bdw_A          122 REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG  195 (362)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCcc
Confidence            457899999999999999999999999   99999999999998654   599999999976543221   122467889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++.+..++.++|||||||++|+|++|..||......      .. ......+.. ....     ......+..+.
T Consensus       196 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~-~~~i~~~~~-~~~~-----~~~~~~~~~~~  262 (362)
T 2bdw_A          196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RL-YAQIKAGAY-DYPS-----PEWDTVTPEAK  262 (362)
T ss_dssp             TCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHTCC-CCCT-----TGGGGSCHHHH
T ss_pred             ccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHhCCC-CCCc-----ccccCCCHHHH
Confidence            99999999889999999999999999999999998542211      00 011111100 0000     00112234588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcCCChhhCcCHHHHhc
Confidence            9999999999999999999876

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=1.8e-28  Score=197.81  Aligned_cols=162  Identities=20%  Similarity=0.225  Sum_probs=126.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.......    .....++..|+||
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aP  181 (284)
T 2vgo_A          109 GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPP  181 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCH
Confidence            46899999999999999999999999   9999999999999999999999999987653321    1223567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||........      . ......      +    ..++...+..+.+++.
T Consensus       182 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~-~~~~~~------~----~~~~~~~~~~~~~li~  244 (284)
T 2vgo_A          182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------H-RRIVNV------D----LKFPPFLSDGSKDLIS  244 (284)
T ss_dssp             HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H-HHHHTT------C----CCCCTTSCHHHHHHHH
T ss_pred             HHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------H-HHHhcc------c----cCCCCcCCHHHHHHHH
Confidence            999988899999999999999999999999864321110      0 000010      0    1112223446889999


Q ss_pred             hhcCCCCCCCCCHHHHHH--HhhcCCCC
Q 026939          164 LCVQADSADRPTMSSVVV--MLASDNVT  189 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~--~L~~~~~~  189 (230)
                      +||+.||.+|||+.++++  .+......
T Consensus       245 ~~l~~~p~~Rps~~~ll~h~~~~~~~~~  272 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEHPWVKANSRR  272 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred             HHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence            999999999999999987  56554443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=7.1e-29  Score=208.56  Aligned_cols=170  Identities=17%  Similarity=0.140  Sum_probs=123.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++..++.++.||+.||+|||+.|   |+||||+|+||+++ .++.++|+|||++.........   ....++..|+
T Consensus       135 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~  208 (383)
T 3eb0_A          135 GRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYR  208 (383)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCcc
Confidence            467999999999999999999999999   99999999999997 6789999999999875433221   1235678899


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh----------h-----hhhhhchh
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG----------E-----ALELMEPV  145 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~-----~~~~~~~~  145 (230)
                      |||.+.+. .++.++||||+||++|+|++|..||..........  ... ......          .     ........
T Consensus       209 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  285 (383)
T 3eb0_A          209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLV--RII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKD  285 (383)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCC
T ss_pred             CHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHH--HHH-HHhCCCCHHHHHHhCcccccccCCccCccc
Confidence            99998875 48999999999999999999999986433221100  000 000000          0     00000011


Q ss_pred             hcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....++...+..+.+++.+||+.||.+|||+.++++
T Consensus       286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          286 WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111123334556899999999999999999999985

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=7.7e-29  Score=206.37  Aligned_cols=156  Identities=25%  Similarity=0.267  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.|   |+||||+|+||+++.+|.++|+|||++........  ......|++.|+||
T Consensus       116 ~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aP  190 (353)
T 2i0e_A          116 GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAP  190 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccCh
Confidence            57899999999999999999999999   99999999999999999999999999875322211  12234678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..++.++|+|||||++|+|++|..||......      ..... .....          ..++...+..+.+++.
T Consensus       191 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~-i~~~~----------~~~p~~~s~~~~~li~  253 (353)
T 2i0e_A          191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS-IMEHN----------VAYPKSMSKEAVAICK  253 (353)
T ss_dssp             HHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCC----------CCCCTTSCHHHHHHHH
T ss_pred             hhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhCC----------CCCCCCCCHHHHHHHH
Confidence            9999999999999999999999999999998643211      01111 11110          1122334456889999


Q ss_pred             hhcCCCCCCCCC-----HHHHHH
Q 026939          164 LCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs-----~~~i~~  181 (230)
                      +||+.||++||+     +++|++
T Consensus       254 ~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          254 GLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999995     577764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=1.6e-28  Score=201.62  Aligned_cols=160  Identities=21%  Similarity=0.206  Sum_probs=122.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC----CeEEcccccceeecCCCCCcccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM----NPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      +..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++    .++|+|||++........   .....++.
T Consensus       109 ~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~  182 (321)
T 2a2a_A          109 KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTP  182 (321)
T ss_dssp             CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCC
Confidence            356889999999999999999999999   99999999999999887    799999999987643222   12235688


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||.......      .... ....      ............+..+
T Consensus       183 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~-i~~~------~~~~~~~~~~~~~~~~  249 (321)
T 2a2a_A          183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN-ITSV------SYDFDEEFFSHTSELA  249 (321)
T ss_dssp             GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHH-HHTT------CCCCCHHHHTTCCHHH
T ss_pred             CccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHhc------ccccChhhhcccCHHH
Confidence            9999999998899999999999999999999999985432111      0000 0000      0000111122334568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.||++|||+.++++
T Consensus       250 ~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          250 KDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhc
Confidence            89999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=2.9e-29  Score=208.35  Aligned_cols=155  Identities=26%  Similarity=0.279  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||++|   |+||||+|+||+++.+|.++|+|||++........  ......+++.|+||
T Consensus       113 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aP  187 (345)
T 1xjd_A          113 HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAP  187 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCCh
Confidence            57899999999999999999999999   99999999999999999999999999875422211  12234678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..++.++|+|||||++|+|++|..||.......      .... ....          ...++...+..+.+++.
T Consensus       188 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~-i~~~----------~~~~p~~~s~~~~~li~  250 (345)
T 1xjd_A          188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHS-IRMD----------NPFYPRWLEKEAKDLLV  250 (345)
T ss_dssp             HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHC----------CCCCCTTSCHHHHHHHH
T ss_pred             hhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHH-HHhC----------CCCCCcccCHHHHHHHH
Confidence            99999999999999999999999999999986432111      0001 1010          01122233456889999


Q ss_pred             hhcCCCCCCCCCHH-HHH
Q 026939          164 LCVQADSADRPTMS-SVV  180 (230)
Q Consensus       164 ~cl~~dP~~RPs~~-~i~  180 (230)
                      +||+.||++||++. +|+
T Consensus       251 ~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          251 KLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHSCSSGGGSBTTBSCGG
T ss_pred             HHhcCCHhHcCCChHHHH
Confidence            99999999999997 665

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.9e-28  Score=204.60  Aligned_cols=160  Identities=13%  Similarity=0.080  Sum_probs=123.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-----------CCCeEEcccccceeecCCCCCccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-----------EMNPKISDFEMARIFGGNQSEAST   71 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-----------~~~~~l~d~~~~~~~~~~~~~~~~   71 (230)
                      ...+++.+++.++.||+.||+|||+.+   |+||||||+||+++.           ++.+||+|||++............
T Consensus       166 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~  242 (365)
T 3e7e_A          166 EKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF  242 (365)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEE
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCcee
Confidence            457999999999999999999999999   999999999999998           899999999999765422222222


Q ss_pred             cccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhh
Q 026939           72 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV  151 (230)
Q Consensus        72 ~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (230)
                      ....++..|+|||++.+..++.++|||||||++|+|++|..||.........              ....+...      
T Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------------~~~~~~~~------  302 (365)
T 3e7e_A          243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--------------PEGLFRRL------  302 (365)
T ss_dssp             CCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--------------ECSCCTTC------
T ss_pred             eeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--------------echhcccc------
Confidence            3346789999999999999999999999999999999999998432211100              00000100      


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCC-CCHHHHHHHhhcC
Q 026939          152 AAELLKFIHIGLLCVQADSADR-PTMSSVVVMLASD  186 (230)
Q Consensus       152 ~~~~~~l~~l~~~cl~~dP~~R-Ps~~~i~~~L~~~  186 (230)
                       .....+.+++..|++.+|.+| |++.++.+.|++.
T Consensus       303 -~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          303 -PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence             113346778889999999999 5788887777654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.95  E-value=2e-28  Score=201.47  Aligned_cols=169  Identities=20%  Similarity=0.247  Sum_probs=120.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++...++.++.||+.||+|||+.|   ++|+||+|+||+++.++ .++|+|||++.........   ....++..|+||
T Consensus       126 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aP  199 (330)
T 3nsz_A          126 TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP  199 (330)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSCCSCGGGCCH
T ss_pred             hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc---ccccccccccCh
Confidence            5788999999999999999999999   99999999999999776 7999999999875433221   123567889999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhc-------------------
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELME-------------------  143 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  143 (230)
                      |.+.+ ..++.++|||||||++|+|++|..||......... ... .............+.                   
T Consensus       200 E~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (330)
T 3nsz_A          200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVR-IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR  277 (330)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHH-HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCC
T ss_pred             hhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHH-HHHhcCCchhhhHHHHhccccccchhhhhhhccc
Confidence            99987 56899999999999999999999998432221110 000 000000001100000                   


Q ss_pred             ----hhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          144 ----PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       144 ----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                          ..............+.+++.+||+.||++|||++++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          278 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                00011111223556899999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=8e-29  Score=205.43  Aligned_cols=164  Identities=21%  Similarity=0.246  Sum_probs=121.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC----CCeEEcccccceeecCCCCCcccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE----MNPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      ...+++..++.++.||+.||+|||++|   |+||||+|+||++...    +.++|+|||++.........  .....++.
T Consensus       110 ~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~  184 (342)
T 2qr7_A          110 QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTA  184 (342)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC--BCCSSCCS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc--eeccCCCc
Confidence            457899999999999999999999999   9999999999998533    34999999999875433221  12235688


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      .|+|||++.+..++.++|+|||||++|+|++|..||..........   . ......+...      ....+....+..+
T Consensus       185 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~-~~~i~~~~~~------~~~~~~~~~s~~~  254 (342)
T 2qr7_A          185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE---I-LARIGSGKFS------LSGGYWNSVSDTA  254 (342)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH---H-HHHHHHCCCC------CCSTTTTTSCHHH
T ss_pred             cccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH---H-HHHHccCCcc------cCccccccCCHHH
Confidence            9999999988888999999999999999999999986432111111   1 0111111100      0111122334568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||..||++|||+.++++
T Consensus       255 ~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          255 KDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhc
Confidence            89999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.95  E-value=1e-28  Score=207.91  Aligned_cols=159  Identities=18%  Similarity=0.189  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC--CCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH--EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ..+++..++.++.||+.||+|||+.|   ++||||+|+||+++.  ++.++|+|||++........   .....++..|+
T Consensus       144 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~  217 (387)
T 1kob_A          144 YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFA  217 (387)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCcc
Confidence            47899999999999999999999999   999999999999974  46799999999987643222   12235788999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+..++.++|||||||++|+|++|..||.......      ..... ....      ...........+..+.++
T Consensus       218 aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i-~~~~------~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNV-KRCD------WEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHH-HHCC------CCCCSSTTTTSCHHHHHH
T ss_pred             CchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCC------CCCCccccccCCHHHHHH
Confidence            9999998889999999999999999999999986432111      00000 0000      000111112234568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHhh
Confidence            99999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=9.9e-29  Score=197.41  Aligned_cols=160  Identities=21%  Similarity=0.279  Sum_probs=121.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.+++.++.||+.||+|||+.+ .+++|+||+|+||+++.++.+++.||++......       ....+++.|+|||
T Consensus       107 ~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE  178 (271)
T 3kmu_A          107 VVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPE  178 (271)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChh
Confidence            5899999999999999999999875 3499999999999999999999998887643211       1135578999999


Q ss_pred             hhhcCCCCc---cccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           85 YAMEGLFSV---KSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        85 ~~~~~~~~~---~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      .+.+..+..   ++||||||+++|+|++|..||.......      ....         ..........+...+..+.++
T Consensus       179 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~~~~l  243 (271)
T 3kmu_A          179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMK---------VALEGLRPTIPPGISPHVSKL  243 (271)
T ss_dssp             HHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHH---------HHHSCCCCCCCTTCCHHHHHH
T ss_pred             hhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHH---------HHhcCCCCCCCCCCCHHHHHH
Confidence            998765444   7999999999999999999986432111      0011         111111112233344568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      +..||+.||++|||+.++++.|+...
T Consensus       244 i~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          244 MKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            99999999999999999999998653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=2e-28  Score=206.19  Aligned_cols=180  Identities=17%  Similarity=0.184  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCC-----CCcccccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ-----SEASTNRIVGTY   78 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~   78 (230)
                      ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++.......     .........++.
T Consensus       123 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~  199 (389)
T 3gni_B          123 DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL  199 (389)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccc
Confidence            57899999999999999999999999   9999999999999999999999999876532111     011111235677


Q ss_pred             CccChhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh-hhhHHHHh------hhh------------
Q 026939           79 GYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL-SYTWKLWC------EGE------------  137 (230)
Q Consensus        79 ~~~aPe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~------~~~------------  137 (230)
                      .|+|||++.+  ..++.++|||||||++|+|++|..||............ ........      ...            
T Consensus       200 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (389)
T 3gni_B          200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS  279 (389)
T ss_dssp             GGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------
T ss_pred             cccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccc
Confidence            8999999987  57899999999999999999999998643221110000 00000000      000            


Q ss_pred             -hhhhh---------chhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          138 -ALELM---------EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       138 -~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                       .....         .......++......+.+++.+||+.||++|||+.++++  .+++.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          280 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             --------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             ccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence             00000         000001122334556899999999999999999999986  35443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=2.1e-28  Score=208.87  Aligned_cols=110  Identities=27%  Similarity=0.435  Sum_probs=89.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--------------
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--------------   68 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------   68 (230)
                      +..+++..++.++.||+.||+|||+.|   |+||||||+||+++.++.+||+|||++.........              
T Consensus       123 ~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~  199 (432)
T 3n9x_A          123 PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP  199 (432)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccc
Confidence            356999999999999999999999999   999999999999999999999999999875432211              


Q ss_pred             ------ccccccccccCccChhhhh-cCCCCccccchhhHHHHHHHHhcCCCCC
Q 026939           69 ------ASTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGKKNSG  115 (230)
Q Consensus        69 ------~~~~~~~~~~~~~aPe~~~-~~~~~~~~DiwslG~ll~~ll~g~~p~~  115 (230)
                            .......++..|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus       200 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence                  0112346788999999864 5569999999999999999998766653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=1.5e-28  Score=204.35  Aligned_cols=161  Identities=21%  Similarity=0.279  Sum_probs=114.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.   ++.++|+|||++........   .....++..
T Consensus       142 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~  215 (349)
T 2w4o_A          142 KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPG  215 (349)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCC
Confidence            456899999999999999999999999   999999999999975   78899999999876533211   112356889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++.+..++.++|||||||++|+|++|..||.......      ............ .     ........+..+.
T Consensus       216 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~-----~~~~~~~~~~~~~  283 (349)
T 2w4o_A          216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-F-----ISPWWDEVSLNAK  283 (349)
T ss_dssp             GSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-C-----CTTTTTTSCHHHH
T ss_pred             ccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-c-----CCchhhhCCHHHH
Confidence            999999998899999999999999999999999985332111      011111111100 0     0011122345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       284 ~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          284 DLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.95  E-value=4.4e-29  Score=205.78  Aligned_cols=174  Identities=21%  Similarity=0.266  Sum_probs=119.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       118 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~a  192 (331)
T 4aaa_A          118 PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVATRWYRA  192 (331)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc--cCCCcCCccccC
Confidence            457899999999999999999999999   999999999999999999999999998765432211  122356788999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhhhhhhh------hhchhhc
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCEGEALE------LMEPVLK  147 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~  147 (230)
                      ||.+.+. .++.++|||||||++|+|++|..||.............        .....+.......      .......
T Consensus       193 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
T 4aaa_A          193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPL  272 (331)
T ss_dssp             HHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCH
T ss_pred             cccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchh
Confidence            9999875 68899999999999999999999986543221110000        0000000000000      0000000


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .......+..+.+++.+||+.||++|||+.++++
T Consensus       273 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          273 ERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0111233566999999999999999999999886

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=1e-28  Score=198.50  Aligned_cols=156  Identities=26%  Similarity=0.368  Sum_probs=102.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aP  181 (278)
T 3cok_A          107 KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISP  181 (278)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCc
Confidence            57899999999999999999999999   999999999999999999999999998765432211  1123567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||..........               ......  ...+......+.+++.
T Consensus       182 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~--~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLAD--YEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             ----------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC--CCCCTTSCHHHHHHHH
T ss_pred             chhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhcc--cCCccccCHHHHHHHH
Confidence            99988889999999999999999999999986432211100               000000  0111223345889999


Q ss_pred             hhcCCCCCCCCCHHHHHH
Q 026939          164 LCVQADSADRPTMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~  181 (230)
                      +||+.||++|||+.++++
T Consensus       245 ~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          245 QLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHSCSSGGGSCCHHHHTT
T ss_pred             HHcccCHhhCCCHHHHhc
Confidence            999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=9.4e-29  Score=202.21  Aligned_cols=173  Identities=21%  Similarity=0.217  Sum_probs=116.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC---eEEcccccceeecCCCC-----Cccccccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN---PKISDFEMARIFGGNQS-----EASTNRIV   75 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~-----~~~~~~~~   75 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.   ++|+|||++........     ........
T Consensus       106 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  182 (316)
T 2ac3_A          106 RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC  182 (316)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------C
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccccccc
Confidence            56899999999999999999999999   999999999999998765   99999999875432111     01111234


Q ss_pred             cccCccChhhhhc-----CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchh
Q 026939           76 GTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC  150 (230)
Q Consensus        76 ~~~~~~aPe~~~~-----~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (230)
                      ++..|+|||++.+     ..++.++|||||||++|+|++|..||................... .......+.... ..+
T Consensus       183 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~-~~~  260 (316)
T 2ac3_A          183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC-QNMLFESIQEGK-YEF  260 (316)
T ss_dssp             CSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH-HHHHHHHHHHCC-CCC
T ss_pred             CCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH-HHHHHHHHhccC-ccc
Confidence            6889999999975     457899999999999999999999986543221100000000000 000000000000 001


Q ss_pred             h----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 V----AAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~----~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +    ...+..+.+++.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          261 PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1    123456889999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=3.2e-29  Score=202.40  Aligned_cols=159  Identities=19%  Similarity=0.297  Sum_probs=119.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC--------eEEcccccceeecCCCCCcccccccc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN--------PKISDFEMARIFGGNQSEASTNRIVG   76 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~   76 (230)
                      .+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.        ++|+|||++.....      .....+
T Consensus       109 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~  179 (289)
T 4fvq_A          109 CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQE  179 (289)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCC
Confidence            4899999999999999999999999   999999999999988876        99999998754321      112345


Q ss_pred             ccCccChhhhhc-CCCCccccchhhHHHHHHHHhcCCCC-CCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           77 TYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNS-GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        77 ~~~~~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      +..|+|||.+.+ ..++.++||||||+++|+|++|..|+ ........       ......           ....+...
T Consensus       180 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-------~~~~~~-----------~~~~~~~~  241 (289)
T 4fvq_A          180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-------LQFYED-----------RHQLPAPK  241 (289)
T ss_dssp             TTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHT-----------TCCCCCCS
T ss_pred             cCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-------HHHhhc-----------cCCCCCCC
Confidence            778999999987 66899999999999999999965553 32111100       000000           00111112


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      ...+.+++.+||+.||++|||+.++++.|++...+-
T Consensus       242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          242 AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            345889999999999999999999999999887643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.95  E-value=1.8e-28  Score=207.88  Aligned_cols=168  Identities=19%  Similarity=0.182  Sum_probs=125.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.||+.||+|||+.|   |+||||||+||+++.++.+||+|||++......... ......|++.|+|
T Consensus       162 ~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~A  237 (410)
T 3v8s_A          162 NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYIS  237 (410)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCCcCCccccC
Confidence            457899999999999999999999999   999999999999999999999999999775433211 1223467899999


Q ss_pred             hhhhhcCC----CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           83 PEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        83 Pe~~~~~~----~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      ||++.+..    ++.++|+|||||++|+|++|..||.......      ..............       ......+..+
T Consensus       238 PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~-------p~~~~~s~~~  304 (410)
T 3v8s_A          238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKNSLTF-------PDDNDISKEA  304 (410)
T ss_dssp             HHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHHHCCC-------CTTCCCCHHH
T ss_pred             HHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHHHhccccccC-------CCcccccHHH
Confidence            99998765    7899999999999999999999986432111      11111100000000       0011234458


Q ss_pred             HHHHhhhcCCCCCC--CCCHHHHHH--HhhcCC
Q 026939          159 IHIGLLCVQADSAD--RPTMSSVVV--MLASDN  187 (230)
Q Consensus       159 ~~l~~~cl~~dP~~--RPs~~~i~~--~L~~~~  187 (230)
                      .+++.+||+.+|.+  ||++++|++  .+++..
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             HHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            89999999999988  999999997  455543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.95  E-value=3.2e-28  Score=206.44  Aligned_cols=168  Identities=17%  Similarity=0.140  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++......... ......+++.|+||
T Consensus       157 ~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          157 ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSP  232 (412)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCH
Confidence            47999999999999999999999999   999999999999999999999999999875432221 11224678999999


Q ss_pred             hhhhc-------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           84 EYAME-------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        84 e~~~~-------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      |++..       ..++.++|+|||||++|+|++|..||........      ............      .+......+.
T Consensus       233 E~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~~~------~p~~~~~~s~  300 (412)
T 2vd5_A          233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------YGKIVHYKEHLS------LPLVDEGVPE  300 (412)
T ss_dssp             HHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHHCC------CC----CCCH
T ss_pred             HHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhcccCcC------CCccccCCCH
Confidence            99983       4688999999999999999999999864321110      001100000000      0111123345


Q ss_pred             HHHHHHhhhcCCCCCCC---CCHHHHHH--HhhcCCC
Q 026939          157 KFIHIGLLCVQADSADR---PTMSSVVV--MLASDNV  188 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~R---Ps~~~i~~--~L~~~~~  188 (230)
                      .+.+++.+||. +|++|   |++++|++  ++.+..+
T Consensus       301 ~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          301 EARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence            68999999999 99998   58999986  5555543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=3.1e-28  Score=201.17  Aligned_cols=162  Identities=25%  Similarity=0.298  Sum_probs=125.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+++   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus       136 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aP  210 (335)
T 2owb_A          136 KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAP  210 (335)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccccCH
Confidence            57899999999999999999999999   999999999999999999999999999875432221  1223568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++||||||+++|+|++|..||.......      .. .......          ...+......+.+++.
T Consensus       211 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~~~~~~----------~~~~~~~~~~~~~li~  273 (335)
T 2owb_A          211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TY-LRIKKNE----------YSIPKHINPVAASLIQ  273 (335)
T ss_dssp             HHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHHTC----------CCCCTTSCHHHHHHHH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HH-HHHhcCC----------CCCCccCCHHHHHHHH
Confidence            99998889999999999999999999999986432111      00 0000000          0112223345888999


Q ss_pred             hhcCCCCCCCCCHHHHHH--HhhcCC
Q 026939          164 LCVQADSADRPTMSSVVV--MLASDN  187 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~--~L~~~~  187 (230)
                      +||+.||++|||+.++++  .+....
T Consensus       274 ~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          274 KMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHccCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999997  555443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=1.1e-28  Score=205.90  Aligned_cols=162  Identities=23%  Similarity=0.221  Sum_probs=112.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC--eEEcccccceeecCCCCCccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN--PKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..++++..++.++.||+.||+|||+.|   ++||||+|+||+++.++.  +||+|||++.......   ......+++.|
T Consensus       110 ~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y  183 (361)
T 3uc3_A          110 AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY  183 (361)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCc
Confidence            357899999999999999999999999   999999999999987765  9999999986432211   11223578899


Q ss_pred             cChhhhhcCCCCcc-ccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVK-SDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        81 ~aPe~~~~~~~~~~-~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      +|||++.+..+..+ +|||||||++|+|++|..||........  ........         .............+..+.
T Consensus       184 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRI---------LSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             SCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHH---------HTTCCCCCTTSCCCHHHH
T ss_pred             CChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHH---------hcCCCCCCCcCCCCHHHH
Confidence            99999988877655 8999999999999999999864332111  01110000         000000000112234588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          253 HLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHHh
Confidence            9999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=1.9e-28  Score=200.22  Aligned_cols=170  Identities=19%  Similarity=0.191  Sum_probs=118.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus       129 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  204 (309)
T 2h34_A          129 GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAP  204 (309)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCH
Confidence            46899999999999999999999999   999999999999999999999999998765432211 11123567889999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||......      .. .... ....    ..  ....+...+..+.+++.
T Consensus       205 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~-~~~~----~~--~~~~~~~~~~~l~~li~  270 (309)
T 2h34_A          205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VM-GAHI-NQAI----PR--PSTVRPGIPVAFDAVIA  270 (309)
T ss_dssp             GGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HH-HHHH-HSCC----CC--GGGTSTTCCTHHHHHHH
T ss_pred             HHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HH-HHHh-ccCC----CC--ccccCCCCCHHHHHHHH
Confidence            9998888999999999999999999999998643211      00 0000 0000    00  01112233445889999


Q ss_pred             hhcCCCCCCCC-CHHHHHHHhhcCCCCCC
Q 026939          164 LCVQADSADRP-TMSSVVVMLASDNVTLP  191 (230)
Q Consensus       164 ~cl~~dP~~RP-s~~~i~~~L~~~~~~~~  191 (230)
                      +||+.||++|| +++++++.|+.......
T Consensus       271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          271 RGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            99999999999 99999999988765543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.95  E-value=4.7e-28  Score=203.51  Aligned_cols=107  Identities=25%  Similarity=0.321  Sum_probs=92.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHh--CCCCCeeecCCCCCceEeC--CCCCeEEcccccceeecCCCCCccccccccccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHE--DSRLRIIHRDLKASNVLLD--HEMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~--~~~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ..+++..++.++.||+.||.|||+  .+   |+||||||+||+++  .++.+||+|||++........     ...++..
T Consensus       152 ~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~  223 (382)
T 2vx3_A          152 RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-----QYIQSRF  223 (382)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCC-----SSCSCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccccc-----cccCCcc
Confidence            468999999999999999999994  56   99999999999995  467899999999987643211     2356788


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCc
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYL  118 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~  118 (230)
                      |+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       224 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999999999999999996543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=2.3e-28  Score=204.98  Aligned_cols=163  Identities=21%  Similarity=0.193  Sum_probs=123.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe--CCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL--DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ..+++..++.++.||+.||+|||+.+   |+||||+|+||++  +.++.++|+|||++.........   ....+++.|+
T Consensus       182 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~  255 (373)
T 2x4f_A          182 YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFL  255 (373)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---CCCCSSCTTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---ccccCCCcEe
Confidence            46899999999999999999999999   9999999999999  56778999999999876433221   1235788999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+..++.++|||||||++|+|++|..||........      ..... .... .     ............+.++
T Consensus       256 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~-~~~~-~-----~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNIL-ACRW-D-----LEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH-HTCC-C-----SCSGGGTTSCHHHHHH
T ss_pred             ChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hccC-C-----CChhhhccCCHHHHHH
Confidence            99999888899999999999999999999999864322110      00100 0000 0     0001112234568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH--Hhhc
Q 026939          162 GLLCVQADSADRPTMSSVVV--MLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~--~L~~  185 (230)
                      +.+||+.||.+|||+.++++  .+.+
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            99999999999999999987  5543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=2.9e-28  Score=200.13  Aligned_cols=154  Identities=24%  Similarity=0.238  Sum_probs=122.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.|   ++||||+|+||+++.+|.++|+|||++.......     ....+++.|+|
T Consensus       100 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-----~~~~gt~~y~a  171 (318)
T 1fot_A          100 SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIA  171 (318)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCcc-----ccccCCccccC
Confidence            357899999999999999999999999   9999999999999999999999999998654321     12457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|+|||||++|+|++|..||......      ... .......          ..++......+.+++
T Consensus       172 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~-~~i~~~~----------~~~p~~~~~~~~~li  234 (318)
T 1fot_A          172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY-EKILNAE----------LRFPPFFNEDVKDLL  234 (318)
T ss_dssp             HHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHHCC----------CCCCTTSCHHHHHHH
T ss_pred             HhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCC----------CCCCCCCCHHHHHHH
Confidence            99999999999999999999999999999998543211      000 1111110          012223345688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||+.||++||     ++++|++
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhc
Confidence            999999999999     8999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=4.9e-29  Score=205.45  Aligned_cols=171  Identities=19%  Similarity=0.166  Sum_probs=116.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-----CCCCeEEcccccceeecCCCCCccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-----HEMNPKISDFEMARIFGGNQSEASTNRIVGT   77 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~   77 (230)
                      ...+++..++.++.||+.||+|||+.+   |+|+||+|+||+++     .++.++|+|||++.........  .....++
T Consensus       126 ~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t  200 (329)
T 3gbz_A          126 NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIIT  200 (329)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------C
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc--cCCCcCC
Confidence            346899999999999999999999999   99999999999994     4455999999999765432221  1123557


Q ss_pred             cCccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh----------------hhhh
Q 026939           78 YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG----------------EALE  140 (230)
Q Consensus        78 ~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~  140 (230)
                      ..|+|||++.+. .++.++|||||||++|+|++|..||............  . ......                ....
T Consensus       201 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (329)
T 3gbz_A          201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI--F-EVLGLPDDTTWPGVTALPDWKQSFPK  277 (329)
T ss_dssp             CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H-HHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             ccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH--H-HHhCCCchhhhhhhhhhhhhhhhhhh
Confidence            899999999875 4899999999999999999999998643322110000  0 000000                0000


Q ss_pred             hhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          141 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       141 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .....+...........+.+++.+||+.||++|||+.++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00001111111223456889999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.95  E-value=4.6e-28  Score=197.92  Aligned_cols=160  Identities=25%  Similarity=0.342  Sum_probs=123.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a  193 (314)
T 3com_A          119 NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMA  193 (314)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--BCCCCSCGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--cCccCCCCCccC
Confidence            457899999999999999999999999   999999999999999999999999999775433221  122356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+.+..++.++|+||||+++|+|++|..||........      ... .....     ....  ..+...+..+.+++
T Consensus       194 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~-----~~~~--~~~~~~~~~l~~li  259 (314)
T 3com_A          194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFM-IPTNP-----PPTF--RKPELWSDNFTDFV  259 (314)
T ss_dssp             HHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHSC-----CCCC--SSGGGSCHHHHHHH
T ss_pred             hhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-HhcCC-----Cccc--CCcccCCHHHHHHH
Confidence            9999988899999999999999999999999864321110      000 00000     0000  11222345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||.+|||+.++++
T Consensus       260 ~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          260 KQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHTCSCTTTSCCHHHHTT
T ss_pred             HHHccCChhhCcCHHHHHh
Confidence            9999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=2.3e-28  Score=202.88  Aligned_cols=178  Identities=24%  Similarity=0.236  Sum_probs=123.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc--------ccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA--------STNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--------~~~~~   74 (230)
                      ...+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++..........        .....
T Consensus       106 ~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~  182 (353)
T 2b9h_A          106 TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF  182 (353)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCC
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhc
Confidence            356899999999999999999999999   9999999999999999999999999998754321111        01123


Q ss_pred             ccccCccChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhh------------hhhhhh
Q 026939           75 VGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCE------------GEALEL  141 (230)
Q Consensus        75 ~~~~~~~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~  141 (230)
                      .++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........   ........            ......
T Consensus       183 ~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (353)
T 2b9h_A          183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIGTPHSDNDLRCIESPRAREY  259 (353)
T ss_dssp             CCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCSTTTTTTCCCHHHHHH
T ss_pred             cccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCchhccccccccchhhHH
Confidence            56788999998765 678999999999999999999999986433211000   00000000            000000


Q ss_pred             hchhh------cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          142 MEPVL------KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       142 ~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      .....      ........+..+.+++.+||+.||++|||+.++++  .++..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          260 IKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            00000      00111233456889999999999999999999987  45443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=2.3e-28  Score=196.88  Aligned_cols=164  Identities=19%  Similarity=0.219  Sum_probs=122.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC---eEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN---PKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.   ++|+|||++........   .....++..
T Consensus        99 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~  172 (284)
T 3kk8_A           99 REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG  172 (284)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcC
Confidence            356899999999999999999999999   999999999999986655   99999999976543222   122456889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||.+.+..++.++||||||+++|+|++|..||.......      .. .....+.. ....     .........+.
T Consensus       173 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~-~~~~~~~~-~~~~-----~~~~~~~~~~~  239 (284)
T 3kk8_A          173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LY-AQIKAGAY-DYPS-----PEWDTVTPEAK  239 (284)
T ss_dssp             GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHTCC-CCCT-----TTTTTSCHHHH
T ss_pred             CcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HH-HHHHhccc-cCCc-----hhhcccCHHHH
Confidence            999999999899999999999999999999999985322111      00 00000000 0000     00112234588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH--Hhhc
Q 026939          160 HIGLLCVQADSADRPTMSSVVV--MLAS  185 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~--~L~~  185 (230)
                      +++.+||+.||++|||+.++++  .+.+
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICN  267 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccC
Confidence            9999999999999999999987  4444

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.95  E-value=1.5e-28  Score=199.54  Aligned_cols=169  Identities=27%  Similarity=0.398  Sum_probs=118.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC---CccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS---EASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........   ........++..
T Consensus       115 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  191 (303)
T 2vwi_A          115 SGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC  191 (303)
T ss_dssp             TCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCcc
Confidence            346999999999999999999999999   99999999999999999999999999875432211   111122356788


Q ss_pred             ccChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           80 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        80 ~~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |+|||.+.+ ..++.++|+||||+++|+|++|..||........      ..... .......................+
T Consensus       192 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  264 (303)
T 2vwi_A          192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTL-QNDPPSLETGVQDKEMLKKYGKSF  264 (303)
T ss_dssp             TCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHH-TSSCCCTTC-----CCCCCCCHHH
T ss_pred             ccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHh-ccCCCccccccccchhhhhhhHHH
Confidence            999999876 5688999999999999999999999865332211      00000 000000000000001111223458


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.||.+|||+.++++
T Consensus       265 ~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          265 RKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCcCHHHHhh
Confidence            89999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.1e-28  Score=204.66  Aligned_cols=170  Identities=22%  Similarity=0.202  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aP  181 (346)
T 1ua2_A          107 LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAP  181 (346)
T ss_dssp             SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCccc--CCcccccccccCc
Confidence            46889999999999999999999999   999999999999999999999999999765432211  1223568899999


Q ss_pred             hhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh---hh---hhhch---hhcc-----
Q 026939           84 EYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE---AL---ELMEP---VLKQ-----  148 (230)
Q Consensus        84 e~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~---~~~~-----  148 (230)
                      |.+.+. .++.++|||||||++|+|++|..||.........   ...........   ..   ...+.   ....     
T Consensus       182 E~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (346)
T 1ua2_A          182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH  258 (346)
T ss_dssp             HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHH
T ss_pred             hHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCChhhhhhhccCcccccccccCCCChH
Confidence            999764 5889999999999999999999998643321110   00000000000   00   00000   0000     


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .........+.+++.+||+.||++|||+.++++
T Consensus       259 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          259 HIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            011223456899999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.95  E-value=6.3e-29  Score=199.74  Aligned_cols=162  Identities=26%  Similarity=0.307  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCC--CCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDS--RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~--~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ..+++..++.++.||+.||+|||+.+  ..+++|+||+|+||+++.++.++|+|||++........  ......++..|+
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~  183 (279)
T 2w5a_A          106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYM  183 (279)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCcccc
Confidence            45999999999999999999999975  23499999999999999999999999999876532211  112235678999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||.+.+..++.++|+||||+++|+|++|..||.......      .. .....+..         ...+...+..+.++
T Consensus       184 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~i~~~~~---------~~~~~~~~~~l~~l  247 (279)
T 2w5a_A          184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LA-GKIREGKF---------RRIPYRYSDELNEI  247 (279)
T ss_dssp             CHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHTCC---------CCCCTTSCHHHHHH
T ss_pred             ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HH-HHHhhccc---------ccCCcccCHHHHHH
Confidence            9999998889999999999999999999999986432110      00 11111111         11222334568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHh
Q 026939          162 GLLCVQADSADRPTMSSVVVML  183 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L  183 (230)
                      +.+||+.||++|||+.+|++.+
T Consensus       248 i~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          248 ITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHcCCCcccCCCHHHHHhCh
Confidence            9999999999999999999765

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=1.7e-28  Score=204.16  Aligned_cols=175  Identities=17%  Similarity=0.173  Sum_probs=124.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhH--hCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLH--EDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh--~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||.|||  +.+   |+|+||+|+||+++. ++.++|+|||++.........   ....++..
T Consensus       123 ~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~  196 (360)
T 3e3p_A          123 QVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRY  196 (360)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcc
Confidence            457889999999999999999999  988   999999999999986 889999999999765433221   12356888


Q ss_pred             ccChhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHh--hhhhhhhhch------------
Q 026939           80 YMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWC--EGEALELMEP------------  144 (230)
Q Consensus        80 ~~aPe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~------------  144 (230)
                      |+|||++.+.. ++.++|||||||++|+|++|..||............   .....  .........+            
T Consensus       197 y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (360)
T 3e3p_A          197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI---VRVLGCPSREVLRKLNPSHTDVDLYNSKG  273 (360)
T ss_dssp             GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHHHHHHHCTTCCCGGGGCCCC
T ss_pred             eeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH---HHHcCCCCHHHHHhcccchhhcccccccc
Confidence            99999987654 899999999999999999999998653322111000   00000  0000000000            


Q ss_pred             ----hhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          145 ----VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       145 ----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                          .............+.+++.+||+.||.+|||+.++++  .+++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          274 IPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             CCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             CCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                0000111224567999999999999999999999986  34443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=4.3e-28  Score=194.76  Aligned_cols=159  Identities=19%  Similarity=0.204  Sum_probs=119.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe---CCCCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +..+++..++.++.|++.||+|||+.+   ++|+||+|+||++   +.++.++|+|||++........   .....++..
T Consensus       100 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~  173 (277)
T 3f3z_A          100 KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPY  173 (277)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCC
Confidence            356899999999999999999999999   9999999999999   7788999999999987643322   122356889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||.+.+ .++.++|+||||+++|+|++|..||........      ... ...+.. ..     ........+..+.
T Consensus       174 y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~~-~~-----~~~~~~~~~~~~~  239 (277)
T 3f3z_A          174 YVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV------MLK-IREGTF-TF-----PEKDWLNVSPQAE  239 (277)
T ss_dssp             TCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHCCC-CC-----CHHHHTTSCHHHH
T ss_pred             ccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH------HHH-HHhCCC-CC-----CchhhhcCCHHHH
Confidence            999999865 489999999999999999999999864322110      000 000000 00     0000012345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.5e-28  Score=206.13  Aligned_cols=173  Identities=16%  Similarity=0.207  Sum_probs=127.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe----CCCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL----DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      .+++..++.++.||+.||+|||+.+   |+||||+|+||++    +.++.+||+|||++........   .....++..|
T Consensus       108 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y  181 (396)
T 4eut_A          108 GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY  181 (396)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccc
Confidence            3999999999999999999999999   9999999999999    7777899999999987543221   1123578899


Q ss_pred             cChhhhhc--------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhh----------
Q 026939           81 MAPEYAME--------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELM----------  142 (230)
Q Consensus        81 ~aPe~~~~--------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  142 (230)
                      +|||++.+        ..++.++|||||||++|+|++|..||........  ........... ......          
T Consensus       182 ~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~-~p~~~~~~~~~~~~~~  258 (396)
T 4eut_A          182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITG-KPSGAISGVQKAENGP  258 (396)
T ss_dssp             CCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHS-CCTTCCEEEECSTTCC
T ss_pred             cCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcC-CCcccchhheeccCCC
Confidence            99999875        4577899999999999999999999854322111  11111111111 100000          


Q ss_pred             -----chhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          143 -----EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       143 -----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                           .-.............+.+++.+||+.||++||++.++++.+++.
T Consensus       259 ~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             EEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence                 00001123467778899999999999999999999999988664

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=2.6e-28  Score=201.07  Aligned_cols=156  Identities=22%  Similarity=0.223  Sum_probs=117.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||++|   |+||||+|+||+++.++.++|+|||++........  ......++..|+||
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  190 (327)
T 3a62_A          116 GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAP  190 (327)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCH
Confidence            46889999999999999999999999   99999999999999999999999999865322211  11224578899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+|||||++|+|++|..||.......      ..... ...          ...++......+.+++.
T Consensus       191 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i-~~~----------~~~~p~~~~~~~~~li~  253 (327)
T 3a62_A          191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKI-LKC----------KLNLPPYLTQEARDLLK  253 (327)
T ss_dssp             HHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHH-HHT----------CCCCCTTSCHHHHHHHH
T ss_pred             hhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HhC----------CCCCCCCCCHHHHHHHH
Confidence            99998889999999999999999999999986432111      00010 000          01122233456889999


Q ss_pred             hhcCCCCCCCC-----CHHHHHH
Q 026939          164 LCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +||+.||++||     ++.++++
T Consensus       254 ~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          254 KLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHhcCHhhccCCCCCCHHHHHc
Confidence            99999999999     7778876

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=3.2e-28  Score=218.05  Aligned_cols=156  Identities=25%  Similarity=0.280  Sum_probs=123.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........  ......|++.|+||
T Consensus       437 ~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~AP  511 (674)
T 3pfq_A          437 GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAP  511 (674)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCH
Confidence            57899999999999999999999999   99999999999999999999999999976432221  12234678999999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..++.++|+|||||++|+|++|..||......      +..... ..        .  ...++......+.+|+.
T Consensus       512 E~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i-~~--------~--~~~~p~~~s~~~~~li~  574 (674)
T 3pfq_A          512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSI-ME--------H--NVAYPKSMSKEAVAICK  574 (674)
T ss_dssp             HHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HS--------S--CCCCCTTSCHHHHHHHH
T ss_pred             hhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHH-Hh--------C--CCCCCccCCHHHHHHHH
Confidence            9999999999999999999999999999998643211      111111 11        1  01223344556899999


Q ss_pred             hhcCCCCCCCCCH-----HHHHH
Q 026939          164 LCVQADSADRPTM-----SSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RPs~-----~~i~~  181 (230)
                      .||+.||++||++     ++|++
T Consensus       575 ~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          575 GLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHccCCHHHCCCCCCCcHHHHhc
Confidence            9999999999998     77764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=1.5e-28  Score=206.07  Aligned_cols=153  Identities=23%  Similarity=0.188  Sum_probs=118.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||++|   |+||||||+||+++.+|.++|+|||++........  ......+++.|+||
T Consensus       134 ~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aP  208 (373)
T 2r5t_A          134 RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAP  208 (373)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCH
Confidence            56889999999999999999999999   99999999999999999999999999875322211  12234678999999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..++.++|+|||||++|+|++|..||.......      .. .......          ..++......+.+++.
T Consensus       209 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~~----------~~~~~~~~~~~~~li~  271 (373)
T 2r5t_A          209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MY-DNILNKP----------LQLKPNITNSARHLLE  271 (373)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HH-HHHHHSC----------CCCCSSSCHHHHHHHH
T ss_pred             HHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HH-HHHHhcc----------cCCCCCCCHHHHHHHH
Confidence            99999999999999999999999999999985432110      10 1111110          0112223445889999


Q ss_pred             hhcCCCCCCCCCHHH
Q 026939          164 LCVQADSADRPTMSS  178 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~  178 (230)
                      +||+.||.+||++.+
T Consensus       272 ~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          272 GLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHTCSSGGGSTTTTT
T ss_pred             HHcccCHHhCCCCCC
Confidence            999999999999853

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=8.1e-28  Score=201.02  Aligned_cols=159  Identities=25%  Similarity=0.379  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++........   .....+++.|+||
T Consensus       195 ~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aP  268 (365)
T 2y7j_A          195 VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAP  268 (365)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccCh
Confidence            47899999999999999999999999   99999999999999999999999999877643222   1224678899999


Q ss_pred             hhhhcC------CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           84 EYAMEG------LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        84 e~~~~~------~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      |++.+.      .++.++|||||||++|+|++|..||.......      .. .....+.. ....     ......+..
T Consensus       269 E~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------~~-~~i~~~~~-~~~~-----~~~~~~~~~  335 (365)
T 2y7j_A          269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------ML-RMIMEGQY-QFSS-----PEWDDRSST  335 (365)
T ss_dssp             HHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHTCC-CCCH-----HHHSSSCHH
T ss_pred             hhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhCCC-CCCC-----cccccCCHH
Confidence            998743      57889999999999999999999985422110      00 00001000 0000     000122345


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.||++|||+.++++
T Consensus       336 ~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          336 VKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhc
Confidence            889999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=1.8e-28  Score=201.31  Aligned_cols=169  Identities=21%  Similarity=0.226  Sum_probs=122.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.......   ......++..|+||
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aP  188 (326)
T 1blx_A          115 PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAP  188 (326)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCH
Confidence            35899999999999999999999999   9999999999999999999999999987643211   12224567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh---hhhh-------hhc---hhhcchh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG---EALE-------LME---PVLKQSC  150 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~---~~~~~~~  150 (230)
                      |.+.+..++.++||||||+++|+|++|..||..........   .........   ....       ...   ......+
T Consensus       189 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 1blx_A          189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF  265 (326)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGT
T ss_pred             HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCCcccCccccccchhhhcccCcchhhhc
Confidence            99998899999999999999999999999986433221100   000000000   0000       000   0000011


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .......+.+++.+||+.||++|||+.++++
T Consensus       266 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          266 VTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            2233456889999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=3.2e-28  Score=195.98  Aligned_cols=159  Identities=20%  Similarity=0.208  Sum_probs=119.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC----CeEEcccccceeecCCCCCccccccccccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM----NPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++    .++|+|||++........   .....++..
T Consensus       103 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~  176 (283)
T 3bhy_A          103 ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPE  176 (283)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcC
Confidence            56899999999999999999999999   99999999999998876    799999999976543221   112356789


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||.+.+..++.++|+||||+++|+|++|..||.......      .. ......      ............+..+.
T Consensus       177 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~------~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TL-TNISAV------NYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTT------CCCCCHHHHTTCCHHHH
T ss_pred             ccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HH-HHhHhc------ccCCcchhcccCCHHHH
Confidence            999999998899999999999999999999999985432111      00 000000      00001111223345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHh
Confidence            9999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=2.3e-28  Score=198.08  Aligned_cols=161  Identities=25%  Similarity=0.305  Sum_probs=124.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus       110 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aP  184 (294)
T 2rku_A          110 KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAP  184 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCccc--cccccCCCCcCCc
Confidence            57899999999999999999999999   999999999999999999999999999875432221  2223567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|+||||+++|+|++|..||........      . .......          ...+......+.+++.
T Consensus       185 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~-~~~~~~~----------~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------Y-LRIKKNE----------YSIPKHINPVAASLIQ  247 (294)
T ss_dssp             HHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H-HHHHTTC----------CCCCTTSCHHHHHHHH
T ss_pred             chhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHhhcc----------CCCccccCHHHHHHHH
Confidence            999988899999999999999999999999864321110      0 0000000          0112223345889999


Q ss_pred             hhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          164 LCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      +||+.||++|||+.++++  .+.+.
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHcccChhhCcCHHHHhhChheecC
Confidence            999999999999999997  45443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=2.6e-28  Score=203.36  Aligned_cols=178  Identities=20%  Similarity=0.207  Sum_probs=119.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........   .....++..|+|
T Consensus       128 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~a  201 (362)
T 3pg1_A          128 RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRA  201 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecC
Confidence            347999999999999999999999999   99999999999999999999999999875432211   122356788999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchh-hh-------hHHHHhhhhhhhhhchhh-------
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL-SY-------TWKLWCEGEALELMEPVL-------  146 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~-------  146 (230)
                      ||.+.+ ..++.++|||||||++|+|++|..||............ ..       ....+.............       
T Consensus       202 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (362)
T 3pg1_A          202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA  281 (362)
T ss_dssp             HHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC
T ss_pred             cHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhh
Confidence            999887 67899999999999999999999998643321110000 00       000000000000000000       


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ...........+.+++.+||+.||++|||+.++++  .+++.
T Consensus       282 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          282 WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            00112233456889999999999999999999987  44444

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.1e-28  Score=202.83  Aligned_cols=163  Identities=21%  Similarity=0.258  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   |+||||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus       154 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aP  229 (355)
T 1vzo_A          154 ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAP  229 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccCh
Confidence            46899999999999999999999999   999999999999999999999999999765322111 12234678899999


Q ss_pred             hhhhcC--CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           84 EYAMEG--LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        84 e~~~~~--~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |++.+.  .++.++|||||||++|+|++|..||.........  ........ .          ....++......+.++
T Consensus       230 E~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~-~----------~~~~~~~~~~~~~~~l  296 (355)
T 1vzo_A          230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRIL-K----------SEPPYPQEMSALAKDL  296 (355)
T ss_dssp             HHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHH-H----------CCCCCCTTSCHHHHHH
T ss_pred             hhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHh-c----------cCCCCCcccCHHHHHH
Confidence            999853  4788999999999999999999998643222111  11111100 0          0112233344568899


Q ss_pred             HhhhcCCCCCCCC-----CHHHHHHHh
Q 026939          162 GLLCVQADSADRP-----TMSSVVVML  183 (230)
Q Consensus       162 ~~~cl~~dP~~RP-----s~~~i~~~L  183 (230)
                      +.+||+.||.+||     ++.++++..
T Consensus       297 i~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          297 IQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            9999999999999     999998743

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=2.1e-28  Score=200.96  Aligned_cols=158  Identities=25%  Similarity=0.335  Sum_probs=114.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++........  ......++..|+||
T Consensus       124 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          124 NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAP  198 (326)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccCh
Confidence            57899999999999999999999999   99999999999999999999999999876532211  11223567899999


Q ss_pred             hhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           84 EYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        84 e~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |.+.     +..++.++|||||||++|+|++|..||........      ... ........    .    .....+..+
T Consensus       199 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~----~----~~~~~~~~l  263 (326)
T 2x7f_A          199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFL-IPRNPAPR----L----KSKKWSKKF  263 (326)
T ss_dssp             HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHSCCCC----C----SCSCSCHHH
T ss_pred             hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHH-hhcCcccc----C----CccccCHHH
Confidence            9987     45688999999999999999999999854321110      000 00000000    0    011223458


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||..||++|||+.++++
T Consensus       264 ~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          264 QSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhccChhhCCCHHHHhh
Confidence            89999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.95  E-value=2.1e-28  Score=218.65  Aligned_cols=163  Identities=23%  Similarity=0.272  Sum_probs=124.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.+   ++||||+|+||+++.++.++|+|||++.......... .....++..|+||
T Consensus       486 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~~t~~y~aP  561 (656)
T 2j0j_A          486 FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAP  561 (656)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCccee-ccCCCCCcceeCH
Confidence            46899999999999999999999999   9999999999999999999999999997654322211 1122445789999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++|+|++ |..||.......      ....          +........+...+..+.+++
T Consensus       562 E~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~----------i~~~~~~~~~~~~~~~l~~li  625 (656)
T 2j0j_A          562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGR----------IENGERLPMPPNCPPTLYSLM  625 (656)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH----------HHHTCCCCCCTTCCHHHHHHH
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHH----------HHcCCCCCCCccccHHHHHHH
Confidence            99999999999999999999999997 888986432211      0000          011111122334455689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|+..
T Consensus       626 ~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          626 TKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=3.5e-28  Score=196.38  Aligned_cols=158  Identities=23%  Similarity=0.289  Sum_probs=114.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe---CCCCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      +..+++..++.++.||+.||+|||+.+   ++|+||+|+||++   +.++.++|+|||++........   .....++..
T Consensus       118 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~  191 (285)
T 3is5_A          118 GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTAL  191 (285)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccC
Confidence            367999999999999999999999999   9999999999999   4567899999999976543221   122356889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||.+. ..++.++|+||||+++|+|++|..||........      ...........    ......    ....+.
T Consensus       192 y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~----~~~~~~----~~~~~~  256 (285)
T 3is5_A          192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATYKEPNY----AVECRP----LTPQAV  256 (285)
T ss_dssp             GCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCC----CC--CC----CCHHHH
T ss_pred             cCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------HhhhccCCccc----ccccCc----CCHHHH
Confidence            99999985 5688999999999999999999999864321111      00000000000    000001    234588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.+|++
T Consensus       257 ~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.95  E-value=4.3e-28  Score=203.01  Aligned_cols=170  Identities=19%  Similarity=0.245  Sum_probs=118.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++.......     ....++..|+||
T Consensus       139 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aP  210 (371)
T 4exu_A          139 MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAP  210 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccCc-----CCcccCccccCH
Confidence            46899999999999999999999999   9999999999999999999999999987653221     123568899999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH----HHHh----hhhhhhhhc---hhhc---c
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW----KLWC----EGEALELME---PVLK---Q  148 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~---~~~~---~  148 (230)
                      |.+.+ ..++.++|||||||++|+|++|..||................    ..+.    .........   ....   .
T Consensus       211 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (371)
T 4exu_A          211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT  290 (371)
T ss_dssp             HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHH
T ss_pred             HHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHH
Confidence            99987 678999999999999999999999986433211100000000    0000    000000000   0000   0


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .........+.+++.+||+.||++|||+.++++
T Consensus       291 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          291 QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            111223566899999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=4.5e-28  Score=200.49  Aligned_cols=167  Identities=19%  Similarity=0.158  Sum_probs=120.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC--CeEEcccccceeecCCCCC--ccccccccccCcc
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM--NPKISDFEMARIFGGNQSE--ASTNRIVGTYGYM   81 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (230)
                      +++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++  .++|+|||++.........  .......+++.|+
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~  241 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV  241 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence            467788999999999999999999   99999999999998776  7999999999865322111  1122345688999


Q ss_pred             Chhhhhc--CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           82 APEYAME--GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        82 aPe~~~~--~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |||.+.+  ..++.++|||||||++|+|++|..||........      ....... .. ..     ...........+.
T Consensus       242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~-~~-~~-----~~~~~~~~~~~~~  308 (345)
T 3hko_A          242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNK-KL-CF-----ENPNYNVLSPLAR  308 (345)
T ss_dssp             CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC-CC-CT-----TSGGGGGSCHHHH
T ss_pred             CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhc-cc-cc-----CCcccccCCHHHH
Confidence            9999975  5788999999999999999999999864332111      1111100 00 00     0011112344688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH--HhhcCCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVV--MLASDNV  188 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~  188 (230)
                      +++.+||+.||.+|||+.++++  .+++...
T Consensus       309 ~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          309 DLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            9999999999999999999987  5555443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=2.7e-28  Score=196.38  Aligned_cols=150  Identities=19%  Similarity=0.275  Sum_probs=115.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-------------------CCeEEcccccceeecC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-------------------MNPKISDFEMARIFGG   64 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-------------------~~~~l~d~~~~~~~~~   64 (230)
                      ..+++..++.++.||+.||+|||+++   ++|+||+|+||+++.+                   ..++|+|||++.....
T Consensus       110 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  186 (289)
T 1x8b_A          110 SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS  186 (289)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence            56899999999999999999999999   9999999999999844                   4789999999877543


Q ss_pred             CCCCccccccccccCccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhc
Q 026939           65 NQSEASTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELME  143 (230)
Q Consensus        65 ~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (230)
                      ...      ..++..|+|||.+.+. .++.++|||||||++|+|++|.+++.....          ......+..     
T Consensus       187 ~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~~~~~~~~~-----  245 (289)
T 1x8b_A          187 PQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----------WHEIRQGRL-----  245 (289)
T ss_dssp             SCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----------HHHHHTTCC-----
T ss_pred             ccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----------HHHHHcCCC-----
Confidence            221      2467899999999865 566899999999999999999877532110          111111111     


Q ss_pred             hhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          144 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       144 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                          ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       246 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          246 ----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                1122233456899999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=5e-28  Score=205.79  Aligned_cols=162  Identities=26%  Similarity=0.305  Sum_probs=115.7

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC---CeEEcccccceeecCCCCCcccccccccc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM---NPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      ++..+++.+++.++.||+.||+|||+.+   ++||||+|+||+++.++   .+||+|||++........   .....+++
T Consensus       232 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~  305 (419)
T 3i6u_A          232 GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTP  305 (419)
T ss_dssp             SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------C
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCCC
Confidence            3467999999999999999999999999   99999999999997554   499999999976543221   12246788


Q ss_pred             CccChhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHH
Q 026939           79 GYMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL  155 (230)
Q Consensus        79 ~~~aPe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (230)
                      .|+|||++.+   ..++.++|||||||++|+|++|..||........  ..    .....+... .     ........+
T Consensus       306 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~----~~i~~~~~~-~-----~~~~~~~~~  373 (419)
T 3i6u_A          306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQITSGKYN-F-----IPEVWAEVS  373 (419)
T ss_dssp             TTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----HHHHTTCCC-C-----CHHHHTTSC
T ss_pred             CccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----HHHhcCCCC-C-----CchhhcccC
Confidence            9999999863   5678899999999999999999999864322111  00    001111000 0     001112234


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          156 LKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       156 ~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       374 ~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          374 EKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhC
Confidence            56889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=2.6e-27  Score=206.75  Aligned_cols=161  Identities=27%  Similarity=0.300  Sum_probs=123.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.|   |+||||||+||+++.+|.+||+|||++.........  .....|++.|+|
T Consensus       283 ~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~A  357 (543)
T 3c4z_A          283 NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA  357 (543)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSC
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccC
Confidence            347999999999999999999999999   999999999999999999999999999876433221  122467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|+|||||++|+|++|..||........  ........ ...          ...++...+..+.+++
T Consensus       358 PE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i-~~~----------~~~~p~~~s~~~~~li  424 (543)
T 3c4z_A          358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRV-LEQ----------AVTYPDKFSPASKDFC  424 (543)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHH-HHC----------CCCCCTTSCHHHHHHH
T ss_pred             hhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHH-hhc----------ccCCCcccCHHHHHHH
Confidence            9999999999999999999999999999999864322111  01111111 000          0112233445688999


Q ss_pred             hhhcCCCCCCCCCH-----HHHHH
Q 026939          163 LLCVQADSADRPTM-----SSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~-----~~i~~  181 (230)
                      .+||+.||++||++     ++|++
T Consensus       425 ~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          425 EALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHhccCCHhHCCCCcccCHHHHHc
Confidence            99999999999975     66664

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.95  E-value=2.5e-28  Score=199.59  Aligned_cols=184  Identities=19%  Similarity=0.250  Sum_probs=124.0

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCC-CccccccccccC
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQS-EASTNRIVGTYG   79 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~   79 (230)
                      +..++++..++.++.||+.||+|||+.|   ++|+||+|+||+++ .++.++|+|||++........ ........++..
T Consensus       113 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  189 (320)
T 2i6l_A          113 EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW  189 (320)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCT
T ss_pred             hcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccccccc
Confidence            3567899999999999999999999999   99999999999997 567899999999876532211 111122345778


Q ss_pred             ccChhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhh---hhhhhhh----chhhc----
Q 026939           80 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCE---GEALELM----EPVLK----  147 (230)
Q Consensus        80 ~~aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----~~~~~----  147 (230)
                      |+|||.+.+ ..++.++|+||||+++|+|++|..||.....................   ......+    .....    
T Consensus       190 y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (320)
T 2i6l_A          190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHK  269 (320)
T ss_dssp             TCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCC
T ss_pred             ccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCC
Confidence            999999876 67899999999999999999999998654322110000000000000   0000000    00000    


Q ss_pred             --chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCC
Q 026939          148 --QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNV  188 (230)
Q Consensus       148 --~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~  188 (230)
                        .......+..+.+++.+||+.||++|||+.++++  .+.....
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          270 PLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             CHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             ChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence              0111223556899999999999999999999987  5655443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=5.7e-28  Score=195.51  Aligned_cols=158  Identities=26%  Similarity=0.387  Sum_probs=118.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-CCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-EMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .+++..++.++.||+.||+|||+.+   ++|+||+|+||+++. ++.++|+|||++........  ......++..|+||
T Consensus       118 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP  192 (295)
T 2clq_A          118 KDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAP  192 (295)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCH
T ss_pred             CccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccCh
Confidence            5678899999999999999999999   999999999999987 88999999999976543221  11223567899999


Q ss_pred             hhhhcCC--CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           84 EYAMEGL--FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        84 e~~~~~~--~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |.+.+..  ++.++|+||||+++|+|++|..||........    .. ...     ..    .......+...+..+.++
T Consensus       193 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~-~~~-----~~----~~~~~~~~~~~~~~~~~l  258 (295)
T 2clq_A          193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AM-FKV-----GM----FKVHPEIPESMSAEAKAF  258 (295)
T ss_dssp             HHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HH-HHH-----HH----HCCCCCCCTTSCHHHHHH
T ss_pred             hhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HH-Hhh-----cc----ccccccccccCCHHHHHH
Confidence            9997653  78999999999999999999999853211100    00 000     00    001112223344568899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       259 i~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          259 ILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHccCChhhCCCHHHHhc
Confidence            99999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=9.2e-28  Score=197.11  Aligned_cols=148  Identities=21%  Similarity=0.299  Sum_probs=118.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++ .++.++|+|||++........    ....++..|+|
T Consensus       144 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~a  216 (320)
T 3a99_A          144 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSP  216 (320)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccccccccc----cCCCCCccCCC
Confidence            57899999999999999999999999   99999999999998 678999999999987643221    12356789999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..+ +.++||||||+++|+|++|..||......             ....      ..    ++...+..+.++
T Consensus       217 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------------~~~~------~~----~~~~~~~~~~~l  273 (320)
T 3a99_A          217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------------IRGQ------VF----FRQRVSSECQHL  273 (320)
T ss_dssp             HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------HHCC------CC----CSSCCCHHHHHH
T ss_pred             hHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------------hccc------cc----ccccCCHHHHHH
Confidence            999987775 68889999999999999999998532110             0000      00    111223458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.+|++
T Consensus       274 i~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          274 IRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=1.5e-27  Score=192.82  Aligned_cols=158  Identities=23%  Similarity=0.335  Sum_probs=118.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.||+.||+|||+.+ .+++|+||+|+||+++ .++.++|+|||++.......    .....++..|+|
T Consensus       124 ~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~a  198 (290)
T 1t4h_A          124 KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMA  198 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCC
Confidence            57899999999999999999999875 2399999999999997 78899999999986543221    122356889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||.+. ..++.++|+||||+++|+|++|..||........      .......+.        ....++......+.+++
T Consensus       199 PE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~--------~~~~~~~~~~~~l~~li  263 (290)
T 1t4h_A          199 PEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGV--------KPASFDKVAIPEVKEII  263 (290)
T ss_dssp             GGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTC--------CCGGGGGCCCHHHHHHH
T ss_pred             HHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccC--------CccccCCCCCHHHHHHH
Confidence            99886 4589999999999999999999999854221110      001111100        01111222234588999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      ..||+.||.+|||+.++++
T Consensus       264 ~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          264 EGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHSCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhh
Confidence            9999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.95  E-value=1.1e-27  Score=196.72  Aligned_cols=161  Identities=26%  Similarity=0.317  Sum_probs=120.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC---eEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN---PKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.   ++|+|||++.......   ......++..
T Consensus       108 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~  181 (322)
T 2ycf_A          108 NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPT  181 (322)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcC
Confidence            467899999999999999999999999   999999999999987654   9999999997754321   1122356889


Q ss_pred             ccChhhhh---cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           80 YMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        80 ~~aPe~~~---~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      |+|||++.   +..++.++|||||||++|+|++|..||........  ..    .....+...      .........+.
T Consensus       182 y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~~~~~~------~~~~~~~~~~~  249 (322)
T 2ycf_A          182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQITSGKYN------FIPEVWAEVSE  249 (322)
T ss_dssp             TCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH----HHHHHTCCC------CCHHHHTTSCH
T ss_pred             ccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH----HHHHhCccc------cCchhhhhcCH
Confidence            99999975   45688999999999999999999999864322111  00    001111000      00011122345


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          250 KALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHcccCHhhCCCHHHHhh
Confidence            6889999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=6.9e-28  Score=211.22  Aligned_cols=159  Identities=26%  Similarity=0.311  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||++|   |+||||+|+||+++.+|.++|+|||++........   .....+++.|+||
T Consensus       281 ~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~AP  354 (576)
T 2acx_A          281 AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAP  354 (576)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCH
Confidence            35999999999999999999999999   99999999999999999999999999987643221   1223678999999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..++.++|+|||||++|+|++|..||.........   .........          ....++...+..+.+++.
T Consensus       355 Evl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~----------~~~~~p~~~s~~~~dLI~  421 (576)
T 2acx_A          355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE----------VPEEYSERFSPQARSLCS  421 (576)
T ss_dssp             HHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHH----------CCCCCCTTSCHHHHHHHH
T ss_pred             HHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhc----------ccccCCccCCHHHHHHHH
Confidence            9999888999999999999999999999999643321110   000011000          011122333456899999


Q ss_pred             hhcCCCCCCCC-----CHHHHHH
Q 026939          164 LCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       164 ~cl~~dP~~RP-----s~~~i~~  181 (230)
                      +||+.||.+||     ++++|++
T Consensus       422 ~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          422 QLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HhccCCHHHcCCCCCCCHHHHHh
Confidence            99999999999     7888875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=8.9e-28  Score=199.63  Aligned_cols=167  Identities=20%  Similarity=0.266  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||++|   ++|+||+|+||+++.++.++|+|||++......     .....++..|+||
T Consensus       121 ~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aP  192 (353)
T 3coi_A          121 LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP  192 (353)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCH
Confidence            46899999999999999999999999   999999999999999999999999998754322     1123567899999


Q ss_pred             hhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHH-----------hhhhhhhhhc---hhhc-
Q 026939           84 EYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLW-----------CEGEALELME---PVLK-  147 (230)
Q Consensus        84 e~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~---~~~~-  147 (230)
                      |.+.+ ..++.++|+|||||++|+|++|..||........   ........           ........+.   .... 
T Consensus       193 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (353)
T 3coi_A          193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK  269 (353)
T ss_dssp             HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSC
T ss_pred             HHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCc
Confidence            99887 5789999999999999999999999864332111   00000000           0000000000   0000 


Q ss_pred             --chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          148 --QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       148 --~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        ..........+.+++.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          270 DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0111234556899999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=6.4e-28  Score=208.56  Aligned_cols=159  Identities=23%  Similarity=0.264  Sum_probs=121.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe---CCCCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||+|||+.|   |+||||+|+||++   +.++.++|+|||++........   .....+++.
T Consensus       120 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~  193 (484)
T 3nyv_A          120 RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAY  193 (484)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCcc
Confidence            467899999999999999999999999   9999999999999   4678899999999976543322   122357889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++.+ .++.++|||||||++|+|++|..||.......      .... ...+...      .........+..+.
T Consensus       194 y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~-i~~~~~~------~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          194 YIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKK-VEKGKYT------FELPQWKKVSESAK  259 (484)
T ss_dssp             TCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCCCC------CCSGGGGGSCHHHH
T ss_pred             ccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHcCCCC------CCCcccccCCHHHH
Confidence            999999865 68999999999999999999999986432211      1111 1111000      00011122345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||.+|||+.++++
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhh
Confidence            9999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.94  E-value=5.9e-28  Score=199.66  Aligned_cols=167  Identities=19%  Similarity=0.216  Sum_probs=105.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC---CCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++.+++.++.||+.||+|||+.|   ++|+||+|+||+++.+   +.++|+|||++........    ....+++.|
T Consensus       123 ~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y  195 (336)
T 3fhr_A          123 QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYY  195 (336)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecccccc----ccCCCCcCc
Confidence            46999999999999999999999999   9999999999999764   4599999999976542211    123557899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||.+.+..++.++||||||+++|+|++|..||.............   ......      ............+..+.+
T Consensus       196 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~------~~~~~~~~~~~~~~~~~~  266 (336)
T 3fhr_A          196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLG------QYGFPNPEWSEVSEDAKQ  266 (336)
T ss_dssp             --------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CCCTTTSTTCCHHHHH
T ss_pred             cChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhcc------ccccCchhhccCCHHHHH
Confidence            99999988888999999999999999999999985432211100000   000000      000000111223446889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ++.+||+.||++|||+.++++  .+.+.
T Consensus       267 li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          267 LIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            999999999999999999998  55543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=3.1e-28  Score=202.84  Aligned_cols=171  Identities=24%  Similarity=0.344  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..+++..++.++.|++.||+|||+. +   ++|+||+|+||+++.++.++|+|||++......    ......++..|+|
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~a  198 (360)
T 3eqc_A          126 GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS  198 (360)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeEC
Confidence            4689999999999999999999996 8   999999999999999999999999988644211    1112356889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhh-----------------------hHHHHhhhhhh
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSY-----------------------TWKLWCEGEAL  139 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~  139 (230)
                      ||.+.+..++.++|||||||++|+|++|..||..............                       ...........
T Consensus       199 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (360)
T 3eqc_A          199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIF  278 (360)
T ss_dssp             HHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHH
T ss_pred             HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccch
Confidence            9999999999999999999999999999999865332211100000                       00000000000


Q ss_pred             hhhchhhcc---h-hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          140 ELMEPVLKQ---S-CVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       140 ~~~~~~~~~---~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...+.....   . .....+..+.+++.+||+.||++|||+.++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          279 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             HHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            111110000   0 01123446899999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=7.6e-28  Score=193.12  Aligned_cols=155  Identities=24%  Similarity=0.321  Sum_probs=113.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........   .....++..|+||
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aP  179 (276)
T 2h6d_A          106 GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAP  179 (276)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCH
Confidence            46899999999999999999999999   99999999999999999999999999876543221   1123567889999


Q ss_pred             hhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..+ +.++|+||||+++|+|++|..||.......      . ......+.          ...+......+.+++
T Consensus       180 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~~~~~~~~----------~~~~~~~~~~l~~li  242 (276)
T 2h6d_A          180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------L-FKKIRGGV----------FYIPEYLNRSVATLL  242 (276)
T ss_dssp             GGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHCC----------CCCCTTSCHHHHHHH
T ss_pred             HHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------H-HHHhhcCc----------ccCchhcCHHHHHHH
Confidence            99987765 589999999999999999999985422110      0 00000000          011222334588999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||++|||+.+|++
T Consensus       243 ~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHh
Confidence            9999999999999999997

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.94  E-value=4e-28  Score=199.57  Aligned_cols=162  Identities=30%  Similarity=0.391  Sum_probs=104.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++........   .....++..|+
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~  192 (327)
T 3aln_A          119 DDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYM  192 (327)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------
T ss_pred             cccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCcccc
Confidence            46789999999999999999999998 8   99999999999999999999999999876533221   11225678899


Q ss_pred             Chhhh----hcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           82 APEYA----MEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        82 aPe~~----~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      |||.+    .+..++.++||||||+++|+|++|..||.......... ..     ...+..     +.+...........
T Consensus       193 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-----~~~~~~-----~~~~~~~~~~~~~~  261 (327)
T 3aln_A          193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQ-----VVKGDP-----PQLSNSEEREFSPS  261 (327)
T ss_dssp             -------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CC-----CCCSCC-----CCCCCCSSCCCCHH
T ss_pred             CceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-HH-----HhcCCC-----CCCCCcccccCCHH
Confidence            99998    45568899999999999999999999986432111000 00     000000     00111111123345


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.||++|||+.+|++
T Consensus       262 l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          262 FINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhhCChhhCcCHHHHHh
Confidence            899999999999999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=1.7e-27  Score=206.12  Aligned_cols=164  Identities=23%  Similarity=0.259  Sum_probs=120.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC---CCCCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||.|||+.|   |+||||+|+||+++   .++.++|+|||++........   .....+++.
T Consensus       115 ~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~  188 (486)
T 3mwu_A          115 RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY  188 (486)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCC
Confidence            357899999999999999999999999   99999999999995   456799999999876543221   122357889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++.+ .++.++|||||||++|+|++|..||.......      ..... ..+....      ........+..+.
T Consensus       189 y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~~~~------~~~~~~~~s~~~~  254 (486)
T 3mwu_A          189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRV-ETGKYAF------DLPQWRTISDDAK  254 (486)
T ss_dssp             GCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCCCS------CSGGGGGSCHHHH
T ss_pred             CCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCCCCC------CCcccCCCCHHHH
Confidence            999999865 58999999999999999999999985432111      11111 1110000      0011122344588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          160 HIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      +++.+||+.||.+|||+.++++  .++..
T Consensus       255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            9999999999999999999997  45443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=2.5e-27  Score=205.38  Aligned_cols=159  Identities=26%  Similarity=0.335  Sum_probs=119.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC---CCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||+|||+.|   |+||||+|+||+++..   +.++|+|||++........   .....+++.
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~  203 (494)
T 3lij_A          130 RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAY  203 (494)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcC
Confidence            357899999999999999999999999   9999999999999764   4599999999987653322   122467889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++. ..++.++||||+||++|+|++|..||.......      .... ...+.. ...     .......+..+.
T Consensus       204 y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~-i~~~~~-~~~-----~~~~~~~s~~~~  269 (494)
T 3lij_A          204 YIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRK-VEKGKY-TFD-----SPEWKNVSEGAK  269 (494)
T ss_dssp             TCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHTCC-CCC-----SGGGTTSCHHHH
T ss_pred             eeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhCCC-CCC-----chhcccCCHHHH
Confidence            99999985 568999999999999999999999986432211      1101 001100 000     001112344588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||.+|||+.++++
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHCCCChhhCccHHHHhc
Confidence            9999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.94  E-value=8.8e-28  Score=195.14  Aligned_cols=160  Identities=22%  Similarity=0.308  Sum_probs=117.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.......  .......++..|+|
T Consensus       111 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~a  185 (302)
T 2j7t_A          111 DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMA  185 (302)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcC
Confidence            357899999999999999999999999   9999999999999999999999999875321110  01112356788999


Q ss_pred             hhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||.+.     +..++.++|+||||+++|+|++|..||.......      ..... .......       ...+...+..
T Consensus       186 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~-------~~~~~~~~~~  251 (302)
T 2j7t_A          186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKI-AKSDPPT-------LLTPSKWSVE  251 (302)
T ss_dssp             HHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-HHSCCCC-------CSSGGGSCHH
T ss_pred             CeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHH-hccCCcc-------cCCccccCHH
Confidence            99984     5668899999999999999999999986432211      00000 0000000       0112233456


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.||++|||+.++++
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHcccChhhCCCHHHHhc
Confidence            889999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=2.5e-27  Score=192.15  Aligned_cols=159  Identities=23%  Similarity=0.314  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++........   .....++..|+||
T Consensus       119 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aP  192 (298)
T 1phk_A          119 VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAP  192 (298)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCH
Confidence            47899999999999999999999999   99999999999999999999999999977543221   1223567899999


Q ss_pred             hhhh------cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           84 EYAM------EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        84 e~~~------~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      |.+.      ...++.++|+||||+++|+|++|..||.......      . ......+.. ..     ........+..
T Consensus       193 E~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~~~~~~~~~-~~-----~~~~~~~~~~~  259 (298)
T 1phk_A          193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------M-LRMIMSGNY-QF-----GSPEWDDYSDT  259 (298)
T ss_dssp             HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHTCC-CC-----CTTTGGGSCHH
T ss_pred             HHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------H-HHHHhcCCc-cc-----CcccccccCHH
Confidence            9986      3467889999999999999999999985432111      0 011111100 00     00111223456


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+++.+||+.||++|||+.++++
T Consensus       260 l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          260 VKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHccCCcccCCCHHHHHh
Confidence            889999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=195.23  Aligned_cols=160  Identities=25%  Similarity=0.374  Sum_probs=112.4

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHED-SRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~-~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||.|||++ |   ++|+||+|+||+++.++.++|+|||++........   .....++..|+
T Consensus       118 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~  191 (318)
T 2dyl_A          118 QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYM  191 (318)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCcccc
Confidence            35789999999999999999999995 8   99999999999999999999999999876533221   11235678999


Q ss_pred             Chhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           82 APEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        82 aPe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      |||.+.     ...++.++||||||+++|+|++|..||......     ........ .....     ...  .....+.
T Consensus       192 aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~~-----~~~--~~~~~~~  258 (318)
T 2dyl_A          192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVL-QEEPP-----LLP--GHMGFSG  258 (318)
T ss_dssp             CHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH-HSCCC-----CCC--SSSCCCH
T ss_pred             ChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHh-ccCCC-----CCC--ccCCCCH
Confidence            999984     456889999999999999999999998642211     01111110 11000     000  0011234


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+.+++.+||+.||.+|||+.+|++
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhh
Confidence            5889999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=4.6e-27  Score=191.93  Aligned_cols=148  Identities=20%  Similarity=0.320  Sum_probs=118.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .++++..++.++.||+.||+|||+.+   ++|+||+|+||+++ .++.++|+|||++........    ....++..|+|
T Consensus       134 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~a  206 (312)
T 2iwi_A          134 GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSP  206 (312)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccC
Confidence            46899999999999999999999999   99999999999998 788999999999887643221    12356789999


Q ss_pred             hhhhhcCCCC-ccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~-~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..+. .++||||||+++|+|++|..||.....             .....          ..++......+.++
T Consensus       207 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------~~~~~----------~~~~~~~~~~~~~l  263 (312)
T 2iwi_A          207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------------ILEAE----------LHFPAHVSPDCCAL  263 (312)
T ss_dssp             HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHTC----------CCCCTTSCHHHHHH
T ss_pred             ceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------Hhhhc----------cCCcccCCHHHHHH
Confidence            9999877664 589999999999999999999853210             00000          01122234458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       264 i~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          264 IRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            99999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=3.1e-27  Score=195.64  Aligned_cols=166  Identities=21%  Similarity=0.268  Sum_probs=121.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||+|||+ .|   ++|+||+|+||+++.++.++|+|||++......    ......++..|+
T Consensus       145 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~  217 (348)
T 2pml_X          145 TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFM  217 (348)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCcc
Confidence            4679999999999999999999999 98   999999999999999999999999999875432    122235678999


Q ss_pred             ChhhhhcC-CCCc-cccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhh------hch---hhcchh
Q 026939           82 APEYAMEG-LFSV-KSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALEL------MEP---VLKQSC  150 (230)
Q Consensus        82 aPe~~~~~-~~~~-~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~---~~~~~~  150 (230)
                      |||.+.+. .++. ++|+||||+++|+|++|..||.......     ... .....+.....      ..+   ......
T Consensus       218 aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (348)
T 2pml_X          218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-----ELF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCS  291 (348)
T ss_dssp             CGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-----HHH-HHHTSCCCCCCCSSSSSTTTTCC------
T ss_pred             CchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHH-HHHhccCcCCccchhhhhccccccccccc
Confidence            99999877 5665 9999999999999999999986433210     000 00101100000      000   000001


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....+..+.+++.+||+.||.+|||+.++++
T Consensus       292 ~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          292 NNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1233456899999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=1.1e-27  Score=194.98  Aligned_cols=162  Identities=22%  Similarity=0.261  Sum_probs=122.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEe---CCCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLL---DHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++..++.++.||+.||.|||+.|   ++|+||+|+||++   +.++.++|+|||++......    ......++..|
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y  173 (304)
T 2jam_A          101 GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGY  173 (304)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCB
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCc
Confidence            46899999999999999999999999   9999999999999   67889999999998654321    11223568899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||.+.+..++.++|+||||+++|+|++|..||.......      .. .....+.. .     .........+..+.+
T Consensus       174 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~i~~~~~-~-----~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LF-EKIKEGYY-E-----FESPFWDDISESAKD  240 (304)
T ss_dssp             CCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-HHHHHCCC-C-----CCTTTTTTSCHHHHH
T ss_pred             cChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHcCCC-C-----CCccccccCCHHHHH
Confidence            99999998889999999999999999999999985432110      00 00001000 0     001112233456889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH--Hhhc
Q 026939          161 IGLLCVQADSADRPTMSSVVV--MLAS  185 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~--~L~~  185 (230)
                      ++.+||+.||++|||+.++++  .+.+
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          241 FICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHcCCChhHCcCHHHHhcCccccC
Confidence            999999999999999999987  4544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=3.5e-27  Score=204.99  Aligned_cols=164  Identities=25%  Similarity=0.307  Sum_probs=122.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC---CeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM---NPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||+|||+.|   |+||||+|+||+++.++   .++|+|||++........   .....+++.
T Consensus       140 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~  213 (504)
T 3q5i_A          140 RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAY  213 (504)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcC
Confidence            357899999999999999999999999   99999999999998775   599999999987643322   122367889


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||++. ..++.++||||+||++|+|++|..||.......      .... ...+...      .........+..+.
T Consensus       214 y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~-i~~~~~~------~~~~~~~~~s~~~~  279 (504)
T 3q5i_A          214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKK-VEKGKYY------FDFNDWKNISDEAK  279 (504)
T ss_dssp             TCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCCCC------CCHHHHTTSCHHHH
T ss_pred             CCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHcCCCC------CCccccCCCCHHHH
Confidence            99999986 568999999999999999999999986432211      1000 0010000      00000112345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          160 HIGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      +++.+||+.||.+|||+.++++  .+.+.
T Consensus       280 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          280 ELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            9999999999999999999986  44443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=5.1e-27  Score=190.26  Aligned_cols=160  Identities=23%  Similarity=0.322  Sum_probs=112.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC------------Cccc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS------------EAST   71 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------~~~~   71 (230)
                      ..+++..++.++.||+.||+|||+++   ++|+||+|+||+++.++.++|+|||++........            ....
T Consensus       111 ~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (303)
T 1zy4_A          111 LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL  187 (303)
T ss_dssp             GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccccccc
Confidence            45788899999999999999999999   99999999999999999999999999875432110            0111


Q ss_pred             cccccccCccChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchh
Q 026939           72 NRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC  150 (230)
Q Consensus        72 ~~~~~~~~~~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (230)
                      ....++..|+|||.+.+. .++.++|+|||||++|+|++   ||......     .... .....      ........+
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-----~~~~-~~~~~------~~~~~~~~~  252 (303)
T 1zy4_A          188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-----VNIL-KKLRS------VSIEFPPDF  252 (303)
T ss_dssp             ------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----HHHH-HHHHS------TTCCCCTTC
T ss_pred             ccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-----HHHH-Hhccc------cccccCccc
Confidence            223567889999999865 68999999999999999998   43211100     0000 00000      011111223


Q ss_pred             hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          151 VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       151 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +......+.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          253 DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            3344556889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.94  E-value=5.5e-27  Score=200.21  Aligned_cols=157  Identities=31%  Similarity=0.385  Sum_probs=111.4

Q ss_pred             HHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-------------CCeEEcccccceeecCCCCCc--ccccc
Q 026939           10 RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-------------MNPKISDFEMARIFGGNQSEA--STNRI   74 (230)
Q Consensus        10 ~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-------------~~~~l~d~~~~~~~~~~~~~~--~~~~~   74 (230)
                      .++.++.||+.||+|||+.+   |+||||+|+||+++.+             +.++|+|||++..........  .....
T Consensus       116 ~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~  192 (434)
T 2rio_A          116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP  192 (434)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC------------
T ss_pred             hHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCC
Confidence            45789999999999999999   9999999999999654             479999999998764332211  11234


Q ss_pred             ccccCccChhhhhc-------CCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhh
Q 026939           75 VGTYGYMAPEYAME-------GLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVL  146 (230)
Q Consensus        75 ~~~~~~~aPe~~~~-------~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (230)
                      .++..|+|||++.+       ..++.++|||||||++|+|++ |..||+......        .... .+.. ..  ...
T Consensus       193 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~i~-~~~~-~~--~~~  260 (434)
T 2rio_A          193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--------SNII-RGIF-SL--DEM  260 (434)
T ss_dssp             --CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--------HHHH-HTCC-CC--CCC
T ss_pred             CCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--------HHHh-cCCC-Cc--ccc
Confidence            67889999999975       568899999999999999999 899986432111        0000 0000 00  000


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...........+.+++.+||+.||.+|||+.+|++
T Consensus       261 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          261 KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11113445667899999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.94  E-value=6.4e-27  Score=199.70  Aligned_cols=160  Identities=24%  Similarity=0.323  Sum_probs=110.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-----CCCeEEcccccceeecCCCC-Ccccccccccc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-----EMNPKISDFEMARIFGGNQS-EASTNRIVGTY   78 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~   78 (230)
                      .+....++.++.||+.||+|||+.+   |+||||||+||+++.     ...++|+|||++........ ........+++
T Consensus       114 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~  190 (432)
T 3p23_A          114 AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE  190 (432)
T ss_dssp             CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCT
T ss_pred             CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCc
Confidence            3455567899999999999999999   999999999999953     23578999999976543221 11222346789


Q ss_pred             CccChhhhh---cCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           79 GYMAPEYAM---EGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        79 ~~~aPe~~~---~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .|+|||++.   ...++.++|||||||++|+|++ |..||+.......        ............      ......
T Consensus       191 ~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--------~~~~~~~~~~~~------~~~~~~  256 (432)
T 3p23_A          191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--------NILLGACSLDCL------HPEKHE  256 (432)
T ss_dssp             TSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--------HHHTTCCCCTTS------CTTCHH
T ss_pred             CccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--------HHHhccCCcccc------Cccccc
Confidence            999999997   3567789999999999999999 8888853221110        000000000000      111233


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...+.+++.+||+.||++|||+.+|++
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            455788999999999999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.94  E-value=6.5e-27  Score=188.96  Aligned_cols=159  Identities=24%  Similarity=0.242  Sum_probs=117.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC---CCeEEcccccceeecCCCCCccccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE---MNPKISDFEMARIFGGNQSEASTNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   79 (230)
                      ...+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.+   +.++|+|||++.........   ....++..
T Consensus       115 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~  188 (287)
T 2wei_A          115 RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAY  188 (287)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC---SCHHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc---ccccCccc
Confidence            357899999999999999999999999   9999999999999754   46999999998765432211   12245778


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      |+|||.+.+ .++.++|+||||+++|+|++|..||.......      ... ....+....      ........+..+.
T Consensus       189 y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~------~~~~~~~~~~~~~  254 (287)
T 2wei_A          189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILK-RVETGKYAF------DLPQWRTISDDAK  254 (287)
T ss_dssp             TCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH-HHHHCCCCC------CSGGGTTSCHHHH
T ss_pred             ccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHcCCCCC------CchhhhhcCHHHH
Confidence            999999865 48899999999999999999999985432111      111 111111000      0001112344588


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||++|||+.++++
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhc
Confidence            9999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.92  E-value=4.5e-25  Score=179.31  Aligned_cols=147  Identities=16%  Similarity=0.197  Sum_probs=105.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..+++.+++.++.||+.||+|||+.+   ++|+||+|+||+++.   ++.++|+|||++....                 
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------  171 (299)
T 3m2w_A          112 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------  171 (299)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------
Confidence            46999999999999999999999999   999999999999998   7889999999886432                 


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                             +..++.++|||||||++|+|++|..||.............         ..................+..+.+
T Consensus       172 -------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T 3m2w_A          172 -------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------TRIRMGQYEFPNPEWSEVSEEVKM  235 (299)
T ss_dssp             -------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------CSSCTTCCSSCHHHHTTSCHHHHH
T ss_pred             -------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------HHHhhccccCCchhcccCCHHHHH
Confidence                   1335678999999999999999999985432211100000         000000000000011223456899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH--HhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVV--MLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~--~L~~~  186 (230)
                      ++.+||+.||.+|||+.++++  .+.+.
T Consensus       236 li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          236 LIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHHHHcccChhhCCCHHHHhcChhhccc
Confidence            999999999999999999997  45443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.92  E-value=7.8e-26  Score=200.61  Aligned_cols=168  Identities=24%  Similarity=0.257  Sum_probs=116.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC---eEEcccccceeecCCCCCccccccccccCcc
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN---PKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      .+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.   ++|+|||++.........   ....++..|+
T Consensus       117 ~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~  190 (676)
T 3qa8_A          117 GLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYL  190 (676)
T ss_dssp             CCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccccc---ccccCCcccC
Confidence            6889999999999999999999999   999999999999987665   899999999765433221   2246688999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccc-cchhhh-hHHH-Hhhhhhhhh--hchh--hcchhhHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG-QSLLSY-TWKL-WCEGEALEL--MEPV--LKQSCVAAE  154 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~-~~~~~~-~~~~-~~~~~~~~~--~~~~--~~~~~~~~~  154 (230)
                      |||.+.+..++.++||||||+++|+|++|..||........ ...... .... .........  ....  .........
T Consensus       191 APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~l  270 (676)
T 3qa8_A          191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL  270 (676)
T ss_dssp             SSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGG
T ss_pred             ChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhh
Confidence            99999988999999999999999999999999854221100 000000 0000 000000000  0000  011223345


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHH
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSS  178 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~  178 (230)
                      +..+.+++.+||..||++|||+.+
T Consensus       271 s~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          271 AGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             HHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hHHHHHHHHHHccCCHhhCcCHHH
Confidence            667999999999999999999966

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.91  E-value=1.3e-24  Score=195.10  Aligned_cols=148  Identities=21%  Similarity=0.253  Sum_probs=115.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.+++.++.||+.||.|||++|   |+||||||+||+++.+ .+||+|||++......      ....+++.|+||
T Consensus       177 ~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aP  246 (681)
T 2pzi_A          177 QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAP  246 (681)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCH
Confidence            37899999999999999999999999   9999999999999975 8999999999765432      224578899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+.. +.++|||||||++|+|++|..||........                   .    ...........+.+++.
T Consensus       247 E~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------~----~~~~~~~~~~~l~~li~  302 (681)
T 2pzi_A          247 EIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------P----EDDPVLKTYDSYGRLLR  302 (681)
T ss_dssp             THHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------C----TTCHHHHHCHHHHHHHH
T ss_pred             HHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------c----ccccccccCHHHHHHHh
Confidence            9987654 8899999999999999999887643111100                   0    00111223356889999


Q ss_pred             hhcCCCCCCCCC-HHHHHHHhhc
Q 026939          164 LCVQADSADRPT-MSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs-~~~i~~~L~~  185 (230)
                      +||+.||++||+ ++++...|.+
T Consensus       303 ~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          303 RAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             hhccCChhhCCCHHHHHHHHHHH
Confidence            999999999995 5556555543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.89  E-value=2.7e-23  Score=171.41  Aligned_cols=151  Identities=13%  Similarity=0.096  Sum_probs=112.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhH-hCCCCCeeecCCCCCceEeCCCC--------------------CeEEccccccee
Q 026939            3 SVQLDWKRRISIINGIARGLLYLH-EDSRLRIIHRDLKASNVLLDHEM--------------------NPKISDFEMARI   61 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh-~~~~~~i~H~di~~~nil~~~~~--------------------~~~l~d~~~~~~   61 (230)
                      +..+++..++.++.||+.||+||| +.+   |+||||||+|||++.++                    .+||+|||++..
T Consensus       155 ~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~  231 (336)
T 2vuw_A          155 TKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRL  231 (336)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBE
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEe
Confidence            467899999999999999999999 899   99999999999999887                    899999999987


Q ss_pred             ecCCCCCccccccccccCccChhhhhcCCCCccccchhhHHH-HHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhh
Q 026939           62 FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL-LLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALE  140 (230)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~DiwslG~l-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (230)
                      ....       ...++..|+|||++.+.. +.++||||++++ .+++++|..||...           .+..........
T Consensus       232 ~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----------~~~~~~~~~~~~  292 (336)
T 2vuw_A          232 ERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----------LWLHYLTDKMLK  292 (336)
T ss_dssp             EETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----------HHHHHHHHHHHH
T ss_pred             cCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----------hhhhHHHHhhhh
Confidence            6432       236788999999998666 889999998766 77788888886310           000000000110


Q ss_pred             --hhchhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 026939          141 --LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV  180 (230)
Q Consensus       141 --~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~  180 (230)
                        ..............+..+.+++.+||+.|     |+++++
T Consensus       293 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          293 QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             TCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence              01111122334567788999999999977     898887

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.88  E-value=4.3e-23  Score=166.90  Aligned_cols=139  Identities=13%  Similarity=0.059  Sum_probs=101.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChhh
Q 026939            6 LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPEY   85 (230)
Q Consensus         6 l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe~   85 (230)
                      ....++++++.||+.||+|||++|   |+||||||+||+++.++.++|++++                      |++   
T Consensus       126 ~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------------------~~~---  177 (286)
T 3uqc_A          126 PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP---  177 (286)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------------------CCT---
T ss_pred             CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------------------ccC---
Confidence            355678999999999999999999   9999999999999999999988432                      222   


Q ss_pred             hhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccc-hhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHhh
Q 026939           86 AMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS-LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL  164 (230)
Q Consensus        86 ~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  164 (230)
                          .++.++|||||||++|+|++|..||.......... .....     .....   .   ........+..+.+++.+
T Consensus       178 ----~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~---~---~~~~~~~~~~~l~~li~~  242 (286)
T 3uqc_A          178 ----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-----AGQPI---E---PADIDRDIPFQISAVAAR  242 (286)
T ss_dssp             ----TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-----TSCBC---C---HHHHCTTSCHHHHHHHHH
T ss_pred             ----CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-----ccCCC---C---hhhcccCCCHHHHHHHHH
Confidence                25789999999999999999999986543321100 00000     00000   0   001112234458899999


Q ss_pred             hcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          165 CVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       165 cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      ||+.||++| |+.++++.|+....
T Consensus       243 ~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          243 SVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             HcccCCccC-CHHHHHHHHHHHhc
Confidence            999999999 99999999987543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.75  E-value=1.8e-19  Score=158.40  Aligned_cols=101  Identities=19%  Similarity=0.170  Sum_probs=66.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.+++..   +|+.||+.||+|+|++|   |+||||||+|||++.+|.+||+|||++.........  .....|++.|++
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~--~~t~vGTp~YmA  407 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW--PTNLVQSFFVFV  407 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---CC--SHHHHHHHHHHH
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc--ccCceechhhcc
Confidence            3466654   47899999999999999   999999999999999999999999999765433222  223468999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCC
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKK  112 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~  112 (230)
                      ||++.+ .+...+|+|++|++.+++.++..
T Consensus       408 PE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          408 NELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             HHHC------------------CCCCTTHH
T ss_pred             HHHhCC-CCCCcccccccccchhhhccccc
Confidence            999865 45678999999998877655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.45  E-value=1.6e-14  Score=126.36  Aligned_cols=99  Identities=20%  Similarity=0.244  Sum_probs=80.0

Q ss_pred             HHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-----cccccccccCccChhh
Q 026939           11 RISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-----STNRIVGTYGYMAPEY   85 (230)
Q Consensus        11 ~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPe~   85 (230)
                      ++.++.||+.||+|||+++   |+||||||+||+++.  .+||+|||++..........     ......+++.|+|||+
T Consensus       433 ~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv  507 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEI  507 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHH
Confidence            4589999999999999999   999999999999998  99999999998764322111     1123467899999999


Q ss_pred             hhc--CCCCccccchhhHHHHHHHHhcCCCC
Q 026939           86 AME--GLFSVKSDVFSFGVLLLEIISGKKNS  114 (230)
Q Consensus        86 ~~~--~~~~~~~DiwslG~ll~~ll~g~~p~  114 (230)
                      +..  ..|+...|+|+...-..+.+.+..+|
T Consensus       508 ~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          508 WERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            986  56888899999888777777665554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.20  E-value=1e-11  Score=99.89  Aligned_cols=49  Identities=24%  Similarity=0.272  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939            9 KRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus         9 ~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .....++.||+.||.+||+.|   ++||||+|+||+++ ++.++|+|||++..
T Consensus       193 ~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          193 ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            445689999999999999999   99999999999999 99999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.92  E-value=1.5e-09  Score=85.89  Aligned_cols=50  Identities=20%  Similarity=0.215  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHHhH-hCCCCCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939            8 WKRRISIINGIARGLLYLH-EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus         8 ~~~~~~i~~qi~~al~~Lh-~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      +..+..++.||+.||.+|| +.|   ++||||+|.|||++.  .++|+|||++...
T Consensus       169 ~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          169 ELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             hHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            3467889999999999999 999   999999999999998  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.41  E-value=2.1e-07  Score=77.65  Aligned_cols=50  Identities=24%  Similarity=0.367  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCC----------eEEcccccceee
Q 026939           10 RRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMN----------PKISDFEMARIF   62 (230)
Q Consensus        10 ~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~----------~~l~d~~~~~~~   62 (230)
                      ....++.||+.+|.+||+.|   ++||||||.|||++.++.          +.++||+.+...
T Consensus       206 ~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          206 DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            45678899999999999999   999999999999987763          789999876543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.61  E-value=2.2e-05  Score=63.22  Aligned_cols=81  Identities=22%  Similarity=0.272  Sum_probs=48.0

Q ss_pred             CeeecCCCCCceEeCC--CCCeEEcccccceeecCCCCCccc------------cccccccCccC-hhhhhcCCCCcccc
Q 026939           32 RIIHRDLKASNVLLDH--EMNPKISDFEMARIFGGNQSEAST------------NRIVGTYGYMA-PEYAMEGLFSVKSD   96 (230)
Q Consensus        32 ~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~------------~~~~~~~~~~a-Pe~~~~~~~~~~~D   96 (230)
                      .++|+|+++.||+++.  .+.+.++||+.+............            ........... |+.....  ....+
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~  269 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY--RMKEK  269 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH--HHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH--HHHHH
Confidence            4899999999999987  455789999988654221100000            00000001111 2222111  12357


Q ss_pred             chhhHHHHHHHHhcCCCC
Q 026939           97 VFSFGVLLLEIISGKKNS  114 (230)
Q Consensus        97 iwslG~ll~~ll~g~~p~  114 (230)
                      .|+++.++|.+.+|..+|
T Consensus       270 ~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          270 YWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHcCCHHH
Confidence            899999999999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.38  E-value=0.00058  Score=52.05  Aligned_cols=91  Identities=9%  Similarity=0.044  Sum_probs=55.8

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHh-HhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYL-HEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~L-h~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ++++|++.++|.++.|.+.+|.-+ ....   -..+=+.+..|++..+|.+.+.+ +...              .....+
T Consensus        42 ~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~  103 (229)
T 2yle_A           42 YNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPP  103 (229)
T ss_dssp             HTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C-----------------------
T ss_pred             cCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc--------------ccccCC
Confidence            468999999999999999998765 2211   11233446788888888776664 1100              012245


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcC
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGK  111 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~  111 (230)
                      .+||... ...+.+.=||+||+++|.-+--.
T Consensus       104 ~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          104 VAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ---CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             CChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence            6676652 23456677999999999887633

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.33  E-value=0.00037  Score=57.27  Aligned_cols=57  Identities=18%  Similarity=0.323  Sum_probs=46.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCC-------------------------------------------------------
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDS-------------------------------------------------------   29 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~-------------------------------------------------------   29 (230)
                      .++..++..++.+++..|+.||+..                                                       
T Consensus       135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  214 (359)
T 3dxp_A          135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD  214 (359)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence            4567888999999999999999731                                                       


Q ss_pred             CCCeeecCCCCCceEeCCCCC--eEEccccccee
Q 026939           30 RLRIIHRDLKASNVLLDHEMN--PKISDFEMARI   61 (230)
Q Consensus        30 ~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~   61 (230)
                      ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            134999999999999997653  68999998765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.17  E-value=0.00033  Score=54.82  Aligned_cols=30  Identities=20%  Similarity=0.216  Sum_probs=24.4

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+++.||+++.++.+.|+||+.+..
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            389999999999997655567999987643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.00  E-value=0.00044  Score=53.67  Aligned_cols=29  Identities=14%  Similarity=0.209  Sum_probs=24.7

Q ss_pred             eeecCCCCCceEeCCCCCeEEccccccee
Q 026939           33 IIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        33 i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ++|+|+++.||+++.++.+.|+||+.+..
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            99999999999998765567999997654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.96  E-value=0.013  Score=47.22  Aligned_cols=30  Identities=20%  Similarity=0.345  Sum_probs=26.4

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+++.||+++.++.+.++||+.+..
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            399999999999998888899999987643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=94.85  E-value=0.056  Score=43.18  Aligned_cols=31  Identities=35%  Similarity=0.434  Sum_probs=25.2

Q ss_pred             CeeecCCCCCceEeCC---CCCe-EEcccccceee
Q 026939           32 RIIHRDLKASNVLLDH---EMNP-KISDFEMARIF   62 (230)
Q Consensus        32 ~i~H~di~~~nil~~~---~~~~-~l~d~~~~~~~   62 (230)
                      .++|+|+++.||+++.   ++.+ .|+||+.+...
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence            3799999999999987   4554 79999877553

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.83  E-value=0.032  Score=46.72  Aligned_cols=30  Identities=23%  Similarity=0.378  Sum_probs=26.4

Q ss_pred             CeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      .++|+|+++.||+++.++ +.++||+.+...
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            399999999999998776 999999988654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.21  E-value=0.14  Score=41.14  Aligned_cols=31  Identities=32%  Similarity=0.444  Sum_probs=26.6

Q ss_pred             CeeecCCCCCceEeCCC----CCeEEcccccceee
Q 026939           32 RIIHRDLKASNVLLDHE----MNPKISDFEMARIF   62 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~   62 (230)
                      .++|+|+.+.||+++.+    +.+.++||+.+...
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            49999999999999874    67899999988654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=92.83  E-value=0.048  Score=42.40  Aligned_cols=30  Identities=20%  Similarity=0.232  Sum_probs=25.4

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||+++..+.+.|+||+.+..
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            389999999999998776677999987754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.53  E-value=0.13  Score=41.11  Aligned_cols=28  Identities=32%  Similarity=0.474  Sum_probs=24.3

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+++.||+++ + .+.++||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            389999999999999 4 889999987654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.57  E-value=0.17  Score=38.48  Aligned_cols=50  Identities=8%  Similarity=0.057  Sum_probs=42.0

Q ss_pred             CCCHHHHHHHHHHHHHHHH-HhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccc
Q 026939            5 QLDWKRRISIINGIARGLL-YLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMA   59 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~-~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~   59 (230)
                      .++...+++++.+|+.... +++.     -+|.-++|+|++++.++.+++.-.|+-
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEET
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence            4678899999999988777 5654     678899999999999999999976653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.48  E-value=0.067  Score=42.76  Aligned_cols=30  Identities=30%  Similarity=0.324  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+++.||+++.++.+.++||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            499999999999998765568999987643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=91.05  E-value=0.079  Score=43.04  Aligned_cols=30  Identities=23%  Similarity=0.349  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            499999999999998544478999988754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=90.79  E-value=0.24  Score=40.13  Aligned_cols=32  Identities=28%  Similarity=0.405  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939           31 LRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      ..++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            34999999999999998788999999877543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.32  E-value=0.35  Score=41.03  Aligned_cols=16  Identities=31%  Similarity=0.478  Sum_probs=14.5

Q ss_pred             CCeeecCCCCCceEeC
Q 026939           31 LRIIHRDLKASNVLLD   46 (230)
Q Consensus        31 ~~i~H~di~~~nil~~   46 (230)
                      ..++|+|+.+.||+++
T Consensus       290 ~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          290 IVLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEEECSCCCGGGEEEC
T ss_pred             eeEEecCCCCCcEEee
Confidence            3589999999999998

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=89.96  E-value=0.45  Score=39.21  Aligned_cols=30  Identities=27%  Similarity=0.367  Sum_probs=25.3

Q ss_pred             CeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      .++|+|+.+.||+++.+ .++++||..+...
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            39999999999999865 4899999877653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=89.68  E-value=0.39  Score=37.93  Aligned_cols=31  Identities=29%  Similarity=0.264  Sum_probs=25.3

Q ss_pred             CCeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939           31 LRIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      ..++|+|+.+.||+ ..++.+.++||..+...
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            35899999999999 55667899999877643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.39  E-value=0.2  Score=40.91  Aligned_cols=29  Identities=24%  Similarity=0.473  Sum_probs=23.9

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||+++.++ +.++||+.+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            499999999999998654 89999987653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.57  E-value=0.3  Score=36.92  Aligned_cols=82  Identities=9%  Similarity=0.045  Sum_probs=57.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++...+++++.+|+....++++     -+|--++|+|++++.++.+++.-.|+-...                   +|.
T Consensus        77 ~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~  132 (215)
T 4ann_A           77 SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL  132 (215)
T ss_dssp             GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEETTTB-------------------SCC
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccCccCC-------------------CCC
Confidence            56788999999999998866654     578899999999999999999876643211                   111


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcCCCCC
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGKKNSG  115 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~  115 (230)
                           ..+...=.-.+=|++..+++++..|.
T Consensus       133 -----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          133 -----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             -----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             -----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence                 01111123355678888888888763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=87.82  E-value=0.22  Score=41.81  Aligned_cols=30  Identities=33%  Similarity=0.478  Sum_probs=23.9

Q ss_pred             CeeecCCCCCceEeCCC----------------------------CCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHE----------------------------MNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~----------------------------~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||+++.+                            +.+.|+||..+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            48999999999999875                            6788999877653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=86.08  E-value=0.38  Score=39.76  Aligned_cols=31  Identities=29%  Similarity=0.442  Sum_probs=26.2

Q ss_pred             CCeeecCCCCCceEeCCC----CCeEEccccccee
Q 026939           31 LRIIHRDLKASNVLLDHE----MNPKISDFEMARI   61 (230)
Q Consensus        31 ~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~   61 (230)
                      ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            359999999999999876    6889999987653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.83  E-value=0.56  Score=38.91  Aligned_cols=30  Identities=27%  Similarity=0.431  Sum_probs=24.6

Q ss_pred             CeeecCCCCCceEe------CCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLL------DHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~------~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||++      +.+..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4556799999987754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	230
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-39
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-38
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-36
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-35
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-35
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-33
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-32
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-31
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-26
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-25
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-25
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-24
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-24
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-23
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-23
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-22
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-22
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-22
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-21
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-21
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-20
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-19
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-19
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-19
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-18
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-18
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-18
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-15
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-14
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-14
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-08

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 6e-43
 Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 17/194 (8%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
              + +  + I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DF +A +
Sbjct: 97  IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYL 118
                      ++ G+  +MAPE      +  +S +SDV++FG++L E+++G+    +  
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YS- 210

Query: 119 SELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSS 178
                +       +   G     +  V  +S     + + +     C++    +RP    
Sbjct: 211 ---NINNRDQIIFMVGRGYLSPDLSKV--RSNCPKAMKRLM---AECLKKKRDERPLFPQ 262

Query: 179 VVVMLASDNVTLPQ 192
           ++  +     +LP+
Sbjct: 263 ILASIELLARSLPK 276

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 7e-39
 Identities = 41/201 (20%), Positives = 77/201 (38%), Gaps = 18/201 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-----SRLRIIHRDLKASNVLLDHEMNPKISD 55
           +    +  +  I +    A GL +LH +      +  I HRDLK+ N+L+       I+D
Sbjct: 92  LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151

Query: 56  FEMARIF--GGNQSEASTNRIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEI 107
             +A       +  + + N  VGT  YMAPE   + +         ++D+++ G++  EI
Sbjct: 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

Query: 108 ISGKKNSGFYLSE----LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH-IG 162
                  G +               + +   +    + + P +     + E L+ +  I 
Sbjct: 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 271

Query: 163 LLCVQADSADRPTMSSVVVML 183
             C  A+ A R T   +   L
Sbjct: 272 RECWYANGAARLTALRIKKTL 292

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-38
 Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 19/182 (10%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DF +AR+
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
              N+  A          + APE    G F++KSDV+SFG+LL EI++  +     ++  
Sbjct: 159 IEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN- 216

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
                    +    G  +   +   ++            +  LC +    DRPT   +  
Sbjct: 217 -----PEVIQNLERGYRMVRPDNCPEE---------LYQLMRLCWKERPEDRPTFDYLRS 262

Query: 182 ML 183
           +L
Sbjct: 263 VL 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (332), Expect = 5e-38
 Identities = 43/178 (24%), Positives = 72/178 (40%), Gaps = 18/178 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L    ++ I   +A G+ YL E    + +HRDL   N L+   M  KI+DF ++R     
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
               +         +M PE      ++ +SDV+++GV+L EI S       Y     + +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMAHEEV 251

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           +        +G  L   E    +           ++  LC     ADRP+  S+  +L
Sbjct: 252 I----YYVRDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-37
 Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 19/190 (10%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS 67
             + + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DF +AR+   N+ 
Sbjct: 112 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS 127
            A          + APE A+ G F++KSDV+SFG+LL E+ +  +               
Sbjct: 169 TARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-------------- 213

Query: 128 YTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDN 187
             +      E L+ +E   +  C          +   C + +  +RPT   +   L    
Sbjct: 214 -PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

Query: 188 VTLPQPTEPA 197
            +     +P 
Sbjct: 273 TSTEPQYQPG 282

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 4e-37
 Identities = 40/183 (21%), Positives = 80/183 (43%), Gaps = 19/183 (10%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
           +  +    + + ++ GIA G+ YL     +  +HRDL A N+L++  +  K+SDF ++R+
Sbjct: 103 KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159

Query: 62  FGGNQSEAST-NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE 120
              +     T +       + APE      F+  SDV+SFG+++ E+++  +   + LS 
Sbjct: 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS- 218

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                           E ++ +    +             + + C Q + A RP  + +V
Sbjct: 219 --------------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

Query: 181 VML 183
            +L
Sbjct: 265 SIL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-36
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 17/180 (9%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L ++  +     +A+G+ +L        +HRDL A NVL+ H    KI DF +AR    +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
            +            +MAPE   EG++++KSDV+S+G+LL EI S   N  +     G  +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YP----GIPV 272

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
            +  +KL   G  ++      ++            I   C   DS  RP+  ++   L  
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTSFLGC 323

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 6e-36
 Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 32/207 (15%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ 66
             +  ++    IA+G+ YL      R++HRDL A NVL+    + KI+DF +A++ G  +
Sbjct: 109 GSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

Query: 67  SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL 126
            E           +MA E  +  +++ +SDV+S+GV + E+++                 
Sbjct: 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-------------- 211

Query: 127 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML--- 183
              +      E   ++E   +        +    I + C   D+  RP    +++     
Sbjct: 212 -KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

Query: 184 -----------ASDNVTLPQPTEPAFS 199
                        + + LP PT+  F 
Sbjct: 271 ARDPQRYLVIQGDERMHLPSPTDSNFY 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 7e-36
 Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 17/178 (9%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L  +  I     +A+G+ +L      + IHRDL A N+LL  +   KI DF +AR    +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
                         +MAPE   + +++++SDV+SFGVLL EI S   +        G  +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKI 242

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                +   EG  +   +    +              L C   + + RPT S +V  L
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (314), Expect = 2e-35
 Identities = 40/180 (22%), Positives = 75/180 (41%), Gaps = 21/180 (11%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ 66
              + + ++ GIA G+ YL     +  +HRDL A N+L++  +  K+SDF ++R    + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 67  SEASTNRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
           S+ +    +G      + APE      F+  SDV+S+G+++ E++S  +           
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----------- 231

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                 +      + +  +E   +             + L C Q D   RP    +V  L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-35
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 17/181 (9%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIF 62
            + LD +  +S    +A+G+ +L        IHRDL A N+LL H    KI DF +AR  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG 122
             + +            +MAPE     +++ +SDV+S+G+ L E+ S   +    +    
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 182
           +      +K+  EG  +   E    +            I   C  AD   RPT   +V +
Sbjct: 256 K-----FYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 183 L 183
           +
Sbjct: 302 I 302

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 2e-35
 Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 39/209 (18%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            ++ ++  +    +   + +GL YL    + +I+HRD+K SN+L++     K+ DF ++ 
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK--------- 111
               +      N  VGT  YM+PE      +SV+SD++S G+ L+E+  G+         
Sbjct: 154 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

Query: 112 --------------KNSGFYLSELGQSLLSYTWKLWCEGEALELME-------PVLKQSC 150
                           +       G+ L SY           EL++       P L    
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV 269

Query: 151 VAAELLKFIHIGLLCVQADSADRPTMSSV 179
            + E   F++    C+  + A+R  +  +
Sbjct: 270 FSLEFQDFVN---KCLIKNPAERADLKQL 295

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-35
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 19/184 (10%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            ++  +  K  I +++ ++ G+ YL        +HRDL A NVLL  +   KISDF +++
Sbjct: 99  QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 155

Query: 61  IFGGNQSEASTN-RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
               +++             + APE      FS KSDV+SFGVL+ E  S  +    Y  
Sbjct: 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRG 213

Query: 120 ELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
             G  +      +  +GE +       ++            +  LC   D  +RP  ++V
Sbjct: 214 MKGSEVT----AMLEKGERMGCPAGCPRE---------MYDLMNLCWTYDVENRPGFAAV 260

Query: 180 VVML 183
            + L
Sbjct: 261 ELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 6e-35
 Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 18/179 (10%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             + +         + +  G++YLH    + I HRD+K  N+LLD   N KISDF +A +
Sbjct: 96  PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV 152

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSE 120
           F  N  E   N++ GT  Y+APE      F +   DV+S G++L  +++G+         
Sbjct: 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD----- 207

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
              S     +  W E +    + P  K       LL         +  + + R T+  +
Sbjct: 208 -QPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLH------KILVENPSARITIPDI 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 1e-34
 Identities = 42/179 (23%), Positives = 72/179 (40%), Gaps = 19/179 (10%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++     + +   I+  + YL    +   IHRDL A N L+      K++DF ++R+  G
Sbjct: 111 EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
           +   A          + APE      FS+KSDV++FGVLL EI +   +           
Sbjct: 168 DTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------- 215

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                +      +  EL+E   +         K   +   C Q + +DRP+ + +    
Sbjct: 216 ----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-34
 Identities = 44/177 (24%), Positives = 68/177 (38%), Gaps = 19/177 (10%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ 66
             +  + +   +  G+ YL E     +IHRDL A N L+      K+SDF M R    +Q
Sbjct: 99  AAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155

Query: 67  SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL 126
              S+        + +PE      +S KSDV+SFGVL+ E+ S  K              
Sbjct: 156 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK-------------- 200

Query: 127 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
              ++     E +E +    +             I   C +    DRP  S ++  L
Sbjct: 201 -IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 4e-34
 Identities = 53/179 (29%), Positives = 78/179 (43%), Gaps = 18/179 (10%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           QL  K  +S    +ARG+ YL      + IHRDL A NVL+  +   KI+DF +AR    
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
                 T        +MAPE   + +++ +SDV+SFGVLL EI +   +   Y     + 
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEE 245

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           L    +KL  EG  ++       +            +   C  A  + RPT   +V  L
Sbjct: 246 L----FKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 8e-34
 Identities = 43/195 (22%), Positives = 77/195 (39%), Gaps = 19/195 (9%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           ++       +++ ++ G+ YL        +HRDL A NVLL +    KISDF +++  G 
Sbjct: 105 EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161

Query: 65  NQSEAS-TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
           + S  +  +       + APE      FS +SDV+S+GV + E +S  +    Y    G 
Sbjct: 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGP 219

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
            ++        +G+ +E       +            +   C      DRP   +V   +
Sbjct: 220 EVM----AFIEQGKRMECPPECPPE---------LYALMSDCWIYKWEDRPDFLTVEQRM 266

Query: 184 ASDNVTLPQPTEPAF 198
            +   +L    E   
Sbjct: 267 RACYYSLASKVEGHH 281

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 8e-34
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 21/178 (11%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L  ++ +     +ARG+ YL +    + IHRDL A N+L+      KI+DF ++R   G 
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 177

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
           +             +MA E     +++  SDV+S+GVLL EI+S        ++      
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--- 234

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
               ++   +G  LE       +            +   C +    +RP+ + ++V L
Sbjct: 235 ---LYEKLPQGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQILVSL 280

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-33
 Identities = 39/180 (21%), Positives = 76/180 (42%), Gaps = 21/180 (11%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMAR 60
           R   +  K   S    I +GL +LH  +   IIHRDLK  N+ +     + KI D  +A 
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE 120
           +   +        ++GT  +MAPE   E  +    DV++FG+ +LE+ + +    +    
Sbjct: 164 LKRASF----AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YS--- 213

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                 +  ++    G     ++P         E+ + I     C++ +  +R ++  ++
Sbjct: 214 -ECQNAAQIYRRVTSG-----VKPASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-33
 Identities = 40/183 (21%), Positives = 73/183 (39%), Gaps = 19/183 (10%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
               +   ++ + +   +   + YL      + +HRDL A N L++ +   K+SDF ++R
Sbjct: 92  EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE 120
               ++  +S         +  PE  M   FS KSD+++FGVL+ EI S  K        
Sbjct: 149 YVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-------- 199

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                    ++ +   E  E +   L+         K   I   C    + +RPT   ++
Sbjct: 200 -------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILL 252

Query: 181 VML 183
             +
Sbjct: 253 SNI 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-33
 Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 20/185 (10%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
             +     K  I     +A+G+      +  + +HRDL A N +LD +   K++DF +AR
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 61  IFGGNQSEASTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYL 118
                + ++  N+        +MA E      F+ KSDV+SFGVLL E+++       Y 
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYP 236

Query: 119 SELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSS 178
                 +  Y  +             +L+       L + +   L C    +  RP+ S 
Sbjct: 237 DVNTFDITVYLLQ----------GRRLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSE 283

Query: 179 VVVML 183
           +V  +
Sbjct: 284 LVSRI 288

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 4e-33
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 22/178 (12%)

Query: 6   LDWKRRISIINGIARGLLYLHE--DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG 63
           LD +  + ++  +   L   H   D    ++HRDLK +NV LD + N K+ DF +ARI  
Sbjct: 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165

Query: 64  GNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK-NSGFYLSELG 122
            + S A     VGT  YM+PE      ++ KSD++S G LL E+ +     + F   EL 
Sbjct: 166 HDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL- 222

Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                       EG+   +          + EL + I      +      RP++  ++
Sbjct: 223 -------AGKIREGKFRRIPYR------YSDELNEII---TRMLNLKDYHRPSVEEIL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 7e-33
 Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 23/178 (12%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L     +     +   + YL        +HRDL A NVL+  +   K+SDF + +     
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--- 153

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
              ++ +       + APE   E  FS KSDV+SFG+LL EI S  +    Y     + +
Sbjct: 154 --SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDV 209

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           +        +G  ++  +                 +   C   D+A RP+   +   L
Sbjct: 210 V----PRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-32
 Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 34/180 (18%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
            D +R  + I  +A  L Y H     R+IHRD+K  N+LL      KI+DF  +     +
Sbjct: 103 FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
           +       + GT  Y+ PE     +   K D++S GVL  E + GK              
Sbjct: 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-------------- 201

Query: 126 LSYTWKLWCEGEALELMEPVLKQ-----SCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
                  +      E  + + +        V       I      ++ + + RP +  V+
Sbjct: 202 -----PPFEANTYQETYKRISRVEFTFPDFVTEGARDLI---SRLLKHNPSQRPMLREVL 253

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 9e-32
 Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 20/198 (10%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
                   + I +   IA G+ YL+ +   + +HRDL A N ++  +   KI DF M R 
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSEL 121
                      + +    +M+PE   +G+F+  SDV+SFGV+L EI +  +     LS  
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN- 241

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 181
                    +   EG  L+  +                 +  +C Q +   RP+   ++ 
Sbjct: 242 -----EQVLRFVMEGGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIIS 287

Query: 182 MLASDNVTLPQPTEPAFS 199
            +  +    P   E +F 
Sbjct: 288 SIKEE--MEPGFREVSFY 303

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-31
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 24/179 (13%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L   +   +       L YLH+    +IIHRDLKA N+L   + + K++DF ++      
Sbjct: 107 LTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163

Query: 66  QSEASTNRIVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSE 120
                +   +GT  +MAPE  M     +  +  K+DV+S G+ L+E+   +     +   
Sbjct: 164 IQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHEL 218

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
               +L        + E   L +P    S  ++    F+     C++ +   R T S +
Sbjct: 219 NPMRVL----LKIAKSEPPTLAQP----SRWSSNFKDFL---KKCLEKNVDARWTTSQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-31
 Identities = 45/180 (25%), Positives = 64/180 (35%), Gaps = 18/180 (10%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
                        +A G+ YL      R IHRDL A N+LL      KI DF + R    
Sbjct: 107 HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163

Query: 65  NQSEAS-TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
           N             + + APE      FS  SD + FGV L E+ +  +        +G 
Sbjct: 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGL 218

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
           +      K+  EGE L   E   +            ++ + C      DRPT  ++   L
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQ---------DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (288), Expect = 2e-31
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 27/178 (15%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           L      ++ +G  +GL YLH      +IHRD+KA N+LL      K+ DF  A I    
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM--- 165

Query: 66  QSEASTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG 122
              A  N  VGT  +MAPE  +   EG +  K DV+S G+  +E+   K     +     
Sbjct: 166 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK--PPLF----N 216

Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 180
            + +S  + +       +   P L+    +     F+     C+Q    DRPT   ++
Sbjct: 217 MNAMSALYHI------AQNESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 9e-31
 Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 19/180 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           LD    I     ++  L YL      R +HRD+ A NVL+      K+ DF ++R    +
Sbjct: 105 LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSL 125
               ++ +      +MAPE      F+  SDV+ FGV + EI+         +       
Sbjct: 162 TYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----- 215

Query: 126 LSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 185
            +        GE L +             L   +     C   D + RP  + +   L++
Sbjct: 216 -NDVIGRIENGERLPMPP------NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 3e-29
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 19/173 (10%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ 66
           D  +  ++     + L +LH     ++IHRD+K+ N+LL  + + K++DF         Q
Sbjct: 114 DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 67  SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL 126
           S+ ST  +VGT  +MAPE      +  K D++S G++ +E+I G+     YL+E     L
Sbjct: 171 SKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL 225

Query: 127 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
                L       EL  P      ++A    F+     C+  D   R +   +
Sbjct: 226 ----YLIATNGTPELQNP----EKLSAIFRDFL---NRCLDMDVEKRGSAKEL 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-26
 Identities = 40/184 (21%), Positives = 75/184 (40%), Gaps = 16/184 (8%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           +  +    ++  + RGL +LH     R++HRDLK  N+L+      K++DF +ARI+   
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-----KNSGFYLSE 120
            +      +V T  Y APE  ++  ++   D++S G +  E+   K      +    L +
Sbjct: 170 MA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226

Query: 121 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL-----CVQADSADRPT 175
           +   +     + W    AL       K +    + +  I          C+  + A R +
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286

Query: 176 MSSV 179
             S 
Sbjct: 287 AYSA 290

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.3 bits (247), Expect = 1e-25
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 3/111 (2%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            +    D          I   L YLH      IIHRDLK  N+LL+ +M+ +I+DF  A+
Sbjct: 100 RKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK 156

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
           +      +A  N  VGT  Y++PE   E      SD+++ G ++ ++++G 
Sbjct: 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 98.4 bits (244), Expect = 3e-25
 Identities = 32/187 (17%), Positives = 65/187 (34%), Gaps = 20/187 (10%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVL---LDHEMNPKISDFEMARI 61
           +   K  + + + +   + Y+H       IHRD+K  N L           I DF +A+ 
Sbjct: 99  KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155

Query: 62  FGGNQSEA-----STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGF 116
           +   ++           + GT  Y +    +    S + D+ S G +L+    G      
Sbjct: 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS----L 211

Query: 117 YLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTM 176
               L  +     ++   E + +     VL +    +E   +++    C      D+P  
Sbjct: 212 PWQGLKAATKRQKYERISEKK-MSTPIEVLCKGY-PSEFATYLN---FCRSLRFDDKPDY 266

Query: 177 SSVVVML 183
           S +  + 
Sbjct: 267 SYLRQLF 273

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 97.2 bits (241), Expect = 8e-25
 Identities = 27/189 (14%), Positives = 58/189 (30%), Gaps = 22/189 (11%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP-----KISDFEMA 59
           +   K        +   +  +HE     +++RD+K  N L+    +       + DF M 
Sbjct: 97  KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153

Query: 60  RIFGGNQSEA-----STNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNS 114
           + +    ++          + GT  YM+    +    S + D+ + G + +  + G    
Sbjct: 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213

Query: 115 GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP 174
                  G    +   K    GE  +        +    E  K++H             P
Sbjct: 214 Q------GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATP 264

Query: 175 TMSSVVVML 183
               +  + 
Sbjct: 265 DYDYLQGLF 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 95.9 bits (238), Expect = 2e-24
 Identities = 36/185 (19%), Positives = 70/185 (37%), Gaps = 27/185 (14%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
             V L  K    I+  +   +  LH+   L I+HRDLK  N+LLD +MN K++DF  +  
Sbjct: 103 EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISGKK-NS 114
               +       + GT  Y+APE     +      +  + D++S GV++  +++G     
Sbjct: 160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216

Query: 115 GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP 174
                 + + ++S  ++               +    +  +   +      +      R 
Sbjct: 217 HRKQMLMLRMIMSGNYQF-----------GSPEWDDYSDTVKDLV---SRFLVVQPQKRY 262

Query: 175 TMSSV 179
           T    
Sbjct: 263 TAEEA 267

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 95.1 bits (236), Expect = 9e-24
 Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 23/178 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMARIF 62
           ++     +  +  + +GL ++HE      +H DLK  N++   + +   K+ DF +    
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176

Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK-NSGFYLSEL 121
              QS        GT  + APE A        +D++S GVL   ++SG     G    E 
Sbjct: 177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
            +++ S  W +                S ++ +   FI      + AD   R T+   
Sbjct: 234 LRNVKSCDWNM-----------DDSAFSGISEDGKDFI---RKLLLADPNTRMTIHQA 277

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 92.5 bits (229), Expect = 3e-23
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 17/171 (9%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFG-G 64
           +  KR I +I    + L + H+     IIHRD+K +N+++      K+ DF +AR     
Sbjct: 108 MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQS 124
             S   T  ++GT  Y++PE A       +SDV+S G +L E+++G+    F     G S
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FT----GDS 218

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 175
            +S  ++   E    + + P  +   ++A+L   +   L  +  +  +R  
Sbjct: 219 PVSVAYQHVRE----DPIPPSARHEGLSADLDAVV---LKALAKNPENRYQ 262

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 93.2 bits (231), Expect = 5e-23
 Identities = 37/181 (20%), Positives = 67/181 (37%), Gaps = 23/181 (12%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMA 59
              ++     I+ +     GL ++HE     I+H D+K  N++ + +     KI DF +A
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLA 176

Query: 60  RIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYL 118
                ++          T  + APE          +D+++ GVL   ++SG    +G   
Sbjct: 177 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233

Query: 119 SELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSS 178
            E  Q++    W+                 S V+ E   FI      +Q +   R T+  
Sbjct: 234 LETLQNVKRCDWEF-----------DEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHD 279

Query: 179 V 179
            
Sbjct: 280 A 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 91.7 bits (227), Expect = 1e-22
 Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 8/112 (7%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            +S +            +   L YLH      II+RDLK  N+LLD   + KI+DF  A+
Sbjct: 96  RKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK 152

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 112
                        + GT  Y+APE      ++   D +SFG+L+ E+++G  
Sbjct: 153 YVPDVTY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 2e-22
 Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 19/195 (9%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           +++  L        +  I RGL Y+H      ++HRDLK SN+LL+   + KI DF +AR
Sbjct: 101 LKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157

Query: 61  IFGGNQSEAST-NRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK-----KN 113
           +   +          V T  Y APE  +      KS D++S G +L E++S +     K+
Sbjct: 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217

Query: 114 SGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL---------KFIHIGLL 164
               L+ +   L S + +       L+    +L                   K + +   
Sbjct: 218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277

Query: 165 CVQADSADRPTMSSV 179
            +  +   R  +   
Sbjct: 278 MLTFNPHKRIEVEQA 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.9 bits (225), Expect = 2e-22
 Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 18/177 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP---KISDFEMARIF 62
              +    I+  I   + YLH    + I HRD+K  N+L   +      K++DF  A+  
Sbjct: 108 FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164

Query: 63  GGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELG 122
             + S  +      T  Y+APE      +    D++S GV++  ++ G     FY     
Sbjct: 165 TSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFY----S 215

Query: 123 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
              L+ +  +       +   P  + S V+ E+   I      ++ +   R T++  
Sbjct: 216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.4 bits (221), Expect = 7e-22
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 5/107 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
           + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DF M +    
Sbjct: 99  KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             ++ +T    GT  Y+APE  +   ++   D +SFGVLL E++ G+
Sbjct: 156 GDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.2 bits (223), Expect = 7e-22
 Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 22/170 (12%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS 67
                     I  GL ++H      +++RDLK +N+LLD   + +ISD  +A  F   + 
Sbjct: 106 EADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161

Query: 68  EASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL 126
               +  VGT+GYMAPE   +G+ +   +D FS G +L +++ G                
Sbjct: 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH-----------SPFR 207

Query: 127 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTM 176
            +  K   E + + L   V      + EL   +      +Q D   R   
Sbjct: 208 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRLGC 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 8e-22
 Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 30/214 (14%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI 61
            S+ L      + +    +GL YLH+     I+HRDLK +N+LLD     K++DF +A+ 
Sbjct: 93  NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 149

Query: 62  FGGNQSEASTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK-----KNSG 115
           FG      +    V T  Y APE      ++ V  D+++ G +L E++         +  
Sbjct: 150 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207

Query: 116 FYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ---------SCVAAELLKFIHIGLLCV 166
             L+ + ++L + T + W +  +L                  S    +LL  I       
Sbjct: 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLF 264

Query: 167 QADSADRPTMSSVVVM-------LASDNVTLPQP 193
             +   R T +  + M         +    LP+P
Sbjct: 265 LFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 2e-21
 Identities = 36/180 (20%), Positives = 71/180 (39%), Gaps = 21/180 (11%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP--KISDFEMA 59
            + +L+ +  +S ++ +   L +LH      I H D++  N++     +   KI +F  A
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

Query: 60  RIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLS 119
           R      +            Y APE     + S  +D++S G L+  ++SG      +L+
Sbjct: 152 RQLKPGDNFRLLF---TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN---PFLA 205

Query: 120 ELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
           E  Q ++    +     E     E   K+  ++ E + F+      +  +   R T S  
Sbjct: 206 ETNQQII----ENIMNAE-YTFDEEAFKE--ISIEAMDFVD---RLLVKERKSRMTASEA 255

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (214), Expect = 5e-21
 Identities = 37/190 (19%), Positives = 75/190 (39%), Gaps = 24/190 (12%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
           +      S +  + +GL + H     R++HRDLK  N+L++ E   K++DF +AR FG  
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query: 66  QSEASTNRIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEIISGK-----KNSGFYLS 119
               +    V T  Y APE       +S   D++S G +  E+++ +      +    L 
Sbjct: 156 VRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213

Query: 120 ELGQSLLSYTWKLWCEGEALELMEPVLKQ----------SCVAAELLKFIHIGLLCVQAD 169
            + ++L +    +W    ++   +P   +            +  +    +      +  D
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYD 270

Query: 170 SADRPTMSSV 179
              R +  + 
Sbjct: 271 PNKRISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 8e-21
 Identities = 44/200 (22%), Positives = 76/200 (38%), Gaps = 27/200 (13%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
              V+        ++  +  GL Y+H +   +I+HRD+KA+NVL+  +   K++DF +AR
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165

Query: 61  IFGGNQSEASTNR--IVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK-----K 112
            F   ++         V T  Y  PE  + E  +    D++  G ++ E+ +        
Sbjct: 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225

Query: 113 NSGFYLSELGQSLLSYTWKLWCEGEALELMEPV-------------LKQSCVAAELLKFI 159
                L+ + Q   S T ++W   +  EL E +             LK        L  I
Sbjct: 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 285

Query: 160 HIGLLCVQADSADRPTMSSV 179
                 +  D A R      
Sbjct: 286 D---KLLVLDPAQRIDSDDA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 1e-20
 Identities = 39/192 (20%), Positives = 67/192 (34%), Gaps = 32/192 (16%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGG 64
           L  +   S    +   + + H      ++HRD+K  N+L+D      K+ DF    +   
Sbjct: 107 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163

Query: 65  NQSEASTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQ 123
                      GT  Y  PE+          + V+S G+LL +++ G             
Sbjct: 164 TV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------- 206

Query: 124 SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 183
                   +  E +   +   V  +  V++E    I     C+    +DRPT   +    
Sbjct: 207 -------DIPFEHDEEIIRGQVFFRQRVSSECQHLI---RWCLALRPSDRPTFEEIQNHP 256

Query: 184 ASDNVTLPQPTE 195
              +V LPQ T 
Sbjct: 257 WMQDVLLPQETA 268

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.5 bits (205), Expect = 9e-20
 Identities = 33/185 (17%), Positives = 69/185 (37%), Gaps = 17/185 (9%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS 67
            +   S +  + +GL + H      ++HRDLK  N+L++     K+++F +AR FG    
Sbjct: 100 PEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-V 155

Query: 68  EASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK------KNSGFYLSEL 121
              +  +V  +           L+S   D++S G +  E+ +         +    L  +
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

Query: 122 GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG-----LL--CVQADSADRP 174
            + L + T + W     L   +P        + +     +      LL   ++ +   R 
Sbjct: 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275

Query: 175 TMSSV 179
           +    
Sbjct: 276 SAEEA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 82.2 bits (202), Expect = 2e-19
 Identities = 42/191 (21%), Positives = 73/191 (38%), Gaps = 24/191 (12%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGG 64
            L+     S +  +  G+ Y H+    R++HRDLK  N+L++ E   KI+DF +AR FG 
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFG- 151

Query: 65  NQSEASTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK-----KNSGFYL 118
                     + T  Y AP+  M    +S   D++S G +  E+++G       +    L
Sbjct: 152 -IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210

Query: 119 SELGQSLLSYTWKLWCEGEALELMEPVLKQ----------SCVAAELLKFIHIGLLCVQA 168
             + + L +   K W     L   +P                +    +  +      ++ 
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKL 267

Query: 169 DSADRPTMSSV 179
           D   R T    
Sbjct: 268 DPNQRITAKQA 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 3e-19
 Identities = 30/111 (27%), Positives = 52/111 (46%), Gaps = 5/111 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            R      +R       I   L YLH      +++RD+K  N++LD + + KI+DF + +
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              G    A+     GT  Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 154 E--GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 82.5 bits (203), Expect = 3e-19
 Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 8/111 (7%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
            R  +            I     YLH    L +I+RDLK  N+L+D +   +++DF  A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
              G         + GT   +APE  +   ++   D ++ GVL+ E+ +G 
Sbjct: 190 RVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.6 bits (201), Expect = 5e-19
 Identities = 30/175 (17%), Positives = 60/175 (34%), Gaps = 18/175 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGN 65
              +    +I  +   + YLH+   +    +        LD +    ISDF ++++    
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQS 124
                 +   GT GY+APE   +  +S   D +S GV+   ++ G         ++L + 
Sbjct: 164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220

Query: 125 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 179
           +L   ++                   ++     FI      ++ D   R T    
Sbjct: 221 ILKAEYEF-----------DSPYWDDISDSAKDFI---RHLMEKDPEKRFTCEQA 261

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 4e-18
 Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 35/200 (17%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DF +AR
Sbjct: 113 MKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK-------- 111
                Q+++     V T  Y APE  +  + ++   D++S G ++ E+I+GK        
Sbjct: 170 -----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224

Query: 112 ------------KNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 159
                            ++  L         K   E E  +    +   S +A  LL+  
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE-- 282

Query: 160 HIGLLCVQADSADRPTMSSV 179
                 +  D+  R T    
Sbjct: 283 ----KMLVLDAEQRVTAGEA 298

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.1 bits (194), Expect = 5e-18
 Identities = 40/188 (21%), Positives = 67/188 (35%), Gaps = 20/188 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGG 64
           L        +  + R L Y+H      I HRD+K  N+LLD +    K+ DF  A+    
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 65  NQSEASTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK-----KNSGFYL 118
            +   S    + +  Y APE       ++   DV+S G +L E++ G+      +    L
Sbjct: 176 GEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

Query: 119 SELGQSLLSYTWKLWCEG--EALELMEPVLKQSCVAAELLKFIHIGLL-----CVQADSA 171
            E+ + L + T +   E      E   P +K                +      ++    
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292

Query: 172 DRPTMSSV 179
            R T    
Sbjct: 293 ARLTPLEA 300

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.3 bits (192), Expect = 6e-18
 Identities = 41/183 (22%), Positives = 66/183 (36%), Gaps = 23/183 (12%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNP----KISDF 56
                L  +     +  I  G+ YLH    L+I H DLK  N++L     P    KI DF
Sbjct: 105 AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161

Query: 57  EMARIFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGF 116
            +A              I GT  ++APE        +++D++S GV+   ++SG      
Sbjct: 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---P 215

Query: 117 YLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTM 176
           +L +  Q  L                E     S +A + ++        +  D   R T+
Sbjct: 216 FLGDTKQETL----ANVSAVNYEFEDEYFSNTSALAKDFIR------RLLVKDPKKRMTI 265

Query: 177 SSV 179
              
Sbjct: 266 QDS 268

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.5 bits (174), Expect = 3e-15
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 6/105 (5%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQ 66
           D +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DF +AR  G + 
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 67  SEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
                   V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 174 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 69.9 bits (170), Expect = 9e-15
 Identities = 40/200 (20%), Positives = 74/200 (37%), Gaps = 35/200 (17%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGG 64
           L        +  I + L Y H    + I+HRD+K  NV++DHE    ++ D+ +A  +  
Sbjct: 126 LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 65  NQSEASTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK------KNSGFY 117
            Q     N  V +  +  PE  ++  ++    D++S G +L  +I  K       ++   
Sbjct: 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239

Query: 118 LSELGQSLLSYTWKLWCEGEALEL------------------MEPVLKQSCVAAELLKFI 159
           L  + + L +     + +   +EL                        Q  V+ E L F+
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299

Query: 160 HIGLLCVQADSADRPTMSSV 179
                 ++ D   R T    
Sbjct: 300 D---KLLRYDHQSRLTAREA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 70.1 bits (170), Expect = 1e-14
 Identities = 25/106 (23%), Positives = 45/106 (42%), Gaps = 3/106 (2%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGN 65
                  I   +  GL Y+H   R  IIH D+K  NVL++       +   ++A +    
Sbjct: 123 PLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 66  QSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 111
             +      + T  Y +PE  +   +   +D++S   L+ E+I+G 
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (168), Expect = 2e-14
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 3/100 (3%)

Query: 14  IINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNR 73
           +   +   +L L    +L II+RD+K  N+LLD   +  ++DF +++ F  +++E     
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYD 189

Query: 74  IVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGK 111
             GT  YMAP+    G        D +S GVL+ E+++G 
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.0 bits (152), Expect = 2e-12
 Identities = 39/191 (20%), Positives = 75/191 (39%), Gaps = 21/191 (10%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMAR 60
           ++  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

Query: 61  IFGGNQSEASTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-----KNSG 115
                     T  +   +            ++   D++S G ++ E+++G+      +  
Sbjct: 170 HTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

Query: 116 FYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG-------LL--CV 166
             L  + + + +   +L  +  +      +   + +       + IG       LL   +
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285

Query: 167 QADSADRPTMS 177
             DS  R T +
Sbjct: 286 VLDSDKRITAA 296

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 51.3 bits (122), Expect = 1e-08
 Identities = 19/100 (19%), Positives = 34/100 (34%), Gaps = 11/100 (11%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS 67
            +    +++ I   +   +      I+H DL   NVL+  E    I DF  +   G    
Sbjct: 102 VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Query: 68  EASTNR-IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 106
                R +     Y +  Y        + D+ S    +L+
Sbjct: 158 REILERDVRNIITYFSRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	230
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.98
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.98
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.98
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.98
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.98
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.98
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.28
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.48
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	92.62
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	91.61
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	90.32
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	88.74

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-37  Score=247.98  Aligned_cols=174  Identities=24%  Similarity=0.389  Sum_probs=127.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++................+++.|+|
T Consensus        98 ~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  174 (276)
T d1uwha_          98 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA  174 (276)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCC
Confidence            457999999999999999999999999   99999999999999999999999999976543322222333567899999


Q ss_pred             hhhhhcC---CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAMEG---LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~~---~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||++.+.   .++.++|||||||++|||++|..||........      .......+.    ..+. ....+...+..+.
T Consensus       175 PE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~----~~p~-~~~~~~~~~~~l~  243 (276)
T d1uwha_         175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGY----LSPD-LSKVRSNCPKAMK  243 (276)
T ss_dssp             HHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTS----CCCC-GGGSCTTCCHHHH
T ss_pred             HHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCC----CCCc-chhccccchHHHH
Confidence            9999753   478999999999999999999999864321110      001111110    0000 0112233455699


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 026939          160 HIGLLCVQADSADRPTMSSVVVMLASDNVTL  190 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~~L~~~~~~~  190 (230)
                      +++.+||+.||++|||+++|++.|+.....+
T Consensus       244 ~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         244 RLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            9999999999999999999999998765443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-37  Score=251.14  Aligned_cols=163  Identities=29%  Similarity=0.395  Sum_probs=129.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++................+++.|+||
T Consensus       159 ~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         159 NVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            36899999999999999999999999   999999999999999999999999999765443333333334568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |++.+..++.++|||||||++|||++ |..||........               ....+....+...+...+..+.+|+
T Consensus       236 E~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~---------------~~~~~~~~~~~~~p~~~~~~l~~li  300 (325)
T d1rjba_         236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIM  300 (325)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             HHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH---------------HHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            99999999999999999999999998 8999854321110               1111122222233444556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhh
Q 026939          163 LLCVQADSADRPTMSSVVVMLA  184 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~  184 (230)
                      .+||+.||++|||+++|++.|.
T Consensus       301 ~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         301 QSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHh
Confidence            9999999999999999999984

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=245.95  Aligned_cols=165  Identities=27%  Similarity=0.311  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................+++.|+||
T Consensus       129 ~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         129 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             -CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence            46899999999999999999999999   999999999999999999999999999765443333333345678899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcC-CCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |++.+..++.++|||||||++|||++|. .||.......      ..         ...+........+...+..+.+++
T Consensus       206 E~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------~~---------~~~~~~~~~~~~~~~~~~~l~~li  270 (299)
T d1ywna1         206 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EF---------CRRLKEGTRMRAPDYTTPEMYQTM  270 (299)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HH---------HHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             hHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------HH---------HHHHhcCCCCCCCccCCHHHHHHH
Confidence            9999999999999999999999999975 4664322110      00         111111112223334455689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||++|||+.+|++.|++.
T Consensus       271 ~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         271 LDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-36  Score=243.55  Aligned_cols=165  Identities=25%  Similarity=0.370  Sum_probs=121.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCcc---ccccccccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEAS---TNRIVGTYG   79 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~   79 (230)
                      ...+++.+++.++.||+.||+|||+++   ++||||||+|||++.++.+||+|||++...........   .....+++.
T Consensus       122 ~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~  198 (299)
T d1jpaa_         122 DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR  198 (299)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCcc
Confidence            347999999999999999999999999   99999999999999999999999999986543222111   112345778


Q ss_pred             ccChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           80 YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        80 ~~aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      |+|||.+.+..++.++|||||||++|||+| |..||.......                ....+....+...+...+..+
T Consensus       199 y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~l  262 (299)
T d1jpaa_         199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD----------------VINAIEQDYRLPPPMDCPSAL  262 (299)
T ss_dssp             GSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCccchHHH
Confidence            999999999999999999999999999998 888985432111                111111222223344556679


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          159 IHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+|+.+||+.||++|||+.+|++.|+..
T Consensus       263 ~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         263 HQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-36  Score=239.28  Aligned_cols=162  Identities=25%  Similarity=0.346  Sum_probs=123.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++.+++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++................|++.|+|
T Consensus        97 ~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~A  173 (271)
T d1nvra_          97 DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA  173 (271)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccC
Confidence            457999999999999999999999999   99999999999999999999999999987543322222333578999999


Q ss_pred             hhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..+ +.++|||||||++|+|++|..||........      ...........        .......+..+.++
T Consensus       174 PE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~~~~~~~~~--------~~~~~~~s~~~~~l  239 (271)
T d1nvra_         174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--------LNPWKKIDSAPLAL  239 (271)
T ss_dssp             THHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------HHHHHHTTCTT--------STTGGGSCHHHHHH
T ss_pred             HhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCCC--------CCccccCCHHHHHH
Confidence            999988876 5789999999999999999999864332111      00111111100        01112223457889


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||++++++
T Consensus       240 i~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHhc
Confidence            99999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-36  Score=241.59  Aligned_cols=167  Identities=25%  Similarity=0.345  Sum_probs=132.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      +..+++.+++.++.||+.||+|||+++   ++||||||+||+++.++.+||+|||++......... .......+++.|+
T Consensus       103 ~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~  179 (285)
T d1u59a_         103 REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY  179 (285)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCcccc
Confidence            457999999999999999999999999   999999999999999999999999999876543221 1122235678999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||++.+..++.++|||||||++|||++ |..||.......                ....+....+...+...+..+.+
T Consensus       180 aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~p~~~~~~l~~  243 (285)
T d1u59a_         180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQGKRMECPPECPPELYA  243 (285)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----------------HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCCcCCHHHHH
Confidence            9999999999999999999999999998 899986432111                11111112222334445567999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      |+.+||+.||++|||+.+|.+.|+....
T Consensus       244 li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         244 LMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999999976543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-36  Score=240.39  Aligned_cols=166  Identities=24%  Similarity=0.393  Sum_probs=123.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......... .......++..|+
T Consensus       104 ~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~  180 (283)
T d1mqba_         104 DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT  180 (283)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGS
T ss_pred             cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCcccc
Confidence            357999999999999999999999999   999999999999999999999999999765432211 1222235678999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||.+.+..++.++|||||||++|||++|..|+......     .          .....+....+...+...+..+.+|
T Consensus       181 APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~----------~~~~~i~~~~~~~~~~~~~~~l~~l  245 (283)
T d1mqba_         181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----H----------EVMKAINDGFRLPTPMDCPSAIYQL  245 (283)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H----------HHHHHHHTTCCCCCCTTCBHHHHHH
T ss_pred             CHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----H----------HHHHHHhccCCCCCchhhHHHHHHH
Confidence            999999999999999999999999999976665322111     0          1111122222333344455679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||++|||+.+|++.|+..
T Consensus       246 i~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         246 MMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHCcCCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-36  Score=241.17  Aligned_cols=165  Identities=29%  Similarity=0.391  Sum_probs=129.7

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC-ccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE-ASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (230)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++......... .......+++.|+
T Consensus       101 ~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~  177 (277)
T d1xbba_         101 NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY  177 (277)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGC
T ss_pred             ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceec
Confidence            457999999999999999999999999   999999999999999999999999999875433221 2222345678999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++|||||||++|||++ |..||.......                ....+....+...+...+..+.+
T Consensus       178 APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----------------~~~~i~~~~~~~~p~~~~~~~~~  241 (277)
T d1xbba_         178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERMGCPAGCPREMYD  241 (277)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCcccCHHHHH
Confidence            9999999999999999999999999998 899986432111                11111112222334445567999


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      |+.+||+.||++|||+++|++.|+..
T Consensus       242 li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         242 LMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            99999999999999999999988753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=238.41  Aligned_cols=164  Identities=27%  Similarity=0.306  Sum_probs=118.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+|
T Consensus        95 ~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~a  170 (263)
T d1sm2a_          95 RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS  170 (263)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCC
Confidence            357899999999999999999999999   999999999999999999999999999765433222 1222456889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCC-CCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-SGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.+..++.++|||||||++|||+++..| |.....      .+..          ..+....+...+..++..+.++
T Consensus       171 PE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~----------~~i~~~~~~~~p~~~~~~l~~l  234 (263)
T d1sm2a_         171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVV----------EDISTGFRLYKPRLASTHVYQI  234 (263)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHH----------HHHHHTCCCCCCTTSCHHHHHH
T ss_pred             hHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHH----------HHHHhcCCCCCccccCHHHHHH
Confidence            9999999999999999999999999996554 432111      1111          1111111122233445568999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||++|||+++|++.|++.
T Consensus       235 i~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         235 MNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-36  Score=238.42  Aligned_cols=164  Identities=27%  Similarity=0.421  Sum_probs=127.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      .++++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+||
T Consensus       104 ~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~AP  179 (272)
T d1qpca_         104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP  179 (272)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccCh
Confidence            36899999999999999999999999   999999999999999999999999999876433221 12224567899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |++.+..++.++|||||||++|||+||..|+......     .+          ....+....+...+...+..+.+++.
T Consensus       180 E~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~----------~~~~i~~~~~~~~p~~~~~~l~~li~  244 (272)
T d1qpca_         180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PE----------VIQNLERGYRMVRPDNCPEELYQLMR  244 (272)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH----------HHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             HHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HH----------HHHHHHhcCCCCCcccChHHHHHHHH
Confidence            9999999999999999999999999976664321111     00          01111111222223344556899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.||++|||+++|++.|++.
T Consensus       245 ~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         245 LCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhhh
Confidence            99999999999999999998763

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-36  Score=239.07  Aligned_cols=177  Identities=25%  Similarity=0.417  Sum_probs=131.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      +.+++.+++.++.||+.||+|||+++   ++||||||+||+++.++.+||+|||++......... ......+++.|+||
T Consensus       108 ~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aP  183 (285)
T d1fmka3         108 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP  183 (285)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCH
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccCh
Confidence            46899999999999999999999999   999999999999999999999999999765432221 22223568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|||||||++|||++|..|+.......     +          ....+....+...+...++.+.+++.
T Consensus       184 E~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~----------~~~~i~~~~~~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----E----------VLDQVERGYRMPCPPECPESLHDLMC  248 (285)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H----------HHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             HHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----H----------HHHHHHhcCCCCCCcccCHHHHHHHH
Confidence            99999999999999999999999999777653322110     0          11111112222334455667999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCCccCcc
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNVTLPQPTEPAFSVGRN  203 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~~~~~~~~p~~~~~~~  203 (230)
                      +||+.||++|||+++|++.|++.....+    |.+.+|.|
T Consensus       249 ~cl~~dP~~Rps~~~i~~~L~~~~~~~~----p~~~p~~~  284 (285)
T d1fmka3         249 QCWRKEPEERPTFEYLQAFLEDYFTSTE----PQYQPGEN  284 (285)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTTSCSC----CCCCCSCC
T ss_pred             HHcccCHhHCcCHHHHHHHHhhhhcCCC----CCCCCCCC
Confidence            9999999999999999999988665533    45556655

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-36  Score=243.85  Aligned_cols=165  Identities=23%  Similarity=0.365  Sum_probs=128.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++................++..|+|
T Consensus       105 ~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  181 (317)
T d1xkka_         105 KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  181 (317)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccC
Confidence            568999999999999999999999999   99999999999999999999999999987654333333333457889999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|||+| |..||.......                +...+....+...+...+..+.++
T Consensus       182 PE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----------------~~~~i~~~~~~~~p~~~~~~~~~l  245 (317)
T d1xkka_         182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGERLPQPPICTIDVYMI  245 (317)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------HHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred             hHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCcccCHHHHHH
Confidence            999999999999999999999999998 778875432111                111111222223344455679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +.+||+.||.+|||+.+|++.|+..
T Consensus       246 i~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         246 MVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhCCCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999987653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.4e-36  Score=240.09  Aligned_cols=166  Identities=25%  Similarity=0.318  Sum_probs=129.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......... ......++..|+|
T Consensus       109 ~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~a  184 (287)
T d1opja_         109 RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA  184 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCC
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccC
Confidence            357899999999999999999999999   999999999999999999999999999765432221 2222346788999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|||||||++|+|++|..|+....+..               ...+.+........+...+..+.+|+
T Consensus       185 PE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYELLEKDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---------------HHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             hHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---------------HHHHHHhcCCCCCCCccchHHHHHHH
Confidence            999999999999999999999999999777653211110               11112222222333444556799999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.||++|||+++|++.|+...
T Consensus       250 ~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            9999999999999999999997654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-35  Score=240.82  Aligned_cols=165  Identities=26%  Similarity=0.356  Sum_probs=127.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++.+++.++.||+.||+|||+++   ++||||||+||+++.++.+||+|||++................+++.|+||
T Consensus       135 ~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            46899999999999999999999999   999999999999999999999999999755332222222234567889999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcC-CCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..++.++|||||||++|||++|. +||.......      .... ...+         .....+...+..+.+|+
T Consensus       212 E~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e------~~~~-v~~~---------~~~~~p~~~~~~~~~li  275 (301)
T d1lufa_         212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------VIYY-VRDG---------NILACPENCPLELYNLM  275 (301)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHH-HHTT---------CCCCCCTTCCHHHHHHH
T ss_pred             HHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH------HHHH-HHcC---------CCCCCCccchHHHHHHH
Confidence            9999999999999999999999999986 4554322111      1111 1111         11222334445689999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      .+||+.||++|||+.+|+++|++.+
T Consensus       276 ~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         276 RLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHhc
Confidence            9999999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-35  Score=237.42  Aligned_cols=160  Identities=23%  Similarity=0.323  Sum_probs=125.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++.+++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++........  ......|++.|+|
T Consensus       110 ~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~a  184 (293)
T d1yhwa1         110 ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMA  184 (293)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccC
Confidence            457999999999999999999999999   99999999999999999999999999987643322  1223467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|||||||++|+|++|..||.......      ......... ..       ....+...+..+.+++
T Consensus       185 PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~-~~-------~~~~~~~~s~~~~~li  250 (293)
T d1yhwa1         185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TP-------ELQNPEKLSAIFRDFL  250 (293)
T ss_dssp             HHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC-SC-------CCSSGGGSCHHHHHHH
T ss_pred             hhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-CC-------CCCCcccCCHHHHHHH
Confidence            999999999999999999999999999999985432111      111111110 00       0112233345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||.+|||+.++++
T Consensus       251 ~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=234.97  Aligned_cols=155  Identities=25%  Similarity=0.306  Sum_probs=124.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..++.++.||+.||+|||++|   |+||||||+||+++.++.+||+|||++.......    .....|++.|+|
T Consensus       100 ~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~A  172 (263)
T d2j4za1         100 LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLP  172 (263)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccC
Confidence            457999999999999999999999999   9999999999999999999999999997654322    223467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|||||||++|+|++|..||.......      .. .......          ..++...+..+.+++
T Consensus       173 PE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~-~~i~~~~----------~~~p~~~s~~~~~li  235 (263)
T d2j4za1         173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TY-KRISRVE----------FTFPDFVTEGARDLI  235 (263)
T ss_dssp             HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTC----------CCCCTTSCHHHHHHH
T ss_pred             HHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCC----------CCCCccCCHHHHHHH
Confidence            999999999999999999999999999999986432111      00 1111111          112223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHHH
Q 026939          163 LLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+||+.||++|||++++++
T Consensus       236 ~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         236 SRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHccCCHhHCcCHHHHHc
Confidence            9999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-35  Score=230.66  Aligned_cols=163  Identities=24%  Similarity=0.325  Sum_probs=129.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..+++++.||+.||+|||+++   |+||||+|+||+++.++.+||+|||++......... ......++..|+|
T Consensus        94 ~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~a  169 (258)
T d1k2pa_          94 RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP  169 (258)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCC
Confidence            457899999999999999999999999   999999999999999999999999999765433222 2222456789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|||+| |..||.......      ...          .+....+...+...+..+.++
T Consensus       170 PE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~----------~i~~~~~~~~p~~~~~~l~~l  233 (258)
T d1k2pa_         170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAE----------HIAQGLRLYRPHLASEKVYTI  233 (258)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHH----------HHHTTCCCCCCTTCCHHHHHH
T ss_pred             cHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHH----------HHHhCCCCCCcccccHHHHHH
Confidence            999999999999999999999999998 788886432211      111          111111222334445679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+||+.||++|||+++|++.|.+
T Consensus       234 i~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-35  Score=235.71  Aligned_cols=164  Identities=30%  Similarity=0.336  Sum_probs=130.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      +.+++.+++.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++................+++.|+||
T Consensus       130 ~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  206 (299)
T d1fgka_         130 EQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  206 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence            56899999999999999999999999   999999999999999999999999999876544333333344667899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      |.+.+..|+.++|||||||++|+|++ |..||.......                ....+........+...+..+.+|+
T Consensus       207 E~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~----------------~~~~i~~~~~~~~p~~~~~~l~~li  270 (299)
T d1fgka_         207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMMM  270 (299)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------HHHHHHTTCCCCCCSSCCHHHHHHH
T ss_pred             hHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCccchHHHHHHH
Confidence            99999999999999999999999998 677775322110                1111112222233334455699999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          163 LLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      .+||+.||.+|||+.+|++.|++.
T Consensus       271 ~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         271 RDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHHHHHH
Confidence            999999999999999999999764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-35  Score=233.66  Aligned_cols=163  Identities=23%  Similarity=0.255  Sum_probs=119.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ..++++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus       102 ~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~a  177 (273)
T d1mp8a_         102 KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMA  177 (273)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccch
Confidence            457899999999999999999999999   999999999999999999999999999765433222 1222456789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|||++ |..||........      ... ..+         ......+...+..+.++
T Consensus       178 pE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~------~~~-i~~---------~~~~~~~~~~~~~~~~l  241 (273)
T d1mp8a_         178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGR-IEN---------GERLPMPPNCPPTLYSL  241 (273)
T ss_dssp             HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHH-HHT---------TCCCCCCTTCCHHHHHH
T ss_pred             hhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH------HHH-HHc---------CCCCCCCCCCCHHHHHH
Confidence            999999999999999999999999998 7888764332211      111 111         11122334455679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhc
Q 026939          162 GLLCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +.+||+.||++|||+.+|++.|+.
T Consensus       242 i~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         242 MTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHH
Confidence            999999999999999999998865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-35  Score=233.47  Aligned_cols=161  Identities=26%  Similarity=0.307  Sum_probs=115.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCC--CCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDS--RLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~--~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      +..+++.+++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+||+|||++.........  .....+++.|
T Consensus       103 ~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y  180 (269)
T d2java1         103 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYY  180 (269)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCc--cccCCCCccc
Confidence            357999999999999999999999854  124999999999999999999999999999875432221  1224678999


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..++.++|||||||++|+|++|..||.......      .. .....+...         ..+...+..+.+
T Consensus       181 ~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~-~~i~~~~~~---------~~~~~~s~~l~~  244 (269)
T d2java1         181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LA-GKIREGKFR---------RIPYRYSDELNE  244 (269)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH-HHHHHTCCC---------CCCTTSCHHHHH
T ss_pred             CCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HH-HHHHcCCCC---------CCCcccCHHHHH
Confidence            99999999999999999999999999999999986432111      11 111111111         122233456899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||+.||.+|||+.+|++
T Consensus       245 li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         245 IITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCChhHCcCHHHHHh
Confidence            999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-35  Score=234.64  Aligned_cols=158  Identities=25%  Similarity=0.296  Sum_probs=121.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++................|++.|+|
T Consensus       102 ~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~A  178 (288)
T d1uu3a_         102 IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS  178 (288)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccC
Confidence            457999999999999999999999999   99999999999999999999999999987653332222333468999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|||||||++|+|++|..||.......      .. ....+..          ..++...+..+.+|+
T Consensus       179 PE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~-~~i~~~~----------~~~p~~~s~~~~~li  241 (288)
T d1uu3a_         179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IF-QKIIKLE----------YDFPEKFFPKARDLV  241 (288)
T ss_dssp             HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHTTC----------CCCCTTCCHHHHHHH
T ss_pred             ceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HH-HHHHcCC----------CCCCccCCHHHHHHH
Confidence            999999999999999999999999999999986432111      10 1111111          112223345688999


Q ss_pred             hhhcCCCCCCCCCHHHHH
Q 026939          163 LLCVQADSADRPTMSSVV  180 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~~i~  180 (230)
                      .+||+.||.+|||+++++
T Consensus       242 ~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         242 EKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             HTTSCSSGGGSTTSGGGT
T ss_pred             HHHccCCHhHCcCHHHHc
Confidence            999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-34  Score=235.33  Aligned_cols=155  Identities=30%  Similarity=0.370  Sum_probs=121.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.+++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++......      ....|++.|+|
T Consensus       109 ~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~A  179 (309)
T d1u5ra_         109 KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMA  179 (309)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccC
Confidence            468999999999999999999999999   999999999999999999999999999764321      22467899999


Q ss_pred             hhhhhc---CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHH
Q 026939           83 PEYAME---GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI  159 (230)
Q Consensus        83 Pe~~~~---~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  159 (230)
                      ||++.+   ..|+.++|||||||++|+|++|..||......      ....... ......        ..+...+..+.
T Consensus       180 PE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~-~~~~~~--------~~~~~~s~~~~  244 (309)
T d1u5ra_         180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNESPA--------LQSGHWSEYFR  244 (309)
T ss_dssp             HHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCC--------CSCTTSCHHHH
T ss_pred             HHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCCCC--------CCCCCCCHHHH
Confidence            999864   35889999999999999999999998533211      1111111 111111        11122345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 026939          160 HIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       160 ~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +++.+||+.||.+|||++++++
T Consensus       245 ~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         245 NFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCcCChhHCcCHHHHHh
Confidence            9999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-35  Score=232.65  Aligned_cols=166  Identities=23%  Similarity=0.257  Sum_probs=127.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCc-cccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEA-STNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......... ......++..|+
T Consensus       105 ~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~  181 (273)
T d1u46a_         105 QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC  181 (273)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccC
Confidence            356999999999999999999999999   9999999999999999999999999998764433222 222335567899


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||.+.+..++.++||||||+++|||++ |..||.......      ......         ....+...+...+..+.+
T Consensus       182 aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~---------~~~~~~~~~~~~~~~l~~  246 (273)
T d1u46a_         182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKID---------KEGERLPRPEDCPQDIYN  246 (273)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHH---------TSCCCCCCCTTCCHHHHH
T ss_pred             CHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHH---------hCCCCCCCcccccHHHHH
Confidence            9999999999999999999999999998 899985322111      111111         111111223333456899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      |+.+||+.||++|||+.+|++.|.+.
T Consensus       247 li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         247 VMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            99999999999999999999998753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=232.36  Aligned_cols=160  Identities=24%  Similarity=0.308  Sum_probs=122.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.++..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++.......  .......|++.|+|
T Consensus       104 ~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~A  178 (288)
T d2jfla1         104 ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMA  178 (288)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCC
Confidence            357999999999999999999999999   9999999999999999999999999987643211  11223467899999


Q ss_pred             hhhhh-----cCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHH
Q 026939           83 PEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK  157 (230)
Q Consensus        83 Pe~~~-----~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (230)
                      ||++.     +..|+.++|||||||++|+|++|..||.......      ..... ......       ....+...+..
T Consensus       179 PE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i-~~~~~~-------~~~~~~~~s~~  244 (288)
T d2jfla1         179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKI-AKSEPP-------TLAQPSRWSSN  244 (288)
T ss_dssp             HHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHH-HHSCCC-------CCSSGGGSCHH
T ss_pred             HHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHH-HcCCCC-------CCCccccCCHH
Confidence            99985     3457899999999999999999999986432211      11111 111100       01122334456


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          158 FIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       158 l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            889999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-34  Score=227.72  Aligned_cols=159  Identities=23%  Similarity=0.338  Sum_probs=120.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC-CCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD-HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++.+++.++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||++......    ......|++.|+
T Consensus       106 ~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~  180 (270)
T d1t4ha_         106 FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFM  180 (270)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCC
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCcccc
Confidence            357899999999999999999999875 3499999999999996 5789999999999754322    122346899999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+ .++.++|||||||++|+|++|..||.......      ........+..        ...++......+.++
T Consensus       181 aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~--------~~~~~~~~~~~~~~l  245 (270)
T d1t4ha_         181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVK--------PASFDKVAIPEVKEI  245 (270)
T ss_dssp             CGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCC--------CGGGGGCCCHHHHHH
T ss_pred             CHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCC--------CcccCccCCHHHHHH
Confidence            9999864 69999999999999999999999985322111      00111111110        111222233458899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||+.||++|||+.++++
T Consensus       246 i~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         246 IEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCHhHCcCHHHHhC
Confidence            99999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-34  Score=234.28  Aligned_cols=172  Identities=24%  Similarity=0.348  Sum_probs=121.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++..+..++.||+.||.|||+ ++   |+||||||+|||++.++.+||+|||++.......    .....|+..|+
T Consensus        98 ~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~  170 (322)
T d1s9ja_          98 AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYM  170 (322)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCcccc
Confidence            4579999999999999999999997 48   9999999999999999999999999987653211    12247899999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHH-----------------------HHhhhhh
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWK-----------------------LWCEGEA  138 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~  138 (230)
                      |||++.+..|+.++||||+||++|+|++|..||.................                       .......
T Consensus       171 APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (322)
T d1s9ja_         171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAI  250 (322)
T ss_dssp             CHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCH
T ss_pred             CchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhH
Confidence            99999999999999999999999999999999964332211000000000                       0000000


Q ss_pred             hhhhchhhcc---hh-hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          139 LELMEPVLKQ---SC-VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       139 ~~~~~~~~~~---~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+..+.....   .. ....+..+.+++.+||+.||.+|||++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         251 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             HHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0000000000   00 0112346889999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-34  Score=231.72  Aligned_cols=165  Identities=26%  Similarity=0.384  Sum_probs=129.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++++|||++................+++.|+||
T Consensus       140 ~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            36899999999999999999999999   999999999999999999999999999876544433344445778899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      |.+.+..++.++|||||||++|+|+++..|+.......     ..         ..+.+....+...+...+..+.+|+.
T Consensus       217 E~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-----~~---------~~~~i~~~~~~~~~~~~~~~l~~Li~  282 (311)
T d1t46a_         217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SK---------FYKMIKEGFRMLSPEHAPAEMYDIMK  282 (311)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----HH---------HHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             HHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-----HH---------HHHHHhcCCCCCCcccccHHHHHHHH
Confidence            99999999999999999999999999555532211111     00         11122222222333344567999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhc
Q 026939          164 LCVQADSADRPTMSSVVVMLAS  185 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~  185 (230)
                      +||+.||.+|||+.+|++.|++
T Consensus       283 ~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         283 TCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHHHHH
Confidence            9999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-33  Score=229.21  Aligned_cols=161  Identities=20%  Similarity=0.201  Sum_probs=114.3

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC---CCCCeEEcccccceeecCCCCCcccccccccc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD---HEMNPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      ++..+++.++..++.||+.||+|||++|   |+||||||+||++.   .++.+||+|||++........   .....|++
T Consensus       100 ~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~  173 (307)
T d1a06a_         100 EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTP  173 (307)
T ss_dssp             TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------C
T ss_pred             cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCc
Confidence            3467999999999999999999999999   99999999999995   468899999999976543222   12246799


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      .|+|||++.+..++.++|||||||++|+|++|..||.......      .. ........      ..........+..+
T Consensus       174 ~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~-~~i~~~~~------~~~~~~~~~~s~~~  240 (307)
T d1a06a_         174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LF-EQILKAEY------EFDSPYWDDISDSA  240 (307)
T ss_dssp             TTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH-HHHHTTCC------CCCTTTTTTSCHHH
T ss_pred             cccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HH-HHHhccCC------CCCCccccCCCHHH
Confidence            9999999999999999999999999999999999986432111      10 11111110      00111122334568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.||++|||+.++++
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHhc
Confidence            89999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=223.74  Aligned_cols=158  Identities=27%  Similarity=0.304  Sum_probs=121.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++..+++++.||+.||.|||+.+   ++||||+|+||+++.++.++++|||++.......     ....++..|+|||
T Consensus        99 ~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE  170 (262)
T d1byga_          99 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPE  170 (262)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChH
Confidence            5899999999999999999999999   9999999999999999999999999987643221     1224577899999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHh-cCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIIS-GKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++|||||||++|||++ |..||.......                ....+....+...+...+..+.+++.
T Consensus       171 ~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----------------HHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             HHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            9999999999999999999999998 566664322111                11111122223334445567899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcC
Q 026939          164 LCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +||+.||++|||+.+|++.|+..
T Consensus       235 ~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcccCHhHCcCHHHHHHHHHHH
Confidence            99999999999999999999764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-33  Score=229.98  Aligned_cols=158  Identities=21%  Similarity=0.213  Sum_probs=125.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++.......     ....|++.|+|
T Consensus       135 ~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~A  206 (350)
T d1rdqe_         135 IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALA  206 (350)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----ccccCccccCC
Confidence            457999999999999999999999999   9999999999999999999999999998764322     12467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|||||||++|+|++|..||......      ...... ..+.          ...+...+..+.+++
T Consensus       207 PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i-~~~~----------~~~p~~~s~~~~~li  269 (350)
T d1rdqe_         207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKI-VSGK----------VRFPSHFSSDLKDLL  269 (350)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HHCC----------CCCCTTCCHHHHHHH
T ss_pred             HHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHH-hcCC----------CCCCccCCHHHHHHH
Confidence            99999999999999999999999999999998643211      111111 1110          111223445688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH--Hhhc
Q 026939          163 LLCVQADSADRP-----TMSSVVV--MLAS  185 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~--~L~~  185 (230)
                      .+||+.||.+|+     |+++|++  ++++
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccC
Confidence            999999999994     8999986  4444

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-33  Score=227.84  Aligned_cols=168  Identities=24%  Similarity=0.299  Sum_probs=128.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   80 (230)
                      ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.........  .......++..|
T Consensus       124 ~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y  200 (311)
T d1r0pa_         124 THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW  200 (311)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGG
T ss_pred             cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccc
Confidence            446788999999999999999999999   999999999999999999999999999865432221  122223567899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||.+.+..++.++||||||+++|||++|..||.......     +.... ...+.         +...+...+..+.+
T Consensus       201 ~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~-i~~g~---------~~~~p~~~~~~l~~  265 (311)
T d1r0pa_         201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVY-LLQGR---------RLLQPEYCPDPLYE  265 (311)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHH-HHTTC---------CCCCCTTCCHHHHH
T ss_pred             cChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHH-HHcCC---------CCCCcccCcHHHHH
Confidence            99999999999999999999999999999888865322111     01111 11111         11122334456899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      |+.+||+.||++|||+.+|++.|++...
T Consensus       266 li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         266 VMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999999987644

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.1e-33  Score=230.39  Aligned_cols=160  Identities=21%  Similarity=0.229  Sum_probs=123.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC--CCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      ..++++..++.++.||+.||+|||++|   |+||||||+|||++  .++.+||+|||++........   .....+++.|
T Consensus       118 ~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y  191 (350)
T d1koaa2         118 HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEF  191 (350)
T ss_dssp             TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccc
Confidence            347999999999999999999999999   99999999999996  467899999999987643322   2224678999


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..++.++|||||||++|+|++|..||.......      .... ......      ..........+..+.+
T Consensus       192 ~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~-i~~~~~------~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRN-VKSCDW------NMDDSAFSGISEDGKD  258 (350)
T ss_dssp             CCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHTCC------CSCCGGGGGCCHHHHH
T ss_pred             cCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHH-HHhCCC------CCCcccccCCCHHHHH
Confidence            99999999999999999999999999999999986432111      1111 111100      0011112223456889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||+.||++|||++++++
T Consensus       259 li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-33  Score=228.78  Aligned_cols=171  Identities=21%  Similarity=0.235  Sum_probs=125.1

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......   .......|++.|+
T Consensus       109 ~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~  182 (305)
T d1blxa_         109 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR  182 (305)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhc
Confidence            3467899999999999999999999999   999999999999999999999999998654322   2223347789999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh-------------hhhhhchhhcc
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE-------------ALELMEPVLKQ  148 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~  148 (230)
                      |||++.+..|+.++||||+||++|+|++|..||....+.......   ........             ...........
T Consensus       183 APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (305)
T d1blxa_         183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE  259 (305)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGG
T ss_pred             CcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCchhcccccccchhhhhccccccchh
Confidence            999999999999999999999999999999999643322110000   00000000             00000000001


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+.......+.+|+.+||+.||++|||+.++++
T Consensus       260 ~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         260 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            122233456888999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-33  Score=227.12  Aligned_cols=165  Identities=24%  Similarity=0.338  Sum_probs=128.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .+++.++++++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++................+++.|+|||
T Consensus       129 ~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe  205 (308)
T d1p4oa_         129 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  205 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence            5788999999999999999999999   9999999999999999999999999997654333333333346788999999


Q ss_pred             hhhcCCCCccccchhhHHHHHHHHhcC-CCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHHh
Q 026939           85 YAMEGLFSVKSDVFSFGVLLLEIISGK-KNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL  163 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~ll~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  163 (230)
                      .+.+..++.++||||||+++|||++|. .||......      +.. ....++         .....+...+..+.++|.
T Consensus       206 ~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~~-~~i~~~---------~~~~~p~~~~~~l~~li~  269 (308)
T d1p4oa_         206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVL-RFVMEG---------GLLDKPDNCPDMLFELMR  269 (308)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHH-HHHHTT---------CCCCCCTTCCHHHHHHHH
T ss_pred             HHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHhC---------CCCCCcccchHHHHHHHH
Confidence            999999999999999999999999985 555432111      110 111111         112223334456999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHhhcCCC
Q 026939          164 LCVQADSADRPTMSSVVVMLASDNV  188 (230)
Q Consensus       164 ~cl~~dP~~RPs~~~i~~~L~~~~~  188 (230)
                      +||+.||++|||+.+|++.|++...
T Consensus       270 ~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         270 MCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHcCCChhHCcCHHHHHHHHHHhcC
Confidence            9999999999999999999987643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=228.38  Aligned_cols=182  Identities=22%  Similarity=0.221  Sum_probs=128.3

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHh--------CCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHE--------DSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--AST   71 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~--------~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   71 (230)
                      ++.++++.++++++.|++.||+|||+        ++   |+||||||+||+++.++.+||+|||++.........  ...
T Consensus        93 ~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~  169 (303)
T d1vjya_          93 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP  169 (303)
T ss_dssp             HHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC--
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCccccccCCCcceeccc
Confidence            34678999999999999999999997        46   999999999999999999999999999876443221  122


Q ss_pred             cccccccCccChhhhhcCC------CCccccchhhHHHHHHHHhcCCCCCCCccccccchh----hhhHHHHhhhhhhhh
Q 026939           72 NRIVGTYGYMAPEYAMEGL------FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLL----SYTWKLWCEGEALEL  141 (230)
Q Consensus        72 ~~~~~~~~~~aPe~~~~~~------~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  141 (230)
                      ....|++.|+|||++.+..      ++.++|||||||++|||++|..||+...........    ...............
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T d1vjya_         170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK  249 (303)
T ss_dssp             --CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC
T ss_pred             cceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc
Confidence            3356789999999987543      567899999999999999998887543222110000    000011111111111


Q ss_pred             hchhhcch-hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          142 MEPVLKQS-CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       142 ~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      ..+.+... ...+....+.+++.+||+.||++|||+.+|++.|++.
T Consensus       250 ~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11111111 1334566799999999999999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.7e-33  Score=227.57  Aligned_cols=177  Identities=21%  Similarity=0.227  Sum_probs=125.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..+..+++||+.||+|||++|   |+||||||+||+++.++.+||+|||++.........  .....+++.|+|
T Consensus        94 ~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~a  168 (299)
T d1ua2a_          94 SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRA  168 (299)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhcc
Confidence            567899999999999999999999999   999999999999999999999999999765432221  222467889999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhh-----------hhhhchhhc---
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEA-----------LELMEPVLK---  147 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~---  147 (230)
                      ||++... .++.++|||||||++|+|++|..||....+......+   .........           .........   
T Consensus       169 PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (299)
T d1ua2a_         169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL  245 (299)
T ss_dssp             HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred             HHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhccchhccchhhhhccCCCCCh
Confidence            9998754 5799999999999999999999998643322111000   000000000           000000000   


Q ss_pred             chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCC
Q 026939          148 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDN  187 (230)
Q Consensus       148 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~  187 (230)
                      .......+..+.+|+.+||+.||++|||++++++  ++++..
T Consensus       246 ~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            0011123456899999999999999999999986  565443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.98  E-value=3.1e-33  Score=230.50  Aligned_cols=167  Identities=19%  Similarity=0.203  Sum_probs=127.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeC--CCCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLD--HEMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      +.+|++.+++.++.||+.||+|||++|   |+||||||+|||++  .++.+||+|||++........   .....+++.|
T Consensus       121 ~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y  194 (352)
T d1koba_         121 DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEF  194 (352)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccc
Confidence            347999999999999999999999999   99999999999997  568899999999987654322   2224668899


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..++.++|||||||++|+|++|..||........      .... .....      ..........+..+.+
T Consensus       195 ~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i-~~~~~------~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNV-KRCDW------EFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHH-HHCCC------CCCSSTTTTSCHHHHH
T ss_pred             cCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-HhCCC------CCCcccccCCCHHHHH
Confidence            999999999999999999999999999999999864322111      0010 01000      0111112233456889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH--HhhcCCC
Q 026939          161 IGLLCVQADSADRPTMSSVVV--MLASDNV  188 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~--~L~~~~~  188 (230)
                      |+.+||+.||.+|||+.++++  .+++...
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            999999999999999999987  4655433

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.5e-33  Score=229.72  Aligned_cols=157  Identities=25%  Similarity=0.282  Sum_probs=123.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++.+++.++.||+.||+|||+++   ++||||||+|||++.++.+||+|||++........  ......|++.|+|
T Consensus        97 ~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~a  171 (320)
T d1xjda_          97 CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIA  171 (320)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCC
Confidence            357899999999999999999999999   99999999999999999999999999976543222  2223467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|||||||++|+|++|..||.......      ..... ..+          ...++...+..+.+|+
T Consensus       172 PE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i-~~~----------~~~~p~~~s~~~~dli  234 (320)
T d1xjda_         172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSI-RMD----------NPFYPRWLEKEAKDLL  234 (320)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHC----------CCCCCTTSCHHHHHHH
T ss_pred             HHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHH-HcC----------CCCCCccCCHHHHHHH
Confidence            999999999999999999999999999999996432211      11111 011          0112223345689999


Q ss_pred             hhhcCCCCCCCCCHH-HHHH
Q 026939          163 LLCVQADSADRPTMS-SVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs~~-~i~~  181 (230)
                      .+||+.||++|||+. +|++
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGG
T ss_pred             HHhcccCCCCCcCHHHHHHh
Confidence            999999999999996 6754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.9e-33  Score=227.12  Aligned_cols=163  Identities=24%  Similarity=0.265  Sum_probs=126.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...|++.++++++.||+.||.|||+++   ++||||+|+|||++.++.+||+|||++........   .....++..|+|
T Consensus       121 ~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~a  194 (309)
T d1fvra_         121 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMA  194 (309)
T ss_dssp             SCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccc
Confidence            467999999999999999999999999   99999999999999999999999999875432211   122356789999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCC-CCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKK-NSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||.+.+..++.++|||||||++|+|++|.. ||.......                +...+....+...+...+..+.+|
T Consensus       195 PE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~l  258 (309)
T d1fvra_         195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------------LYEKLPQGYRLEKPLNCDDEVYDL  258 (309)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHGGGTCCCCCCTTBCHHHHHH
T ss_pred             hHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHhcCCCCCCccCCHHHHHH
Confidence            999999999999999999999999999765 553221110                111111112222333445679999


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          162 GLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                      +.+||+.||++|||+.+|++.|+...
T Consensus       259 i~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         259 MRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            99999999999999999999887653

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=2.5e-32  Score=220.53  Aligned_cols=172  Identities=18%  Similarity=0.195  Sum_probs=126.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCC-----cccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSE-----ASTNRI   74 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~-----~~~~~~   74 (230)
                      ...+++..++.++.|++.||+|||++|   |+||||||+||+++.   +..++++|||++.........     ......
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~  173 (299)
T d1ckia_          97 SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL  173 (299)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSC
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCc
Confidence            467999999999999999999999999   999999999999864   456999999999876533221     122234


Q ss_pred             ccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHH
Q 026939           75 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE  154 (230)
Q Consensus        75 ~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (230)
                      .|++.|+|||.+.+..++.++|||||||++|+|++|..||...................     .....+..    ....
T Consensus       174 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~----~~~~  244 (299)
T d1ckia_         174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEVL----CKGY  244 (299)
T ss_dssp             CCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-----HHSCHHHH----TTTS
T ss_pred             CCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-----CCCChhHh----ccCC
Confidence            68899999999999999999999999999999999999996544332222111110000     00001111    1123


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcC
Q 026939          155 LLKFIHIGLLCVQADSADRPTMSSVVVMLASD  186 (230)
Q Consensus       155 ~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~  186 (230)
                      +..+.+++..||+.||++||++.+|.+.|+..
T Consensus       245 p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            34589999999999999999999998887654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.6e-33  Score=226.84  Aligned_cols=157  Identities=21%  Similarity=0.220  Sum_probs=123.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||++|   |+||||||+||+++.+|.+||+|||++........  ......|++.|+|
T Consensus        99 ~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~a  173 (337)
T d1o6la_          99 ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA  173 (337)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCC
T ss_pred             ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhh
Confidence            457899999999999999999999999   99999999999999999999999999976533222  2223568999999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..|+.++|+|||||++|+|++|..||.......      .. .....+.          ..++...+..+.+++
T Consensus       174 PE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~-~~i~~~~----------~~~p~~~s~~~~dli  236 (337)
T d1o6la_         174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LF-ELILMEE----------IRFPRTLSPEAKSLL  236 (337)
T ss_dssp             GGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCC----------CCCCTTSCHHHHHHH
T ss_pred             hhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HH-HHHhcCC----------CCCCccCCHHHHHHH
Confidence            999999999999999999999999999999986432211      00 1111111          112333445688999


Q ss_pred             hhhcCCCCCCCCC-----HHHHHH
Q 026939          163 LLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      .+||+.||.+|++     +++|++
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhhccCCchhhcccccccHHHHHc
Confidence            9999999999995     788876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-32  Score=222.28  Aligned_cols=160  Identities=21%  Similarity=0.198  Sum_probs=123.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC----CeEEcccccceeecCCCCCcccccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM----NPKISDFEMARIFGGNQSEASTNRIVGTY   78 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   78 (230)
                      +.++++..++.++.||+.||+|||+.+   |+||||||+||+++.++    .+|++|||++.........   ....+++
T Consensus       107 ~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~  180 (293)
T d1jksa_         107 KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTP  180 (293)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBC---SCCCCCG
T ss_pred             ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCccc---cccCCCC
Confidence            357999999999999999999999999   99999999999998776    4899999999876433221   2235688


Q ss_pred             CccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHH
Q 026939           79 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF  158 (230)
Q Consensus        79 ~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  158 (230)
                      .|+|||++.+..++.++||||+||++|+|++|..||.......      .... .....      .......+...+..+
T Consensus       181 ~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~-i~~~~------~~~~~~~~~~~s~~~  247 (293)
T d1jksa_         181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN-VSAVN------YEFEDEYFSNTSALA  247 (293)
T ss_dssp             GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHTTC------CCCCHHHHTTSCHHH
T ss_pred             cccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHH-HHhcC------CCCCchhcCCCCHHH
Confidence            9999999999899999999999999999999999986432111      0000 00100      001111222344568


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 026939          159 IHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       159 ~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+++.+||+.||++|||++++++
T Consensus       248 ~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         248 KDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            89999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.8e-33  Score=226.50  Aligned_cols=163  Identities=18%  Similarity=0.177  Sum_probs=122.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC---CCCeEEcccccceeecCCCCCccccccccccCc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH---EMNPKISDFEMARIFGGNQSEASTNRIVGTYGY   80 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   80 (230)
                      +++++.+++.++.||+.||+|||+.|   |+||||||+||+++.   ++.+||+|||++.........   ....|++.|
T Consensus       106 ~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~---~~~~gt~~y  179 (335)
T d2ozaa1         106 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYY  179 (335)
T ss_dssp             CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC---CCCSCCCSS
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCCcc---ccccCCccc
Confidence            47999999999999999999999999   999999999999985   456999999999876543322   224679999


Q ss_pred             cChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           81 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        81 ~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      +|||++.+..|+.++|||||||++|+|++|..||............   .......      ............+..+.+
T Consensus       180 ~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~------~~~~~~~~~~~~s~~~~~  250 (335)
T d2ozaa1         180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMG------QYEFPNPEWSEVSEEVKM  250 (335)
T ss_dssp             CCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC------SSSCCTTHHHHSCHHHHH
T ss_pred             CCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcC------CCCCCCcccccCCHHHHH
Confidence            9999999889999999999999999999999998533211110000   0000000      000011112344566899


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      |+.+||+.||++|||+.++++
T Consensus       251 li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         251 LIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHc
Confidence            999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=1.6e-32  Score=227.31  Aligned_cols=158  Identities=23%  Similarity=0.256  Sum_probs=122.0

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..++.++.||+.||+|||++|   ++||||||+|||++.+|.+||+|||++........    ....|++.|+|
T Consensus       101 ~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~----~~~~GT~~y~A  173 (364)
T d1omwa3         101 HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMA  173 (364)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC----CSCCSCGGGCC
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCcc----cccccccccch
Confidence            457889999999999999999999999   99999999999999999999999999987643322    22467899999


Q ss_pred             hhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           83 PEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        83 Pe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      ||++.. ..++.++|||||||++|+|++|..||.........   ... ...        ..  .....+...+..+.++
T Consensus       174 PE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~-~~~--------~~--~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EID-RMT--------LT--MAVELPDSFSPELRSL  239 (364)
T ss_dssp             HHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHH-HHS--------SS--CCCCCCSSSCHHHHHH
T ss_pred             hHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHH-Hhc--------cc--CCCCCCCCCCHHHHHH
Confidence            999975 46899999999999999999999999643322110   000 000        00  0011122334558999


Q ss_pred             HhhhcCCCCCCCCC-----HHHHHH
Q 026939          162 GLLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      +.+||+.||++|||     +++|++
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHc
Confidence            99999999999999     688875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=3.6e-32  Score=217.39  Aligned_cols=167  Identities=23%  Similarity=0.332  Sum_probs=121.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC-CccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS-EASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~   81 (230)
                      ..++++.+++.++.||+.||+|||++|   |+||||||+||+++.++..+++|||.+........ ........|++.|+
T Consensus       105 ~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~  181 (277)
T d1o6ya_         105 EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL  181 (277)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCccccc
Confidence            457999999999999999999999999   99999999999999999999999998875433221 12222346789999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||++.+..++.++|||||||++|+|++|..||......      +...........       .........+..+.++
T Consensus       182 aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~-------~~~~~~~~~s~~l~~l  248 (277)
T d1o6ya_         182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI-------PPSARHEGLSADLDAV  248 (277)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC-------CGGGTSSSCCHHHHHH
T ss_pred             CHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC-------CCchhccCCCHHHHHH
Confidence            999999989999999999999999999999998643211      111111111100       0001112234568899


Q ss_pred             HhhhcCCCCCCCC-CHHHHHHHhhc
Q 026939          162 GLLCVQADSADRP-TMSSVVVMLAS  185 (230)
Q Consensus       162 ~~~cl~~dP~~RP-s~~~i~~~L~~  185 (230)
                      +.+||+.||++|| |+++++..|..
T Consensus       249 i~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         249 VLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999 89999888754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-32  Score=219.15  Aligned_cols=149  Identities=21%  Similarity=0.316  Sum_probs=118.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC-CCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE-MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +..+++.+++.++.||+.||+|||+++   |+||||||+||+++.+ +.+||+|||++.......    .....|++.|+
T Consensus       104 ~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~  176 (273)
T d1xwsa_         104 RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYS  176 (273)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcC
Confidence            457999999999999999999999999   9999999999999854 789999999997654322    12246789999


Q ss_pred             ChhhhhcCCC-CccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           82 APEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        82 aPe~~~~~~~-~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      |||++.+..+ +.++|||||||++|+|++|..||.....             .....      ......    .+..+.+
T Consensus       177 aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~------~~~~~~----~s~~~~~  233 (273)
T d1xwsa_         177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ------VFFRQR----VSSECQH  233 (273)
T ss_dssp             CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC------CCCSSC----CCHHHHH
T ss_pred             CHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhcc------cCCCCC----CCHHHHH
Confidence            9999988775 5678999999999999999999853210             00000      011112    2345889


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 026939          161 IGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ++.+||+.||++|||++++++
T Consensus       234 li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=2.9e-32  Score=221.73  Aligned_cols=154  Identities=25%  Similarity=0.232  Sum_probs=123.1

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +..+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++........     ...|++.|+|
T Consensus        98 ~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~-----~~~Gt~~Y~A  169 (316)
T d1fota_          98 SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIA  169 (316)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC-----CCCSCTTTCC
T ss_pred             cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccc-----cccCcccccC
Confidence            457889999999999999999999999   99999999999999999999999999987643222     2467899999


Q ss_pred             hhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHHH
Q 026939           83 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG  162 (230)
Q Consensus        83 Pe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  162 (230)
                      ||++.+..++.++|||||||++|+|++|..||.......      .... ..++.          ..++...+..+.+++
T Consensus       170 PE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~-i~~~~----------~~~p~~~s~~~~~li  232 (316)
T d1fota_         170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEK-ILNAE----------LRFPPFFNEDVKDLL  232 (316)
T ss_dssp             HHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHHCC----------CCCCTTSCHHHHHHH
T ss_pred             HHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHH-HHcCC----------CCCCCCCCHHHHHHH
Confidence            999999999999999999999999999999986432111      1111 11111          112223345688999


Q ss_pred             hhhcCCCCCCCC-----CHHHHHH
Q 026939          163 LLCVQADSADRP-----TMSSVVV  181 (230)
Q Consensus       163 ~~cl~~dP~~RP-----s~~~i~~  181 (230)
                      .+||+.||.+|+     |+++|++
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhhhCHHhccccchhhHHHHHc
Confidence            999999999996     8999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-32  Score=219.78  Aligned_cols=182  Identities=19%  Similarity=0.200  Sum_probs=127.5

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||++|   |+||||||+||+++.++.+||+|||++........  ......+++.|+|
T Consensus        96 ~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~a  170 (298)
T d1gz8a_          96 LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRA  170 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeee
Confidence            457999999999999999999999999   99999999999999999999999999976543322  2222467899999


Q ss_pred             hhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhh-hhhhhhhchhhcc---h
Q 026939           83 PEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCE-GEALELMEPVLKQ---S  149 (230)
Q Consensus        83 Pe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~---~  149 (230)
                      ||.+.... ++.++|+||+||++|+|++|..||.............        ..+..... .............   .
T Consensus       171 pE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T d1gz8a_         171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK  250 (298)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHH
T ss_pred             hhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhh
Confidence            99987765 4789999999999999999999986432211100000        00000000 0000000000000   0


Q ss_pred             hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCCC
Q 026939          150 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNVT  189 (230)
Q Consensus       150 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~~  189 (230)
                      .....+..+.+++.+||+.||++|||++++++  ++++...+
T Consensus       251 ~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         251 VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            11123456889999999999999999999998  46555443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=1.6e-31  Score=215.35  Aligned_cols=173  Identities=13%  Similarity=0.109  Sum_probs=128.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCC-----CCCeEEcccccceeecCCCCC-----cccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDH-----EMNPKISDFEMARIFGGNQSE-----ASTN   72 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~~~-----~~~~   72 (230)
                      +..++..+++.++.|++.||+|||++|   |+||||||+||+++.     ++.++|+|||++.........     ....
T Consensus        95 ~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~  171 (293)
T d1csna_          95 GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK  171 (293)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccC
Confidence            457999999999999999999999999   999999999999974     567999999999876432211     1122


Q ss_pred             ccccccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhH
Q 026939           73 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA  152 (230)
Q Consensus        73 ~~~~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (230)
                      ...|++.|+|||.+.+..++.++|||||||++|+|++|..||.......................     .+.+...   
T Consensus       172 ~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~-----~~~l~~~---  243 (293)
T d1csna_         172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-----LRELCAG---  243 (293)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-----HHHHTTT---
T ss_pred             ceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-----hHHhcCC---
Confidence            34689999999999999999999999999999999999999964433322211111111100000     0111112   


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHhhcCC
Q 026939          153 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASDN  187 (230)
Q Consensus       153 ~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~L~~~~  187 (230)
                       .++.+.+++..|+..+|++||+++.+.+.|++..
T Consensus       244 -~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         244 -FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             -SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence             2345889999999999999999999988876643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=7.2e-32  Score=215.53  Aligned_cols=160  Identities=23%  Similarity=0.294  Sum_probs=122.9

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.++++.+++.++.||+.||+|||++|   |+||||+|+||+++.++.+||+|||++.........   ....|+..|.+
T Consensus       104 ~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~  177 (277)
T d1phka_         104 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLA  177 (277)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCCce---eeeeccCCCCC
Confidence            357999999999999999999999999   999999999999999999999999999876543221   22467889999


Q ss_pred             hhhhhc------CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHH
Q 026939           83 PEYAME------GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL  156 (230)
Q Consensus        83 Pe~~~~------~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (230)
                      ||.+.+      ..++.++||||+||++|+|++|..||.......       .......+...      .........+.
T Consensus       178 PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~~~~~~------~~~~~~~~~s~  244 (277)
T d1phka_         178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMSGNYQ------FGSPEWDDYSD  244 (277)
T ss_dssp             HHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC------CCTTTGGGSCH
T ss_pred             HHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHHhCCCC------CCCcccccCCH
Confidence            999874      346889999999999999999999996432211       11111111110      01111223445


Q ss_pred             HHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          157 KFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       157 ~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .+.+++.+||+.||++|||+++|++
T Consensus       245 ~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         245 TVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHc
Confidence            6889999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=220.65  Aligned_cols=173  Identities=18%  Similarity=0.145  Sum_probs=122.3

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ...+++.++..++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||++..........   ...++..|+
T Consensus       116 ~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~  189 (350)
T d1q5ka_         116 KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYR  189 (350)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCC---SCCSCTTSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcccc---ccccccccc
Confidence            457999999999999999999999999   99999999999999875 79999999998764332222   236788999


Q ss_pred             Chhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh--------hhHHHHhhh----hhhhhhchhhcc
Q 026939           82 APEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS--------YTWKLWCEG----EALELMEPVLKQ  148 (230)
Q Consensus        82 aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~----~~~~~~~~~~~~  148 (230)
                      |||.+.+ ..++.++||||+||++|+|++|..||.............        ..+......    ............
T Consensus       190 aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (350)
T d1q5ka_         190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK  269 (350)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGG
T ss_pred             ChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhh
Confidence            9998875 468999999999999999999999986433221100000        000000000    000000000000


Q ss_pred             hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          149 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       149 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ......+..+.+|+.+||+.||++|||+.++++
T Consensus       270 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         270 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111223446889999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=8.2e-32  Score=216.21  Aligned_cols=172  Identities=23%  Similarity=0.293  Sum_probs=121.4

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++..+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+|++|||.+.........  .....+++.|.
T Consensus        93 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~y~  167 (286)
T d1ob3a_          93 CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR  167 (286)
T ss_dssp             STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTC
T ss_pred             hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccc--cceecccchhh
Confidence            3568999999999999999999999999   999999999999999999999999999775433221  12235678999


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh------hhhh---------hhchh
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG------EALE---------LMEPV  145 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~---------~~~~~  145 (230)
                      +||.+.+. .++.++|+|||||++|+|++|..||............   .......      ....         ...+.
T Consensus       168 ~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (286)
T d1ob3a_         168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKNWPNVTELPKYDPNFTVYEPL  244 (286)
T ss_dssp             CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC
T ss_pred             hHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCChhhccchhhhhhcccccccccCc
Confidence            99998765 4689999999999999999999998643221110000   0000000      0000         00000


Q ss_pred             hcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      .........+..+.+++.+||+.||++|||++++++
T Consensus       245 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            011122233456889999999999999999999984

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=215.65  Aligned_cols=176  Identities=20%  Similarity=0.238  Sum_probs=121.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCC--ccccccccccCc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSE--ASTNRIVGTYGY   80 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   80 (230)
                      ...++...++.++.||+.||.|||++|   |+||||||+||+++.++.++++|||++.........  .......+++.|
T Consensus       111 ~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y  187 (318)
T d3blha1         111 LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY  187 (318)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGG
T ss_pred             ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHH
Confidence            457889999999999999999999999   999999999999999999999999999765432211  112223578899


Q ss_pred             cChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhh--------hhhhhh------chh
Q 026939           81 MAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEG--------EALELM------EPV  145 (230)
Q Consensus        81 ~aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~------~~~  145 (230)
                      +|||++.+. .++.++||||+||++|+|++|..||....+.................        ......      ...
T Consensus       188 ~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T d3blha1         188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK  267 (318)
T ss_dssp             CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBC
T ss_pred             hhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccccccc
Confidence            999999865 68899999999999999999999985432221111100000000000        000000      000


Q ss_pred             hcchh-hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          146 LKQSC-VAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       146 ~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....+ .......+.+|+.+||+.||++|||++++++
T Consensus       268 ~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             chhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00000 1122445778999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-31  Score=219.35  Aligned_cols=183  Identities=21%  Similarity=0.209  Sum_probs=125.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCC-CccccccccccCcc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQS-EASTNRIVGTYGYM   81 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~   81 (230)
                      ...+++..++.++.||+.||+|||++|   |+||||||+||+++.++.+||+|||++........ ........+++.|+
T Consensus       103 ~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~  179 (345)
T d1pmea_         103 TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR  179 (345)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceec
Confidence            457999999999999999999999999   99999999999999999999999999976533221 11222346788999


Q ss_pred             Chhhhhc-CCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhH-----HHHhhh---hhhhh---hchhhc--
Q 026939           82 APEYAME-GLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTW-----KLWCEG---EALEL---MEPVLK--  147 (230)
Q Consensus        82 aPe~~~~-~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~---~~~~~~--  147 (230)
                      |||++.. ..++.++||||+||++++|++|..||................     ......   .....   ......  
T Consensus       180 aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (345)
T d1pmea_         180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP  259 (345)
T ss_dssp             CGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred             hHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCC
Confidence            9999854 467899999999999999999999986433211100000000     000000   00000   000000  


Q ss_pred             -chhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--hhcCCC
Q 026939          148 -QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM--LASDNV  188 (230)
Q Consensus       148 -~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~~--L~~~~~  188 (230)
                       ..........+.+++.+||+.||.+|||+.++++.  |+....
T Consensus       260 ~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         260 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence             00111223468899999999999999999999873  544433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.1e-31  Score=216.99  Aligned_cols=180  Identities=22%  Similarity=0.235  Sum_probs=126.9

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      ++.++++..++.++.||+.||+|||++|   |+||||||+|||++.++.++++|||++........     ...+++.|+
T Consensus       114 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~  185 (346)
T d1cm8a_         114 KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWYR  185 (346)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC-----SSCSCGGGC
T ss_pred             HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCccc-----ccccccccc
Confidence            3468999999999999999999999999   99999999999999999999999999987643322     235688999


Q ss_pred             ChhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHh--hhh----hhhhhchhh---
Q 026939           82 APEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWC--EGE----ALELMEPVL---  146 (230)
Q Consensus        82 aPe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~--~~~----~~~~~~~~~---  146 (230)
                      |||.+.+. .++.++||||+||++|+|++|..||...............     ...+.  ...    .........   
T Consensus       186 aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (346)
T d1cm8a_         186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD  265 (346)
T ss_dssp             CTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC
T ss_pred             CHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccc
Confidence            99998865 5689999999999999999999998644322110000000     00000  000    000000000   


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCCC
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNVT  189 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~~  189 (230)
                      ...........+.+|+.+||..||++|||+.++++  .+++....
T Consensus       266 ~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         266 FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence            00111223445789999999999999999999997  46665443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-31  Score=216.78  Aligned_cols=159  Identities=18%  Similarity=0.258  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCC--CCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHE--MNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      .++++.+++.++.||+.||+|||++|   |+||||||+||+++.+  ..++|+|||++........   .....+++.|+
T Consensus        97 ~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~  170 (321)
T d1tkia_          97 FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY  170 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCc---ccccccccccc
Confidence            37999999999999999999999999   9999999999999854  4799999999987543222   22245688999


Q ss_pred             ChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHHH
Q 026939           82 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI  161 (230)
Q Consensus        82 aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  161 (230)
                      |||...+..++.++|||||||++|+|++|..||.......      ..... .+...      ..........+..+.++
T Consensus       171 ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i-~~~~~------~~~~~~~~~~s~~~~~l  237 (321)
T d1tkia_         171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENI-MNAEY------TFDEEAFKEISIEAMDF  237 (321)
T ss_dssp             CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HHTCC------CCCHHHHTTSCHHHHHH
T ss_pred             cchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCCC------CCChhhccCCCHHHHHH
Confidence            9999999999999999999999999999999986432211      11111 01000      00001111234558899


Q ss_pred             HhhhcCCCCCCCCCHHHHHH
Q 026939          162 GLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       162 ~~~cl~~dP~~RPs~~~i~~  181 (230)
                      +.+||..||.+|||+.++++
T Consensus       238 i~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         238 VDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            99999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=3.6e-30  Score=210.38  Aligned_cols=172  Identities=20%  Similarity=0.199  Sum_probs=121.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCC-CeEEcccccceeecCCCCCccccccccccCccC
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEM-NPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      +.+++..+..++.||+.||+|||++|   |+||||||+|||++.++ .++|+|||++.........   ....++..|+|
T Consensus       124 ~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~---~~~~~t~~y~a  197 (328)
T d3bqca1         124 QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKG  197 (328)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC---CSCCSCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcc---cccccCccccC
Confidence            57899999999999999999999999   99999999999998655 5899999999876433221   22356889999


Q ss_pred             hhhhhcC-CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh---------HHHHhhhh----hhhhh------
Q 026939           83 PEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT---------WKLWCEGE----ALELM------  142 (230)
Q Consensus        83 Pe~~~~~-~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~----~~~~~------  142 (230)
                      ||.+.+. .++.++|+||+||++++|++|..||...............         +.......    .....      
T Consensus       198 PE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (328)
T d3bqca1         198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK  277 (328)
T ss_dssp             HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCC
T ss_pred             cccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhccccccc
Confidence            9998865 4789999999999999999999998654332211100000         00000000    00000      


Q ss_pred             --chhhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          143 --EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       143 --~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                        ...............+.+|+.+||+.||++|||++++++
T Consensus       278 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         278 RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000001111223456889999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4e-30  Score=211.68  Aligned_cols=179  Identities=24%  Similarity=0.270  Sum_probs=121.7

Q ss_pred             CcCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCcc
Q 026939            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYM   81 (230)
Q Consensus         2 ~~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (230)
                      +.+++++.++..++.||+.||+|||++|   |+||||||+||+++.++.++++|||++......     .....++..|+
T Consensus       114 ~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~  185 (348)
T d2gfsa1         114 KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR  185 (348)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTS
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc-----ccccccccccc
Confidence            4568999999999999999999999999   999999999999999999999999998654322     12235678899


Q ss_pred             ChhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhh-----HHHHhh---hhhhhh---hchhhcc-
Q 026939           82 APEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYT-----WKLWCE---GEALEL---MEPVLKQ-  148 (230)
Q Consensus        82 aPe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~---~~~~~~~-  148 (230)
                      |||...+.. ++.++|||||||++|+|++|..||...............     ......   ......   ....... 
T Consensus       186 apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (348)
T d2gfsa1         186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN  265 (348)
T ss_dssp             CHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCC
T ss_pred             CchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcc
Confidence            999877764 688999999999999999999998643322111100000     000000   000000   0000000 


Q ss_pred             --hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcCCC
Q 026939          149 --SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDNV  188 (230)
Q Consensus       149 --~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~~~  188 (230)
                        .........+.+|+.+||+.||.+|||+.++++  .+.+...
T Consensus       266 ~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         266 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence              001123445889999999999999999999997  5655433

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.2e-30  Score=207.39  Aligned_cols=162  Identities=21%  Similarity=0.229  Sum_probs=121.2

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++..+...... ......+++.|++
T Consensus       123 ~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~  198 (322)
T d1vzoa_         123 RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMA  198 (322)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCC
T ss_pred             cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccch
Confidence            356788999999999999999999999   999999999999999999999999999876432222 1223467889999


Q ss_pred             hhhhhcC--CCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhhhhhhhchhhcchhhHHHHHHHHH
Q 026939           83 PEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH  160 (230)
Q Consensus        83 Pe~~~~~--~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  160 (230)
                      ||.+.+.  .++.++|||||||++|+|++|..||...........+   ....    ..      ....++...+..+.+
T Consensus       199 pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~----~~------~~~~~~~~~s~~~~~  265 (322)
T d1vzoa_         199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRI----LK------SEPPYPQEMSALAKD  265 (322)
T ss_dssp             HHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHH----HH------CCCCCCTTSCHHHHH
T ss_pred             hHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhc----cc------CCCCCcccCCHHHHH
Confidence            9999765  4678999999999999999999998644322211110   0000    00      011223344567999


Q ss_pred             HHhhhcCCCCCCCCC-----HHHHHH
Q 026939          161 IGLLCVQADSADRPT-----MSSVVV  181 (230)
Q Consensus       161 l~~~cl~~dP~~RPs-----~~~i~~  181 (230)
                      ++.+||++||++|||     ++++++
T Consensus       266 li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         266 LIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHHcccCHHHcCCCCcccHHHHHc
Confidence            999999999999994     788875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.5e-30  Score=205.04  Aligned_cols=172  Identities=20%  Similarity=0.207  Sum_probs=121.6

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccC
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMA   82 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~a   82 (230)
                      .+.+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.+...........  ...++..|.|
T Consensus        95 ~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~--~~~~~~~~~~  169 (292)
T d1unla_          95 NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS--AEVVTLWYRP  169 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC--SCCSCGGGCC
T ss_pred             ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccce--eeccccchhh
Confidence            467899999999999999999999999   99999999999999999999999999987643322211  2345678999


Q ss_pred             hhhhhcCC-CCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHHHHhhhh------hhhhh---------chhh
Q 026939           83 PEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWKLWCEGE------ALELM---------EPVL  146 (230)
Q Consensus        83 Pe~~~~~~-~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---------~~~~  146 (230)
                      ||.+.... ++.++||||+||++|+|++|..||.........  ............      .....         ....
T Consensus       170 pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T d1unla_         170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS  247 (292)
T ss_dssp             HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred             hhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhhhcccccccccccccch
Confidence            99987665 689999999999999999999996322211110  000000000000      00000         0000


Q ss_pred             cchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          147 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       147 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ...........+.+|+.+||+.||.+|||++++++
T Consensus       248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01122233456889999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.9e-29  Score=207.11  Aligned_cols=172  Identities=23%  Similarity=0.213  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccCh
Q 026939            4 VQLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAP   83 (230)
Q Consensus         4 ~~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP   83 (230)
                      ..+++..++.++.||+.||.|||++|   |+||||||+||+++.++.++++|||++........   .....++..|+||
T Consensus       114 ~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aP  187 (355)
T d2b1pa1         114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAP  187 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccccc---cccccccccccCh
Confidence            46899999999999999999999999   99999999999999999999999998876543222   1223568899999


Q ss_pred             hhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhh---------------hhHHHHhhhh-------hhhh
Q 026939           84 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLS---------------YTWKLWCEGE-------ALEL  141 (230)
Q Consensus        84 e~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~---------------~~~~~~~~~~-------~~~~  141 (230)
                      |++.+..++.++||||+||++++|++|..||.............               ..........       ....
T Consensus       188 E~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (355)
T d2b1pa1         188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL  267 (355)
T ss_dssp             HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHH
T ss_pred             hhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccc
Confidence            99999999999999999999999999999985433211110000               0000000000       0000


Q ss_pred             hchh---hcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 026939          142 MEPV---LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV  181 (230)
Q Consensus       142 ~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~  181 (230)
                      ....   .........+..+.+|+.+||..||++|||++++++
T Consensus       268 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000   011223455677999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=2.5e-28  Score=201.64  Aligned_cols=194  Identities=20%  Similarity=0.213  Sum_probs=134.8

Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCeeecCCCCCceEeCCCCC------eEEcccccceeecCCCCCccccccc
Q 026939            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLRIIHRDLKASNVLLDHEMN------PKISDFEMARIFGGNQSEASTNRIV   75 (230)
Q Consensus         3 ~~~l~~~~~~~i~~qi~~al~~Lh~-~~~~~i~H~di~~~nil~~~~~~------~~l~d~~~~~~~~~~~~~~~~~~~~   75 (230)
                      ...+++..+..++.||+.||+|||+ .|   |+||||||+|||++.++.      ++++|||.+.......     ....
T Consensus       119 ~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~  190 (362)
T d1q8ya_         119 HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSI  190 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccccccccccc-----cccc
Confidence            4578899999999999999999998 88   999999999999976543      8999999987653222     2235


Q ss_pred             cccCccChhhhhcCCCCccccchhhHHHHHHHHhcCCCCCCCccccccchhhhhHH---H--------Hhhhh-------
Q 026939           76 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNSGFYLSELGQSLLSYTWK---L--------WCEGE-------  137 (230)
Q Consensus        76 ~~~~~~aPe~~~~~~~~~~~DiwslG~ll~~ll~g~~p~~~~~~~~~~~~~~~~~~---~--------~~~~~-------  137 (230)
                      +++.|+|||.+.+..++.++|+||+||++++|++|..||.................   .        .....       
T Consensus       191 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  270 (362)
T d1q8ya_         191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN  270 (362)
T ss_dssp             SCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBC
T ss_pred             ccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccc
Confidence            68899999999999999999999999999999999999853322111111100000   0        00000       


Q ss_pred             ---hhhhhch----------hhcchhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HhhcC--CCCCCCCCCCCCcc
Q 026939          138 ---ALELMEP----------VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASD--NVTLPQPTEPAFSV  200 (230)
Q Consensus       138 ---~~~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i~~--~L~~~--~~~~~~~~~p~~~~  200 (230)
                         ....+..          .............+.+|+.+||+.||.+|||++++++  ++++.  ......|.++...+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~~~  350 (362)
T d1q8ya_         271 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS  350 (362)
T ss_dssp             C--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTTCB
T ss_pred             cchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccCCC
Confidence               0000000          0011234567788999999999999999999999987  46543  33355677777777


Q ss_pred             CccC
Q 026939          201 GRNV  204 (230)
Q Consensus       201 ~~~~  204 (230)
                      |+..
T Consensus       351 ~~~~  354 (362)
T d1q8ya_         351 GSDI  354 (362)
T ss_dssp             STTS
T ss_pred             CCCC
Confidence            6654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.28  E-value=2.1e-13  Score=101.68  Aligned_cols=90  Identities=20%  Similarity=0.171  Sum_probs=61.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhHhCCCCCeeecCCCCCceEeCCCCCeEEcccccceeecCCCCCccccccccccCccChh
Q 026939            5 QLDWKRRISIINGIARGLLYLHEDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARIFGGNQSEASTNRIVGTYGYMAPE   84 (230)
Q Consensus         5 ~l~~~~~~~i~~qi~~al~~Lh~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPe   84 (230)
                      .++...+..++.|++.++++||+.|   ++||||||+|||++.+ .++|+|||++..............-..    ...+
T Consensus        99 ~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~----~~~~  170 (191)
T d1zara2          99 RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR----NIIT  170 (191)
T ss_dssp             GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH----HHHH
T ss_pred             chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHH----HHHH
Confidence            3555667889999999999999999   9999999999999865 589999999876542221100000000    0011


Q ss_pred             hhhcCCCCccccchhhHHH
Q 026939           85 YAMEGLFSVKSDVFSFGVL  103 (230)
Q Consensus        85 ~~~~~~~~~~~DiwslG~l  103 (230)
                      .+ ...|..++|+||+.--
T Consensus       171 ~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         171 YF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             HH-HHHHCCCCCHHHHHHH
T ss_pred             HH-cCCCCCcccHHHHHHH
Confidence            11 3457789999997543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.48  E-value=0.01  Score=45.59  Aligned_cols=30  Identities=30%  Similarity=0.324  Sum_probs=26.2

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.++|++++.+....++||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            499999999999999887778999987753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=92.62  E-value=0.025  Score=41.90  Aligned_cols=30  Identities=20%  Similarity=0.216  Sum_probs=24.9

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhccc
Confidence            389999999999998766667999987643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=91.61  E-value=0.031  Score=41.18  Aligned_cols=30  Identities=13%  Similarity=0.180  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      .++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            389999999999998776677999987643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=90.32  E-value=0.073  Score=42.19  Aligned_cols=30  Identities=27%  Similarity=0.367  Sum_probs=25.7

Q ss_pred             CeeecCCCCCceEeCCCCCeEEcccccceee
Q 026939           32 RIIHRDLKASNVLLDHEMNPKISDFEMARIF   62 (230)
Q Consensus        32 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   62 (230)
                      .++|+|+.+.|||++.+ .++++||..+...
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhcccC
Confidence            49999999999999876 4899999887654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=88.74  E-value=0.25  Score=37.81  Aligned_cols=49  Identities=22%  Similarity=0.277  Sum_probs=30.9

Q ss_pred             HHHHHHHHHHHHHHhH-hCCCCCeeecCCCCCceEeCCCCCeEEccccccee
Q 026939           11 RISIINGIARGLLYLH-EDSRLRIIHRDLKASNVLLDHEMNPKISDFEMARI   61 (230)
Q Consensus        11 ~~~i~~qi~~al~~Lh-~~~~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   61 (230)
                      ....+..++..+...- +.....++|+|+.+.||+++.+  ..++||+-+..
T Consensus       171 ~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         171 FLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            3344455555543322 2222348999999999999743  46899987754